Citrus Sinensis ID: 006347
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 649 | 2.2.26 [Sep-21-2011] | |||||||
| Q9SXB4 | 820 | G-type lectin S-receptor- | no | no | 0.978 | 0.774 | 0.525 | 0.0 | |
| Q9SXB8 | 842 | G-type lectin S-receptor- | no | no | 0.959 | 0.739 | 0.520 | 0.0 | |
| Q9SXB5 | 820 | G-type lectin S-receptor- | no | no | 0.973 | 0.770 | 0.509 | 0.0 | |
| Q9LPZ9 | 830 | G-type lectin S-receptor- | no | no | 0.973 | 0.761 | 0.494 | 1e-174 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.964 | 0.737 | 0.455 | 1e-161 | |
| Q9SY89 | 842 | Putative G-type lectin S- | no | no | 0.979 | 0.755 | 0.438 | 1e-159 | |
| O64784 | 821 | G-type lectin S-receptor- | no | no | 0.966 | 0.763 | 0.434 | 1e-155 | |
| O64783 | 814 | G-type lectin S-receptor- | no | no | 0.970 | 0.773 | 0.439 | 1e-155 | |
| O64782 | 805 | G-type lectin S-receptor- | no | no | 0.963 | 0.776 | 0.431 | 1e-155 | |
| Q9SY95 | 802 | G-type lectin S-receptor- | no | no | 0.964 | 0.780 | 0.430 | 1e-154 |
| >sp|Q9SXB4|Y1130_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300 OS=Arabidopsis thaliana GN=At1g11300 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 685 bits (1767), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/668 (52%), Positives = 466/668 (69%), Gaps = 33/668 (4%)
Query: 8 IILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMP 67
I++LSCF L ++A + + S +L D + I+S+ F+ GFF+P +S RY GIWY+
Sbjct: 13 ILVLSCFFLSVSLAQERAFFSGKL-NDSETIVSSFRTFRFGFFSPVNSTSRYAGIWYNSV 71
Query: 68 SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVN-NSTSAQLLD 126
S + VIWVAN+D P+ DSSG+I++S+DGNLV+ +GQ+ VLWS+NVS + NST A+LLD
Sbjct: 72 SVQTVIWVANKDKPINDSSGVISVSQDGNLVVTDGQRRVLWSTNVSTQASANSTVAELLD 131
Query: 127 SGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK-KVQLTSWKSLSDPSTGSFS 185
SGNLVL++ + A +WESF+ PTDS+LP M G + R G V +TSWKS SDPS GS++
Sbjct: 132 SGNLVLKEASSDAYLWESFKYPTDSWLPNMLVGTNARIGGGNVTITSWKSPSDPSPGSYT 191
Query: 186 AGLIHQNIPEIFVWNVS---RPYWRSGPWNGQIFIGIPELKS-VYLFRH--------NFT 233
A L+ PE+F+ N + WRSGPWNGQ+F G+P++ + V+L+R + T
Sbjct: 192 AALVLAAYPELFIMNNNNNNSTVWRSGPWNGQMFNGLPDVYAGVFLYRFIVNDDTNGSVT 251
Query: 234 FGFANDWT--FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
+AND T +F + +G + R W + + NW VG TECD Y +CG F CN ++
Sbjct: 252 MSYANDSTLRYFYMDYRGSVIRRDWSETRRNWTVGLQVPATECDNYRRCGEFATCNPRKN 311
Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
P+CSC+ GF P+N EWN GNW+ GC RR LQCER+N G DGF +L +MK+PDF
Sbjct: 312 PLCSCIRGFRPRNLIEWNNGNWSGGCTRRVPLQCERQNNNGSA---DGFLRLRRMKLPDF 368
Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
S A+E EC CL+ CSCIA A G GCM+W +L+D Q L G DLYIR+A+
Sbjct: 369 AR-RSEASEPECLRTCLQTCSCIAAAHGLGYGCMIWNG-SLVDSQELSASGLDLYIRLAH 426
Query: 412 SDVDEKGKKDVFVSPLIKG-MFALAICTLFLWRWIAKRK---------EVIAKLSA-TNV 460
S++ K K+ + + ++ G +F +A C L R + K++ ++ ++ A
Sbjct: 427 SEIKTKDKRPILIGTILAGGIFVVAACVLLARRIVMKKRAKKKGRDAEQIFERVEALAGG 486
Query: 461 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 520
N KL++LPLF+F+ LA ATNNF L +KLGQGGFGPVY G+L++GQEIAVKRLS+ASGQG
Sbjct: 487 NKGKLKELPLFEFQVLAAATNNFSLRNKLGQGGFGPVYKGKLQEGQEIAVKRLSRASGQG 546
Query: 521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
LEE +NEV+VISKLQHRNLV+LLGCC+ GEE+ML+YE+MP +SLD LFD + + LDW+
Sbjct: 547 LEELVNEVVVISKLQHRNLVKLLGCCIAGEERMLVYEFMPKKSLDYYLFDSRRAKLLDWK 606
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
RFNII GI RGLLYLHRDSRLRIIHRDLKASNILLDE L PKISDFG+A+IF GN+D+A
Sbjct: 607 TRFNIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNEDEA 666
Query: 641 DTGRVVGT 648
+T RVVGT
Sbjct: 667 NTRRVVGT 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q9SXB8|Y1133_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330 OS=Arabidopsis thaliana GN=At1g11330 PE=1 SV=3 | Back alignment and function description |
|---|
Score = 672 bits (1735), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/663 (52%), Positives = 458/663 (69%), Gaps = 40/663 (6%)
Query: 23 DSSITSSQLIRDPDA--ILSNGSNFKLGFFNPADSP--YRYMGIWYDMPSEKAVIWVANR 78
+ IT S I+D ++ +L F+ GFF P +S RY+GIWY+ + V+WVAN+
Sbjct: 30 EDRITFSSPIKDSESETLLCKSGIFRFGFFTPVNSTTRLRYVGIWYEKIPIQTVVWVANK 89
Query: 79 DNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVS-NLVNNSTSAQLLDSGNLVLRDNIN 137
D+P+ D+SG+I+I +DGNL + +G+ ++WS+NVS + N+T QL+DSGNL+L+DN N
Sbjct: 90 DSPINDTSGVISIYQDGNLAVTDGRNRLVWSTNVSVPVAPNATWVQLMDSGNLMLQDNRN 149
Query: 138 RA-IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEI 196
I+WESF+ P DSF+P M G D RTG ++LTSW S DPSTG+++AG+ PE+
Sbjct: 150 NGEILWESFKHPYDSFMPRMTLGTDGRTGGNLKLTSWTSHDDPSTGNYTAGIAPFTFPEL 209
Query: 197 FVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFAND--WTFFA 244
+W + P WRSGPWNGQ+FIG+P + S+ LF F + +AND F
Sbjct: 210 LIWKNNVPTWRSGPWNGQVFIGLPNMDSL-LFLDGFNLNSDNQGTISMSYANDSFMYHFN 268
Query: 245 LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKN 304
L +GI+ ++ W W +G T+CD YG+CG FG C++ E P C C++GF PKN
Sbjct: 269 LDPEGIIYQKDWSTSMRTWRIGVKFPYTDCDAYGRCGRFGSCHAGENPPCKCVKGFVPKN 328
Query: 305 AEEWNRGNWTSGCIRRSKLQCER-RNITGKVG--KEDGFSKLNKMKVPDFTEWTSPATED 361
EWN GNW++GC+R++ LQCER RN++ G K DGF KL KMKVP E S A+E
Sbjct: 329 NTEWNGGNWSNGCMRKAPLQCERQRNVSNGGGGGKADGFLKLQKMKVPISAE-RSEASEQ 387
Query: 362 ECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKD 421
C + CL NCSC AYA+D GIGCM+W S +L+D+Q G DL+IRVA+S++
Sbjct: 388 VCPKVCLDNCSCTAYAYDRGIGCMLW-SGDLVDMQSFLGSGIDLFIRVAHSELKTHSNLA 446
Query: 422 VFVS-PLIKGMFALAICTLFLWR---------------WIAKRKEVIAKLSATNVNTVKL 465
V ++ P+I M A+C L R + KR E + + + N +KL
Sbjct: 447 VMIAAPVIGVMLIAAVCVLLACRKYKKRPAPAKDRSAELMFKRMEALTSDNESASNQIKL 506
Query: 466 QDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFM 525
++LPLF+F+ LAT+T++F L +KLGQGGFGPVY G+L +GQEIAVKRLS+ SGQGLEE M
Sbjct: 507 KELPLFEFQVLATSTDSFSLRNKLGQGGFGPVYKGKLPEGQEIAVKRLSRKSGQGLEELM 566
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
NEV+VISKLQHRNLV+LLGCC+EGEE+ML+YEYMP +SLDA LFDP+K++ LDW+ RFNI
Sbjct: 567 NEVVVISKLQHRNLVKLLGCCIEGEERMLVYEYMPKKSLDAYLFDPMKQKILDWKTRFNI 626
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
+EGI RGLLYLHRDSRL+IIHRDLKASNILLDE LNPKISDFG+A+IF N+D+A+T RV
Sbjct: 627 MEGICRGLLYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFRANEDEANTRRV 686
Query: 646 VGT 648
VGT
Sbjct: 687 VGT 689
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SXB5|Y1135_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11305 OS=Arabidopsis thaliana GN=At1g11305 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/671 (50%), Positives = 455/671 (67%), Gaps = 39/671 (5%)
Query: 8 IILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMP 67
++ LSCF L ++A + ++ S L D + I+S+ F+ GFF+P +S RY GIWY+
Sbjct: 13 VLSLSCFFLSVSLAHERALFSGTL-NDSETIVSSFRTFRFGFFSPVNSTNRYAGIWYNSI 71
Query: 68 SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVN-NSTSAQLLD 126
+ VIWVAN+D P+ DSSG+I+ISEDGNLV+ +GQ+ VLWS+NVS + NST A+LL+
Sbjct: 72 PVQTVIWVANKDTPINDSSGVISISEDGNLVVTDGQRRVLWSTNVSTRASANSTVAELLE 131
Query: 127 SGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK-KVQLTSWKSLSDPSTGSFS 185
SGNLVL+D A +WESF+ PTDS+LP M G + RTG + +TSW + SDPS GS++
Sbjct: 132 SGNLVLKDANTDAYLWESFKYPTDSWLPNMLVGTNARTGGGNITITSWTNPSDPSPGSYT 191
Query: 186 AGLIHQNIPEIFVWNVS---RPYWRSGPWNGQIFIGIPEL-KSVYLFRHNF--------T 233
A L+ PE+F++N + WRSGPWNG +F G+P++ ++L+R T
Sbjct: 192 AALVLAPYPELFIFNNNDNNATVWRSGPWNGLMFNGLPDVYPGLFLYRFKVNDDTNGSAT 251
Query: 234 FGFANDWTF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
+AND T L +G R W + + NW +G TECD+Y +CG + CN ++
Sbjct: 252 MSYANDSTLRHLYLDYRGFAIRRDWSEARRNWTLGSQVPATECDIYSRCGQYTTCNPRKN 311
Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
P CSC++GF P+N EWN GNW+ GCIR+ LQCER+N G D F KL +MK+PDF
Sbjct: 312 PHCSCIKGFRPRNLIEWNNGNWSGGCIRKLPLQCERQN---NKGSADRFLKLQRMKMPDF 368
Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
S A+E EC CL++CSCIA+A G GCM+W +L+D Q L G DL IR+A+
Sbjct: 369 AR-RSEASEPECFMTCLQSCSCIAFAHGLGYGCMIWNR-SLVDSQVLSASGMDLSIRLAH 426
Query: 412 SDVDEKGKKDVFV-SPLIKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNTV------- 463
S+ + ++ + + + L G+F +A C L R + K++ AK T+ +
Sbjct: 427 SEFKTQDRRPILIGTSLAGGIFVVATCVLLARRIVMKKR---AKKKGTDAEQIFKRVEAL 483
Query: 464 ------KLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS 517
KL++LPLF+F+ LATAT+NF LS+KLGQGGFGPVY G L +GQEIAVKRLS+AS
Sbjct: 484 AGGSREKLKELPLFEFQVLATATDNFSLSNKLGQGGFGPVYKGMLLEGQEIAVKRLSQAS 543
Query: 518 GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL 577
GQGLEE + EV+VISKLQHRNLV+L GCC+ GEE+ML+YE+MP +SLD +FDP + + L
Sbjct: 544 GQGLEELVTEVVVISKLQHRNLVKLFGCCIAGEERMLVYEFMPKKSLDFYIFDPREAKLL 603
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
DW RF II GI RGLLYLHRDSRLRIIHRDLKASNILLDE L PKISDFG+A+IF GN+
Sbjct: 604 DWNTRFEIINGICRGLLYLHRDSRLRIIHRDLKASNILLDENLIPKISDFGLARIFPGNE 663
Query: 638 DQADTGRVVGT 648
D+A+T RVVGT
Sbjct: 664 DEANTRRVVGT 674
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ9|SD113_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-13 OS=Arabidopsis thaliana GN=SD113 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 611 bits (1575), Expect = e-174, Method: Compositional matrix adjust.
Identities = 331/669 (49%), Positives = 444/669 (66%), Gaps = 37/669 (5%)
Query: 13 CFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAV 72
CF L +A D IT S RD + ++SN S F+ GFF+P +S RY GIW++ + V
Sbjct: 13 CFSLRLCLATDV-ITFSSEFRDSETVVSNHSTFRFGFFSPVNSTGRYAGIWFNNIPVQTV 71
Query: 73 IWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV-SNLVNNSTSAQLLDSGNLV 131
+WVAN ++P+ DSSG+++IS++GNLV+++G+ +V WS+NV + N+ A+LL++GNLV
Sbjct: 72 VWVANSNSPINDSSGMVSISKEGNLVVMDGRGQVHWSTNVLVPVAANTFYARLLNTGNLV 131
Query: 132 LRDNINRA--IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLI 189
L N I+WESF+ P + +LP M D +TG+ ++L SWKS DPS G +SAGLI
Sbjct: 132 LLGTTNTGDEILWESFEHPQNIYLPTMSLATDTKTGRSLKLRSWKSPFDPSPGRYSAGLI 191
Query: 190 HQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELK-SVYLF--------RHNFTFGFANDW 240
PE+ VW WRSGPWNGQ FIG+P + + LF R + + +A +
Sbjct: 192 PLPFPELVVWKDDLLMWRSGPWNGQYFIGLPNMDYRINLFELTLSSDNRGSVSMSYAGNT 251
Query: 241 TF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGIC--NSQEKPICSC 296
F L ++G + +R W W+ T+CD Y CG F C N P C C
Sbjct: 252 LLYHFLLDSEGSVFQRDWNVAIQEWKTWLKVPSTKCDTYATCGQFASCRFNPGSTPPCMC 311
Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
+ GF+P++ EWN GNWT GC+R++ LQCE R+ K DGF ++ KMKVP + S
Sbjct: 312 IRGFKPQSYAEWNNGNWTQGCVRKAPLQCESRDNNDGSRKSDGFVRVQKMKVPHNPQ-RS 370
Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
A E +C E CLKNCSC AY+FD GIGC++W S NL+D+Q G YIR+A+S+ +
Sbjct: 371 GANEQDCPESCLKNCSCTAYSFDRGIGCLLW-SGNLMDMQEFSGTGVVFYIRLADSEFKK 429
Query: 417 KGKKDVFVS-PLIKGMFALA-ICTLFLWRWIAKRKEV----------IAKLSATNV---- 460
+ + + ++ L+ G F A L LW+ IAK +E + LS+ +V
Sbjct: 430 RTNRSIVITVTLLVGAFLFAGTVVLALWK-IAKHREKNRNTRLLNERMEALSSNDVGAIL 488
Query: 461 -NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ 519
N KL++LPLF+F+ LA ATNNF +++KLGQGGFG VY GRL++G +IAVKRLS+ SGQ
Sbjct: 489 VNQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQ 548
Query: 520 GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
G+EEF+NEV+VISKLQHRNLVRLLG C+EGEE+ML+YE+MP LDA LFDP+K+ LDW
Sbjct: 549 GVEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDW 608
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
+ RFNII+GI RGL+YLHRDSRL+IIHRDLKASNILLDE LNPKISDFG+A+IF GN+D+
Sbjct: 609 KTRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDE 668
Query: 640 ADTGRVVGT 648
T RVVGT
Sbjct: 669 VSTVRVVGT 677
|
Receptor-like serine/threonine-protein kinase that represses the disease resistance signaling pathway triggered in response to bacterial pathogen such as Pseudomonas syringae pv. tomato. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 569 bits (1466), Expect = e-161, Method: Compositional matrix adjust.
Identities = 319/700 (45%), Positives = 429/700 (61%), Gaps = 74/700 (10%)
Query: 7 LIILLSCFCLDFAVAIDSSITSSQLIRD---PDAILSNGSNFKLGFFNPADSPYRYMGIW 63
L + L F + ++A ++ I + +RD ++S F+LGFF+P S +R++GIW
Sbjct: 11 LSLFLYFFLYESSMAANT-IRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNV--SNLVNNSTS 121
Y +KAV+WVANR P+ D SG++ IS DGNLVL++G+ +WSSN+ S NN+
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGNLVLLDGKNITVWSSNIESSTTNNNNRV 129
Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
+ D+GN VL + +WESF PTD+FLP M ++ +TG SW+S +DPS
Sbjct: 130 VSIHDTGNFVLSETDTDRPIWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSETDPSP 189
Query: 182 GSFSAGLIHQNIPEIFVW--NVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFAND 239
G++S G+ PEI +W N +R WRSG WN IF GIP + + + + F D
Sbjct: 190 GNYSLGVDPSGAPEIVLWEGNKTRK-WRSGQWNSAIFTGIPNMSLLTNYLYGFKLSSPPD 248
Query: 240 WT----------------FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAF 283
T F + G EE W + W +ECD Y +CG F
Sbjct: 249 ETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWTKFQSEPDSECDQYNRCGKF 308
Query: 284 GICNSQ-EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSK 342
GIC+ + ICSC+ G+E + + GNW+ GC RR+ L+CER G ED F
Sbjct: 309 GICDMKGSNGICSCIHGYE-----QVSVGNWSRGCRRRTPLKCERNISVG----EDEFLT 359
Query: 343 LNKMKVPDFT--EWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPF 400
L +K+PDF E ED CRE+CL+NCSC AY+ GGIGCM+W +L+D+Q+
Sbjct: 360 LKSVKLPDFEIPEHNLVDPED-CRERCLRNCSCNAYSLVGGIGCMIWNQ-DLVDLQQFEA 417
Query: 401 GGTDLYIRVANSDVDE--KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKE-------- 450
GG+ L+IR+A+S+V E K K V V+ L+ G+ + I L LWR+ KRK+
Sbjct: 418 GGSSLHIRLADSEVGENRKTKIAVIVAVLV-GVILIGIFALLLWRF--KRKKDVSGAYCG 474
Query: 451 -------VIAKLSATNVNT---------------VKLQDLPLFQFEELATATNNFQLSSK 488
V+A L+ + T V +LP+F +A ATN+F ++
Sbjct: 475 KNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAIAIATNDFCKENE 534
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548
LG+GGFGPVY G L+DG+EIAVKRLS SGQG++EF NE+++I+KLQHRNLVRLLGCC E
Sbjct: 535 LGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQHRNLVRLLGCCFE 594
Query: 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 608
GEEKML+YEYMPN+SLD LFD K+ +DW+ RF+IIEGI+RGLLYLHRDSRLRIIHRD
Sbjct: 595 GEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYLHRDSRLRIIHRD 654
Query: 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
LK SN+LLD E+NPKISDFGMA+IFGGNQ++A+T RVVGT
Sbjct: 655 LKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGT 694
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY89|Y1661_ARATH Putative G-type lectin S-receptor-like serine/threonine-protein kinase At1g61610 OS=Arabidopsis thaliana GN=At1g61610 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 561 bits (1445), Expect = e-159, Method: Compositional matrix adjust.
Identities = 304/694 (43%), Positives = 418/694 (60%), Gaps = 58/694 (8%)
Query: 2 IPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG 61
+ + +++ C + + + +S T + IR+ D+++S +F+LGFF P +S RY+G
Sbjct: 8 LTLVTTLLIFHQLCSNVSCSTSNSFTRNHTIREGDSLISEDESFELGFFTPKNSTLRYVG 67
Query: 62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
IWY + V+WVANR+ PL D G + I++DGNLV+VNGQ E +WS+NV NN T
Sbjct: 68 IWYKNIEPQTVVWVANREKPLLDHKGALKIADDGNLVIVNGQNETIWSTNVEPESNN-TV 126
Query: 122 AQLLDSGNLVL-RDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS 180
A L +G+LVL D+ R WESF PTD+FLPGM ++ G+ WKS SDPS
Sbjct: 127 AVLFKTGDLVLCSDSDRRKWYWESFNNPTDTFLPGMRVRVNPSLGENRAFIPWKSESDPS 186
Query: 181 TGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGF---- 236
G +S G+ EI +W + WRSGPWN IF GIP++ L N+ +GF
Sbjct: 187 PGKYSMGIDPVGALEIVIWEGEKRKWRSGPWNSAIFTGIPDM----LRFTNYIYGFKLSS 242
Query: 237 ----------------ANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKC 280
++D+ F + G+ E+ W K NW + TEC+ Y +C
Sbjct: 243 PPDRDGSVYFTYVASDSSDFLRFWIRPDGVEEQFRWNKDIRNWNLLQWKPSTECEKYNRC 302
Query: 281 GAFGICNSQEK---PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE 337
G + +C+ ++ CSC++GFEP + ++WN +++ GC RR L C + + G+E
Sbjct: 303 GNYSVCDDSKEFDSGKCSCIDGFEPVHQDQWNNRDFSGGCQRRVPLNCNQSLV---AGQE 359
Query: 338 DGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQR 397
DGF+ L +KVPDF + C++ C ++CSC AYA GIGCM+W + +LID++
Sbjct: 360 DGFTVLKGIKVPDFGSVVLHNNSETCKDVCARDCSCKAYALVVGIGCMIW-TRDLIDMEH 418
Query: 398 LPFGGTDLYIRVANSDVDEKGKKD----VFVSPLIKGMFALAICTLFLWRWIAKRKEVIA 453
GG + IR+A S + GK++ + V +I G F L +C LW++ K +
Sbjct: 419 FERGGNSINIRLAGSKLG-GGKENSTLWIIVFSVI-GAFLLGLCIWILWKFKKSLKAFLW 476
Query: 454 KLSATNV-------------------NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGF 494
K V + V DLP+F F+ +A+AT +F +KLGQGGF
Sbjct: 477 KKKDITVSDIIENRDYSSSPIKVLVGDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGF 536
Query: 495 GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554
G VY G +G+EIAVKRLS S QGLEEF NE+++I+KLQHRNLVRLLGCC+E EKML
Sbjct: 537 GTVYKGNFSEGREIAVKRLSGKSKQGLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKML 596
Query: 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
+YEYMPN+SLD LFD K+ LDWRKR+ +I GI+RGLLYLHRDSRL+IIHRDLKASNI
Sbjct: 597 LYEYMPNKSLDRFLFDESKQGSLDWRKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNI 656
Query: 615 LLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
LLD E+NPKISDFGMA+IF QD A+T RVVGT
Sbjct: 657 LLDTEMNPKISDFGMARIFNYRQDHANTIRVVGT 690
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64784|Y1136_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61360 OS=Arabidopsis thaliana GN=At1g61360 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 550 bits (1416), Expect = e-155, Method: Compositional matrix adjust.
Identities = 290/667 (43%), Positives = 418/667 (62%), Gaps = 40/667 (5%)
Query: 15 CLDFAVAIDSS-----ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSE 69
CL A+ SS IT+S + + S G +++LGFF+ +S +Y+GIW+ +
Sbjct: 6 CLLLITALFSSYGYAAITTSSPLSIGVTLSSPGGSYELGFFSSNNSGNQYVGIWFKKVTP 65
Query: 70 KAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGN 129
+ ++WVANR+ P+ + +TIS +G+L+L++ +K+++WSS + +N A+LLD+GN
Sbjct: 66 RVIVWVANREKPVSSTMANLTISSNGSLILLDSKKDLVWSSG-GDPTSNKCRAELLDTGN 124
Query: 130 LVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLI 189
LV+ DN+ +W+SF+ D+ LP D KK LTSWKS +DPS G F A +
Sbjct: 125 LVVVDNVTGNYLWQSFEHLGDTMLPLTSLMYDIPNNKKRVLTSWKSETDPSPGEFVAEIT 184
Query: 190 HQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL---------FRHNFTFGFAN-- 238
Q + + S PYWRSGPW G F GIPE+ + Y+ F F
Sbjct: 185 PQVPSQGLIRKGSSPYWRSGPWAGTRFTGIPEMDASYVNPLGMVQDEVNGTGVFAFCVLR 244
Query: 239 --DWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
+ ++ LT +G L RI +W F T CD+YG+CG FG+C P+C C
Sbjct: 245 NFNLSYIKLTPEGSL--RITRNNGTDWIKHFEGPLTSCDLYGRCGPFGLCVRSGTPMCQC 302
Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKLNKMKVPDFTEWT 355
L+GFEPK+ EEW GNW+ GC+RR+ L C+ + GK+ D F ++ +K PD E
Sbjct: 303 LKGFEPKSDEEWRSGNWSRGCVRRTNLSCQGNSSVETQGKDRDVFYHVSNIKPPDSYELA 362
Query: 356 SPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVD 415
S + E++C + CL+NCSC A+++ GIGC+VW L+D + GG L +R+A+S++
Sbjct: 363 SFSNEEQCHQGCLRNCSCTAFSYVSGIGCLVWNQ-ELLDTVKFIGGGETLSLRLAHSEL- 420
Query: 416 EKGKKDVFVSPLIKGMFALAICTLFL------WRWIAKR-------KEVIAKLSATNVNT 462
G+K + + + +L++C + + WR+ K+ K+ + +++ +
Sbjct: 421 -TGRKRIKI--ITVATLSLSVCLILVLVACGCWRYRVKQNGSSLVSKDNVEGAWKSDLQS 477
Query: 463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
+ L F+ +L TATNNF + +KLGQGGFG VY G+L+DG+EIAVKRL+ +S QG E
Sbjct: 478 QDVSGLNFFEIHDLQTATNNFSVLNKLGQGGFGTVYKGKLQDGKEIAVKRLTSSSVQGTE 537
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
EFMNE+ +ISKLQHRNL+RLLGCC++GEEK+L+YEYM N+SLD +FD KK +DW R
Sbjct: 538 EFMNEIKLISKLQHRNLLRLLGCCIDGEEKLLVYEYMVNKSLDIFIFDLKKKLEIDWATR 597
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
FNII+GI+RGLLYLHRDS LR++HRDLK SNILLDE++NPKISDFG+A++F GNQ Q T
Sbjct: 598 FNIIQGIARGLLYLHRDSFLRVVHRDLKVSNILLDEKMNPKISDFGLARLFHGNQHQDST 657
Query: 643 GRVVGTL 649
G VVGTL
Sbjct: 658 GSVVGTL 664
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64783|Y1137_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61370 OS=Arabidopsis thaliana GN=At1g61370 PE=3 SV=2 | Back alignment and function description |
|---|
Score = 549 bits (1414), Expect = e-155, Method: Compositional matrix adjust.
Identities = 293/667 (43%), Positives = 415/667 (62%), Gaps = 37/667 (5%)
Query: 6 LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
LLII SC A+ S ++ Q + P NG+ ++LGFF+P +S +Y+GIW+
Sbjct: 15 LLIIFPSCAFA--AITRASPLSIGQTLSSP-----NGT-YELGFFSPNNSRNQYVGIWFK 66
Query: 66 MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLL 125
+ + V+WVANRD P+ +++ +TI+ +G+L+LV ++ V+WS +N A+LL
Sbjct: 67 NITPRVVVWVANRDKPVTNNAANLTINSNGSLILVEREQNVVWSIG-ETFSSNELRAELL 125
Query: 126 DSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFS 185
++GNLVL D ++ +WESF+ D+ L D KK L+SWK+ +DPS G F
Sbjct: 126 ENGNLVLIDGVSERNLWESFEHLGDTMLLESSVMYDVPNNKKRVLSSWKNPTDPSPGEFV 185
Query: 186 AGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFA-------- 237
A L Q P+ F+ SRPYWR GPW F GIPE+ ++ + + + A
Sbjct: 186 AELTTQVPPQGFIMRGSRPYWRGGPWARVRFTGIPEMDGSHVSKFDISQDVAAGTGSLTY 245
Query: 238 ------NDWTFFALTAQGILEERIWIKWKDN--WEVGFLNLRTECDVYGKCGAFGICNSQ 289
++ ++ LT+ G L+ I W + W + CDVY CG FG+C
Sbjct: 246 SLERRNSNLSYTTLTSAGSLK----IIWNNGSGWVTDLEAPVSSCDVYNTCGPFGLCIRS 301
Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCE-RRNITGKVGKEDGFSKLNKMKV 348
P C CL+GF PK+ EEWN+ NWT GC+RR+ L C+ + T + D F + +K
Sbjct: 302 NPPKCECLKGFVPKSDEEWNKRNWTGGCMRRTNLSCDVNSSATAQANNGDIFDIVANVKP 361
Query: 349 PDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
PDF E+ S E++C+++CL NCSC A+++ IGC+VW L+D+ + GG L IR
Sbjct: 362 PDFYEYLSLINEEDCQQRCLGNCSCTAFSYIEQIGCLVWNR-ELVDVMQFVAGGETLSIR 420
Query: 409 VANSDVDEKGKKDVFVSPL--IKGMFALAICTLFLWRWIAKRKEVIAKLSATNVNT---- 462
+A+S++ + + V+ + I L + + WR+ AK+ + T+ +
Sbjct: 421 LASSELAGSNRVKIIVASIVSISVFMILVFASYWYWRYKAKQNDSNPIPLETSQDAWREQ 480
Query: 463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
+K QD+ F + + T TNNF + +KLGQGGFGPVY G L+DG+EIA+KRLS SGQGLE
Sbjct: 481 LKPQDVNFFDMQTILTITNNFSMENKLGQGGFGPVYKGNLQDGKEIAIKRLSSTSGQGLE 540
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
EFMNE+++ISKLQHRNLVRLLGCC+EGEEK+LIYE+M N+SL+ +FD KK LDW KR
Sbjct: 541 EFMNEIILISKLQHRNLVRLLGCCIEGEEKLLIYEFMANKSLNTFIFDSTKKLELDWPKR 600
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
F II+GI+ GLLYLHRDS LR++HRD+K SNILLDEE+NPKISDFG+A++F G Q QA+T
Sbjct: 601 FEIIQGIACGLLYLHRDSCLRVVHRDMKVSNILLDEEMNPKISDFGLARMFQGTQHQANT 660
Query: 643 GRVVGTL 649
RVVGTL
Sbjct: 661 RRVVGTL 667
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O64782|SD129_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-29 OS=Arabidopsis thaliana GN=SD129 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 548 bits (1413), Expect = e-155, Method: Compositional matrix adjust.
Identities = 287/665 (43%), Positives = 415/665 (62%), Gaps = 40/665 (6%)
Query: 6 LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
LL++++ C A+ S ++ Q + P G ++LGFF+P ++ +Y+GIW+
Sbjct: 9 LLLLIIFPTCGYAAINTSSPLSIRQTLSSP------GGFYELGFFSPNNTQNQYVGIWFK 62
Query: 66 MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLL 125
+ V+WVANRD P+ S+ +TIS +G+L+L++G+++V+WS+ + +N A+LL
Sbjct: 63 KIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDGKQDVIWSTGKA-FTSNKCHAELL 121
Query: 126 DSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFS 185
D+GN V+ D+++ +W+SF+ ++ LP D GKK LT+WKS SDPS G FS
Sbjct: 122 DTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEFS 181
Query: 186 AGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF---------TFGF 236
+ Q + + S PYWR GPW F GI + + Y+ + +F +
Sbjct: 182 LEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFSY 241
Query: 237 AN----DWTFFALTAQGILEERIWIKWKD--NWEVGFLNLRTECDVYGKCGAFGICNSQE 290
+ + ++ LT +G ++ I W D NW++ CD+YG+CG +G+C +
Sbjct: 242 STLRNYNLSYVTLTPEGKMK----ILWDDGNNWKLHLSLPENPCDLYGRCGPYGLCVRSD 297
Query: 291 KPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKLNKMKVP 349
P C CL+GF PK+ EEW +GNWTSGC+RR+KL C+ ++ GK+ D F ++ +K P
Sbjct: 298 PPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTP 357
Query: 350 DFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRV 409
D ++ S ++C + CL NCSC A+A+ GIGC+VW L D + G L+IR+
Sbjct: 358 DLHQFASFLNAEQCYQGCLGNCSCTAFAYISGIGCLVWNG-ELADTVQFLSSGEFLFIRL 416
Query: 410 ANSDVDEKGKKDVFVSPLIKG--MFALAICTLFLWRWIAKRKEVIAKLSATNVNTVKLQD 467
A+S++ ++ + V + L + LWR+ AK+ + N + QD
Sbjct: 417 ASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWK-------NGFERQD 469
Query: 468 LP---LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF 524
+ F+ + TATNNF S+KLGQGGFGPVY G+L DG+EI VKRL+ +SGQG EEF
Sbjct: 470 VSGVNFFEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEF 529
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
MNE+ +ISKLQHRNLVRLLG C++GEEK+LIYE+M N+SLD +FDP K LDW KRFN
Sbjct: 530 MNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFN 589
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
II+GI+RGLLYLHRDSRLR+IHRDLK SNILLD+ +NPKISDFG+A++F G Q Q +T R
Sbjct: 590 IIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRR 649
Query: 645 VVGTL 649
VVGTL
Sbjct: 650 VVGTL 654
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SY95|Y1155_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g61550 OS=Arabidopsis thaliana GN=At1g61550 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 544 bits (1402), Expect = e-154, Method: Compositional matrix adjust.
Identities = 286/664 (43%), Positives = 415/664 (62%), Gaps = 38/664 (5%)
Query: 9 ILLSCFCLDF---AVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
L S L F A+ S ++ Q + P+ I F+LGFF+P +S Y+GIW+
Sbjct: 7 FLFSTLLLSFSYAAITPTSPLSIGQTLSSPNGI------FELGFFSPNNSRNLYVGIWFK 60
Query: 66 MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLL 125
+ V+WVANR+N + D++ + IS +G+L+L +G+ +WS+ +N +SA+L
Sbjct: 61 GIIPRTVVWVANRENSVTDATADLAISSNGSLLLFDGKHSTVWSTG-ETFASNGSSAELS 119
Query: 126 DSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFS 185
DSGNL++ D ++ +W+SF+ D+ LP + TG+K L+SWKS +DP G F
Sbjct: 120 DSGNLLVIDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFV 179
Query: 186 AGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGF-ANDWTFFA 244
+ Q P+ F+ S+PYWRSGPW F G+P Y H F+ AN +F+
Sbjct: 180 GYITTQVPPQGFIMRGSKPYWRSGPWAKTRFTGVPLTDESY--THPFSVQQDANGSVYFS 237
Query: 245 ------------LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKP 292
LT++G L ++ +W + CD YG CG FG+C P
Sbjct: 238 HLQRNFKRSLLVLTSEGSL--KVTHHNGTDWVLNIDVPANTCDFYGVCGPFGLCVMSIPP 295
Query: 293 ICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFT 352
C C +GF P+ +EEW RGNWT GC+RR++L C+ N TG+ + F + +K PDF
Sbjct: 296 KCKCFKGFVPQFSEEWKRGNWTGGCVRRTELLCQG-NSTGR--HVNVFHPVANIKPPDFY 352
Query: 353 EWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANS 412
E+ S + +EC + CL NCSC+A+A+ GIGC++W L+D+ + GG L IR+A+S
Sbjct: 353 EFVSSGSAEECYQSCLHNCSCLAFAYINGIGCLIWNQ-ELMDVMQFSVGGELLSIRLASS 411
Query: 413 DVDEKGKKDVFVSPLIK-GMF-ALAICTLFLWRWIAKRKEVIAKLSATNV--NTVKLQD- 467
++ +K ++ ++ +F LA WR+ K +++K+S N +K +D
Sbjct: 412 EMGGNQRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSEDV 471
Query: 468 --LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFM 525
L F+ + + ATNNF L +KLGQGGFGPVY G+L+DG+EIAVKRLS +SGQG EEFM
Sbjct: 472 SGLYFFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFM 531
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
NE+++ISKLQH NLVR+LGCC+EGEE++L+YE+M N+SLD +FD K+ +DW KRF+I
Sbjct: 532 NEILLISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSI 591
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
I+GI+RGLLYLHRDSRLRIIHRD+K SNILLD+++NPKISDFG+A+++ G + Q +T R+
Sbjct: 592 IQGIARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRI 651
Query: 646 VGTL 649
VGTL
Sbjct: 652 VGTL 655
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 649 | ||||||
| 359496521 | 844 | PREDICTED: G-type lectin S-receptor-like | 0.981 | 0.754 | 0.604 | 0.0 | |
| 224114125 | 832 | predicted protein [Populus trichocarpa] | 0.984 | 0.768 | 0.584 | 0.0 | |
| 224114137 | 827 | predicted protein [Populus trichocarpa] | 0.987 | 0.775 | 0.584 | 0.0 | |
| 359497280 | 920 | PREDICTED: G-type lectin S-receptor-like | 0.935 | 0.659 | 0.610 | 0.0 | |
| 224112032 | 824 | predicted protein [Populus trichocarpa] | 0.989 | 0.779 | 0.570 | 0.0 | |
| 224114141 | 824 | predicted protein [Populus trichocarpa] | 0.989 | 0.779 | 0.569 | 0.0 | |
| 224078778 | 831 | predicted protein [Populus trichocarpa] | 0.989 | 0.772 | 0.584 | 0.0 | |
| 359496519 | 854 | PREDICTED: G-type lectin S-receptor-like | 0.983 | 0.747 | 0.579 | 0.0 | |
| 296084622 | 817 | unnamed protein product [Vitis vinifera] | 0.979 | 0.778 | 0.592 | 0.0 | |
| 147840284 | 827 | hypothetical protein VITISV_016155 [Viti | 0.952 | 0.747 | 0.573 | 0.0 |
| >gi|359496521|ref|XP_002262970.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 807 bits (2085), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 418/691 (60%), Positives = 508/691 (73%), Gaps = 54/691 (7%)
Query: 4 IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
+ L++LLS C F AID+ +TS++ I DP+ ++SNGS FKLGFF+ ADS RY+GIW
Sbjct: 9 VIALLLLLSVICFGFCTAIDT-MTSTRFIEDPETLVSNGSAFKLGFFSLADSTNRYVGIW 67
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
Y PS VIWVANRD PL DSSGI+TISEDGNL+++NGQKE++WSSNVSN NS SAQ
Sbjct: 68 YSTPSLSTVIWVANRDKPLNDSSGIVTISEDGNLLVMNGQKEIVWSSNVSNASANS-SAQ 126
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
LLDSGNLVL+DN + +I WES Q P+ S LP M D TG+KV LTSWKS SDPS GS
Sbjct: 127 LLDSGNLVLQDN-SGSITWESIQHPSHSLLPNMKISTDTNTGEKVVLTSWKSPSDPSIGS 185
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------- 232
FS G+ NIP+IF+WN S PYWRSGPW+ QIFIGIP++ SVY R F
Sbjct: 186 FSLGMNPLNIPQIFIWNGSHPYWRSGPWSSQIFIGIPDMDSVY--RSGFQVVDDKEGTVY 243
Query: 233 -TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
TF AN + ++ LT+QG L + K+ W V + + ++ECDVYG CGAFGICNS
Sbjct: 244 ATFTEANSSIFLYYVLTSQGSLVQTDREYGKEEWGVTWRSNKSECDVYGTCGAFGICNSG 303
Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
PICSCL G+EPK EEW+RGNWTSGC+R++ LQCER N +G+ GK DGF +L +KVP
Sbjct: 304 TSPICSCLRGYEPKYTEEWSRGNWTSGCVRKTTLQCERTNSSGQQGKIDGFFRLTTVKVP 363
Query: 350 DFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRV 409
D+ +W S A EDECRE+CLKNCSCIAY++ GIGCM+W S +LID+Q+ G DLYIR+
Sbjct: 364 DYADW-SLAHEDECREECLKNCSCIAYSYYSGIGCMLW-SGSLIDLQKFTKRGADLYIRL 421
Query: 410 ANSDVDEKGKKDVFV---SPLIKGMFALAICTLFLWRWIA------KRKEVIAK------ 454
A+S++ K K+D+ V ++ G A+AICT FLWRWI K KE++
Sbjct: 422 AHSELG-KNKRDMKVIISVTIVIGTIAIAICTYFLWRWIGRQAVKEKSKEILPSDRGHAY 480
Query: 455 ------LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI 508
+ NVN VKL++LPL FE+LA ATNNF ++KLGQGGFGPVY G L GQ+I
Sbjct: 481 QNYDMNMLGDNVNRVKLEELPLLDFEKLAAATNNFHEANKLGQGGFGPVYRGNLPGGQKI 540
Query: 509 AVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG-C----------CVEGEEKMLIYE 557
AVKRLS+AS QG EEFMNE++VISK+QHRNLVRLLG C C+EG+EK+LIYE
Sbjct: 541 AVKRLSRASAQGQEEFMNEMIVISKIQHRNLVRLLGFCIEGDVRLLGFCIEGDEKLLIYE 600
Query: 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617
YMPN+SLDA LFDPLK+E LDWR+RF+IIEGI RGLLYLHRDSRL+IIHRDLKASNILLD
Sbjct: 601 YMPNKSLDAFLFDPLKRESLDWRRRFSIIEGIGRGLLYLHRDSRLKIIHRDLKASNILLD 660
Query: 618 EELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
E+LN KISDFGMA+IFG NQDQA+T RVVGT
Sbjct: 661 EDLNAKISDFGMARIFGSNQDQANTMRVVGT 691
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114125|ref|XP_002316674.1| predicted protein [Populus trichocarpa] gi|222859739|gb|EEE97286.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 790 bits (2039), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 397/679 (58%), Positives = 493/679 (72%), Gaps = 40/679 (5%)
Query: 4 IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
I L ++L CFCL+F +ID+ I+ SQ IRDP+ I+S G F+LGFF+P +S RY+ IW
Sbjct: 9 IIALHLILYCFCLEFGASIDT-ISLSQFIRDPETIVSAGKKFELGFFSPVNSTNRYVAIW 67
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
Y S +WVANR+ PL DSSGI+TISEDGNLV++NGQKE LWSSNVS +N+S AQ
Sbjct: 68 YSNISITTPVWVANRNKPLNDSSGIMTISEDGNLVVLNGQKETLWSSNVSTGMNDS-RAQ 126
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
L+D GNLVL + N +W+SFQEP+D+++P M + RTGKK LTSWKS SDPS GS
Sbjct: 127 LMDDGNLVLGGSENGNSLWQSFQEPSDTYIPKMRLTANPRTGKKTPLTSWKSPSDPSIGS 186
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
FS G+ +IPE+ +WN SRP WR+GPWNGQ+FIG+PE+ SVYL N +
Sbjct: 187 FSLGIDPSSIPEVVLWNDSRPIWRTGPWNGQVFIGVPEMNSVYLDGFNLADDGNGGFTLS 246
Query: 234 FGFAND--WTFFALTAQGILEERIWI-----KWKDNWEVGFLNLRTECDVYGKCGAFGIC 286
GFA++ T F L+++G + W W+ WE +++ ECDVYGKCG+F C
Sbjct: 247 VGFADESYITNFVLSSEGKFGQVFWDDMNEGSWRYQWE----SVQDECDVYGKCGSFASC 302
Query: 287 NSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKM 346
+++ PICSCL+GFEPKNA+EWN NWT GC+RR ++CER G++GKEDGFSKL ++
Sbjct: 303 DAKNTPICSCLKGFEPKNADEWNSRNWTHGCVRRKAMRCERIQNGGELGKEDGFSKLERV 362
Query: 347 KVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLY 406
KVP F EW+S TE +CR+ C NCSCIAYA+ GI CM+W+ NL DI++ GG DLY
Sbjct: 363 KVPGFAEWSSSITEQKCRDDCWNNCSCIAYAYYTGIYCMLWKG-NLTDIKKFSSGGADLY 421
Query: 407 IRVANSDVDEK--GKKDVFVSPLIKGMFALAICTLFLWRWI-----------AKRKEVI- 452
IR+A +++D K K + ++ G A+AIC + WRWI KRK I
Sbjct: 422 IRLAYTELDNKKINMKVIISLTVVVGAIAIAICVFYSWRWIERKRTSKKVLLPKRKHPIL 481
Query: 453 --AKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 510
+ N+N VKLQ+LPLF + L AT+NF ++KLGQGGFGPVY G+ DGQEIA+
Sbjct: 482 LDENVIQDNLNHVKLQELPLFSLQMLIVATDNFNTANKLGQGGFGPVYKGKFPDGQEIAL 541
Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
KRLS+ASGQG EEFM EV+VISKLQH NLVRLLGCCVEGEEKML+YEYMPNRSLDA LFD
Sbjct: 542 KRLSRASGQGQEEFMTEVVVISKLQHMNLVRLLGCCVEGEEKMLVYEYMPNRSLDAFLFD 601
Query: 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
P +K+ LDW+KRFNI+EGI RGLLYLHRDSRLRIIHRDLKASNILLD+ELNPKISDFGMA
Sbjct: 602 PSRKQLLDWKKRFNIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDFGMA 661
Query: 631 KIFGGNQDQADTGRVVGTL 649
+IFG N+DQADTGRVVGT
Sbjct: 662 RIFGRNEDQADTGRVVGTF 680
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114137|ref|XP_002316677.1| predicted protein [Populus trichocarpa] gi|222859742|gb|EEE97289.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 787 bits (2033), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/676 (58%), Positives = 495/676 (73%), Gaps = 35/676 (5%)
Query: 4 IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
IA L+IL CFC +F ++D+ ITSSQ I+DP+ I+S G+ FKLGFF+P +S RY IW
Sbjct: 10 IAFLLILY-CFCWEFGASVDT-ITSSQYIKDPEDIVSAGNKFKLGFFSPVNSTNRYAAIW 67
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
Y S +WVANR+ PL DSSGI+TISEDGNLV++NGQKE+LWSSNVS +N+S AQ
Sbjct: 68 YSNISITTPVWVANRNMPLNDSSGIMTISEDGNLVVLNGQKEILWSSNVSTGMNDS-RAQ 126
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
L+D GNLVL + N +W+SFQEP+D+++P M + RTGKK L SW S+SDPS GS
Sbjct: 127 LMDDGNLVLGGSENGNSLWQSFQEPSDTYMPKMRLTANSRTGKKTLLKSWTSVSDPSIGS 186
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHN----------FT 233
S G+ IP+ ++WN SRP WR+GPWNGQ+FIGIPE+ SVYL N +
Sbjct: 187 ISGGIDPSRIPQFYIWNGSRPIWRTGPWNGQVFIGIPEMVSVYLDGFNIADEGNGTFTLS 246
Query: 234 FGFANDWTF--FALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
GFAN+ + L+++G + +W + +W + + ECDVYGKCG+FG CN ++
Sbjct: 247 VGFANESLISNYILSSEGKFGKVLWDDTEGSWRYEWKFPKDECDVYGKCGSFGSCNPKDS 306
Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
PICSCL+GFEPKNA+EWN GNWT+GC+RR +LQCER G+VGKEDGF KL +MKVPDF
Sbjct: 307 PICSCLKGFEPKNADEWNNGNWTNGCVRRRELQCERTQNGGQVGKEDGFLKLERMKVPDF 366
Query: 352 TEWTSPATEDECREQCLK-NCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410
+EW S +E C+ +CL NCSCIAY++ G GCM+WR NL D+++ P DLYIR+A
Sbjct: 367 SEWLSSTSEHTCKNECLNINCSCIAYSYYPGFGCMLWRG-NLTDLKKFPIKAADLYIRLA 425
Query: 411 NSDVDEK--GKKDVFVSPLIKGMFALAICTLFLWR-----------WIAKRKEVIAKLS- 456
+S++D K K + ++ G A+AIC + WR +++KRK LS
Sbjct: 426 DSELDNKKINLKVIISLTVVVGAIAIAICVFYSWRRIDRKRKSKKVFLSKRKVGYPILSD 485
Query: 457 ----ATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR 512
N+N VKLQ+LPLF + L AT+NF ++KLGQGGFGPVY G L DGQEIAVKR
Sbjct: 486 ENMIQDNLNHVKLQELPLFSLQTLIAATDNFNTANKLGQGGFGPVYKGNLSDGQEIAVKR 545
Query: 513 LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL 572
LS++SGQGLEEFMNEV+VISKLQHRNLVR+LGCCVEGEEKMLIYEYMPN+SLDA LFD L
Sbjct: 546 LSRSSGQGLEEFMNEVVVISKLQHRNLVRILGCCVEGEEKMLIYEYMPNKSLDAFLFDSL 605
Query: 573 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
+K+ LDW+ RF I+EGI RGLLYLHRDSRLRIIHRDLKASNILLD+ELNPKISDFGMA+I
Sbjct: 606 RKQLLDWKNRFKIVEGICRGLLYLHRDSRLRIIHRDLKASNILLDQELNPKISDFGMARI 665
Query: 633 FGGNQDQADTGRVVGT 648
FG ++DQA+T RVVGT
Sbjct: 666 FGNHEDQANTRRVVGT 681
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359497280|ref|XP_003635472.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 784 bits (2025), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/642 (61%), Positives = 474/642 (73%), Gaps = 35/642 (5%)
Query: 38 ILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNL 97
++SNGS FKLGFF PADS RY+GIWY PS VIWVANRD PL D SGI+TISEDGNL
Sbjct: 229 LVSNGSAFKLGFFTPADSTNRYVGIWYSTPSLSTVIWVANRDKPLTDFSGIVTISEDGNL 288
Query: 98 VLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMH 157
+++NGQK ++WSSN+SN NS SAQLLDSGNLVLRDN R I WES Q P+ SFLP M
Sbjct: 289 LVMNGQKVIVWSSNLSNAAPNS-SAQLLDSGNLVLRDNSGR-ITWESIQHPSHSFLPKMK 346
Query: 158 HGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFI 217
+ TG+KV LTSWKS SDPS GSFSAG+ NIP++FVWN S PYWRSGPWNGQIFI
Sbjct: 347 ISTNTHTGEKVVLTSWKSPSDPSIGSFSAGINPLNIPQVFVWNGSHPYWRSGPWNGQIFI 406
Query: 218 GIPELKSVYL------------FRHNFTFGFANDWTFFALTAQGILEERIWIKWKDNWEV 265
G+PE+ SV+L FT ++ + ++ LT +G + + K+ W+V
Sbjct: 407 GVPEMNSVFLNGFQVVDDKEGTVYETFTLANSSIFLYYVLTPEGTVVKTYREFGKEKWQV 466
Query: 266 GFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQC 325
+ + ++ECDVYG CGA GIC+S PIC+CL+G++PK EEW+RGNWT GC+R++ LQC
Sbjct: 467 AWKSNKSECDVYGTCGASGICSSGNSPICNCLKGYKPKYMEEWSRGNWTRGCVRKTPLQC 526
Query: 326 ERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCM 385
ER N +G+ GK DGF +L +KVPDF +W S A EDECR+QC KNCSC+AY++ IGCM
Sbjct: 527 ERTNSSGQQGKIDGFFRLTSVKVPDFADW-SLALEDECRKQCFKNCSCVAYSYYSSIGCM 585
Query: 386 VWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKDVFVS-PLIKGMFALAICTLFLWRW 444
W S N+ID Q+ GG DLYIR+A S++D+K +S ++ G A ICT F WRW
Sbjct: 586 SW-SGNMIDSQKFTQGGADLYIRLAYSELDKKRDMKAIISVTIVIGTIAFGICTYFSWRW 644
Query: 445 --------------IAKRKEVI----AKLSATNVNTVKLQDLPLFQFEELATATNNFQLS 486
++ R +V + + N VK ++LPL E+LATATNNF +
Sbjct: 645 RGKQTVKDKSKGILLSDRGDVYQIYDKNMLGDHANQVKFEELPLLALEKLATATNNFHEA 704
Query: 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
+ LGQGGFGPVY G+L GQEIAVKRLS+AS QGLEEFMNEVMVISK+QHRNLVRLLGCC
Sbjct: 705 NMLGQGGFGPVYRGKLPGGQEIAVKRLSRASAQGLEEFMNEVMVISKIQHRNLVRLLGCC 764
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+EG+EK+LIYEYMPN+SLDA LFDPLK+E LDWRKRF+IIEGI RGLLYLHRDSRLRIIH
Sbjct: 765 IEGDEKLLIYEYMPNKSLDAFLFDPLKREFLDWRKRFSIIEGIGRGLLYLHRDSRLRIIH 824
Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
RDLKASNILLDE+LN KISDFGMA+IFG NQDQA+T RVVGT
Sbjct: 825 RDLKASNILLDEDLNAKISDFGMARIFGSNQDQANTMRVVGT 866
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224112032|ref|XP_002332843.1| predicted protein [Populus trichocarpa] gi|222833304|gb|EEE71781.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 777 bits (2007), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 387/678 (57%), Positives = 492/678 (72%), Gaps = 36/678 (5%)
Query: 4 IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
+A L +LL CFC A+D+ ITSSQ I+DP+A++S G+ FKLGFF+P +S RY+GIW
Sbjct: 1 MAALRLLLCCFCWQLGAAVDT-ITSSQYIKDPEAVVSAGNKFKLGFFSPGNSTNRYVGIW 59
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
Y S +W+ANR+ PL DSSGI+TISEDGN+V+++G+KE+LWSSNVSN V+NS SAQ
Sbjct: 60 YSNISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS-SAQ 118
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
L D GN++LR +W+SFQEP+D+F+ M ++RTGKK Q+TSWKS SDPS GS
Sbjct: 119 LTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSDPSVGS 178
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
FS+G+ +IPE+FVWN SRP+WRSGPWNGQ FIGIPE+ SVYL +N +
Sbjct: 179 FSSGIEPSSIPEVFVWNDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGDGTFSLS 238
Query: 234 FGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
G AN+ T FAL+ +G E W + WE +CD+YGKCG FG CN+Q
Sbjct: 239 VGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFGFCNTQNS 298
Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
IC CL+GFEPKN++EWNR NWT+GC+RR +L+CER G+V KED F KL+K+KVPDF
Sbjct: 299 LICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLDKVKVPDF 358
Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
+EW+S A+E C+++CL NCSCIAY++ GIGCM+WR L DI++ GG +LY+R+A+
Sbjct: 359 SEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRG-KLTDIRKFSSGGANLYVRLAD 417
Query: 412 SDVDE-KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKE-------------------- 450
+ + + K V ++ G +A+ F WR +AK +E
Sbjct: 418 LEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRKKGYPIF 477
Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 510
L ++N VK Q+LPLF+ + L AT+ F ++KLG+GGFGPVY G L DGQEIAV
Sbjct: 478 FNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPDGQEIAV 537
Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
KRLS+ASGQG EEFMNEV+VIS+LQHRNLVRLLGCCVEG+EKML+YEYMPN+SLDA LFD
Sbjct: 538 KRLSRASGQGQEEFMNEVVVISELQHRNLVRLLGCCVEGDEKMLVYEYMPNKSLDASLFD 597
Query: 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
P++KE LDW+KRFNI++GI RGLLYLHRDSRLRIIHRDLK SNILLD+ELNPKISDFGMA
Sbjct: 598 PVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKISDFGMA 657
Query: 631 KIFGGNQDQADTGRVVGT 648
+IFGGN+D T RVVGT
Sbjct: 658 RIFGGNEDHVKTRRVVGT 675
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224114141|ref|XP_002316678.1| predicted protein [Populus trichocarpa] gi|222859743|gb|EEE97290.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 776 bits (2004), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 386/678 (56%), Positives = 492/678 (72%), Gaps = 36/678 (5%)
Query: 4 IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
+A L +LL CFC A+D+ ITSSQ I+DP+A++S G+ FKLGFF+P +S RY+GIW
Sbjct: 1 MAALRLLLCCFCWQLGAAVDT-ITSSQYIKDPEAVVSAGNKFKLGFFSPGNSTNRYVGIW 59
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
Y S +W+ANR+ PL DSSGI+TISEDGN+V+++G+KE+LWSSNVSN V+NS SAQ
Sbjct: 60 YSNISVTTPVWIANRNKPLNDSSGIMTISEDGNIVVLDGRKEILWSSNVSNGVSNS-SAQ 118
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
L D GN++LR +W+SFQEP+D+F+ M ++RTGKK Q+TSWKS SDPS GS
Sbjct: 119 LTDDGNVILRGGEIGNSLWQSFQEPSDTFMLKMRLTANRRTGKKTQITSWKSPSDPSVGS 178
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------T 233
FS+G+ +IPE+FVWN SRP+WRSGPWNGQ FIGIPE+ SVYL +N +
Sbjct: 179 FSSGIEPSSIPEVFVWNDSRPFWRSGPWNGQAFIGIPEMNSVYLNGYNLVQDGDGTFSLS 238
Query: 234 FGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEK 291
G AN+ T FAL+ +G E W + WE +CD+YGKCG FG CN+Q
Sbjct: 239 VGLANESYITNFALSYEGRFGEMYWDSANERWEHKKQYPGDDCDIYGKCGPFGFCNTQNS 298
Query: 292 PICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDF 351
IC CL+GFEPKN++EWNR NWT+GC+RR +L+CER G+V KED F KL+K+KVPDF
Sbjct: 299 LICRCLKGFEPKNSDEWNRRNWTNGCVRRRELKCERTQSDGQVPKEDEFLKLDKVKVPDF 358
Query: 352 TEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVAN 411
+EW+S A+E C+++CL NCSCIAY++ GIGCM+WR L DI++ GG +LY+R+A+
Sbjct: 359 SEWSSSASEQNCKDECLNNCSCIAYSYHTGIGCMLWRG-KLTDIRKFSSGGANLYVRLAD 417
Query: 412 SDVDE-KGKKDVFVSPLIKGMFALAICTLFLWRWIAKRKE-------------------- 450
+ + + K V ++ G +A+ F WR +AK +E
Sbjct: 418 LEFGKNRDMKAVICITVVTGAIIVAVGAFFWWRRMAKYRERKRESERILSSRRKKGYPIF 477
Query: 451 VIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAV 510
L ++N VK Q+LPLF+ + L AT+ F ++KLG+GGFGPVY G L DGQEIAV
Sbjct: 478 FNGNLIQESMNQVKFQELPLFKLQMLIAATDYFDAANKLGEGGFGPVYRGNLPDGQEIAV 537
Query: 511 KRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570
KRLS+ASGQG EEFMNEV+VIS+LQH+NLVRLLGCCVEG+EKML+YEYMPN+SLDA LFD
Sbjct: 538 KRLSRASGQGQEEFMNEVVVISELQHKNLVRLLGCCVEGDEKMLVYEYMPNKSLDASLFD 597
Query: 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
P++KE LDW+KRFNI++GI RGLLYLHRDSRLRIIHRDLK SNILLD+ELNPKISDFGMA
Sbjct: 598 PVRKEVLDWKKRFNIVDGICRGLLYLHRDSRLRIIHRDLKPSNILLDQELNPKISDFGMA 657
Query: 631 KIFGGNQDQADTGRVVGT 648
+IFGGN+D T RVVGT
Sbjct: 658 RIFGGNEDHVKTRRVVGT 675
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224078778|ref|XP_002305625.1| predicted protein [Populus trichocarpa] gi|222848589|gb|EEE86136.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1991), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 395/676 (58%), Positives = 492/676 (72%), Gaps = 34/676 (5%)
Query: 2 IPIALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG 61
I +ALL+ L S FC++ AID+ ITS+Q ++DP+AI+SNG+ + LGFF+P +S RY+G
Sbjct: 8 ISVALLL-LTSSFCVEIITAIDT-ITSTQFLKDPEAIVSNGNIYTLGFFSPVNSTDRYVG 65
Query: 62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
IW++ IWVANR+NPL DSSGI+ IS+DG LV++NGQ+E+LWS+NVSN V+NS S
Sbjct: 66 IWFNEVPVVTAIWVANRNNPLNDSSGILAISKDGALVVLNGQQEILWSTNVSNFVSNS-S 124
Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
AQL D+GNLVLRDN N I+WESFQ P+D+F M ++RTG K +TSWKS +DPS
Sbjct: 125 AQLSDTGNLVLRDNNNEEIMWESFQYPSDTFFSNMKLSANKRTGGKTLITSWKSATDPSI 184
Query: 182 GSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF--------- 232
GSFSAGL H +IPEIF+W + PY+RSGPWN +FIG+P + S + N
Sbjct: 185 GSFSAGLNHLDIPEIFIWKDNYPYFRSGPWNRLVFIGVPYMNSAAVDGLNLVDDGEGTID 244
Query: 233 -TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
TF +AN + F LT+QG LE+ W ++ V + +C+ YG+CG FG CN+Q
Sbjct: 245 LTFSYANQSIMSSFVLTSQGQLEQTRWEHGMEDRIVLWSVPMFDCEFYGRCGLFGSCNAQ 304
Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCER-RNITGKVGKEDGFSKLNKMKV 348
PICSCL GFEP N EEW GNWT GCIRR LQCER ++ + GK D F KL MKV
Sbjct: 305 ASPICSCLRGFEPNNPEEWYVGNWTGGCIRRKSLQCERVKSESEAAGKNDVFLKLGNMKV 364
Query: 349 PDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIR 408
PD +W S TE EC+++CL NCSCIAYA+D GIGCM W +LID+Q P GG DLYIR
Sbjct: 365 PDLAQW-SRLTEIECKDKCLTNCSCIAYAYDSGIGCMSWIG-DLIDVQEFPTGGADLYIR 422
Query: 409 VANSDVDEKGKKDVFV--SPLIKGMFALAICTLFLWRWIAK-RKEVIAK----------- 454
+A S++D +K V V S +I + + IC L WR+++K R E +
Sbjct: 423 MAYSELDGNHRKKVIVIVSAVIGTITSAMICALLTWRFMSKHRGEKLHSDTNEKHPSFLD 482
Query: 455 --LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR 512
++ +++ VKLQ+LPLF E L AT+ F LS+KLGQGGFGPVY G+L DG+EIAVKR
Sbjct: 483 RDMAGDSMDHVKLQELPLFSLESLTAATDGFDLSNKLGQGGFGPVYKGKLSDGKEIAVKR 542
Query: 513 LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL 572
LS+ASGQGL+EFMNEV VISKLQHRNLVRLLGCCVEGEEK+L+YEYMPN+SLDA L+DPL
Sbjct: 543 LSRASGQGLKEFMNEVEVISKLQHRNLVRLLGCCVEGEEKLLVYEYMPNKSLDAFLYDPL 602
Query: 573 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
+K+ LDW+KRFNIIEGI RGLLYLHRDSRLRIIHRDLKASNILLD EL PKISDFG A+I
Sbjct: 603 RKQLLDWKKRFNIIEGICRGLLYLHRDSRLRIIHRDLKASNILLDPELKPKISDFGAARI 662
Query: 633 FGGNQDQADTGRVVGT 648
FGG++DQA+T RVVGT
Sbjct: 663 FGGDEDQANTIRVVGT 678
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359496519|ref|XP_002263029.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g11330-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 771 bits (1990), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 408/704 (57%), Positives = 495/704 (70%), Gaps = 66/704 (9%)
Query: 4 IALLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
+ L++LLS C F AID+ +TS++ I DP+ ++S+GS FKLGFF+ ADS RY+GIW
Sbjct: 9 VIALLLLLSVICFGFCTAIDT-MTSTRFIEDPETLVSDGSAFKLGFFSLADSTNRYVGIW 67
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQ 123
Y PS +IWVANRD PL DSSG++TISEDGNL+++NGQKE+ WS+NVSN NS SAQ
Sbjct: 68 YSTPSLSTIIWVANRDKPLNDSSGLVTISEDGNLLVMNGQKEIFWSTNVSNAAANS-SAQ 126
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
LLDSGNLVLRDN R I WES Q P+ SFLP M D +G+KV LTSWKS SDPS GS
Sbjct: 127 LLDSGNLVLRDNSGR-ITWESIQHPSHSFLPKMKISADTDSGEKVVLTSWKSPSDPSIGS 185
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIG-----IPELKSVYLFRHNF------ 232
FS G+ NIP+ FVWN S PYWRSGPWNGQIFIG +P++ SV+L F
Sbjct: 186 FSLGMNPLNIPQAFVWNGSHPYWRSGPWNGQIFIGQIYIGVPKMNSVFLNGFGFQVVDDK 245
Query: 233 ------TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFG 284
TF AN + ++ LT QG + E K+ WEV + + +ECDVYG CGAFG
Sbjct: 246 AGTVYETFTLANSSIFLYYVLTPQGTVVETYREDGKEEWEVTWRSNNSECDVYGTCGAFG 305
Query: 285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLN 344
ICNS PICSCL G+EPK EEW+RGNWTSGC+R++ LQCER N +G+ GK DGF +L
Sbjct: 306 ICNSGNSPICSCLRGYEPKYIEEWSRGNWTSGCVRKTPLQCERTNSSGQQGKLDGFFRLT 365
Query: 345 KMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTD 404
+KVPDF +W S A EDECREQCLKNCSC+AY++ GIGCM W S NLID+ + GG D
Sbjct: 366 TVKVPDFADW-SLALEDECREQCLKNCSCMAYSYYSGIGCMSW-SGNLIDLGKFTQGGAD 423
Query: 405 LYIRVANSDVD-----------------EKGKKDVFVSPLIKGMFALAICTLFLWRWIAK 447
LYIR+ANS+++ ++ K + ++ G A+ I T F WRW +
Sbjct: 424 LYIRLANSELEWNMRTPKLIKHLMATYKKRDMKAIISVTIVIGTIAIGIYTYFSWRW--R 481
Query: 448 RKEVIAKLS--------------------ATNVNTVKLQDLPLFQFEELATATNNFQLSS 487
RK+ + S N N KL++LPL E+L TATNNF ++
Sbjct: 482 RKQTVKDKSKEILLSDRGDAYQIYDMNRLGDNANQFKLEELPLLALEKLETATNNFHEAN 541
Query: 488 KLGQGGFGPVY---WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
KLGQGGFGPVY G+L GQEIAVKRLS+AS QGLEEF NEV+VISK+QHRNLVRLLG
Sbjct: 542 KLGQGGFGPVYRVMLGKLPGGQEIAVKRLSRASAQGLEEFGNEVVVISKIQHRNLVRLLG 601
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
C+EG+EK+LIYEYMPN+SLD+ LFDPLK++ LDWR+RFNIIEGI RGLLYLHRDSR RI
Sbjct: 602 YCIEGDEKLLIYEYMPNKSLDSFLFDPLKRDFLDWRRRFNIIEGIGRGLLYLHRDSRFRI 661
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
IHRDLKASNILLDE+L KISDFG+A+I GGNQDQA+T RVVGT
Sbjct: 662 IHRDLKASNILLDEDLTAKISDFGIARIVGGNQDQANTMRVVGT 705
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|296084622|emb|CBI25710.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 761 bits (1966), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 392/662 (59%), Positives = 489/662 (73%), Gaps = 26/662 (3%)
Query: 9 ILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPS 68
+LL+CF F + +ITS+ I+DP+ I+S+G FKLGFF+ S RY+GIWY+ S
Sbjct: 11 LLLTCFWFVFGCSAIDTITSTHFIKDPETIVSSGRVFKLGFFSLDGSSNRYVGIWYNTTS 70
Query: 69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSG 128
+IWVAN+D PL DSSG++TISEDGN+ ++NG+KE+LWSSNVSN ++SAQL DSG
Sbjct: 71 LLTIIWVANKDRPLNDSSGVLTISEDGNIQVLNGRKEILWSSNVSNPAAVNSSAQLQDSG 130
Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
NLVLRD N VWES Q P+ SF+P M + RT + LTSWKS SDPS GSF+AG+
Sbjct: 131 NLVLRDK-NGVSVWESLQNPSHSFVPQMKISTNTRTRVRKVLTSWKSSSDPSMGSFTAGV 189
Query: 189 IHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF----------TFGFAN 238
NIP++F+WN SRPYWRSGPW+GQI G+ ++K + L N TF
Sbjct: 190 EPLNIPQVFIWNGSRPYWRSGPWDGQILTGV-DVKWITLDGLNIVDDKEGTVYVTFAHPE 248
Query: 239 DWTFFA--LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
F+A LT +GIL E K ++WE + EC++YGKCG FG CNS++ PICSC
Sbjct: 249 SGFFYAYVLTPEGILVETSRDKRNEDWERVWTTKENECEIYGKCGPFGHCNSRDSPICSC 308
Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
L+G+EPK+ +EWNRGNWT GC+R++ LQCER + K DGF KL MKVPDF E S
Sbjct: 309 LKGYEPKHTQEWNRGNWTGGCVRKTPLQCERTKNGSEEAKVDGFLKLTNMKVPDFAE-QS 367
Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
A ED+CR+QCL+NCSCIAY++ GIGCM W S +LIDIQ+L G +L+IRVA+S++ +
Sbjct: 368 YALEDDCRQQCLRNCSCIAYSYYTGIGCMWW-SGDLIDIQKLSSTGANLFIRVAHSELKQ 426
Query: 417 KGKKDV---FVSPLIKGMFALAICTLFLWRWIAKRKE--VIAKLS-----ATNVNTVKLQ 466
K+D + +I G A+A+CT FL RWIA+++ +I K S VN VKL+
Sbjct: 427 DRKRDARVIVIVTVIIGTIAIALCTYFLRRWIARQRGNLLIGKFSDPSVPGDGVNQVKLE 486
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN 526
+LPL F +LATATNNF ++KLGQGGFGPVY G+L +GQ+IAVKRLS+AS QGLEEFMN
Sbjct: 487 ELPLIDFNKLATATNNFHEANKLGQGGFGPVYRGKLAEGQDIAVKRLSRASTQGLEEFMN 546
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
EV+VISKLQHRNLVRL+GCC+EG+EKMLIYE+MPN+SLDA LFDP+K++ LDWR RF II
Sbjct: 547 EVVVISKLQHRNLVRLIGCCIEGDEKMLIYEFMPNKSLDASLFDPVKRQILDWRTRFKII 606
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
EGI RGLLYLHRDSRLRIIHRDLKASNILLDE+LNPKISDFGMA+IFG NQDQA+T RVV
Sbjct: 607 EGIGRGLLYLHRDSRLRIIHRDLKASNILLDEDLNPKISDFGMARIFGSNQDQANTKRVV 666
Query: 647 GT 648
GT
Sbjct: 667 GT 668
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147840284|emb|CAN63987.1| hypothetical protein VITISV_016155 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 754 bits (1948), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 388/677 (57%), Positives = 475/677 (70%), Gaps = 59/677 (8%)
Query: 12 SCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKA 71
S C F A D+ ITS+Q I+DP+ ++SNGS FK+GFF+P +S RY GIWY+ S
Sbjct: 17 SGLCFQFCTATDT-ITSTQFIKDPETMVSNGSLFKMGFFSPGNSTKRYFGIWYNSTSLFT 75
Query: 72 VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
VIW+ANR+NPL DSSGI+ +SEDGNL+++N QKE+ WSSNVSN NS AQLLDSGNLV
Sbjct: 76 VIWIANRENPLNDSSGIVMVSEDGNLLVLNDQKEIFWSSNVSNAALNS-RAQLLDSGNLV 134
Query: 132 LRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQ 191
L+D + I W+SFQ P+ +FL M + +TG+K LTSWKS SDPS GSFS G+
Sbjct: 135 LQDKNSGRITWQSFQHPSHAFLQKMELSENMKTGEKQGLTSWKSPSDPSVGSFSTGIDPS 194
Query: 192 NIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFR----------HNFTFGFANDWT 241
+IPEIFVWN SRP+WRSGPWNGQ IG+P++ + F F +A+
Sbjct: 195 DIPEIFVWNGSRPFWRSGPWNGQTLIGVPDMNYLNGFHIVNDKEGNVSVTFEHAYASILW 254
Query: 242 FFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFE 301
++ L+ QG + E NWE+ + + +TECDVYGKCGAFGICN++ PICSCL G+E
Sbjct: 255 YYVLSPQGTIVEIYSDDGMKNWEITWQSRKTECDVYGKCGAFGICNAKNSPICSCLRGYE 314
Query: 302 PKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATED 361
P+N EEW+RGNWT GC+R++ QCE+ N + + G+ DGF +L +KVPDF EW S A ED
Sbjct: 315 PRNIEEWSRGNWTGGCVRKTPFQCEKINGSMEEGEADGFIRLTTVKVPDFAEW-SLALED 373
Query: 362 ECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDEKGKKD 421
+C+E CLKNCSCIAYA+ GIGCM W S NL D+Q+ G DLYIRV S++
Sbjct: 374 DCKEFCLKNCSCIAYAYYTGIGCMSW-SRNLTDVQKFSSNGADLYIRVPYSEL------- 425
Query: 422 VFVSPLIKGMFALAICTLFLWRWI---------------AKRKEVIAKLSATNV-----N 461
G +A+ F RWI + R +V +S N+ N
Sbjct: 426 --------GTIFVAVFIYFSRRWITKRRAKNKKRKEMLSSDRGDVHLNVSDANILGDRMN 477
Query: 462 TVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVY----------WGRLKDGQEIAVK 511
VKL++LPL F +L TATNNF ++KLGQGGFG VY GRL +GQEIAVK
Sbjct: 478 QVKLEELPLVDFGKLVTATNNFDEANKLGQGGFGSVYRVMLAHLELHGGRLPEGQEIAVK 537
Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
RLS+AS QGLEEFMNEV+VISKLQHRNLVRLLGCC+EG+EKMLIYEYMP +SLDALLFDP
Sbjct: 538 RLSRASAQGLEEFMNEVVVISKLQHRNLVRLLGCCIEGDEKMLIYEYMPKKSLDALLFDP 597
Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L++E LDW+KRF+IIEGI RGLLYLHRDSRLRIIHRDLKASNILLD LNPKISDFGMA+
Sbjct: 598 LRQETLDWKKRFSIIEGIGRGLLYLHRDSRLRIIHRDLKASNILLDXNLNPKISDFGMAR 657
Query: 632 IFGGNQDQADTGRVVGT 648
IFGGNQDQA+T RVVGT
Sbjct: 658 IFGGNQDQANTIRVVGT 674
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 649 | ||||||
| TAIR|locus:2200888 | 804 | AT1G61500 [Arabidopsis thalian | 0.964 | 0.778 | 0.448 | 3.4e-141 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.973 | 0.785 | 0.434 | 4.3e-141 | |
| TAIR|locus:2197664 | 804 | AT1G61490 [Arabidopsis thalian | 0.976 | 0.788 | 0.440 | 1.1e-140 | |
| TAIR|locus:2200923 | 802 | AT1G61550 [Arabidopsis thalian | 0.967 | 0.783 | 0.430 | 4.9e-140 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.286 | 0.219 | 0.704 | 1.7e-139 | |
| TAIR|locus:2197744 | 807 | AT1G61420 [Arabidopsis thalian | 0.970 | 0.780 | 0.437 | 7.2e-139 | |
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.628 | 0.521 | 0.377 | 1.9e-138 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.662 | 0.505 | 0.360 | 2.4e-138 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.691 | 0.532 | 0.336 | 6.5e-138 | |
| TAIR|locus:2197709 | 809 | AT1G61480 [Arabidopsis thalian | 0.972 | 0.779 | 0.430 | 2.8e-137 |
| TAIR|locus:2200888 AT1G61500 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1381 (491.2 bits), Expect = 3.4e-141, P = 3.4e-141
Identities = 297/662 (44%), Positives = 407/662 (61%)
Query: 10 LLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSN-FKLGFFNPADSPYRYMGIWYDMPS 68
L + F S++ +++ LS+ + ++LGFF+P ++ +Y+GIW+
Sbjct: 10 LFTMFLFTLLSGSSSAVITTESPLSMGQTLSSANEVYELGFFSPNNTQDQYVGIWFKDTI 69
Query: 69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSG 128
+ V+WVANR+ P+ DS+ + IS G+L+L+NG K A+L DSG
Sbjct: 70 PRVVVWVANREKPVTDSTAYLAISSSGSLLLLNG-KHGTVWSSGVTFSSSGCRAELSDSG 128
Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
NL + DN++ +W+SF D+ L + T +K LTSWKS +DPS G F G
Sbjct: 129 NLKVIDNVSERALWQSFDHLGDTLLHTSSLTYNLATAEKRVLTSWKSYTDPSPGDF-LGQ 187
Query: 189 IHQNIP-EIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR-HNFTFG------FAN 238
I +P + FV S PYWRSGPW F GIP + Y F H G F
Sbjct: 188 ITPQVPSQGFVMRGSTPYWRSGPWAKTRFTGIPFMDESYTGPFTLHQDVNGSGYLTYFQR 247
Query: 239 DWTF--FALTAQGILEERIWIKWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPI 293
D+ LT++G ++ ++DN WE+ + + CD YG CG FG+C P+
Sbjct: 248 DYKLSRITLTSEGSIK-----MFRDNGMGWELYYEAPKKLCDFYGACGPFGLCVMSPSPM 302
Query: 294 CSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTE 353
C C GF PK+ EEW RGNWT GC+R ++L C N TG+ D F ++ +K PDF E
Sbjct: 303 CKCFRGFVPKSVEEWKRGNWTGGCVRHTELDC-LGNSTGE--DADDFHQIANIKPPDFYE 359
Query: 354 WTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSD 413
+ S +EC ++C+ NCSC+A+A+ GIGC+VW +L+D + G L IR+A S+
Sbjct: 360 FASSVNAEECHQRCVHNCSCLAFAYIKGIGCLVWNQ-DLMDAVQFSATGELLSIRLARSE 418
Query: 414 VD-EKGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKEVIAKLSATN-VNTVKLQDLPL 470
+D K KK + S + +F + T F +WR R E IA +S N +K QD+P
Sbjct: 419 LDGNKRKKTIVASIVSLTLFMILGFTAFGVWRC---RVEHIAHISKDAWKNDLKPQDVPG 475
Query: 471 FQFEELAT---ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
F ++ T ATNNF LS+KLGQGGFG VY G+L+DG+EIAVKRLS +SGQG EEFMNE
Sbjct: 476 LDFFDMHTIQNATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 535
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
+++ISKLQHRNLVR+LGCC+E EEK+LIYE+M N+SLD LFD K+ +DW KRF+II+
Sbjct: 536 IVLISKLQHRNLVRVLGCCIEEEEKLLIYEFMVNKSLDTFLFDSRKRLEIDWPKRFDIIQ 595
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
GI+RGLLYLH DSRLR+IHRDLK SNILLDE++NPKISDFG+A+++ G + Q +T RVVG
Sbjct: 596 GIARGLLYLHHDSRLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVG 655
Query: 648 TL 649
TL
Sbjct: 656 TL 657
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1380 (490.8 bits), Expect = 4.3e-141, P = 4.3e-141
Identities = 291/669 (43%), Positives = 415/669 (62%)
Query: 1 MIPIALLIILLSCFCLDFAVAIDSSITSSQL-IRDPDAILSNGSNFKLGFFNPADSPYRY 59
M+ A L++L+ +A AI+ TSS L IR + S G ++LGFF+P ++ +Y
Sbjct: 3 MVLFACLLLLIIFPTCGYA-AIN---TSSPLSIRQ--TLSSPGGFYELGFFSPNNTQNQY 56
Query: 60 MGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXX 119
+GIW+ + V+WVANRD P+ S+ +TIS +G+L+L++G K+
Sbjct: 57 VGIWFKKIVPRVVVWVANRDTPVTSSAANLTISSNGSLILLDG-KQDVIWSTGKAFTSNK 115
Query: 120 TSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDP 179
A+LLD+GN V+ D+++ +W+SF+ ++ LP D GKK LT+WKS SDP
Sbjct: 116 CHAELLDTGNFVVIDDVSGNKLWQSFEHLGNTMLPQSSLMYDTSNGKKRVLTTWKSNSDP 175
Query: 180 STGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR-------- 229
S G FS + Q + + S PYWR GPW F GI + + Y+ F
Sbjct: 176 SPGEFSLEITPQIPTQGLIRRGSVPYWRCGPWAKTRFSGISGIDASYVSPFSVVQDTAAG 235
Query: 230 -HNFTFGFANDW--TFFALTAQGILEERIWIKWKD--NWEVGFLNLRTECDVYGKCGAFG 284
+F++ ++ ++ LT +G ++ I W D NW++ CD+YG+CG +G
Sbjct: 236 TGSFSYSTLRNYNLSYVTLTPEGKMK----ILWDDGNNWKLHLSLPENPCDLYGRCGPYG 291
Query: 285 ICNSQEKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKE-DGFSKL 343
+C + P C CL+GF PK+ EEW +GNWTSGC+RR+KL C+ ++ GK+ D F ++
Sbjct: 292 LCVRSDPPKCECLKGFVPKSDEEWGKGNWTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRM 351
Query: 344 NKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGT 403
+K PD ++ S ++C + CL NCSC A+A+ GIGC+VW L D + G
Sbjct: 352 TDVKTPDLHQFASFLNAEQCYQGCLGNCSCTAFAYISGIGCLVWNG-ELADTVQFLSSGE 410
Query: 404 DLYIRVANSDVDEKGKKDVFVSPLIK-GMFALAI-CTLFLWRWIAKRKEVIAK-LSATNV 460
L+IR+A+S++ ++ + V + +F + + + LWR+ AK+ + +V
Sbjct: 411 FLFIRLASSELAGSSRRKIIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDV 470
Query: 461 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG 520
+ V F+ + TATNNF S+KLGQGGFGPVY G+L DG+EI VKRL+ +SGQG
Sbjct: 471 SGVNF-----FEMHTIRTATNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQG 525
Query: 521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
EEFMNE+ +ISKLQHRNLVRLLG C++GEEK+LIYE+M N+SLD +FDP K LDW
Sbjct: 526 TEEFMNEITLISKLQHRNLVRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWP 585
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
KRFNII+GI+RGLLYLHRDSRLR+IHRDLK SNILLD+ +NPKISDFG+A++F G Q Q
Sbjct: 586 KRFNIIQGIARGLLYLHRDSRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQD 645
Query: 641 DTGRVVGTL 649
+T RVVGTL
Sbjct: 646 NTRRVVGTL 654
|
|
| TAIR|locus:2197664 AT1G61490 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1376 (489.4 bits), Expect = 1.1e-140, P = 1.1e-140
Identities = 290/659 (44%), Positives = 403/659 (61%)
Query: 8 IILLSCFCLDFAVAIDSS---ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWY 64
I+ +C L F V + S IT+ + + S+ ++LGFF+P +S Y+GIW+
Sbjct: 6 IVFFACLLL-FTVLLRFSYAGITTESPLSVEQTLSSSNGIYELGFFSPNNSQNLYVGIWF 64
Query: 65 DMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQL 124
+ V+WVANR+ P D+S + IS +G+L+L NG K + A+L
Sbjct: 65 KGIIPRVVVWVANRETPTTDTSANLAISSNGSLLLFNG-KHGVVWSIGENFASNGSRAEL 123
Query: 125 LDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSF 184
D+GNLV+ DN + +WESF+ D+ LP + TG+K LTSWK+ +DPS G F
Sbjct: 124 TDNGNLVVIDNASGRTLWESFEHFGDTMLPFSSLMYNLATGEKRVLTSWKTDTDPSPGVF 183
Query: 185 SAGLIHQNIP-EIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGFANDWTFF 243
G I +P ++ + S Y+R+GPW F GIP + Y + AN FF
Sbjct: 184 -VGQITPQVPSQVLIMRGSTRYYRTGPWAKTRFTGIPLMDDTYASPFSLQQD-ANGSGFF 241
Query: 244 ALTAQGILEERIWI-------KWKDN---WEVGFLNLRTECDVYGKCGAFGICNSQEKPI 293
+ RI I +++ N WE+ ++ CD+YG CG FG+C
Sbjct: 242 TYFDRSFKLSRIIISSEGSMKRFRHNGTDWELSYMAPANSCDIYGVCGPFGLCIVSVPLK 301
Query: 294 CSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTE 353
C CL+GF P + EEW RGNWT GC R ++L C+ N TGK + F + +K+PDF E
Sbjct: 302 CKCLKGFVPHSTEEWKRGNWTGGCARLTELHCQG-NSTGK--DVNIFHPVTNVKLPDFYE 358
Query: 354 WTSPATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSD 413
+ S +EC + CL NCSC+A+A+ GIGC++W NL+D + GG L IR+A+S+
Sbjct: 359 YESSVDAEECHQSCLHNCSCLAFAYIHGIGCLIWNQ-NLMDAVQFSAGGEILSIRLAHSE 417
Query: 414 VD-EKGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKEVIAKLSATN-VNTVKLQDLPL 470
+ K K + S + +F + F WR+ K K K + N + + ++ L
Sbjct: 418 LGGNKRNKIIVASTVSLSLFVILTSAAFGFWRYRVKHKAYTLKDAWRNDLKSKEVPGLEF 477
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 530
F+ + TATNNF LS+KLGQGGFG VY G+L+DG+EIAVK+LS +SGQG EEFMNE+++
Sbjct: 478 FEMNTIQTATNNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKQLSSSSGQGKEEFMNEIVL 537
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
ISKLQHRNLVR+LGCC+EGEEK+LIYE+M N+SLD +FD KK +DW KRF+I++GI+
Sbjct: 538 ISKLQHRNLVRVLGCCIEGEEKLLIYEFMLNKSLDTFVFDARKKLEVDWPKRFDIVQGIA 597
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
RGLLYLHRDSRL++IHRDLK SNILLDE++NPKISDFG+A+++ G Q Q T RVVGTL
Sbjct: 598 RGLLYLHRDSRLKVIHRDLKVSNILLDEKMNPKISDFGLARMYEGTQCQDKTRRVVGTL 656
|
|
| TAIR|locus:2200923 AT1G61550 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1370 (487.3 bits), Expect = 4.9e-140, P = 4.9e-140
Identities = 284/660 (43%), Positives = 408/660 (61%)
Query: 10 LLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSE 69
L S L F+ A +IT + + + S F+LGFF+P +S Y+GIW+
Sbjct: 8 LFSTLLLSFSYA---AITPTSPLSIGQTLSSPNGIFELGFFSPNNSRNLYVGIWFKGIIP 64
Query: 70 KAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSGN 129
+ V+WVANR+N + D++ + IS +G+L+L +G K +SA+L DSGN
Sbjct: 65 RTVVWVANRENSVTDATADLAISSNGSLLLFDG-KHSTVWSTGETFASNGSSAELSDSGN 123
Query: 130 LVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLI 189
L++ D ++ +W+SF+ D+ LP + TG+K L+SWKS +DP G F +
Sbjct: 124 LLVIDKVSGITLWQSFEHLGDTMLPYSSLMYNPGTGEKRVLSSWKSYTDPLPGEFVGYIT 183
Query: 190 HQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFTFGF-ANDWTFFA---- 244
Q P+ F+ S+PYWRSGPW F G+P Y H F+ AN +F+
Sbjct: 184 TQVPPQGFIMRGSKPYWRSGPWAKTRFTGVPLTDESYT--HPFSVQQDANGSVYFSHLQR 241
Query: 245 --------LTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
LT++G L ++ +W + CD YG CG FG+C P C C
Sbjct: 242 NFKRSLLVLTSEGSL--KVTHHNGTDWVLNIDVPANTCDFYGVCGPFGLCVMSIPPKCKC 299
Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
+GF P+ +EEW RGNWT GC+RR++L C+ N TG+ + F + +K PDF E+ S
Sbjct: 300 FKGFVPQFSEEWKRGNWTGGCVRRTELLCQG-NSTGR--HVNVFHPVANIKPPDFYEFVS 356
Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
+ +EC + CL NCSC+A+A+ GIGC++W L+D+ + GG L IR+A+S++
Sbjct: 357 SGSAEECYQSCLHNCSCLAFAYINGIGCLIWNQ-ELMDVMQFSVGGELLSIRLASSEMGG 415
Query: 417 KGKKDVFVSPLIK-GMFA-LAICTLFLWRWIAKRKEVIAKLSATNV--NTVKLQDLPLFQ 472
+K ++ ++ +F LA WR+ K +++K+S N +K +D+
Sbjct: 416 NQRKKTIIASIVSISLFVTLASAAFGFWRYRLKHNAIVSKVSLQGAWRNDLKSEDVSGLY 475
Query: 473 FEELAT---ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVM 529
F E+ T ATNNF L +KLGQGGFGPVY G+L+DG+EIAVKRLS +SGQG EEFMNE++
Sbjct: 476 FFEMKTIEIATNNFSLVNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIL 535
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
+ISKLQH NLVR+LGCC+EGEE++L+YE+M N+SLD +FD K+ +DW KRF+II+GI
Sbjct: 536 LISKLQHINLVRILGCCIEGEERLLVYEFMVNKSLDTFIFDSRKRVEIDWPKRFSIIQGI 595
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+RGLLYLHRDSRLRIIHRD+K SNILLD+++NPKISDFG+A+++ G + Q +T R+VGTL
Sbjct: 596 ARGLLYLHRDSRLRIIHRDVKVSNILLDDKMNPKISDFGLARMYEGTKYQDNTRRIVGTL 655
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 700 (251.5 bits), Expect = 1.7e-139, Sum P(2) = 1.7e-139
Identities = 131/186 (70%), Positives = 159/186 (85%)
Query: 463 VKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE 522
V +LP+F +A ATN+F ++LG+GGFGPVY G L+DG+EIAVKRLS SGQG++
Sbjct: 509 VNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVD 568
Query: 523 EFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
EF NE+++I+KLQHRNLVRLLGCC EGEEKML+YEYMPN+SLD LFD K+ +DW+ R
Sbjct: 569 EFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLR 628
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
F+IIEGI+RGLLYLHRDSRLRIIHRDLK SN+LLD E+NPKISDFGMA+IFGGNQ++A+T
Sbjct: 629 FSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANT 688
Query: 643 GRVVGT 648
RVVGT
Sbjct: 689 VRVVGT 694
|
|
| TAIR|locus:2197744 AT1G61420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1359 (483.5 bits), Expect = 7.2e-139, P = 7.2e-139
Identities = 289/660 (43%), Positives = 400/660 (60%)
Query: 9 ILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPS 68
+LLS F F + + IT + + S+ ++LGFFN +S +Y+GIW+
Sbjct: 12 LLLSSF---FISSSSAGITKESPLPIGQTLSSSNGFYELGFFNFNNSQNQYVGIWFKGII 68
Query: 69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDSG 128
+ V+WVANR+ P+ DS+ + IS +G+L+L NG K + A+L D+G
Sbjct: 69 PRVVVWVANREKPVTDSTANLAISNNGSLLLFNG-KHGVAWSSGEALVSNGSRAELSDTG 127
Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
NL++ DN + +W+SF D+ LP + TG+K L+SWKS +DPS G F +
Sbjct: 128 NLIVIDNFSGRTLWQSFDHLGDTMLPSSTLKYNLATGEKQVLSSWKSYTDPSVGDFVLQI 187
Query: 189 IHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLF----------RHNFTFGFAN 238
Q ++ V S PY+RSGPW F GIP + + + T+ N
Sbjct: 188 TPQVPTQVLVTKGSTPYYRSGPWAKTRFTGIPLMDDTFTGPVSVQQDTNGSGSLTYLNRN 247
Query: 239 D-WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCL 297
D LT++G +E W D W + F+ CD YG CG FG+C P C+C
Sbjct: 248 DRLQRTMLTSKGT-QELSWHNGTD-WVLNFVAPEHSCDYYGVCGPFGLCVKSVPPKCTCF 305
Query: 298 EGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSP 357
+GF PK EEW RGNWT GC+RR++L C+ N TGK F + ++K PDF E+ S
Sbjct: 306 KGFVPKLIEEWKRGNWTGGCVRRTELYCQG-NSTGKYANV--FHPVARIKPPDFYEFASF 362
Query: 358 ATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVD-E 416
+EC++ CL NCSC+A+A+ GIGC++W +L+D + GG L IR+A S++
Sbjct: 363 VNVEECQKSCLHNCSCLAFAYIDGIGCLMWNQ-DLMDAVQFSEGGELLSIRLARSELGGN 421
Query: 417 KGKKDVFVSPLIKGMFALAICTLF-LWRWIAKRKEVIAKLSATNV---NTVKLQDLP--- 469
K KK + S + + + F WR+ K I A+ V N +K QD+P
Sbjct: 422 KRKKAITASIVSLSLVVIIAFVAFCFWRYRVKHNADITT-DASQVSWRNDLKPQDVPGLD 480
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVM 529
F + TATNNF +S+KLGQGGFGPVY G+L+DG+EIAVKRLS +SGQG EEFMNE++
Sbjct: 481 FFDMHTIQTATNNFSISNKLGQGGFGPVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNEIV 540
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
+ISKLQH+NLVR+LGCC+EGEEK+LIYE+M N SLD LFD K+ +DW KR +II+GI
Sbjct: 541 LISKLQHKNLVRILGCCIEGEEKLLIYEFMLNNSLDTFLFDSRKRLEIDWPKRLDIIQGI 600
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+RG+ YLHRDS L++IHRDLK SNILLDE++NPKISDFG+A+++ G + Q +T RVVGTL
Sbjct: 601 ARGIHYLHRDSHLKVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVVGTL 660
|
|
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 762 (273.3 bits), Expect = 1.9e-138, Sum P(2) = 1.9e-138
Identities = 167/442 (37%), Positives = 251/442 (56%)
Query: 6 LLIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYD 65
L+I L S L A A D I ++Q ++D D I+S G +F++GFF+P S RY+GIWY
Sbjct: 10 LIISLFSTILL--AQATDILI-ANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYK 66
Query: 66 MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTS---- 121
S + V+WVANRD+PL D SG + +SE+G+L L N + +
Sbjct: 67 KISLQTVVWVANRDSPLYDLSGTLKVSENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPI 126
Query: 122 AQLLDSGNLVLRDN-INRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS 180
Q+LD+GNLV+R++ ++ +W+S P D FLPGM +G++ TG LTSW+++ DPS
Sbjct: 127 VQILDTGNLVVRNSGDDQDYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPS 186
Query: 181 TGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNF-------- 232
TG+++ + +P+ F+ S +R+GPWNG F G+P LK ++R+ +
Sbjct: 187 TGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVY 246
Query: 233 -TFGFAND--WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
T+ N T L G L+ W+ +W + CD Y CG++G CN
Sbjct: 247 YTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYLSAMMDSCDQYTLCGSYGSCNIN 306
Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
E P C CL+GF K + W G+W+ GC+RR KL C GK G EDGF K++K+K+P
Sbjct: 307 ESPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDC------GK-G-EDGFLKISKLKLP 358
Query: 350 DF-TEWTSPATE-DECREQCLKNCSCIAYA-FD---GGIGCMVWRSINLIDIQRLPFGGT 403
D T W + +EC++ CL+NC+C AY+ FD GG GC++W +LIDI+ G
Sbjct: 359 DTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFG-DLIDIREYNENGQ 417
Query: 404 DLYIRVANSDVDEKGKKDVFVS 425
DLY+R+A+S+++ ++ VS
Sbjct: 418 DLYVRLASSEIETLQRESSRVS 439
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 739 (265.2 bits), Expect = 2.4e-138, Sum P(2) = 2.4e-138
Identities = 170/472 (36%), Positives = 259/472 (54%)
Query: 7 LIILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPA-DSPYRYMGIWYD 65
L+IL + + A S + S I + I+S G+ F+LGFF P DS + Y+GIWY
Sbjct: 18 LLILFPAYSIS---ANTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRW-YLGIWYK 73
Query: 66 MPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTS--AQ 123
S++ +WVANRD PL S G + IS D NLV+++ Q + + A+
Sbjct: 74 AISKRTYVWVANRDTPLSSSIGTLKIS-DSNLVVLD-QSDTPVWSTNLTGGDVRSPLVAE 131
Query: 124 LLDSGNLVLRDNINRA---IVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS 180
LLD+GN VLRD+ N A ++W+SF PTD+ LP M G D +TG + SWKS DPS
Sbjct: 132 LLDNGNFVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPS 191
Query: 181 TGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFT------- 233
+G FS L + PEIF+WN +RSGPWNG F G+PE++ NFT
Sbjct: 192 SGDFSFKLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVT 251
Query: 234 FGFA---ND-WTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQ 289
+ F +D ++ ++++ G+L+ WI+ NW + + +CD Y +CG +G C+S
Sbjct: 252 YSFRITKSDVYSRLSISSSGLLQRFTWIETAQNWNQFWYAPKDQCDEYKECGVYGYCDSN 311
Query: 290 EKPICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVP 349
P+C+C++GF+P+N + W + + GC+R++ L C G DGF +L KMK+P
Sbjct: 312 TSPVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSC---------GGGDGFVRLKKMKLP 362
Query: 350 DFTEWTSPAT--EDECREQCLKNCSCIAYA-FD---GGIGCMVWRSINLIDIQRLPFGGT 403
D T + EC ++CL++C+C A+A D G GC+ W L DI+ GG
Sbjct: 363 DTTTASVDRGIGVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTG-ELFDIRNYAKGGQ 421
Query: 404 DLYIRVANSDVDEKGKKDVFV--SPL-IKGMFALAICTLFLWRWIAKRKEVI 452
DLY+R+A +D+++K + + S + + + L+ FLW+ KR +I
Sbjct: 422 DLYVRLAATDLEDKRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILI 473
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 718 (257.8 bits), Expect = 6.5e-138, Sum P(2) = 6.5e-138
Identities = 163/484 (33%), Positives = 261/484 (53%)
Query: 5 ALLIILLSCFCLDFAVAIDS-SITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIW 63
+ I L+ L F+V+ ++ S T S I I+S F+LGFFNPA S Y+GIW
Sbjct: 10 SFFIFLILILFLAFSVSPNTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIW 69
Query: 64 YDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQ 123
Y + + +WVANRDNPL S+G + IS + ++ + +A+
Sbjct: 70 YKIIPIRTYVWVANRDNPLSSSNGTLKISGNNLVIFDQSDRPVWSTNITGGDVRSPVAAE 129
Query: 124 LLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGS 183
LLD+GN +LRD+ NR ++W+SF PTD+ L M G DQ+TG L SWK+ DPS+G
Sbjct: 130 LLDNGNFLLRDSNNR-LLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGE 188
Query: 184 FSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYLFRHNFT-------FGF 236
FS L PE ++ + +RSGPWNG F +P V +NFT + +
Sbjct: 189 FSTKLETSEFPEFYICSKESILYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSY 248
Query: 237 ----ANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKP 292
N ++ L + G+L+ W + +W+ + + + CD Y CG FG C+S P
Sbjct: 249 RINKTNLYSRLYLNSAGLLQRLTWFETTQSWKQLWYSPKDLCDNYKVCGNFGYCDSNSLP 308
Query: 293 ICSCLEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFT 352
C C++GF+P N + W+ + ++GC+R+++L C+ R DGF++L +MK+PD T
Sbjct: 309 NCYCIKGFKPVNEQAWDLRDGSAGCMRKTRLSCDGR---------DGFTRLKRMKLPDTT 359
Query: 353 EWTSPATE---DECREQCLKNCSCIAYAF----DGGIGCMVWRSINLIDIQRLPFGGTDL 405
T E C+E+CL++C+C A+A +GG GC++W ++D++ GG DL
Sbjct: 360 A-TIVDREIGLKVCKERCLEDCNCTAFANADIRNGGSGCVIWTR-EILDMRNYAKGGQDL 417
Query: 406 YIRVANSDVDEKG-KKDVFVSPLIKGMFALAICTLFLWR-WIAKRKEVIAKLSATNVNTV 463
Y+R+A +++++K K + + I G+ L + + ++ W K+K I + NV+ V
Sbjct: 418 YVRLAAAELEDKRIKNEKIIGSSI-GVSILLLLSFVIFHFWKRKQKRSIT-IQTPNVDQV 475
Query: 464 KLQD 467
+ QD
Sbjct: 476 RSQD 479
|
|
| TAIR|locus:2197709 AT1G61480 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
Identities = 285/662 (43%), Positives = 408/662 (61%)
Query: 8 IILLSCFCLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMP 67
++L++ F L F+ A IT + + S+ ++LGFF+ +S +Y+GIW+
Sbjct: 12 LLLITIF-LSFSYA---GITRESPLSIGKTLSSSNGVYELGFFSFNNSQNQYVGIWFKGI 67
Query: 68 SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEXXXXXXXXXXXXXXTSAQLLDS 127
+ V+WVANR+ P+ DS+ +TIS +G+L+L N + + A+L D+
Sbjct: 68 IPRVVVWVANREKPVTDSAANLTISSNGSLLLFN-ENHSVVWSIGETFASNGSRAELTDN 126
Query: 128 GNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAG 187
GNLV+ DN + +WESF+ D+ LP + + TG+K LTSWKS +DPS G F+
Sbjct: 127 GNLVVIDNNSGRTLWESFEHFGDTMLPFSNLMYNLATGEKRVLTSWKSHTDPSPGDFTVQ 186
Query: 188 LIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVYL--FR--------HNFTFGFA 237
+ Q + S+ YWRSGPW F GIP + Y F +FT+
Sbjct: 187 ITPQVPSQACTMRGSKTYWRSGPWAKTRFTGIPVMDDTYTSPFSLQQDTNGSGSFTYFER 246
Query: 238 N-DWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSC 296
N ++ +T++G L +I+ +WE+ F CD+YG CG FGIC P C C
Sbjct: 247 NFKLSYIMITSEGSL--KIFQHNGMDWELNFEAPENSCDIYGFCGPFGICVMSVPPKCKC 304
Query: 297 LEGFEPKNAEEWNRGNWTSGCIRRSKLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTS 356
+GF PK+ EEW RGNWT GC+R ++L C+ N GK +GF + +K PDF E+ S
Sbjct: 305 FKGFVPKSIEEWKRGNWTDGCVRHTELHCQG-NTNGKT--VNGFYHVANIKPPDFYEFAS 361
Query: 357 PATEDECREQCLKNCSCIAYAFDGGIGCMVWRSINLIDIQRLPFGGTDLYIRVANSDVDE 416
+ C + CL NCSC+A+A+ GIGC++W +L+D + GG L IR+A+S++
Sbjct: 362 FVDAEGCYQICLHNCSCLAFAYINGIGCLMWNQ-DLMDAVQFSAGGEILSIRLASSELGG 420
Query: 417 KGKKDVFVSPLIK-GMFA-LAICTLFLWRWIAKR--KEVIAKLSATNV--NTVKLQD--- 467
+ + V+ ++ +F LA R+ K I+K+++ N ++ QD
Sbjct: 421 NKRNKIIVASIVSLSLFVILAFAAFCFLRYKVKHTVSAKISKIASKEAWNNDLEPQDVSG 480
Query: 468 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
L F+ + TAT+NF LS+KLGQGGFG VY G+L+DG+EIAVKRLS +SGQG EEFMNE
Sbjct: 481 LKFFEMNTIQTATDNFSLSNKLGQGGFGSVYKGKLQDGKEIAVKRLSSSSGQGKEEFMNE 540
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
+++ISKLQH+NLVR+LGCC+EGEE++L+YE++ N+SLD LFD K+ +DW KRFNIIE
Sbjct: 541 IVLISKLQHKNLVRILGCCIEGEERLLVYEFLLNKSLDTFLFDSRKRLEIDWPKRFNIIE 600
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
GI+RGL YLHRDS LR+IHRDLK SNILLDE++NPKISDFG+A+++ G + Q +T RV G
Sbjct: 601 GIARGLHYLHRDSCLRVIHRDLKVSNILLDEKMNPKISDFGLARMYQGTEYQDNTRRVAG 660
Query: 648 TL 649
TL
Sbjct: 661 TL 662
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00010996001 | SubName- Full=Chromosome undetermined scaffold_298, whole genome shotgun sequence; (813 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 649 | |||
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-43 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 7e-43 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-38 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-38 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-38 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-37 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 7e-37 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-33 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-32 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 6e-31 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-29 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-29 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 6e-29 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 4e-27 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-26 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-24 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-24 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 8e-24 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 2e-23 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-23 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 3e-23 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 5e-23 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 7e-23 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-22 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 3e-22 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-22 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-22 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-22 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-22 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 8e-22 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-21 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 1e-21 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-21 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-21 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-20 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 2e-20 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-20 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 5e-20 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 8e-20 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-19 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-19 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 6e-19 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-19 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 9e-19 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 1e-18 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-18 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-18 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-18 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-18 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 4e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-18 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 4e-18 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 6e-18 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 6e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 6e-18 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 1e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 4e-17 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 5e-17 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-17 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 6e-17 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 6e-17 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 6e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-17 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 9e-17 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-17 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-16 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-16 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-16 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 2e-16 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-16 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 2e-16 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-16 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-16 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-16 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-16 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 4e-16 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 5e-16 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 5e-16 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 7e-16 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 8e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 9e-16 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 2e-15 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-15 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 2e-15 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 3e-15 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 3e-15 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-15 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 3e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-15 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 4e-15 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 5e-15 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 7e-15 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 8e-15 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 9e-15 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 9e-15 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 1e-14 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-14 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 2e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-14 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-14 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 3e-14 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-14 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 3e-14 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 3e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 4e-14 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 4e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 4e-14 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-14 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 6e-14 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 7e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 7e-14 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-14 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-13 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 1e-13 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-13 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-13 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-13 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-13 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 2e-13 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-13 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-13 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 3e-13 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-13 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 4e-13 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 4e-13 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 5e-13 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 7e-13 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 7e-13 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-12 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 1e-12 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-12 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 2e-12 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 3e-12 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-12 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-12 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 4e-12 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 4e-12 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 6e-12 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 6e-12 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 6e-12 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 7e-12 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 7e-12 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 7e-12 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 8e-12 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 9e-12 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 9e-12 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-11 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-11 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-11 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-11 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-11 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-11 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-11 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-11 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-11 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 3e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 3e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 3e-11 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 3e-11 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-11 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 3e-11 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 4e-11 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 4e-11 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 5e-11 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 7e-11 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 8e-11 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 9e-11 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-10 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-10 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-10 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-10 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 1e-10 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 1e-10 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-10 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 3e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 4e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-10 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-10 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 6e-10 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 6e-10 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-10 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 7e-10 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 8e-10 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 1e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-09 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-09 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 2e-09 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 3e-09 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-09 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-09 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 4e-09 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 5e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-09 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 9e-09 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-08 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 2e-08 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-08 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 2e-08 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 3e-08 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-08 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 3e-08 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 3e-08 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 3e-08 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-08 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-08 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-08 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-08 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 4e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 5e-08 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 5e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 6e-08 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 7e-08 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-08 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-07 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 1e-07 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 1e-07 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 1e-07 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 2e-07 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 2e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-07 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 3e-07 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-07 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 3e-07 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-07 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-07 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 4e-07 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 4e-07 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 4e-07 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 4e-07 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 5e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 6e-07 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-06 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-06 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-06 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-06 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 2e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-06 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-06 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 3e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-06 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 4e-06 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 4e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 5e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 5e-06 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 6e-06 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 6e-06 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-06 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 7e-06 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-06 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 9e-06 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-05 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 1e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-05 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-05 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 2e-05 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 4e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-05 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 5e-05 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 5e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 7e-05 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 7e-05 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-05 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 1e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 1e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-04 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 2e-04 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 2e-04 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 3e-04 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| COG1718 | 268 | COG1718, RIO1, Serine/threonine protein kinase inv | 4e-04 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 5e-04 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-04 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 7e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 0.001 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 0.001 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.002 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 0.002 | |
| COG3642 | 204 | COG3642, COG3642, Mn2+-dependent serine/threonine | 0.002 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 0.003 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 0.003 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.003 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 0.003 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 156 bits (396), Expect = 2e-43
Identities = 62/154 (40%), Positives = 84/154 (54%), Gaps = 11/154 (7%)
Query: 484 QLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHR 537
L KLG+G FG VY G+LK E+AVK L + AS Q +EEF+ E ++ KL H
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHP 61
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V+LLG C E E ++ EYM L + L + +L + I+RG+ YL
Sbjct: 62 NVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRK--NRPKLSLSDLLSFALQIARGMEYLE 119
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
IHRDL A N L+ E L KISDFG+++
Sbjct: 120 ---SKNFIHRDLAARNCLVGENLVVKISDFGLSR 150
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 154 bits (392), Expect = 7e-43
Identities = 64/153 (41%), Positives = 84/153 (54%), Gaps = 10/153 (6%)
Query: 485 LSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
L KLG+G FG VY G LK E+AVK L + AS Q +EEF+ E ++ KL H N
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V+LLG C E E M++ EYMP L L + + L + I+RG+ YL
Sbjct: 63 IVKLLGVCTEEEPLMIVMEYMPGGDLLDYLRKN-RPKELSLSDLLSFALQIARGMEYLE- 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
IHRDL A N L+ E L KISDFG+++
Sbjct: 121 --SKNFIHRDLAARNCLVGENLVVKISDFGLSR 151
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 1e-38
Identities = 61/155 (39%), Positives = 85/155 (54%), Gaps = 14/155 (9%)
Query: 488 KLGQGGFGPVYWGRLKDGQ----EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 542
KLG+G FG VY G+LK E+AVK L + AS + ++F+ E V+ KL H N+VRL
Sbjct: 2 KLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRL 61
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNIIEGISRGLLYL 596
LG C E E L+ EYM L L F +K L + + I++G+ YL
Sbjct: 62 LGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYL 121
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ +HRDL A N L+ E+L KISDFG+++
Sbjct: 122 A---SKKFVHRDLAARNCLVGEDLVVKISDFGLSR 153
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 141 bits (358), Expect = 1e-38
Identities = 62/164 (37%), Positives = 89/164 (54%), Gaps = 10/164 (6%)
Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
LG+GGFG VY R K G+++A+K + K S LEE + E+ ++ KL H N+V+L G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ L+ EY SL LL + + +L + I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLH---SNGIIH 115
Query: 607 RDLKASNILLDE-ELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
RDLK NILLD K++DFG++K+ ++ T +VGT
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTP 157
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 2e-38
Identities = 61/155 (39%), Positives = 84/155 (54%), Gaps = 11/155 (7%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH 536
+L KLG+G FG VY G LK ++AVK L AS + EEF+ E ++ KL H
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSH 60
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
N+VRLLG C +GE ++ EYMP L L E+L + + I++G+ YL
Sbjct: 61 PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRK--HGEKLTLKDLLQMALQIAKGMEYL 118
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+HRDL A N L+ E L KISDFG+++
Sbjct: 119 E---SKNFVHRDLAARNCLVTENLVVKISDFGLSR 150
|
Length = 258 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 139 bits (353), Expect = 2e-37
Identities = 61/170 (35%), Positives = 82/170 (48%), Gaps = 11/170 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 539
++L KLG G FG VY + K G+ +AVK L K + + E+ ++ +L H N+
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNI 60
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
VRL+ + + L+ EY L L + L + I I RGL YLH
Sbjct: 61 VRLIDAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLHS- 116
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
IIHRDLK NILLDE KI+DFG+AK + T VGT
Sbjct: 117 --NGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTP 162
|
Length = 260 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 132 bits (335), Expect = 7e-37
Identities = 54/113 (47%), Positives = 68/113 (60%), Gaps = 5/113 (4%)
Query: 69 EKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSG 128
+ V+WVANR NPL DSS + + DGNLVL +G V+WSSN S + A L D G
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQSDGNLVLYDGNGRVVWSSNTSGKGSG-CVAVLQDDG 59
Query: 129 NLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRT-GKKVQLTSWKSLSDPS 180
NLVL DN + ++W+SF PTD+ LPG G +LTSWKS +DPS
Sbjct: 60 NLVLYDN-SGKVLWQSFDHPTDTLLPGQ--KDGNVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 65/176 (36%), Positives = 95/176 (53%), Gaps = 19/176 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
+ LG+G FG VY KD G+ +AVK LS S + LE E+ ++S LQH N
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPN 60
Query: 539 LVRLLGCCVEGEEKML-IY-EYMPNRSLDALL--FDPLKKERLDWRKRF--NIIEGISRG 592
+VR G + E+ L I+ EY+ SL +LL F L + + +++ I+EG++
Sbjct: 61 IVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI---RKYTRQILEGLA-- 115
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
YLH I+HRD+K +NIL+D + K++DFG AK G + TG V GT
Sbjct: 116 --YLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGT 166
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-32
Identities = 60/170 (35%), Positives = 90/170 (52%), Gaps = 13/170 (7%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLV 540
+++ KLG+G FG VY R K G+ +A+K + K + E + E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRD 599
RL + ++ L+ EY L LL K+ RL RF + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARF-YLRQILSALEYLHS- 115
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
I+HRDLK NILLDE+ + K++DFG+A+ + + T VGT
Sbjct: 116 --KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGE-KLTT--FVGTP 160
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 6e-31
Identities = 50/120 (41%), Positives = 67/120 (55%), Gaps = 4/120 (3%)
Query: 29 SQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGI 88
S + ++S+GS F+LGFF Y I Y S + V+WVANRDNP SS
Sbjct: 1 SNPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYK-GSSRTVVWVANRDNP-SGSSCT 58
Query: 89 ITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP 148
+T+ DGNLV+ +G V+WSSN + + N LLD GNLVL D+ + W+SF P
Sbjct: 59 LTLQSDGNLVIYDGSGTVVWSSNTTRVNGN-YVLVLLDDGNLVLYDSDGNFL-WQSFDYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 116 bits (294), Expect = 2e-29
Identities = 57/172 (33%), Positives = 91/172 (52%), Gaps = 15/172 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRN 538
N+QL +G+G FG VY G L+ G +A+K++S K + L+ M E+ ++ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 596
+V+ +G + +I EY N SL ++ F P E L + +++G L YL
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFP-ESLVAVYVYQVLQG----LAYL 115
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H +IHRD+KA+NIL ++ K++DFG+A + VVGT
Sbjct: 116 HEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDAS--VVGT 162
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 111 bits (281), Expect = 2e-29
Identities = 42/114 (36%), Positives = 61/114 (53%), Gaps = 19/114 (16%)
Query: 206 WRSGPWNGQIFIGIPELKSVYLFRHNF---------TFGFANDWTF--FALTAQGILEER 254
WRSGPWNG F GIPE++ + + +NF T+ N+ + L+++G LE
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 255 IWIK----WKDNWEVGFLNLRTECDVYGKCGAFGICNSQEKPICSCLEGFEPKN 304
WI W W + +CDVYG+CG +G C+ P C+C++GF PKN
Sbjct: 61 TWIPNSQDWNLFWSAP----KDQCDVYGRCGPYGYCDVNTSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-29
Identities = 48/117 (41%), Positives = 66/117 (56%), Gaps = 5/117 (4%)
Query: 29 SQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGI 88
S + ++S S F+LGFF Y I Y S + V+WVANRDNP+ DS
Sbjct: 1 SNTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYK-SSSRTVVWVANRDNPVSDS-CT 57
Query: 89 ITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
+T+ DGNLVL +G V+WSSN + N + LLD GNLV+ D+ + +W+SF
Sbjct: 58 LTLQSDGNLVLYDGDGRVVWSSNTTG-ANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112
|
Length = 114 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 4e-27
Identities = 49/158 (31%), Positives = 84/158 (53%), Gaps = 18/158 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
F++ K+G+GGFG VY R + G+E+A+K + S + E+ +NE+ ++ K +H N+V+
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLY 595
G ++ +E ++ E+ SL LL + + + + +GL Y
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--------KSTNQTLTESQIAYVCKELLKGLEY 113
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
LH IIHRD+KA+NILL + K+ DFG++
Sbjct: 114 LHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL 148
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 9e-26
Identities = 52/150 (34%), Positives = 78/150 (52%), Gaps = 4/150 (2%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
F L KLG G FG V+ G K+ +A+K L ++F EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
C GE +I E M SL A L P + L ++ ++ G+ YL
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFLRSPEGQV-LPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKI 632
IHRDL A NIL+ E+L K++DFG+A++
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARL 153
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 53/159 (33%), Positives = 84/159 (52%), Gaps = 13/159 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ 535
+ + +LG+G FG V R G+++AVK L+ + Q +F E+ ++ L
Sbjct: 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD 64
Query: 536 HRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
H N+V+ G C + G LI EY+P+ SL L +++++ ++ I +G+
Sbjct: 65 HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYL--QRHRDQINLKRLLLFSSQICKGM 122
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
YL R IHRDL A NIL++ E KISDFG+AK+
Sbjct: 123 DYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKV 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 96.7 bits (241), Expect = 2e-24
Identities = 36/90 (40%), Positives = 50/90 (55%), Gaps = 8/90 (8%)
Query: 322 KLQCERRNITGKVGKEDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFD-G 380
L C G DGF KL +K+PD + + +ECRE CL NCSC AYA++ G
Sbjct: 2 PLNCGGD------GSTDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNG 55
Query: 381 GIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410
GC++W L +++ L GG LY+R+A
Sbjct: 56 SGGCLLWNG-LLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 60/164 (36%), Positives = 84/164 (51%), Gaps = 7/164 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +L KLG G FG V+ G ++AVK L K E F+ E ++ KL+H LV
Sbjct: 6 ESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTL-KPGTMSPEAFLQEAQIMKKLRHDKLV 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+L C E E ++ EYM SL D L KK RL + ++ I+ G+ YL
Sbjct: 65 QLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLP--QLVDMAAQIAEGMAYLES- 121
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
IHRDL A NIL+ E L KI+DFG+A++ ++ A G
Sbjct: 122 --RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREG 163
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 51/165 (30%), Positives = 89/165 (53%), Gaps = 14/165 (8%)
Query: 489 LGQGGFGPVY---WGRLKDGQEI--AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
LG G FG VY W + +I A+K L + + + +E ++E V++ + H ++VRL
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
LG C+ + LI + MP L + + K+ + + N I++G+ YL
Sbjct: 75 LGICL-SSQVQLITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYL---EEK 128
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRV 645
R++HRDL A N+L+ + KI+DFG+AK+ ++ + A+ G+V
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKV 173
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 53/176 (30%), Positives = 94/176 (53%), Gaps = 20/176 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHR 537
++ +++G+G +G VY R K G+ +A+K++ + + E F + E+ ++ KL+H
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEK--EGFPITAIREIKLLQKLRHP 58
Query: 538 NLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGL 593
N+VRL + +++EYM + L LL P K K + ++EG+
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQ--- 114
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
YLH + I+HRD+K SNIL++ + K++DFG+A+ + T RV+ TL
Sbjct: 115 -YLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TL 165
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 2e-23
Identities = 53/162 (32%), Positives = 84/162 (51%), Gaps = 10/162 (6%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH-R 537
++++ KLG+G FG VY +D + +A+K L+K + +E F+ E+ +++ L H
Sbjct: 1 SYRILRKLGEGSFGEVY--LARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V+L + L+ EY+ SL+ LL +K L + I+ I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 598 RDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQD 638
IIHRD+K NILLD + K+ DFG+AK+
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157
|
Length = 384 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.3 bits (248), Expect = 3e-23
Identities = 62/165 (37%), Positives = 85/165 (51%), Gaps = 20/165 (12%)
Query: 489 LGQGGFGPVYWG--RLKDGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLL 543
LG G FG V G +K G+E+ AVK L + G +EF+ E V+++L H +VRL+
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHRDS 600
G C +GE ML+ E P L LL LKK R ++ E ++ G+ YL
Sbjct: 63 GVC-KGEPLMLVMELAP---LGPLL-KYLKKRRE--IPVSDLKELAHQVAMGMAYLESK- 114
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTG 643
+HRDL A N+LL KISDFGM++ G D +A T
Sbjct: 115 --HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 60/166 (36%), Positives = 87/166 (52%), Gaps = 12/166 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L KLG G FG V+ G ++A+K L + S E F+ E ++ +LQH LV
Sbjct: 6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLV 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLH 597
RL V E +I EYM N SL D LK +L K ++ I+ G+ ++
Sbjct: 65 RLYAV-VTQEPIYIITEYMENGSL----VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIE 119
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
R + IHRDL+A+NIL+ E L KI+DFG+A++ N+ A G
Sbjct: 120 RKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREG 162
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 98.2 bits (245), Expect = 7e-23
Identities = 57/163 (34%), Positives = 86/163 (52%), Gaps = 16/163 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L + +G+G FG V G + GQ++AVK L K + F+ E V++ L+H NLV
Sbjct: 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLV 63
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK-KER----LDWRKRFNIIEGISRGLLY 595
+LLG ++G ++ EYM SL D L+ + R L + F + + G+ Y
Sbjct: 64 QLLGVVLQGNPLYIVTEYMAKGSL----VDYLRSRGRAVITLAQQLGFAL--DVCEGMEY 117
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
L +HRDL A N+L+ E+L K+SDFG+AK QD
Sbjct: 118 LEEK---NFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD 157
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 49/172 (28%), Positives = 91/172 (52%), Gaps = 18/172 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
N + K+G+G G VY G+E+A+K++ + Q E +NE++++ +H N+
Sbjct: 22 KNLE---KIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKELIINEILIMKDCKHPNI 77
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNIIEGISRGLLYL 596
V + G+E ++ EYM SL ++ F + + ++ + + + +GL YL
Sbjct: 78 VDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAY-----VCREVLQGLEYL 132
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H +IHRD+K+ NILL ++ + K++DFG A + + ++ VVGT
Sbjct: 133 HS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNS--VVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 96.5 bits (241), Expect = 3e-22
Identities = 53/176 (30%), Positives = 86/176 (48%), Gaps = 21/176 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 538
++ + LGQG G VY R K G+ A+K++ + ++ + E+ + +
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPY 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN--IIEGISR----G 592
+V+ G + E ++ EYM SL LL KK + ++ I+R G
Sbjct: 61 VVKCYGAFYKEGEISIVLEYMDGGSLADLL----KK-----VGKIPEPVLAYIARQILKG 111
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
L YLH IIHRD+K SN+L++ + KI+DFG++K+ DQ +T VGT
Sbjct: 112 LDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT--FVGT 163
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 96.8 bits (241), Expect = 4e-22
Identities = 55/170 (32%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL 534
+ +LG+G FG VY G L +A+K L + A + +EF E ++S L
Sbjct: 6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKKERLDWRK 581
QH N+V LLG C + + +++EY+ + L L D K LD
Sbjct: 66 QHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSD 125
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+I I+ G+ YL S +HRDL A N L+ E L KISDFG+++
Sbjct: 126 FLHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 96.4 bits (240), Expect = 4e-22
Identities = 57/159 (35%), Positives = 86/159 (54%), Gaps = 12/159 (7%)
Query: 487 SKLGQGGFGPVYWGR---LKD--GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+LG+G FG V R L+D G+ +AVK+L ++ + L +F E+ ++ LQH N+V+
Sbjct: 10 QQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVK 69
Query: 542 LLGCCVE-GEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
G C G + L+ EY+P SL L +ERLD RK I +G+ YL
Sbjct: 70 YKGVCYSAGRRNLRLVMEYLPYGSLRDYLQK--HRERLDHRKLLLYASQICKGMEYL--- 124
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
R +HRDL NIL++ E KI DFG+ K+ +++
Sbjct: 125 GSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKE 163
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 95.7 bits (239), Expect = 4e-22
Identities = 62/167 (37%), Positives = 86/167 (51%), Gaps = 18/167 (10%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+G FG V R KD G+ A+K L K + +E + E ++S++ H +V+L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSR 601
+ EEK+ L+ EY P L F L KE + R RF E I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGEL----FSHLSKEGRFSEERARFYAAE-IVLALEYLHS--- 111
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
L II+RDLK NILLD + + K++DFG+AK + +T GT
Sbjct: 112 LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGT 156
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.6 bits (238), Expect = 5e-22
Identities = 55/145 (37%), Positives = 80/145 (55%), Gaps = 6/145 (4%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G FG VY G LK E+AVK L +F+ E ++ + H N+V+L+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
V+ + ++ E +P SL L F KK RL +K + + G+ YL +S+ IH
Sbjct: 62 VQKQPIYIVMELVPGGSL--LTFLRKKKNRLTVKKLLQMSLDAAAGMEYL--ESK-NCIH 116
Query: 607 RDLKASNILLDEELNPKISDFGMAK 631
RDL A N L+ E KISDFGM++
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 94.9 bits (237), Expect = 8e-22
Identities = 55/170 (32%), Positives = 84/170 (49%), Gaps = 19/170 (11%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
++G+G FG VY R DG+ +K LS S + E+ +NEV ++ KL H N+++
Sbjct: 7 QIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYE 66
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF---NIIE---GISRGLLYLHR 598
E + ++ EY L + K++ K F I++ + L YLH
Sbjct: 67 SFEEKGKLCIVMEYADGGDLSQKI-----KKQKKEGKPFPEEQILDWFVQLCLALKYLH- 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
SR +I+HRD+K NI L K+ DFG++K+ D A T VVGT
Sbjct: 121 -SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT--VVGT 166
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 1e-21
Identities = 56/173 (32%), Positives = 91/173 (52%), Gaps = 15/173 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
+F++ +K+G+G FG V+ K D + A+K+ LSK + + EE ++E V++KL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK---ERLDWRKRFNIIEGISRGLLY 595
++R ++ + ++ EY N L LL + E WR I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWR----FFIQILLGLAH 116
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
LH +I+HRD+K+ N+ LD N KI D G+AK+ N + A+T +VGT
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGT 164
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 1e-21
Identities = 46/161 (28%), Positives = 76/161 (47%), Gaps = 21/161 (13%)
Query: 489 LGQGGFGPVYWGR---LKDGQE---IAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVR 541
LG+G FG V+ G L+ + +AVK L + + + F E +++ QH N+V+
Sbjct: 13 LGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVK 72
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLKKERLDWRKRFNIIEGIS 590
G C EG+ ++++EYM + L+ L L + I I+
Sbjct: 73 FYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIA 132
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
G++YL + +HRDL N L+ +L KI DFGM++
Sbjct: 133 SGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 1e-21
Identities = 53/159 (33%), Positives = 85/159 (53%), Gaps = 10/159 (6%)
Query: 489 LGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
+G G FG V GRLK +EI A+K L + +S + +F+ E ++ + H N++RL
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G + M+I EYM N SLD L + + + ++ GI+ G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFLRE--NDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+HRDL A NIL++ L K+SDFG+++ ++ T
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTT 165
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 93.1 bits (232), Expect = 3e-21
Identities = 48/167 (28%), Positives = 86/167 (51%), Gaps = 10/167 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
F + KLG+G +G VY K+ GQ +A+K + + L+E + E+ ++ + +V+
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
G + + ++ EY S+ ++ + + L + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ IHRD+KA NILL+EE K++DFG++ + +T V+GT
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNT--VIGT 162
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 91.9 bits (229), Expect = 1e-20
Identities = 54/169 (31%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNL 539
F L +G+G FG VY K Q +A+K L +A + +E+ E+ +S+ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+ G ++G + +I EY S D LK +LD I+ + GL YLH +
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGSC----LDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
IHRD+KA+NILL EE + K++DFG++ + +T VGT
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGT 161
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 2e-20
Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 11/166 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ QL KLG G FG V+ G + +AVK L K ++F+ E ++ KL+H L+
Sbjct: 6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTL-KPGTMDPKDFLAEAQIMKKLRHPKLI 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLH 597
+L C E ++ E M SL + L+ K +I+ ++ G+ YL
Sbjct: 65 QLYAVCTLEEPIYIVTELMKYGSL----LEYLQGGAGRALKLPQLIDMAAQVASGMAYLE 120
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL A N+L+ E K++DFG+A++ + +A G
Sbjct: 121 AQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 57/166 (34%), Positives = 87/166 (52%), Gaps = 11/166 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +L KLG G FG V+ G + ++AVK L K ++ F+ E ++ LQH LV
Sbjct: 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTL-KPGTMSVQAFLEEANLMKTLQHDKLV 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLH 597
RL + E +I EYM SL D LK + ++ K + I+ G+ Y+
Sbjct: 65 RLYAVVTKEEPIYIITEYMAKGSL----LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIE 120
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
R + IHRDL+A+N+L+ E L KI+DFG+A++ N+ A G
Sbjct: 121 RKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREG 163
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.8 bits (223), Expect = 5e-20
Identities = 54/151 (35%), Positives = 77/151 (50%), Gaps = 16/151 (10%)
Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLS-----KASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG G FG VY G L DG AVK +S + + +++ E+ ++SKLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
LG E + + E +P SL LL + + + I GL YLH
Sbjct: 68 LGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIR-----LYTRQILLGLEYLH--D 120
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAK 631
R +HRD+K +NIL+D K++DFGMAK
Sbjct: 121 R-NTVHRDIKGANILVDTNGVVKLADFGMAK 150
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 89.6 bits (222), Expect = 8e-20
Identities = 56/151 (37%), Positives = 75/151 (49%), Gaps = 15/151 (9%)
Query: 489 LGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNLVRL 542
LG+G FG V G+ +AVK L + GQ + E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKY 71
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
GCC E K LI EY+P SL D L K +L+ + + I G+ YLH
Sbjct: 72 KGCCSEQGGKGLQLIMEYVPLGSL----RDYLPKHKLNLAQLLLFAQQICEGMAYLHSQ- 126
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAK 631
IHRDL A N+LLD + KI DFG+AK
Sbjct: 127 --HYIHRDLAARNVLLDNDRLVKIGDFGLAK 155
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 88.4 bits (219), Expect = 2e-19
Identities = 58/169 (34%), Positives = 83/169 (49%), Gaps = 19/169 (11%)
Query: 489 LGQGGFGPVYWGRLKDGQ-EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
LG+G +G VY R Q IA+K + + + ++ E+ + S L+HRN+V+ LG
Sbjct: 16 LGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 548 EGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNII---EGISRGLLYLHRDSR 601
E + E +P SL ALL + PLK II + I GL YLH
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLRSKWGPLKD------NEQTIIFYTKQILEGLKYLH---D 126
Query: 602 LRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGTL 649
+I+HRD+K N+L++ KISDFG +K G +T GTL
Sbjct: 127 NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTET--FTGTL 173
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.7 bits (218), Expect = 5e-19
Identities = 50/163 (30%), Positives = 91/163 (55%), Gaps = 16/163 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFM-NEVMVISKLQ---H 536
++ +++G+G +G VY R L G+ +A+K++ S +G+ E+ ++ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 537 RNLVRLLGCC----VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
N+VRLL C + E K+ L++E++ ++ L L K L +++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
G+ +LH RI+HRDLK NIL+ + KI+DFG+A+I+
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYS 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.7 bits (215), Expect = 6e-19
Identities = 46/143 (32%), Positives = 75/143 (52%), Gaps = 6/143 (4%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548
LG G FG V+ G+ + ++A+K + + + ++F+ E V+ KL H NLV+L G C +
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 608
++ EYM N L L + K +W ++ + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYLRERKGKLGTEW--LLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 609 LKASNILLDEELNPKISDFGMAK 631
L A N L+ E+ K+SDFG+A+
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLAR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.4 bits (214), Expect = 8e-19
Identities = 54/159 (33%), Positives = 81/159 (50%), Gaps = 16/159 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKR-----LSKASGQGLEEFMNEVMVISKL 534
N++ LGQG FG VY D G+E+AVK+ S + + + E+ ++ L
Sbjct: 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNL 61
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-DAL-LFDPLKKERLDWRKRFNIIEGISRG 592
QH +V+ GC + E + EYMP S+ D L + L E + + I+EG+
Sbjct: 62 QHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALT-ETVTRKYTRQILEGVE-- 118
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
YLH + I+HRD+K +NIL D N K+ DFG +K
Sbjct: 119 --YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 53/189 (28%), Positives = 94/189 (49%), Gaps = 31/189 (16%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVIS 532
+ ++++ KLG+G FG VY R +K G+ +A+K++ + + + F + E+ ++
Sbjct: 5 SKLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK--DGFPITALREIKILK 62
Query: 533 KLQHRNLVRLLGCCVE-----GEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRF-- 583
KL+H N+V L+ VE ++ +Y P + L LL +P +
Sbjct: 63 KLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENP--------SVKLTE 114
Query: 584 ----NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
+ + G+ YLH + I+HRD+KA+NIL+D + KI+DFG+A+ + G
Sbjct: 115 SQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDGPPPN 171
Query: 640 ADTGRVVGT 648
G GT
Sbjct: 172 PKGGGGGGT 180
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 80.0 bits (198), Expect = 1e-18
Identities = 28/66 (42%), Positives = 37/66 (56%), Gaps = 6/66 (9%)
Query: 335 GKEDGFSKLNKMKVPDFTEWT--SPATEDECREQCLKNCSCIAYAFD---GGIGCMVWRS 389
G DGF +L MK+PD T EC ++CL NCSC AYA+ GG GC++W
Sbjct: 2 GGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRGGSGCLIWTG 61
Query: 390 INLIDI 395
L+D+
Sbjct: 62 -ELVDM 66
|
Length = 66 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (214), Expect = 1e-18
Identities = 53/169 (31%), Positives = 85/169 (50%), Gaps = 19/169 (11%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHRNLVRL 542
KLG+G +G VY R K G+ +A+K++ E + E+ ++ +L+H N+V+L
Sbjct: 6 KLGEGTYGVVYKARDKKTGEIVALKKI--RLDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR--FNIIEGISRGLLYLHRDS 600
L + L++EY + L L + K + ++ RGL Y H
Sbjct: 64 LDVIHTERKLYLVFEYC-DMDLKKYLDKRPGPLSPNLIKSIMYQLL----RGLAYCHSH- 117
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
RI+HRDLK NIL++ + K++DFG+A+ F G + T VV TL
Sbjct: 118 --RILHRDLKPQNILINRDGVLKLADFGLARAF-GIPLRTYTHEVV-TL 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 85.7 bits (212), Expect = 2e-18
Identities = 52/160 (32%), Positives = 82/160 (51%), Gaps = 6/160 (3%)
Query: 485 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
+ KLG G +G VY G K +AVK L K +EEF+ E V+ +++H NLV+LL
Sbjct: 10 MKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLL 68
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G C +I E+M +L L + ++ ++ + IS + YL + +
Sbjct: 69 GVCTREPPFYIITEFMTYGNLLDYLRE-CNRQEVNAVVLLYMATQISSAMEYLEKKN--- 124
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
IHRDL A N L+ E K++DFG++++ G+ A G
Sbjct: 125 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 164
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 2e-18
Identities = 52/170 (30%), Positives = 85/170 (50%), Gaps = 19/170 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK--DG--QEIAVK--RLSKASGQGLEEFMNEVMVISKLQH 536
+L LG+G FG V G+L DG ++AVK +L + +EEF++E + H
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDH 60
Query: 537 RNLVRLLGCCVEGEEK------MLIYEYMPNRSLDALLFDP---LKKERLDWRKRFNIIE 587
N+++L+G C E M+I +M + L + L E+L + +
Sbjct: 61 PNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMV 120
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGN 636
I+ G+ YL S IHRDL A N +L E++ ++DFG++ KI+ G+
Sbjct: 121 DIALGMEYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 51/165 (30%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWG----RLKDGQEIAVK---RLSKASGQGLEEFMNEVMVISKL 534
+ L LG G FG VY G R D E+ V S Q +F+ E +++SK
Sbjct: 7 SITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKF 66
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGIS 590
H+N+VRL+G E + ++ E M L + L + P + L + ++
Sbjct: 67 NHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVA 126
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAK 631
+G YL + IHRD+ A N LL + P KI+DFGMA+
Sbjct: 127 KGCKYLEEN---HFIHRDIAARNCLLTCK-GPGRVAKIADFGMAR 167
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 4e-18
Identities = 48/159 (30%), Positives = 80/159 (50%), Gaps = 6/159 (3%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
L ++G G FG V+ G + +++A+K + + + E+F+ E V+ KL H LV+L G
Sbjct: 8 LVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYG 66
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
C E L++E+M + L L ++ + + + G+ YL + +
Sbjct: 67 VCTERSPICLVFEFMEHGCLSDYL--RAQRGKFSQETLLGMCLDVCEGMAYLESSN---V 121
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
IHRDL A N L+ E K+SDFGM + +Q + TG
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTG 160
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 4e-18
Identities = 51/167 (30%), Positives = 86/167 (51%), Gaps = 19/167 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 534
+N L +LG+G FG V+ +D +AVK L AS ++F E +++ L
Sbjct: 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNL 64
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD----------ALLFDPLKKERLDWRKRFN 584
QH ++V+ G CVEG+ ++++EYM + L+ L+ + + L + +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLH 124
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I + I+ G++YL + +HRDL N L+ E L KI DFGM++
Sbjct: 125 IAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR 168
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 84.6 bits (210), Expect = 4e-18
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 13/164 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEF-MNEVMVISKL-Q 535
++F+ +G+G F V + K +E A+K L K + ++ E V+++L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
H +++L + EE + + EY PN L + K LD + I L
Sbjct: 61 HPGIIKLY-YTFQDEENLYFVLEYAPNGELLQYI---RKYGSLDEKCTRFYAAEILLALE 116
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
YLH IIHRDLK NILLD++++ KI+DFG AK+ N
Sbjct: 117 YLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS 157
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 6e-18
Identities = 56/161 (34%), Positives = 82/161 (50%), Gaps = 22/161 (13%)
Query: 489 LGQGGFGPVYWGRLKD-------GQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLV 540
LG G FG VY G D +AVK L K A+ Q +EF+ E ++S H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----LDWRKRFNIIEGISRGLLY 595
+LLG C+ E + +I E M L + L D + ER L ++ +I +++G +Y
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDA-RVERFGPPLLTLKELLDICLDVAKGCVY 121
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNP-----KISDFGMAK 631
L ++ IHRDL A N L+ E+ KI DFG+A+
Sbjct: 122 LE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR 159
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 6e-18
Identities = 55/159 (34%), Positives = 83/159 (52%), Gaps = 28/159 (17%)
Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKR--LSKASGQG-------LEEFMNEVMVISKLQHRN 538
+G G FG VY G G+ +AVK+ L S L+ E+ ++ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------DPLKKERLDWRKRFNIIEGISRG 592
+V+ LG ++ + + EY+P S+ ALL + L + N + I +G
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR---------NFVRQILKG 118
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L YLH +R IIHRD+K +NIL+D + KISDFG++K
Sbjct: 119 LNYLH--NR-GIIHRDIKGANILVDNKGGIKISDFGISK 154
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 6e-18
Identities = 56/170 (32%), Positives = 89/170 (52%), Gaps = 28/170 (16%)
Query: 489 LGQGGFGPVYWGRLK--DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLL 543
+G G FG V GRLK +EI V + +G + +F++E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK---RFNIIE------GISRGLL 594
G + + M++ EYM N SLDA L RK +F +I+ GI+ G+
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL-----------RKHDGQFTVIQLVGMLRGIASGMK 120
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
YL S + +HRDL A NIL++ L K+SDFG++++ + + A T R
Sbjct: 121 YL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR 167
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 1e-17
Identities = 53/165 (32%), Positives = 84/165 (50%), Gaps = 21/165 (12%)
Query: 485 LSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
L +LG+G FG V+ +D +AVK L +AS ++F E +++ LQH++
Sbjct: 9 LKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQH 68
Query: 539 LVRLLGCCVEGEEKMLIYEYMP----NRSL-----DALLFDPLKKE---RLDWRKRFNII 586
+VR G C EG ++++EYM NR L DA + + +L + I
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIA 128
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I+ G++YL + L +HRDL N L+ + L KI DFGM++
Sbjct: 129 SQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR 170
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 47/175 (26%), Positives = 87/175 (49%), Gaps = 23/175 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
+++ ++G+G G V+ + + G+ +A+K+ L + G + + E+ + QH
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPY 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRKRFNIIEGISRGLL- 594
+V+LL G +L+ EYMP L +L D PL + ++ R LL
Sbjct: 61 VVKLLDVFPHGSGFVLVMEYMP-SDLSEVLRDEERPLPEA---------QVKSYMRMLLK 110
Query: 595 ---YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
Y+H I+HRDLK +N+L+ + KI+DFG+A++F + + + +V
Sbjct: 111 GVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA 162
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 58/165 (35%), Positives = 86/165 (52%), Gaps = 12/165 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+ +L KLGQG FG V+ G +A+K L K E F+ E V+ KL+H LV+
Sbjct: 7 SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLVQ 65
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---LDWRKRFNIIEGISRGLLYLHR 598
L E E ++ EYM SL D LK E L + ++ I+ G+ Y+ R
Sbjct: 66 LYAVVSE-EPIYIVTEYMSKGSL----LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ +HRDL+A+NIL+ E L K++DFG+A++ N+ A G
Sbjct: 121 ---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 5e-17
Identities = 56/183 (30%), Positives = 93/183 (50%), Gaps = 26/183 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS----KASGQG--LEEFMNEVMVISKL 534
+ +LG G F Y R +K G +AVK+++ +S Q +E E+ ++++L
Sbjct: 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARL 60
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRG 592
H +++R+LG E L E+M S+ LL + K+ + N E + RG
Sbjct: 61 NHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI-----INYTEQLLRG 115
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMA-----KIFGGNQDQADTGRVV 646
L YLH + +IIHRD+K +N+L+D +I+DFG A K G + Q G+++
Sbjct: 116 LSYLHEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQ---GQLL 169
Query: 647 GTL 649
GT+
Sbjct: 170 GTI 172
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.8 bits (202), Expect = 5e-17
Identities = 51/177 (28%), Positives = 82/177 (46%), Gaps = 29/177 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQE---IAVKRLSK-ASGQGLEEFMNEVMVISK 533
NN + +GQG FG V+ R L + +AVK L + AS +F E ++++
Sbjct: 5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 64
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-------------------PLKK 574
H N+V+LLG C G+ L++EYM L+ L L
Sbjct: 65 FDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP 124
Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L ++ I + ++ G+ YL S + +HRDL N L+ E + KI+DFG+++
Sbjct: 125 LPLSCTEQLCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR 178
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 6/165 (3%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ QL KLG G FG V+ G ++AVK L K E F+ E ++ KL+H
Sbjct: 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTL-KPGTMSPESFLEEAQIMKKLRHDK 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
LV+L E E ++ EYM SL L D + L ++ ++ G+ Y+ R
Sbjct: 63 LVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIER 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL+++NIL+ + L KI+DFG+A++ N+ A G
Sbjct: 121 ---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 6e-17
Identities = 49/150 (32%), Positives = 84/150 (56%), Gaps = 10/150 (6%)
Query: 489 LGQGGFGPVYWGRLK-DGQE---IAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 543
+G G FG V+ G LK G++ +A+K L + + ++F++E ++ + H N++RL
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G + + M+I EYM N +LD L D + ++ GI+ G+ YL S +
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYL---SDMN 127
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIF 633
+HRDL A NIL++ L K+SDFG++++
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVL 157
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 6e-17
Identities = 53/159 (33%), Positives = 72/159 (45%), Gaps = 16/159 (10%)
Query: 488 KLGQGGFGPVYWGRLKDGQ----EIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRL 542
KLG G FG V G +AVK L +++F+ E ++ L H NL+RL
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRD 599
G V M++ E P SL D L+K+ L + I+ G+ YL
Sbjct: 62 YGV-VLTHPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
R IHRDL A NILL + KI DFG+ + N+D
Sbjct: 117 ---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 80.3 bits (198), Expect = 9e-17
Identities = 46/144 (31%), Positives = 79/144 (54%), Gaps = 6/144 (4%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
+LG G FG V+ G+ + ++A+K +++ + E+F+ E V+ KL H LV+L G C
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
+ + ++ E+M N L L + ++ +L ++ + + G+ YL R+S IHR
Sbjct: 70 QQKPLYIVTEFMENGCL--LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHR 124
Query: 608 DLKASNILLDEELNPKISDFGMAK 631
DL A N L+ K+SDFGM +
Sbjct: 125 DLAARNCLVSSTGVVKVSDFGMTR 148
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 9e-17
Identities = 49/170 (28%), Positives = 77/170 (45%), Gaps = 27/170 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
L +LGQG FG VY G K +A+K +++ AS + EF+NE V+ +
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKE 65
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------------FDPLKKERLDWRK 581
++VRLLG G+ +++ E M L + L P ++
Sbjct: 66 FNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKF---- 121
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ I+ G+ YL + +HRDL A N ++ E+L KI DFGM +
Sbjct: 122 -IQMAAEIADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 81.3 bits (200), Expect = 9e-17
Identities = 54/165 (32%), Positives = 97/165 (58%), Gaps = 14/165 (8%)
Query: 489 LGQGGFGPVYWG-RLKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
LG G FG VY G + +G+ + A+K L++ +G + EFM+E ++++ + H +LVRL
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
LG C+ + L+ + MP+ L L + K+ + + N I++G++YL
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCL--LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEER--- 128
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRV 645
R++HRDL A N+L+ + KI+DFG+A++ G++ + AD G++
Sbjct: 129 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKM 173
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 1e-16
Identities = 43/161 (26%), Positives = 79/161 (49%), Gaps = 13/161 (8%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHRNL 539
+Q K+G+G +G VY R G+ +A+K++ E+ ++ +L H N+
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNI 60
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLH 597
++LL + L++E+M D L+ +K + L + + + +GL + H
Sbjct: 61 IKLLDVFRHKGDLYLVFEFM-----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
I+HRDLK N+L++ E K++DFG+A+ FG
Sbjct: 116 SH---GILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR 153
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 50/144 (34%), Positives = 78/144 (54%), Gaps = 6/144 (4%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCCV 547
LG+G FG V+ G LKD +AVK + Q L+ +F++E ++ + H N+V+L+G C
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
+ + ++ E +P D L F KK+ L ++ + G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 608 DLKASNILLDEELNPKISDFGMAK 631
DL A N L+ E KISDFGM++
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR 141
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 79.9 bits (197), Expect = 2e-16
Identities = 46/148 (31%), Positives = 78/148 (52%), Gaps = 10/148 (6%)
Query: 489 LGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLL 543
+G G FG V GRLK +A+K L + + +F++E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G + M+I E+M N +LD+ L + + ++ GI+ G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFL--RQNDGQFTVIQLVGMLRGIAAGMKYL---SEMN 126
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAK 631
+HRDL A NIL++ L K+SDFG+++
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSR 154
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 2e-16
Identities = 47/144 (32%), Positives = 77/144 (53%), Gaps = 6/144 (4%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
+LG G FG V +G+ + ++A+K + + S +EF+ E V+ KL H LV+L G C
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607
+ ++ EYM N L L + K R + + + + G+ YL + IHR
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGK--RFQPSQLLEMCKDVCEGMAYLESK---QFIHR 124
Query: 608 DLKASNILLDEELNPKISDFGMAK 631
DL A N L+D++ K+SDFG+++
Sbjct: 125 DLAARNCLVDDQGCVKVSDFGLSR 148
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 51/156 (32%), Positives = 80/156 (51%), Gaps = 16/156 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN--EVMVISKLQ-HRN 538
+++ +LG G FG VY R K+ E+ A+K++ K EE MN EV + KL H N
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPN 59
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---LDWRKRFNIIEGISRGLLY 595
+V+L E +E ++EYM + L+ +K + +II I +GL +
Sbjct: 60 IVKLKEVFRENDELYFVFEYM-----EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH 114
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+H+ HRDLK N+L+ KI+DFG+A+
Sbjct: 115 IHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAR 147
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 2e-16
Identities = 45/154 (29%), Positives = 82/154 (53%), Gaps = 12/154 (7%)
Query: 487 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-----EVMVISKLQHRNLV 540
KLG+G + VY R + G+ +A+K++ + ++ +N E+ ++ +L+H N++
Sbjct: 6 KKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNII 65
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
LL L++E+M L+ ++ D K L + + RGL YLH +
Sbjct: 66 GLLDVFGHKSNINLVFEFMET-DLEKVIKD--KSIVLTPADIKSYMLMTLRGLEYLHSNW 122
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
I+HRDLK +N+L+ + K++DFG+A+ FG
Sbjct: 123 ---ILHRDLKPNNLLIASDGVLKLADFGLARSFG 153
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 79.4 bits (196), Expect = 3e-16
Identities = 50/170 (29%), Positives = 79/170 (46%), Gaps = 16/170 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLE-EFMNEVMVISKLQHRN 538
S+LG+G G V RLK+ I A+K ++ L+ + + E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 539 LVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
+V+ G ++ + EY SLD++ K+ R+ + I E + +GL Y
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFG--------MAKIFGGNQ 637
LH SR +IIHRD+K SNILL + K+ DFG +A F G
Sbjct: 121 LH--SR-KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFTGTS 167
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.6 bits (193), Expect = 3e-16
Identities = 56/165 (33%), Positives = 87/165 (52%), Gaps = 12/165 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+ +L KLGQG FG V+ G ++A+K L K E F+ E ++ KL+H LV
Sbjct: 7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTL-KPGTMMPEAFLQEAQIMKKLRHDKLVP 65
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK---ERLDWRKRFNIIEGISRGLLYLHR 598
L E E ++ E+M SL D LK+ + L + ++ I+ G+ Y+ R
Sbjct: 66 LYAVVSE-EPIYIVTEFMGKGSL----LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL+A+NIL+ + L KI+DFG+A++ N+ A G
Sbjct: 121 ---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQG 162
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 50/154 (32%), Positives = 86/154 (55%), Gaps = 10/154 (6%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ +++ +LG G FG VY + K+ G A K + S + LE+FM E+ ++S+ +H N
Sbjct: 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPN 63
Query: 539 LVRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISRGLLYL 596
+V L E + +LI E+ +LD+++ L+ ER L + + + L +L
Sbjct: 64 IVGLYEAYFYENKLWILI-EFCDGGALDSIM---LELERGLTEPQIRYVCRQMLEALNFL 119
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
H ++IHRDLKA NILL + + K++DFG++
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 78.5 bits (194), Expect = 4e-16
Identities = 53/158 (33%), Positives = 80/158 (50%), Gaps = 13/158 (8%)
Query: 484 QLSSKLGQGGFGPVYWG-RLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLV 540
Q +K+G G FG VY L G+ +AVK R+ + ++E +E+ V+ L+H NLV
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLV 62
Query: 541 RLLGCCVEGEEKMLIY-EYMPNRSLDALL-FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+ G V EK+ I+ EY +L+ LL + E + ++EG++ YLH
Sbjct: 63 KYYGVEVH-REKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLA----YLHS 117
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
I+HRD+K +NI LD K+ DFG A N
Sbjct: 118 H---GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN 152
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 4e-16
Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+ +L KLG G FG V+ ++AVK + K +E F+ E V+ LQH LV+
Sbjct: 7 SLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLVK 65
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEGISRGLLYLHR 598
L V E +I E+M SL D LK + + K + I+ G+ ++ +
Sbjct: 66 L-HAVVTKEPIYIITEFMAKGSL----LDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQ 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL+A+NIL+ L KI+DFG+A++ N+ A G
Sbjct: 121 RN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 79.3 bits (195), Expect = 5e-16
Identities = 53/165 (32%), Positives = 92/165 (55%), Gaps = 14/165 (8%)
Query: 489 LGQGGFGPVYWGR-LKDGQEI----AVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRL 542
LG G FG VY G + +G+++ A+K L +A S + +E ++E V++ + + ++ RL
Sbjct: 15 LGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRL 74
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
LG C+ + LI + MP L L + K+ + + N I++G+ YL
Sbjct: 75 LGICLTSTVQ-LITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER--- 128
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRV 645
R++HRDL A N+L+ + KI+DFG+AK+ G ++ A+ G+V
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKV 173
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 5e-16
Identities = 50/149 (33%), Positives = 81/149 (54%), Gaps = 10/149 (6%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
++G G FG VY+ R +++ + +A+K++S K S + ++ + EV + KL+H N ++
Sbjct: 22 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 81
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
GC + L+ EY + D L + K+ L + + G +GL YLH +
Sbjct: 82 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHSHN--- 135
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKI 632
+IHRD+KA NILL E K+ DFG A I
Sbjct: 136 MIHRDVKAGNILLSEPGLVKLGDFGSASI 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 77.8 bits (192), Expect = 7e-16
Identities = 53/173 (30%), Positives = 86/173 (49%), Gaps = 9/173 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKR--LSKASGQGLEEFMNEVMVISKLQHR 537
++++L +G G VY E +A+KR L K ++E EV +S+ H
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHP 59
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V+ V G+E L+ Y+ SL ++ + LD +++ + +GL YLH
Sbjct: 60 NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGR-VVGT 648
+ + IHRD+KA NILL E+ + KI+DFG+ A + G + VGT
Sbjct: 120 SNGQ---IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT 169
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 8e-16
Identities = 51/176 (28%), Positives = 81/176 (46%), Gaps = 28/176 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE---------------IAVKRL-SKASGQGLEEF 524
+L KLG+G FG V+ + E +AVK L + + +F
Sbjct: 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDF 64
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
+ E+ ++S+L++ N++RLLG CV + +I EYM N L+ L ++E N
Sbjct: 65 LKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLS---QREIESTFTHAN 121
Query: 585 IIEGISRG-LLYLHRD--------SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I +S LLY+ + L +HRDL N L+ KI+DFGM++
Sbjct: 122 NIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 9e-16
Identities = 54/169 (31%), Positives = 83/169 (49%), Gaps = 16/169 (9%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQ 535
A +L +G+G FG V G + G ++AVK + + A+ Q F+ E V+++L+
Sbjct: 2 ALNMKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATAQA---FLAEASVMTQLR 57
Query: 536 HRNLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLK---KERLDWRKRFNIIEGISR 591
H NLV+LLG VE + + I EYM SL D L+ + L +
Sbjct: 58 HSNLVQLLGVIVEEKGGLYIVTEYMAKGSL----VDYLRSRGRSVLGGDCLLKFSLDVCE 113
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
+ YL ++ +HRDL A N+L+ E+ K+SDFG+ K QD
Sbjct: 114 AMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTG 159
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-15
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 15/170 (8%)
Query: 482 NFQLSSKLGQGGFGPVYW-GRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
+F++ KLG+G +G VY RL D Q A+K L S + E+ +NE+ +++ + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-----DWRKRFNIIEGISRGL 593
++ ++G + ++ EY P L + KK +L WR I + RGL
Sbjct: 61 IISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IFIQLLRGL 116
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
LH +I+HRDLK++NILL KI D G++K+ N + G
Sbjct: 117 QALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQIG 163
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 52/154 (33%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRN 538
F ++G G FG VY+ R ++ + +A+K++S K S + ++ + EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+ GC + L+ EY + D L + KK L + I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASDIL--EVHKKP-LQEVEIAAICHGALQGLAYLHS 133
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
R IHRD+KA NILL E K++DFG A +
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL 164
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 52/168 (30%), Positives = 72/168 (42%), Gaps = 29/168 (17%)
Query: 488 KLGQGGFGPVYWGR--------LKDGQE---------IAVKRLSK-ASGQGLEEFMNEVM 529
KLG+G FG V+ K E +AVK L AS E+F+ EV
Sbjct: 12 KLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVK 71
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--------FDPLKKERLDWRK 581
++S+L N+ RLLG C +I EYM N L+ L + L +
Sbjct: 72 ILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFST 131
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629
+ I+ G+ YL L +HRDL N L+ + KI+DFGM
Sbjct: 132 LLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 51/157 (32%), Positives = 81/157 (51%), Gaps = 14/157 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
+FQ+ +++GQGG+G V+ + KD EI A+KR+ K+ L E + E +++ +
Sbjct: 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKS 60
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP--LKKERLDWRKRFNIIEGISRGLL 594
LV+LL + E L EY+P LL + L ++ RF + E +
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDH----ARFYMAEMFE-AVD 115
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
LH L IHRDLK N L+D + K++DFG++K
Sbjct: 116 ALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSK 149
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 2e-15
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 485 LSSKLGQGGFGPVYWGR------LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
L +LG+G FG V+ KD +AVK L + ++F E +++ LQH +
Sbjct: 9 LKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEH 68
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSL---------DALLF---DPLK-KERLDWRKRFNI 585
+V+ G C +G+ ++++EYM + L DA++ P + K L + +I
Sbjct: 69 IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I+ G++YL + +HRDL N L+ L KI DFGM++
Sbjct: 129 ASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR 171
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 2e-15
Identities = 51/164 (31%), Positives = 79/164 (48%), Gaps = 11/164 (6%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE---FMNEVMVISKLQHRNLVRLLGC 545
+G+G FG V+ R K Q++ + + +E NE V+ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYEN 67
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
+E + M++ EY P +L + ++K I+ + LL LH I+
Sbjct: 68 FLEDKALMIVMEYAPGGTL----AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLIL 123
Query: 606 HRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQADTGRVVGT 648
HRDLK NILLD+ KI DFG++KI ++ +A T VVGT
Sbjct: 124 HRDLKTQNILLDKHKMVVKIGDFGISKIL-SSKSKAYT--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 2e-15
Identities = 56/175 (32%), Positives = 86/175 (49%), Gaps = 25/175 (14%)
Query: 475 ELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLS-KASGQGLEEFMNE 527
E+ +T F +LG+ FG VY G L + Q +A+K L KA G EEF +E
Sbjct: 1 EINLSTVRFM--EELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHE 58
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKK 574
M+ S+LQH N+V LLG + + +I+ Y + L L D K
Sbjct: 59 AMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVK 118
Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629
L+ +I+ I+ G+ +L S ++H+DL N+L+ ++LN KISD G+
Sbjct: 119 STLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGL 170
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (188), Expect = 3e-15
Identities = 51/175 (29%), Positives = 84/175 (48%), Gaps = 12/175 (6%)
Query: 483 FQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNL 539
+++ +G+G FG V R DG+ + K + + + ++ ++EV ++ +L+H N+
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNI 61
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKER--LDWRKRFNIIEGISRGLLY 595
VR ++ +Y M L L KKER ++ + I+ + L
Sbjct: 62 VRYYDRIID-RSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYE 120
Query: 596 LHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H D ++HRDLK +NI LD N K+ DFG+AKI G + A T VGT
Sbjct: 121 CHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGT 173
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 76.7 bits (188), Expect = 3e-15
Identities = 49/149 (32%), Positives = 80/149 (53%), Gaps = 10/149 (6%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
++G G FG VY+ R ++ + +A+K++S K S + ++ + EV + +++H N +
Sbjct: 32 EIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYK 91
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
GC + L+ EY + D L + K+ L + I G +GL YLH +
Sbjct: 92 GCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 145
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKI 632
+IHRD+KA NILL E K++DFG A I
Sbjct: 146 MIHRDIKAGNILLTEPGQVKLADFGSASI 174
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 57/163 (34%), Positives = 86/163 (52%), Gaps = 24/163 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 535
N++L LG+G FG VY D G+E+AVK++ S+ + + + E+ ++ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 536 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-----KERLDWRKRFNIIEG 588
H +V+ GC + EEK L EYMP S+ D LK E + R I++G
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK----DQLKAYGALTENVTRRYTRQILQG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+S YLH + I+HRD+K +NIL D N K+ DFG +K
Sbjct: 119 VS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 3e-15
Identities = 51/151 (33%), Positives = 79/151 (52%), Gaps = 13/151 (8%)
Query: 489 LGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRL 542
LG+G FG V R G+++AVK L SG + + E+ ++ L H N+V+
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 71
Query: 543 LGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
G C E LI E++P+ SL L P K +++ +++ I +G+ YL S
Sbjct: 72 KGICTEDGGNGIKLIMEFLPSGSLKEYL--PRNKNKINLKQQLKYAVQICKGMDYL--GS 127
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAK 631
R + +HRDL A N+L++ E KI DFG+ K
Sbjct: 128 R-QYVHRDLAARNVLVESEHQVKIGDFGLTK 157
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 76.0 bits (187), Expect = 3e-15
Identities = 54/183 (29%), Positives = 91/183 (49%), Gaps = 21/183 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDG-------QEIAVKRLS-----KASGQGLEEFMNEVM 529
+ + LG G FG VY R K+ +EI V + + + + + ++EV
Sbjct: 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVT 60
Query: 530 VISK-LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNII 586
+I + L+H N+VR +E + ++ + + L F+ LK K+R + +NI
Sbjct: 61 IIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPL-GEHFNSLKEKKQRFTEERIWNIF 119
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
+ L YLH++ R I+HRDL +NI+L E+ I+DFG+AK Q ++ VV
Sbjct: 120 VQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAK---QKQPESKLTSVV 174
Query: 647 GTL 649
GT+
Sbjct: 175 GTI 177
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 4e-15
Identities = 55/176 (31%), Positives = 91/176 (51%), Gaps = 20/176 (11%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEI---AVKRLSKA--SGQGLEEFMNEVMVISKLQHRNL 539
L LG+G FG V G+L I AVK + A + +E+F++E + + + H N+
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNV 62
Query: 540 VRLLGCCVEGEEK------MLIYEYMPNRSLDA-LLFDPL--KKERLDWRKRFNIIEGIS 590
+RL+G C++ E ++I +M + L + LL+ L + L + + I+
Sbjct: 63 MRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA 122
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRV 645
G+ YL S IHRDL A N +L+E +N ++DFG++ KI+ G D GR+
Sbjct: 123 SGMEYL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNG--DYYRQGRI 173
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 5e-15
Identities = 51/157 (32%), Positives = 84/157 (53%), Gaps = 21/157 (13%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE------FMNEVMVISKLQHRNLV 540
K+G+G +G VY GR K GQ +A+K++ S EE + E+ ++ +LQH N+V
Sbjct: 7 KIGEGTYGVVYKGRNKKTGQIVAMKKIRLES----EEEGVPSTAIREISLLKELQHPNIV 62
Query: 541 RLLGCCVEGEEKMLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
L ++ LI+E++ + LD+L L + I++GI L+ H
Sbjct: 63 CLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGI----LFCH 118
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
R++HRDLK N+L+D + K++DFG+A+ FG
Sbjct: 119 SR---RVLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 75.1 bits (184), Expect = 7e-15
Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 24/163 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 535
N++L LGQG FG VY D G+E+AVK++ S + + + E+ ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL 62
Query: 536 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKK-----ERLDWRKRFNIIEG 588
H +V+ GC + E+ L E+MP S+ D LK E + + I+EG
Sbjct: 63 HERIVQYYGCLRDPMERTLSIFMEHMPGGSIK----DQLKSYGALTENVTRKYTRQILEG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+S YLH + I+HRD+K +NIL D N K+ DFG +K
Sbjct: 119 VS----YLHSN---MIVHRDIKGANILRDSVGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 74.6 bits (183), Expect = 8e-15
Identities = 48/151 (31%), Positives = 83/151 (54%), Gaps = 16/151 (10%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLS------KASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG+G +G VY G GQ IAVK++ A+ + E+ EV ++ L+H N+V+
Sbjct: 8 LGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQY 67
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
LG C++ + E++P S+ ++L F PL E + + I++G++ YLH +
Sbjct: 68 LGTCLDDNTISIFMEFVPGGSISSILNRFGPL-PEPVFCKYTKQILDGVA----YLHNNC 122
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++HRD+K +N++L K+ DFG A+
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCAR 150
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 8e-15
Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 20/156 (12%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
++L ++G G +G VY R + G+ +A+K + G E E+ ++ + +H N+V
Sbjct: 5 YELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVA 64
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDAL---LFDPLKKERLDWRKRFNIIEGISR----GLL 594
G + ++ ++ EY SL + PL + + I + R GL
Sbjct: 65 YFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQ---------IAYVCRETLKGLA 115
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
YLH IHRD+K +NILL E+ + K++DFG++
Sbjct: 116 YLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS 148
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 9e-15
Identities = 52/168 (30%), Positives = 83/168 (49%), Gaps = 25/168 (14%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
L +G+G FG V G GQ++AVK + + Q F+ E V++KL H+NLVRLL
Sbjct: 10 LGEIIGEGEFGAVLQGEYT-GQKVAVKNIKCDVTAQA---FLEETAVMTKLHHKNLVRLL 65
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE------GISRGLLYLH 597
G + ++ E M +L L R R ++I+ ++ G+ YL
Sbjct: 66 GVILH-NGLYIVMELMSKGNLVNFL-------RTRGRALVSVIQLLQFSLDVAEGMEYLE 117
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
+++HRDL A NIL+ E+ K+SDFG+A++ D ++
Sbjct: 118 SK---KLVHRDLAARNILVSEDGVAKVSDFGLARV---GSMGVDNSKL 159
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 9e-15
Identities = 53/163 (32%), Positives = 80/163 (49%), Gaps = 16/163 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSKASGQGLE-EFMNEVMVISKL 534
N Q + LG+G FG V+ + K +E + VK L K + L+ EF E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------FDPLKKERLDWRKRFNIIEG 588
H+N+VRLLG C E E +I EY L L + LK L +++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I+ G+ +L S R +HRDL A N L+ + K+S ++K
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSK 165
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 46/158 (29%), Positives = 86/158 (54%), Gaps = 14/158 (8%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGL-EEFMNEVMVISKLQHRNL 539
+Q K+G+G +G VY R G+ +A+K++ + +G+ + E+ ++ +L H N+
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNI 60
Query: 540 VRLLGCCVEGEEKMLIYEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
VRLL + L++E++ + +D+ L + K + + + +G+ Y
Sbjct: 61 VRLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTGLDPPLI---KSY--LYQLLQGIAYC 115
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
H S R++HRDLK N+L+D E K++DFG+A+ FG
Sbjct: 116 H--SH-RVLHRDLKPQNLLIDREGALKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 1e-14
Identities = 48/170 (28%), Positives = 82/170 (48%), Gaps = 23/170 (13%)
Query: 489 LGQGGFG-PVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
LG+G FG + R +D + K L++ S + + +NE++++S LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNH 67
Query: 546 CVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
++ ++ EY +L LF+ +E + W + I + Y+H+
Sbjct: 68 FMDDNTLLIEMEYANGGTLYDKIVRQKGQLFE---EEMVLW-----YLFQIVSAVSYIHK 119
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
I+HRD+K NI L + K+ DFG++KI G A+T VVGT
Sbjct: 120 AG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.1 bits (185), Expect = 1e-14
Identities = 55/184 (29%), Positives = 95/184 (51%), Gaps = 23/184 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF----MNEVMVISKLQ 535
+ ++ +K+GQG FG V+ R K ++I A+K++ E F + E+ ++ L+
Sbjct: 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKV--LMENEKEGFPITALREIKILQLLK 69
Query: 536 HRNLVRLLGCC-----VEGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEG 588
H N+V L+ C K Y L LL + K L K+ +++
Sbjct: 70 HENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKK--VMKM 127
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRV 645
+ GL Y+HR+ +I+HRD+KA+NIL+ ++ K++DFG+A+ F +++ T RV
Sbjct: 128 LLNGLYYIHRN---KILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRV 184
Query: 646 VGTL 649
V TL
Sbjct: 185 V-TL 187
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 73.7 bits (181), Expect = 2e-14
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 23/173 (13%)
Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLS---------KASGQGLEEFMN-EVMVISKLQHR 537
+G+G +G VY + G+ +AVK++ + + + + + E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 538 NLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
N+V+ LG EE + I+ EY+P S+ + L + E + F E + GL YL
Sbjct: 69 NIVQYLGF-ETTEEYLSIFLEYVPGGSIGSCLRTYGRFEE-QLVRFFT--EQVLEGLAYL 124
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK----IFGGNQDQADTGRV 645
H I+HRDLKA N+L+D + KISDFG++K I+ +Q+ + G V
Sbjct: 125 HSKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSV 174
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 58/169 (34%), Positives = 80/169 (47%), Gaps = 28/169 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA----SGQGLEEFMNEVMVISKLQ 535
++F+ LG G FG V R K + A+K LSKA Q +E +NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR---- 591
H LV L G + L+ EY+P L F L+K RF E ++R
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGEL----FSHLRKSG-----RFP--EPVARFYAA 108
Query: 592 ----GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
L YLH L I++RDLK N+LLD + KI+DFG AK G
Sbjct: 109 QVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 2e-14
Identities = 57/170 (33%), Positives = 91/170 (53%), Gaps = 15/170 (8%)
Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
F ++G+G FG VY G R K+ I + L +A + +E+ E+ V+S+ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYI 64
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
R G ++G + +I EY+ S LD L PL++ + I+ I +GL YLH
Sbjct: 65 TRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGPLEETYIA-----TILREILKGLDYLHS 119
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ R IHRD+KA+N+LL E+ + K++DFG+A Q + +T VGT
Sbjct: 120 E---RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 48/146 (32%), Positives = 80/146 (54%), Gaps = 7/146 (4%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
++G+G FG V+ GRL+ D +AVK + L+ +F+ E ++ + H N+VRL+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
C + + ++ E + + D L F + RL ++ ++E + G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 606 HRDLKASNILLDEELNPKISDFGMAK 631
HRDL A N L+ E+ KISDFGM++
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSR 142
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 56/173 (32%), Positives = 86/173 (49%), Gaps = 29/173 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRL-KDG--QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
N+ + +G+G FG V R+ KDG + A+KR+ + AS +F E+ V+ KL
Sbjct: 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 66
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LD 578
H N++ LLG C L EY P+ +L D L+K R L
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLS 122
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++ + ++RG+ YL S+ + IHRDL A NIL+ E KI+DFG+++
Sbjct: 123 SQQLLHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 49/153 (32%), Positives = 85/153 (55%), Gaps = 14/153 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+++ +LG G FG VY + K+ G A K + S + LE++M E+ +++ H +V+
Sbjct: 14 WEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVK 73
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLH 597
LLG + ++ E+ P ++DA++ + LD I+ I R +L YLH
Sbjct: 74 LLGAFYWDGKLWIMIEFCPGGAVDAIMLE------LDRGLTEPQIQVICRQMLEALQYLH 127
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
++IIHRDLKA N+LL + + K++DFG++
Sbjct: 128 S---MKIIHRDLKAGNVLLTLDGDIKLADFGVS 157
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 52/163 (31%), Positives = 87/163 (53%), Gaps = 12/163 (7%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G G V R K G+++AVK + Q E NEV+++ QH+N+V +
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ GEE ++ E++ +L D + + RL+ + + E + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGT 648
RD+K+ +ILL + K+SDFG A+I ++D +VGT
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQI---SKDVPKRKSLVGT 180
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 4e-14
Identities = 52/178 (29%), Positives = 84/178 (47%), Gaps = 37/178 (20%)
Query: 488 KLGQGGFGPVYWGRLKDGQE-----------------IAVKRL-SKASGQGLEEFMNEVM 529
KLG+G FG V+ + + Q+ +AVK L A+ +F+ EV
Sbjct: 12 KLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVK 71
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER------------- 576
++S+L+ N++RLLG CV+ + +I EYM N L+ L ++
Sbjct: 72 ILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHC 131
Query: 577 ---LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + ++ I+ G+ YL S L +HRDL N L+ E L KI+DFGM++
Sbjct: 132 LPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 72.9 bits (179), Expect = 4e-14
Identities = 51/164 (31%), Positives = 89/164 (54%), Gaps = 24/164 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
NFQ K+G+G +G VY R G+ +A+K RL + + E+ ++ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 539 LVRLLGCCVEGEEKM-LIYEYMPN---RSLDAL----LFDPLKKERLDWRKRFNIIEGIS 590
+V+LL + E K+ L++E++ + +DA + PL K L F +++G++
Sbjct: 61 IVKLLDV-IHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYL-----FQLLQGLA 114
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+ H R++HRDLK N+L++ E K++DFG+A+ FG
Sbjct: 115 ----FCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 4e-14
Identities = 49/149 (32%), Positives = 77/149 (51%), Gaps = 10/149 (6%)
Query: 488 KLGQGGFGPVYWGRLKDGQEI-AVKRLS---KASGQGLEEFMNEVMVISKLQHRNLVRLL 543
++G G FG VY+ E+ AVK++S K + + ++ + EV + +L+H N +
Sbjct: 28 EIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYK 87
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
GC ++ L+ EY + D L + K+ L + I G +GL YLH +
Sbjct: 88 GCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHSHN--- 141
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKI 632
+IHRD+KA NILL E K++DFG A
Sbjct: 142 MIHRDIKAGNILLTEPGQVKLADFGSASK 170
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 5e-14
Identities = 48/176 (27%), Positives = 77/176 (43%), Gaps = 23/176 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN----EVMVISKLQ 535
N +++ +G+G +G V R K G+ +A+K+ K S + E+ EV V+ +L+
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLR 58
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGIS 590
H N+V L L++EY+ L+ L P W+ +++ I+
Sbjct: 59 HENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQ----LLQAIA 114
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
Y H IIHRD+K NIL+ E K+ DFG A+ T V
Sbjct: 115 ----YCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA 163
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 66.8 bits (163), Expect = 6e-14
Identities = 28/76 (36%), Positives = 45/76 (59%), Gaps = 3/76 (3%)
Query: 337 EDGFSKLNKMKVPDFTE-WTSPATEDECREQCLK-NCSCIAYAFD-GGIGCMVWRSINLI 393
+D F +L K+P F+ S A+ +EC +CL NCSC ++ ++ G GC++W +L
Sbjct: 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSESSLG 62
Query: 394 DIQRLPFGGTDLYIRV 409
D + P GG DLY ++
Sbjct: 63 DARLFPSGGVDLYEKI 78
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 72.7 bits (179), Expect = 7e-14
Identities = 47/172 (27%), Positives = 84/172 (48%), Gaps = 32/172 (18%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRL--SKASGQGLEE-FMNEVMVISKLQH 536
+++ +G+G +G VY + K DG+E A+K+ K G+ + E+ ++ +L+H
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKH 61
Query: 537 RNLVRLLGCCVEGEEKM--LIYEYMP---------NRSLDALLFDPLKKERLDWRKRFNI 585
N+V L+ +E +K L+++Y +R + P + L W+
Sbjct: 62 ENVVSLVEVFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ----- 116
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIF 633
I G+ YLH + ++HRDLK +NIL+ E KI D G+A++F
Sbjct: 117 ---ILNGVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 71.7 bits (176), Expect = 7e-14
Identities = 47/149 (31%), Positives = 82/149 (55%), Gaps = 11/149 (7%)
Query: 489 LGQGGFGPVYWGRL--KDGQEI--AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLL 543
+G+G FG VY G L DGQ+I AVK L++ + + +E+F+ E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 544 GCCVEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
G C+ E +++ YM + L + + F + +++G+ YL +
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGL--QVAKGMEYL---ASK 117
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
+ +HRDL A N +LDE K++DFG+A+
Sbjct: 118 KFVHRDLAARNCMLDESFTVKVADFGLAR 146
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 50/166 (30%), Positives = 85/166 (51%), Gaps = 18/166 (10%)
Query: 488 KLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+GQG G VY + GQE+A+K+++ E +NE++V+ + +H N+V L
Sbjct: 26 KIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSY 85
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL----YLHRDSRL 602
+ G+E ++ EY+ SL ++ + E I + R L +LH +
Sbjct: 86 LVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECLQALEFLHSN--- 134
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
++IHRD+K+ NILL + + K++DFG Q + T +VGT
Sbjct: 135 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 1e-13
Identities = 51/164 (31%), Positives = 84/164 (51%), Gaps = 11/164 (6%)
Query: 488 KLGQGGFGPVYWG--RLKDGQ-EIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNLVRLL 543
+LG G FG V G +++ Q ++A+K L + + + +E M E ++ +L + +VR++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G C E E ML+ E L+ L KK+ + ++ +S G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
+HRDL A N+LL + KISDFG++K G + D R G
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGAD-DSYYKARSAG 158
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-13
Identities = 56/163 (34%), Positives = 82/163 (50%), Gaps = 24/163 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRL-----SKASGQGLEEFMNEVMVISKLQ 535
N++ LGQG FG VY D G+E+A K++ S + + + E+ ++ LQ
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ 62
Query: 536 HRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-----KERLDWRKRFNIIEG 588
H +V+ GC + EK L EYMP S+ D LK E + + I+EG
Sbjct: 63 HERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEG 118
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+S YLH + I+HRD+K +NIL D N K+ DFG +K
Sbjct: 119 MS----YLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASK 154
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 71.4 bits (175), Expect = 2e-13
Identities = 56/159 (35%), Positives = 87/159 (54%), Gaps = 25/159 (15%)
Query: 488 KLGQGGFGPVYWGRLKDGQE-IAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
K+G+G +G VY R + E IA+K RL + + E+ ++ ++QH N+VRL
Sbjct: 9 KIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQD 68
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKE---RLDWRKRFNIIEG----ISRGLLYL 596
V E+++ L++EY+ LD LKK D+ K +I+ I RG+ Y
Sbjct: 69 V-VHSEKRLYLVFEYL---DLD------LKKHMDSSPDFAKNPRLIKTYLYQILRGIAYC 118
Query: 597 HRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFG 634
H S R++HRDLK N+L+D N K++DFG+A+ FG
Sbjct: 119 H--SH-RVLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154
|
Length = 294 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-13
Identities = 45/149 (30%), Positives = 68/149 (45%), Gaps = 9/149 (6%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIA---VKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
++G G FG V G G A VK L + A+ F+ EV +L H N+++ L
Sbjct: 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCL 61
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGLLYLHRDSR 601
G C+E +L+ E+ P L L +K + ++ GLL+LH +
Sbjct: 62 GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLH---Q 118
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMA 630
IH DL N L +L+ KI D+G+A
Sbjct: 119 ADFIHSDLALRNCQLTADLSVKIGDYGLA 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 71.1 bits (174), Expect = 2e-13
Identities = 47/170 (27%), Positives = 79/170 (46%), Gaps = 29/170 (17%)
Query: 488 KLGQGGFGPVYWGRLKDGQE-----------------IAVKRL-SKASGQGLEEFMNEVM 529
KLG+G FG V+ + ++ +AVK L A+ +F+ E+
Sbjct: 12 KLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIK 71
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF------DPLKKER--LDWRK 581
++S+L+ N++RLL C+ + +I EYM N L+ L K + + +
Sbjct: 72 IMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYST 131
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ I+ G+ YL S L +HRDL N L+ + KI+DFGM++
Sbjct: 132 LIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 50/178 (28%), Positives = 82/178 (46%), Gaps = 31/178 (17%)
Query: 482 NFQLSSKLGQGGFGPVYWG---RLKDG---QEIAVKRLSKASGQG-LEEFMNEVMVISKL 534
N L LG+G FG V RLK +AVK L + + L + ++E ++ ++
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQV 60
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--------------------- 573
H ++++L G C + +LI EY SL + L + K
Sbjct: 61 NHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPD 120
Query: 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ L + ISRG+ YL + ++++HRDL A N+L+ E KISDFG+++
Sbjct: 121 ERALTMGDLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSR 175
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 70.4 bits (173), Expect = 2e-13
Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 14/159 (8%)
Query: 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLG 544
+LG G G V + G+ +AVK + + ++ + + E+ ++ K +V G
Sbjct: 7 GELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYG 66
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
+ + EYM SLD +L + R+ R I + +GL YLH +I
Sbjct: 67 AFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLHEK--HKI 122
Query: 605 IHRDLKASNILLDEELNPKISDFG--------MAKIFGG 635
IHRD+K SNIL++ K+ DFG +AK F G
Sbjct: 123 IHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVG 161
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 2e-13
Identities = 52/167 (31%), Positives = 85/167 (50%), Gaps = 17/167 (10%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWG----RLKDGQE--IAVKRLSK-ASGQGLEEFMNEVMVI 531
A +S +LGQG FG VY G +KD E +A+K +++ AS + EF+NE V+
Sbjct: 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVM 63
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-------WRKRFN 584
+ ++VRLLG +G+ ++I E M L + L + + +K
Sbjct: 64 KEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQ 123
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ I+ G+ YL+ + + +HRDL A N ++ E+ KI DFGM +
Sbjct: 124 MAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 70.6 bits (173), Expect = 3e-13
Identities = 41/142 (28%), Positives = 74/142 (52%), Gaps = 8/142 (5%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G G V K G+++AVK++ Q E NEV+++ QH N+V +
Sbjct: 26 KIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSY 85
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ G+E ++ E++ +L D + R++ + + + + L +LH +IH
Sbjct: 86 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLAVLKALSFLHAQ---GVIH 138
Query: 607 RDLKASNILLDEELNPKISDFG 628
RD+K+ +ILL + K+SDFG
Sbjct: 139 RDIKSDSILLTSDGRVKLSDFG 160
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 3e-13
Identities = 55/171 (32%), Positives = 86/171 (50%), Gaps = 21/171 (12%)
Query: 483 FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ 535
F L LG+G FG V +LK Q++AVK L KA S +EEF+ E + +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKML-KADIFSSSDIEEFLREAACMKEFD 59
Query: 536 HRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDA-LLFDPLKKE--RLDWRKRFNII 586
H N+++L+G + K M+I +M + L LL + +E L + +
Sbjct: 60 HPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFM 119
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA-KIFGGN 636
I+ G+ YL S IHRDL A N +L+E + ++DFG++ KI+ G+
Sbjct: 120 IDIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGD 167
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 3e-13
Identities = 47/162 (29%), Positives = 87/162 (53%), Gaps = 10/162 (6%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+GQG G V+ + GQE+A+K+++ E +NE++V+ +L++ N+V L
Sbjct: 26 KIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSF 85
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ G+E ++ EY+ SL D + + +D + + + L +LH + ++IH
Sbjct: 86 LVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALEFLHAN---QVIH 138
Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
RD+K+ N+LL + + K++DFG Q + T +VGT
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 52/164 (31%), Positives = 86/164 (52%), Gaps = 24/164 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGL-EEFMNEVMVISKLQHRNL 539
NF+ KLG+G + VY GR + EI A+K + + +G + E+ ++ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 540 VRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKK------ER--LDWRKRFNIIEGIS 590
VRL + E K ML++EYM LKK R LD + +
Sbjct: 61 VRLHDV-IHTENKLMLVFEYMDK---------DLKKYMDTHGVRGALDPNTVKSFTYQLL 110
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+G+ + H + R++HRDLK N+L+++ K++DFG+A+ FG
Sbjct: 111 KGIAFCHEN---RVLHRDLKPQNLLINKRGELKLADFGLARAFG 151
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 49/157 (31%), Positives = 74/157 (47%), Gaps = 25/157 (15%)
Query: 488 KLGQGGFGPVYWGRLKDG---QEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
++G G FG V G + G ++ VK L AS Q +F+ E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 544 GCCVEGEEKMLIYEYMP----------NRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
G C E +L+ E+ P R + + DP +R+ I+ GL
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACE--------IALGL 113
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
L+LH+++ IH DL N LL +L KI D+G++
Sbjct: 114 LHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 4e-13
Identities = 54/160 (33%), Positives = 75/160 (46%), Gaps = 14/160 (8%)
Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKDGQ--EIAVKRL-SKASGQGLEEFMNEVMVISK 533
NN LG G FG V +G K ++AVK L A E M+E+ ++S
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-LDWRKRFNIIEGISR 591
L H N+V LLG C G ++I EY D L F K+E L + +++
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYC--CYGDLLNFLRRKRESFLTLEDLLSFSYQVAK 152
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
G+ +L + IHRDL A N+LL KI DFG+A+
Sbjct: 153 GMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 5e-13
Identities = 51/153 (33%), Positives = 80/153 (52%), Gaps = 16/153 (10%)
Query: 489 LGQGGFGPVYWG-RLKDGQEI----AVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRL 542
LG G FG V+ G + +G I A+K + SG Q +E + ++ + L H +VRL
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDS 600
LG C G L+ + P SL D +++ R LD ++ N I++G+ YL
Sbjct: 75 LGIC-PGASLQLVTQLSPLGSL----LDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEH- 128
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
R++HR+L A NILL + +I+DFG+A +
Sbjct: 129 --RMVHRNLAARNILLKSDSIVQIADFGVADLL 159
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 7e-13
Identities = 45/156 (28%), Positives = 78/156 (50%), Gaps = 15/156 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQH 536
LS L +G FG +++G L D +E+ VK + AS + + E ++ L H
Sbjct: 8 VTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSH 67
Query: 537 RNLVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDP-----LKKERLDWRKRFNIIEGIS 590
+N++ +L C+E E ++Y YM +L L + L ++ ++ I+
Sbjct: 68 QNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 626
G+ YLH+ +IH+D+ A N ++DEEL KI+D
Sbjct: 128 CGMSYLHK---RGVIHKDIAARNCVIDEELQVKITD 160
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 49/167 (29%), Positives = 75/167 (44%), Gaps = 19/167 (11%)
Query: 476 LATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL 534
L T F+L +G+G +G VY R K GQ +A+K + EE E ++ K
Sbjct: 1 LPDPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIM-DIIEDEEEEIKEEYNILRKY 59
Query: 535 -QHRNLVRLLGC------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN--- 584
H N+ G ++ L+ E S+ L+ KK + R +
Sbjct: 60 SNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGK---RLKEEWIA 116
Query: 585 -IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
I+ RGL YLH + ++IHRD+K NILL + K+ DFG++
Sbjct: 117 YILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVS 160
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 50/164 (30%), Positives = 78/164 (47%), Gaps = 23/164 (14%)
Query: 488 KLGQGGFGPVYWGRL-----KDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVR 541
+LG+ FG +Y G L Q +A+K L + Q EF E ++++L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLF--------------DPLKKERLDWRKRFNIIE 587
LLG + + +++EY+ L L D K LD +I
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I+ G+ YL S +H+DL A NIL+ E+L+ KISD G+++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 68.0 bits (167), Expect = 1e-12
Identities = 52/178 (29%), Positives = 85/178 (47%), Gaps = 30/178 (16%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRNLVRLLG 544
+ +G +G V+ + K G A+K + KA +++ + E ++S+ Q +V+L
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY- 59
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+G++ + L+ EY+P L +LL D D + I I L YLH
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDE------DVAR--IYIAEIVLALEYLHS 111
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ-------ADTGRVVGTL 649
IIHRDLK NIL+D + K++DFG++K G + Q + R+VGT
Sbjct: 112 ---NGIIHRDLKPDNILIDSNGHLKLTDFGLSK-VGLVRRQINLNDDEKEDKRIVGTP 165
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 52/167 (31%), Positives = 91/167 (54%), Gaps = 18/167 (10%)
Query: 489 LGQGGFGPVYWG-RLKDGQEI----AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG G FG VY G + DG+ + A+K L + S + +E ++E V++ + + RL
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDS 600
LG C+ + L+ + MP L D ++ K+R+ + N I++G+ YL
Sbjct: 75 LGICLTSTVQ-LVTQLMPY----GCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE-- 127
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ--ADTGRV 645
+R++HRDL A N+L+ + KI+DFG+A++ ++ + AD G+V
Sbjct: 128 -VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKV 173
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 2e-12
Identities = 48/158 (30%), Positives = 80/158 (50%), Gaps = 17/158 (10%)
Query: 488 KLGQGGFGPVYWGRLKD---GQ---EIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLV 540
+LGQG FG VY G +D G+ +AVK +++ AS + EF+NE V+ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 541 RLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
RLLG +G+ +++ E M + RSL + + ++ + I+ G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
YL+ + +HRDL A N ++ + KI DFGM +
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR 167
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 68.0 bits (166), Expect = 3e-12
Identities = 56/154 (36%), Positives = 76/154 (49%), Gaps = 13/154 (8%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+G FG V RLK G+ AVK L K +E M E ++S ++ + L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLY 62
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRLR 603
CC + +++ N L+F K R D R RF E S L++LH
Sbjct: 63 CCFQTPDRLFFVMEFVNGG--DLMFHIQKSRRFDEARARFYAAEITS-ALMFLHDKG--- 116
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAK--IFGG 635
II+RDLK N+LLD E + K++DFGM K IF G
Sbjct: 117 IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG 150
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 3e-12
Identities = 46/178 (25%), Positives = 88/178 (49%), Gaps = 18/178 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRL-------SKASGQGLEEFMNEVMVI 531
NF++ K+G+G F VY L DG+ +A+K++ +KA ++ + E+ ++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKAR----QDCLKEIDLL 56
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGIS 590
+L H N+++ L +E E ++ E L ++ K++RL R + +
Sbjct: 57 KQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLC 116
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
L ++H S+ RI+HRD+K +N+ + K+ D G+ + F A + +VGT
Sbjct: 117 SALEHMH--SK-RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 48/171 (28%), Positives = 86/171 (50%), Gaps = 14/171 (8%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQH---R 537
+Q +G+G +G VY G+ + G+ +A+K ++ + + + EV ++S+L+
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+ + G ++G +I EY S+ L+ K + + II + L Y+H
Sbjct: 63 NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIH 118
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ +IHRD+KA+NIL+ N K+ DFG+A + N + T VGT
Sbjct: 119 KVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST--FVGT 164
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 67.1 bits (163), Expect = 4e-12
Identities = 48/162 (29%), Positives = 86/162 (53%), Gaps = 10/162 (6%)
Query: 488 KLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+GQG G VY + GQE+A+K+++ E +NE++V+ + ++ N+V L
Sbjct: 26 KIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 85
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ G+E ++ EY+ SL D + + +D + + + L +LH + ++IH
Sbjct: 86 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALDFLHSN---QVIH 138
Query: 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
RD+K+ NILL + + K++DFG Q + T +VGT
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 178
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 42/150 (28%), Positives = 84/150 (56%), Gaps = 9/150 (6%)
Query: 488 KLGQGGFGPVYWGRLKDGQEI-AVKRLS-KASGQGLEEF-MNEVMVISKLQHRNLVRLLG 544
K+G+G +G V+ + ++ EI A+KR+ +G+ + E+ ++ +L+H+N+VRL
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
++ L++EY ++ L FD + +D + + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGD-IDPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFG 634
+HRDLK N+L+++ K++DFG+A+ FG
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFG 150
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 66.7 bits (163), Expect = 6e-12
Identities = 43/161 (26%), Positives = 80/161 (49%), Gaps = 9/161 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQHR 537
++ +G+G +G V + K+ GQ +A+K+ ++ + + M E+ ++ +L+H
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHE 60
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
NLV L+ + L++E++ + LD L P + RK + I RG+ + H
Sbjct: 61 NLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRK---YLFQILRGIEFCH 117
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+ IIHRD+K NIL+ + K+ DFG A+ +
Sbjct: 118 SHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 6e-12
Identities = 42/155 (27%), Positives = 68/155 (43%), Gaps = 11/155 (7%)
Query: 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 536
A+ + + L G G V+ K GQ V + K GQ + E M++ + H
Sbjct: 62 VVASLGYTVIKTLTPGSEGRVFVAT-KPGQPDPV--VLKI-GQKGTTLI-EAMLLQNVNH 116
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+++R+ V G ++ +P+ S D + + L + I + I GL YL
Sbjct: 117 PSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYL 173
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
H RIIHRD+K NI +++ I D G A+
Sbjct: 174 HA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ 205
|
Length = 357 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 6e-12
Identities = 50/166 (30%), Positives = 81/166 (48%), Gaps = 22/166 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
+F+L +G+G FG V + +D +++ A+K ++K + +NE ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLD-WRKRFNIIEGISR 591
LV L + EE M Y+ +D LL + +K + + +F I E I
Sbjct: 61 FLVNLWYS-FQDEENM----YL---VVDLLLGGDLRYHLSQKVKFSEEQVKFWICE-IVL 111
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
L YLH IIHRD+K NILLDE+ + I+DF +A +
Sbjct: 112 ALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 66.3 bits (161), Expect = 7e-12
Identities = 48/163 (29%), Positives = 89/163 (54%), Gaps = 12/163 (7%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+GQG G VY + GQE+A+++++ E +NE++V+ + ++ N+V L
Sbjct: 27 KIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSY 86
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ G+E ++ EY+ SL D + + +D + + + L +LH + ++IH
Sbjct: 87 LVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN---QVIH 139
Query: 607 RDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGRVVGT 648
RD+K+ NILL + + K++DFG A+I +Q+ +VGT
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQI---TPEQSKRSTMVGT 179
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 57/175 (32%), Positives = 90/175 (51%), Gaps = 28/175 (16%)
Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKDGQE----IAVKRLS-KASGQGLEEFMNEVMVI 531
+ L LG+G FG V +G K + +AVK L A+ + L + ++E M +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISE-MEL 70
Query: 532 SKL--QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KER 576
KL +H+N++ LLG C + +I EY +L L FD K +E+
Sbjct: 71 MKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQ 130
Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L ++ + ++RG+ YL +SR R IHRDL A N+L+ E+ KI+DFG+A+
Sbjct: 131 LSFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 7e-12
Identities = 51/170 (30%), Positives = 90/170 (52%), Gaps = 15/170 (8%)
Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
F ++G+G FG V+ G R + I + L +A + +E+ E+ V+S+ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+ G ++G + +I EY+ S LD L P + ++ +++ I +GL YLH
Sbjct: 65 TKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGPFDEFQIA-----TMLKEILKGLDYLHS 119
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ + IHRD+KA+N+LL E+ + K++DFG+A Q + +T VGT
Sbjct: 120 EKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGT 164
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 8e-12
Identities = 49/181 (27%), Positives = 95/181 (52%), Gaps = 27/181 (14%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEF----MNEVMVISKLQHR 537
F + ++G+G +G VY R KD G+ +A+K++ + + E F + E+ ++ +L HR
Sbjct: 9 FDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLNHR 66
Query: 538 NLVRLLGCCVEGEEKM----------LIYEYMPNRSLDALLFDPLKKERLDWRKRFN--I 585
N+V L + ++ + L++EYM D L L+ + + +
Sbjct: 67 NIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSEDHIKSF 121
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
++ + GL Y H+ + L HRD+K SNILL+ + K++DFG+A+++ + + T +V
Sbjct: 122 MKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKV 178
Query: 646 V 646
+
Sbjct: 179 I 179
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 45/150 (30%), Positives = 82/150 (54%), Gaps = 8/150 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAV-KRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+++ +LG G FG VY + K+ +A K + S + LE++M E+ +++ H N+V+
Sbjct: 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVK 66
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII-EGISRGLLYLHRDS 600
LL ++ E+ ++DA++ L+ ER + ++ + L YLH +
Sbjct: 67 LLDAFYYENNLWILIEFCAGGAVDAVM---LELERPLTEPQIRVVCKQTLEALNYLHEN- 122
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMA 630
+IIHRDLKA NIL + + K++DFG++
Sbjct: 123 --KIIHRDLKAGNILFTLDGDIKLADFGVS 150
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 9e-12
Identities = 44/153 (28%), Positives = 79/153 (51%), Gaps = 11/153 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
++++L ++G G +G VY R L G+ AVK + G E+ ++ + +H N+
Sbjct: 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNI 68
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
V G + E+ + EY SL + + PL + ++ + R + +GL YLH
Sbjct: 69 VAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLH 123
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
++ HRD+K +NILL + + K++DFG+A
Sbjct: 124 SKGKM---HRDIKGANILLTDNGDVKLADFGVA 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 47/156 (30%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 488 KLGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRL 542
+LG G FG V + K + +AVK L + +E + E V+ +L + +VR+
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRM 61
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
+G C E E ML+ E L+ L K + + + ++ +S G+ YL +
Sbjct: 62 IGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN-- 115
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+HRDL A N+LL + KISDFG++K G +++
Sbjct: 116 -FVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 40/163 (24%), Positives = 78/163 (47%), Gaps = 30/163 (18%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--EVMVISKLQ-HRN 538
+++ K+G+G F V + K G+ A+K + K + LE+ N E+ + +L H N
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPN 59
Query: 539 LVRLLGCCVEGEEK----------MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
++RL+ + + M +YE + R K L ++ + +
Sbjct: 60 ILRLIEVLFDRKTGRLALVFELMDMNLYELIKGR-----------KRPLPEKRVKSYMYQ 108
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + L ++HR+ I HRD+K NIL+ +++ K++DFG +
Sbjct: 109 LLKSLDHMHRNG---IFHRDIKPENILIKDDI-LKLADFGSCR 147
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 1e-11
Identities = 54/167 (32%), Positives = 79/167 (47%), Gaps = 15/167 (8%)
Query: 485 LSSKLGQGGFGPVYW---------GRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
L +LG+G FG VY RLK +EI V L+ + E ++SKL
Sbjct: 4 LQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNE---TVQANQEAQLLSKLD 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H +V+ +E + +I EY R LD L + + + + E + LL
Sbjct: 61 HPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQ--VCEWFIQLLLG 118
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+H + RI+HRDLKA NI L L KI DFG++++ G+ D A T
Sbjct: 119 VHYMHQRRILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 55/176 (31%), Positives = 90/176 (51%), Gaps = 19/176 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
F+ +++G+G +G VY R EI A+K R+ + E+ ++ L+H N
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPN 67
Query: 539 LVRLLGCCV--EGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRKRFNIIEGISRGL 593
+V L V + L+ EY + L +LL + P + ++ ++ + RGL
Sbjct: 68 IVELKEVVVGKHLDSIFLVMEYC-EQDLASLLDNMPTPFSESQVK-----CLMLQLLRGL 121
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
YLH + IIHRDLK SN+LL ++ KI+DFG+A+ + G + T +VV TL
Sbjct: 122 QYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTY-GLPAKPMTPKVV-TL 172
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 65.7 bits (161), Expect = 2e-11
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 34/165 (20%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMN---------EVMVIS 532
+++ KLG+G +G V+ + +E+ A+K++ A F N E+M +
Sbjct: 9 YEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDA-------FRNATDAQRTFREIMFLQ 61
Query: 533 KL-QHRNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNII 586
+L H N+V+LL V E L++EYM + L ++ L D KR+ I+
Sbjct: 62 ELGDHPNIVKLLN--VIKAENDKDIYLVFEYM-----ETDLHAVIRANILEDVHKRY-IM 113
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + L Y+H S +IHRDLK SNILL+ + K++DFG+A+
Sbjct: 114 YQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 2e-11
Identities = 48/152 (31%), Positives = 80/152 (52%), Gaps = 13/152 (8%)
Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
F K+G+G FG V+ G R + I + L +A + +E+ E+ V+S+ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDE-IEDIQQEITVLSQCDSPYV 64
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRS-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+ G ++ + +I EY+ S LD L PL + ++ I+ I +GL YLH
Sbjct: 65 TKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDETQIA-----TILREILKGLDYLHS 119
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ + IHRD+KA+N+LL E K++DFG+A
Sbjct: 120 EKK---IHRDIKAANVLLSEHGEVKLADFGVA 148
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 65.1 bits (158), Expect = 2e-11
Identities = 42/142 (29%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G G V K G+++AVK++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ G+E ++ E++ +L D + R++ + + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 607 RDLKASNILLDEELNPKISDFG 628
RD+K+ +ILL + K+SDFG
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFG 163
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 65.0 bits (159), Expect = 3e-11
Identities = 49/173 (28%), Positives = 79/173 (45%), Gaps = 33/173 (19%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---------EVMVISKLQHRN 538
+G G +G V G+++A+K+LS F + E+ ++ + H N
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLS-------RPFQSAIHAKRTYRELRLLKHMDHEN 75
Query: 539 LVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 596
++ LL + Y+ + A L + +K ++L D +F ++ I RGL Y+
Sbjct: 76 VIGLLDVFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQF-LVYQILRGLKYI 134
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---TGRVV 646
H IIHRDLK SNI ++E+ KI DFG+A+ D TG V
Sbjct: 135 HS---AGIIHRDLKPSNIAVNEDCELKILDFGLAR-------HTDDEMTGYVA 177
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 24/164 (14%)
Query: 489 LGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHRNLV 540
LG+G FG V +AVK L A+ + L + ++E+ ++ + +H+N++
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNII 79
Query: 541 RLLGCCVEGEEKMLIYEYM-------------PNRSLDALLFDPLKKERLDWRKRFNIIE 587
LLG C + ++ EY P + +E L + +
Sbjct: 80 NLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAY 139
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++RG+ +L S+ + IHRDL A N+L+ E+ KI+DFG+A+
Sbjct: 140 QVARGMEFL--ASK-KCIHRDLAARNVLVTEDHVMKIADFGLAR 180
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 64.7 bits (158), Expect = 3e-11
Identities = 58/157 (36%), Positives = 79/157 (50%), Gaps = 17/157 (10%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKL-QHRNLVRLL 543
LG+G FG V LK E+ AVK L K +E M E V++ +H L +L
Sbjct: 3 LGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLH 62
Query: 544 GCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSR 601
C + ++++ + EY+ L +F + R D R RF E I GL +LH
Sbjct: 63 -SCFQTKDRLFFVMEYVNGGDL---MFHIQRSGRFDEPRARFYAAE-IVLGLQFLHERG- 116
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAK--IFGGN 636
II+RDLK N+LLD E + KI+DFGM K I GG
Sbjct: 117 --IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV 151
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-11
Identities = 48/158 (30%), Positives = 85/158 (53%), Gaps = 16/158 (10%)
Query: 487 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ-GLE-EFMNEVMVISKLQ---HRNLV 540
+++G G +G VY R G +A+K + + + GL + EV ++ +L+ H N+V
Sbjct: 6 AEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIV 65
Query: 541 RLLGCC----VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
RL+ C + E K+ L++E++ ++ L L D + L +++ RGL +
Sbjct: 66 RLMDVCATSRTDRETKVTLVFEHV-DQDLRTYL-DKVPPPGLPAETIKDLMRQFLRGLDF 123
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
LH + I+HRDLK NIL+ K++DFG+A+I+
Sbjct: 124 LHAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY 158
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 3e-11
Identities = 46/146 (31%), Positives = 75/146 (51%), Gaps = 12/146 (8%)
Query: 489 LGQGGFGPVYWGRLK--DGQE--IAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
LG G FG + G LK +E +A+ L + S + F+ E + + + H N+VRL
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLYLHRDSRL 602
G G M++ EYM N +LD+ L K E +L + ++ G++ G+ YL S +
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFL---RKHEGQLVAGQLMGMLPGLASGMKYL---SEM 126
Query: 603 RIIHRDLKASNILLDEELNPKISDFG 628
+H+ L A +L++ +L KIS F
Sbjct: 127 GYVHKGLAAHKVLVNSDLVCKISGFR 152
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 3e-11
Identities = 48/149 (32%), Positives = 76/149 (51%), Gaps = 13/149 (8%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+G FG V LK E+ A+K L K ++ M E +++ + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRL 602
CC + ++++ + EY+ L +F + + D R RF E ++ L++LHR
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAE-VTLALMFLHRHG-- 116
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
+I+RDLK NILLD E + K++DFGM K
Sbjct: 117 -VIYRDLKLDNILLDAEGHCKLADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 53/170 (31%), Positives = 84/170 (49%), Gaps = 16/170 (9%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQH 536
TN + +G G FG V R GQ +A+K++ K ++ + E+ ++ L+H
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRH 68
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLY 595
N++ L + E + + L LL PL+K+ + + + I RGL Y
Sbjct: 69 ENIISLSDIFISPLEDIYFVTELLGTDLHRLLTSRPLEKQFIQY-----FLYQILRGLKY 123
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
+H ++HRDLK SNIL++E + KI DFG+A+I QD TG V
Sbjct: 124 VHSAG---VVHRDLKPSNILINENCDLKICDFGLARI----QDPQMTGYV 166
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 3e-11
Identities = 43/152 (28%), Positives = 70/152 (46%), Gaps = 11/152 (7%)
Query: 485 LSSKLGQGGFGPVYWG--RLKDGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQHRNL 539
L +G+G FG VY G + ++I AVK S E+F+ E ++ + H ++
Sbjct: 10 LGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHI 69
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
V+L+G E ++ E P L + L + K LD +S L YL
Sbjct: 70 VKLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES- 125
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
R +HRD+ A N+L+ K+ DFG+++
Sbjct: 126 --KRFVHRDIAARNVLVSSPDCVKLGDFGLSR 155
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 3e-11
Identities = 40/152 (26%), Positives = 79/152 (51%), Gaps = 11/152 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+F+L ++G G +G VY R + G+ A+K + G+ E++++ +H N+V
Sbjct: 10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIV 69
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDAL--LFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
G + ++ + E+ SL + + PL + ++ + R + +GL YLH
Sbjct: 70 AYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETL-----QGLYYLHS 124
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ +HRD+K +NILL + + K++DFG++
Sbjct: 125 KGK---MHRDIKGANILLTDNGHVKLADFGVS 153
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 63.7 bits (155), Expect = 4e-11
Identities = 47/147 (31%), Positives = 77/147 (52%), Gaps = 10/147 (6%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+GGFG V ++K G+ A K+L K +G + +NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSL-A 59
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
E ++ + L+ M L +++ + + R F + I GL +LH+ R
Sbjct: 60 YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQ-IICGLEHLHQ---RR 115
Query: 604 IIHRDLKASNILLDEELNPKISDFGMA 630
I++RDLK N+LLD+ N +ISD G+A
Sbjct: 116 IVYRDLKPENVLLDDHGNVRISDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 64.6 bits (158), Expect = 4e-11
Identities = 50/171 (29%), Positives = 83/171 (48%), Gaps = 22/171 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA----SGQGLEEFMNE--VMVISK 533
++F++ +G+G FG V+ R KD ++ A+K L K+ Q E ++ +
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAH-VRAERDILADAD 59
Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLD--WRKRFNIIEGIS 590
+V+L + EE + L+ EYMP L LL ++K+ RF I E +
Sbjct: 60 --SPWIVKLY-YSFQDEEHLYLVMEYMPGGDLMNLL---IRKDVFPEET-ARFYIAELV- 111
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
L L +L IHRD+K NIL+D + + K++DFG+ K +D+
Sbjct: 112 ---LALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY 159
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 64.1 bits (157), Expect = 5e-11
Identities = 49/183 (26%), Positives = 85/183 (46%), Gaps = 35/183 (19%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVMVIS 532
++L +G G +G V + G+++A+K++S F + E+ ++
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNV-------FDDLIDAKRILREIKLLR 54
Query: 533 KLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALLFD--PLKKERLDWRKRFNI 585
L+H N++ LL E ++ E M L ++ PL + + +
Sbjct: 55 HLRHENIIGLLDILRPPSPEDFNDVYIVTELMET-DLHKVIKSPQPLTDDHIQY-----F 108
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TG 643
+ I RGL YLH + +IHRDLK SNIL++ + KI DFG+A+ ++D+ T
Sbjct: 109 LYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTE 165
Query: 644 RVV 646
VV
Sbjct: 166 YVV 168
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 7e-11
Identities = 54/179 (30%), Positives = 97/179 (54%), Gaps = 20/179 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQE-IAVKRLS-KASGQGLE-EFMNEVMVISKLQ--- 535
++ +++G+G +G V+ R LK+G +A+KR+ + +G+ + EV V+ L+
Sbjct: 3 YECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFE 62
Query: 536 HRNLVRLLGCCV----EGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
H N+VRL C + E K+ L++E++ ++ L L D + + + +++ +
Sbjct: 63 HPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETIKDMMFQLL 120
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
RGL +LH R++HRDLK NIL+ K++DFG+A+I+ Q VV TL
Sbjct: 121 RGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTL 173
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 8e-11
Identities = 50/160 (31%), Positives = 82/160 (51%), Gaps = 21/160 (13%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
F+L +G G +G VY GR +K GQ A+K + +G EE E+ ++ K HRN+
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD-VTGDEEEEIKQEINMLKKYSHHRNIA 66
Query: 541 RLLGCCVE------GEEKMLIYEYMPNRSLDALLFDP----LKKERLDWRKRFNIIEGIS 590
G ++ ++ L+ E+ S+ L+ + LK+E + + I I
Sbjct: 67 TYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY-----ICREIL 121
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
RGL +LH+ ++IHRD+K N+LL E K+ DFG++
Sbjct: 122 RGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 158
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.1 bits (153), Expect = 9e-11
Identities = 50/191 (26%), Positives = 93/191 (48%), Gaps = 31/191 (16%)
Query: 464 KLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLS- 514
+L + P ++F + + L LG+G FG V + K+ +AVK L
Sbjct: 3 ELPEDPRWEF-----SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKD 57
Query: 515 KASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----- 568
A+ + L + ++E+ ++ + +H+N++ LLG C + +I EY +L L
Sbjct: 58 DATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRP 117
Query: 569 ------FD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
+D + E++ ++ + ++RG+ YL + + IHRDL A N+L+ E
Sbjct: 118 PGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENN 174
Query: 621 NPKISDFGMAK 631
KI+DFG+A+
Sbjct: 175 VMKIADFGLAR 185
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 1e-10
Identities = 49/166 (29%), Positives = 83/166 (50%), Gaps = 23/166 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL---SKASGQGLEEF----MNEVMVISK 533
++ +++ +G +G VY R K EI A+K+L + G F + E+ ++ K
Sbjct: 6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEG-----FPITSLREINILLK 60
Query: 534 LQHRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
LQH N+V + V G IY EY+ + L +L+ K+ + ++ +
Sbjct: 61 LQHPNIVTVKEVVV-GSNLDKIYMVMEYVEH-DLKSLMET--MKQPFLQSEVKCLMLQLL 116
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
G+ +LH + I+HRDLK SN+LL+ KI DFG+A+ +G
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSP 159
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 14/170 (8%)
Query: 470 LFQFEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEV 528
+ E L T+ +++ +G+G +G VY KDG AVK L S EE E
Sbjct: 11 MLGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEY 69
Query: 529 MVISKL-QHRNLVRLLGC------CVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWR 580
++ L H N+V+ G V G+ L+ E S+ L+ L +RLD
Sbjct: 70 NILQSLPNHPNVVKFYGMFYKADKLVGGQ-LWLVLELCNGGSVTELVKGLLICGQRLDEA 128
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
I+ G GL +LH + RIIHRD+K +NILL E K+ DFG++
Sbjct: 129 MISYILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVS 175
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 62.3 bits (152), Expect = 1e-10
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 14/155 (9%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHRNLVRLLG 544
LG GGFG V ++K + A+K + K G +E +E ++ + H +V+L
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYR 60
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
+ + ++ EY L + L+ L ++ RF I + YLH
Sbjct: 61 TFKDKKYIYMLMEYCLGGEL----WTILRDRGLFDEYTARF-YIACVVLAFEYLHN---R 112
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
II+RDLK N+LLD K+ DFG AK Q
Sbjct: 113 GIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ 147
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 1e-10
Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 29/165 (17%)
Query: 489 LGQGGFGPVYWGRLK-DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLL 543
+G+G FG V R+K DG + A+KR+ + AS +F E+ V+ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LDWRKRFNII 586
G C L EY P+ +L D L+K R L ++ +
Sbjct: 63 GACEHRGYLYLAIEYAPHGNL----LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFA 118
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++RG+ YL S+ + IHRDL A NIL+ E KI+DFG+++
Sbjct: 119 ADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 160
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 41/142 (28%), Positives = 73/142 (51%), Gaps = 8/142 (5%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G G V +K G+ +AVK++ Q E NEV+++ QH N+V +
Sbjct: 27 KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSY 86
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
+ G+E ++ E++ +L D + R++ + + + + L LH +IH
Sbjct: 87 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQG---VIH 139
Query: 607 RDLKASNILLDEELNPKISDFG 628
RD+K+ +ILL + K+SDFG
Sbjct: 140 RDIKSDSILLTHDGRVKLSDFG 161
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 1e-10
Identities = 52/165 (31%), Positives = 79/165 (47%), Gaps = 29/165 (17%)
Query: 489 LGQGGFGPVYWGRLK-DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKL-QHRNLVRLL 543
+G+G FG V +K DG ++ A+K L + AS +F E+ V+ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER-----------------LDWRKRFNII 586
G C + EY P +L D L+K R L ++
Sbjct: 70 GACENRGYLYIAIEYAPYGNL----LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFA 125
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++ G+ YL S + IHRDL A N+L+ E L KI+DFG+++
Sbjct: 126 SDVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSR 167
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 61.1 bits (148), Expect = 3e-10
Identities = 49/178 (27%), Positives = 86/178 (48%), Gaps = 24/178 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
+++ K+G+G FG +Y + K D + +K L+K + E EV++++K++H N
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPN 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSL-------DALLFDPLKKERLDWRKRFNIIEGISR 591
+V E ++ EY L +LF + + L W + IS
Sbjct: 61 IVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFS--EDQILSWFVQ------ISL 112
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGT 648
GL ++H +I+HRD+K+ NI L + + K+ DFG+A+ + + A T VGT
Sbjct: 113 GLKHIHDR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT--CVGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 3e-10
Identities = 48/170 (28%), Positives = 84/170 (49%), Gaps = 26/170 (15%)
Query: 485 LSSKLGQGGFGPVYWG--------RLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL- 534
L LG+G FG V + +AVK L A+ + L + ++E+ ++ +
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIG 75
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDPLK--KERLDWRK 581
+H+N++ LLG C + ++ EY +L L FD K +E+L ++
Sbjct: 76 KHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKD 135
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ ++RG+ YL + + IHRDL A N+L+ E+ KI+DFG+A+
Sbjct: 136 LVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLAR 182
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 61.0 bits (148), Expect = 4e-10
Identities = 51/170 (30%), Positives = 82/170 (48%), Gaps = 18/170 (10%)
Query: 482 NFQLSSKLGQGGFGPVYW----GRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISK 533
NF+L LG G +G V+ G G+ A+K L KA+ + E E V+
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISR 591
++ + L + + K+ LI +Y+ L L+ ++E R I E I
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLY---QREHFTESEVRVYIAE-IVL 116
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQA 640
L +LH+ L II+RD+K NILLD E + ++DFG++K F +++A
Sbjct: 117 ALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERA 163
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 61.3 bits (149), Expect = 4e-10
Identities = 45/162 (27%), Positives = 81/162 (50%), Gaps = 28/162 (17%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL----- 542
LG G G V+ D + +AVK++ Q ++ + E+ +I +L H N+V++
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 543 ---------LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISR 591
+G E ++ EYM + L + L++ L + + F + + R
Sbjct: 73 PSGSDLTEDVGSLTELNSVYIVQEYM-----ETDLANVLEQGPLSEEHARLF--MYQLLR 125
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKI 632
GL Y+H + ++HRDLK +N+ ++ E+L KI DFG+A+I
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI 164
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 60.8 bits (148), Expect = 4e-10
Identities = 45/160 (28%), Positives = 81/160 (50%), Gaps = 19/160 (11%)
Query: 487 SKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-------FMNEVMVISKLQHRN 538
SK+G+G +G V+ R ++ GQ +A+K+ ++ E+ + E+ ++ +L+H N
Sbjct: 7 SKIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLKQLKHPN 61
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
LV L+ + L++EY + L+ L +P +K II + + + H+
Sbjct: 62 LVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKK---IIWQTLQAVNFCHK 118
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
IHRD+K NIL+ ++ K+ DFG A+I G D
Sbjct: 119 ---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD 155
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 46/146 (31%), Positives = 76/146 (52%), Gaps = 8/146 (5%)
Query: 488 KLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
KLG+G + VY GR K +A+K + +G + EV ++ L+H N+V L
Sbjct: 13 KLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
+ L++EY+ ++ L L D + K F + + RGL Y HR +++
Sbjct: 73 IHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLF--LFQLLRGLNYCHRR---KVL 126
Query: 606 HRDLKASNILLDEELNPKISDFGMAK 631
HRDLK N+L++E K++DFG+A+
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 6e-10
Identities = 45/146 (30%), Positives = 77/146 (52%), Gaps = 8/146 (5%)
Query: 488 KLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
KLG+G + V+ GR K + +A+K + +G + EV ++ L+H N+V L
Sbjct: 13 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 72
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRII 605
+ L++EY+ ++ L + D + K F + I RGL Y HR +++
Sbjct: 73 VHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIF--LYQILRGLAYCHRR---KVL 126
Query: 606 HRDLKASNILLDEELNPKISDFGMAK 631
HRDLK N+L++E K++DFG+A+
Sbjct: 127 HRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 50/170 (29%), Positives = 89/170 (52%), Gaps = 26/170 (15%)
Query: 485 LSSKLGQGGFGPVYW----GRLKDG----QEIAVKRL-SKASGQGLEEFMNEVMVISKL- 534
L LG+G FG V G K+ ++AVK L S A+ + L + ++E+ ++ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIG 81
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----------FDP--LKKERLDWRK 581
+H+N++ LLG C + +I EY +L L ++P + +E+L ++
Sbjct: 82 KHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKD 141
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ ++RG+ YL + + IHRDL A N+L+ E+ KI+DFG+A+
Sbjct: 142 LVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 188
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.6 bits (147), Expect = 7e-10
Identities = 35/125 (28%), Positives = 62/125 (49%), Gaps = 16/125 (12%)
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF--N 584
E+ ++ + H N+V+ E ++ E+M SL+ ++F +
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---------THIADEQFLAD 172
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
+ I G+ YLHR I+HRD+K SN+L++ N KI+DFG+++I D ++
Sbjct: 173 VARQILSGIAYLHRR---HIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCNSS- 228
Query: 645 VVGTL 649
VGT+
Sbjct: 229 -VGTI 232
|
Length = 353 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 8e-10
Identities = 48/156 (30%), Positives = 69/156 (44%), Gaps = 14/156 (8%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNE---VMVISKLQ 535
F+ + LG+G FG V K G+ A+K L K + +E M E + +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H LV L C + + EY L + + E R F + GL Y
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEP---RAVFYAAC-VVLGLQY 116
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
LH + +I++RDLK N+LLD E KI+DFG+ K
Sbjct: 117 LHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCK 149
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 1e-09
Identities = 45/160 (28%), Positives = 80/160 (50%), Gaps = 19/160 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQHRNL 539
+Q S +G+G +G V G ++A+K++S Q + + E+ ++ + +H N+
Sbjct: 6 RYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENI 65
Query: 540 VRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
+ +L E ++ E M L+ +K + L D + F + I RG
Sbjct: 66 IGILDIIRPPSFESFNDVYIVQELMETD-----LYKLIKTQHLSNDHIQYF--LYQILRG 118
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
L Y+H + ++HRDLK SN+LL+ + KI DFG+A+I
Sbjct: 119 LKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 1e-09
Identities = 53/150 (35%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 543
+G+G FG V + K DG+ AVK L K + +E M E V+ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 601
++ + +Y+ L F L++ER + R RF E I+ L YLH
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL----FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAK 631
L II+RDLK NILLD + + ++DFG+ K
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 2e-09
Identities = 47/162 (29%), Positives = 76/162 (46%), Gaps = 26/162 (16%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
+ + +G G FG V+ R + + A+K ++ + + NE V+ ++ H
Sbjct: 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHP 61
Query: 538 NLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG------I 589
++RL E +++ L + EY+P L F L+ RF+ G I
Sbjct: 62 FIIRLF--WTEHDQRFLYMLMEYVPGGEL----FSYLRN-----SGRFSNSTGLFYASEI 110
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L YLH I++RDLK NILLD+E + K++DFG AK
Sbjct: 111 VCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAK 149
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 2e-09
Identities = 43/176 (24%), Positives = 83/176 (47%), Gaps = 18/176 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 537
NFQ+ K+G+G F VY L D + +A+K++ + ++ + E+ ++ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-----WRKRFNIIEGISRG 592
N+++ L +E E ++ E L ++ K++RL W+ + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H SR R++HRD+K +N+ + K+ D G+ + F A + +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (142), Expect = 3e-09
Identities = 58/167 (34%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 543
+G+G FG V + K DG AVK L K + +E M E V+ K L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 601
E+ + +Y+ L F L++ER L+ R RF E ++ + YLH
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL----FFHLQRERCFLEPRARFYAAE-VASAIGYLHS--- 114
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
L II+RDLK NILLD + + ++DFG+ K G + + T GT
Sbjct: 115 LNIIYRDLKPENILLDSQGHVVLTDFGLCK--EGVEPEETTSTFCGT 159
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 58.7 bits (142), Expect = 3e-09
Identities = 54/152 (35%), Positives = 84/152 (55%), Gaps = 18/152 (11%)
Query: 489 LGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQGLEEF--MNEVMVISKLQHRNLVRL 542
LGQG FG V+ R GQ A+K L KA+ + + E +++++ H +V+L
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 543 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRD 599
+ E K+ LI +++ R D LF L KE + + +F + E ++ L +LH
Sbjct: 64 -HYAFQTEGKLYLILDFL--RGGD--LFTRLSKEVMFTEEDVKFYLAE-LALALDHLHS- 116
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L II+RDLK NILLDEE + K++DFG++K
Sbjct: 117 --LGIIYRDLKPENILLDEEGHIKLTDFGLSK 146
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 4e-09
Identities = 48/160 (30%), Positives = 80/160 (50%), Gaps = 21/160 (13%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
F+L +G G +G VY GR +K GQ A+K + + EE E+ ++ K HRN+
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEE-EEIKLEINMLKKYSHHRNIA 76
Query: 541 RLLGCCVE------GEEKMLIYEYMPNRSLDALLF----DPLKKERLDWRKRFNIIEGIS 590
G ++ ++ L+ E+ S+ L+ + LK++ + + I I
Sbjct: 77 TYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY-----ICREIL 131
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
RGL +LH ++IHRD+K N+LL E K+ DFG++
Sbjct: 132 RGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGVS 168
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 58.2 bits (141), Expect = 4e-09
Identities = 41/171 (23%), Positives = 80/171 (46%), Gaps = 32/171 (18%)
Query: 484 QLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMN------------EV 528
Q + LG+G +G V G+ +A+K+ + + S ++ E+
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN---RSLDA--LLFDPLKKERLDWRKRF 583
++++++H N++ L+ VEG+ L+ + M + + +D L + K
Sbjct: 72 KIMNEIKHENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKIRLTESQVK--------- 122
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
I+ I GL LH+ +HRDL +NI ++ + KI+DFG+A+ +G
Sbjct: 123 CILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYG 170
|
Length = 335 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 57.9 bits (140), Expect = 5e-09
Identities = 54/150 (36%), Positives = 74/150 (49%), Gaps = 15/150 (10%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVIS-KLQHRNLVRLL 543
LG+G FG V LK E A+K L K +E M E V++ +H L L
Sbjct: 3 LGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLF 62
Query: 544 GCCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRDSR 601
C + +E + + EY+ L +F R D R RF E I GL +LH+
Sbjct: 63 -CTFQTKEHLFFVMEYLNGGDL---MFHIQSSGRFDEARARFYAAEIIC-GLQFLHKKG- 116
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAK 631
II+RDLK N+LLD++ + KI+DFGM K
Sbjct: 117 --IIYRDLKLDNVLLDKDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 9e-09
Identities = 48/150 (32%), Positives = 74/150 (49%), Gaps = 14/150 (9%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRL-SKASGQGLEEFMNEVMVISKLQH-RNLVRLLGC 545
+G+G FG V K G +AVKR+ S + + + ++ V+ + +V+ G
Sbjct: 12 IGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGA 71
Query: 546 CV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLLYLHRDS 600
EG+ + + E M + SLD F E L I+ I+ + L YL +
Sbjct: 72 LFREGDCWICM-ELM-DISLD--KFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE- 126
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMA 630
L+IIHRD+K SNILLD N K+ DFG++
Sbjct: 127 -LKIIHRDVKPSNILLDRNGNIKLCDFGIS 155
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 9e-09
Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 20/166 (12%)
Query: 489 LGQGGFGPVYWG-RLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLG- 544
+G G +G V + G+++A+K+LS+ S + E+ ++ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 545 --CCVEGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
V G+E Y MP L ++ PL ++++ + ++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQY-----LVYQMLCGLKYIHSAG 137
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
IIHRDLK N+ ++E+ KI DFG+A+ + D TG VV
Sbjct: 138 ---IIHRDLKPGNLAVNEDCELKILDFGLAR----HADAEMTGYVV 176
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 54/157 (34%), Positives = 77/157 (49%), Gaps = 15/157 (9%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+G FG V LK G+ AVK L K +E M E V++ + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLYLHRDSRL 602
C + +E + + E++ L +F K R D +R F E I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDL---MFHIQDKGRFDLYRATFYAAE-IVCGLQFLHSKG-- 116
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK--IFGGNQ 637
II+RDLK N++LD + + KI+DFGM K +FG N+
Sbjct: 117 -IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNR 152
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 46/153 (30%), Positives = 75/153 (49%), Gaps = 22/153 (14%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
KLG+G + V+ GR K +A+K + +G + EV ++ L+H N+V L
Sbjct: 12 KLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDI 71
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS-------RGLLYLHR 598
L++EY LD+ L K+ LD + + RGL Y H+
Sbjct: 72 IHTERCLTLVFEY-----LDSDL-----KQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHK 121
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+I+HRDLK N+L++E+ K++DFG+A+
Sbjct: 122 R---KILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 46/158 (29%), Positives = 78/158 (49%), Gaps = 32/158 (20%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
KLG+G + VY GR K GQ +A+K + +G + E ++ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIV-TLHD 70
Query: 546 CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKR-----------FNIIEGISRGL 593
+ ++ + L++EY+ + L K+ +D F ++ RGL
Sbjct: 71 IIHTKKTLTLVFEYL-DTDL---------KQYMDDCGGGLSMHNVRLFLFQLL----RGL 116
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
Y H+ R++HRDLK N+L+ E K++DFG+A+
Sbjct: 117 AYCHQR---RVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 2e-08
Identities = 44/147 (29%), Positives = 74/147 (50%), Gaps = 10/147 (6%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGC 545
KLG+G + VY G + +GQ +A+K +S + +G+ + E ++ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDI 71
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK-RFNIIEGISRGLLYLHRDSRLRI 604
E ++EYM ++ P + R F ++ RGL Y+H I
Sbjct: 72 IHTKETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLL----RGLAYIHGQ---HI 124
Query: 605 IHRDLKASNILLDEELNPKISDFGMAK 631
+HRDLK N+L+ K++DFG+A+
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 51/167 (30%), Positives = 81/167 (48%), Gaps = 15/167 (8%)
Query: 489 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG+GGFG V G++ +++ KR+ K G+ + +NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNSRFVVSL 65
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
+ L+ M L ++ + + R F E I GL LH++
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAE-ICCGLEDLHQE--- 121
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
RI++RDLK NILLD+ + +ISD G+A + Q GR VGT+
Sbjct: 122 RIVYRDLKPENILLDDHGHIRISDLGLAVHV--PEGQTIKGR-VGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 3e-08
Identities = 49/150 (32%), Positives = 80/150 (53%), Gaps = 14/150 (9%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+GGFG V +++ G+ A K+L+K +G E M E +++K+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSL-A 59
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRDS 600
+ + + L+ M L +++ + +E + R F + IS GL +LH+
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDLRYHIYN-VDEENPGFPEPRACFYTAQIIS-GLEHLHQR- 116
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMA 630
RII+RDLK N+LLD + N +ISD G+A
Sbjct: 117 --RIIYRDLKPENVLLDNDGNVRISDLGLA 144
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 3e-08
Identities = 54/171 (31%), Positives = 87/171 (50%), Gaps = 19/171 (11%)
Query: 483 FQLSSKLGQGGFGPV---YWGRLKDGQEIAVKRLSKASGQGL---EEFMNEVMVISKLQH 536
+Q + +G G +G V Y RL+ Q++AVK+LS+ Q L E+ ++ ++H
Sbjct: 17 YQNLTPVGSGAYGSVCSAYDTRLR--QKVAVKKLSRPF-QSLIHARRTYRELRLLKHMKH 73
Query: 537 RNLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLL 594
N++ LL E Y+ + A L + +K ++L D +F +I + RGL
Sbjct: 74 ENVIGLLDVFTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQF-LIYQLLRGLK 132
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
Y+H IIHRDLK SN+ ++E+ +I DFG+A+ D TG V
Sbjct: 133 YIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLAR----QADDEMTGYV 176
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 55.5 bits (133), Expect = 3e-08
Identities = 45/154 (29%), Positives = 79/154 (51%), Gaps = 10/154 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 537
++++ KLG+G + VY G+ K +G+ +A+K RL + G + E ++ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTA-IREASLLKGLKHA 63
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V L E L++EY+ + P + K F + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHP-GGLHPENVKLF--LFQLLRGLSYIH 120
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ I+HRDLK N+L+ + K++DFG+A+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.9 bits (132), Expect = 3e-08
Identities = 44/158 (27%), Positives = 74/158 (46%), Gaps = 21/158 (13%)
Query: 489 LGQGGFGPVYWG---RLKDGQ-----EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
LGQG F ++ G + D E+ +K L K+ E F ++S+L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
G CV G+E +++ EY+ SLD L + W + + + ++ L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISW--KLEVAKQLAWALHFLEDKG 120
Query: 601 RLRIIHRDLKASNILLDEEL-----NP---KISDFGMA 630
+ H ++ A N+LL E NP K+SD G++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 3e-08
Identities = 48/174 (27%), Positives = 82/174 (47%), Gaps = 27/174 (15%)
Query: 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
K+G+G FG + K DG++ +K + SK S + EE EV V+S ++H N+V+
Sbjct: 6 KKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQ 65
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER---------LDWRKRFNIIEGISRGLL 594
E ++ +Y L + + +R LDW + I L
Sbjct: 66 ESFEENGNLYIVMDYCEGGDL----YKKINAQRGVLFPEDQILDWFVQ------ICLALK 115
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
++H +I+HRD+K+ NI L ++ K+ DFG+A++ + A T +GT
Sbjct: 116 HVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELART--CIGT 164
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 3e-08
Identities = 51/149 (34%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
LG+G FG V+ LK Q A+K L K +E M E V+S + L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLY 62
Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERLDW-RKRFNIIEGISRGLLYLHRDSRL 602
C + +E + + EY+ L +F + D R F E I GL +LH
Sbjct: 63 CTFQTKENLFFVMEYLNGGDL---MFHIQSCHKFDLPRATFYAAE-IICGLQFLHSKG-- 116
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
I++RDLK NILLD + + KI+DFGM K
Sbjct: 117 -IVYRDLKLDNILLDTDGHIKIADFGMCK 144
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 4e-08
Identities = 44/164 (26%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 467 DLPLFQFEELATATNNFQLSSK-----LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG 520
+L F + + T N LSS + +G G Y G+ +K+G + VK ++ +
Sbjct: 671 ELQFFDSKVSKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP 730
Query: 521 LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
E + + KLQH N+V+L+G C + LI+EY+ ++L +L L W
Sbjct: 731 SSEIAD----MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVL------RNLSWE 780
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624
+R I GI++ L +LH ++ +L I++D + P +
Sbjct: 781 RRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824
|
Length = 968 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 53/168 (31%), Positives = 84/168 (50%), Gaps = 13/168 (7%)
Query: 483 FQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 539
+Q S +G G +G V K G +AVK+LS+ S + E+ ++ ++H N+
Sbjct: 19 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENV 78
Query: 540 VRLLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLH 597
+ LL + Y+ + A L + +K ++L D +F +I I RGL Y+H
Sbjct: 79 IGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQF-LIYQILRGLKYIH 137
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
IIHRDLK SN+ ++E+ KI DFG+A+ + D TG V
Sbjct: 138 SAD---IIHRDLKPSNLAVNEDCELKILDFGLAR----HTDDEMTGYV 178
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 4e-08
Identities = 42/176 (23%), Positives = 81/176 (46%), Gaps = 18/176 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHR 537
NF++ K+G+G F VY L DG +A+K++ + + + E+ ++ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKK---ERLDWRKRFNIIEGISRG 592
N+++ +E E ++ E L ++ F K+ E+ W+ + +
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALE-- 120
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H SR R++HRD+K +N+ + K+ D G+ + F A + +VGT
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 169
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 56.0 bits (135), Expect = 5e-08
Identities = 50/165 (30%), Positives = 77/165 (46%), Gaps = 32/165 (19%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRN--- 538
F + + +G FG VY GR K+ ++ AVK + KA + +N+ MV R+
Sbjct: 6 FVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKA------DMINKNMVHQVQAERDALA 59
Query: 539 ------LVRLLGCCVEGEEKMLIYEYMPNRSLDALL-----FDPLKKERLDWRKRFNIIE 587
+V L L+ EY+ + +LL FD E + I E
Sbjct: 60 LSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD----EEM---AVKYISE 112
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
++ L YLHR IIHRDLK N+L+ E + K++DFG++K+
Sbjct: 113 -VALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 55.0 bits (133), Expect = 5e-08
Identities = 21/43 (48%), Positives = 31/43 (72%), Gaps = 3/43 (6%)
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ RGL Y+H + +IHRDLK SN+L++E+ +I DFGMA+
Sbjct: 116 LLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR 155
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 54.8 bits (132), Expect = 6e-08
Identities = 51/159 (32%), Positives = 79/159 (49%), Gaps = 20/159 (12%)
Query: 489 LGQGGFGPVYWGRLKDGQE----IAVKRLSKA----SGQGLEEFMNEVMVISKLQHRNLV 540
LG+GG+G V+ R G + A+K L KA + + E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHR 598
L+ G + LI EY+ L F L++E ++ F + E IS L +LH+
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGEL----FMHLEREGIFMEDTACFYLSE-ISLALEHLHQ 118
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGG 635
II+RDLK NILLD + + K++DFG+ K I G
Sbjct: 119 ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG 154
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 7e-08
Identities = 47/154 (30%), Positives = 76/154 (49%), Gaps = 12/154 (7%)
Query: 483 FQLSSKLGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 536
F+ LG+GGFG V G++ +++ KR+ K G+ + +NE ++ K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNS 59
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
R +V L + L+ M L +++ + R F E I+ GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAE-ITCGLEDL 118
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
HR+ RI++RDLK NILLD+ + +ISD G+A
Sbjct: 119 HRE---RIVYRDLKPENILLDDYGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 8e-08
Identities = 48/166 (28%), Positives = 79/166 (47%), Gaps = 19/166 (11%)
Query: 489 LGQGGFGPV-YWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRNLVRLLGC 545
+G G +G V + G ++A+K+L + L + E+ ++ ++H N++ LL
Sbjct: 23 VGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLD- 81
Query: 546 CVEGEEKML-----IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
V + L Y MP D L +K E+L + ++ + +GL Y+H
Sbjct: 82 -VFTPDLSLDRFHDFYLVMPFMGTD--LGKLMKHEKLSEDRIQFLVYQMLKGLKYIHAAG 138
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
IIHRDLK N+ ++E+ KI DFG+A+ D TG VV
Sbjct: 139 ---IIHRDLKPGNLAVNEDCELKILDFGLAR----QTDSEMTGYVV 177
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 47/149 (31%), Positives = 70/149 (46%), Gaps = 14/149 (9%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
LG+G FG V R K + A+K L K +E + E V+ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKY 62
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
+ + EY L F L +ER+ + R RF E +S L YLH
Sbjct: 63 SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-ALGYLHSCD-- 115
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
+++RDLK N++LD++ + KI+DFG+ K
Sbjct: 116 -VVYRDLKLENLMLDKDGHIKITDFGLCK 143
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 1e-07
Identities = 27/76 (35%), Positives = 40/76 (52%), Gaps = 9/76 (11%)
Query: 557 EYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614
E+M SLD + P+ E L I + GL YL+ + RI+HRD+K SNI
Sbjct: 83 EFMDCGSLDRIYKKGGPIPVEILG-----KIAVAVVEGLTYLY--NVHRIMHRDIKPSNI 135
Query: 615 LLDEELNPKISDFGMA 630
L++ K+ DFG++
Sbjct: 136 LVNSRGQIKLCDFGVS 151
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 1e-07
Identities = 52/150 (34%), Positives = 78/150 (52%), Gaps = 15/150 (10%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISK-LQHRNLVRLL 543
+G+G FG V R K ++ AVK L K + +E M+E V+ K ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLLYLHRDSR 601
++ + +Y+ L F L++ER L+ R RF E I+ L YLH
Sbjct: 63 FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASALGYLHS--- 114
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAK 631
L I++RDLK NILLD + + ++DFG+ K
Sbjct: 115 LNIVYRDLKPENILLDSQGHIVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 1e-07
Identities = 45/166 (27%), Positives = 71/166 (42%), Gaps = 31/166 (18%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
++ ++ +LG+G +G V R G +AVKR+ +A+ V S+ Q R L
Sbjct: 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRI-RAT------------VNSQEQKRLL 47
Query: 540 VRL-----LGCCVE---------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
+ L C E + I + + SLD K
Sbjct: 48 MDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGK 107
Query: 586 IE-GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
I I + L YLH S+L +IHRD+K SN+L++ K+ DFG++
Sbjct: 108 IAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGIS 151
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-07
Identities = 45/163 (27%), Positives = 77/163 (47%), Gaps = 31/163 (19%)
Query: 489 LGQGGFGPVYWGRLKD---------GQEIAVKR-LSKASGQGLEEFMNEVMVISKLQHRN 538
LGQG F +Y G L+ GQE++V + + + F ++S+L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER----LDWRKRFNIIEGISRGLL 594
LV+L G CV E M + EY+ LD L +E+ L W + ++ + ++ L
Sbjct: 63 LVKLYGVCVRDENIM-VEEYVKFGPLDVF----LHREKNNVSLHW--KLDVAKQLASALH 115
Query: 595 YLHRDSRLRIIHRDLKASNILL-----DEELNP--KISDFGMA 630
YL +++H ++ NIL+ +E P K+SD G+
Sbjct: 116 YLEDK---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIP 155
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 48/161 (29%), Positives = 73/161 (45%), Gaps = 13/161 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 537
+F LG+G FG V K E+ A+K L K +E M E V++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+ L C + +++ + EY+ L ++ + + I+ GL +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGKFKEPHAVFYAAEIAIGLFFL 117
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK--IFGG 635
H II+RDLK N++LD E + KI+DFGM K IFGG
Sbjct: 118 HSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 42/158 (26%), Positives = 77/158 (48%), Gaps = 15/158 (9%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G +G VY + KDG++ L + G G+ E+ ++ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVF 67
Query: 547 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 599
+ ++ L+++Y + + F K +K + G+ + LLY +H
Sbjct: 68 LSHADRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYL 124
Query: 600 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIF 633
++HRDLK +NIL+ E KI+D G A++F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 2e-07
Identities = 46/163 (28%), Positives = 73/163 (44%), Gaps = 28/163 (17%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVM---VISKLQH 536
N+ + ++G G G VY R K G +AVK++ + + EE +M V+ K H
Sbjct: 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLK-SH 71
Query: 537 R--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK-------ERLDWRKRFNIIE 587
+V+ G + + + E M + D L K E + + I+
Sbjct: 72 DCPYIVKCYGYFITDSDVFICMELM------STCLDKLLKRIQGPIPEDILGKMTVAIV- 124
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ L YL + +IHRD+K SNILLD N K+ DFG++
Sbjct: 125 ---KALHYL--KEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 2e-07
Identities = 49/166 (29%), Positives = 82/166 (49%), Gaps = 14/166 (8%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
+G+G +G V R + DG++ +K+L+ AS + + E ++S+L+H N+V
Sbjct: 8 VGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRES 67
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE---GISRGLLYLHRDSRL 602
EGE+ +L Y M L+ LK+++ ++E I+ L YLH
Sbjct: 68 W-EGEDGLL-YIVM-GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
I+HRDLK N+ L K+ D G+A++ D A T ++GT
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGT 165
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 41/158 (25%), Positives = 76/158 (48%), Gaps = 15/158 (9%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLVRLLGCC 546
K+G+G +G VY + KDG++ L + G G+ E+ ++ +L+H N++ L
Sbjct: 8 KVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVF 67
Query: 547 VEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY-----LHRD 599
+ ++ L+++Y + + F K +K + + + LLY +H
Sbjct: 68 LSHSDRKVWLLFDYAEHDLWHIIKFHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYL 124
Query: 600 SRLRIIHRDLKASNILL----DEELNPKISDFGMAKIF 633
++HRDLK +NIL+ E KI+D G A++F
Sbjct: 125 HANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF 162
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 50/150 (33%), Positives = 77/150 (51%), Gaps = 15/150 (10%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISK-LQHRNLVRLL 543
+G+G FG V + K DG+ AVK L K + + + M E V+ K ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSR 601
E+ + +++ L F L++ER + R RF E I+ L YLH
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL----FFHLQRERSFPEPRARFYAAE-IASALGYLHS--- 114
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ I++RDLK NILLD + + ++DFG+ K
Sbjct: 115 INIVYRDLKPENILLDSQGHVVLTDFGLCK 144
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 3e-07
Identities = 37/149 (24%), Positives = 70/149 (46%), Gaps = 15/149 (10%)
Query: 491 QGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMN----EVMVISKLQHRNLVRLLGC 545
+G FG VY + + G A+K L K+ + N +++ + + + +L
Sbjct: 6 KGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS 65
Query: 546 CVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
+ L+ EY+ +L+ L DW K++ I + G+ LH+
Sbjct: 66 FQSKDYLYLVMEYLNGGDCASLIKTLGGLP---EDWAKQY--IAEVVLGVEDLHQRG--- 117
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKI 632
IIHRD+K N+L+D+ + K++DFG+++
Sbjct: 118 IIHRDIKPENLLIDQTGHLKLTDFGLSRN 146
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-07
Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 13/164 (7%)
Query: 489 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG+GGFG V G++ + + KR+ K G+ + +NE ++ K+ + +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNSQFVVNL 65
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
+ L+ M L +++ + R F E I GL LHR++
Sbjct: 66 AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAE-ILCGLEDLHREN-- 122
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMA-KIFGGNQDQADTGRV 645
++RDLK NILLD+ + +ISD G+A KI G + G V
Sbjct: 123 -TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTV 165
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 4e-07
Identities = 46/155 (29%), Positives = 72/155 (46%), Gaps = 11/155 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 537
+F LG+G FG V K E+ A+K L K +E M E V++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+ L C + +++ + EY+ + L++ + + + IS GL +L
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYV---NGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFL 117
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
HR II+RDLK N++LD E + KI+DFGM K
Sbjct: 118 HRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 4e-07
Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 28/161 (17%)
Query: 505 GQEIAVKRLSKASGQGLEE---FMNEVMVISKLQHRNLVRLLGCCVEGEEKML-IYEYMP 560
G E+A+K L + + + F E + ++L H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 561 NRSLDALL-----FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615
R+L +L + RL + + L H I+HRDLK NI+
Sbjct: 63 GRTLREVLAADGALPAGETGRL--------MLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 616 L---DEELNPKISDFGMAKIFGGNQDQAD-----TGRVVGT 648
+ + K+ DFG+ + G +D T V+GT
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGT 152
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-07
Identities = 43/149 (28%), Positives = 75/149 (50%), Gaps = 14/149 (9%)
Query: 489 LGQGGFGPV------YWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG+GGFG V G++ +++ KR+ K G+ + +NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNSRFVVSL 65
Query: 543 LGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
E ++ + L+ M L +++ + D ++ + GL L R+
Sbjct: 66 -AYAYETKDALCLVLTIMNGGDLKFHIYN-MGNPGFDEQRAIFYAAELCCGLEDLQRE-- 121
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMA 630
RI++RDLK NILLD+ + +ISD G+A
Sbjct: 122 -RIVYRDLKPENILLDDRGHIRISDLGLA 149
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 4e-07
Identities = 41/153 (26%), Positives = 70/153 (45%), Gaps = 20/153 (13%)
Query: 488 KLGQGGFGPVYWGRLKDGQEIA---VKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
++G G FG V + +A VK L + AS + EF+ + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-------GLLYL 596
G CVE +L++EY L + L + W +R + + + R G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYL------SQEQWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629
H + +H DL N L +L K+ D+G+
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGI 145
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 35/158 (22%), Positives = 63/158 (39%), Gaps = 29/158 (18%)
Query: 485 LSSKLGQG--GFGPVYWGRLKD-GQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRNL 539
L + +G+ V+ + K +AVK+ L S + L+ E++ +LQH N+
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNI 61
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF----------NIIEGI 589
+ + + E ++ M S + LL + F I++ +
Sbjct: 62 LPYVTSFIVDSELYVVSPLMAYGSCEDLL-----------KTHFPEGLPELAIAFILKDV 110
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627
L Y+H IHR +KAS+ILL + +S
Sbjct: 111 LNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGL 145
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-07
Identities = 47/166 (28%), Positives = 80/166 (48%), Gaps = 12/166 (7%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVY-WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVI 531
F+ ++ +++ +G+G +G V+ K+G + AVK L EE E ++
Sbjct: 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEYNIL 68
Query: 532 SKLQ-HRNLVRLLGC-----CVEGEEKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFN 584
L H N+V+ G G++ L+ E S+ L+ LK+ ER++
Sbjct: 69 KALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY 128
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
I+ GL +LH + + IHRD+K +NILL E K+ DFG++
Sbjct: 129 ILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVS 171
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-07
Identities = 47/161 (29%), Positives = 76/161 (47%), Gaps = 15/161 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKAS----GQGLEEFMNEVMVISK 533
NF+L LG G +G V+ R G + A+K L KA+ + E E V+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
++ + L + + K+ LI +Y+ L L ++ER ++ I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHL---SQRERFKEQEVQIYSGEIVLA 117
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
L +LH+ L II+RD+K NILLD + ++DFG++K F
Sbjct: 118 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 24/161 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHR 537
+F++ LG G FG V + K G+ A+K L K + ++ E ++ +L H
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHP 78
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRF--NIIEGISRGLL 594
+V ++ C + E ++ + E++ + LF L+K RF ++ + L+
Sbjct: 79 FIVNMM-CSFQDENRVYFLLEFV----VGGELFTHLRKA-----GRFPNDVAKFYHAELV 128
Query: 595 ----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
YLH II+RDLK N+LLD + + K++DFG AK
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK 166
|
Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 49/160 (30%), Positives = 79/160 (49%), Gaps = 14/160 (8%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLG 544
+G+G FG V R +D Q I A+K + KA S + + E V++++ +V L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKF 60
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLD-WRKRFNIIEGISRGLLYLHRDSRL 602
E+ L+ ++ L F L++E R D R RF E + L LH+
Sbjct: 61 SFQSPEKLYLVLAFINGGEL----FHHLQREGRFDLSRARFYTAE-LLCALENLHK---F 112
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+I+RDLK NILLD + + + DFG+ K+ + D+ +T
Sbjct: 113 NVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNT 152
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 44/179 (24%), Positives = 81/179 (45%), Gaps = 44/179 (24%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR-LSKASGQGL-EEFMNEVMVISKLQHR 537
+ ++ K+G+G +G VY R G+ +A+K+ + +G+ + E+ ++ L
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60
Query: 538 N-LVRLLGCCVEGEEK-------MLIYEYM--------------PNRSLDALLFDPLKKE 575
+VRLL VE E+ L++EY+ P R L A
Sbjct: 61 IYIVRLL--DVEHVEEKNGKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTI------ 112
Query: 576 RLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIF 633
K F + + +G+ + H+ ++HRDLK N+L+D++ KI+D G+ + F
Sbjct: 113 -----KSF--MYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAF 161
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 2e-06
Identities = 54/166 (32%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
LG+G FG V R K G+ A+K L K +E + E V+ +H L L
Sbjct: 3 LGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKY 62
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
+ + EY+ L F L +ER+ + R RF E +S L YLH
Sbjct: 63 SFQTKDRLCFVMEYVNGGEL----FFHLSRERVFSEDRTRFYGAEIVS-ALDYLHSG--- 114
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+I++RDLK N++LD++ + KI+DFG+ K G D A GT
Sbjct: 115 KIVYRDLKLENLMLDKDGHIKITDFGLCK--EGITDAATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 49/197 (24%), Positives = 83/197 (42%), Gaps = 37/197 (18%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK-ASGQGL--EEFMNEVMVISKLQHRN 538
+ + +G+GG G VY + +A+K++ + S L + F+ E + + L H
Sbjct: 4 YDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPG 63
Query: 539 LVRLLGCCVEGEEKMLIYEYMP---NRSLDALL-----FDPLKK---ERLDWRKRFNIIE 587
+V + C +G+ +Y MP +L +LL + L K E+ +I
Sbjct: 64 IVPVYSICSDGD---PVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFH 120
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD-QADT---- 642
I + Y+H S+ ++HRDLK NILL I D+G A ++ D
Sbjct: 121 KICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDE 177
Query: 643 -----------GRVVGT 648
G++VGT
Sbjct: 178 RNICYSSMTIPGKIVGT 194
|
Length = 932 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 31/86 (36%), Positives = 44/86 (51%), Gaps = 8/86 (9%)
Query: 481 NNFQLSSKLGQGGFGPVY------WGRLKDGQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
+N Q LG G FG V G+ + +AVK L + A E M+E+ ++S
Sbjct: 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSH 97
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY 558
L QH+N+V LLG C G ++I EY
Sbjct: 98 LGQHKNIVNLLGACTHGGPVLVITEY 123
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-06
Identities = 49/176 (27%), Positives = 83/176 (47%), Gaps = 16/176 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVISKLQ 535
++F+ +G+G FG V + KD I A+K+L K+ Q + E ++++
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEAD 59
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGL 593
+ +V+L + E + LI EY+P + LL +KK+ + RF I E I
Sbjct: 60 NPWVVKLY-YSFQDENYLYLIMEYLPGGDMMTLL---MKKDTFTEEETRFYIAETI---- 111
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
L + +L IHRD+K N+LLD + + K+SDFG+ + + L
Sbjct: 112 LAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHAL 167
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 3e-06
Identities = 49/182 (26%), Positives = 80/182 (43%), Gaps = 35/182 (19%)
Query: 483 FQLSSKLGQGGFGPVYWGRL--KDGQEIAVKRLSKASGQGLEEFMN---------EVMVI 531
+ +G G FG V W +DG+ +A+K++ F N E+ ++
Sbjct: 2 VEPDRPIGYGAFG-VVWSVTDPRDGKRVALKKMPNV-------FQNLVSCKRVFRELKML 53
Query: 532 SKLQHRNLVRLLGCCVEG-----EEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFN 584
+H N++ L EE ++ E M L ++ P + L D K F
Sbjct: 54 CFFKHDNVLSALDILQPPHIDPFEEIYVVTELM-QSDLHKIIVSP---QPLSSDHVKVF- 108
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
+ I RGL YLH I+HRD+K N+L++ KI DFG+A++ ++ + T
Sbjct: 109 -LYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQE 164
Query: 645 VV 646
VV
Sbjct: 165 VV 166
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 48.7 bits (116), Expect = 3e-06
Identities = 42/147 (28%), Positives = 71/147 (48%), Gaps = 8/147 (5%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
+LG+G +G VY + G +A+K RL + + + E+ ++ K +V G
Sbjct: 8 ELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESK-FNQIIMELDILHKAVSPYIVDFYG 66
Query: 545 C-CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
+EG M + EYM SLD L + E + I + +GL +L +
Sbjct: 67 AFFIEGAVYMCM-EYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEE--HN 123
Query: 604 IIHRDLKASNILLDEELNPKISDFGMA 630
IIHRD+K +N+L++ K+ DFG++
Sbjct: 124 IIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 49.2 bits (117), Expect = 4e-06
Identities = 42/159 (26%), Positives = 73/159 (45%), Gaps = 17/159 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQ--EIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
+F LG G FG V K+ +A+KR K+ + ++ +E +++ + H
Sbjct: 31 DFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINH 90
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI---SRGL 593
V L G + L+ E++ + F L++ KRF G ++ +
Sbjct: 91 PFCVNLYGSFKDESYLYLVLEFV----IGGEFFTFLRRN-----KRFPNDVGCFYAAQIV 141
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
L L I++RDLK N+LLD++ K++DFG AK+
Sbjct: 142 LIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
|
Length = 340 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-06
Identities = 39/104 (37%), Positives = 52/104 (50%), Gaps = 21/104 (20%)
Query: 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS----RGLLYLHRDSRLRIIHRDLKAS 612
E+M SLD +L KK R NI+ IS RGL YL R+ + +I+HRD+K S
Sbjct: 79 EHMDGGSLDQVL----KKAG---RIPENILGKISIAVLRGLTYL-RE-KHKIMHRDVKPS 129
Query: 613 NILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGT 648
NIL++ K+ DFG MA F G + R+ GT
Sbjct: 130 NILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 173
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 42/147 (28%), Positives = 72/147 (48%), Gaps = 31/147 (21%)
Query: 505 GQEIAVKRLSKASGQGLEEFMN---------EVMVISKLQHRNLVRLLGCCV------EG 549
GQ +A+K+LS+ F N E++++ + H+N++ LL E
Sbjct: 41 GQNVAIKKLSRP-------FQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93
Query: 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL 609
++ L+ E M DA L ++ + LD + ++ + G+ +LH IIHRDL
Sbjct: 94 QDVYLVMELM-----DANLCQVIQMD-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDL 144
Query: 610 KASNILLDEELNPKISDFGMAKIFGGN 636
K SNI++ + KI DFG+A+ G +
Sbjct: 145 KPSNIVVKSDCTLKILDFGLARTAGTS 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 42/148 (28%), Positives = 75/148 (50%), Gaps = 12/148 (8%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542
LG+GGFG V ++K+ G+ A K RL K SG+ + E++ K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
L+ M L +++ + + L+ + + I+ G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYN-VGERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMA 630
I++RD+K N+LLD++ N ++SD G+A
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLA 142
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 5e-06
Identities = 20/41 (48%), Positives = 29/41 (70%), Gaps = 3/41 (7%)
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
RGL Y+H + ++HRDLK SN+LL+ + KI DFG+A+
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 6e-06
Identities = 49/163 (30%), Positives = 80/163 (49%), Gaps = 19/163 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSKAS----GQGLEEFMNEVMVISK 533
NF+L LG G +G V+ R G + A+K L KA+ + +E E V+
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLF--DPLKKERLDWRKRFNIIEGIS 590
++ + L + E K+ LI +Y+ + L+ D ++ + RF E I
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEV----RFYSGE-II 115
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
L +LH+ L I++RD+K NILLD E + ++DFG++K F
Sbjct: 116 LALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 38/135 (28%), Positives = 70/135 (51%), Gaps = 17/135 (12%)
Query: 505 GQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------EGEEKMLIY 556
G +AVK+LS+ + + E++++ + H+N++ LL E ++ L+
Sbjct: 46 GINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVM 105
Query: 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
E M + +L ++ L ER+ + ++ + G+ +LH IIHRDLK SNI++
Sbjct: 106 ELM-DANLCQVIHMELDHERMSY-----LLYQMLCGIKHLHSAG---IIHRDLKPSNIVV 156
Query: 617 DEELNPKISDFGMAK 631
+ KI DFG+A+
Sbjct: 157 KSDCTLKILDFGLAR 171
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 46/163 (28%), Positives = 76/163 (46%), Gaps = 15/163 (9%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
+ +L +F + +G+G FG V R K +++ A+K LSK + F E
Sbjct: 34 KITKLRMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
+++ +V+L ++K L + EYMP L L+ + E W RF
Sbjct: 94 RDIMAHANSEWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE--KW-ARFYT 148
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628
E + L +H + IHRD+K N+LLD+ + K++DFG
Sbjct: 149 AE-VVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-06
Identities = 40/154 (25%), Positives = 78/154 (50%), Gaps = 9/154 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRL--SKASGQGLEEFMNEVMVISKLQHR 537
N F++ +G+G +G V R K+ +EI A+K+ S+ + + E + E+ ++ L+
Sbjct: 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQE 60
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V L + L++EY+ L+ L + + + R I + I + + + H
Sbjct: 61 NIVELKEAFRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCH 117
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++ I+HRD+K N+L+ K+ DFG A+
Sbjct: 118 KND---IVHRDIKPENLLISHNDVLKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 7e-06
Identities = 44/149 (29%), Positives = 74/149 (49%), Gaps = 25/149 (16%)
Query: 510 VKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE---YMPNRSLDA 566
VK S+A+ Q LE NE++ + +L H N++++ E++L E YM + D
Sbjct: 200 VKAGSRAAIQ-LE---NEILALGRLNHENILKI--------EEILRSEANTYMITQKYDF 247
Query: 567 LLFDPLKKERLDWRKR------FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
L+ + E DW+ R I++ + + Y+H ++IHRD+K NI L+ +
Sbjct: 248 DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDG 304
Query: 621 NPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+ DFG A F ++ D G VGT+
Sbjct: 305 KIVLGDFGTAMPFEKEREAFDYGW-VGTV 332
|
Length = 501 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 9e-06
Identities = 43/149 (28%), Positives = 71/149 (47%), Gaps = 13/149 (8%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
+G+G + V RLK + I ++ K + ++ E V + + + L
Sbjct: 3 IGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLH 62
Query: 545 CCVEGEEKML-IYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 602
C + E ++ + EY+ L +F ++ +L + RF E IS L YLH
Sbjct: 63 SCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNYLHERG-- 116
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
II+RDLK N+LLD E + K++D+GM K
Sbjct: 117 -IIYRDLKLDNVLLDSEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 52/166 (31%), Positives = 76/166 (45%), Gaps = 16/166 (9%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
LG+G FG V R K G+ A+K L K +E + E V+ +H L L
Sbjct: 3 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKY 62
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
+ + EY L F L +ER+ + R RF E +S L YLH
Sbjct: 63 AFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAEIVS-ALEYLHSRD-- 115
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+++RD+K N++LD++ + KI+DFG+ K G D A GT
Sbjct: 116 -VVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGT 158
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-05
Identities = 44/161 (27%), Positives = 76/161 (47%), Gaps = 11/161 (6%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS--GQGLEEFMNEV 528
+ +L ++ + +G+G FG V R K Q++ A+K LSK + F E
Sbjct: 34 KIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 529 MVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
I + V L C + ++ + ++ EYMP L L+ + E+ W K +
Sbjct: 94 RDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEK--WAKFYT--- 148
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628
+ +L L + +IHRD+K N+LLD+ + K++DFG
Sbjct: 149 --AEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 41/171 (23%), Positives = 81/171 (47%), Gaps = 19/171 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQ- 535
++L +LGQG +G V R + + +A+K+++ + + + + E+ ++ +
Sbjct: 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRG 60
Query: 536 HRNLVRLLGCCV---EGEEKMLIYEYMPNRSLDALLFD--PLKKERLDWRKRFNIIEGIS 590
H+N+ L + ++ +YE + L ++ PL + F I I
Sbjct: 61 HKNITCLYDMDIVFPGNFNELYLYEELMEADLHQIIRSGQPLTDAHF---QSF--IYQIL 115
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD 641
GL Y+H + ++HRDLK N+L++ + KI DFG+A+ F N +
Sbjct: 116 CGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENA 163
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 2e-05
Identities = 51/161 (31%), Positives = 76/161 (47%), Gaps = 35/161 (21%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
+G+G FG VY R KD + I A+K LSK +E + + V + RN+ L +
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSK------KEIVAKKEVAHTIGERNI---LVRTL 51
Query: 548 EGE---------------EKMLIYEYMPNRSLDALLFDPLKKE-RL-DWRKRFNIIEGIS 590
E + L+ +YM L F L+KE R + R +F I E +
Sbjct: 52 LDESPFIVGLKFSFQTDSDLYLVTDYMSGGEL----FWHLQKEGRFSEDRAKFYIAELV- 106
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L +LH+ I++RDLK NILLD + + DFG++K
Sbjct: 107 LALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSK 144
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 39/137 (28%), Positives = 70/137 (51%), Gaps = 17/137 (12%)
Query: 506 QEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------EGEEKMLIYE 557
+ +A+K+LS+ + + E++++ + H+N++ LL E ++ L+ E
Sbjct: 43 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVME 102
Query: 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617
M DA L ++ E LD + ++ + G+ +LH IIHRDLK SNI++
Sbjct: 103 LM-----DANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVK 153
Query: 618 EELNPKISDFGMAKIFG 634
+ KI DFG+A+ G
Sbjct: 154 SDCTLKILDFGLARTAG 170
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 53/166 (31%), Positives = 78/166 (46%), Gaps = 15/166 (9%)
Query: 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
LG+G FG V + K G+ A+K L K +E + E V+ +H L L
Sbjct: 3 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKY 62
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRL 602
+ + EY L F L +ER+ + R RF E +S L YLH S
Sbjct: 63 SFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-ALDYLH--SEK 115
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+++RDLK N++LD++ + KI+DFG+ K G +D A GT
Sbjct: 116 NVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGT 159
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 42/157 (26%), Positives = 73/157 (46%), Gaps = 15/157 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
+F + S +G+G FG V R K +I A+K + K+ E F E ++S
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNIIEGISRGL 593
+ +L + + L+ EY P L +LL D ++ +F + E +
Sbjct: 61 PWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMA----QFYLAELV---- 112
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
L +H ++ +HRD+K N+L+D + K++DFG A
Sbjct: 113 LAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSA 149
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 3e-05
Identities = 41/153 (26%), Positives = 64/153 (41%), Gaps = 19/153 (12%)
Query: 483 FQLSSKLGQGGFGPVY----WGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ + S L G G V+ G + +++ VK ++ G E+ ++ + HR
Sbjct: 94 YNILSSLTPGSEGEVFVCTKHGD-EQRKKVIVKAVTGGKTPG-----REIDILKTISHRA 147
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLH 597
++ L+ K + MP D LF + + L + I + L YLH
Sbjct: 148 IINLIHAY---RWKSTVCMVMPKYKCD--LFTYVDRSGPLPLEQAITIQRRLLEALAYLH 202
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
IIHRD+K NI LDE N + DFG A
Sbjct: 203 GRG---IIHRDVKTENIFLDEPENAVLGDFGAA 232
|
Length = 392 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 45/155 (29%), Positives = 69/155 (44%), Gaps = 11/155 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSK---ASGQGLEEFMNEVMVISKLQHR 537
+F LG+G FG V K E+ A+K L K +E M E V++
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+ L C + +++ + EY+ L ++ + R I+ GL +L
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---MYQIQQVGRFKEPHAVFYAAEIAIGLFFL 117
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
H II+RDLK N++LD E + KI+DFGM K
Sbjct: 118 HSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCK 149
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 4e-05
Identities = 43/149 (28%), Positives = 70/149 (46%), Gaps = 13/149 (8%)
Query: 489 LGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQHRNLVRLLG 544
+G+G + V LK + I A+K + K E+ E V + + L
Sbjct: 3 IGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLH 62
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 602
C + E ++ + E++ L +F ++ +L + RF E IS L +LH
Sbjct: 63 SCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAE-ISLALNFLHERG-- 116
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
II+RDLK N+LLD E + K++D+GM K
Sbjct: 117 -IIYRDLKLDNVLLDAEGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-05
Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 12/154 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---EVMVISKLQH 536
++F+ +G+G FG V + KD G A+K L KA E+ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLY 595
+V++ + LI E++P + LL +KK+ L + +F I E + L
Sbjct: 61 AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLL---MKKDTLSEEATQFYIAETV----LA 113
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629
+ +L IHRD+K N+LLD + + K+SDFG+
Sbjct: 114 IDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 46/184 (25%), Positives = 79/184 (42%), Gaps = 45/184 (24%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQE-IAVKRLSKASGQGLEEFMN-EVMVISKLQ 535
+ +++L + +G G FG VY D E +A+K++ + ++ N E++++ L
Sbjct: 63 SPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-----QYKNRELLIMKNLN 117
Query: 536 HRNLVRLLGC----CVEGEEKML----IYEYMP-------------NRSLDALLFDPLKK 574
H N++ L C + EK + + E++P N +L L
Sbjct: 118 HINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSY 177
Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIF 633
+ + R L Y+H S+ I HRDLK N+L+D + K+ DFG AK
Sbjct: 178 Q-------------LCRALAYIH--SKF-ICHRDLKPQNLLIDPNTHTLKLCDFGSAKNL 221
Query: 634 GGNQ 637
Q
Sbjct: 222 LAGQ 225
|
Length = 440 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 51/172 (29%), Positives = 77/172 (44%), Gaps = 33/172 (19%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
+G+GGFG VY R D G+ A+K L K QG +NE +++S +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS--------- 52
Query: 545 CCVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWR-----------KRFNIIEGISR 591
G+ ++ + D L F D + L + RF E I
Sbjct: 53 ---TGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATE-IIL 108
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
GL ++H +R +++RDLK +NILLDE + +ISD G+A F + A G
Sbjct: 109 GLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 5e-05
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
++F+ S+LG G G V + K I ++L + + + E+ V+ +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V G E + E+M SLD +L + +R+ + + RGL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 121
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGT 648
+ +I+HRD+K SNIL++ K+ DFG MA F G + R+ GT
Sbjct: 122 --KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-05
Identities = 40/149 (26%), Positives = 69/149 (46%), Gaps = 13/149 (8%)
Query: 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLG 544
+G+G + V RLK +I ++ K + ++ E V + + L
Sbjct: 3 IGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLH 62
Query: 545 CCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYLHRDSRL 602
C + ++ L+ EY+ L +F ++ +L + RF E I L +LH
Sbjct: 63 SCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAE-ICIALNFLHERG-- 116
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAK 631
II+RDLK N+LLD + + K++D+GM K
Sbjct: 117 -IIYRDLKLDNVLLDADGHIKLTDYGMCK 144
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 45/153 (29%), Positives = 76/153 (49%), Gaps = 12/153 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN---EVMVISKLQHR 537
+F+ +G+G FG V + KD G A+K L KA E+ + E ++ +
Sbjct: 2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSL 61
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNIIEGISRGLLYL 596
+V++ + LI E++P + LL +KK+ L + +F I E + L +
Sbjct: 62 WVVKMFYSFQDKLNLYLIMEFLPGGDMMTLL---MKKDTLTEEETQFYIAETV----LAI 114
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629
+L IHRD+K N+LLD + + K+SDFG+
Sbjct: 115 DSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-05
Identities = 39/134 (29%), Positives = 69/134 (51%), Gaps = 11/134 (8%)
Query: 506 QEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG---EEKMLIYEYMP 560
+ +A+K+LS+ + + E++++ + H+N++ LL EE +Y M
Sbjct: 50 RNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVM- 108
Query: 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
+DA L ++ E LD + ++ + G+ +LH IIHRDLK SNI++ +
Sbjct: 109 -ELMDANLCQVIQME-LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDC 163
Query: 621 NPKISDFGMAKIFG 634
KI DFG+A+ G
Sbjct: 164 TLKILDFGLARTAG 177
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 7e-05
Identities = 38/149 (25%), Positives = 72/149 (48%), Gaps = 10/149 (6%)
Query: 489 LGQGGFGPVYWGRLKDG-QEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC 545
+G+G FG + + Q+ A+K RL K+S +E+ E ++++K++H N+V
Sbjct: 8 VGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS-SAVEDSRKEAVLLAKMKHPNIVAFKES 66
Query: 546 CVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604
E + + ++ EY L +K +R I++ + L + R+
Sbjct: 67 -FEADGHLYIVMEYCD----GGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRV 121
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIF 633
+HRD+K+ NI L + K+ DFG A++
Sbjct: 122 LHRDIKSKNIFLTQNGKVKLGDFGSARLL 150
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 1e-04
Identities = 55/198 (27%), Positives = 86/198 (43%), Gaps = 43/198 (21%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE-----FMN 526
++++ + N +++ K+G G FG V+ + K QE + S +GL+E +
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWK--AISYRGLKEREKSQLVI 61
Query: 527 EVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
EV V+ +L+H+N+VR + + + L Y+ DA L + K F I
Sbjct: 62 EVNVMRELKHKNIVRYIDRFLNKANQKL---YILMEFCDA---GDLSRNIQKCYKMFGKI 115
Query: 587 E-----GISRGLL----YLHR----DSRLRIIHRDLKASNILLD-------------EEL 620
E I+R LL Y H + R++HRDLK NI L L
Sbjct: 116 EEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNL 175
Query: 621 N----PKISDFGMAKIFG 634
N KI DFG++K G
Sbjct: 176 NGRPIAKIGDFGLSKNIG 193
|
Length = 1021 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-04
Identities = 47/158 (29%), Positives = 69/158 (43%), Gaps = 18/158 (11%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRN 538
F+ LG+G G V+ RLK G+ A+K L K ++ + E +++ L H
Sbjct: 3 FKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPF 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR-----KRFNIIEGISRGL 593
L L L+ +Y P L LL + + RF E + L
Sbjct: 63 LPTLYASFQTETYLCLVMDYCPGGELFRLL-----QRQPGKCLSEEVARFYAAE-VLLAL 116
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
YLH L I++RDLK NILL E + +SDF ++K
Sbjct: 117 EYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSK 151
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 1e-04
Identities = 59/215 (27%), Positives = 83/215 (38%), Gaps = 70/215 (32%)
Query: 484 QLSSKLGQGGFGPVYW------GRLKDGQEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
+L LG+G FG V + + +AVK L + A+ + M E+ ++ +
Sbjct: 10 KLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGH 69
Query: 536 HRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALL------FDP---------------LK 573
H N+V LLG C + G M+I EY +L L F P K
Sbjct: 70 HLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGK 129
Query: 574 KERLDWR--------------KRFNIIEGIS-----------------------RGLLYL 596
K+RLD K + +E RG+ +L
Sbjct: 130 KQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFL 189
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
SR + IHRDL A NILL E KI DFG+A+
Sbjct: 190 --ASR-KCIHRDLAARNILLSENNVVKICDFGLAR 221
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 2e-04
Identities = 55/176 (31%), Positives = 79/176 (44%), Gaps = 41/176 (23%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLG 544
+G+GGFG VY R D G+ A+K L K QG +NE +++S LV
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS------LVSTGD 55
Query: 545 C----CVEGEEKMLIYEYMPNRSLDALLF--DPLKKERLDWR-----------KRFNIIE 587
C C + Y + + D L F D + L + RF E
Sbjct: 56 CPFIVC-------MSYAF---HTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAE 105
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
I GL ++H +R +++RDLK +NILLDE + +ISD G+A F + A G
Sbjct: 106 -IILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 157
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-04
Identities = 47/178 (26%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGL--EEFMNEVMVISKLQHRN 538
++F+ S+LG G G V+ K I ++L + + + E+ V+ +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 64
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V G E + E+M SLD +L K R+ + + + +GL YL
Sbjct: 65 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLRE 121
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFG--------MAKIFGGNQDQADTGRVVGT 648
+ +I+HRD+K SNIL++ K+ DFG MA F G + R+ GT
Sbjct: 122 --KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGT 177
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 31/112 (27%), Positives = 51/112 (45%), Gaps = 23/112 (20%)
Query: 527 EVMVISKLQHRNLVRLLG--------CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
E ++ + H ++++L G C + K +Y Y+ + A+ D L ER
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKTDLYCYLAAKRNIAIC-DILAIER-- 189
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ R + YLH + RIIHRD+KA NI ++ + + DFG A
Sbjct: 190 ---------SVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFGAA 229
|
Length = 391 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 42.9 bits (102), Expect = 3e-04
Identities = 48/166 (28%), Positives = 78/166 (46%), Gaps = 16/166 (9%)
Query: 474 EELATATNNFQLSSKLG--QGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMV 530
EL N ++ KL G FG V + K Q++ V+++ KA +E ++++M
Sbjct: 7 SELVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLMK 66
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGI 589
+ N ++L + +LI +Y+ D LFD LKKE +L + II +
Sbjct: 67 ----DNPNFIKLYYSVTTLKGHVLIMDYIK----DGDLFDLLKKEGKLSEAEVKKIIRQL 118
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFG 634
L LH+ IIH D+K N+L D + + D+G+ KI G
Sbjct: 119 VEALNDLHKH---NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIG 161
|
Length = 267 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 47/166 (28%), Positives = 76/166 (45%), Gaps = 14/166 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
+F +G+G FG V + KD G+ A+K L K+ L E V+++
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDS 60
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLL 594
+V L + + LI E++P L +L +D ++ RF + E + L
Sbjct: 61 PWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDV----TRFYMAECV----L 112
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
+ +L IHRD+K NIL+D + K+SDFG++ F D A
Sbjct: 113 AIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 50/179 (27%), Positives = 74/179 (41%), Gaps = 38/179 (21%)
Query: 482 NFQLSSKLGQGGFGPVYWG-----RLKDGQEIAVKRLSKASGQG-LEEFMNEVM------ 529
+F L KLG+G FG VY + K + +K KA+ G +E +MNE +
Sbjct: 133 DFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLK---KATEYGAVEIWMNERVRRACPN 189
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD---PLKKERLDWRK----- 581
+ + L + + +E L++ Y +L L+ P E K
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 582 ----RFN-IIEGISRGLLY----LHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMA 630
R N II+ I R +L+ LH I+HRD+K NI+ E KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 4e-04
Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 25/161 (15%)
Query: 489 LGQGGFGPVYWGRLKD---------GQEIAVKRLSKASGQGLEE----FMNEVMVISKLQ 535
LG+G +Y G L E +K + K + F ++ ++
Sbjct: 3 LGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS 62
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H+++V L G CV E +++ E++ LD LF K + L +F + + ++ L Y
Sbjct: 63 HKHIVLLYGVCVRDVENIMVEEFVEFGPLD--LFMHRKSDVLTTPWKFKVAKQLASALSY 120
Query: 596 LHRDSRLRIIHRDLKASNILL-----DEELNP--KISDFGM 629
L D L +H ++ NILL D E P K+SD G+
Sbjct: 121 L-EDKDL--VHGNVCTKNILLAREGIDGECGPFIKLSDPGI 158
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|224632 COG1718, RIO1, Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 4e-04
Identities = 37/157 (23%), Positives = 57/157 (36%), Gaps = 30/157 (19%)
Query: 497 VYWGRLKDGQEIAVK--RLSKASGQGLEE-------FMNEVMVISKLQH-------RNLV 540
VY DG+ +AVK R S + + + F N KL RNL
Sbjct: 64 VYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLK 123
Query: 541 RLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN-IIEGISRGL 593
R V +L+ E++ + L A + E + + ++E + R
Sbjct: 124 RAYEAGVRVPEPIAFRNNVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRR-- 181
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
LY ++H DL NIL+ + P I D A
Sbjct: 182 LY----KEAGLVHGDLSEYNILVHDG-EPYIIDVSQA 213
|
Length = 268 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 5e-04
Identities = 40/152 (26%), Positives = 72/152 (47%), Gaps = 12/152 (7%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQHRN 538
F +G G FG V R D + A+K L KA E ++++ +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEW 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLH 597
+V+L + + + +Y+P + +LL + +E L RF I E ++ + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL---ARFYIAE-LTCAIESVH 118
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGM 629
+ + IHRD+K NIL+D + + K++DFG+
Sbjct: 119 K---MGFIHRDIKPDNILIDRDGHIKLTDFGL 147
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 42.2 bits (99), Expect = 6e-04
Identities = 31/86 (36%), Positives = 39/86 (45%), Gaps = 8/86 (9%)
Query: 481 NNFQLSSKLGQGGFGPVY----WGRLKD--GQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
N LG G FG V +G K +AVK L A E M+E+ V+S
Sbjct: 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 94
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEY 558
L H N+V LLG C G ++I EY
Sbjct: 95 LGNHINIVNLLGACTVGGPTLVITEY 120
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 7e-04
Identities = 18/42 (42%), Positives = 26/42 (61%), Gaps = 3/42 (7%)
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
R L Y+H + + HRDLK NIL + + KI DFG+A++
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARV 152
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.001
Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 13/143 (9%)
Query: 484 QLSSKLGQG--GFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
+L ++G+G VY R G + V+ L + + L+ NEV++ +H N
Sbjct: 1 ELQVEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPN 60
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYL 596
++ G +I +M S ++LL + P E + NI+ G RGL YL
Sbjct: 61 IMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFP---EGMSEALIGNILFGALRGLNYL 117
Query: 597 HRDSRLRIIHRDLKASNILLDEE 619
H++ IHR++KAS+IL+ +
Sbjct: 118 HQNG---YIHRNIKASHILISGD 137
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.001
Identities = 23/80 (28%), Positives = 29/80 (36%), Gaps = 7/80 (8%)
Query: 337 EDGFSKLNKMKVPDFT---EWTSPATEDECREQCLKN---CSCIAYAFDGGIGCMVWRSI 390
D F K + + T T DEC +C KN SC A+ F +W
Sbjct: 1 VDEFCKSAGTTLIKIALKIKTTKANTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPF 60
Query: 391 NLIDIQRLPFG-GTDLYIRV 409
N + R F G DLY
Sbjct: 61 NSMSGVRKEFSHGFDLYENK 80
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.002
Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 38/159 (23%)
Query: 487 SKLGQGGFGPVYWGRLK-----------------------DGQEIAV--KRLSKASGQGL 521
+ LGQG +Y GRL+ +G+E+ V K L +
Sbjct: 1 AHLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIA 60
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL---- 577
F ++S++ H +L + G CV G E +++ E++ + LD L+KE+
Sbjct: 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVC----LRKEKGRVPV 116
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616
W + + + ++ L YL + ++H ++ A NILL
Sbjct: 117 AW--KITVAQQLASALSYLEDKN---LVHGNVCAKNILL 150
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 30/72 (41%), Positives = 38/72 (52%), Gaps = 8/72 (11%)
Query: 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 619
P + D L PL E L F + +RG+ +L SR + IHRDL A NILL E
Sbjct: 159 PPQETDDLWKSPLTMEDLICYS-FQV----ARGMEFLA--SR-KCIHRDLAARNILLSEN 210
Query: 620 LNPKISDFGMAK 631
KI DFG+A+
Sbjct: 211 NVVKICDFGLAR 222
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|226168 COG3642, COG3642, Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 0.002
Identities = 24/113 (21%), Positives = 43/113 (38%), Gaps = 26/113 (23%)
Query: 526 NEVMVISKLQHRNLVRLLGCC------VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
E +++K R G V+ + +++ EY+ L L
Sbjct: 48 REARILAKA------REAGVPVPIVYDVDPDNGLIVMEYIEGELLKDAL----------E 91
Query: 580 RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
R +++ + R + LH+ I+H DL SNI+L DFG+ +
Sbjct: 92 EARPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGG-RIYFIDFGLGEF 140
|
Length = 204 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 42/152 (27%), Positives = 68/152 (44%), Gaps = 12/152 (7%)
Query: 482 NFQLSSKLGQGGFGPVYWG-RLKDGQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNL 539
+ Q LG G G VY L + +AVK + L+ + M+E+ ++ K +
Sbjct: 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYI 61
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+ G + E+M SLD P E + R I + +GL YL
Sbjct: 62 IGFYGAFFVENRISICTEFMDGGSLDVYRKIP---EHVLGR----IAVAVVKGLTYLWS- 113
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L+I+HRD+K SN+L++ K+ DFG++
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVST 143
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.1 bits (93), Expect = 0.003
Identities = 20/52 (38%), Positives = 33/52 (63%), Gaps = 1/52 (1%)
Query: 580 RKRFNIIEGISRGLLY-LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
++ N+I+G+ R +L L + R+ I+HRD+K N+L+ + KI DFG A
Sbjct: 305 KRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAA 356
|
Length = 507 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 43/161 (26%), Positives = 75/161 (46%), Gaps = 11/161 (6%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNE 527
+ +L ++++ +G+G FG V R K +++ A+K LSK + F E
Sbjct: 34 KIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEE 93
Query: 528 VMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587
+++ +V+L + ++ EYMP L L+ + E+ W RF E
Sbjct: 94 RDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEK--W-ARFYTAE 150
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628
+ L L + IHRD+K N+LLD+ + K++DFG
Sbjct: 151 VV----LALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.9 bits (93), Expect = 0.003
Identities = 20/52 (38%), Positives = 29/52 (55%), Gaps = 1/52 (1%)
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
LL +H +IHRD+K++NILL K+ DFG +K++ D GR
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY-AATVSDDVGR 203
|
Length = 496 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 649 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 99.97 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 99.96 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 99.96 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 99.96 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.96 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.96 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 99.96 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.95 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.94 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 99.94 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 99.94 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 99.94 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.94 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 99.94 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 99.93 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.93 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.93 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 99.93 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.93 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 99.93 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.93 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 99.93 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 99.92 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.92 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 99.92 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.92 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.92 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.92 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 99.92 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.92 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 99.92 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.91 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 99.91 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.91 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.91 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.91 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.91 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.91 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.91 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 99.91 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.91 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.91 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.91 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 99.91 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.91 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 99.91 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.91 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.91 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.91 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.91 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.91 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.91 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 99.91 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.91 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.91 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.91 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.91 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.91 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.9 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.9 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.9 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.9 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.9 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.9 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.9 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.9 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 99.9 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.9 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.9 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.9 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.9 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.9 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.9 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.9 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.9 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.9 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.9 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.9 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.9 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.9 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.9 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.9 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.9 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.9 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.89 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.89 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.89 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.89 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.89 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.89 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.89 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.89 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.89 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.89 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.89 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.89 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.89 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.89 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.89 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.89 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.89 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.89 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.89 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.89 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.89 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.89 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.89 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.89 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.89 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.89 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.89 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.89 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.89 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.89 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.89 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.89 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.89 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.89 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.89 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.89 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.89 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.88 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.88 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.88 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.88 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.88 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.88 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.88 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.88 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.88 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.88 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.88 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.88 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.88 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.88 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.88 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.88 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.88 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.88 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.88 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.88 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.88 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.88 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.88 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.88 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.88 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.88 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.88 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.88 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.88 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.87 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.87 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.87 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.87 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.87 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.87 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.87 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.87 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.87 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.87 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.87 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.87 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.87 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.87 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.87 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.87 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.87 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.87 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.87 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.87 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.87 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.87 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.87 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.87 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.87 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.87 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.87 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.87 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.87 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.87 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.87 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.87 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.87 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.87 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.87 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.87 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.87 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.86 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.86 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.86 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.86 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.86 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.86 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.86 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.86 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.86 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.86 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.86 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.86 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.86 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.86 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.86 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.86 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.86 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.86 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.86 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.86 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.86 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.86 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.86 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.86 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.86 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.86 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.86 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.86 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.86 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.86 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.86 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.86 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.86 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.86 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.85 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.85 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.85 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.85 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.85 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.85 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.85 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.85 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.85 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.85 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.85 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.85 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.85 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.85 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.85 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.85 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.85 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.85 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.85 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.85 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.85 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.85 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.85 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.84 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.84 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.84 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.84 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.84 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.84 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.84 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.84 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.84 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.84 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.84 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.84 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.84 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.84 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.84 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.84 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.84 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.84 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.84 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.84 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.84 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.84 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.84 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.84 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.84 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.84 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.83 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.83 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.83 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.83 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.83 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.83 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.83 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.83 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.83 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.83 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.82 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.82 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.82 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.82 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.82 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.82 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.82 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.82 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.82 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.82 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.82 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.82 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.81 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.81 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.81 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.81 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.81 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.81 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.81 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.81 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.81 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.81 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.81 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.81 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.8 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.8 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.8 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.8 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.8 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.8 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.8 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.79 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.79 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.79 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.78 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.78 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.78 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.78 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.77 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.77 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.76 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.76 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.75 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.74 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.73 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.73 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.73 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.72 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.72 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.72 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.72 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.72 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.71 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.71 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.7 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.67 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.67 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.66 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.66 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.65 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.64 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.6 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.59 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.59 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.59 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.58 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.56 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.51 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.47 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.41 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.41 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.33 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.28 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.19 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.19 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.17 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.07 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.01 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.01 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 98.95 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.87 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 98.82 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 98.82 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.79 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 98.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 98.67 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.62 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.61 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.57 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.53 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.52 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.51 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.47 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.44 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.44 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 98.36 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.34 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.32 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.3 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.26 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.21 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.21 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 98.12 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.12 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 98.11 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.06 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.05 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 97.93 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.92 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.75 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.74 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.66 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.58 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 97.55 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.49 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.48 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.45 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.1 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.06 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.93 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.81 | |
| PLN02236 | 344 | choline kinase | 96.75 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.74 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.32 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.27 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 96.16 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.07 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.89 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 95.78 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 95.69 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 95.57 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.45 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.29 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 95.18 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.13 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 94.93 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=333.80 Aligned_cols=167 Identities=54% Similarity=0.906 Sum_probs=154.0
Q ss_pred CCCCCCHHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEE
Q 006347 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC 546 (649)
Q Consensus 467 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~ 546 (649)
....|++.+++.||++|+..+.||+|+||.||+|.+++|+.||||++.....+..++|.+|+.++.+++|||||+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 56679999999999999999999999999999999999999999998764432167799999999999999999999999
Q ss_pred EeCC-eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 547 VEGE-EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 547 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
.+.+ +++||||||++|+|.++|+..... +++|..|++||.++|+||+|||+.+.++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875433 89999999999999999999999999999999999999999999999999
Q ss_pred ecCCceeeC
Q 006347 626 DFGMAKIFG 634 (649)
Q Consensus 626 DFGla~~~~ 634 (649)
|||||+...
T Consensus 220 DFGLa~~~~ 228 (361)
T KOG1187|consen 220 DFGLAKLGP 228 (361)
T ss_pred CccCcccCC
Confidence 999997653
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=272.69 Aligned_cols=161 Identities=32% Similarity=0.572 Sum_probs=140.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
..+|...++||+|+||+||+|++. ++.+||||.+.+. .....+-+..|+.+|+.++|||||+|+.++.+++..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 356778889999999999999987 6899999999765 4456677889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC------CceEEEecCCc
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE------LNPKISDFGMA 630 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~------~~~Ki~DFGla 630 (649)
|||.+|+|.+||+. .+.+++.....++.|+|.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 457999999999999999999999998 9999999999999865 45899999999
Q ss_pred eeeCCCCCccccCceeecC
Q 006347 631 KIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 631 ~~~~~~~~~~~~~~~~GT~ 649 (649)
|.+.... ...++.|||
T Consensus 163 R~L~~~~---~a~tlcGSp 178 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSP 178 (429)
T ss_pred hhCCchh---HHHHhhCCc
Confidence 9986433 223466664
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-30 Score=268.35 Aligned_cols=159 Identities=36% Similarity=0.603 Sum_probs=136.5
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccc--cHHHHHHHHHHHhcCCCCCccceEEEEEeCC-eEEEEEecCCCC
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--GLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEYMPNR 562 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~g 562 (649)
.+.||+|+||+||+|.++....||||++...... ..++|.+|+.++.+++|||||+++|+|.+.. ...||||||++|
T Consensus 46 ~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~G 125 (362)
T KOG0192|consen 46 EEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGG 125 (362)
T ss_pred hhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCC
Confidence 3569999999999999994444999999754322 2569999999999999999999999999988 799999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceeeCCCCCccc
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQAD 641 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~~~~~~~~~ 641 (649)
+|.++|++. .+..+++..+++||.+||+||.|||++.. ||||||||+|||++.+. ++||+|||+++...... ..
T Consensus 126 sL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~ 200 (362)
T KOG0192|consen 126 SLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TS 200 (362)
T ss_pred cHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--cc
Confidence 999999764 46789999999999999999999999864 99999999999999997 99999999999875432 22
Q ss_pred cCceeecC
Q 006347 642 TGRVVGTL 649 (649)
Q Consensus 642 ~~~~~GT~ 649 (649)
.+...||+
T Consensus 201 ~~~~~GT~ 208 (362)
T KOG0192|consen 201 MTSVAGTY 208 (362)
T ss_pred ccCCCCCc
Confidence 22356664
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=257.45 Aligned_cols=160 Identities=29% Similarity=0.458 Sum_probs=136.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc-------cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
+.|-+.+.||+|+||.|-+|... +|+.||||.+++.... ......+|+++|++|+|||||++++++...+..
T Consensus 172 d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~ 251 (475)
T KOG0615|consen 172 DYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSS 251 (475)
T ss_pred ceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCce
Confidence 45677899999999999999865 7999999999764211 122346999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEecCC
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGM 629 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~DFGl 629 (649)
||||||+++|+|.+++- .++.+.+..-..+++|++.|+.|||+.+ |+||||||+|||+..+ ..+||+||||
T Consensus 252 YmVlE~v~GGeLfd~vv---~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGl 325 (475)
T KOG0615|consen 252 YMVLEYVEGGELFDKVV---ANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGL 325 (475)
T ss_pred EEEEEEecCccHHHHHH---hccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccch
Confidence 99999999999999984 3456777777889999999999999998 9999999999999765 8899999999
Q ss_pred ceeeCCCCCccccCceeecC
Q 006347 630 AKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 630 a~~~~~~~~~~~~~~~~GT~ 649 (649)
|+..+..+ .+.+..|||
T Consensus 326 AK~~g~~s---fm~TlCGTp 342 (475)
T KOG0615|consen 326 AKVSGEGS---FMKTLCGTP 342 (475)
T ss_pred hhccccce---ehhhhcCCc
Confidence 99986322 355688886
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=266.35 Aligned_cols=161 Identities=32% Similarity=0.494 Sum_probs=147.8
Q ss_pred cCcccceeeccCCcEEEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
..|...+.||+|||++||+++. ..|+.||+|++.+. .....+...+||++.++|+|||||+++++|.+.++.|||+
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688889999999999999998 78999999999763 3456778999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+|++++|..+++ +.+++++.++..+..||+.||.|||+.+ |||||||..|++|++++++||+|||||..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999999995 4577999999999999999999999988 999999999999999999999999999999877
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
..+..| +.|||
T Consensus 172 ~Erk~T--lCGTP 182 (592)
T KOG0575|consen 172 GERKKT--LCGTP 182 (592)
T ss_pred ccccce--ecCCC
Confidence 666665 89996
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=264.85 Aligned_cols=152 Identities=36% Similarity=0.647 Sum_probs=137.7
Q ss_pred cccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
++..++||+|-||.|+.|.++....||||.++.. ....+.|.+|+.+|++|+|+|||+++|+|..+++.+||||||+.|
T Consensus 208 l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~G 286 (468)
T KOG0197|consen 208 LKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKG 286 (468)
T ss_pred HHHHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccC
Confidence 4456899999999999999998789999999653 345689999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCc
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 639 (649)
+|.+||++ .....+...+.+.++.|||+||+||++++ +|||||.++|||++++..+||+||||||.+..++..
T Consensus 287 sLl~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~ 359 (468)
T KOG0197|consen 287 SLLDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYT 359 (468)
T ss_pred cHHHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCcee
Confidence 99999976 24567899999999999999999999988 999999999999999999999999999977665543
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-30 Score=229.38 Aligned_cols=111 Identities=46% Similarity=0.768 Sum_probs=81.4
Q ss_pred CCcEEEEecCCCCCCCC--cceEEEeeCCcEEEEcCCceEEEEe-cCcccccccccceeecccCeEEeeCCCCceEeeec
Q 006347 69 EKAVIWVANRDNPLKDS--SGIITISEDGNLVLVNGQKEVLWSS-NVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145 (649)
Q Consensus 69 ~~~~vW~Anr~~pv~~~--~~~l~~~~~G~L~l~~~~~~~~Wss-~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSF 145 (649)
++||||+|||+.|+..+ ..+|.|+.||+|+|++..++++|++ ++.+.+..+..|+|+|+|||||++. .+.+|||||
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~-~~~~lW~Sf 79 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQSDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDS-SGNVLWQSF 79 (114)
T ss_dssp ---------TTEEEEECETTEEEEEETTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEET-TSEEEEEST
T ss_pred CcccccccccccccccccccccceECCCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEee-cceEEEeec
Confidence 37999999999999543 3889999999999999999999999 5553222478999999999999995 688999999
Q ss_pred CCCcccccCCCcccccccCCceeEEEEcccCCCCC
Q 006347 146 QEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPS 180 (649)
Q Consensus 146 D~PTDTlLpg~~l~~~~~~g~~~~L~S~~s~~dps 180 (649)
||||||+||||+|+.+..++.+..++||++.+|||
T Consensus 80 ~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 80 DYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp TSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred CCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 99999999999999988887767899999999996
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-28 Score=254.24 Aligned_cols=159 Identities=29% Similarity=0.475 Sum_probs=138.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (649)
.|..+++||+|.||.|||++.. +|+.||+|++.... +....-..+||.+|++|+||||++|.+...+. ...|||+
T Consensus 118 ~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVF 197 (560)
T KOG0600|consen 118 SFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVF 197 (560)
T ss_pred HHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEE
Confidence 4666789999999999999854 79999999997543 34456677999999999999999999999987 6899999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|||++ +|..++.. ..-.++..++..++.|++.||+|+|..+ |+|||||.+|||||.++.+||+|||||+++...
T Consensus 198 eYMdh-DL~GLl~~--p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~ 271 (560)
T KOG0600|consen 198 EYMDH-DLSGLLSS--PGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYTPS 271 (560)
T ss_pred ecccc-hhhhhhcC--CCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeeccCC
Confidence 99976 78777743 2346899999999999999999999998 999999999999999999999999999999888
Q ss_pred CCccccCcee
Q 006347 637 QDQADTGRVV 646 (649)
Q Consensus 637 ~~~~~~~~~~ 646 (649)
+....|++++
T Consensus 272 ~~~~~T~rVv 281 (560)
T KOG0600|consen 272 GSAPYTSRVV 281 (560)
T ss_pred CCcccccceE
Confidence 8777777654
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=252.02 Aligned_cols=159 Identities=35% Similarity=0.548 Sum_probs=139.6
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCCccceEEEEEeCC----eEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK--LQHRNLVRLLGCCVEGE----EKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~----~~~lV 555 (649)
...+.+.+|+|+||.||||.+. ++.||||++. .++.+.|.+|-.+... ++|+||+++++.-..+. +.+||
T Consensus 211 pl~l~eli~~Grfg~V~KaqL~-~~~VAVKifp---~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLV 286 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQLD-NRLVAVKIFP---EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLV 286 (534)
T ss_pred chhhHHHhhcCccceeehhhcc-CceeEEEecC---HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEE
Confidence 3455679999999999999998 5999999985 4566788888877665 47999999999977665 78999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------CCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
+||.++|+|.+||. ...++|.+..+|+..+++||+|||+. .+++|+|||||.+|||+.+|+++.|+||||
T Consensus 287 t~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGL 362 (534)
T KOG3653|consen 287 TEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGL 362 (534)
T ss_pred eeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccce
Confidence 99999999999994 46799999999999999999999975 456899999999999999999999999999
Q ss_pred ceeeCCCCCccccCceeec
Q 006347 630 AKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 630 a~~~~~~~~~~~~~~~~GT 648 (649)
|.++.....+..+..-+||
T Consensus 363 Al~~~p~~~~~d~~~qVGT 381 (534)
T KOG3653|consen 363 ALRLEPGKPQGDTHGQVGT 381 (534)
T ss_pred eEEecCCCCCcchhhhhhh
Confidence 9999887777777667887
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-28 Score=246.31 Aligned_cols=154 Identities=32% Similarity=0.434 Sum_probs=135.1
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-eEEEEEecCCCC
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEYMPNR 562 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey~~~g 562 (649)
.+.||+|..|+|||+.++ +++.+|+|.+... .+...+++.+|++++.+.+||+||+++|.|.... +..|+||||.+|
T Consensus 84 ~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgG 163 (364)
T KOG0581|consen 84 LGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGG 163 (364)
T ss_pred hhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCC
Confidence 478999999999999987 6889999999543 3455689999999999999999999999999998 599999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCcccc
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~ 642 (649)
||++++.. .+.+++...-+|+.+|++||.|||+.. .||||||||+|||++..+.+||+|||.++.+.+. ..
T Consensus 164 SLd~~~k~---~g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a 234 (364)
T KOG0581|consen 164 SLDDILKR---VGRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IA 234 (364)
T ss_pred CHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hc
Confidence 99999953 356899999999999999999999732 3999999999999999999999999999998554 23
Q ss_pred Cceeec
Q 006347 643 GRVVGT 648 (649)
Q Consensus 643 ~~~~GT 648 (649)
++.+||
T Consensus 235 ~tfvGT 240 (364)
T KOG0581|consen 235 NTFVGT 240 (364)
T ss_pred cccccc
Confidence 346776
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=246.01 Aligned_cols=162 Identities=31% Similarity=0.432 Sum_probs=143.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||+||.++.. +++.+|+|.+++.. ..+.+..+.|..+|.+++||.||+++-.+.+.+.+|||
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 457999999999999999999876 68899999997642 34567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+||+.||.|..+|. ++..+++.....++.+|+.||.|||+.+ ||||||||+|||||++|++||+||||++....
T Consensus 104 ld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~ 177 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLK 177 (357)
T ss_pred EeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhccc
Confidence 99999999999993 4567889988889999999999999998 99999999999999999999999999997644
Q ss_pred CCCccccCceeecC
Q 006347 636 NQDQADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~~~~~~~~GT~ 649 (649)
... .+.++.||+
T Consensus 178 ~~~--~t~tfcGT~ 189 (357)
T KOG0598|consen 178 DGD--ATRTFCGTP 189 (357)
T ss_pred CCC--ccccccCCc
Confidence 433 344588885
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=262.03 Aligned_cols=166 Identities=31% Similarity=0.569 Sum_probs=143.9
Q ss_pred CCCHHHHHHHhcC---------cccceeeccCCcEEEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCC
Q 006347 470 LFQFEELATATNN---------FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQ 535 (649)
Q Consensus 470 ~~~~~~l~~~~~~---------f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~ 535 (649)
.++||+.-.|... .++.+.||.|.||.|++|.++ ....||||.|+.. .++.+++|+.|+.||+++.
T Consensus 609 P~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd 688 (996)
T KOG0196|consen 609 PHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD 688 (996)
T ss_pred CccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC
Confidence 4556655444443 355678999999999999987 2357999999754 4567889999999999999
Q ss_pred CCCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006347 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615 (649)
Q Consensus 536 H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 615 (649)
||||++|.|+.......+||.|||+||+|+.||+.+ ...+++.++.-++++||.||.||.+.+ +|||||.++|||
T Consensus 689 HPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNIL 763 (996)
T KOG0196|consen 689 HPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNIL 763 (996)
T ss_pred CCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhhee
Confidence 999999999999999999999999999999999763 455999999999999999999999887 999999999999
Q ss_pred EcCCCceEEEecCCceeeCCCCCcc
Q 006347 616 LDEELNPKISDFGMAKIFGGNQDQA 640 (649)
Q Consensus 616 l~~~~~~Ki~DFGla~~~~~~~~~~ 640 (649)
++.+..+||+||||+|.+.++....
T Consensus 764 VNsnLvCKVsDFGLSRvledd~~~~ 788 (996)
T KOG0196|consen 764 VNSNLVCKVSDFGLSRVLEDDPEAA 788 (996)
T ss_pred eccceEEEeccccceeecccCCCcc
Confidence 9999999999999999997666433
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=249.22 Aligned_cols=148 Identities=32% Similarity=0.568 Sum_probs=131.7
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
...+.++||+|.||.|..+....+..||||+++.... ...++|.+|+++|.+++|||||+|+|+|..++..++|+|||+
T Consensus 539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmE 618 (807)
T KOG1094|consen 539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYME 618 (807)
T ss_pred heehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHh
Confidence 3455689999999999999999889999999986544 345899999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|+|.+||..+.. ..+.-....+|+.|||.||+||.+.. +|||||.++|+|+|.++++||+|||++|-+
T Consensus 619 nGDLnqFl~ahea-pt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~l 687 (807)
T KOG1094|consen 619 NGDLNQFLSAHEL-PTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNL 687 (807)
T ss_pred cCcHHHHHHhccC-cccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCccccccc
Confidence 9999999965321 22455667789999999999999876 999999999999999999999999999954
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.2e-27 Score=261.77 Aligned_cols=153 Identities=33% Similarity=0.577 Sum_probs=135.3
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGE 550 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (649)
..+.+....++||+|+||+||+|+.. +.+.||||.++..... ..++|++|+++++.++|||||+|+|+|.+++
T Consensus 483 i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~ 562 (774)
T KOG1026|consen 483 IPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGD 562 (774)
T ss_pred echhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCC
Confidence 33445566789999999999999854 3457999999876554 7889999999999999999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCC-------C----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 006347 551 EKMLIYEYMPNRSLDALLFDPL-------K----KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 619 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~-------~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 619 (649)
..++|+|||..|+|.+||+.+. . ..+|+..+.+.||.|||.||+||-++. +|||||..+|+|+.++
T Consensus 563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGEN 639 (774)
T ss_pred eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccc
Confidence 9999999999999999997321 1 234889999999999999999999887 9999999999999999
Q ss_pred CceEEEecCCceee
Q 006347 620 LNPKISDFGMAKIF 633 (649)
Q Consensus 620 ~~~Ki~DFGla~~~ 633 (649)
..+||+||||+|-+
T Consensus 640 l~VKIsDfGLsRdi 653 (774)
T KOG1026|consen 640 LVVKISDFGLSRDI 653 (774)
T ss_pred eEEEecccccchhh
Confidence 99999999999965
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-28 Score=238.37 Aligned_cols=166 Identities=25% Similarity=0.444 Sum_probs=140.9
Q ss_pred CcccceeeccCCcEEEEEEEe-cCCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCCccceEE-EEEeCCe-EEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLG-CCVEGEE-KMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g-~~~~~~~-~~lV~ 556 (649)
+|.+.++||+|.||+|||+.. .+|..+|.|.+.- ...+..+....|+.+|++|+|||||++++ -+.++.+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 477788999999999999974 5899999998863 24456788999999999999999999999 4555555 78999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC-CCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDS-RLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+..|+|..++... .+++.+++..++++..|+++||.++|..= +..|+||||||.||+|+.++.+|++||||+|.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 999999999998653 23567899999999999999999999831 2349999999999999999999999999999997
Q ss_pred CCCCccccCceeecC
Q 006347 635 GNQDQADTGRVVGTL 649 (649)
Q Consensus 635 ~~~~~~~~~~~~GT~ 649 (649)
..+..+ .+.+|||
T Consensus 180 s~~tfA--~S~VGTP 192 (375)
T KOG0591|consen 180 SKTTFA--HSLVGTP 192 (375)
T ss_pred chhHHH--HhhcCCC
Confidence 665443 4589996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.1e-27 Score=246.66 Aligned_cols=156 Identities=34% Similarity=0.483 Sum_probs=138.3
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
+...++|...+.||+|+|.+|++|+.. +++++|||++.+. .+...+-...|-.+|.+| .||.|++|+-.|.+...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 334467888999999999999999866 6899999999763 234456677899999999 89999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
+|+|+||+++|+|.++|.+ -+.++......++.+|+.||+|||..+ ||||||||+|||||+|+++||+|||-|+
T Consensus 149 LYFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK 222 (604)
T KOG0592|consen 149 LYFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAK 222 (604)
T ss_pred eEEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccc
Confidence 9999999999999999954 467899888999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCC
Q 006347 632 IFGGNQD 638 (649)
Q Consensus 632 ~~~~~~~ 638 (649)
++.+.+.
T Consensus 223 ~l~~~~~ 229 (604)
T KOG0592|consen 223 ILSPSQK 229 (604)
T ss_pred cCChhhc
Confidence 9865443
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=225.38 Aligned_cols=150 Identities=29% Similarity=0.531 Sum_probs=133.3
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|...++||+|.||.||+|... +|+.||||+++.... .-.....+|+..|+.++|+||+.|++++.+.+..-||+||
T Consensus 3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEf 82 (318)
T KOG0659|consen 3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEF 82 (318)
T ss_pred hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEe
Confidence 4666789999999999999865 799999999975422 2245678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+ .+|...+++ +...++..+...++.++.+||+|||++. |+||||||.|+|+++++.+||+||||||.++...
T Consensus 83 m~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 83 MP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred cc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 95 589999976 4567899999999999999999999988 9999999999999999999999999999997543
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=227.31 Aligned_cols=158 Identities=35% Similarity=0.447 Sum_probs=140.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.+|...+.||.|+||+|..++.+ +|.-+|+|++++.. -.+.+...+|..+|+.+.||++++|++.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 35677789999999999999977 68899999997643 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||.++|.|.++|++ .+.++......+|.+|+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+.+.
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR 197 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecCc
Confidence 99999999999954 456889999999999999999999988 999999999999999999999999999998544
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
|-++.|||
T Consensus 198 -----T~TlCGTP 205 (355)
T KOG0616|consen 198 -----TWTLCGTP 205 (355)
T ss_pred -----EEEecCCc
Confidence 34578885
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.9e-26 Score=204.09 Aligned_cols=115 Identities=43% Similarity=0.734 Sum_probs=101.4
Q ss_pred CCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCCceEEEE
Q 006347 30 QLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWS 109 (649)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Ws 109 (649)
+.|.++++|+|+++.|++|||.+......+.+|||.+.+ .++||.|||+.|. ...+.|.|+.||+|+|+|.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~~-~~~~~l~l~~dGnLvl~~~~g~~vW~ 79 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNPS-GSSCTLTLQSDGNLVIYDGSGTVVWS 79 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCCC-CCCEEEEEecCCCeEEEcCCCcEEEE
Confidence 578899999999999999999987554478999999877 7899999999984 45688999999999999999999999
Q ss_pred ecCcccccccccceeecccCeEEeeCCCCceEeeecCCC
Q 006347 110 SNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP 148 (649)
Q Consensus 110 s~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~P 148 (649)
+++.+ .....+|+|+|+|||||++. .+.+||||||||
T Consensus 80 S~~~~-~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~P 116 (116)
T cd00028 80 SNTTR-VNGNYVLVLLDDGNLVLYDS-DGNFLWQSFDYP 116 (116)
T ss_pred ecccC-CCCceEEEEeCCCCEEEECC-CCCEEEcCCCCC
Confidence 99874 34567899999999999985 478999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.2e-27 Score=249.57 Aligned_cols=148 Identities=38% Similarity=0.570 Sum_probs=131.4
Q ss_pred cCcccceeeccCCcEEEEEEEecC--C---cEEEEEEecc---cccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD--G---QEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~--g---~~vAVK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
++..+.++||+|+||.||+|++.. + ..||||..+. ......++|.+|+++|++++|||||+++|++.+..+.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 344455899999999999999762 2 2389999874 3356778999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+||||+|+||+|+++|.+. ...++..+++.++.++|+||+|||++. +|||||.++|+|+..+..+||+||||++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~--~~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKN--KKSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999653 236999999999999999999999998 99999999999999999999999999886
Q ss_pred e
Q 006347 633 F 633 (649)
Q Consensus 633 ~ 633 (649)
-
T Consensus 312 ~ 312 (474)
T KOG0194|consen 312 G 312 (474)
T ss_pred C
Confidence 4
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=228.90 Aligned_cols=148 Identities=25% Similarity=0.424 Sum_probs=129.1
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.|+...++|+|++|.|||++.+ +|+.||||++..... .-.+-.++|++.|++++|+|+|.|+.+|......+||+||
T Consensus 3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~ 82 (396)
T KOG0593|consen 3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEY 82 (396)
T ss_pred HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeee
Confidence 4666779999999999999987 699999999865332 2234567999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++..-|++.-+ ....++.....+++.|+++|+.|+|++. +|||||||+|||+..++.+||+|||+||.+..
T Consensus 83 ~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~ 153 (396)
T KOG0593|consen 83 CDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA 153 (396)
T ss_pred cchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC
Confidence 98876665542 2345788899999999999999999998 99999999999999999999999999999874
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=243.22 Aligned_cols=160 Identities=30% Similarity=0.487 Sum_probs=142.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|.+.+.||+|+||.||||+.+ +.+.||+|.+.+.. +++.+.+++|++++++++|||||.++.++....+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 56778899999999999999876 68899999997643 3456779999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+.+ +|..+|. ..+.+++..+..|+.++..||.|||+.+ |+|||+||+||||+.++.+|++|||+||.++.+.
T Consensus 82 ~a~g-~L~~il~---~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILE---QDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHH---hccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9976 9999994 4567999999999999999999999987 9999999999999999999999999999986533
Q ss_pred CccccCceeecC
Q 006347 638 DQADTGRVVGTL 649 (649)
Q Consensus 638 ~~~~~~~~~GT~ 649 (649)
...+++.|||
T Consensus 155 --~vltsikGtP 164 (808)
T KOG0597|consen 155 --SVLTSIKGTP 164 (808)
T ss_pred --eeeeeccCcc
Confidence 3456788886
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.3e-27 Score=241.24 Aligned_cols=153 Identities=29% Similarity=0.455 Sum_probs=134.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCC-CCCccceEEEEEeCC-eEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE-EKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~-~~~lV 555 (649)
.++|.+.++||.|.||.||+|+-. +++.||||++++.-. .++-.=++|+..|++|+ |||||+|..++.+.+ ..++|
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fV 88 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFV 88 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeee
Confidence 357888899999999999999865 789999999975432 22233468999999998 999999999999988 89999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||||+ -+|.++++++ +..+++..+..|+.||++||+|+|.++ +.|||+||+|||+.....+||+||||||.+..
T Consensus 89 fE~Md-~NLYqLmK~R--~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S 162 (538)
T KOG0661|consen 89 FEFMD-CNLYQLMKDR--NRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS 162 (538)
T ss_pred HHhhh-hhHHHHHhhc--CCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc
Confidence 99995 4899999774 678999999999999999999999998 99999999999999999999999999999865
Q ss_pred CCC
Q 006347 636 NQD 638 (649)
Q Consensus 636 ~~~ 638 (649)
.+.
T Consensus 163 kpP 165 (538)
T KOG0661|consen 163 KPP 165 (538)
T ss_pred CCC
Confidence 443
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-26 Score=234.47 Aligned_cols=149 Identities=28% Similarity=0.544 Sum_probs=135.9
Q ss_pred cCcccceeeccCCcEEEEEEEe-cCCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.+|.+.+.||+|.+|.|-++.. ..|+.||||.+++. ++++.-.+++|+++|..|+||||+.++.+|...+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577778999999999999986 47999999999765 3456677899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||..+|.|.+|+. ..+.|++.+..++++||..|+.|+|.+. ++|||||.+|||||.++++||+||||+-++..
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 9999999999994 4567999999999999999999999987 99999999999999999999999999988744
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=230.71 Aligned_cols=164 Identities=33% Similarity=0.479 Sum_probs=137.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC--eEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE--EKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~E 557 (649)
.++...+.||+|+||.||++... +|+..|||.+........+.+.+|+.+|.+++|||||+.+|.....+ ..+|.||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 34666789999999999999987 48999999987653333677899999999999999999999855555 5889999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~~~ 636 (649)
|+++|+|.+++.+... .+++..+.++..||++||+|||+++ ||||||||+|||++. ++.+||+|||+|+.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965322 6999999999999999999999988 999999999999999 799999999999988641
Q ss_pred CCc-cccCceeecC
Q 006347 637 QDQ-ADTGRVVGTL 649 (649)
Q Consensus 637 ~~~-~~~~~~~GT~ 649 (649)
... .....++||+
T Consensus 172 ~~~~~~~~~~~Gtp 185 (313)
T KOG0198|consen 172 GTKSDSELSVQGTP 185 (313)
T ss_pred cccccccccccCCc
Confidence 111 2233467764
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=231.78 Aligned_cols=165 Identities=32% Similarity=0.488 Sum_probs=135.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--------------cccHHHHHHHHHHHhcCCCCCccceE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--------------GQGLEEFMNEVMVISKLQHRNLVRLL 543 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--------------~~~~~~f~~E~~~l~~l~H~niv~l~ 543 (649)
..|+|++.++||+|.||.|-+|... +++.||||.+.+.. ....+..++|+.+|++++|+|||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 4478999999999999999999876 78999999996521 01235788999999999999999999
Q ss_pred EEEEeC--CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 544 GCCVEG--EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 544 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
.+.-+. +..|||+|||..|.+...- .....++..+..++++++..||+|||.++ ||||||||+|+||+++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p---~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~ 248 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCP---PDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGT 248 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCC---CCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCc
Confidence 997654 4789999999998885443 12223899999999999999999999998 999999999999999999
Q ss_pred eEEEecCCceeeCCC---CCccccCceeecC
Q 006347 622 PKISDFGMAKIFGGN---QDQADTGRVVGTL 649 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~---~~~~~~~~~~GT~ 649 (649)
+||+|||.+-..... .......+.+|||
T Consensus 249 VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTP 279 (576)
T KOG0585|consen 249 VKISDFGVSNEFPQGSDEGSDDQLSRTVGTP 279 (576)
T ss_pred EEeeccceeeecccCCccccHHHHhhcCCCc
Confidence 999999999877222 1222344578886
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.9e-25 Score=236.35 Aligned_cols=164 Identities=28% Similarity=0.476 Sum_probs=139.2
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc----cc-ccHHHHHHHHHHHhcCC-CCCccceEEEEEeCC
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA----SG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE 550 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~----~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~ 550 (649)
...++|.+.+.||+|.||.|+.|... +++.||||.+++. .. ...+.+.+|+.++++++ ||||++++.+.....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 34467889999999999999999765 7899999977653 11 23456668999999998 999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCC
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGM 629 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGl 629 (649)
..++||||+.+|+|.+++.+ ...+.+.+...++.|++.|++|+|+.+ |+||||||+|||+|.+ +++||+|||+
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~ 167 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGL 167 (370)
T ss_pred eEEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccc
Confidence 99999999999999999954 466888999999999999999999988 9999999999999999 9999999999
Q ss_pred ceeeCCCCCccccCceeecC
Q 006347 630 AKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 630 a~~~~~~~~~~~~~~~~GT~ 649 (649)
+...... .....+..||+
T Consensus 168 s~~~~~~--~~~l~t~cGsp 185 (370)
T KOG0583|consen 168 SAISPGE--DGLLKTFCGSP 185 (370)
T ss_pred ccccCCC--CCcccCCCCCc
Confidence 9988411 12233456664
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.6e-26 Score=241.47 Aligned_cols=152 Identities=36% Similarity=0.636 Sum_probs=134.9
Q ss_pred HHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 474 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
++.+...+.+.+.+.||+|+||+||+|.+. ..||||+++... ....++|++|+..+++.+|.||+-+.|+|..+..
T Consensus 385 ~~WeIp~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~ 462 (678)
T KOG0193|consen 385 EEWEIPPEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL 462 (678)
T ss_pred cccccCHHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce
Confidence 444444455667789999999999999998 369999997543 4577899999999999999999999999998877
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.||..+|++-+|..+|+.. +..++..+...||.|||+||.|||.++ |||||||..||+|.+++.+||+|||||.
T Consensus 463 -AIiTqwCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLat 536 (678)
T KOG0193|consen 463 -AIITQWCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLAT 536 (678)
T ss_pred -eeeehhccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEeccccee
Confidence 9999999999999999763 456899999999999999999999998 9999999999999999999999999997
Q ss_pred ee
Q 006347 632 IF 633 (649)
Q Consensus 632 ~~ 633 (649)
.-
T Consensus 537 vk 538 (678)
T KOG0193|consen 537 VK 538 (678)
T ss_pred ee
Confidence 64
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=222.34 Aligned_cols=150 Identities=29% Similarity=0.447 Sum_probs=129.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 555 (649)
++|...+.|++|.||.||+|+.. +++.||+|+++...+ ...-.-++||.+|.+++|||||.+-.+.+.. +..|||
T Consensus 76 ~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V 155 (419)
T KOG0663|consen 76 EEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV 155 (419)
T ss_pred HHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence 35777889999999999999976 688999999975432 1223457899999999999999999887743 478999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||||++ +|...+.. -.+++...+...+..|+++|++|||..- |+||||||+|+|+.+.|.+||+||||||.++.
T Consensus 156 Me~~Eh-DLksl~d~--m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs 229 (419)
T KOG0663|consen 156 MEYVEH-DLKSLMET--MKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGS 229 (419)
T ss_pred HHHHHh-hHHHHHHh--ccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcC
Confidence 999965 78888854 2367899999999999999999999987 99999999999999999999999999999976
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 230 p 230 (419)
T KOG0663|consen 230 P 230 (419)
T ss_pred C
Confidence 5
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.9e-25 Score=233.04 Aligned_cols=149 Identities=29% Similarity=0.428 Sum_probs=136.3
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
..++|.++..||+|+||.||.++.+ +|..+|+|++++.. ..+.+..+.|-.+|....++.||+|+..|.+.+..||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 4568999999999999999999876 69999999998753 3456788899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||||+|||++..+|. +...|+......++.+++.|+.-||+.+ +|||||||+|+|||..|++||+||||++-+
T Consensus 219 iMEylPGGD~mTLL~---~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl 291 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLLM---RKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGL 291 (550)
T ss_pred EEEecCCccHHHHHH---hcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchh
Confidence 999999999999994 5678999988899999999999999988 999999999999999999999999999755
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.2e-25 Score=228.65 Aligned_cols=164 Identities=27% Similarity=0.440 Sum_probs=138.9
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC--CCCCccceEEEEEeCC----
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL--QHRNLVRLLGCCVEGE---- 550 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~~---- 550 (649)
+...++..+.+.||+|.||.|++|.++ |+.||||++.. .+++.+.+|.++.+.+ +|+||+.+++.-..++
T Consensus 207 RTiarqI~L~e~IGkGRyGEVwrG~wr-Ge~VAVKiF~s---rdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 207 RTIARQIVLQEIIGKGRFGEVWRGRWR-GEDVAVKIFSS---RDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred HhhhheeEEEEEecCccccceeecccc-CCceEEEEecc---cchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 344467788899999999999999999 89999999953 4567788888887764 9999999998866544
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-----DSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
.++||.+|.++|||.+||. ...++-...++++..+|.||+|||- ++++.|.|||||+.|||+.+++.+.|+
T Consensus 283 QLwLvTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IA 358 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 358 (513)
T ss_pred EEEEeeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEe
Confidence 5799999999999999993 4678999999999999999999996 488899999999999999999999999
Q ss_pred ecCCceeeCCCCCc--cccCceeec
Q 006347 626 DFGMAKIFGGNQDQ--ADTGRVVGT 648 (649)
Q Consensus 626 DFGla~~~~~~~~~--~~~~~~~GT 648 (649)
|+|||.....+... ...+.-+||
T Consensus 359 DLGLAv~h~~~t~~idi~~N~rVGT 383 (513)
T KOG2052|consen 359 DLGLAVRHDSDTDTIDIPPNPRVGT 383 (513)
T ss_pred eceeeEEecccCCcccCCCCCccce
Confidence 99999998655322 234455666
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=237.23 Aligned_cols=159 Identities=35% Similarity=0.543 Sum_probs=142.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.|...++||+|+.|.||.+... +++.||||++........+-+++|+.+|+..+|+|||+++..+...++.|+|||||+
T Consensus 274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ 353 (550)
T KOG0578|consen 274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYME 353 (550)
T ss_pred hhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecC
Confidence 3555679999999999999754 788999999987655556678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCcc
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 640 (649)
+|+|.+.+. ...+++.++..|++++++||+|||.++ |||||||.+|||++.++.+||+|||++..+...+.+.
T Consensus 354 ggsLTDvVt----~~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR 426 (550)
T KOG0578|consen 354 GGSLTDVVT----KTRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR 426 (550)
T ss_pred CCchhhhhh----cccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence 999999984 345899999999999999999999998 9999999999999999999999999999998888765
Q ss_pred ccCceeecC
Q 006347 641 DTGRVVGTL 649 (649)
Q Consensus 641 ~~~~~~GT~ 649 (649)
.+ ++|||
T Consensus 427 ~T--mVGTP 433 (550)
T KOG0578|consen 427 ST--MVGTP 433 (550)
T ss_pred cc--ccCCC
Confidence 54 89996
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=234.06 Aligned_cols=153 Identities=31% Similarity=0.458 Sum_probs=129.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCC-
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE- 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~- 550 (649)
.++|.+.++||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.++ +||||++++++|.+.+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 457888899999999999999742 35689999986533 23456799999999999 8999999999987654
Q ss_pred eEEEEEecCCCCChhhhhcCCCC---------------------------------------------------------
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLK--------------------------------------------------------- 573 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 573 (649)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999999864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 574 --KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 574 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~ 226 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 226 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeeccccccccc
Confidence 134788899999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.92 E-value=9e-26 Score=214.82 Aligned_cols=150 Identities=33% Similarity=0.507 Sum_probs=134.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|.+.+.||+|.||.||.|..+ ++..||+|++.+.. .+-.+++++|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 357888899999999999999976 67899999997642 34457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||.+.|+|...|.+. ....++......++.|+|.||.|+|..+ +|||||||+|+|++.++..||+|||.+..-
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~ 174 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA 174 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeec
Confidence 9999999999999642 3455788888899999999999999887 999999999999999999999999998864
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.92 E-value=6.7e-25 Score=221.58 Aligned_cols=150 Identities=31% Similarity=0.520 Sum_probs=128.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCC-ccceEEEEEeCC------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGE------ 550 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~------ 550 (649)
..|...++||+|.||+||+|+.. +|+.||+|++.-..+ .-.....+|+.++.+++|+| ||+|++++.+.+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 34556678999999999999876 789999999975433 23345689999999999999 999999999887
Q ss_pred eEEEEEecCCCCChhhhhcCCCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKK-ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
..++|+||+ .-+|..++...... ..++...+..++.||++||+|||+++ |+||||||+|||+++.+.+||+|||+
T Consensus 91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 788999999 45899998653322 45777889999999999999999998 99999999999999999999999999
Q ss_pred ceeeC
Q 006347 630 AKIFG 634 (649)
Q Consensus 630 a~~~~ 634 (649)
||.++
T Consensus 167 Ara~~ 171 (323)
T KOG0594|consen 167 ARAFS 171 (323)
T ss_pred HHHhc
Confidence 99775
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=9.3e-25 Score=193.88 Aligned_cols=113 Identities=42% Similarity=0.712 Sum_probs=99.6
Q ss_pred CCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCCceEEEE
Q 006347 30 QLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWS 109 (649)
Q Consensus 30 ~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Ws 109 (649)
+.|..++.|+|+++.|++|||.+... ..+.+|||+..+ .++||+|||+.|+.+ ++.|.|+.||+|+|+|.+|.++|+
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~-~~~l~l~~dGnLvl~~~~g~~vW~ 78 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSD-SCTLTLQSDGNLVLYDGDGRVVWS 78 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCC-CEEEEEeCCCCEEEEeCCCCEEEE
Confidence 56889999999999999999998754 578899999877 889999999999865 488999999999999999999999
Q ss_pred ecCcccccccccceeecccCeEEeeCCCCceEeeecCC
Q 006347 110 SNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE 147 (649)
Q Consensus 110 s~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~ 147 (649)
|++. .+....+|+|+|+|||||++. .++++||||||
T Consensus 79 S~t~-~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~~ 114 (114)
T smart00108 79 SNTT-GANGNYVLVLLDDGNLVIYDS-DGNFLWQSFDY 114 (114)
T ss_pred eccc-CCCCceEEEEeCCCCEEEECC-CCCEEeCCCCC
Confidence 9986 334567899999999999985 46799999997
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-24 Score=227.50 Aligned_cols=152 Identities=32% Similarity=0.541 Sum_probs=131.0
Q ss_pred cCcccceeeccCCcEEEEEEEecC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccce
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-----------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRL 542 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 542 (649)
++|.+.++||+|+||.||++..++ +..||||.+.... .....+|.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467888999999999999997532 3469999986542 3345689999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCChhhhhcCCC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 006347 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPL----------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606 (649)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 606 (649)
++++.+.+..++||||+++|+|.+++.... ....++|..+++++.||+.||.|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999985321 1134788999999999999999999987 999
Q ss_pred cCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 607 RDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 607 rDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||||+|||+++++.+||+|||+++.+..
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~ 190 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYA 190 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceeccc
Confidence 99999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2e-24 Score=232.31 Aligned_cols=150 Identities=25% Similarity=0.332 Sum_probs=133.1
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
..++|++.+.||+|+||.||++... +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3467889999999999999999986 5789999998642 22344568899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++.. ..+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~ 193 (370)
T cd05621 121 VMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecc
Confidence 9999999999999843 34788889999999999999999987 9999999999999999999999999999874
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 194 ~ 194 (370)
T cd05621 194 E 194 (370)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=3e-24 Score=227.60 Aligned_cols=148 Identities=29% Similarity=0.445 Sum_probs=133.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|+.++..++|+||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 46888999999999999999987 58899999987532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++++|.+++.. ...+++.....++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+...
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~ 152 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIV 152 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCcccc
Confidence 99999999999943 346889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.7e-24 Score=230.77 Aligned_cols=148 Identities=26% Similarity=0.384 Sum_probs=132.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||++... +++.+|||.+.+.. ......+..|+.++.+++|+||+++++.+.+....+|||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 46888899999999999999876 68899999996532 233467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~ 152 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLK 152 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccc
Confidence 99999999999853 356899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.6e-24 Score=230.87 Aligned_cols=148 Identities=26% Similarity=0.398 Sum_probs=133.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||+++.. +++.||||++.... ......+.+|+.++..++|+||+++++.+.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 46888999999999999999976 68999999996532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 152 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLK 152 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecc
Confidence 99999999999853 346899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.5e-24 Score=225.34 Aligned_cols=141 Identities=28% Similarity=0.322 Sum_probs=126.6
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.||+|+||.||+++.. +|+.+|||.+++.. ......+.+|+.++.+++||||+++++.+.+++..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 68999999987532 234467889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~ 145 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCccc
Confidence 99999853 456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-25 Score=249.66 Aligned_cols=149 Identities=36% Similarity=0.642 Sum_probs=133.3
Q ss_pred CcccceeeccCCcEEEEEEEec--CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK--DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~--~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+.+..+.||+|+||.||+|.+. ++. .||||.+++. +.++..+|++|..+|++++|||||+++|.|.+....+|
T Consensus 693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i 772 (1025)
T KOG1095|consen 693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLI 772 (1025)
T ss_pred heEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEE
Confidence 3455678999999999999976 243 4999999775 45677899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 555 IYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
++|||++|+|..||++.+ +...++..+++.|+.|||+|+.||++++ .|||||.++|+||++...+||+|||||
T Consensus 773 ~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGlA 849 (1025)
T KOG1095|consen 773 LLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGLA 849 (1025)
T ss_pred EehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccchh
Confidence 999999999999998642 2456899999999999999999999988 999999999999999999999999999
Q ss_pred eee
Q 006347 631 KIF 633 (649)
Q Consensus 631 ~~~ 633 (649)
|.+
T Consensus 850 rDi 852 (1025)
T KOG1095|consen 850 RDI 852 (1025)
T ss_pred Hhh
Confidence 944
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=230.73 Aligned_cols=147 Identities=27% Similarity=0.374 Sum_probs=131.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.++||+|+||.||++... +++.||||++.+.. ....+++.+|+.++.+++||||+++++++.+++..+|||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999875 68899999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~ 151 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGF 151 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeeccccccc
Confidence 99999999999853 356888889999999999999999987 999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.9e-24 Score=231.07 Aligned_cols=146 Identities=24% Similarity=0.347 Sum_probs=131.0
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.|...+.||+|+||+||+|+.. +++.+|||++.+.. ....+.+.+|+.++.+++|+||+++++++.+.+..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 5788899999999999999875 68899999996532 2345678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+++.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~ 151 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGF 151 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccc
Confidence 9999999999853 346888888999999999999999987 999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.91 E-value=4e-25 Score=222.92 Aligned_cols=149 Identities=32% Similarity=0.507 Sum_probs=122.2
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE-----EEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK-----MLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-----~lV 555 (649)
.|...+.+|.|+||.||+|++. ++++||||++-...+ .--+|+++|+++.|||||+|.-++....+. .||
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 3566689999999999999987 568999999854332 234789999999999999999988754432 489
Q ss_pred EecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla~~~ 633 (649)
|||||. +|.++++... .+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||-|+++
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999976 7888886421 2345677777789999999999999977 9999999999999976 89999999999998
Q ss_pred CCCCC
Q 006347 634 GGNQD 638 (649)
Q Consensus 634 ~~~~~ 638 (649)
...+.
T Consensus 177 ~~~ep 181 (364)
T KOG0658|consen 177 VKGEP 181 (364)
T ss_pred ccCCC
Confidence 65543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=219.57 Aligned_cols=149 Identities=29% Similarity=0.414 Sum_probs=131.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.|+..+.||+|+||.||++... +++.||||.+.... ......+.+|+.++.+++|+||+++++.+.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 3677889999999999999875 78999999986432 2334568899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05631 81 IMNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIP 153 (285)
T ss_pred ecCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcC
Confidence 99999999888542 2346899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.5e-24 Score=226.24 Aligned_cols=149 Identities=26% Similarity=0.395 Sum_probs=132.2
Q ss_pred cCcccceeeccCCcEEEEEEEecC--CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|.... +..||+|++.+.. ....+.+.+|+.++..++||||+++++++.+.+..++|
T Consensus 30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv 109 (340)
T PTZ00426 30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV 109 (340)
T ss_pred hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence 468888999999999999998653 3689999986432 23456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 110 ~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 110 LEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999953 346889999999999999999999987 99999999999999999999999999998643
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.6e-24 Score=225.18 Aligned_cols=149 Identities=27% Similarity=0.401 Sum_probs=133.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|+.++.+++||||+++++.+.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 46888899999999999999986 68899999986432 234567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~ 170 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPD 170 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCC
Confidence 99999999999853 346788888999999999999999987 99999999999999999999999999998743
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.3e-24 Score=218.64 Aligned_cols=165 Identities=27% Similarity=0.419 Sum_probs=140.4
Q ss_pred cCcccceeeccCCcEEEEEEEe-cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+.|++.++||.|..++||+|.. +.++.||||++.-.. .....++++|+..+..++||||++++..|+.+.+.|+||.|
T Consensus 26 ~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpf 105 (516)
T KOG0582|consen 26 KDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPF 105 (516)
T ss_pred cceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehh
Confidence 5688889999999999999985 468999999997543 33468999999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
|.+||+.++++..-. ..+++..+..|.+++++||.|||.++ .||||||+.||||+++|.+||+|||....+-....
T Consensus 106 Ma~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~ 181 (516)
T KOG0582|consen 106 MAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGD 181 (516)
T ss_pred hcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeecccCc
Confidence 999999999975433 34889999999999999999999998 99999999999999999999999997665532222
Q ss_pred c--cccCceeecC
Q 006347 639 Q--ADTGRVVGTL 649 (649)
Q Consensus 639 ~--~~~~~~~GT~ 649 (649)
+ ...+..+|||
T Consensus 182 R~~~rf~tfvgtp 194 (516)
T KOG0582|consen 182 RQVTRFNTFVGTP 194 (516)
T ss_pred eeeEeeccccCcc
Confidence 2 1224567764
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.9e-25 Score=235.89 Aligned_cols=161 Identities=33% Similarity=0.502 Sum_probs=138.4
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------eEEE
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------EKML 554 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 554 (649)
+...+.||+|+||.||+|+.+ +|+.||||..++.. ....+...+|++++++++|+|||++++.-.+.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445578999999999999965 79999999987643 345567789999999999999999999866544 5689
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCC--ceEEEecCCc
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EEL--NPKISDFGMA 630 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~--~~Ki~DFGla 630 (649)
|||||++|||...|.+......|++.+.+.+..+++.||.|||+++ |+||||||.||++- +++ .-||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988777788999999999999999999999988 99999999999984 333 4799999999
Q ss_pred eeeCCCCCccccCceeecC
Q 006347 631 KIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 631 ~~~~~~~~~~~~~~~~GT~ 649 (649)
|-+.+++ ...+++||+
T Consensus 172 rel~d~s---~~~S~vGT~ 187 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTE 187 (732)
T ss_pred ccCCCCC---eeeeecCch
Confidence 9986655 455789984
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.4e-24 Score=224.21 Aligned_cols=141 Identities=29% Similarity=0.346 Sum_probs=126.8
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.||+|+||.||++... +++.||||.+.+. ......++.+|+.++++++||||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999876 6899999999753 2334567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~ 145 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEG 145 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccC
Confidence 99988843 346899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.3e-24 Score=222.89 Aligned_cols=149 Identities=28% Similarity=0.385 Sum_probs=133.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 36788899999999999999976 68899999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~ 153 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRD 153 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccC
Confidence 99999999999853 346889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.5e-24 Score=222.98 Aligned_cols=140 Identities=27% Similarity=0.334 Sum_probs=126.1
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||+|+||.||++... +++.||+|.+.+. .......+..|+.++.+++||||+++++++.+.+..++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 799999999999976 5789999998643 234456788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~ 144 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNM 144 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCc
Confidence 999853 346899999999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=4.4e-24 Score=229.67 Aligned_cols=150 Identities=26% Similarity=0.338 Sum_probs=132.4
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
..++|++.+.||+|+||.||+++.. +++.+|||.+++. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 3457888999999999999999876 6889999998642 22344567899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++.. ..++......++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999999843 34778888889999999999999987 9999999999999999999999999998875
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 194 ~ 194 (370)
T cd05596 194 A 194 (370)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3e-24 Score=231.32 Aligned_cols=163 Identities=32% Similarity=0.468 Sum_probs=141.4
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (649)
...++|.....||+|.||+|+++.++ +++.+|||.+++.. ..+.+..+.|.+++... +||.|++|+.++...++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 34468999999999999999999987 67899999998753 45667788898888877 599999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+.||||..||++..+. +...+++.....+|..|+.||.|||+++ ||+||||.+|||||.+|++||+||||+|.
T Consensus 445 ~fvmey~~Ggdm~~~~----~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHHI----HTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEEE----ecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 9999999999954443 4467899999999999999999999998 99999999999999999999999999998
Q ss_pred eCCCCCccccCceeecC
Q 006347 633 FGGNQDQADTGRVVGTL 649 (649)
Q Consensus 633 ~~~~~~~~~~~~~~GT~ 649 (649)
-..... .|+++.|||
T Consensus 518 ~m~~g~--~TsTfCGTp 532 (694)
T KOG0694|consen 518 GMGQGD--RTSTFCGTP 532 (694)
T ss_pred cCCCCC--ccccccCCh
Confidence 654433 345689996
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.4e-24 Score=223.80 Aligned_cols=151 Identities=26% Similarity=0.359 Sum_probs=134.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||++... +++.+|||+++... ....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999876 68899999997532 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999999542 346899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.7e-24 Score=190.64 Aligned_cols=99 Identities=47% Similarity=0.957 Sum_probs=88.4
Q ss_pred eecCCCCCccccccccceeeeEEeeeEEe---------c--cCCeEEEEEEccCCcEEEEEEcCCCCCeEEEEEeeccCC
Q 006347 206 WRSGPWNGQIFIGIPELKSVYLFRHNFTF---------G--FANDWTFFALTAQGILEERIWIKWKDNWEVGFLNLRTEC 274 (649)
Q Consensus 206 w~sg~~~~~~~~~~~~~~~~~~~~~~~~~---------~--~~~~~~~~~l~~~G~l~~~~~~~~~~~W~~~~~~~~~~C 274 (649)
||+|+|||..|.++|++.....+.+.|+. . ..+.++|++||++|+++++.|++..+.|.+.|++|.++|
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~p~d~C 80 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSAPKDQC 80 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEecccCC
Confidence 89999999999999999855555555543 1 156789999999999999999999999999999999999
Q ss_pred ccccccCCcccccCCCCCcccCCCCCccCC
Q 006347 275 DVYGKCGAFGICNSQEKPICSCLEGFEPKN 304 (649)
Q Consensus 275 ~~~~~CG~~g~C~~~~~~~C~C~~gf~~~~ 304 (649)
|+|+.||+||+|+.+..|.|+||+||+|++
T Consensus 81 d~y~~CG~~g~C~~~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 81 DVYGFCGPNGICNSNNSPKCSCLPGFEPKN 110 (110)
T ss_pred CCccccCCccEeCCCCCCceECCCCcCCCc
Confidence 999999999999988889999999999984
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=9.3e-24 Score=234.69 Aligned_cols=164 Identities=19% Similarity=0.238 Sum_probs=138.3
Q ss_pred CcccceeeccCCcEEEEEEEec-C-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-D-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.|.+.+.||+|+||.||++... + ++.||+|.+..........+..|+.++++++|||||++++++.+++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 3888899999999999999865 3 6788999875544455567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 560 PNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 560 ~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
++|+|.++|.+.. ....+++.+...++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 9999999886432 2446889999999999999999999987 99999999999999999999999999998754433
Q ss_pred ccccCceeec
Q 006347 639 QADTGRVVGT 648 (649)
Q Consensus 639 ~~~~~~~~GT 648 (649)
........||
T Consensus 225 ~~~~~~~~gt 234 (478)
T PTZ00267 225 LDVASSFCGT 234 (478)
T ss_pred cccccccCCC
Confidence 2223334555
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=6.9e-24 Score=229.21 Aligned_cols=146 Identities=25% Similarity=0.365 Sum_probs=130.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.|+..++||+|+||+||+|... +++.+|||.+.+.. ....+.+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 5788899999999999999875 68899999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+++|+|.+++.+ ...+++.....++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~ 151 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccc
Confidence 9999999999853 345788888899999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.2e-24 Score=229.55 Aligned_cols=153 Identities=33% Similarity=0.469 Sum_probs=132.1
Q ss_pred hcCcccceeeccCCcEEEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
.++|++.+.||+|+||.||+|+. .++..||||+++... ....+.+.+|+.++..+ +||||++++++|.+++.
T Consensus 34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~ 113 (375)
T cd05104 34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP 113 (375)
T ss_pred hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence 45688889999999999999974 245689999986432 33456788999999999 89999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCC----------------------------------------------------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------- 573 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 573 (649)
.++||||+++|+|.+++.....
T Consensus 114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (375)
T cd05104 114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS 193 (375)
T ss_pred ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence 9999999999999999854210
Q ss_pred --------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 574 --------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 574 --------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
...+++..+..++.||++||+|||+.+ |+||||||+|||++++..+||+|||+++.+..
T Consensus 194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~ 266 (375)
T cd05104 194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRN 266 (375)
T ss_pred ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccC
Confidence 125789999999999999999999987 99999999999999999999999999987644
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.3e-24 Score=228.06 Aligned_cols=147 Identities=24% Similarity=0.361 Sum_probs=131.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+++.. +++.||||.+.+.. ....+.+.+|+.++.+++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVM 80 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEE
Confidence 36888999999999999999876 68899999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++.. ...++......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+
T Consensus 81 E~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~ 151 (376)
T cd05598 81 DYIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGF 151 (376)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccc
Confidence 99999999999954 345788888899999999999999987 999999999999999999999999998644
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.3e-23 Score=222.49 Aligned_cols=150 Identities=25% Similarity=0.326 Sum_probs=133.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||++... +++.||||.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 46888899999999999999976 6889999998642 2234566889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++.+ ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 81 e~~~g~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 154 (331)
T cd05597 81 DYYVGGDLLTLLSK--FEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLA 154 (331)
T ss_pred ecCCCCcHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCC
Confidence 99999999999853 2345889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=99.91 E-value=8.1e-24 Score=227.69 Aligned_cols=156 Identities=24% Similarity=0.324 Sum_probs=136.2
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
..++....++|++.+.||+|+||.||++... +++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++.+.+
T Consensus 35 ~~~~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~ 114 (371)
T cd05622 35 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 114 (371)
T ss_pred HhhcCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEc
Confidence 3344455678999999999999999999976 6789999998642 22344567899999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
++..++||||+++|+|.+++.. ..++...+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 115 ~~~~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG 187 (371)
T cd05622 115 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 187 (371)
T ss_pred CCEEEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCC
Confidence 9999999999999999999843 34788888899999999999999987 9999999999999999999999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+|+.+..
T Consensus 188 ~a~~~~~ 194 (371)
T cd05622 188 TCMKMNK 194 (371)
T ss_pred ceeEcCc
Confidence 9998754
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.2e-24 Score=223.79 Aligned_cols=141 Identities=28% Similarity=0.327 Sum_probs=126.4
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.||+|+||.||++... +|+.||+|.++... ......+.+|+.++.+++||||+++++.+.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999875 68999999986532 234567788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~ 145 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEG 145 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccc
Confidence 99988843 346899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.2e-23 Score=222.92 Aligned_cols=151 Identities=23% Similarity=0.297 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||+++.. +++.+|||.+.+. .....+.+.+|+.++..++|+||+++++++.+.+..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 46888999999999999999976 6788999998642 1233456888999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999999642 346889999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.8e-23 Score=220.87 Aligned_cols=141 Identities=28% Similarity=0.323 Sum_probs=125.6
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.||+|+||.||++... +++.||+|.+++.. .....++..|++++..++|+||+++++++.+.+..++||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 68999999997532 234567788999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~ 146 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEG 146 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeec
Confidence 99988843 3468999999999999999999997 55 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.7e-24 Score=220.95 Aligned_cols=156 Identities=32% Similarity=0.496 Sum_probs=133.6
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
.+.||.|.||+||-|+++ +|+.||||.|++. ..+++..+++|+.+|.+++||.||.|...|...+..++|||-+ +|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl-~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKL-HG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhh-cc
Confidence 378999999999999876 7999999999764 3456688999999999999999999999999999999999999 45
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEecCCceeeCCCCCc
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~DFGla~~~~~~~~~ 639 (649)
+..++|.. .++..|+......++.||+.||.|||.++ |+|+||||+||||.+. -.+||+|||+||+++..+.+
T Consensus 648 DMLEMILS-sEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR 723 (888)
T KOG4236|consen 648 DMLEMILS-SEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR 723 (888)
T ss_pred hHHHHHHH-hhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhhhh
Confidence 55455433 35667889888999999999999999998 9999999999999754 36999999999999765543
Q ss_pred cccCceeecC
Q 006347 640 ADTGRVVGTL 649 (649)
Q Consensus 640 ~~~~~~~GT~ 649 (649)
.+++|||
T Consensus 724 ---rsVVGTP 730 (888)
T KOG4236|consen 724 ---RSVVGTP 730 (888)
T ss_pred ---hhhcCCc
Confidence 3478886
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-23 Score=224.70 Aligned_cols=150 Identities=29% Similarity=0.431 Sum_probs=135.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||+||++... +++.||||++++.. ....+.+..|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999977 68999999986532 245567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999999542 56899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.8e-23 Score=226.71 Aligned_cols=153 Identities=30% Similarity=0.443 Sum_probs=131.7
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~ 551 (649)
.++|.+.+.||+|+||.||+|+.. .+..||||+++... ....+.|.+|+.++.++. ||||++++++|.+.+.
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 467888899999999999999863 23479999996543 234567999999999995 9999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCC----------------------------------------------------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------- 573 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 573 (649)
.+|||||+++|+|.++|.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999998854210
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006347 574 -----------------------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 574 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~ 618 (649)
...+++.++..++.|+++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999987 999999999999999
Q ss_pred CCceEEEecCCceeeCC
Q 006347 619 ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~~ 635 (649)
++.+||+|||+++.+..
T Consensus 273 ~~~~kL~DfGla~~~~~ 289 (400)
T cd05105 273 GKIVKICDFGLARDIMH 289 (400)
T ss_pred CCEEEEEeCCcceeccc
Confidence 99999999999997643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.7e-23 Score=215.66 Aligned_cols=148 Identities=28% Similarity=0.440 Sum_probs=130.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|.+.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 46888899999999999999876 68899999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ ++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 85 ~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~ 154 (288)
T cd07871 85 LD-SDLKQYLDN--CGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKS 154 (288)
T ss_pred CC-cCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeecc
Confidence 97 489888853 2345788999999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.9e-23 Score=220.06 Aligned_cols=149 Identities=23% Similarity=0.298 Sum_probs=131.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.++||+|+||.||+++.. +++.+|+|.+.+. .....+.+..|+.++..++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 46888899999999999999977 5788999998642 1223456889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++|+|.+++.+. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~ 153 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLM 153 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecc
Confidence 999999999999642 345889999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=226.59 Aligned_cols=153 Identities=32% Similarity=0.494 Sum_probs=131.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
.++|++.+.||+|+||.||++... ++..||||++.... ....+.+.+|+.+++.+ +|+|||+++++|.+...
T Consensus 37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~ 116 (374)
T cd05106 37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGP 116 (374)
T ss_pred HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCC
Confidence 356888899999999999998742 34579999996543 23356788999999999 89999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCC-----------------------------------------------------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPL----------------------------------------------------------- 572 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~----------------------------------------------------------- 572 (649)
.++||||+++|+|.++++...
T Consensus 117 ~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (374)
T cd05106 117 VLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196 (374)
T ss_pred eEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccccc
Confidence 999999999999999985321
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 573 --------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 573 --------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
....+++.+..+|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 197 ~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~ 264 (374)
T cd05106 197 SKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMN 264 (374)
T ss_pred ccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccC
Confidence 1124788999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=233.87 Aligned_cols=149 Identities=32% Similarity=0.558 Sum_probs=131.7
Q ss_pred ceeeccCCcEEEEEEEec-CC----cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 486 SSKLGQGGFGPVYWGRLK-DG----QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g----~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++||+|+||+||||.+- +| -+||||.+... ..+.-++++.|+.+|.++.|+||+||+|+|.... ..||++||
T Consensus 701 ~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~m 779 (1177)
T KOG1025|consen 701 DKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLM 779 (1177)
T ss_pred hceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhc
Confidence 468999999999999753 44 37899988654 3456789999999999999999999999999776 88999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCc
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 639 (649)
|.|.|.+|++. .+..+..+..+.|..|||+||.|||++. ++||||.++|+|+.+...+||.|||+|+++..+..+
T Consensus 780 P~G~LlDyvr~--hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e 854 (1177)
T KOG1025|consen 780 PLGCLLDYVRE--HRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE 854 (1177)
T ss_pred ccchHHHHHHH--hhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccccc
Confidence 99999999975 4566888999999999999999999887 999999999999999999999999999999776554
Q ss_pred c
Q 006347 640 A 640 (649)
Q Consensus 640 ~ 640 (649)
.
T Consensus 855 y 855 (1177)
T KOG1025|consen 855 Y 855 (1177)
T ss_pred c
Confidence 3
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.7e-24 Score=228.37 Aligned_cols=162 Identities=31% Similarity=0.512 Sum_probs=142.9
Q ss_pred HHHHHHhcCcccceeeccCCcEEEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 474 EELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 474 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
++.+....+..+..+||-|.+|.||.|.++. .-.||||.++.. .-..++|+.|+.+|+.++|||+|+|+|+|......
T Consensus 260 DkWEmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPF 338 (1157)
T KOG4278|consen 260 DKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPF 338 (1157)
T ss_pred chhhccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCe
Confidence 4445555567777899999999999999873 568999999653 45679999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
|||+|||.+|+|.+||++- .+..++.-.++.+|.||+.||.||..+. +|||||.++|+|+.++..+||+||||+|+
T Consensus 339 YIiTEfM~yGNLLdYLRec-nr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRl 414 (1157)
T KOG4278|consen 339 YIITEFMCYGNLLDYLREC-NRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRL 414 (1157)
T ss_pred EEEEecccCccHHHHHHHh-chhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhh
Confidence 9999999999999999763 3455777888999999999999999887 99999999999999999999999999999
Q ss_pred eCCCCCcc
Q 006347 633 FGGNQDQA 640 (649)
Q Consensus 633 ~~~~~~~~ 640 (649)
+.++...+
T Consensus 415 MtgDTYTA 422 (1157)
T KOG4278|consen 415 MTGDTYTA 422 (1157)
T ss_pred hcCCceec
Confidence 98776543
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.1e-23 Score=219.04 Aligned_cols=144 Identities=31% Similarity=0.465 Sum_probs=125.6
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHH---hcCCCCCccceEEEEEeCCeEEEE
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVI---SKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l---~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
|++.+.||+|+||.||++... +++.||||.+++.. ....+.+..|+.++ .+++||||+++++++.+++..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 567789999999999999876 68999999996532 23345667776655 566899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||+++++|..++. ...+++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEG 151 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccC
Confidence 99999999988874 346899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.4e-23 Score=213.27 Aligned_cols=148 Identities=28% Similarity=0.496 Sum_probs=131.2
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|.+. .+..||+|.++... ....+.|.+|+.++.+++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999864 35689999987543 23346789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||+++|+|.+++... ...+++..++.++.|++.||+|||+.+ ++||||||+|||++.++.+|++|||++...
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 9999999999999642 346899999999999999999999987 999999999999999999999999987754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.2e-23 Score=218.84 Aligned_cols=141 Identities=32% Similarity=0.404 Sum_probs=124.9
Q ss_pred eeeccCCcEEEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+.||+|+||.||++... .++.||||.+++.. ......+.+|+.++++++||||+++++++.+++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 68999999999999853 57899999986532 23345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++++|.+++.. ...+.+.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 150 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKES 150 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeec
Confidence 999999999843 345788888899999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.5e-23 Score=219.26 Aligned_cols=148 Identities=30% Similarity=0.391 Sum_probs=130.0
Q ss_pred CcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (649)
+|++.+.||+|+||.||+++.. +++.||+|.+.+.. ....+.+..|+.++.++ +|+||+++++++.+.+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998753 57899999986432 23345688999999999 599999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999999853 346889999999999999999999987 99999999999999999999999999987
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 155 ~~~ 157 (332)
T cd05614 155 FLS 157 (332)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-23 Score=218.86 Aligned_cols=149 Identities=32% Similarity=0.583 Sum_probs=129.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.+|++.+.||+|+||.||+|+.. +++ .||||.++... ....+++.+|+.+++.++|+||++++|+|... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 45888899999999999999864 333 48999986543 34567899999999999999999999999865 5679
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+||+++|+|.+++... ...+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999999642 345889999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 161 ~ 161 (316)
T cd05108 161 A 161 (316)
T ss_pred C
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-24 Score=227.35 Aligned_cols=147 Identities=33% Similarity=0.482 Sum_probs=133.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
+-|++.+.||.|+-|.|-.|++. +|+.+|||.+.+.. ......+.+|+.+|+.|.|||+++|+.++.+..++|||+
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 34788899999999999999876 79999999997642 233466789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|.|.++|. +++++.+.+..+++.||..|+.|+|..+ |+||||||+|+|||..+++||+|||||.+-
T Consensus 92 Eyv~gGELFdylv---~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe 162 (786)
T KOG0588|consen 92 EYVPGGELFDYLV---RKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLE 162 (786)
T ss_pred EecCCchhHHHHH---hhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeecc
Confidence 9999999999994 5678999999999999999999999887 999999999999999999999999999974
|
|
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=215.44 Aligned_cols=149 Identities=28% Similarity=0.440 Sum_probs=130.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|.+.++||+|+||.||+|... +++.||||.+..... .....+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 367888999999999999999986 688999999865432 234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|++ ++|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 154 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKS 154 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceecc
Confidence 995 678777753 2345888999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=218.06 Aligned_cols=146 Identities=30% Similarity=0.404 Sum_probs=128.2
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCC-CCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~ 556 (649)
+|++.+.||+|+||.||+|... +++.||||.+.+. .....+.+..|++++..+.| ++|+++++++.+.+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4778899999999999999876 5789999998753 23455678899999999965 56889999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~ 151 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKEN 151 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceec
Confidence 99999999999853 345889999999999999999999987 999999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.3e-23 Score=222.12 Aligned_cols=148 Identities=26% Similarity=0.391 Sum_probs=132.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|+..+.||+|+||.||++... +++.||||.+.... ....+.+..|+.++.+++|+||+++++.+.+.+..+|||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888899999999999999876 68899999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~ 152 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLK 152 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccc
Confidence 99999999999853 356889999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=218.59 Aligned_cols=141 Identities=30% Similarity=0.387 Sum_probs=125.0
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||++... +++.+|+|.+++. .....+.+..|+.++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 47999999999999976 6789999999753 223445678899888877 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~ 146 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 146 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccc
Confidence 999988843 356899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=217.97 Aligned_cols=146 Identities=31% Similarity=0.409 Sum_probs=128.1
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 556 (649)
+|.+.+.||+|+||.||+|... +++.||||.+.+.. ....+.+..|..++..+ +|++|+++++++.+.+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4778899999999999999876 57899999987532 23345677788888877 6899999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~ 151 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 151 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceec
Confidence 99999999988843 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.7e-23 Score=217.82 Aligned_cols=143 Identities=31% Similarity=0.337 Sum_probs=126.8
Q ss_pred eeeccCCcEEEEEEEe----cCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 487 SKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
+.||+|+||.||++.. .+|+.+|||++.+.. ......+..|++++.+++|+||+++++++.+++..++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5899999999999875 357899999997532 2244567889999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~ 150 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESID 150 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCC
Confidence 9999999843 356899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.1e-23 Score=217.78 Aligned_cols=141 Identities=30% Similarity=0.442 Sum_probs=125.0
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+|+.. +++.||||.+.+.. ....+.+..|.+++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 36999999999999876 57899999987532 33456678899998876 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~ 146 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEG 146 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceec
Confidence 999988853 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.9e-23 Score=217.05 Aligned_cols=150 Identities=27% Similarity=0.351 Sum_probs=133.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|++++.+++|+||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 367888999999999999999976 68899999886542 2345679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+++++|.+++.. ...+++..+..++.|++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 155 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccc
Confidence 9999999999853 345889999999999999999999853 39999999999999999999999999998764
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-23 Score=217.67 Aligned_cols=146 Identities=32% Similarity=0.426 Sum_probs=128.0
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~ 556 (649)
+|...+.||+|+||+||++... +++.||||.+.+.. ....+.+..|..++..+. |++|+++++++.+.+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999876 68899999987532 234567888999998885 678889999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~ 151 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEH 151 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEecccccccc
Confidence 99999999999843 356899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.1e-23 Score=233.73 Aligned_cols=152 Identities=28% Similarity=0.444 Sum_probs=134.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEecCC-cEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEE-EEe------C
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGC-CVE------G 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~~g-~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~-~~~------~ 549 (649)
...+.++.+.|.+|||+.||.+....+ .++|+|++-..++...+..++||++|++|. |+|||.+++. ... .
T Consensus 35 g~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~ 114 (738)
T KOG1989|consen 35 GSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGV 114 (738)
T ss_pred CCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCce
Confidence 334567778999999999999998865 999999987778888999999999999996 9999999993 322 1
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
-+.+|.||||++|+|-+++..+.+.. |++.++++|+.++++|+++||.. ++||||||||.|||||..+++.||||||-
T Consensus 115 ~EvllLmEyC~gg~Lvd~mn~Rlq~~-lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCDFGS 192 (738)
T KOG1989|consen 115 WEVLLLMEYCKGGSLVDFMNTRLQTR-LTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCDFGS 192 (738)
T ss_pred eEEEeehhhccCCcHHHHHHHHHhcc-CChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCcccc
Confidence 26789999999999999997665554 99999999999999999999986 58999999999999999999999999998
Q ss_pred cee
Q 006347 630 AKI 632 (649)
Q Consensus 630 a~~ 632 (649)
|.-
T Consensus 193 att 195 (738)
T KOG1989|consen 193 ATT 195 (738)
T ss_pred ccc
Confidence 864
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.2e-23 Score=212.96 Aligned_cols=149 Identities=24% Similarity=0.417 Sum_probs=131.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||+++.. +++.+|||++.... ....+.+.+|+.++.+++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 46888999999999999999986 67899999986532 2345678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|++++.|..+.. ....+++..+..++.|++.||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~ 152 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSE 152 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccc
Confidence 999887765542 2346889999999999999999999887 99999999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=3.6e-23 Score=221.17 Aligned_cols=143 Identities=27% Similarity=0.436 Sum_probs=125.4
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
|...++||+|+||.||+++.. +++.||||.+..... ...+.+.+|++++++++|+||+++++++.+.+..++||||++
T Consensus 76 ~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 155 (353)
T PLN00034 76 LERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMD 155 (353)
T ss_pred HhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCC
Confidence 445679999999999999876 689999999865332 345678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+.. ..++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 156 ~~~L~~~~-------~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~ 220 (353)
T PLN00034 156 GGSLEGTH-------IADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220 (353)
T ss_pred CCcccccc-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccc
Confidence 99985432 3456778889999999999999987 99999999999999999999999999998743
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=216.82 Aligned_cols=141 Identities=30% Similarity=0.383 Sum_probs=122.4
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||+||++... +++.||||.+.+.. ....+++..|.. ++..++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 37999999999999986 68999999986532 223345556655 56788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|.+++.. ...+++.....++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~ 146 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCccc
Confidence 999999853 456889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=216.15 Aligned_cols=142 Identities=33% Similarity=0.426 Sum_probs=123.3
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+|... +++.||||.++... ....+.+..|..++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999976 57899999986532 23445666777777654 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+|.+++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~ 147 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENM 147 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECC
Confidence 999998853 346889999999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.4e-23 Score=217.68 Aligned_cols=140 Identities=28% Similarity=0.374 Sum_probs=125.3
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||++... +++.||||.+++.. ....+.+..|..++.++ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 36999999999999876 68899999997532 23456688999999998 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++.
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~ 145 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKE 145 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccc
Confidence 999988843 356899999999999999999999987 99999999999999999999999999985
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.6e-25 Score=214.67 Aligned_cols=159 Identities=26% Similarity=0.494 Sum_probs=142.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
-|.+.++||+|++|.|||+.++ .|+.+|||++.- +.+.+++.+|+.++++...+.+|+++|.+......+||||||-
T Consensus 34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV--~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCG 111 (502)
T KOG0574|consen 34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPV--DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCG 111 (502)
T ss_pred HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCc--cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcC
Confidence 3777899999999999999877 699999999854 4678999999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCcc
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 640 (649)
.|+..++++- ++++|++.++..++...++||+|||.-. -||||||+.||||+-++.+|++|||.|..+...-.+.
T Consensus 112 AGSiSDI~R~--R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKR 186 (502)
T KOG0574|consen 112 AGSISDIMRA--RRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKR 186 (502)
T ss_pred CCcHHHHHHH--hcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHhh
Confidence 9999999964 5678999999999999999999999865 8999999999999999999999999999885433333
Q ss_pred ccCceeecC
Q 006347 641 DTGRVVGTL 649 (649)
Q Consensus 641 ~~~~~~GT~ 649 (649)
+++.|||
T Consensus 187 --NTVIGTP 193 (502)
T KOG0574|consen 187 --NTVIGTP 193 (502)
T ss_pred --CccccCc
Confidence 4488886
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6e-23 Score=212.12 Aligned_cols=144 Identities=31% Similarity=0.417 Sum_probs=126.8
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||+|+||+||++... +++.+|||.+.... ....+.+..|+.++++++|+||+++.+++.++...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 699999999999876 68899999986432 22346778999999999999999999999999999999999999999
Q ss_pred hhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 565 DALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 565 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
..++.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~ 149 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKD 149 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCC
Confidence 98875422 3456899999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.2e-23 Score=216.80 Aligned_cols=141 Identities=29% Similarity=0.368 Sum_probs=122.6
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||+||+++.. +|+.+|||++.+.. ....+++..|.. +++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999875 68999999986532 233455666665 46778999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|..++.. ...+++.....++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~ 146 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccC
Confidence 999988843 456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.9e-23 Score=216.53 Aligned_cols=141 Identities=34% Similarity=0.476 Sum_probs=125.2
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+++.. +++.||||.+.+. .....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 37999999999999976 6889999998653 233456778898888877 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~ 146 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 146 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeec
Confidence 999998853 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.90 E-value=5.8e-23 Score=212.25 Aligned_cols=151 Identities=32% Similarity=0.536 Sum_probs=131.1
Q ss_pred cCcccceeeccCCcEEEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.+|++.+.||+|+||.||+|.. ..+..+|+|.+.... .+...+|.+|+.++++++|+||+++++++..++..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 3567779999999999999985 246789999996432 3345788999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC--------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006347 555 IYEYMPNRSLDALLFDPL--------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~--------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 620 (649)
||||+++++|.+++.... ....+++...+.++.|++.||.|||+.+ |+||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 999999999999985321 1235789999999999999999999987 99999999999999999
Q ss_pred ceEEEecCCceeeC
Q 006347 621 NPKISDFGMAKIFG 634 (649)
Q Consensus 621 ~~Ki~DFGla~~~~ 634 (649)
.+||+|||+++.+.
T Consensus 162 ~~kl~dfg~~~~~~ 175 (283)
T cd05090 162 HVKISDLGLSREIY 175 (283)
T ss_pred cEEecccccccccc
Confidence 99999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.6e-23 Score=216.14 Aligned_cols=141 Identities=30% Similarity=0.369 Sum_probs=121.7
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+++.. +++.+|+|.+.+.. ....+++..|.. +++.++|+||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 37999999999999986 68899999986432 223345556654 57888999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++|..++.. ...++......++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~ 146 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEG 146 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccC
Confidence 999888843 355788888899999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.8e-23 Score=211.81 Aligned_cols=149 Identities=30% Similarity=0.420 Sum_probs=131.6
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
+|+..+.||+|+||+||++... +++.||||.+.... ......+.+|+.++++++|+||+++++.+.+++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4777899999999999999875 68899999986432 2234567889999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIP 153 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecC
Confidence 99999999888642 3346899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=207.96 Aligned_cols=150 Identities=31% Similarity=0.505 Sum_probs=135.5
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|++.+.||+|++|.||+|...+++.||||.++.. ....+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPG-TMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCC-cccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 4568888999999999999999887889999998653 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++.... ...+++..+..++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~ 154 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIK 154 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEcc
Confidence 9999999996532 346899999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.7e-23 Score=221.43 Aligned_cols=140 Identities=22% Similarity=0.314 Sum_probs=125.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.++||+|+||.||++... +++.||||... .+.+.+|+.++++++|||||++++++......++|+|++
T Consensus 92 ~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~ 165 (391)
T PHA03212 92 AGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY 165 (391)
T ss_pred CCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC
Confidence 56899999999999999999875 68899999653 245788999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
. ++|..++.. ...+++.+++.|+.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 166 ~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~ 232 (391)
T PHA03212 166 K-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFP 232 (391)
T ss_pred C-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccc
Confidence 5 788888743 346889999999999999999999987 999999999999999999999999999864
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.8e-23 Score=219.35 Aligned_cols=161 Identities=31% Similarity=0.470 Sum_probs=140.3
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc---cHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 553 (649)
....|.+.++||+|.||.||+++.+ +|+.+|+|.+.+.... ....+.+|+.+|+++. |||||.+.+.+.+.+..+
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 3456888899999999999999987 5999999999765433 3468999999999998 999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CceEEEecCC
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKISDFGM 629 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~Ki~DFGl 629 (649)
+|||++.+|.|.+.+... .+++.+...++.||+.++.|||+.+ |+||||||+|+|+... +.+|++|||+
T Consensus 113 lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 113 LVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 999999999999998653 3899999999999999999999987 9999999999999643 4799999999
Q ss_pred ceeeCCCCCccccCceeecC
Q 006347 630 AKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 630 a~~~~~~~~~~~~~~~~GT~ 649 (649)
|+.... . .....++|||
T Consensus 186 a~~~~~-~--~~~~~~~Gtp 202 (382)
T KOG0032|consen 186 AKFIKP-G--ERLHTIVGTP 202 (382)
T ss_pred ceEccC-C--ceEeeecCCc
Confidence 999876 2 2344578875
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=210.04 Aligned_cols=145 Identities=43% Similarity=0.702 Sum_probs=127.0
Q ss_pred cceeeccCCcEEEEEEEec-----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 485 LSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+.+.||+|.||.||+|.+. .+..|+||.++.. .....++|.+|++.+.+++||||++++|+|.+.+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 4579999999999999987 3568999999653 233578999999999999999999999999988889999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++|+|.++|... ....+++..+..|+.||++||+|||+.+ ++|+||+++|||+++++.+||+|||+++..
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~ 153 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPI 153 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEET
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999999753 2456899999999999999999999987 999999999999999999999999999987
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.3e-23 Score=208.18 Aligned_cols=148 Identities=31% Similarity=0.538 Sum_probs=132.7
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||.||++...++..+|+|.+... ....++|.+|+.++++++||||+++++++.+.+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 357778899999999999999988889999988643 3345789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~ 151 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVL 151 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccC
Confidence 99999998642 235899999999999999999999987 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-24 Score=223.05 Aligned_cols=163 Identities=28% Similarity=0.459 Sum_probs=142.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe-EEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-KMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-~~lV~ 556 (649)
++|...+.+|+|+||.++..+.+ +...+++|.+.-. .....+...+|+.++++++|||||.+.+.+++++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 46777899999999999988876 5778999988643 34455678999999999999999999999999888 89999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||++||+|.+.|.+. +...+++..+..++.|++.|+.|||++. |+|||||+.||++..+..+||.|||+||+++.+
T Consensus 84 ~Y~eGg~l~~~i~~~-k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQ-KGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHH-hhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 999999999999763 3466889999999999999999999877 999999999999999999999999999999776
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
...+ .+++|||
T Consensus 160 ~~~a--~tvvGTp 170 (426)
T KOG0589|consen 160 DSLA--STVVGTP 170 (426)
T ss_pred hhhh--heecCCC
Confidence 5333 3489986
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=4.6e-23 Score=229.63 Aligned_cols=171 Identities=20% Similarity=0.274 Sum_probs=139.5
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE- 550 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~- 550 (649)
+.....++|.+.+.||+|+||+||++... +++.||||.+... .......+.+|+.++..++|+|+++++..+...+
T Consensus 26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~ 105 (496)
T PTZ00283 26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDP 105 (496)
T ss_pred cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccc
Confidence 33445578999999999999999999865 7899999998643 2345567889999999999999999988776433
Q ss_pred -------eEEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 551 -------EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 551 -------~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
..++||||+++|+|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 106 ~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~v 182 (496)
T PTZ00283 106 RNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLV 182 (496)
T ss_pred cCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCE
Confidence 3579999999999999986532 2356889999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeeCCCCCccccCceeec
Q 006347 623 KISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 623 Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
||+|||+++.+.............||
T Consensus 183 kL~DFGls~~~~~~~~~~~~~~~~Gt 208 (496)
T PTZ00283 183 KLGDFGFSKMYAATVSDDVGRTFCGT 208 (496)
T ss_pred EEEecccCeeccccccccccccccCC
Confidence 99999999987543332222334454
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.2e-23 Score=216.30 Aligned_cols=150 Identities=27% Similarity=0.355 Sum_probs=132.6
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||+|+||.||++... ++..+|+|.+.... ......+.+|++++.+++|+||+++++++.++++.++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 367888999999999999999987 68889999886532 2344678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+++++|.+++.. ...+++.....++.+++.||.|||+.+ +|+||||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 9999999999853 345888999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.89 E-value=7.1e-23 Score=217.09 Aligned_cols=146 Identities=23% Similarity=0.452 Sum_probs=126.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM 553 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 553 (649)
+|++.+.||+|+||.||+|... +++.||||++... ......++.+|+.++++++||||+++++++...+ ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4778899999999999999976 6899999998643 2234567889999999999999999999986543 479
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||++ ++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999995 689888843 346899999999999999999999987 999999999999999999999999999875
Q ss_pred C
Q 006347 634 G 634 (649)
Q Consensus 634 ~ 634 (649)
.
T Consensus 154 ~ 154 (338)
T cd07859 154 F 154 (338)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.5e-23 Score=211.14 Aligned_cols=157 Identities=18% Similarity=0.330 Sum_probs=131.5
Q ss_pred CCCCCCHHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccccccc---HHHHHHHHHHHhcCCCCCccceE
Q 006347 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRNLVRLL 543 (649)
Q Consensus 467 ~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~---~~~f~~E~~~l~~l~H~niv~l~ 543 (649)
++...+.+++. ......|++|++|.||+|.+. |+.||||+++...... .+.|.+|+.++.+++|||||+++
T Consensus 11 ~~~~i~~~~i~-----~~~~~~i~~g~~~~v~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~ 84 (283)
T PHA02988 11 DIKCIESDDID-----KYTSVLIKENDQNSIYKGIFN-NKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY 84 (283)
T ss_pred cceecCHHHcC-----CCCCeEEeeCCceEEEEEEEC-CEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEe
Confidence 34445555552 222357999999999999984 8999999997643322 46788999999999999999999
Q ss_pred EEEEe----CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcC
Q 006347 544 GCCVE----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 544 g~~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~ 618 (649)
|++.+ ....++||||+++|+|.+++.. ...+++....+++.+++.||.|||+. + ++||||||+|||+++
T Consensus 85 g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~ 158 (283)
T PHA02988 85 GFIIDIVDDLPRLSLILEYCTRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTE 158 (283)
T ss_pred eeEEecccCCCceEEEEEeCCCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECC
Confidence 99987 3467899999999999999954 35689999999999999999999984 4 789999999999999
Q ss_pred CCceEEEecCCceeeCC
Q 006347 619 ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~~ 635 (649)
++.+||+|||+++.+..
T Consensus 159 ~~~~kl~dfg~~~~~~~ 175 (283)
T PHA02988 159 NYKLKIICHGLEKILSS 175 (283)
T ss_pred CCcEEEcccchHhhhcc
Confidence 99999999999997643
|
|
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=210.35 Aligned_cols=150 Identities=35% Similarity=0.632 Sum_probs=132.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-----CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 553 (649)
++|++.+.||+|+||.||++... ++..||||++........+.|.+|++++.+++|+||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46778899999999999999753 5789999999766666678899999999999999999999987643 4678
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++++|.+++.+. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998542 345899999999999999999999987 999999999999999999999999999976
Q ss_pred CC
Q 006347 634 GG 635 (649)
Q Consensus 634 ~~ 635 (649)
..
T Consensus 159 ~~ 160 (284)
T cd05081 159 PQ 160 (284)
T ss_pred cC
Confidence 43
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.3e-23 Score=208.28 Aligned_cols=150 Identities=34% Similarity=0.578 Sum_probs=135.0
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.++||+|+||.||+|...++..||+|.+... ....+.+.+|+.++++++|+||+++++.+.+++..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 84 (261)
T cd05072 6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPG-TMSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMA 84 (261)
T ss_pred HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCC-chhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCC
Confidence 568888999999999999999888889999998653 3346789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+..
T Consensus 85 ~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 155 (261)
T cd05072 85 KGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIED 155 (261)
T ss_pred CCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCC
Confidence 99999998643 2345889999999999999999999987 99999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.3e-23 Score=209.92 Aligned_cols=149 Identities=28% Similarity=0.510 Sum_probs=130.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCCccceEEEEEe-----CCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-----GEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-----~~~~ 552 (649)
..|...+.||+|++|.|.++... +|+.||||++.. ......++..+|+.+++.++|+||+.+...+.. -+..
T Consensus 22 ~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv 101 (359)
T KOG0660|consen 22 RYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV 101 (359)
T ss_pred ceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence 44555689999999999999876 789999999973 344567889999999999999999999998875 3467
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
|+|+|+| .-+|...++. +..|+......++.|+++||.|+|+.+ |+||||||+|+|++.+...||+||||||.
T Consensus 102 YiV~elM-etDL~~iik~---~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~ 174 (359)
T KOG0660|consen 102 YLVFELM-ETDLHQIIKS---QQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARY 174 (359)
T ss_pred EEehhHH-hhHHHHHHHc---CccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceee
Confidence 9999999 6689999843 345888899999999999999999998 99999999999999999999999999999
Q ss_pred eCCC
Q 006347 633 FGGN 636 (649)
Q Consensus 633 ~~~~ 636 (649)
....
T Consensus 175 ~~~~ 178 (359)
T KOG0660|consen 175 LDKF 178 (359)
T ss_pred cccc
Confidence 8643
|
|
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=222.97 Aligned_cols=154 Identities=30% Similarity=0.462 Sum_probs=131.6
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCC-CCCccceEEEEEeC
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG 549 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 549 (649)
...++|.+.++||+|+||.||+|++. .+..||||+++.... ...+.+.+|+.++.++. |+|||+++++|.+.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~ 113 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKG 113 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccC
Confidence 34456777899999999999999864 346899999975432 23457899999999997 99999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCC---------------------------------------------------------
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPL--------------------------------------------------------- 572 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~--------------------------------------------------------- 572 (649)
...++||||+++|+|.++++...
T Consensus 114 ~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (401)
T cd05107 114 GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQ 193 (401)
T ss_pred CCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchh
Confidence 99999999999999999986421
Q ss_pred --------------------------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 006347 573 --------------------------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614 (649)
Q Consensus 573 --------------------------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI 614 (649)
....+++.....++.|++.||+|||+.+ |+||||||+||
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~Ni 270 (401)
T cd05107 194 DMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNV 270 (401)
T ss_pred cchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceE
Confidence 1124678888999999999999999876 99999999999
Q ss_pred EEcCCCceEEEecCCceeeC
Q 006347 615 LLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 615 Ll~~~~~~Ki~DFGla~~~~ 634 (649)
|+++++.+||+|||+++.+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~ 290 (401)
T cd05107 271 LICEGKLVKICDFGLARDIM 290 (401)
T ss_pred EEeCCCEEEEEecCcceecc
Confidence 99999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.1e-22 Score=215.26 Aligned_cols=141 Identities=28% Similarity=0.371 Sum_probs=125.6
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||++... +++.+|||++++.. ....+.+..|+.++.++ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 37999999999999876 57899999997532 23456788999999888 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~ 146 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEG 146 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceec
Confidence 999988843 356899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=233.46 Aligned_cols=150 Identities=25% Similarity=0.406 Sum_probs=132.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.++||+|+||.||+|... +++.||||++.... ....++|.+|++++++++||||+++++++.+++..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 57888999999999999999876 58999999986532 223467999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 557 EYMPNRSLDALLFDPL--------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 9999999999985311 1234677888999999999999999987 9999999999999999999999999
Q ss_pred Cceee
Q 006347 629 MAKIF 633 (649)
Q Consensus 629 la~~~ 633 (649)
+|+..
T Consensus 159 LAk~i 163 (932)
T PRK13184 159 AAIFK 163 (932)
T ss_pred cceec
Confidence 99987
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=213.39 Aligned_cols=141 Identities=34% Similarity=0.444 Sum_probs=123.9
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+|... +++.||||.++... ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 37999999999999976 57899999987532 23445677788888765 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|.+++.. ...+++.+...++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceEC
Confidence 999999853 346889999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=223.03 Aligned_cols=145 Identities=23% Similarity=0.306 Sum_probs=128.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
...|.+.+.||+|+||.||++... .++.||||... ...+.+|++++++++|+|||++++++..++..++|||+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~ 241 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPK 241 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEc
Confidence 457889999999999999999987 57889999642 23467899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+ .++|.+++... ...++|..++.|+.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 242 ~-~~~L~~~l~~~--~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 242 Y-RSDLYTYLGAR--LRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 9 47888887542 346899999999999999999999987 999999999999999999999999999987543
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.7e-22 Score=206.68 Aligned_cols=148 Identities=28% Similarity=0.471 Sum_probs=133.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.++||+|+||.||+|+.. +++.+|+|++..........+.+|+.++.+++|+||+++++.+..++..++||||+
T Consensus 9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~ 88 (267)
T cd06646 9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYC 88 (267)
T ss_pred hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCC
Confidence 46888899999999999999974 68899999987554455667889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06646 89 GGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeec
Confidence 99999999853 346889999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=211.85 Aligned_cols=148 Identities=28% Similarity=0.464 Sum_probs=129.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|.+.++||+|+||.||+|+.. +++.||||.++... ......+.+|+.++++++|+||+++++++.+++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 46888899999999999999876 67889999986443 23345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++ +|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~ 155 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecC
Confidence 975 888887542 345788999999999999999999987 9999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=208.72 Aligned_cols=144 Identities=28% Similarity=0.444 Sum_probs=123.5
Q ss_pred eeeccCCcEEEEEEEecC---CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
++||+|+||.||+|.... ...+|+|.+.... .....+|.+|+.+++.++|+||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLG 80 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCC
Confidence 369999999999997653 3568888875432 234567889999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~ 150 (269)
T cd05042 81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQ 150 (269)
T ss_pred cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEecccccccc
Confidence 99999965322 233567888899999999999999987 999999999999999999999999999764
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.2e-22 Score=213.68 Aligned_cols=141 Identities=34% Similarity=0.450 Sum_probs=124.0
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+++.. +++.||||.+++.. ....+.+..|..++... +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999986 68899999987532 23456677788888765 899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|.+++.. ...+++.....++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~ 146 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKEN 146 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeec
Confidence 999998843 346889999999999999999999987 999999999999999999999999999853
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=207.28 Aligned_cols=149 Identities=33% Similarity=0.580 Sum_probs=132.7
Q ss_pred cCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|.... ...||||.++... .....+|.+|+.++.+++|+||+++++++.+.+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998752 4579999986543 33456899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.+.
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~ 157 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLE 157 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccc
Confidence 9999999999998542 346899999999999999999999987 9999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.5e-22 Score=206.23 Aligned_cols=148 Identities=30% Similarity=0.564 Sum_probs=132.6
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+|++.+.||+|+||+||++...++..+|||.+... .....+|.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05113 5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSN 83 (256)
T ss_pred HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCC-cccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCC
Confidence 47778899999999999999887778999998643 33457899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++|.+++... ...+++..++.++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 84 ~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~ 152 (256)
T cd05113 84 GCLLNYLREH--GKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD 152 (256)
T ss_pred CcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCC
Confidence 9999998642 236899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1e-22 Score=209.80 Aligned_cols=153 Identities=32% Similarity=0.533 Sum_probs=131.8
Q ss_pred HhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
..++|++.++||+|+||.||+|... .+..||||++.... .....+|.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999999753 35679999986432 2345678999999999999999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK-------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
.++||||+++++|.+++.+... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999854211 234688899999999999999999987 999999999999999999999
Q ss_pred EecCCceeeC
Q 006347 625 SDFGMAKIFG 634 (649)
Q Consensus 625 ~DFGla~~~~ 634 (649)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (277)
T cd05062 161 GDFGMTRDIY 170 (277)
T ss_pred CCCCCccccC
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.2e-23 Score=209.09 Aligned_cols=152 Identities=34% Similarity=0.566 Sum_probs=138.1
Q ss_pred HhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+..+|++.++||+|+||.||+|...+++.+|+|.+.........++..|+.++++++|+||+++++++.+.+..++||||
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 83 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITEL 83 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEee
Confidence 34568888999999999999999988999999999776555677899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++++|.+++.+. ....+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~ 155 (261)
T cd05148 84 MEKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIK 155 (261)
T ss_pred cccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcC
Confidence 9999999999653 3456899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=213.61 Aligned_cols=141 Identities=28% Similarity=0.354 Sum_probs=120.7
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||++... +++.+|+|.+.+.. ....+++..|.. +++.++|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 37999999999999976 57889999986432 223344555544 56788999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++|.+++.. ...+.......++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~ 146 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKEN 146 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCccc
Confidence 999999853 345778888889999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-23 Score=190.87 Aligned_cols=148 Identities=26% Similarity=0.487 Sum_probs=128.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..++||+|.+|+||||+.. +++.||+|+++-. .+.-....++|+.+++.++|+|||+++.....+...-||+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 3455689999999999999976 5788999988643 233346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
| ..+|..|... -++.++......++.|+.+||.|+|++. +.|||+||+|.|++.+++.|++|||+||-++-
T Consensus 83 c-dqdlkkyfds--lng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgi 153 (292)
T KOG0662|consen 83 C-DQDLKKYFDS--LNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGI 153 (292)
T ss_pred h-hHHHHHHHHh--cCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCC
Confidence 9 4578777632 3567899999999999999999999998 99999999999999999999999999998754
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=209.74 Aligned_cols=151 Identities=34% Similarity=0.604 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.+|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++.+++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 46788899999999999999742 345799999876555567789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 555 IYEYMPNRSLDALLFDPL----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
||||+++++|.+++.... +...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986321 2235899999999999999999999987 999999999999999999999
Q ss_pred EecCCceeeC
Q 006347 625 SDFGMAKIFG 634 (649)
Q Consensus 625 ~DFGla~~~~ 634 (649)
+|||+++.+.
T Consensus 162 ~dfg~~~~~~ 171 (288)
T cd05093 162 GDFGMSRDVY 171 (288)
T ss_pred ccCCcccccc
Confidence 9999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.9e-22 Score=207.72 Aligned_cols=150 Identities=28% Similarity=0.485 Sum_probs=124.6
Q ss_pred cCcccceeeccCCcEEEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCCccceEEEEEe-----
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE----- 548 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~----- 548 (649)
++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|+.++..+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 36888899999999999999863 46889999886432 22334667787777665 69999999999863
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
....++||||++ ++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999996 6899888543 2345899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+++....
T Consensus 156 ~~~~~~~ 162 (290)
T cd07862 156 LARIYSF 162 (290)
T ss_pred ceEeccC
Confidence 9998753
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.3e-22 Score=216.05 Aligned_cols=151 Identities=30% Similarity=0.454 Sum_probs=128.2
Q ss_pred cCcccceeeccCCcEEEEEEEe------cCCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeC-Ce
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG-EE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 551 (649)
++|++.+.||+|+||.||+|.. .+++.||||+++... ....+.+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5688889999999999999973 356789999996533 23456788999999999 789999999988754 46
Q ss_pred EEEEEecCCCCChhhhhcCCCC----------------------------------------------------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------- 573 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 573 (649)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999999853210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 574 ------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 574 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~ 230 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIY 230 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccc
Confidence 124688889999999999999999987 9999999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.8e-22 Score=206.93 Aligned_cols=145 Identities=31% Similarity=0.446 Sum_probs=125.0
Q ss_pred eeeccCCcEEEEEEEecC---CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD---GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~---g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.||+|+||.||+|...+ +..+|+|.++... ......+.+|+.++++++|+||+++++++.+....++||||+++|
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g 80 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLG 80 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCC
Confidence 368999999999998653 4579999886543 234467899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCC--CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 563 SLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 563 sL~~~l~~~~--~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+|.+++.... .....++..+..++.|+++||+|||+.+ ++||||||+||++++++++||+|||+++...
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~ 151 (269)
T cd05087 81 DLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKY 151 (269)
T ss_pred cHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCcccccccc
Confidence 9999986432 1234677888899999999999999987 9999999999999999999999999997653
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.9e-22 Score=217.15 Aligned_cols=147 Identities=26% Similarity=0.430 Sum_probs=128.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM 553 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 553 (649)
+|++.+.||+|+||.||++... +++.||||++... .....+++.+|+.+++.++|+||+++++++.+.+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4677899999999999999975 7899999998643 2234567899999999999999999999998876 789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|+||+. ++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+..
T Consensus 81 lv~e~~~-~~l~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIVS---PQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999996 578777743 456899999999999999999999987 999999999999999999999999999976
Q ss_pred CC
Q 006347 634 GG 635 (649)
Q Consensus 634 ~~ 635 (649)
..
T Consensus 154 ~~ 155 (372)
T cd07853 154 EP 155 (372)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-23 Score=202.75 Aligned_cols=164 Identities=29% Similarity=0.400 Sum_probs=139.1
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----c---ccHHHHHHHHHHHhcC-CCCCccceEEEE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----G---QGLEEFMNEVMVISKL-QHRNLVRLLGCC 546 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~---~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 546 (649)
+..-++|...+.||+|..+.|-++.++ +|.+.|+|++.... + .-.++-+.|+.+|+++ .||+|+++..++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 334456777889999999999998776 78899999986321 1 1235567899999999 699999999999
Q ss_pred EeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006347 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 626 (649)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~D 626 (649)
..+...++|+|.|+.|.|.++|. +.-.+++++..+|++|+..|+.|||... ||||||||+|||+|++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLt---s~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLT---SKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhh---hheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 99999999999999999999994 4567899999999999999999999988 99999999999999999999999
Q ss_pred cCCceeeCCCCCccccCceeecC
Q 006347 627 FGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 627 FGla~~~~~~~~~~~~~~~~GT~ 649 (649)
||+|..+..... ...+.|||
T Consensus 167 FGFa~~l~~Gek---LrelCGTP 186 (411)
T KOG0599|consen 167 FGFACQLEPGEK---LRELCGTP 186 (411)
T ss_pred cceeeccCCchh---HHHhcCCC
Confidence 999999865543 23356664
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.5e-22 Score=211.60 Aligned_cols=141 Identities=35% Similarity=0.448 Sum_probs=125.3
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||+||++... +++.+|||.+++.. ......+..|.+++..+ +|+||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 36999999999999886 57899999997532 33456778899999888 799999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|..++.. ...+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~ 146 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEG 146 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeec
Confidence 999988843 346899999999999999999999987 999999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.6e-22 Score=209.64 Aligned_cols=153 Identities=29% Similarity=0.503 Sum_probs=130.8
Q ss_pred HhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
..++|++.+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.++++++|+||+++++++.+++.
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 3467888999999999999999753 24589999886433 2334578899999999999999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK-------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
.++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999964211 234577888999999999999999987 999999999999999999999
Q ss_pred EecCCceeeC
Q 006347 625 SDFGMAKIFG 634 (649)
Q Consensus 625 ~DFGla~~~~ 634 (649)
+|||+++.+.
T Consensus 161 ~Dfg~~~~~~ 170 (288)
T cd05061 161 GDFGMTRDIY 170 (288)
T ss_pred CcCCcccccc
Confidence 9999998653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.89 E-value=1.4e-22 Score=208.63 Aligned_cols=141 Identities=27% Similarity=0.417 Sum_probs=121.8
Q ss_pred eeccCCcEEEEEEEecC-------------------------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccce
Q 006347 488 KLGQGGFGPVYWGRLKD-------------------------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRL 542 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~~-------------------------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l 542 (649)
+||+|+||.||+|.+.. ...||+|.+........++|.+|+.++++++|+||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997521 13589999876544456789999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC--
Q 006347 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-- 620 (649)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-- 620 (649)
+++|.++...++||||+++|+|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRK--EKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 9999999999999999999999999854 2346889999999999999999999887 99999999999998654
Q ss_pred -----ceEEEecCCceee
Q 006347 621 -----NPKISDFGMAKIF 633 (649)
Q Consensus 621 -----~~Ki~DFGla~~~ 633 (649)
.+|++|||+++..
T Consensus 157 ~~~~~~~kl~d~g~~~~~ 174 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTA 174 (274)
T ss_pred cCccceeeecCCcccccc
Confidence 3799999998754
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.1e-22 Score=217.03 Aligned_cols=151 Identities=30% Similarity=0.482 Sum_probs=134.5
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
....|.+...||.|.|++|..+++. ++.+||||.+++.. ....+.+.+|+++|..++|||||+++.+.......|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 3467888899999999999999876 79999999998753 23446689999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+.+|.+.+||... ......+...+..|+.+|++|||.++ |+|||||++||||+.++++||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999643 34455777788999999999999998 99999999999999999999999999998853
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=207.25 Aligned_cols=149 Identities=32% Similarity=0.538 Sum_probs=126.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|++.+.||+|+||.||+|... +++ .+++|.+..... ...+++..|+..++++.|+||+++++++. +...++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 35677789999999999999874 344 478888754322 34467888898999999999999999875 455789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 86 i~e~~~~gsL~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQ--HRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 9999999999999964 2346899999999999999999999987 9999999999999999999999999999764
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 161 ~ 161 (279)
T cd05111 161 P 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.6e-22 Score=210.35 Aligned_cols=151 Identities=30% Similarity=0.513 Sum_probs=129.8
Q ss_pred cCcccceeeccCCcEEEEEEEecC---------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD---------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLG 544 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~---------------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g 544 (649)
++|++.++||+|+||.||++...+ ...||||.+.... ......|.+|++++.+++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 568888999999999999987542 2358999986542 334567999999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCChhhhhcCCC---------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006347 545 CCVEGEEKMLIYEYMPNRSLDALLFDPL---------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615 (649)
Q Consensus 545 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~---------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 615 (649)
++...+..++||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 9999999999999999999999985421 1124788999999999999999999987 999999999999
Q ss_pred EcCCCceEEEecCCceeeC
Q 006347 616 LDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 616 l~~~~~~Ki~DFGla~~~~ 634 (649)
+++++.+||+|||+++.+.
T Consensus 162 l~~~~~~kl~dfg~~~~~~ 180 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLY 180 (295)
T ss_pred EcCCCcEEecccccccccc
Confidence 9999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=207.38 Aligned_cols=151 Identities=30% Similarity=0.581 Sum_probs=132.8
Q ss_pred cCcccceeeccCCcEEEEEEEecC------CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|.+.+.||+|+||.||+|...+ ++.||||.++..... ..+.|.+|++++.+++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 478999998765443 4578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 554 LIYEYMPNRSLDALLFDPL-----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
+||||+++++|.+++.... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999996421 2345789999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeeC
Q 006347 623 KISDFGMAKIFG 634 (649)
Q Consensus 623 Ki~DFGla~~~~ 634 (649)
||+|||+++.+.
T Consensus 162 kl~d~g~~~~~~ 173 (280)
T cd05049 162 KIGDFGMSRDVY 173 (280)
T ss_pred EECCcccceecc
Confidence 999999998753
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=205.07 Aligned_cols=156 Identities=30% Similarity=0.405 Sum_probs=134.8
Q ss_pred HHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 476 LATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 476 l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++.+++++.....||+|+||.||+|... ++..||+|.+........+.+.+|+.++++++|+||+++++++.+++..++
T Consensus 3 ~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~l 82 (268)
T cd06624 3 YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKI 82 (268)
T ss_pred cccccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEE
Confidence 3455667777789999999999999865 678899999876655667889999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~ 633 (649)
|+||+++++|.+++.........++..+..++.||++||+|||+.+ |+||||||+||+++. ++.+||+|||++..+
T Consensus 83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~ 159 (268)
T cd06624 83 FMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRL 159 (268)
T ss_pred EEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheec
Confidence 9999999999999964322212278888899999999999999887 999999999999986 679999999999876
Q ss_pred C
Q 006347 634 G 634 (649)
Q Consensus 634 ~ 634 (649)
.
T Consensus 160 ~ 160 (268)
T cd06624 160 A 160 (268)
T ss_pred c
Confidence 4
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=3e-22 Score=230.65 Aligned_cols=149 Identities=30% Similarity=0.439 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.++||+|+||.||+|... +++.||||+++... ......+..|+.++..++|+||+++++++.+.+..+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 57888999999999999999987 68899999986532 223467889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.. ...+++...+.|+.||+.||.|||..+ ||||||||+|||++.++.+||+|||+++....
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~~~~~ 156 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSKVTLN 156 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCccccC
Confidence 99999999999853 345788999999999999999999987 99999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.5e-22 Score=204.40 Aligned_cols=147 Identities=31% Similarity=0.542 Sum_probs=131.6
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+|++.+.||+|+||.||++...++..+|+|.+.+. .....+|.+|+.++++++|+||+++++++.+.+..++||||+++
T Consensus 5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~ 83 (256)
T cd05059 5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREG-AMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMAN 83 (256)
T ss_pred HcchhhhhccCCCceEEEeEecCCccEEEEEeccC-CCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCC
Confidence 46777899999999999999887778999988643 23456788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 84 ~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~ 151 (256)
T cd05059 84 GCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVL 151 (256)
T ss_pred CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecc
Confidence 9999998642 236899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=208.22 Aligned_cols=152 Identities=30% Similarity=0.557 Sum_probs=133.1
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.+|.+.+.||+|+||.||+++.. ++..+++|.+........+.+.+|++++++++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35777889999999999999743 345799999876555566789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 555 IYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
||||+++++|.+++.... ....+++..++.++.||+.||+|||+.+ |+||||||+|||+++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986421 1235899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCceeeCC
Q 006347 622 PKISDFGMAKIFGG 635 (649)
Q Consensus 622 ~Ki~DFGla~~~~~ 635 (649)
+||+|||+++....
T Consensus 162 ~~l~dfg~a~~~~~ 175 (291)
T cd05094 162 VKIGDFGMSRDVYS 175 (291)
T ss_pred EEECCCCcccccCC
Confidence 99999999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=212.27 Aligned_cols=139 Identities=29% Similarity=0.350 Sum_probs=120.4
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC---CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
||+|+||+||+|+.. +++.||||++.+.. ......+..|..++.+. +||||++++..+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 799999999999876 68999999986432 12334455677766655 699999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~ 146 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKAN 146 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCC
Confidence 999988843 456899999999999999999999987 999999999999999999999999999864
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-22 Score=206.50 Aligned_cols=149 Identities=29% Similarity=0.364 Sum_probs=133.4
Q ss_pred cCcccceeeccCCcEEEEEEEecC-CcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|.-|+||.+++.+ +..+|+|++.+.. .+...+...|.+||+.+.||.++.|++.+..+...+|||
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 346667899999999999999984 5899999998653 445567788999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||+||+|...+.+ +..+.++...+..+|.+|.-||+|||-.+ ||.|||||+||||-++|++.++||.|+...
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~ 229 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRC 229 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccC
Confidence 99999999988865 45667899999999999999999999887 999999999999999999999999998765
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.8e-22 Score=205.57 Aligned_cols=152 Identities=32% Similarity=0.510 Sum_probs=132.8
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeC------
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG------ 549 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~------ 549 (649)
.+++.|+..+.||+|+||.||+|... +++.||+|.+... .....++..|+.++.++ +|+||+++++++.+.
T Consensus 3 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 3 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred ChhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcC-CccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 45677888899999999999999876 5889999998653 34557889999999998 799999999998863
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
...++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+
T Consensus 82 ~~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 82 DQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred cEEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCC
Confidence 4578999999999999998642 3346899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeC
Q 006347 630 AKIFG 634 (649)
Q Consensus 630 a~~~~ 634 (649)
++.+.
T Consensus 158 ~~~~~ 162 (272)
T cd06637 158 SAQLD 162 (272)
T ss_pred ceecc
Confidence 98764
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.4e-22 Score=204.96 Aligned_cols=148 Identities=31% Similarity=0.577 Sum_probs=125.1
Q ss_pred ccceeeccCCcEEEEEEEecC-Cc--EEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------eE
Q 006347 484 QLSSKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------EK 552 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~ 552 (649)
.+.+.||+|+||.||+|+... +. .+|||.++.. .....+.+..|+.++.+++|+||+++++++.+.. ..
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 456799999999999999764 32 6899988643 2345678899999999999999999999986432 46
Q ss_pred EEEEecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 553 MLIYEYMPNRSLDALLFDP---LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
++||||+++|+|.+++... .....+++.....++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 8999999999999887421 12345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeC
Q 006347 630 AKIFG 634 (649)
Q Consensus 630 a~~~~ 634 (649)
++.+.
T Consensus 159 ~~~~~ 163 (272)
T cd05075 159 SKKIY 163 (272)
T ss_pred ccccC
Confidence 99764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.6e-22 Score=207.84 Aligned_cols=149 Identities=27% Similarity=0.334 Sum_probs=131.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||.||++... ++..+|+|.+.... .....++.+|++++.+++||||+++++.+.+++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 36888899999999999999876 67889999886432 23446788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++++|.+++.. ...+++..+..++.|+++||.|||+.. +++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 151 (308)
T cd06615 81 MDGGSLDQVLKK---AGRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151 (308)
T ss_pred cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccc
Confidence 999999999954 356889999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=207.39 Aligned_cols=149 Identities=28% Similarity=0.465 Sum_probs=134.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.+|++.+.||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++..++..++||||+
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 98 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 98 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeeccc
Confidence 56888899999999999999964 78999999997655555677899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++++|.+++.+ ..+++..+..++.+++.||.|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 99 ~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred CCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 99999999843 45789999999999999999999987 999999999999999999999999999876433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.7e-22 Score=206.04 Aligned_cols=151 Identities=34% Similarity=0.591 Sum_probs=131.0
Q ss_pred cCcccceeeccCCcEEEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|++.+.||+|+||.||+|.... ...||+|.+.... .....+|.+|+.++.+++|+||+++++++.+....+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 357778999999999999998652 2579999986433 234567899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006347 554 LIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 620 (649)
++|||+++++|.+++..... ...+++...+.++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864211 145889999999999999999999987 99999999999999999
Q ss_pred ceEEEecCCceeeC
Q 006347 621 NPKISDFGMAKIFG 634 (649)
Q Consensus 621 ~~Ki~DFGla~~~~ 634 (649)
.+||+|||+++...
T Consensus 162 ~~~L~dfg~~~~~~ 175 (283)
T cd05048 162 TVKISDFGLSRDIY 175 (283)
T ss_pred cEEECCCcceeecc
Confidence 99999999998753
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=205.00 Aligned_cols=147 Identities=30% Similarity=0.490 Sum_probs=132.3
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
|++.++||+|+||.||+|... ++..+++|.+........+.+.+|++++..++|+|++++++++.+++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 556688999999999999987 5778999998765556677899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++|..++.+ ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~ 154 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 154 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccc
Confidence 999988754 2356899999999999999999999987 9999999999999999999999999997653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.6e-22 Score=206.21 Aligned_cols=151 Identities=32% Similarity=0.565 Sum_probs=132.9
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+++...++||+|+||.||++... ++..+|+|.+........+.|.+|++++.+++|+||+++++++.+.+..++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45667789999999999999642 356899999876666667889999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 555 IYEYMPNRSLDALLFDPLK------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864211 135889999999999999999999887 9999999999999999999
Q ss_pred EEEecCCceeeC
Q 006347 623 KISDFGMAKIFG 634 (649)
Q Consensus 623 Ki~DFGla~~~~ 634 (649)
||+|||+++.+.
T Consensus 162 kL~dfg~~~~~~ 173 (280)
T cd05092 162 KIGDFGMSRDIY 173 (280)
T ss_pred EECCCCceeEcC
Confidence 999999998664
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=203.72 Aligned_cols=150 Identities=33% Similarity=0.553 Sum_probs=133.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.+|++.++||+|+||.||+|... .++.||+|.+... .....++.+|++++.+++|+||+++++++.+.+..++||||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 34777789999999999999876 5889999998653 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~ 156 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG 156 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccc
Confidence 999999998542 2346899999999999999999999987 99999999999999999999999999988654
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=207.31 Aligned_cols=148 Identities=28% Similarity=0.470 Sum_probs=133.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.+|+..+.||+|+||.||+|... +++.||+|.+........+.+.+|+.+++.+.|+||+++++.+.++.+.++||||+
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~ 99 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeeccc
Confidence 46888899999999999999864 68899999997655556678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++.+ ..+++.++..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~ 168 (296)
T cd06654 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168 (296)
T ss_pred CCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhccc
Confidence 99999999843 35789999999999999999999987 99999999999999999999999999887543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.9e-22 Score=204.22 Aligned_cols=150 Identities=31% Similarity=0.573 Sum_probs=131.7
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.+|++.+.||+|+||.||+|... .+..+|+|.++... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 46778899999999999999864 23479999986532 23456899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++... ...+++.+++.++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||+++.+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999999542 345899999999999999999999987 99999999999999999999999999997754
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.1e-22 Score=213.90 Aligned_cols=152 Identities=32% Similarity=0.481 Sum_probs=128.6
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCCccceEEEEEeC-Ce
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG-EE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~-~~ 551 (649)
++|++.+.||+|+||.||+|... +++.||+|+++.... ...+.+..|+.++.++ +|+||++++++|... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 46888899999999999999643 357899999865332 3346788999999999 899999999988754 56
Q ss_pred EEEEEecCCCCChhhhhcCCCC----------------------------------------------------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK---------------------------------------------------------- 573 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 573 (649)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999999853211
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 574 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
...++|..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~ 225 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYK 225 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhccc
Confidence 136899999999999999999999887 99999999999999999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.4e-22 Score=207.52 Aligned_cols=151 Identities=32% Similarity=0.505 Sum_probs=129.7
Q ss_pred CcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+|.+.++||+|+||.||+|... ++..||||+++..... ..++|.+|+.++.+++|+||+++++++.+.+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 3566789999999999999864 2478999999754322 34678899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 555 IYEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
++||+++++|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 99999999999998421 11245889999999999999999999987 999999999999999999
Q ss_pred eEEEecCCceeeCC
Q 006347 622 PKISDFGMAKIFGG 635 (649)
Q Consensus 622 ~Ki~DFGla~~~~~ 635 (649)
+||+|||+++.+..
T Consensus 163 ~kl~Dfg~~~~~~~ 176 (283)
T cd05091 163 VKISDLGLFREVYA 176 (283)
T ss_pred eEeccccccccccc
Confidence 99999999987643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.3e-22 Score=205.04 Aligned_cols=148 Identities=29% Similarity=0.405 Sum_probs=130.4
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
|+..+.||+|+||+||++... +++.+|+|.+.... ....+.+.+|+.++.+++|+|++++.+.+.+++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566789999999999999876 68899999986432 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~ 153 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIP 153 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecC
Confidence 9999999888642 2346899999999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=2.6e-22 Score=208.34 Aligned_cols=155 Identities=28% Similarity=0.498 Sum_probs=133.7
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG 549 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (649)
...++|++.+.||+|+||.||++... ....+|+|.+... ......++.+|+.++.++ +|+||+++++++.++
T Consensus 9 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 88 (293)
T cd05053 9 LPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE 88 (293)
T ss_pred cCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence 34456888899999999999999864 2367999998653 233456789999999999 799999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 550 EEKMLIYEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+..++||||+++|+|.+++... .....+++..++.++.|++.||+|||+.+ |+||||||+||++
T Consensus 89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~ 165 (293)
T cd05053 89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV 165 (293)
T ss_pred CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence 9999999999999999998532 12356899999999999999999999887 9999999999999
Q ss_pred cCCCceEEEecCCceeeCC
Q 006347 617 DEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~ 635 (649)
++++.+||+|||+++.+..
T Consensus 166 ~~~~~~kL~Dfg~~~~~~~ 184 (293)
T cd05053 166 TEDHVMKIADFGLARDIHH 184 (293)
T ss_pred cCCCeEEeCcccccccccc
Confidence 9999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.1e-22 Score=207.44 Aligned_cols=151 Identities=28% Similarity=0.508 Sum_probs=130.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-----------------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccce
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-----------------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRL 542 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-----------------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l 542 (649)
++|++.++||+|+||.||++... ++..+|+|.+.... ....++|.+|+.++.+++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 56888899999999999998532 23468999987542 3345789999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCChhhhhcCCCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcE
Q 006347 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNI 614 (649)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NI 614 (649)
++++.+++..++||||+++++|.+++..... ...+++.....++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999864221 134788899999999999999999987 99999999999
Q ss_pred EEcCCCceEEEecCCceeeC
Q 006347 615 LLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 615 Ll~~~~~~Ki~DFGla~~~~ 634 (649)
|+++++.+||+|||+++.+.
T Consensus 162 li~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred EEcCCCCEEeccCccccccc
Confidence 99999999999999998763
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-23 Score=221.42 Aligned_cols=156 Identities=29% Similarity=0.476 Sum_probs=132.4
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEec--c--cccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe--EEEEEec
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLS--K--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE--KMLIYEY 558 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~--~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~--~~lV~Ey 558 (649)
.++||+|+|-+||||... +|.+||--.++ + ..+...++|..|+++|+.|+|+|||+++..+.+... .-+|+|.
T Consensus 45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL 124 (632)
T KOG0584|consen 45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITEL 124 (632)
T ss_pred hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeec
Confidence 479999999999999986 57788743222 1 234566899999999999999999999999998776 6799999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~~~~ 637 (649)
|..|+|..|+.+ .+.++.+....|++||++||.|||.+. +||||||||.+||+|+. -|.+||+|+|||+++....
T Consensus 125 ~TSGtLr~Y~kk---~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ 200 (632)
T KOG0584|consen 125 FTSGTLREYRKK---HRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH 200 (632)
T ss_pred ccCCcHHHHHHH---hccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc
Confidence 999999999954 356788999999999999999999985 89999999999999985 5889999999999985433
Q ss_pred CccccCceeecC
Q 006347 638 DQADTGRVVGTL 649 (649)
Q Consensus 638 ~~~~~~~~~GT~ 649 (649)
..+++|||
T Consensus 201 ----aksvIGTP 208 (632)
T KOG0584|consen 201 ----AKSVIGTP 208 (632)
T ss_pred ----cceeccCc
Confidence 23489996
|
|
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=203.44 Aligned_cols=149 Identities=31% Similarity=0.567 Sum_probs=128.2
Q ss_pred cccceeeccCCcEEEEEEEecC----CcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe-----
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE----- 551 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~----- 551 (649)
|.+.+.||+|+||.||+|+... +..||||+++... .....++.+|+..+++++|+||+++++++.+.+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567899999999999998752 3679999986432 2345689999999999999999999999877654
Q ss_pred -EEEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 552 -KMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 552 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
.++|+||+++++|..++.... ....+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 689999999999999985432 2346899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeC
Q 006347 628 GMAKIFG 634 (649)
Q Consensus 628 Gla~~~~ 634 (649)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05035 158 GLSKKIY 164 (273)
T ss_pred cceeecc
Confidence 9999764
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=208.20 Aligned_cols=153 Identities=29% Similarity=0.523 Sum_probs=132.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG 549 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (649)
..+|.+.+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.++..+ +|+||+++++++.+.
T Consensus 14 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~ 93 (304)
T cd05101 14 RDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 93 (304)
T ss_pred HHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC
Confidence 356788899999999999999742 34579999886432 34567899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
...++||||+++++|.+++.+.. ....+++.++..++.||++||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nili 170 (304)
T cd05101 94 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVLV 170 (304)
T ss_pred CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEEE
Confidence 99999999999999999986531 1235789999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCC
Q 006347 617 DEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~ 635 (649)
++++.+||+|||+++.+..
T Consensus 171 ~~~~~~kl~D~g~~~~~~~ 189 (304)
T cd05101 171 TENNVMKIADFGLARDVNN 189 (304)
T ss_pred cCCCcEEECCCccceeccc
Confidence 9999999999999997643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=202.32 Aligned_cols=143 Identities=31% Similarity=0.556 Sum_probs=127.5
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
+.||+|+||.||+|+.. +++.+|+|.+.... ......|.+|++++++++|+||+++++++.+....++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 47999999999999875 68899999876432 33456799999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.+++.. ....+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~ 145 (252)
T cd05084 81 LTFLRT--EGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEE 145 (252)
T ss_pred HHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccc
Confidence 999853 2345899999999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.4e-22 Score=206.84 Aligned_cols=152 Identities=31% Similarity=0.526 Sum_probs=132.4
Q ss_pred hcCcccceeeccCCcEEEEEEEecC-----------------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccc
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD-----------------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVR 541 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~-----------------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~ 541 (649)
..+|++.++||+|+||.||++...+ +..||+|.+.... ....+++.+|++++.+++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3568888999999999999997652 2468999987543 235678999999999999999999
Q ss_pred eEEEEEeCCeEEEEEecCCCCChhhhhcCCC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006347 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN 613 (649)
Q Consensus 542 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 613 (649)
+++++..++..++|+||+++++|.+++.+.. ....+++..++.++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986532 1236899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEecCCceeeC
Q 006347 614 ILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 614 ILl~~~~~~Ki~DFGla~~~~ 634 (649)
|++++++.+||+|||+++.+.
T Consensus 161 ili~~~~~~~l~dfg~~~~~~ 181 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLY 181 (296)
T ss_pred eeecCCCceEEccccceeecc
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.2e-22 Score=206.22 Aligned_cols=150 Identities=29% Similarity=0.471 Sum_probs=135.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|.+.+.||+|+||.||++... +++.+|+|.+........+.|..|+.++++++|+||+++++.+.++...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999976 6889999998765556667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++++|.+++.+. ...+++..+..++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||++....
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~ 154 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNK 154 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhc
Confidence 9999999998542 346899999999999999999999987 9999999999999999999999999987653
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=203.92 Aligned_cols=149 Identities=31% Similarity=0.580 Sum_probs=131.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CC---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DG---QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g---~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.|++.+.||+|+||.||+|... ++ ..||||.+... .....++|..|+.++++++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 4677899999999999999875 23 36999998654 3345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~ 158 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 158 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCcccccccc
Confidence 999999999998542 345899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.6e-22 Score=206.36 Aligned_cols=150 Identities=31% Similarity=0.496 Sum_probs=129.3
Q ss_pred CcccceeeccCCcEEEEEEEec------CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+|.+.+.||+|+||.||+|+.. ....+|+|.+..... ...+++.+|+.++++++||||+++++.+.+++..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 4667789999999999999853 235789998865432 345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006347 555 IYEYMPNRSLDALLFDPL---------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN 613 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 613 (649)
|+||+++++|.+++.... ....+++..++.++.|++.||.|||+.+ |+||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999985321 1235889999999999999999999887 9999999999
Q ss_pred EEEcCCCceEEEecCCceeeC
Q 006347 614 ILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 614 ILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++++.+||+|||+++.+.
T Consensus 158 ill~~~~~~kl~dfg~~~~~~ 178 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVY 178 (290)
T ss_pred EEEcCCCcEEecccccccccc
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.2e-22 Score=203.76 Aligned_cols=148 Identities=26% Similarity=0.477 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.++||+|+||.||+++.. +++.+|+|.++.........+.+|+.++..++|+||+++++.+.+++..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999875 68899999987654455567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++.. ...+++.+...++.|++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+.
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQIT 157 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEcc
Confidence 99999999843 346899999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=205.52 Aligned_cols=153 Identities=29% Similarity=0.507 Sum_probs=133.0
Q ss_pred hcCcccceeeccCCcEEEEEEEecC-----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 552 (649)
.++|.+.+.||+|+||.||+|.... +..|++|++.... ....+.+.+|+.++.+++|+||+++++++.+ +...
T Consensus 5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 84 (280)
T cd05043 5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPP 84 (280)
T ss_pred hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCC
Confidence 4678888999999999999999765 6889999886542 3346778999999999999999999999887 4678
Q ss_pred EEEEecCCCCChhhhhcCCCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 553 MLIYEYMPNRSLDALLFDPLKK-----ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
++++||+++++|.+++...... ..+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 85 ~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 85 FVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred EEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECCC
Confidence 9999999999999998643222 46899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCC
Q 006347 628 GMAKIFGG 635 (649)
Q Consensus 628 Gla~~~~~ 635 (649)
|+++.+..
T Consensus 162 g~~~~~~~ 169 (280)
T cd05043 162 ALSRDLFP 169 (280)
T ss_pred CCcccccC
Confidence 99987643
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.6e-22 Score=200.19 Aligned_cols=150 Identities=30% Similarity=0.464 Sum_probs=134.1
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..+.||+|++|.||+++.. +++.+++|.+... .....+++.+|++++++++|+|++++++++.+++..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999976 6889999988642 234567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~ 153 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSD 153 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccC
Confidence 9999999999653 2456899999999999999999999887 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=3.8e-22 Score=205.14 Aligned_cols=153 Identities=31% Similarity=0.495 Sum_probs=132.5
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|.+.+.||+|+||.||+|... .+..||+|.+.... .....++.+|+.++..++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 356888899999999999999865 24689999986443 23456789999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 553 MLIYEYMPNRSLDALLFDPLK-------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
++||||+++++|.+++..... ...+++..++.++.|++.||.|||+.+ |+||||||+||++++++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864221 234789999999999999999999887 9999999999999999999999
Q ss_pred ecCCceeeCC
Q 006347 626 DFGMAKIFGG 635 (649)
Q Consensus 626 DFGla~~~~~ 635 (649)
|||+++.+..
T Consensus 162 dfg~~~~~~~ 171 (277)
T cd05032 162 DFGMTRDIYE 171 (277)
T ss_pred Ccccchhhcc
Confidence 9999987643
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=201.79 Aligned_cols=148 Identities=34% Similarity=0.615 Sum_probs=133.8
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||.||++... ++.||||.++.... ..+++.+|+.++.+++|+||+++++++.+.+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~g~v~~~~~~-~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 83 (256)
T cd05039 6 KELKLGATIGKGEFGDVMLGDYR-GQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMA 83 (256)
T ss_pred hhccceeeeecCCCceEEEEEec-CcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecC
Confidence 46778899999999999999876 78999999976543 56789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++|+||||+||++++++.+||+|||+++...
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~ 153 (256)
T cd05039 84 KGSLVDYLRSR-GRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153 (256)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccc
Confidence 99999998643 2236899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.1e-22 Score=203.33 Aligned_cols=143 Identities=28% Similarity=0.416 Sum_probs=125.3
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||+|+||.||++... +|+.+|+|.+.... ....+.+..|++++.+++||||+++++.+.++...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 699999999999876 68999999986422 12345567799999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~ 147 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKD 147 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCC
Confidence 9888543 3345889999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.5e-22 Score=204.57 Aligned_cols=148 Identities=31% Similarity=0.509 Sum_probs=134.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.++||+|+||.||+|+.. +++.+|+|.+........+.+..|+.++++++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 45778899999999999999986 58899999997666666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++++|..++.+ ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 92 ~~~~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 160 (292)
T cd06644 92 PGGAVDAIMLE--LDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKN 160 (292)
T ss_pred CCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceec
Confidence 99999888754 2346899999999999999999999887 999999999999999999999999998864
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=202.43 Aligned_cols=149 Identities=34% Similarity=0.561 Sum_probs=130.7
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|.+.++||+|+||.||+|+..+...||+|+++.. ....++|.+|+.++.+++|+||+++++++. .+..++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~-~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccC-ccCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 468888999999999999999877778999999753 234568999999999999999999999874 456799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+|+|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~ 154 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 154 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccc
Confidence 99999999642 2345789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.2e-21 Score=236.47 Aligned_cols=142 Identities=25% Similarity=0.516 Sum_probs=123.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
..++..+.||+|+||.||+|+.. ++..||||+++..... ...|++++++++|||||+++|+|.+.+..++||||+
T Consensus 690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~ 765 (968)
T PLN00113 690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYI 765 (968)
T ss_pred hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCC
Confidence 45677789999999999999974 7899999998653322 234688999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++|+|.++++ .++|.++.+|+.|||+||+|||+.+..+|+||||||+||+++.++.+|+. ||+++..
T Consensus 766 ~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~ 832 (968)
T PLN00113 766 EGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLL 832 (968)
T ss_pred CCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccc
Confidence 9999999994 38999999999999999999997766779999999999999999998886 7766543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.88 E-value=4e-22 Score=202.58 Aligned_cols=145 Identities=37% Similarity=0.604 Sum_probs=129.1
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccccccc--HHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~--~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
|++.+.||+|+||+||++... +++.+|+|.+....... ......|+.++.+++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 567789999999999999987 56689999997654322 223456999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++++|.+++. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||.+..+
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~ 148 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKL 148 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEES
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccc
Confidence 9999999995 3456899999999999999999999987 999999999999999999999999999875
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.88 E-value=7.2e-22 Score=203.64 Aligned_cols=149 Identities=31% Similarity=0.536 Sum_probs=128.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|...+.||+|+||+||+|+.. +++ .||||.++.. .....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 46778899999999999999854 444 4899998643 23346788999999999999999999999975 45779
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++||+++|+|.++++.. ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999998642 346899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 161 ~ 161 (279)
T cd05109 161 I 161 (279)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=6.5e-22 Score=204.60 Aligned_cols=150 Identities=32% Similarity=0.577 Sum_probs=130.6
Q ss_pred cCcccceeeccCCcEEEEEEEec-----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (649)
+.|++.++||+|+||.||++... ++..||+|.++... ....+.+.+|+.++++++|+|++++++++.+. ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 34677899999999999999742 57889999986543 33456899999999999999999999999875 568
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998542 235899999999999999999999987 99999999999999999999999999987
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 159 ~~~ 161 (284)
T cd05079 159 IET 161 (284)
T ss_pred ccc
Confidence 643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.7e-22 Score=202.97 Aligned_cols=149 Identities=32% Similarity=0.524 Sum_probs=131.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|++.+.||+|++|.||+|+.. +++.||||++.... ....+.+.+|+.++.+++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777899999999999999976 68999999986432 23346788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ ++|.+++........+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 152 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFG 152 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecC
Confidence 97 689888855434467899999999999999999999987 9999999999999999999999999998664
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-22 Score=202.04 Aligned_cols=142 Identities=27% Similarity=0.478 Sum_probs=123.4
Q ss_pred eeeccCCcEEEEEEEecCCc-----------EEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 487 SKLGQGGFGPVYWGRLKDGQ-----------EIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~-----------~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
+.||+|+||.||+|...+.. .+++|.+...... ..+|.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 47999999999999986432 5788877544332 6889999999999999999999999988 778999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-------ceEEEecC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-------NPKISDFG 628 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-------~~Ki~DFG 628 (649)
|||+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHRE--KNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 9999999999999643 226899999999999999999999887 99999999999999888 79999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+++.+..
T Consensus 154 ~a~~~~~ 160 (259)
T cd05037 154 IPITVLS 160 (259)
T ss_pred ccccccc
Confidence 9997543
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.9e-22 Score=202.66 Aligned_cols=143 Identities=24% Similarity=0.407 Sum_probs=124.0
Q ss_pred eeeccCCcEEEEEEEecC-------------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 487 SKLGQGGFGPVYWGRLKD-------------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~-------------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
+.||+|+||.||+|+..+ ...||+|.+..........|.+|+.++..++||||+++++++.+....+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 468999999999998542 2358999886655555668899999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-------eEEEe
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-------PKISD 626 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-------~Ki~D 626 (649)
+||||+++++|+.++.. ....+++..+++++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999998854 2346899999999999999999999987 999999999999987664 89999
Q ss_pred cCCceeeC
Q 006347 627 FGMAKIFG 634 (649)
Q Consensus 627 FGla~~~~ 634 (649)
||++..+.
T Consensus 156 ~g~~~~~~ 163 (262)
T cd05077 156 PGIPITVL 163 (262)
T ss_pred CCCCcccc
Confidence 99998653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.7e-22 Score=204.36 Aligned_cols=150 Identities=35% Similarity=0.480 Sum_probs=133.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 46888899999999999999876 68999999986432 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999999854 356899999999999999999999987 999999999999999999999999999986443
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.88 E-value=9.4e-22 Score=203.77 Aligned_cols=148 Identities=29% Similarity=0.409 Sum_probs=130.2
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
|+..+.||+|+||.||++... +++.+|||.+.... ....+.+.+|+.++.+++|+|++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 666789999999999999876 68899999986532 22345678899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++....
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~ 153 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVP 153 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecC
Confidence 9999999988542 2345889999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.88 E-value=6e-22 Score=207.03 Aligned_cols=152 Identities=32% Similarity=0.480 Sum_probs=132.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
.++|.+.+.||+|+||.||++... .+..||||+++... ....+.+.+|+.+++++ +|+||+++++++...+.
T Consensus 34 ~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 113 (302)
T cd05055 34 RNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP 113 (302)
T ss_pred HHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCc
Confidence 356888899999999999999742 34579999987543 23456789999999999 79999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+++|+|.+++... ....+++.++..++.+++.||+|||+.+ |+|+||||+|||++++..+|++|||+++
T Consensus 114 ~~lv~e~~~~~~L~~~i~~~-~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~ 189 (302)
T cd05055 114 ILVITEYCCYGDLLNFLRRK-RESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLAR 189 (302)
T ss_pred eEEEEEcCCCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcccc
Confidence 99999999999999998642 2234899999999999999999999987 9999999999999999999999999998
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 190 ~~~~ 193 (302)
T cd05055 190 DIMN 193 (302)
T ss_pred cccC
Confidence 7643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.3e-22 Score=201.72 Aligned_cols=150 Identities=32% Similarity=0.594 Sum_probs=132.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CC---cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|+..+.||+|+||.||+|+.. ++ ..+|||.++... ....+++..|++++.+++|+|++++.+++.+.+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 46778899999999999999875 23 379999986542 33457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRD--HDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 999999999999854 2356899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=198.77 Aligned_cols=143 Identities=31% Similarity=0.527 Sum_probs=127.8
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChh
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 565 (649)
+.||+|+||.||+|...++..+|+|.+..... .....|.+|+.++.+++|+||+++++++.+.+..++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 36899999999999988889999999865433 23457899999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++... ...+++..+..++.+++.||.|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~ 144 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQED 144 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecc
Confidence 998542 345789999999999999999999987 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=202.95 Aligned_cols=146 Identities=36% Similarity=0.570 Sum_probs=127.1
Q ss_pred cccceeeccCCcEEEEEEEe-----cCCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEE
Q 006347 483 FQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML 554 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 554 (649)
|+..+.||+|+||+||++.. .++..||+|.++... ......|.+|++++++++|+||+++++++.+. ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37778999999999988653 257789999986543 23467889999999999999999999998764 35789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++++|.+++.+ ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999999843 35899999999999999999999987 9999999999999999999999999998764
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 159 ~ 159 (283)
T cd05080 159 E 159 (283)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=199.37 Aligned_cols=152 Identities=23% Similarity=0.454 Sum_probs=134.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++++.+.+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888899999999999999987 7899999988632 2234678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.+.. ....+++..+..++.++++||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999986422 2455899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=209.72 Aligned_cols=144 Identities=24% Similarity=0.368 Sum_probs=126.7
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
....+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++.+++|+||+++++++.++...++|+
T Consensus 63 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 136 (357)
T PHA03209 63 VASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVL 136 (357)
T ss_pred hhhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEE
Confidence 34467999999999999999999976 5678999975332 2356999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+ .++|.+++.. ....+++..+..|+.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 137 e~~-~~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~ 207 (357)
T PHA03209 137 PHY-SSDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFP 207 (357)
T ss_pred Ecc-CCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCcccccc
Confidence 999 4688888854 3456899999999999999999999987 999999999999999999999999999864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=199.78 Aligned_cols=150 Identities=35% Similarity=0.598 Sum_probs=135.6
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|.+.++||+|+||.||++...+++.+|||.+... ....+++.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPG-TMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCC-ccCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 4678888999999999999999888889999998753 345678999999999999999999999999989999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 154 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIE 154 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceecc
Confidence 999999999653 2346899999999999999999999987 9999999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.7e-22 Score=203.33 Aligned_cols=143 Identities=25% Similarity=0.431 Sum_probs=121.8
Q ss_pred eeeccCCcEEEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLKDG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
++||+|+||.||++...++ ..+++|.+.... ....+.|.+|+.+++.++||||+++++.+.+....++||||+++|
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~ 80 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELG 80 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCC
Confidence 3699999999999976533 356677765432 345678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 563 SLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 563 sL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+|.+++.+... ....++.....++.||++||+|||+.+ ++||||||+|||++.++.+||+|||+++.
T Consensus 81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~ 148 (268)
T cd05086 81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPS 148 (268)
T ss_pred cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccc
Confidence 99999965321 234667778899999999999999987 99999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.7e-22 Score=201.34 Aligned_cols=152 Identities=22% Similarity=0.435 Sum_probs=133.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|+.. +++.||||.+... .......+.+|++++++++||||+++++++.+.+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 46888899999999999999875 7899999987542 2234467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.... ....++...+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998885322 2345788999999999999999999987 99999999999999999999999999988643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.1e-22 Score=214.78 Aligned_cols=145 Identities=23% Similarity=0.354 Sum_probs=127.2
Q ss_pred cCcccceeeccCCcEEEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.+|.+.+.||+|+||.||++... .+..||||.+... +.+.+|+.++++++|+|||++++++......++|||
T Consensus 92 ~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e 166 (392)
T PHA03207 92 MQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMP 166 (392)
T ss_pred CceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEeh
Confidence 46889999999999999999754 3578999988542 345689999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
++. ++|.+++. ....+++.+++.++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 167 ~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~ 239 (392)
T PHA03207 167 KYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHP 239 (392)
T ss_pred hcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCccc
Confidence 995 68888883 3456899999999999999999999987 9999999999999999999999999998775443
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=207.42 Aligned_cols=149 Identities=34% Similarity=0.600 Sum_probs=129.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ--EIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|... ++. .+|+|.++.. .....+++.+|++++.++ +|+||+++++++.+++..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 46788899999999999999875 444 4688877643 234556889999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 556 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
|||+++++|.+++.... ....+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986421 1235789999999999999999999887 9999999999999999999
Q ss_pred EEEecCCcee
Q 006347 623 KISDFGMAKI 632 (649)
Q Consensus 623 Ki~DFGla~~ 632 (649)
||+|||+++.
T Consensus 164 kl~dfg~~~~ 173 (303)
T cd05088 164 KIADFGLSRG 173 (303)
T ss_pred EeCccccCcc
Confidence 9999999974
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=6.7e-22 Score=204.53 Aligned_cols=151 Identities=25% Similarity=0.406 Sum_probs=132.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+|++.+.||+|+||.||++... ++..+|+|.+... ......++.+|+.++.+++|+||+++++.+...+..++||||+
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYM 81 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeec
Confidence 5777889999999999999986 7899999988643 2334568999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|..++........+++..+..++.++++||.|||+.. +|+|+||||+||++++++.+||+|||+++.+.
T Consensus 82 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 154 (286)
T cd06622 82 DAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLV 154 (286)
T ss_pred CCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 99999999865333447899999999999999999999742 39999999999999999999999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.1e-23 Score=216.43 Aligned_cols=138 Identities=32% Similarity=0.510 Sum_probs=125.0
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
.++-||.|+.|.||.|++. ++.||||+++... ..+|.-|++|+|+||+.+.|+|.+..-.+||||||+.|.|
T Consensus 128 ELeWlGSGaQGAVF~Grl~-netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRLH-NETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeecc-CceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 3468999999999999998 7899999885432 2578889999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
...|+. ..++.......+..+||.||.|||.+. |||||||.-||||..+-.+||+|||-++.+...
T Consensus 200 ~~VLka---~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~ 265 (904)
T KOG4721|consen 200 YEVLKA---GRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK 265 (904)
T ss_pred HHHHhc---cCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh
Confidence 999953 467888999999999999999999988 999999999999999999999999999988554
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=200.88 Aligned_cols=144 Identities=25% Similarity=0.355 Sum_probs=127.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+|+..+.||+|+||.||+|... +++.+|||.+... .....+++.+|+.++.+++|+||+++++++..++..++||||+
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 81 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFM 81 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecC
Confidence 5677789999999999999864 6889999998654 2334567999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|..+. .+++..+..++.|++.||.|||+.+ |+|+||||+|||++.++.+||+|||++..+..
T Consensus 82 ~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~ 147 (279)
T cd06619 82 DGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVN 147 (279)
T ss_pred CCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceeccc
Confidence 999997553 3678888899999999999999987 99999999999999999999999999987643
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=199.18 Aligned_cols=148 Identities=36% Similarity=0.490 Sum_probs=131.9
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
+|+..+.||+|+||+||+|... +++.|++|.+.... .+..+++.+|+.++++++|+||+++++++.++...++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3666789999999999999987 78999999886432 23457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.+ ...+++..+..++.|+++||+|||+.+ |+|+||+|+||++++++.+||+|||+++....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999853 345889999999999999999999987 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-23 Score=217.91 Aligned_cols=155 Identities=35% Similarity=0.541 Sum_probs=135.0
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
|+.++.||.|+||.||-+... +.+.||||++.-. +...++.++.|+..|.+++|||.+.+-|++......||||||
T Consensus 28 f~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEY 107 (948)
T KOG0577|consen 28 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEY 107 (948)
T ss_pred HHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHH
Confidence 666789999999999999865 6788999998643 334578899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
| -||-.++|.- .++++..-++..|..+.++||+|||+.. .||||||+.||||.+.+.+|++|||-|.+..+.
T Consensus 108 C-lGSAsDlleV--hkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA-- 179 (948)
T KOG0577|consen 108 C-LGSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAPA-- 179 (948)
T ss_pred H-hccHHHHHHH--HhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCch--
Confidence 9 6687777732 3567888999999999999999999988 999999999999999999999999999987543
Q ss_pred ccccCceeecC
Q 006347 639 QADTGRVVGTL 649 (649)
Q Consensus 639 ~~~~~~~~GT~ 649 (649)
++++|||
T Consensus 180 ----nsFvGTP 186 (948)
T KOG0577|consen 180 ----NSFVGTP 186 (948)
T ss_pred ----hcccCCc
Confidence 3477875
|
|
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=7.5e-22 Score=206.68 Aligned_cols=151 Identities=30% Similarity=0.523 Sum_probs=131.3
Q ss_pred cCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 550 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (649)
++|.+.+.||+|+||.||++... +...+|+|.++... .....++..|+.++.++ +|+||+++++++.+.+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 56888899999999999999753 23579999987542 34456788999999999 7999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 617 (649)
..++||||+++|+|.+++.... ....+++.+++.++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 9999999999999999996532 1235899999999999999999999887 99999999999999
Q ss_pred CCCceEEEecCCceeeC
Q 006347 618 EELNPKISDFGMAKIFG 634 (649)
Q Consensus 618 ~~~~~Ki~DFGla~~~~ 634 (649)
+++.+||+|||+++.+.
T Consensus 175 ~~~~~kL~dfg~a~~~~ 191 (307)
T cd05098 175 EDNVMKIADFGLARDIH 191 (307)
T ss_pred CCCcEEECCCccccccc
Confidence 99999999999998653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=201.84 Aligned_cols=149 Identities=32% Similarity=0.569 Sum_probs=129.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.+|++.+.||+|+||.||+|... ++. .+|+|.+..... ....++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 45677789999999999999865 233 689998865432 345789999999999999999999999987 78899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999999642 345899999999999999999999977 9999999999999999999999999998765
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 161 ~ 161 (279)
T cd05057 161 V 161 (279)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=201.47 Aligned_cols=150 Identities=27% Similarity=0.449 Sum_probs=132.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+|++++++++..+...++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 36788899999999999999987 68999999886432 2234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|++++.|..++.. ...+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 153 (286)
T cd07847 81 YCDHTVLNELEKN---PRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGP 153 (286)
T ss_pred ccCccHHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCC
Confidence 9999988887643 345899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=197.99 Aligned_cols=151 Identities=25% Similarity=0.414 Sum_probs=133.9
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..+.||+|+||.||.++.. +++.+++|.+... .....+++.+|+.++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 4778899999999999998865 6889999987643 244567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~ 154 (256)
T cd08221 81 ANGGTLYDKIVRQ-KGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSE 154 (256)
T ss_pred cCCCcHHHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccc
Confidence 9999999999653 2356899999999999999999999887 999999999999999999999999999987443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=4.9e-23 Score=211.52 Aligned_cols=160 Identities=30% Similarity=0.445 Sum_probs=140.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.|+..+.||+|.||.||||... .++.||+|.+.-. ...+.++..+|+.++..++|+||.+++|.+..+...+++||||
T Consensus 14 ~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~ 93 (467)
T KOG0201|consen 14 LYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYC 93 (467)
T ss_pred ccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHh
Confidence 4666689999999999999976 6889999999754 3445678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCc
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 639 (649)
.+|++.+.|.. ...+++....-|++++..||.|||.++ .+|||||+.|||+.+++.+|++|||.|..+.....+
T Consensus 94 ~gGsv~~lL~~---~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~r 167 (467)
T KOG0201|consen 94 GGGSVLDLLKS---GNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKR 167 (467)
T ss_pred cCcchhhhhcc---CCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhhc
Confidence 99999999842 334477777788999999999999998 999999999999999999999999999999777666
Q ss_pred cccCceeecC
Q 006347 640 ADTGRVVGTL 649 (649)
Q Consensus 640 ~~~~~~~GT~ 649 (649)
. .+++|||
T Consensus 168 r--~tfvGTP 175 (467)
T KOG0201|consen 168 R--KTFVGTP 175 (467)
T ss_pred c--ccccccc
Confidence 5 4489996
|
|
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.2e-22 Score=205.00 Aligned_cols=149 Identities=31% Similarity=0.551 Sum_probs=128.9
Q ss_pred cCcccceeeccCCcEEEEEEEecC-Cc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|...+ +. .+++|.++.. .....+.|.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 467888999999999999998763 33 4788888642 234457899999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 556 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
+||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986421 1135889999999999999999999987 9999999999999999999
Q ss_pred EEEecCCcee
Q 006347 623 KISDFGMAKI 632 (649)
Q Consensus 623 Ki~DFGla~~ 632 (649)
||+|||+++.
T Consensus 159 kl~dfg~~~~ 168 (297)
T cd05089 159 KIADFGLSRG 168 (297)
T ss_pred EECCcCCCcc
Confidence 9999999874
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=199.48 Aligned_cols=149 Identities=37% Similarity=0.611 Sum_probs=132.3
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|.+.++||+|+||.||+|...+++.+|+|.+.... ....++.+|+.++++++|+|++++++++ ..+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVV-TQEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEE-ccCCcEEEEEcC
Confidence 35688889999999999999998889999999987543 3457899999999999999999999986 456789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||+++...
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~ 153 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIE 153 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecC
Confidence 999999998543 2346899999999999999999999887 9999999999999999999999999998765
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=199.48 Aligned_cols=142 Identities=33% Similarity=0.576 Sum_probs=123.4
Q ss_pred eeccCCcEEEEEEEec---CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCC
Q 006347 488 KLGQGGFGPVYWGRLK---DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRS 563 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (649)
.||+|+||.||+|... ++..||+|.+..... ...++|.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 356799999865432 33567999999999999999999999875 457899999999999
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|.+++.. ....+++..+++++.|+++||+|||+.+ ++||||||+|||++.+..+||+|||+++.+..
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 147 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGA 147 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccC
Confidence 9999854 2356899999999999999999999987 99999999999999999999999999986643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=199.79 Aligned_cols=149 Identities=34% Similarity=0.579 Sum_probs=131.4
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.++||+|+||.||++...++..+|+|.+.... ...+.|.+|+.++++++|+|++++++++. .+..+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCC-CCHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 4577789999999999999998888899999986533 34578999999999999999999999875 556899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++.+. ....+++..+..++.+++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIED 154 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccC
Confidence 99999998642 2345899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=203.24 Aligned_cols=148 Identities=29% Similarity=0.474 Sum_probs=130.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|.+.++||+|+||.||+|... +++.||+|.++... ......+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 46888899999999999999876 67899999986432 23345678999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ ++|.+++.+. ...+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||+++...
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 155 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKS 155 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccC
Confidence 97 5898888542 345789999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.2e-22 Score=201.53 Aligned_cols=151 Identities=21% Similarity=0.441 Sum_probs=132.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||++... +++.+|||.+... ......++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 35777889999999999999964 7899999987642 2234568899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++++|.+++.... ....+++..+..++.++++||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+.
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~ 157 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFS 157 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccc
Confidence 9999999999886422 2456899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=198.57 Aligned_cols=149 Identities=33% Similarity=0.550 Sum_probs=130.3
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|.+.++||+|++|.||++....+..+|+|.+... ....+.+.+|+.++++++|+|++++++++. .+..++||||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPG-TMMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccC-CccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 457788999999999999999887778999988643 234567899999999999999999999875 556889999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++... ....+++..+..++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIED 154 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccC
Confidence 99999999653 2345889999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-21 Score=203.61 Aligned_cols=148 Identities=28% Similarity=0.489 Sum_probs=133.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.+|+..+.||.|++|.||+|... +++.||+|.+........+.+.+|+.+++.++|+|++++++++.+.+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 45888899999999999999864 78999999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++.+ ..+++.++..++.++++||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~ 167 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITP 167 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccc
Confidence 99999998843 35899999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=203.39 Aligned_cols=152 Identities=30% Similarity=0.547 Sum_probs=132.5
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|+..+.||+|+||.||++... ++..+|+|.+.... ....++|.+|+.++.+++|+||+++++++.+++..
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 456888899999999999999864 46789999986542 23457799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCC-------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006347 553 MLIYEYMPNRSLDALLFDPL-------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN 613 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~-------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 613 (649)
++||||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 99999999999999986321 1134788999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEecCCceeeC
Q 006347 614 ILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 614 ILl~~~~~~Ki~DFGla~~~~ 634 (649)
|++++++.+||+|||+++.+.
T Consensus 161 il~~~~~~~~l~dfg~~~~~~ 181 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIY 181 (288)
T ss_pred eEecCCCceEECccccceecc
Confidence 999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=198.77 Aligned_cols=148 Identities=33% Similarity=0.515 Sum_probs=131.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|.+.+.||+|++|.||++... +++++|+|.+.... ....+.+.+|+.++.+++|+||+++++++.+.+..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 46888899999999999999865 68999999886432 1234578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+||+++++|.+++.. ...+++.....++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+.
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999999853 345788999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=197.71 Aligned_cols=147 Identities=39% Similarity=0.635 Sum_probs=131.1
Q ss_pred eeeccCCcEEEEEEEecC----CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||++.... +..+|||.+...... ..+++.+|+..+.+++|+|++++++++.++...++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 479999999999999764 788999999764433 368899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 562 RSLDALLFDPLK------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 562 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++|.+++..... ...+++..+..++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999965321 367899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 158 ~ 158 (262)
T cd00192 158 D 158 (262)
T ss_pred c
Confidence 3
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.9e-22 Score=213.59 Aligned_cols=149 Identities=28% Similarity=0.395 Sum_probs=130.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-C-----CCccceEEEEEeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-----RNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H-----~niv~l~g~~~~~~~~~l 554 (649)
+|.+.+.||+|.||+|.||... +++.||||+++. ...-.++-..|+.+|..|+ | -|+|++++++..+++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN-~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKN-KKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeecc-ChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 6888999999999999999876 699999999965 3455677788999999996 4 489999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CceEEEecCCcee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE--LNPKISDFGMAKI 632 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~Ki~DFGla~~ 632 (649)
|+|.+ .-+|.++|+.+ +...++...+..|+.||+.||.+||+.+ |||+||||+||||.+. ..+||+|||.|..
T Consensus 266 VfELL-~~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELL-STNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhh-hhhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 99998 56999999764 4567999999999999999999999887 9999999999999864 4699999999987
Q ss_pred eCCC
Q 006347 633 FGGN 636 (649)
Q Consensus 633 ~~~~ 636 (649)
....
T Consensus 341 ~~q~ 344 (586)
T KOG0667|consen 341 ESQR 344 (586)
T ss_pred cCCc
Confidence 6443
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.2e-21 Score=197.53 Aligned_cols=149 Identities=28% Similarity=0.500 Sum_probs=135.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|...+.||+|+||.||++... +++.+|+|.+........+.+.+|+.++++++|+||+++++++.+.+..+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 57888899999999999999875 57889999987655556788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++... ...++...+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..+.
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~ 152 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLT 152 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhh
Confidence 999999998542 256889999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=201.68 Aligned_cols=150 Identities=32% Similarity=0.477 Sum_probs=131.4
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
.+|+..+.||+|+||.||+|+.. +...+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 46788899999999999999864 2467999988654333 4578999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 554 LIYEYMPNRSLDALLFDPLKK------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999999653311 26899999999999999999999987 999999999999999999999999
Q ss_pred CCceee
Q 006347 628 GMAKIF 633 (649)
Q Consensus 628 Gla~~~ 633 (649)
|+++..
T Consensus 162 ~~~~~~ 167 (275)
T cd05046 162 SLSKDV 167 (275)
T ss_pred cccccc
Confidence 998754
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=215.49 Aligned_cols=148 Identities=24% Similarity=0.383 Sum_probs=122.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--------C
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--------E 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~ 550 (649)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+|+.++++++|+|||++++++... .
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~ 140 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNI 140 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCce
Confidence 457999999999999999999875 68899999885422 2345799999999999999999887532 1
Q ss_pred eEEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecC
Q 006347 551 EKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFG 628 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFG 628 (649)
..++||||+++ +|.+++... .....+++.....++.||++||+|||+.+ |+||||||+|||++.+. .+||+|||
T Consensus 141 ~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DFG 216 (440)
T PTZ00036 141 FLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDFG 216 (440)
T ss_pred EEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeeccc
Confidence 35699999975 676666422 23456899999999999999999999987 99999999999999664 79999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+|+.+..
T Consensus 217 la~~~~~ 223 (440)
T PTZ00036 217 SAKNLLA 223 (440)
T ss_pred cchhccC
Confidence 9997643
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.4e-21 Score=195.72 Aligned_cols=150 Identities=21% Similarity=0.368 Sum_probs=132.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+|++.++||+|+||.||++... +++.+|+|.++.. .....+.+.+|+.++++++|+||+++++.+.+++..++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677899999999999999876 6889999988543 2345577889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++... ....++......++.|+++||.|||+.+ |+|+||||+||++++++.++++|||+++.+..
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 152 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTS 152 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecc
Confidence 999999988542 3345788999999999999999999987 99999999999999999999999999987743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=199.80 Aligned_cols=147 Identities=31% Similarity=0.474 Sum_probs=129.0
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc----------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG----------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE 550 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~----------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (649)
+|...+.||+|+||.||+|... +++.+|||.++.... ...+.+..|+.++.+++|+|++++++++..++
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 688999998753211 11346888999999999999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
..++||||+++++|.+++.+. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999998542 56889999999999999999999987 999999999999999999999999999
Q ss_pred eeeC
Q 006347 631 KIFG 634 (649)
Q Consensus 631 ~~~~ 634 (649)
+...
T Consensus 156 ~~~~ 159 (272)
T cd06629 156 KKSD 159 (272)
T ss_pred cccc
Confidence 8754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.2e-21 Score=205.86 Aligned_cols=151 Identities=30% Similarity=0.522 Sum_probs=130.8
Q ss_pred cCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 550 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (649)
.+|.+.++||+|+||.||+++.. ....+|+|.++... .....++..|+.++.++ +|+||+++++++.+.+
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 46778899999999999999742 24579999886432 34456789999999999 6999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 617 (649)
..++||||+++|+|.+++.... ....+++.++..++.|++.||.|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999996421 1245899999999999999999999987 99999999999999
Q ss_pred CCCceEEEecCCceeeC
Q 006347 618 EELNPKISDFGMAKIFG 634 (649)
Q Consensus 618 ~~~~~Ki~DFGla~~~~ 634 (649)
+++.+||+|||+++.+.
T Consensus 169 ~~~~~kL~Dfg~~~~~~ 185 (314)
T cd05099 169 EDNVMKIADFGLARGVH 185 (314)
T ss_pred CCCcEEEcccccccccc
Confidence 99999999999998764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=202.54 Aligned_cols=148 Identities=30% Similarity=0.489 Sum_probs=131.0
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc-----cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
+|+..+.||+|+||.||+|... +++.||||++...... ....+..|++++.+++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999976 6899999999654322 345677899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+ +++|.+++... ...+++..+..++.||++||.|||+.+ |+|+||||+||+++.++.+||+|||+++....
T Consensus 81 ~e~~-~~~L~~~i~~~--~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDK--SIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 99999999542 236899999999999999999999987 99999999999999999999999999988754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.3e-21 Score=201.59 Aligned_cols=152 Identities=32% Similarity=0.538 Sum_probs=131.2
Q ss_pred hcCcccceeeccCCcEEEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|.+.+.||+|+||.||+|.... +..||+|.+.... ......|.+|+.++++++|+||+++++++.+.+..
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999998753 5679999886433 23456799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEE
Q 006347 553 MLIYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL---NPKIS 625 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~Ki~ 625 (649)
++||||+++++|.+++.... ....+++..+++++.||++||+|||+.+ ++||||||+||++++++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 99999999999999986432 1235899999999999999999999987 99999999999998654 69999
Q ss_pred ecCCceeeC
Q 006347 626 DFGMAKIFG 634 (649)
Q Consensus 626 DFGla~~~~ 634 (649)
|||+++.+.
T Consensus 162 dfg~~~~~~ 170 (277)
T cd05036 162 DFGMARDIY 170 (277)
T ss_pred cCccccccC
Confidence 999998763
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.1e-21 Score=202.88 Aligned_cols=159 Identities=29% Similarity=0.438 Sum_probs=135.0
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEE---
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCV--- 547 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~--- 547 (649)
++.+..+.++|++.+.||+|+||.||++... +++.+|+|.++.. .....++.+|+.++.++ +|+||+++++++.
T Consensus 10 ~~~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 88 (286)
T cd06638 10 FDSFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPI-HDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKD 88 (286)
T ss_pred eecCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccc-cchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecc
Confidence 3455567789999999999999999999875 6789999988643 22346788999999999 6999999999885
Q ss_pred --eCCeEEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 548 --EGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 548 --~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
.++..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||
T Consensus 89 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl 165 (286)
T cd06638 89 VKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKL 165 (286)
T ss_pred cCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEE
Confidence 3456899999999999999875322 2356889999999999999999999887 999999999999999999999
Q ss_pred EecCCceeeCC
Q 006347 625 SDFGMAKIFGG 635 (649)
Q Consensus 625 ~DFGla~~~~~ 635 (649)
+|||+++.+..
T Consensus 166 ~dfg~~~~~~~ 176 (286)
T cd06638 166 VDFGVSAQLTS 176 (286)
T ss_pred ccCCceeeccc
Confidence 99999987643
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.87 E-value=8.5e-22 Score=204.90 Aligned_cols=142 Identities=29% Similarity=0.504 Sum_probs=128.5
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
...||+|+||.||++... ++..||||.+........+.+.+|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 27 ~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L 106 (292)
T cd06658 27 FIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGAL 106 (292)
T ss_pred hhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcH
Confidence 468999999999999875 6889999998765555667899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+.
T Consensus 107 ~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~ 169 (292)
T cd06658 107 TDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS 169 (292)
T ss_pred HHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcc
Confidence 998832 35889999999999999999999987 9999999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.8e-21 Score=203.51 Aligned_cols=146 Identities=25% Similarity=0.389 Sum_probs=131.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||++... .++.||+|.+.... ....+.+.+|+.+++.++|+||+++++.+.++++.++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 46888899999999999999876 57899999986543 234567889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
||+++++|.+++.. ...+++..+..++.++++||.|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~ 150 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKI 150 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccc
Confidence 99999999999953 346899999999999999999999987 99999999999999999999999999975
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=208.82 Aligned_cols=147 Identities=28% Similarity=0.418 Sum_probs=125.8
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----- 550 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 550 (649)
..++|++.+.||+|+||.||++... +++.||||.+... .....+++.+|+.++..++|+||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 3478999999999999999999875 6899999998643 2334567889999999999999999999987543
Q ss_pred -eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 551 -EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 551 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
..++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDA-NLCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCc-CHHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 47999999965 5655552 23788889999999999999999987 99999999999999999999999999
Q ss_pred ceeeC
Q 006347 630 AKIFG 634 (649)
Q Consensus 630 a~~~~ 634 (649)
++...
T Consensus 170 a~~~~ 174 (359)
T cd07876 170 ARTAC 174 (359)
T ss_pred ccccc
Confidence 98653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.7e-21 Score=198.32 Aligned_cols=142 Identities=32% Similarity=0.550 Sum_probs=124.1
Q ss_pred eeccCCcEEEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 488 KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+||+|+||.||+|..+ ++..+|+|+++... ....+++.+|+.++++++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 6899999999999753 57889999986433 234578999999999999999999999875 55778999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++.+...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~ 148 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGAD 148 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCC
Confidence 99999843 346899999999999999999999987 999999999999999999999999999877543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-21 Score=206.73 Aligned_cols=152 Identities=29% Similarity=0.515 Sum_probs=131.1
Q ss_pred cCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 550 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (649)
.+|.+.+.||+|+||.||++... ....||+|.++... ....+++.+|+.++.++ +|+||+++++++.+++
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 35788899999999999999742 12468999886432 33467899999999999 7999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 617 (649)
..+++|||+++|+|.+++.... ....+++..+..++.|+++||+|||+.+ |+||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986421 2345889999999999999999999987 99999999999999
Q ss_pred CCCceEEEecCCceeeCC
Q 006347 618 EELNPKISDFGMAKIFGG 635 (649)
Q Consensus 618 ~~~~~Ki~DFGla~~~~~ 635 (649)
+++.+||+|||+++.+..
T Consensus 169 ~~~~~kL~Dfg~~~~~~~ 186 (334)
T cd05100 169 EDNVMKIADFGLARDVHN 186 (334)
T ss_pred CCCcEEECCcccceeccc
Confidence 999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.4e-21 Score=200.96 Aligned_cols=149 Identities=29% Similarity=0.422 Sum_probs=129.3
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++++|.+.+.||+|+||.||+|... +++.+|||.+..... .....+.+|+.++++++|+||+++++++.+++..++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 4578999999999999999999875 688999999865432 33456789999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||++ ++|.+++... ...+.+..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||+++..
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~ 153 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAK 153 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEecccccccc
Confidence 9996 6777776432 345788888899999999999999987 999999999999999999999999999865
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.6e-21 Score=197.83 Aligned_cols=146 Identities=36% Similarity=0.590 Sum_probs=129.7
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc---------cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ---------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~---------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
|.+...||+|+||.||+|... +++.+|+|.+...... ..+.+.+|+.++.+++|+||+++++++.+.+..
T Consensus 2 ~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (267)
T cd06628 2 WIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHL 81 (267)
T ss_pred ccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCcc
Confidence 566789999999999999875 6789999988643221 235688999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++.
T Consensus 82 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 82 NIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred EEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999953 356888999999999999999999987 99999999999999999999999999988
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
+.
T Consensus 156 ~~ 157 (267)
T cd06628 156 LE 157 (267)
T ss_pred cc
Confidence 75
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.3e-21 Score=199.81 Aligned_cols=148 Identities=34% Similarity=0.616 Sum_probs=131.0
Q ss_pred CcccceeeccCCcEEEEEEEec-----CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKM 553 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 553 (649)
.|+..+.||+|+||.||+++.. .+..+|||.+...... ..++|.+|+.++++++|+||+++++++.. +...+
T Consensus 5 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~ 84 (284)
T cd05038 5 HLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLR 84 (284)
T ss_pred hchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceE
Confidence 4666789999999999999864 3678999999754432 46789999999999999999999999987 55789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+
T Consensus 85 lv~e~~~~~~l~~~l~~~--~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 159 (284)
T cd05038 85 LIMEYLPSGSLRDYLQRH--RDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKVL 159 (284)
T ss_pred EEEecCCCCCHHHHHHhC--ccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEccccccccc
Confidence 999999999999999542 235899999999999999999999987 999999999999999999999999999987
Q ss_pred C
Q 006347 634 G 634 (649)
Q Consensus 634 ~ 634 (649)
.
T Consensus 160 ~ 160 (284)
T cd05038 160 P 160 (284)
T ss_pred c
Confidence 5
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.87 E-value=2e-21 Score=198.66 Aligned_cols=148 Identities=32% Similarity=0.494 Sum_probs=128.6
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (649)
++|++.+.||+|+||.||++... ++..||||.+.... ....+.+.+|+.++.+++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 47888899999999999999876 58899999875321 12346788999999999999999999998764 457
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ...+++....+++.|++.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999999853 245788889999999999999999987 99999999999999999999999999986
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
+.
T Consensus 156 ~~ 157 (265)
T cd06652 156 LQ 157 (265)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.5e-21 Score=207.76 Aligned_cols=149 Identities=28% Similarity=0.433 Sum_probs=128.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC------
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------ 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (649)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++|+||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENF 92 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhccccccccc
Confidence 3467888899999999999999865 67899999986532 23446788999999999999999999987643
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
...++++|++ +++|.+++. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 93 ~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 93 NEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred CcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 789988873 345899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
++....
T Consensus 165 ~~~~~~ 170 (343)
T cd07878 165 ARQADD 170 (343)
T ss_pred ceecCC
Confidence 997643
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.87 E-value=3e-21 Score=199.18 Aligned_cols=149 Identities=30% Similarity=0.535 Sum_probs=131.9
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+|+..++||+|++|.||+|+.. +++.||||.++.... .....+.+|+.++++++|+||+++++++.+.+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999986 688999999875432 23567789999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ +|.+++........+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~ 151 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFG 151 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhc
Confidence 85 88888865444456899999999999999999999987 9999999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.3e-21 Score=196.02 Aligned_cols=148 Identities=32% Similarity=0.529 Sum_probs=129.4
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~ 559 (649)
.+|.+.+.||+|+||.||++... +..+|+|.++.. ...+.|.+|+.++++++|+|++++++++.+ ++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~-~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEEc-CCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 35778899999999999999876 788999988643 345689999999999999999999998654 45789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++... ....+++..++.++.+++.||+|||+.+ ++||||||+||++++++.+||+|||+++....
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 154 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 154 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccc
Confidence 999999998653 2345889999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.3e-21 Score=199.94 Aligned_cols=151 Identities=25% Similarity=0.366 Sum_probs=127.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHH-HhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMV-ISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||++... +|+.||||+++... .....++..|+.+ ++.++|+||+++++++.+++..++|||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999976 68999999987542 2334566667765 556689999999999999999999999
Q ss_pred cCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|++ |+|.+++... .....+++..+..++.||+.||+|||++. +++||||||+||++++++.+||+|||+++.+.
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~--~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~ 155 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKL--SVIHRDVKPSNVLINRNGQVKLCDFGISGYLV 155 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcC--CeecCCCCHHHEEECCCCCEEEeecccccccc
Confidence 996 7888887542 23356899999999999999999999862 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=196.64 Aligned_cols=150 Identities=31% Similarity=0.539 Sum_probs=132.5
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|++.++||+|+||.||++...++..+|+|.+... ....+.|.+|+.++++++|+|++++++.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC-hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 3568888999999999999999887888999988643 3345789999999999999999999999887 7789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++... ....+++..+..++.+++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 999999999653 2345789999999999999999999887 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.2e-21 Score=198.28 Aligned_cols=146 Identities=30% Similarity=0.533 Sum_probs=130.0
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
+|+..+.||+|+||+||+|...+++.+|||.++... ....+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 366778999999999999998889999999886422 12335688999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||+++..
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 152 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRL 152 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhh
Confidence 999999999999953 345789999999999999999999887 999999999999999999999999999865
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=197.34 Aligned_cols=144 Identities=33% Similarity=0.489 Sum_probs=128.0
Q ss_pred eeeccCCcEEEEEEEecC--C--cEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD--G--QEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~--g--~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|++|.||+|.... + ..||||.+..... ...+++.+|+.++.+++|+||+++++.+.+ ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 468999999999998753 2 3699999976554 567789999999999999999999999988 889999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++|.+++.+... ..+++.....++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~ 149 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQ 149 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEeccccccccccc
Confidence 999999965422 56899999999999999999999987 99999999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.8e-21 Score=202.94 Aligned_cols=142 Identities=32% Similarity=0.524 Sum_probs=128.2
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
..+||+|+||.||++... +++.||||.+........+.+.+|+.++..++||||+++++++..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 358999999999999875 6899999998655445567788999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
..++. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 106 ~~~~~----~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~ 168 (297)
T cd06659 106 TDIVS----QTRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQIS 168 (297)
T ss_pred HHHHh----hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcc
Confidence 99873 245889999999999999999999987 9999999999999999999999999997654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-22 Score=210.34 Aligned_cols=151 Identities=29% Similarity=0.518 Sum_probs=131.6
Q ss_pred CcccceeeccCCcEEEEEEEecC---C--cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKD---G--QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~---g--~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.....++||+|-||.||+|++.+ | -.||||.-+.. .....+.|+.|..+|++++|||||+|+|.|.+. ..+||
T Consensus 390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wiv 468 (974)
T KOG4257|consen 390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIV 468 (974)
T ss_pred hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEE
Confidence 34556789999999999998642 3 35899988764 345678899999999999999999999999764 78999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||.++-|.|..||.. ++..|+......++.||+.||+|||+.. .|||||.++|||+...-.+|++||||+|-+..
T Consensus 469 mEL~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed 543 (974)
T KOG4257|consen 469 MELAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLED 543 (974)
T ss_pred EecccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccc
Confidence 999999999999964 4556888999999999999999999987 99999999999999999999999999998865
Q ss_pred CCC
Q 006347 636 NQD 638 (649)
Q Consensus 636 ~~~ 638 (649)
+..
T Consensus 544 ~~y 546 (974)
T KOG4257|consen 544 DAY 546 (974)
T ss_pred cch
Confidence 543
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.1e-21 Score=203.01 Aligned_cols=149 Identities=33% Similarity=0.644 Sum_probs=126.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|+..+.||+|+||.||+|... +++ .+|+|.+..... ....++.+|+.++++++|+||+++++++.+. ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 45677789999999999999864 343 578998865432 3345789999999999999999999998754 4679
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++||+++|+|.+++... ...+++..++.++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999998542 345889999999999999999999987 9999999999999999999999999999765
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 161 ~ 161 (303)
T cd05110 161 G 161 (303)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.5e-21 Score=200.94 Aligned_cols=146 Identities=32% Similarity=0.504 Sum_probs=130.2
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
|+..+.||+|+||.||+|... +++.||+|.++... ....+.+.+|+.++++++|+||+++++++..++..++||||++
T Consensus 6 y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06642 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLG 85 (277)
T ss_pred HHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccC
Confidence 556678999999999999875 57899999886432 3445678999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++. ...+++..+..++.++++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 86 ~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06642 86 GGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccC
Confidence 999999884 346889999999999999999999887 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.6e-21 Score=201.37 Aligned_cols=149 Identities=28% Similarity=0.456 Sum_probs=131.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|+..++||+|+||.||+|... +++.+|+|++..... ...+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 46788899999999999999986 589999998865322 234678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.++... ...+++..+..++.||++||+|||+.+ |+|+||+|+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~ 152 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 152 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccC
Confidence 9999999887642 345899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=200.67 Aligned_cols=148 Identities=29% Similarity=0.480 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|...+.||+|+||.||++... ++..||+|.+........+.+.+|+.++++++|||++++++.+...+..++|+||+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~ 98 (293)
T cd06647 19 KKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYL 98 (293)
T ss_pred hhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecC
Confidence 57888899999999999999864 67899999986554455678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++.+ ..+++.++..++.++++||.|||+.+ ++|+||||+||++++++.+||+|||++..+..
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~ 167 (293)
T cd06647 99 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 167 (293)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccc
Confidence 99999999843 35789999999999999999999987 99999999999999999999999999886643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.7e-21 Score=200.62 Aligned_cols=160 Identities=33% Similarity=0.453 Sum_probs=137.2
Q ss_pred CCHHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 006347 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE 548 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 548 (649)
+...++..++++|.+.+.||+|+||.||++... +++.+|+|.+... .....++.+|+.++.++ +|+|++++++++.+
T Consensus 12 ~~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~-~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~ 90 (291)
T cd06639 12 LGLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPI-SDVDEEIEAEYNILQSLPNHPNVVKFYGMFYK 90 (291)
T ss_pred hhcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEeccc-ccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence 445566677889999999999999999999875 6889999998643 23346778899999999 79999999999876
Q ss_pred CC-----eEEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 549 GE-----EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 549 ~~-----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
.+ ..++||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+
T Consensus 91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~ 167 (291)
T cd06639 91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV 167 (291)
T ss_pred ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence 43 5799999999999999885322 2356899999999999999999999887 9999999999999999999
Q ss_pred EEEecCCceeeC
Q 006347 623 KISDFGMAKIFG 634 (649)
Q Consensus 623 Ki~DFGla~~~~ 634 (649)
||+|||+++.+.
T Consensus 168 kl~dfg~~~~~~ 179 (291)
T cd06639 168 KLVDFGVSAQLT 179 (291)
T ss_pred EEeecccchhcc
Confidence 999999998754
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=195.86 Aligned_cols=148 Identities=33% Similarity=0.485 Sum_probs=133.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..+.||+|+||.||+|... +++.+|+|.++.... ...+++..|+.++++++|+||+++++.+.+.+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4777899999999999999875 688999999875543 3678899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++.. ...+++..+..|+.++++||.|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~ 151 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKN 151 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCC
Confidence 999999999853 345788999999999999999999987 99999999999999999999999999988743
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=203.78 Aligned_cols=143 Identities=21% Similarity=0.243 Sum_probs=115.1
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec--CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG 549 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (649)
....++|.+.+.||+|+||+||+|... +++.+|||++... .....+.|.+|++++.+++|+|++..+.. .
T Consensus 14 ~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~ 90 (365)
T PRK09188 14 PALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T 90 (365)
T ss_pred ccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c
Confidence 344567999999999999999999875 5777899987532 11235679999999999999999853322 2
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCceEEEecC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL-KASNILLDEELNPKISDFG 628 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~Ki~DFG 628 (649)
++.+|||||+++++|.... ... ...++.+++++|.|||+.+ |+|||| ||+|||++.++.+||+|||
T Consensus 91 ~~~~LVmE~~~G~~L~~~~----~~~------~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFG 157 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLAR----PHG------DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQ 157 (365)
T ss_pred CCcEEEEEccCCCCHHHhC----ccc------hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECc
Confidence 5679999999999996321 111 1457889999999999987 999999 9999999999999999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+|+.+..
T Consensus 158 lA~~~~~ 164 (365)
T PRK09188 158 LASVFRR 164 (365)
T ss_pred cceeccc
Confidence 9998754
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.2e-21 Score=201.80 Aligned_cols=144 Identities=28% Similarity=0.463 Sum_probs=119.5
Q ss_pred ceeeccCCcEEEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEEEEecCC
Q 006347 486 SSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIYEYMP 560 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 560 (649)
.++||+|+||.||+|... +++.+|+|.+... .....+.+|+.++++++||||+++++++.+ +...++||||++
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCC--CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 368999999999999865 4678999998643 233567899999999999999999999865 446789999985
Q ss_pred CCChhhhhcCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEecCCc
Q 006347 561 NRSLDALLFDPL------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMA 630 (649)
Q Consensus 561 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~Ki~DFGla 630 (649)
++|.+++.... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+ +..+.+||+|||+|
T Consensus 84 -~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 -HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred -CCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 57877764211 1235888999999999999999999987 9999999999999 45678999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+.+..
T Consensus 160 ~~~~~ 164 (317)
T cd07868 160 RLFNS 164 (317)
T ss_pred eccCC
Confidence 98754
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.1e-21 Score=197.85 Aligned_cols=149 Identities=27% Similarity=0.453 Sum_probs=129.1
Q ss_pred cCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|.+.+.||+|+||.||+|...+ ...||||...... ....+.+.+|+.++++++|+||+++++++.+ +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 457778999999999999998653 2468999886544 3456789999999999999999999998875 567899
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++... ...+++..+..++.++++||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999999542 335899999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4e-21 Score=194.52 Aligned_cols=143 Identities=36% Similarity=0.564 Sum_probs=128.8
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChh
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 565 (649)
++||+|+||.||++...+++.||+|.+...... ..+++.+|+.++++++|+||+++++++.+....++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 479999999999999877999999998754333 5678999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++... ...+++..+..++.+++.||+|||+++ ++||||||+||+++.++.+||+|||+++...
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~ 144 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEE 144 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeecccccccc
Confidence 998542 335789999999999999999999987 9999999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-21 Score=194.60 Aligned_cols=149 Identities=30% Similarity=0.568 Sum_probs=132.5
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.+|++.+.||+|+||.||++...++..+|+|.+... .....+|.+|++++++++|+|++++++++.+....++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREG-AMSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCC-CCCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 356778999999999999999877889999988643 2345689999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~ 152 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLD 152 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeeccc
Confidence 99999998542 345789999999999999999999987 99999999999999999999999999987643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-21 Score=199.64 Aligned_cols=147 Identities=29% Similarity=0.474 Sum_probs=129.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|+..+.||+|++|.||+|... +++.||||.+..... .....+.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 56888899999999999999976 688999999865332 2235677899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++ +|.+++.+. ...+++.....++.|++.||.|||+.+ |+||||||+||++++++.+||+|||+++..
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 153 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAK 153 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECcccccccc
Confidence 974 999888542 236889999999999999999999987 999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.2e-21 Score=197.52 Aligned_cols=149 Identities=28% Similarity=0.526 Sum_probs=133.2
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++++++|+||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4778899999999999999975 68999999986543 33457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+ +++|.+++... ...+++.++..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~-~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~ 152 (286)
T cd07832 81 M-PSDLSEVLRDE--ERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEE 152 (286)
T ss_pred c-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCC
Confidence 9 99999998642 356899999999999999999999987 999999999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.1e-21 Score=197.11 Aligned_cols=143 Identities=34% Similarity=0.588 Sum_probs=123.8
Q ss_pred eeeccCCcEEEEEEEecC-Cc--EEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD-GQ--EIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~-g~--~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+|...+ +. .+|+|.++... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 368999999999999863 43 57889886432 34556889999999999 799999999999999999999999999
Q ss_pred CChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 562 RSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 562 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
|+|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+|||+++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986421 1235789999999999999999999987 9999999999999999999999999
Q ss_pred Ccee
Q 006347 629 MAKI 632 (649)
Q Consensus 629 la~~ 632 (649)
+++.
T Consensus 158 l~~~ 161 (270)
T cd05047 158 LSRG 161 (270)
T ss_pred Cccc
Confidence 9863
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=206.63 Aligned_cols=148 Identities=27% Similarity=0.408 Sum_probs=126.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----- 550 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----- 550 (649)
..++|++.+.||+|+||.||++... .++.||||++.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4468999999999999999999865 68899999986532 234567889999999999999999999886543
Q ss_pred -eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 551 -EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 551 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
..++||||+++ +|.+.+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46999999965 6666663 24788899999999999999999987 99999999999999999999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
++....
T Consensus 166 ~~~~~~ 171 (355)
T cd07874 166 ARTAGT 171 (355)
T ss_pred cccCCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.9e-21 Score=196.99 Aligned_cols=148 Identities=29% Similarity=0.508 Sum_probs=131.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~ 556 (649)
.|+..+.||+|+||.||+|... +++.+|||.+... ......++.+|+.++++++ |+|++++++++.++...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999975 6899999998653 2345577889999999996 999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++++|.+++.. ..+++.....++.+++.||.|||+.+ |+|+||+|+||++++++.+||+|||++..+...
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999999843 36899999999999999999999987 999999999999999999999999999887543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.8e-22 Score=190.30 Aligned_cols=153 Identities=29% Similarity=0.371 Sum_probs=136.3
Q ss_pred hcCcccceeeccCCcEEEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM 553 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 553 (649)
.++|.+.+.||+|||.-||.++ +.++..+|+|++.....++.+..++|++.-++++||||++++.++..+. +.|
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~y 99 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAY 99 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEE
Confidence 4678999999999999999998 4578899999998766678889999999999999999999999887544 489
Q ss_pred EEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 554 LIYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
|++.|...|+|.+.+..... ...+++.+.+.|+.+|++||++||+.. ++.+||||||.|||+.+.+.++|.|||-+..
T Consensus 100 ll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~~ 178 (302)
T KOG2345|consen 100 LLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSATQ 178 (302)
T ss_pred EEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCccc
Confidence 99999999999999875433 347899999999999999999999985 6899999999999999999999999998875
Q ss_pred e
Q 006347 633 F 633 (649)
Q Consensus 633 ~ 633 (649)
.
T Consensus 179 a 179 (302)
T KOG2345|consen 179 A 179 (302)
T ss_pred c
Confidence 3
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.7e-21 Score=205.70 Aligned_cols=148 Identities=26% Similarity=0.403 Sum_probs=126.6
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC------
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------ 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (649)
..++|++.+.||+|+||.||++... .++.||||++.... ....+++.+|+.+++.++|+||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~ 101 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEF 101 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeeccccccccc
Confidence 3468999999999999999999875 68899999986532 33456788999999999999999999987643
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
...++||||+++ +|.+++. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 102 ~~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 102 QDVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred CeEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999965 6777663 24788899999999999999999987 99999999999999999999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
|+....
T Consensus 173 a~~~~~ 178 (364)
T cd07875 173 ARTAGT 178 (364)
T ss_pred ccccCC
Confidence 987643
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.7e-21 Score=196.31 Aligned_cols=148 Identities=32% Similarity=0.471 Sum_probs=133.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+|++.+.||.|+||.||+|... +++.+|+|.+.... ......+.+|+.++++++|+|++++++++.++...++|+||+
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYC 81 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEee
Confidence 5777889999999999999976 68899999986543 345577899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++++|.+++.. ..+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.++|+|||+++.+...
T Consensus 82 ~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~ 151 (274)
T cd06609 82 GGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTST 151 (274)
T ss_pred CCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccc
Confidence 99999999853 27899999999999999999999987 999999999999999999999999999987543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.86 E-value=4.4e-21 Score=202.83 Aligned_cols=145 Identities=21% Similarity=0.322 Sum_probs=125.8
Q ss_pred cceeeccC--CcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 485 LSSKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 485 ~~~~LG~G--~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+.++||+| +|++||++... +|+.||||+++... ....+.+.+|+.+++.++||||+++++++.+++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 34789999 78999999876 78999999996532 233456778999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..+
T Consensus 82 ~~~~l~~~~~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~ 151 (327)
T cd08227 82 AYGSAKDLICTH-FMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 151 (327)
T ss_pred CCCcHHHHHHhh-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcc
Confidence 999999998543 2335899999999999999999999987 999999999999999999999999865443
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.5e-22 Score=213.89 Aligned_cols=152 Identities=34% Similarity=0.526 Sum_probs=134.0
Q ss_pred ccceeeccCCcEEEEEEEec--CC--cEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 484 QLSSKLGQGGFGPVYWGRLK--DG--QEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~--~g--~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.+.++||+|.||.|++|.+. .| ..||||.+...... ....|++|+.+|.+|+|+|+++|||+..+ ...++|+|.
T Consensus 113 ~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~EL 191 (1039)
T KOG0199|consen 113 KLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFEL 191 (1039)
T ss_pred HHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhh
Confidence 44579999999999999876 33 46899999765443 67899999999999999999999999988 788999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
++.|||.+.|++ ..+..+-...+..++.|||.||.||..++ +|||||.++|+||...-.+||+||||.|-++.++.
T Consensus 192 aplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ned 267 (1039)
T KOG0199|consen 192 APLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENED 267 (1039)
T ss_pred cccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCCc
Confidence 999999999987 35566778888999999999999999987 99999999999999999999999999999976654
Q ss_pred cc
Q 006347 639 QA 640 (649)
Q Consensus 639 ~~ 640 (649)
..
T Consensus 268 ~Y 269 (1039)
T KOG0199|consen 268 MY 269 (1039)
T ss_pred ce
Confidence 43
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.2e-21 Score=197.08 Aligned_cols=148 Identities=31% Similarity=0.513 Sum_probs=130.2
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+|+..+.||+|++|.||++... +++.+|+|.+.... ....+.+..|+.++++++|+||+++++++.+++..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 4677789999999999999864 68999999986432 1135688999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~ 633 (649)
||||+++++|.+++.+ ...+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++ .+||+|||+++.+
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999999853 346889999999999999999999987 99999999999998775 5999999999877
Q ss_pred CC
Q 006347 634 GG 635 (649)
Q Consensus 634 ~~ 635 (649)
..
T Consensus 155 ~~ 156 (268)
T cd06630 155 AA 156 (268)
T ss_pred cc
Confidence 54
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-21 Score=194.00 Aligned_cols=152 Identities=30% Similarity=0.496 Sum_probs=135.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||+||+|... ++..+|+|++.... ....+.+.+|+.+++.++|+|++++++.+.+++..++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 46888999999999999999865 67899999986432 23567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++........+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~ 154 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLAD 154 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhcc
Confidence 999999999965323356899999999999999999999887 99999999999999999999999999987644
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.3e-21 Score=195.98 Aligned_cols=146 Identities=31% Similarity=0.483 Sum_probs=130.3
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
|+..++||+|+||.||+|... +++.+|||.+.... ....+.+.+|+.++.+++|+||+++++++.+++..++||||++
T Consensus 6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 85 (277)
T cd06641 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLG 85 (277)
T ss_pred hhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCC
Confidence 566789999999999999865 68899999886432 2345678899999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++. ...+++.....++.+++.|+.|||+.+ ++|+||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06641 86 GGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 153 (277)
T ss_pred CCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceeccc
Confidence 999999984 245889999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.86 E-value=2.9e-21 Score=223.19 Aligned_cols=159 Identities=25% Similarity=0.406 Sum_probs=132.1
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--Ce
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EE 551 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~ 551 (649)
....++|.+.++||+|+||+||++... .+..+|+|.+... .......|..|+.++.+|+|||||++++++.+. ..
T Consensus 9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~ 88 (1021)
T PTZ00266 9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQK 88 (1021)
T ss_pred ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCE
Confidence 344568999999999999999999976 5778999988643 233457899999999999999999999988654 46
Q ss_pred EEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CceEecCCCCCcEEEcCC-------
Q 006347 552 KMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSR----LRIIHRDLKASNILLDEE------- 619 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~iiHrDlkp~NILl~~~------- 619 (649)
.+|||||+++|+|.++|.... ....+++..++.|+.||+.||+|||+.+. .+||||||||+||||+.+
T Consensus 89 lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i 168 (1021)
T PTZ00266 89 LYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168 (1021)
T ss_pred EEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccc
Confidence 899999999999999986422 23568999999999999999999998532 349999999999999653
Q ss_pred ----------CceEEEecCCceeeCC
Q 006347 620 ----------LNPKISDFGMAKIFGG 635 (649)
Q Consensus 620 ----------~~~Ki~DFGla~~~~~ 635 (649)
..+||+|||+++.+..
T Consensus 169 ~~~~~n~ng~~iVKLsDFGlAr~l~~ 194 (1021)
T PTZ00266 169 TAQANNLNGRPIAKIGDFGLSKNIGI 194 (1021)
T ss_pred cccccccCCCCceEEccCCccccccc
Confidence 3489999999997743
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.1e-21 Score=195.26 Aligned_cols=148 Identities=32% Similarity=0.500 Sum_probs=128.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (649)
.+|...+.||+|+||.||++... ++..+|+|++.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 47888899999999999999875 68899999886432 12345788999999999999999999998763 567
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++++||+++++|.+++.. ...+++.....++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999999853 345889999999999999999999887 99999999999999999999999999986
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
+.
T Consensus 156 ~~ 157 (266)
T cd06651 156 LQ 157 (266)
T ss_pred cc
Confidence 53
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=197.41 Aligned_cols=149 Identities=29% Similarity=0.508 Sum_probs=124.1
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcC---CCCCccceEEEEEeC-----C
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKL---QHRNLVRLLGCCVEG-----E 550 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~-----~ 550 (649)
+|++.+.||+|+||+||++... +++.||+|.++.... .....+.+|+.++.++ +|+||+++++++.+. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 4778899999999999999876 688999999864321 2234566777777665 699999999998753 3
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
..++||||++ ++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVD-QDLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEcccc-cCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 5789999997 5888888542 2345899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+.+..
T Consensus 156 ~~~~~ 160 (288)
T cd07863 156 RIYSC 160 (288)
T ss_pred ccccC
Confidence 98743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=3.9e-21 Score=198.81 Aligned_cols=148 Identities=24% Similarity=0.351 Sum_probs=131.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||+||++... +++.+|+|.+.... ....+++.+|++++..++|+||+++++++.+.+..++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 45777889999999999999876 68899999876432 34467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++++|.+++.. ...+++.....++.+++.||.|||+.. +++||||||+||++++++.+||+|||+++.+
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~ 154 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGEL 154 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccch
Confidence 999999998843 346899999999999999999999742 3999999999999999999999999998765
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.86 E-value=1.4e-21 Score=199.11 Aligned_cols=143 Identities=29% Similarity=0.467 Sum_probs=124.2
Q ss_pred eeeccCCcEEEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+.||+|+||.||+|.... ..++|+|.+........+++.+|+.+++.++|+|++++++++..++..++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 469999999999998642 235888888655555567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--------eEEEecCCc
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--------PKISDFGMA 630 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~Ki~DFGla 630 (649)
+++|+|.+++... ...+++..++.++.||+.||+|||+.+ |+||||||+||+++.++. +|++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999999643 336899999999999999999999987 999999999999987765 699999998
Q ss_pred eeeC
Q 006347 631 KIFG 634 (649)
Q Consensus 631 ~~~~ 634 (649)
....
T Consensus 156 ~~~~ 159 (258)
T cd05078 156 ITVL 159 (258)
T ss_pred cccC
Confidence 7654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.4e-21 Score=199.31 Aligned_cols=145 Identities=28% Similarity=0.463 Sum_probs=119.6
Q ss_pred ceeeccCCcEEEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEEEEecCC
Q 006347 486 SSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIYEYMP 560 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~Ey~~ 560 (649)
..+||+|+||.||+|+.. ++..+|+|.++... ....+.+|+.++.+++||||+++++++.. +...++||||++
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE 83 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC
Confidence 368999999999999865 35789999986532 33567899999999999999999999864 456789999986
Q ss_pred CCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEecCCc
Q 006347 561 NRSLDALLFDP------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMA 630 (649)
Q Consensus 561 ~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~Ki~DFGla 630 (649)
+ +|.+++... .....+++..+..++.||+.||.|||+.+ |+||||||+|||+ ++++.+||+|||+|
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 84 H-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 4 777766321 12235889999999999999999999987 9999999999999 56678999999999
Q ss_pred eeeCCC
Q 006347 631 KIFGGN 636 (649)
Q Consensus 631 ~~~~~~ 636 (649)
+.+...
T Consensus 160 ~~~~~~ 165 (317)
T cd07867 160 RLFNSP 165 (317)
T ss_pred eccCCC
Confidence 987543
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.2e-21 Score=197.82 Aligned_cols=148 Identities=32% Similarity=0.401 Sum_probs=129.9
Q ss_pred CcccceeeccCCcEEEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (649)
+|++.+.||+|+||.||++.. .+|+.||+|++.... ....+++.+|+.++.++ +|+||+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 467788999999999999986 368899999986532 22346788999999999 699999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++||||||+|||+++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999999853 346888899999999999999999987 99999999999999999999999999987
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 155 ~~~ 157 (290)
T cd05613 155 FHE 157 (290)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.86 E-value=6.5e-21 Score=193.31 Aligned_cols=148 Identities=30% Similarity=0.515 Sum_probs=134.2
Q ss_pred cCcccceeeccCCcEEEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|+..+.||+|+||.||+|...+ ++.+++|.+..... .+++.+|++++++++|+||+++++.+.++...++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 578888999999999999999874 78999999865432 688999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~ 151 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTD 151 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhccc
Confidence 99999999853 2456899999999999999999999987 99999999999999999999999999998644
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=9.3e-21 Score=199.08 Aligned_cols=150 Identities=29% Similarity=0.358 Sum_probs=133.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|+..+.||+|+||.||++... +++.+|||.+..... ...+.+..|++++.+++|+||+++++.+.++...++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 36788899999999999999987 489999999875432 24567899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++....
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 154 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSD 154 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccc
Confidence 999999999998642 3356899999999999999999999987 9999999999999999999999999988653
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.5e-21 Score=195.90 Aligned_cols=147 Identities=30% Similarity=0.485 Sum_probs=131.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.|+..++||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.++.|+||+++++++.++...++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 4666789999999999999976 58899999886432 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++++|.+++.. ..+++.....++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+..
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTD 153 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccC
Confidence 99999999843 45788999999999999999999887 99999999999999999999999999987754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.86 E-value=5.1e-21 Score=195.08 Aligned_cols=143 Identities=29% Similarity=0.536 Sum_probs=122.2
Q ss_pred eeeccCCcEEEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeEEEEEecCC
Q 006347 487 SKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKMLIYEYMP 560 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~Ey~~ 560 (649)
+.||+|+||.||+|... +...+|||++... .....+.+.+|+.+++.++||||+++++++.. ++..++|+||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 46899999999999864 2457999998543 23456788999999999999999999998764 446789999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++|.+++.+. ...+++..++.++.|+++||+|||+.+ ++||||||+|||+++++.+||+|||+++.+.
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~ 149 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIY 149 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCcccccccc
Confidence 99999999642 334678888999999999999999887 9999999999999999999999999998653
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.86 E-value=7.9e-21 Score=199.23 Aligned_cols=150 Identities=27% Similarity=0.471 Sum_probs=127.8
Q ss_pred CcccceeeccCCcEEEEEEEec---CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM 553 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 553 (649)
.|++.++||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+. ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 3677889999999999999975 37899999987632 33456788999999999999999999999988 7899
Q ss_pred EEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC----CCceEEEec
Q 006347 554 LIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDF 627 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~----~~~~Ki~DF 627 (649)
+||||+++ +|.+++..... ...++......++.|++.||+|||+.+ |+||||||+||++++ ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999975 66666543221 236889999999999999999999987 999999999999999 999999999
Q ss_pred CCceeeCC
Q 006347 628 GMAKIFGG 635 (649)
Q Consensus 628 Gla~~~~~ 635 (649)
|+++.+..
T Consensus 157 g~~~~~~~ 164 (316)
T cd07842 157 GLARLFNA 164 (316)
T ss_pred ccccccCC
Confidence 99997643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=191.90 Aligned_cols=150 Identities=24% Similarity=0.383 Sum_probs=130.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~lV~E 557 (649)
+|++.+.||+|++|.||++... +++.+|+|++.... ....+.+.+|++++++++|+|++++++.+.. ....++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 4778899999999999999876 57899999986432 3445678999999999999999999998764 446789999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.+++... ....+++.++..++.+++.||+|||+.+ |+|+||||+||++++++.+||+|||+++.+..
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~ 154 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN 154 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecc
Confidence 99999999998652 2345899999999999999999999987 99999999999999999999999999998743
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.2e-21 Score=192.96 Aligned_cols=149 Identities=40% Similarity=0.649 Sum_probs=131.2
Q ss_pred ccceeeccCCcEEEEEEEecC-----CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 484 QLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++.+.||+|+||.||+++..+ +..||+|.+...... ..+.+..|+..+.+++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456899999999999999763 388999999654433 57789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 82 ~~~~~~l~~~~~~~~-~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 156 (258)
T smart00219 82 YMEGGDLLDYLRKNR-PKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDD 156 (258)
T ss_pred ccCCCCHHHHHHhhh-hccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceecccc
Confidence 999999999985421 122899999999999999999999987 999999999999999999999999999877543
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.6e-21 Score=194.08 Aligned_cols=145 Identities=32% Similarity=0.558 Sum_probs=127.4
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||.||++.. .++.+|+|.++.. ...+.+.+|+.++.+++|+|++++++++.+. ..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCD--VTAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCc--chHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCC
Confidence 3577889999999999999975 4788999998643 2346889999999999999999999998754 5799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++|.+++... ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++..
T Consensus 82 ~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~ 150 (254)
T cd05083 82 KGNLVNFLRTR-GRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVG 150 (254)
T ss_pred CCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceec
Confidence 99999999653 2345889999999999999999999887 999999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=192.22 Aligned_cols=150 Identities=25% Similarity=0.420 Sum_probs=132.6
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|++.+.||+|+||.||++... +++.+|+|++... .....+++.+|+.++++++|+||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999875 6889999998643 233456899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++... ....+++..++.++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++..+..
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~ 153 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNS 153 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCc
Confidence 9999999988542 2335789999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.9e-21 Score=194.88 Aligned_cols=149 Identities=32% Similarity=0.539 Sum_probs=125.7
Q ss_pred cccceeeccCCcEEEEEEEec----CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------ 550 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (649)
|.+.+.||+|+||.||+|... +++.||||.+... .....+++.+|+.++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456689999999999999864 3688999988653 2334677899999999999999999999987643
Q ss_pred eEEEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 551 EKMLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
..++++||+++|+|.+++.... ....+++.....++.|++.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2378999999999998875321 1235788999999999999999999987 999999999999999999999999
Q ss_pred CCceeeC
Q 006347 628 GMAKIFG 634 (649)
Q Consensus 628 Gla~~~~ 634 (649)
|+++.+.
T Consensus 158 g~~~~~~ 164 (273)
T cd05074 158 GLSKKIY 164 (273)
T ss_pred ccccccc
Confidence 9999764
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.6e-21 Score=195.82 Aligned_cols=148 Identities=30% Similarity=0.405 Sum_probs=133.3
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
+|.+.+.||+|+||.||++... +++.+|+|.+.+.. ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 4778899999999999999986 58999999986532 2456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~~~~L~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~ 152 (258)
T cd05578 81 LLLGGDLRYHLSQ---KVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTP 152 (258)
T ss_pred CCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCC
Confidence 9999999999853 257889999999999999999999987 99999999999999999999999999987644
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=8.8e-21 Score=192.99 Aligned_cols=142 Identities=36% Similarity=0.588 Sum_probs=124.2
Q ss_pred eeeccCCcEEEEEEEec--C--CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK--D--GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~--~--g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
++||+|+||.||+|... + +..+|+|.+..... ...+++.+|+.+++++.|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 47999999999999764 2 26899999875443 35678999999999999999999999875 5578999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++|.+++... ..+++..+..++.|++.||+|||+.+ ++|+||||+|||+++++.+||+|||+++.+..
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~ 147 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGA 147 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeec
Confidence 9999999642 36899999999999999999999887 99999999999999999999999999997743
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=196.47 Aligned_cols=150 Identities=25% Similarity=0.426 Sum_probs=128.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe-----
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE----- 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~----- 551 (649)
++|++.+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++.++ +|+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999976 68999999876432 22346788999999999 57999999999987766
Q ss_pred EEEEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecC
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFG 628 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFG 628 (649)
.++||||+++ +|.+++..... ...+++..+..++.||++||.|||+.+ |+||||||+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999985 88888754322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred CceeeC
Q 006347 629 MAKIFG 634 (649)
Q Consensus 629 la~~~~ 634 (649)
+++.+.
T Consensus 157 ~~~~~~ 162 (295)
T cd07837 157 LGRAFS 162 (295)
T ss_pred cceecC
Confidence 998763
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.3e-21 Score=196.34 Aligned_cols=158 Identities=30% Similarity=0.477 Sum_probs=135.0
Q ss_pred CHHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEe-
Q 006347 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE- 548 (649)
Q Consensus 472 ~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~- 548 (649)
+..++..+.+.|++.+.||+|+||.||+|... +++.+|+|.+... .....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC-hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 44555566788999999999999999999975 6889999988653 23456788999999998 79999999999864
Q ss_pred -----CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006347 549 -----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623 (649)
Q Consensus 549 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K 623 (649)
.+..+++|||+++|+|.+++... ....+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+|
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 45789999999999999998642 2345788889999999999999999987 99999999999999999999
Q ss_pred EEecCCceeeC
Q 006347 624 ISDFGMAKIFG 634 (649)
Q Consensus 624 i~DFGla~~~~ 634 (649)
|+|||+++...
T Consensus 162 l~dfg~~~~~~ 172 (282)
T cd06636 162 LVDFGVSAQLD 172 (282)
T ss_pred EeeCcchhhhh
Confidence 99999988653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.3e-20 Score=192.02 Aligned_cols=150 Identities=30% Similarity=0.451 Sum_probs=135.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|.+.+.||+|++|.||+++.. +++.++||++..... ...+++.+|+..+.+++|+|++++++++...+..++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 36788899999999999999987 589999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++++|.+++.. ...+++..+..++.|+++||+|||+ .+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~ 153 (264)
T cd06623 81 MDGGSLADLLKK---VGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENT 153 (264)
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccC
Confidence 999999999954 2568999999999999999999998 77 999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=9.8e-22 Score=193.84 Aligned_cols=141 Identities=28% Similarity=0.454 Sum_probs=128.4
Q ss_pred eeeccCCcEEEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 487 SKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
+.||+|+++.|--++ +.+|.++|||++++.......+..+|++++...+ |+||++|+.|+.+++..|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 689999999999886 5689999999999887788899999999999995 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEecCCceee
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIF 633 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DFGla~~~ 633 (649)
..+|. +...+++.+.-++..+||.||.|||.++ |.||||||+|||-.+... +||+||.|+.-+
T Consensus 164 LshI~---~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~ 229 (463)
T KOG0607|consen 164 LSHIQ---KRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGI 229 (463)
T ss_pred HHHHH---HhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeecccccccc
Confidence 99884 4567899999999999999999999998 999999999999876544 799999987654
|
|
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.8e-21 Score=196.68 Aligned_cols=148 Identities=28% Similarity=0.519 Sum_probs=130.3
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..+.||+|+||.||+|+.. +++.||||++.... ....+.+.+|++++.+++|+||+++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778899999999999999876 68899999886432 22346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~ 151 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFG 151 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcc
Confidence 95 6898888542 3456899999999999999999999887 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.2e-23 Score=196.11 Aligned_cols=161 Identities=29% Similarity=0.423 Sum_probs=134.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecc--cccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
+++|++.+.||+|+|+.||++... +|+.+|+|.++. ....+.+++.+|+.+-+.|+|||||+|.....+....|||+
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvF 89 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 89 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEE
Confidence 456778899999999999999765 788999887753 23457889999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~DFGla~~~ 633 (649)
|+|.+++|-.-+- .+...++...-..+.||+.+|.|+|.++ |||||+||+|+||... --+|++|||+|..+
T Consensus 90 e~m~G~dl~~eIV---~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l 163 (355)
T KOG0033|consen 90 DLVTGGELFEDIV---AREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEV 163 (355)
T ss_pred ecccchHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEe
Confidence 9999999965542 2355788888899999999999999998 9999999999999643 34899999999999
Q ss_pred CCCCCccccCceeecC
Q 006347 634 GGNQDQADTGRVVGTL 649 (649)
Q Consensus 634 ~~~~~~~~~~~~~GT~ 649 (649)
++.+. -...+|||
T Consensus 164 ~~g~~---~~G~~GtP 176 (355)
T KOG0033|consen 164 NDGEA---WHGFAGTP 176 (355)
T ss_pred CCccc---cccccCCC
Confidence 73332 22356665
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.15 Aligned_cols=148 Identities=32% Similarity=0.522 Sum_probs=129.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (649)
.+|.+.+.||+|+||.||++... +++.+|+|.+... .....+.+.+|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 46888899999999999999875 6899999987432 123456888999999999999999999998764 457
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.+||+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999999853 345788999999999999999999987 99999999999999999999999999987
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
+.
T Consensus 156 ~~ 157 (264)
T cd06653 156 IQ 157 (264)
T ss_pred cc
Confidence 63
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=197.47 Aligned_cols=147 Identities=25% Similarity=0.497 Sum_probs=128.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..+.||+|+||.||+++.. +|+.+|+|+++... ......+.+|+.++.+++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999976 68899999986432 22345688899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ ++|.+++... ...+++.....++.||++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+.
T Consensus 81 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 150 (284)
T cd07839 81 CD-QDLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFG 150 (284)
T ss_pred CC-CCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccC
Confidence 97 5788777432 345899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.8e-22 Score=194.88 Aligned_cols=151 Identities=28% Similarity=0.477 Sum_probs=125.9
Q ss_pred CcccceeeccCCcEEEEEEEec---C--CcEEEEEEecccccc-c-HHHHHHHHHHHhcCCCCCccceEEEEEe-CCeEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK---D--GQEIAVKRLSKASGQ-G-LEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKM 553 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~---~--g~~vAVK~l~~~~~~-~-~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~ 553 (649)
.|+...+||+|.+|.|||++-. + ..++|||+++..... + -....+|+.+++.++|+||+.|..++.. +...+
T Consensus 25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~ 104 (438)
T KOG0666|consen 25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVW 104 (438)
T ss_pred HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEE
Confidence 5777789999999999999644 2 237999999754221 1 2456789999999999999999999988 66789
Q ss_pred EEEecCCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CceEEEec
Q 006347 554 LIYEYMPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKISDF 627 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~Ki~DF 627 (649)
|++||.+. +|..+|+- ..+.+.++...+..|+.||+.|++|||++= |+||||||.|||+..+ |.+||+||
T Consensus 105 l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 105 LLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred EEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999976 77777752 223457888999999999999999999986 9999999999999877 89999999
Q ss_pred CCceeeCCC
Q 006347 628 GMAKIFGGN 636 (649)
Q Consensus 628 Gla~~~~~~ 636 (649)
||||++...
T Consensus 181 GlaR~~~~p 189 (438)
T KOG0666|consen 181 GLARLFNNP 189 (438)
T ss_pred cHHHHhhcc
Confidence 999998544
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.85 E-value=6.9e-21 Score=209.56 Aligned_cols=153 Identities=27% Similarity=0.450 Sum_probs=121.5
Q ss_pred HhcCcccceeeccCCcEEEEEEEe-----------------cCCcEEEEEEecccccccHHHH--------------HHH
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRL-----------------KDGQEIAVKRLSKASGQGLEEF--------------MNE 527 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~-----------------~~g~~vAVK~l~~~~~~~~~~f--------------~~E 527 (649)
..++|++.++||+|+||+||+|.. ..++.||||++........++| ..|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 467899999999999999999964 2356899999865332223333 346
Q ss_pred HHHHhcCCCCCc-----cceEEEEEe--------CCeEEEEEecCCCCChhhhhcCCC---------------------C
Q 006347 528 VMVISKLQHRNL-----VRLLGCCVE--------GEEKMLIYEYMPNRSLDALLFDPL---------------------K 573 (649)
Q Consensus 528 ~~~l~~l~H~ni-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 573 (649)
+..+.+++|.++ ++++++|.. .+..+|||||+++++|.++|+... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 678888764 356899999999999999986421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 574 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
...++|..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~ 360 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccc
Confidence 123577888999999999999999987 9999999999999999999999999998653
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1e-20 Score=195.60 Aligned_cols=150 Identities=28% Similarity=0.438 Sum_probs=131.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||+|... +++.||||.++.. .....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 36888899999999999999977 5889999988643 23345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|++++.|..++. +...+++..+..++.+|+.||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+...
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~ 153 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRAR 153 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCC
Confidence 999877776653 2345899999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=196.26 Aligned_cols=150 Identities=29% Similarity=0.458 Sum_probs=130.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV 555 (649)
++|+..+.||+|+||.||+|... +++.+|+|.++... ......+.+|+.++.+++|+||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 46777889999999999999987 68899999986432 22234677899999999999999999999887 889999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||++ ++|.+++... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+++.+..
T Consensus 85 ~e~~~-~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVE-HDLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcC-cCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 99997 5898888542 236899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 159 ~ 159 (293)
T cd07843 159 P 159 (293)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.7e-20 Score=196.35 Aligned_cols=148 Identities=32% Similarity=0.527 Sum_probs=129.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
..|+..+.||+|+||.||+|+.. +++.||+|.+..... ...+++.+|++++++++|+||+++++++.+++..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 45777889999999999999876 688999998864322 33467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ |+|+||+|+||++++++.+||+|||+++...
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~ 166 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS 166 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecC
Confidence 9996 677777642 2346899999999999999999999987 9999999999999999999999999998764
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.1e-20 Score=193.42 Aligned_cols=153 Identities=31% Similarity=0.489 Sum_probs=133.6
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCC-----
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE----- 550 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~----- 550 (649)
.++++|++.+.||+|+||.||+|... +++.+++|.+.... ...+++.+|+.++.++ +|+||+++++++.+..
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE-DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc-hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35678999999999999999999986 57899999986543 3457899999999999 7999999999998755
Q ss_pred -eEEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 551 -EKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 551 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
..++||||+++++|.+++.... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 4899999999999999986422 2456899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeC
Q 006347 629 MAKIFG 634 (649)
Q Consensus 629 la~~~~ 634 (649)
+++...
T Consensus 159 ~~~~~~ 164 (275)
T cd06608 159 VSAQLD 164 (275)
T ss_pred cceecc
Confidence 998753
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-20 Score=189.52 Aligned_cols=150 Identities=29% Similarity=0.447 Sum_probs=131.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|...+.||+|+||.||++... +++.+|||.+... .....+++.+|+.++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778899999999999999875 6889999998653 234567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++... ....+++..+..++.++++||+|||+.+ ++|+||||+||+++++ ..+||+|||+++.+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSS 154 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCC
Confidence 9999999999652 2345899999999999999999999987 9999999999999854 5689999999997753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.3e-21 Score=185.68 Aligned_cols=142 Identities=17% Similarity=0.153 Sum_probs=110.3
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccc--c-------HHHH-----------------HHHHHHHhcCCCCCc
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--G-------LEEF-----------------MNEVMVISKLQHRNL 539 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--~-------~~~f-----------------~~E~~~l~~l~H~ni 539 (649)
.+.||+|+||.||+|...+|+.||||+++..... . ...| ..|+..+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3689999999999999888999999998653211 1 1122 349999999988776
Q ss_pred cceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEEcC
Q 006347 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 540 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl~~ 618 (649)
.....+. ....+|||||+++++|...+. ....++..+...++.|++.+|.|| |+.+ |+||||||+|||+++
T Consensus 82 ~~p~~~~--~~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~~ 153 (190)
T cd05147 82 PCPEPIL--LKSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYHD 153 (190)
T ss_pred CCCcEEE--ecCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEEC
Confidence 4433332 233489999999887765432 234688999999999999999999 5766 999999999999984
Q ss_pred CCceEEEecCCceeeCCC
Q 006347 619 ELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~~~ 636 (649)
+.+||+|||+|.....+
T Consensus 154 -~~v~LiDFG~a~~~~~~ 170 (190)
T cd05147 154 -GKLYIIDVSQSVEHDHP 170 (190)
T ss_pred -CcEEEEEccccccCCCc
Confidence 78999999999876443
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=7.4e-22 Score=221.85 Aligned_cols=170 Identities=27% Similarity=0.315 Sum_probs=144.5
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecc---cccccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
..+++....+|.+.+.||+|+||.|..+++. +++.+|+|++++ .......-|..|-.+|.--+.+=|++|+-.|.+
T Consensus 67 v~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD 146 (1317)
T KOG0612|consen 67 VKELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQD 146 (1317)
T ss_pred HHHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcC
Confidence 3455666678999999999999999999986 678899999976 233455678889999998899999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
..+.|+|||||+||+|-.++.+. .+++......++..|.-||.-||+-+ +|||||||+|||||..|++|++|||
T Consensus 147 ~~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFG 220 (1317)
T KOG0612|consen 147 ERYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFG 220 (1317)
T ss_pred ccceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccch
Confidence 99999999999999999999542 36888888888999999999999877 9999999999999999999999999
Q ss_pred CceeeCCCCCccccCceeecC
Q 006347 629 MAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 629 la~~~~~~~~~~~~~~~~GT~ 649 (649)
-+-.+..+..- .....+|||
T Consensus 221 sClkm~~dG~V-~s~~aVGTP 240 (1317)
T KOG0612|consen 221 SCLKMDADGTV-RSSVAVGTP 240 (1317)
T ss_pred hHHhcCCCCcE-EeccccCCC
Confidence 88887654433 334578997
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.85 E-value=3e-20 Score=187.93 Aligned_cols=148 Identities=32% Similarity=0.518 Sum_probs=133.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|++.+.||+|++|.||+++.. +++.+|+|.+..... ...+.+.+|++++.+++|+|++++++++.+++..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677899999999999999876 678999999876543 4567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+|+||||+||++++++.+||+|||+++....
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 151 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLND 151 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCC
Confidence 999999999853 256899999999999999999999887 99999999999999999999999999998754
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.2e-20 Score=193.49 Aligned_cols=145 Identities=28% Similarity=0.479 Sum_probs=129.6
Q ss_pred ccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 484 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
...+.||+|++|.||++... +++.+++|++........+.+.+|+.++++++|+||+++++++..++..++|+||++++
T Consensus 22 ~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~ 101 (285)
T cd06648 22 DNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGG 101 (285)
T ss_pred hcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCC
Confidence 33469999999999999865 68899999986554455677899999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 102 ~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~ 167 (285)
T cd06648 102 ALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK 167 (285)
T ss_pred CHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhcc
Confidence 99999843 45889999999999999999999987 99999999999999999999999999886543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-21 Score=220.97 Aligned_cols=149 Identities=34% Similarity=0.522 Sum_probs=123.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC-------
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------- 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------- 549 (649)
..++|.+.+.||+||||.|||++.+ ||+.+|||+|... +........+|+.++++|+|||||+++..+++.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ 556 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVL 556 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccc
Confidence 4467888899999999999999987 8999999999654 334556788999999999999999887654221
Q ss_pred --------------------------------------------------------------------------------
Q 006347 550 -------------------------------------------------------------------------------- 549 (649)
Q Consensus 550 -------------------------------------------------------------------------------- 549 (649)
T Consensus 557 ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~ 636 (1351)
T KOG1035|consen 557 EIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDS 636 (1351)
T ss_pred cccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccccc
Confidence
Q ss_pred --------------------------------CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH
Q 006347 550 --------------------------------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597 (649)
Q Consensus 550 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH 597 (649)
.-.||-||||+.-.|.+++.++.-.. .-...++++++|+.||+|+|
T Consensus 637 e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 637 EGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred CCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHHH
Confidence 01367789998888888875432111 35667889999999999999
Q ss_pred hCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 598 ~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+.+ ||||||||.||+||++..+||+|||+|..
T Consensus 715 ~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 715 DQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred hCc---eeeccCCcceeEEcCCCCeeecccccchh
Confidence 998 99999999999999999999999999997
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=195.74 Aligned_cols=152 Identities=28% Similarity=0.519 Sum_probs=130.6
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC----
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE---- 550 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 550 (649)
...++|++.+.||+|+||.||+|+.. +++.||||+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 34567889999999999999999986 58899999986532 233457788999999999999999999987655
Q ss_pred ------eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 551 ------EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 551 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
..++|+||+++ +|..++.. ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 78999999976 67777643 2346899999999999999999999987 999999999999999999999
Q ss_pred EecCCceeeCC
Q 006347 625 SDFGMAKIFGG 635 (649)
Q Consensus 625 ~DFGla~~~~~ 635 (649)
+|||+++.+..
T Consensus 158 ~dfg~~~~~~~ 168 (302)
T cd07864 158 ADFGLARLYNS 168 (302)
T ss_pred CcccccccccC
Confidence 99999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=194.82 Aligned_cols=142 Identities=28% Similarity=0.488 Sum_probs=128.1
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChh
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 565 (649)
.+||+|+||.||++... +++.||||++..........+.+|+.++++++|+|++++++.+.+++..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 58999999999999875 78999999986544455677999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 566 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++.. ..+++.....++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+..
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~ 168 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK 168 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccc
Confidence 98742 35789999999999999999999987 99999999999999999999999999887643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.84 E-value=7.4e-21 Score=194.68 Aligned_cols=144 Identities=37% Similarity=0.565 Sum_probs=124.9
Q ss_pred eeccCCcEEEEEEEecC-------CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 488 KLGQGGFGPVYWGRLKD-------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~~-------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.||+|+||.||+|+..+ +..+|||.+.... .....++.+|+.++++++|+||+++++++..++..++||||+
T Consensus 2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 81 (269)
T cd05044 2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELM 81 (269)
T ss_pred ccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEecc
Confidence 68999999999998642 2579999886533 245678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-----ceEEEecCCc
Q 006347 560 PNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-----NPKISDFGMA 630 (649)
Q Consensus 560 ~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-----~~Ki~DFGla 630 (649)
++++|.+++.+.. ....+++.+++.++.|++.||.|||+.+ ++|+||||+||+++.+. .+|++|||++
T Consensus 82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 82 EGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred CCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 9999999996422 2234789999999999999999999887 99999999999999877 8999999999
Q ss_pred eeeC
Q 006347 631 KIFG 634 (649)
Q Consensus 631 ~~~~ 634 (649)
+.+.
T Consensus 159 ~~~~ 162 (269)
T cd05044 159 RDIY 162 (269)
T ss_pred cccc
Confidence 8653
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=8.8e-21 Score=211.82 Aligned_cols=153 Identities=23% Similarity=0.405 Sum_probs=120.6
Q ss_pred HhcCcccceeeccCCcEEEEEEEecC--CcEEEEE------------------EecccccccHHHHHHHHHHHhcCCCCC
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLKD--GQEIAVK------------------RLSKASGQGLEEFMNEVMVISKLQHRN 538 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK------------------~l~~~~~~~~~~f~~E~~~l~~l~H~n 538 (649)
..++|++.++||+|+||+||++..+. +...++| ++. ........+.+|+.++.+++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 34689999999999999999987542 2222222 111 11223467889999999999999
Q ss_pred ccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK--KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 539 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
||++++++.+.+..++|+|++. ++|.+++..... ...........|+.||+.||.|||+.+ ||||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 9999999999999999999984 577777643211 122335567789999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCC
Q 006347 617 DEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~ 636 (649)
+.++.+||+|||+|+.+...
T Consensus 301 ~~~~~vkL~DFGla~~~~~~ 320 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKE 320 (501)
T ss_pred CCCCCEEEEeCCCceecCcc
Confidence 99999999999999987543
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=193.48 Aligned_cols=142 Identities=30% Similarity=0.429 Sum_probs=125.5
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||+|+||+||++... +++.+|+|.+.... ....+.+..|++++++++|+||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 68899999986432 23355678899999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.+++... ....+++.++..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~~~l~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~ 146 (277)
T cd05577 81 KYHIYNV-GEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELK 146 (277)
T ss_pred HHHHHHc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhc
Confidence 9998653 2246899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.5e-20 Score=185.86 Aligned_cols=150 Identities=34% Similarity=0.597 Sum_probs=135.5
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++++......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 688999999976554567889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 151 (253)
T cd05122 81 GGSLKDLLKST--NQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDT 151 (253)
T ss_pred CCcHHHHHhhc--CCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccc
Confidence 99999998542 256899999999999999999999977 999999999999999999999999999887544
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=194.16 Aligned_cols=151 Identities=28% Similarity=0.407 Sum_probs=130.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (649)
++|...++||.|++|.||++... +++.+|+|.+..... ....++.+|++++++++|+||+++++++.+. ...++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 36778899999999999999986 688999999875332 3557799999999999999999999998754 3689999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||+++++|.+++... .....+++.....++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~ 156 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV 156 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence 999999999887532 13455888999999999999999999987 9999999999999999999999999988653
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.8e-20 Score=191.88 Aligned_cols=153 Identities=30% Similarity=0.516 Sum_probs=128.9
Q ss_pred CcccceeeccCCcEEEEEEEecC--CcEEEEEEeccc----------ccccHHHHHHHHHHHhc-CCCCCccceEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKD--GQEIAVKRLSKA----------SGQGLEEFMNEVMVISK-LQHRNLVRLLGCCVE 548 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~----------~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~ 548 (649)
+|++.+.||+|+||.||+|.... ++.+|||.+... ......++..|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999864 678999987532 12234567889888875 699999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
++..++||||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+||++++++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999999887431 23456889999999999999999999632 3999999999999999999999999
Q ss_pred CCceeeCCC
Q 006347 628 GMAKIFGGN 636 (649)
Q Consensus 628 Gla~~~~~~ 636 (649)
|++......
T Consensus 159 g~~~~~~~~ 167 (269)
T cd08528 159 GLAKQKQPE 167 (269)
T ss_pred cceeecccc
Confidence 999986543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2e-20 Score=190.36 Aligned_cols=155 Identities=28% Similarity=0.492 Sum_probs=130.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 556 (649)
+|++.+.||.|+||.||++... +++.+|+|.+... .....+++..|+.++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4677889999999999999865 6789999988643 23345678899999999999999999998764 44678999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++++|.+++... .....+++.....++.+++.||+|||..+ ..+++|+||||+||++++++.+||+|||+++.+
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 999999999998542 22457899999999999999999999332 334999999999999999999999999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 161 ~~~ 163 (265)
T cd08217 161 GHD 163 (265)
T ss_pred cCC
Confidence 543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.6e-20 Score=190.52 Aligned_cols=150 Identities=25% Similarity=0.465 Sum_probs=131.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|+..+.||+|+||.||++... ++..+|+|.+.... ....+.+.+|+.++++++|+||+++++.+.+++..++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 4778899999999999999986 58899999986432 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++.+. ....+++..+..++.++++||.|||+.+ ++|+||||+||++++++ .+||+|||++..+..
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~ 154 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLND 154 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccC
Confidence 9999999998642 2335799999999999999999999987 99999999999999875 579999999987754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=187.67 Aligned_cols=150 Identities=35% Similarity=0.526 Sum_probs=134.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (649)
+|+..+.||+|++|.||+|... +++.|++|.+..... ...+.+.+|+.++++++|+||+++++.+.+. +..++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3677789999999999999987 688999999865432 4578899999999999999999999999988 8899999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++++|.+++... ..+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+||+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998542 37899999999999999999999987 999999999999999999999999999987554
Q ss_pred C
Q 006347 637 Q 637 (649)
Q Consensus 637 ~ 637 (649)
.
T Consensus 155 ~ 155 (260)
T cd06606 155 E 155 (260)
T ss_pred c
Confidence 3
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=192.71 Aligned_cols=150 Identities=29% Similarity=0.524 Sum_probs=135.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.+++|+..+.||+|++|.||++... ++..+|+|.+..... ..+.+.+|++++++++|+|++++++.+...+..++|+|
T Consensus 17 ~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 95 (286)
T cd06614 17 PRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVME 95 (286)
T ss_pred ccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEe
Confidence 4566788889999999999999987 688999999975443 56789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+++++|.+++.... ..+++..+..++.+++.||+|||+.+ |+|+||+|+||+++.++.+||+|||++....
T Consensus 96 ~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~ 167 (286)
T cd06614 96 YMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT 167 (286)
T ss_pred ccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence 999999999996421 37899999999999999999999977 9999999999999999999999999987654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.8e-20 Score=191.54 Aligned_cols=149 Identities=28% Similarity=0.494 Sum_probs=127.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|++|.||+|... +++.||||.+.... ....+.+.+|+.++++++|+||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 46888899999999999999976 68899999886432 2334678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~ 634 (649)
|++ ++|.+++... ....+++.....++.||+.||+|||+.+ ++|+||+|+||++++ +..+||+|||+++...
T Consensus 82 ~~~-~~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~ 154 (294)
T PLN00009 82 YLD-LDLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFG 154 (294)
T ss_pred ccc-ccHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccC
Confidence 996 5787777432 2234678888899999999999999987 999999999999985 5679999999998754
|
|
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.5e-20 Score=191.87 Aligned_cols=148 Identities=28% Similarity=0.408 Sum_probs=132.1
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+|+..+.||+|+||.||++... +++.+|+|++.... ....+++.+|+.++++++|+||+++++.+...+..++|+||+
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 81 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYM 81 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEec
Confidence 5677789999999999999987 68899999987543 345578999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++... ...++......++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||+++.+.
T Consensus 82 ~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~ 152 (265)
T cd06605 82 DGGSLDKILKEV--QGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV 152 (265)
T ss_pred CCCcHHHHHHHc--cCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhH
Confidence 999999998542 2568899999999999999999998 66 9999999999999999999999999987653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.3e-20 Score=191.30 Aligned_cols=148 Identities=30% Similarity=0.534 Sum_probs=130.4
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEEEe
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIYE 557 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~E 557 (649)
|++.++||+|+||.||+|+.. +++.+|+|++.... ....+.+.+|+.++.+++|+|++++++++.+. ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 556789999999999999977 58899999997653 33456788999999999999999999999988 88999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+++ +|.+++... ...+++..++.++.|+++||+|||+.+ ++|+||||+||++++++.+||+|||+++.....
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~ 153 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKR 153 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCC
Confidence 9975 898888542 246899999999999999999999987 999999999999999999999999999987544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.84 E-value=3e-20 Score=191.90 Aligned_cols=141 Identities=30% Similarity=0.362 Sum_probs=118.9
Q ss_pred eeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHh---cCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVIS---KLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~---~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.||+|+||.||++... +++.+|||.+.+.. ......+.+|..++. ..+|+|++++++.+.+.+..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999875 68899999886432 122233445554433 3479999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~ 148 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence 9999999853 346899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=189.62 Aligned_cols=141 Identities=30% Similarity=0.401 Sum_probs=126.6
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||.|+||.||+++.. +++.+|+|.+.+.. ....+.+.+|+.++++++|+||+++++.+.+++..++|+||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999987 48899999986532 23457899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
.+++.+ ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||+++....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~ 145 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKS 145 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCc
Confidence 999954 345889999999999999999999987 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-21 Score=192.06 Aligned_cols=161 Identities=29% Similarity=0.330 Sum_probs=137.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|..++.||+|.||.|..++.+ +++.+|||++++.. ..+...-+.|-++|...+||.+..|--.+...++.+.||
T Consensus 168 ~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVM 247 (516)
T KOG0690|consen 168 EDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVM 247 (516)
T ss_pred chhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEE
Confidence 57888899999999999999876 78999999998753 234456678999999999999999998999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||..+|.|.-+|. +.+.+++.....+-..|..||.|||+.+ ||.||||.+|.|||.++++||+||||++.-...
T Consensus 248 eyanGGeLf~HLs---rer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~ 321 (516)
T KOG0690|consen 248 EYANGGELFFHLS---RERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY 321 (516)
T ss_pred EEccCceEeeehh---hhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc
Confidence 9999999988873 4567888877788999999999999988 999999999999999999999999999964322
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
. ..+.+..|||
T Consensus 322 g--~t~kTFCGTP 332 (516)
T KOG0690|consen 322 G--DTTKTFCGTP 332 (516)
T ss_pred c--ceeccccCCh
Confidence 2 2344578885
|
|
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=191.48 Aligned_cols=140 Identities=32% Similarity=0.481 Sum_probs=126.2
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||+|+||.||+++.. +++.+|+|.+..... ...+.+.+|+.++.+++|+||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999987 489999999865432 4567889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.+++.+. ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++....
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~ 144 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGL 144 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcc
Confidence 9998542 36899999999999999999999987 9999999999999999999999999988753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.1e-20 Score=198.51 Aligned_cols=149 Identities=30% Similarity=0.542 Sum_probs=128.3
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeC--CeE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG--EEK 552 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~--~~~ 552 (649)
..++|++.+.||+|+||.||+|... +++.+|||++... .......+.+|+.++.++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999976 6889999988542 233456788899999999 999999999998754 368
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 599888843 26789999999999999999999987 99999999999999999999999999987
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 157 ~~~ 159 (337)
T cd07852 157 LSE 159 (337)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-20 Score=179.94 Aligned_cols=143 Identities=20% Similarity=0.243 Sum_probs=113.4
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccc--c------------------------HHHHHHHHHHHhcCCCCCc
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--G------------------------LEEFMNEVMVISKLQHRNL 539 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--~------------------------~~~f~~E~~~l~~l~H~ni 539 (649)
...||+|+||+||+|...+|+.||||.++..... . ...+..|...+.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3689999999999999888999999998754211 0 1123578999999999987
Q ss_pred cceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 006347 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 540 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~ 618 (649)
.....+... +.+|||||++++++..... ....++..+...++.+++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 655544333 3489999999886544321 23457788889999999999999999 77 99999999999999
Q ss_pred CCceEEEecCCceeeCCCC
Q 006347 619 ELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~~~~ 637 (649)
++.++|+|||+|+.+..+.
T Consensus 153 ~~~~~liDFG~a~~~~~~~ 171 (190)
T cd05145 153 DGKPYIIDVSQAVELDHPN 171 (190)
T ss_pred CCCEEEEEcccceecCCCC
Confidence 8899999999999886543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.9e-22 Score=209.60 Aligned_cols=161 Identities=27% Similarity=0.444 Sum_probs=138.8
Q ss_pred CcccceeeccCCcEEEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.|.++..||.|+||.|||++.++ +...|.|.|...++...+.|+-|+++|+...||+||+|++.+...+..+|..|||.
T Consensus 33 ~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~ 112 (1187)
T KOG0579|consen 33 HWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCG 112 (1187)
T ss_pred HHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecC
Confidence 45667899999999999999874 44567888887778888999999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCcc
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~ 640 (649)
||-.+.++.. -...|....+.-++++++.||.|||++. |||||||+.|||+.-+|.++++|||.+........+.
T Consensus 113 GGAVDaimlE--L~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR 187 (1187)
T KOG0579|consen 113 GGAVDAIMLE--LGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR 187 (1187)
T ss_pred CchHhHHHHH--hccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence 9999998854 3467899999999999999999999998 9999999999999999999999999876653332222
Q ss_pred ccCceeecC
Q 006347 641 DTGRVVGTL 649 (649)
Q Consensus 641 ~~~~~~GT~ 649 (649)
. ++.|||
T Consensus 188 D--sFIGTP 194 (1187)
T KOG0579|consen 188 D--SFIGTP 194 (1187)
T ss_pred c--cccCCc
Confidence 2 367775
|
|
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.9e-21 Score=197.54 Aligned_cols=155 Identities=29% Similarity=0.401 Sum_probs=137.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
+.|+.-+.||+|+||.||-+... +|+-+|.|++.+. ..+++...++|-.++.+++.+.||.|--.+...+..+||+
T Consensus 185 n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVL 264 (591)
T KOG0986|consen 185 NTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVL 264 (591)
T ss_pred cceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEE
Confidence 45777789999999999999876 6889999988653 3456778899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
..|.||+|.-+|... .+..+++.....+|.+|+.||++||... ||.|||||+|||||+.|+++|+|+|||..+...
T Consensus 265 tlMNGGDLkfHiyn~-g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g 340 (591)
T KOG0986|consen 265 TLMNGGDLKFHIYNH-GNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPEG 340 (591)
T ss_pred EeecCCceeEEeecc-CCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCCC
Confidence 999999999999764 3467999999999999999999999887 999999999999999999999999999998655
Q ss_pred CCc
Q 006347 637 QDQ 639 (649)
Q Consensus 637 ~~~ 639 (649)
+..
T Consensus 341 ~~~ 343 (591)
T KOG0986|consen 341 KPI 343 (591)
T ss_pred Ccc
Confidence 543
|
|
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.4e-20 Score=193.51 Aligned_cols=149 Identities=32% Similarity=0.492 Sum_probs=133.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 555 (649)
++|.+.+.||+|+||.||+++.. +++.+|+|.+.+. .....+.+..|+.++.+++ |+||+++++++.+++..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999976 6899999998652 2234567889999999998 99999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.+ ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+|++|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999999954 346999999999999999999999987 99999999999999999999999999998754
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.9e-20 Score=207.81 Aligned_cols=152 Identities=22% Similarity=0.289 Sum_probs=122.9
Q ss_pred HHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC------CCccceEEEE
Q 006347 474 EELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH------RNLVRLLGCC 546 (649)
Q Consensus 474 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H------~niv~l~g~~ 546 (649)
+++....++|++.++||+|+||+||++... .++.||||+++.. ....+++..|+.++.+++| .+++++++++
T Consensus 122 ~~~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~ 200 (467)
T PTZ00284 122 EDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNV-PKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYF 200 (467)
T ss_pred CccccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecc-hhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEE
Confidence 344556688999999999999999999875 5788999998643 2334556677777777654 4588899888
Q ss_pred EeC-CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC----
Q 006347 547 VEG-EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEEL---- 620 (649)
Q Consensus 547 ~~~-~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~---- 620 (649)
... .+.++|||++ +++|.+++.+ ...+++..+..|+.||+.||+|||++ + ||||||||+|||++.++
T Consensus 201 ~~~~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~ 273 (467)
T PTZ00284 201 QNETGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVD 273 (467)
T ss_pred EcCCceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccc
Confidence 764 4788999988 7788888853 35689999999999999999999974 5 99999999999998765
Q ss_pred ------------ceEEEecCCceee
Q 006347 621 ------------NPKISDFGMAKIF 633 (649)
Q Consensus 621 ------------~~Ki~DFGla~~~ 633 (649)
.+||+|||++...
T Consensus 274 ~~~~~~~~~~~~~vkl~DfG~~~~~ 298 (467)
T PTZ00284 274 PVTNRALPPDPCRVRICDLGGCCDE 298 (467)
T ss_pred cccccccCCCCceEEECCCCccccC
Confidence 4999999988643
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.84 E-value=3.6e-20 Score=197.29 Aligned_cols=150 Identities=25% Similarity=0.448 Sum_probs=129.2
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC----
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE---- 550 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~---- 550 (649)
...++|++.+.||+|+||.||++... ++..||||++.... ....+.+.+|+.++++++|+||+++++++....
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 34578999999999999999999865 78999999985432 223457889999999999999999999987654
Q ss_pred --eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 551 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 551 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
..++||||+ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg 163 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFG 163 (343)
T ss_pred cceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecc
Confidence 358999999 779988874 246899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+++....
T Consensus 164 ~~~~~~~ 170 (343)
T cd07880 164 LARQTDS 170 (343)
T ss_pred ccccccc
Confidence 9987643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-20 Score=193.44 Aligned_cols=146 Identities=34% Similarity=0.555 Sum_probs=127.5
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
|+..+.||+|+||.||+++.. ++..+|+|.+.... ....+++.+|+.++++++|+|++++++++.+++..++||||
T Consensus 27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 106 (317)
T cd06635 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY 106 (317)
T ss_pred hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence 566789999999999999975 68899999986432 23345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ |+|.+++.. ....+++..+..++.+++.||.|||+.+ |+||||+|+||+++.++.+||+|||++....
T Consensus 107 ~~-g~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~ 176 (317)
T cd06635 107 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS 176 (317)
T ss_pred CC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccC
Confidence 96 578777643 2456899999999999999999999987 9999999999999999999999999988654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.84 E-value=4.1e-20 Score=193.65 Aligned_cols=150 Identities=31% Similarity=0.503 Sum_probs=128.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 554 (649)
.++|++.+.||+|+||.||+|... +|+.||+|.++.... .....+.+|+.++.+++|+||+++++++.+. +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 357888899999999999999976 689999999864322 2234567899999999999999999998765 46899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||++ ++|.+++... ...+++.++..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||+++.+.
T Consensus 86 v~e~~~-~~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCE-QDLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCC-CCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 999996 4888887542 356899999999999999999999988 9999999999999999999999999999875
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 160 ~ 160 (309)
T cd07845 160 L 160 (309)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.9e-20 Score=197.33 Aligned_cols=148 Identities=28% Similarity=0.470 Sum_probs=127.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 552 (649)
.++|++.++||+|+||.||+|... +++.||||.++... ......+.+|+.++.+++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 467999999999999999999865 68999999986432 234567889999999999999999999876543 57
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++|+||++ ++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~-~~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELME-TDLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhcc-cCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 99999996 48877773 346899999999999999999999987 99999999999999999999999999987
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
...
T Consensus 156 ~~~ 158 (336)
T cd07849 156 ADP 158 (336)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=189.93 Aligned_cols=146 Identities=25% Similarity=0.419 Sum_probs=124.9
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCCccceEEEEEeC--CeEEEEEe
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLIYE 557 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~E 557 (649)
|++.++||+|+||.||+|+.. +++.+|+|+++... .........|+.++.++. |+|++++++++.++ +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556789999999999999875 68899999986532 223345567899999985 99999999999988 88999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|++ ++|.+++.. ....+++.++..++.|++.||+|||+.+ ++||||||+||++++ +.+||+|||+++.+..
T Consensus 81 ~~~-~~l~~~l~~--~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~ 151 (282)
T cd07831 81 LMD-MNLYELIKG--RKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYS 151 (282)
T ss_pred cCC-ccHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEeccccccccc
Confidence 996 588888754 2356899999999999999999999987 999999999999999 9999999999987643
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.4e-20 Score=185.20 Aligned_cols=152 Identities=26% Similarity=0.476 Sum_probs=135.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|++.+.||+|+||.||++... ++..+|+|++..... ...+++.+|++++++++|+|++++++.+.++...++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4777899999999999999976 688999999875432 4567889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++++|.+++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~ 156 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST 156 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence 99999999986532 2367899999999999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.6e-20 Score=192.73 Aligned_cols=149 Identities=30% Similarity=0.538 Sum_probs=127.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------- 550 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------- 550 (649)
++|++.++||+|+||.||++... +++.||||.+.... ......+.+|+.++++++||||+++++++....
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 91 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK 91 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence 46888999999999999999976 68899999885432 223345678999999999999999999988654
Q ss_pred -eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 551 -EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 551 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
..++||||++ ++|.+++.. ....+++.+...++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||+
T Consensus 92 ~~~~lv~e~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 92 GSFYLVFEFCE-HDLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred ceEEEEEcCCC-cCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCC
Confidence 3499999996 578887743 2346899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
++.+..
T Consensus 166 ~~~~~~ 171 (310)
T cd07865 166 ARAFSL 171 (310)
T ss_pred cccccC
Confidence 987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=190.33 Aligned_cols=147 Identities=30% Similarity=0.522 Sum_probs=128.9
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
|+..++||.|++|.||+|... +|..||||++.... ....+.+.+|++++++++|+|++++++++.+++..++||||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 456789999999999999875 78999999986432 223467889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+ ++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||+++.+.
T Consensus 81 ~-~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~ 150 (283)
T cd07835 81 D-LDLKKYMDSS-PLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFG 150 (283)
T ss_pred C-cCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccC
Confidence 5 6899988542 2246899999999999999999999987 9999999999999999999999999998764
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=5.6e-20 Score=189.73 Aligned_cols=141 Identities=30% Similarity=0.344 Sum_probs=118.9
Q ss_pred eeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHH---HhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMV---ISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~---l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.||+|+||.||++... +++.||||.+.+... .....+..|..+ +....|+||+++++.+.+.+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999875 588999998865321 222334455443 444579999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.+.
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~ 148 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFS 148 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccC
Confidence 9999998843 356899999999999999999999987 9999999999999999999999999998654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.2e-20 Score=195.60 Aligned_cols=154 Identities=29% Similarity=0.422 Sum_probs=131.5
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG 549 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (649)
..++...+++|.+.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++|+||+++++++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3456667889999999999999999999864 68899999986532 22356788999999999999999999988653
Q ss_pred ------CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceE
Q 006347 550 ------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623 (649)
Q Consensus 550 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~K 623 (649)
...++++|++ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 3467888876 7899888742 35899999999999999999999987 99999999999999999999
Q ss_pred EEecCCceeeC
Q 006347 624 ISDFGMAKIFG 634 (649)
Q Consensus 624 i~DFGla~~~~ 634 (649)
|+|||+++...
T Consensus 161 l~dfg~~~~~~ 171 (345)
T cd07877 161 ILDFGLARHTD 171 (345)
T ss_pred Eeccccccccc
Confidence 99999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=6.8e-20 Score=195.90 Aligned_cols=148 Identities=28% Similarity=0.435 Sum_probs=127.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC------
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------ 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (649)
..++|+..+.||+|+||.||++... +++.||||.+.+. .....+++.+|+.++.+++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3467999999999999999999875 7899999998643 233456788999999999999999999988644
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
...++||||++ ++|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 94 ~~~~lv~e~~~-~~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMD-ANLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccC-CCHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 35699999995 588887732 2788899999999999999999987 99999999999999999999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
++....
T Consensus 165 ~~~~~~ 170 (353)
T cd07850 165 ARTAGT 170 (353)
T ss_pred ceeCCC
Confidence 998644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.83 E-value=3.1e-20 Score=196.93 Aligned_cols=148 Identities=24% Similarity=0.450 Sum_probs=128.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 553 (649)
.+|++.+.||+|+||.||+|... +++.||+|++.... ....+.+.+|+.++.+++|+||+++++++.. ....+
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 84 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVY 84 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEE
Confidence 67888899999999999999876 68999999987532 2345678889999999999999999998763 34689
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+. ++|.+++.. ...+++.....++.||++||+|||+.+ |+||||||+||++++++.+||+|||+++.+
T Consensus 85 lv~e~~~-~~l~~~~~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~ 157 (334)
T cd07855 85 VVMDLME-SDLHHIIHS---DQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGL 157 (334)
T ss_pred EEEehhh-hhHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceee
Confidence 9999995 689888843 345899999999999999999999987 999999999999999999999999999876
Q ss_pred CC
Q 006347 634 GG 635 (649)
Q Consensus 634 ~~ 635 (649)
..
T Consensus 158 ~~ 159 (334)
T cd07855 158 SS 159 (334)
T ss_pred cc
Confidence 43
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.83 E-value=4.7e-20 Score=191.02 Aligned_cols=148 Identities=32% Similarity=0.398 Sum_probs=129.2
Q ss_pred CcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~ 552 (649)
+|++.+.||+|++|.||+++.. +++.+|||.+.+.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3677899999999999999753 57889999986432 23446788999999999 699999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ...+++.....++.|+++||.|||+.+ ++|+||||+||++++++.+||+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999999853 346889999999999999999999887 99999999999999999999999999987
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 155 ~~~ 157 (288)
T cd05583 155 FLA 157 (288)
T ss_pred ccc
Confidence 643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.83 E-value=1.5e-20 Score=201.09 Aligned_cols=155 Identities=33% Similarity=0.477 Sum_probs=133.5
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChh
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 565 (649)
-.||+|.+|+||-|+.. +...+|||-+.....+..+-+..|+.+-++++|.|||+++|.|.+++..-|.||-.|||||.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 37999999999999976 46689999998766677788999999999999999999999999999999999999999999
Q ss_pred hhhcCCCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeCCCCCcccc
Q 006347 566 ALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGNQDQADT 642 (649)
Q Consensus 566 ~~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~~~~~~~~~ 642 (649)
+.|+.. =+++ ++.+.-.+-+||++||.|||++. |||||||-+|+|++- .|.+||+|||-++.+.+-. ..|
T Consensus 661 sLLrsk--WGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~T 733 (1226)
T KOG4279|consen 661 SLLRSK--WGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCT 733 (1226)
T ss_pred HHHHhc--cCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccCC--ccc
Confidence 999653 2344 67888889999999999999998 999999999999974 6899999999999875422 234
Q ss_pred Cceeec
Q 006347 643 GRVVGT 648 (649)
Q Consensus 643 ~~~~GT 648 (649)
.+.-||
T Consensus 734 ETFTGT 739 (1226)
T KOG4279|consen 734 ETFTGT 739 (1226)
T ss_pred cccccc
Confidence 445565
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.83 E-value=7.1e-20 Score=186.53 Aligned_cols=142 Identities=24% Similarity=0.360 Sum_probs=121.1
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHH-hcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVI-SKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.||+|+||.||+|... +++.||||.+++.. ......+..|..++ ...+|+|++++++++.+++..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 57999999999999875 68899999986532 12233455565544 445899999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++|.+++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||+++...
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~ 148 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGL 148 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceecc
Confidence 999999853 346889999999999999999999987 9999999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.82 E-value=6.2e-20 Score=194.93 Aligned_cols=149 Identities=24% Similarity=0.469 Sum_probs=128.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----e
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----E 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~ 551 (649)
.++|.+.+.||+|+||+||+++.. +++.||||.+... ......++.+|+.++.+++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999875 6899999998653 2334567788999999999999999999887543 4
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+. ++|.+++.. ...+++.....++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++
T Consensus 84 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIRS---SQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999995 689888843 356899999999999999999999987 9999999999999999999999999998
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
....
T Consensus 157 ~~~~ 160 (337)
T cd07858 157 TTSE 160 (337)
T ss_pred ccCC
Confidence 7643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=192.07 Aligned_cols=146 Identities=27% Similarity=0.433 Sum_probs=124.3
Q ss_pred CcccceeeccCCcEEEEEEEec-C--CcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCCccceEEEEEeC----Ce
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-D--GQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG----EE 551 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~--g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~----~~ 551 (649)
+|++.+.||+|+||.||++... . +..+|||++.... ....+.+.+|+.++.++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 4777899999999999999976 3 7789999986432 22356788999999999 599999999986543 35
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++++||+. ++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIRS---GQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688899885 689888843 456899999999999999999999987 9999999999999999999999999998
Q ss_pred eeC
Q 006347 632 IFG 634 (649)
Q Consensus 632 ~~~ 634 (649)
.+.
T Consensus 154 ~~~ 156 (332)
T cd07857 154 GFS 156 (332)
T ss_pred ecc
Confidence 764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=194.08 Aligned_cols=151 Identities=26% Similarity=0.378 Sum_probs=132.3
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
-|.+.+.||+|.|+.|-.+++- +|+.||||++++.. ......+.+|++-|+.++|||||+||.+.-.+...|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3666689999999999988754 79999999998643 33456789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEecCCceeeCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki~DFGla~~~~~~~ 637 (649)
=.+|+|.+||.+ ..+.+.+....+++.||..|+.|+|+-+ +|||||||+|+.+- .-|-+|+.|||++-.+.+.+
T Consensus 99 GD~GDl~DyImK--He~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMK--HEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHh--hhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 999999999975 3456899999999999999999999877 99999999998875 56789999999998876544
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.3e-19 Score=184.08 Aligned_cols=149 Identities=27% Similarity=0.367 Sum_probs=122.1
Q ss_pred HHHHhcCcccceee--ccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 476 LATATNNFQLSSKL--GQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 476 l~~~~~~f~~~~~L--G~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
.....++|++.+.+ |+|+||.||++... ++..+|+|.+....... . |+.....+ +|+|++++++.+...+.
T Consensus 9 ~~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~--e~~~~~~~~~h~~iv~~~~~~~~~~~ 83 (267)
T PHA03390 9 LVQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I--EPMVHQLMKDNPNFIKLYYSVTTLKG 83 (267)
T ss_pred HHHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h--hHHHHHHhhcCCCEEEEEEEEecCCe
Confidence 34444566666665 99999999999875 67889999886432111 1 22222222 79999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCc
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMA 630 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla 630 (649)
.++||||+++++|.+++.. ...+++.++..++.|+++||.|||+.+ ++||||||+||+++.++ .+||+|||++
T Consensus 84 ~~iv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~ 157 (267)
T PHA03390 84 HVLIMDYIKDGDLFDLLKK---EGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLC 157 (267)
T ss_pred eEEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccc
Confidence 9999999999999999954 237899999999999999999999987 99999999999999998 9999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 158 ~~~~~ 162 (267)
T PHA03390 158 KIIGT 162 (267)
T ss_pred eecCC
Confidence 87654
|
|
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.82 E-value=8e-20 Score=185.20 Aligned_cols=152 Identities=30% Similarity=0.502 Sum_probs=133.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|++.++||+|+||.||+++.. +++.+|+|.+.... .....++.+|+.++++++|+||+++++++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4778899999999999999865 68899999986532 23456788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++++|.+++.+.. ....+++..+..++.++++||+|||+.+ ++|+||+|+||++++++.+|++|||+++.....
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~ 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence 99999999985422 2356899999999999999999999987 999999999999999999999999999887543
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1e-19 Score=192.92 Aligned_cols=147 Identities=27% Similarity=0.422 Sum_probs=126.6
Q ss_pred cCcc-cceeeccCCcEEEEEEEec-CCcEEEEEEeccccccc--------------HHHHHHHHHHHhcCCCCCccceEE
Q 006347 481 NNFQ-LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG--------------LEEFMNEVMVISKLQHRNLVRLLG 544 (649)
Q Consensus 481 ~~f~-~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~--------------~~~f~~E~~~l~~l~H~niv~l~g 544 (649)
++|. +.+.||+|+||+||+|... +++.||||.+....... ...+.+|+.++.+++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 3454 3467999999999999976 68999999886432211 125789999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 545 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
++...+..++||||++ ++|.+++.. ...+++.....++.|+++||.|||+.+ |+|+||||+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999996 689988843 345889999999999999999999987 999999999999999999999
Q ss_pred EecCCceeeC
Q 006347 625 SDFGMAKIFG 634 (649)
Q Consensus 625 ~DFGla~~~~ 634 (649)
+|||+++.+.
T Consensus 161 ~dfg~~~~~~ 170 (335)
T PTZ00024 161 ADFGLARRYG 170 (335)
T ss_pred CCccceeecc
Confidence 9999998775
|
|
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.3e-19 Score=188.72 Aligned_cols=149 Identities=28% Similarity=0.429 Sum_probs=126.3
Q ss_pred cCcccceeeccCCcEEEEEEEecC-CcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||+|.... ++.||||.++... .....++..|+.++.+.+ |+||+++++++.++...++|||
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e 94 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICME 94 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEee
Confidence 557778999999999999999874 8899999986532 234466777888777775 9999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|++ ++|.+++.. ....+++..+..++.++++||+|||+.. +|+||||+|+||++++++.+||+|||+++.+.
T Consensus 95 ~~~-~~l~~l~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~--~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~ 166 (296)
T cd06618 95 LMS-TCLDKLLKR--IQGPIPEDILGKMTVAIVKALHYLKEKH--GVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166 (296)
T ss_pred ccC-cCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhhC--CEecCCCcHHHEEEcCCCCEEECccccchhcc
Confidence 985 477777643 2347899999999999999999999742 39999999999999999999999999998764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.1e-19 Score=187.38 Aligned_cols=148 Identities=33% Similarity=0.497 Sum_probs=128.4
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
|++.+.||+|+||.||+|+.. +++.||||++..... .......+|+..+.+++ |+|++++++++.+++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 456789999999999999986 578999999865322 23334567999999998 999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++... ....+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.+||+|||+++....
T Consensus 81 -~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~ 151 (283)
T cd07830 81 -EGNLYQLMKDR-KGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRS 151 (283)
T ss_pred -CCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccC
Confidence 88998888542 2346899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.9e-19 Score=187.72 Aligned_cols=145 Identities=34% Similarity=0.535 Sum_probs=125.8
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
|...++||+|+||+||+|+.. +++.||+|.+..... ...+.+.+|++++++++|+|++++++++.+++..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 445578999999999999875 688999999864322 2345788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++ ++|.+++.. ....+++.++..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~ 171 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKS 171 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCccc
Confidence 96 577777743 2356899999999999999999999987 999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.5e-19 Score=199.11 Aligned_cols=170 Identities=29% Similarity=0.477 Sum_probs=144.0
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEe--
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE-- 548 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~-- 548 (649)
++.+...+..|.+.+.||.|.+|.|||++.. +++.+|||++... ....++...|..+++.. +|||++.++|++.-
T Consensus 11 ~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~ 89 (953)
T KOG0587|consen 11 LSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKD 89 (953)
T ss_pred hhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEec
Confidence 3444455677888999999999999999865 6888999987653 45567788899999888 79999999999874
Q ss_pred ---CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 549 ---GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 549 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
++.+|||||||.+||..++++.-. ...+.|..+..|+..+++|+.+||... +||||||-.||||++++.+|+.
T Consensus 90 ~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLv 165 (953)
T KOG0587|consen 90 PGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLV 165 (953)
T ss_pred CCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEe
Confidence 568999999999999999997643 677999999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeeCCCCCccccCceeecC
Q 006347 626 DFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 626 DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
|||++..++..-.+. ++.+|||
T Consensus 166 DFGvSaQldsT~grR--nT~iGtP 187 (953)
T KOG0587|consen 166 DFGVSAQLDSTVGRR--NTFIGTP 187 (953)
T ss_pred eeeeeeeeecccccc--cCcCCCc
Confidence 999999885544433 3467775
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.4e-19 Score=191.63 Aligned_cols=150 Identities=31% Similarity=0.480 Sum_probs=129.8
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEK 552 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~ 552 (649)
...+++|+..+.||+|+||.||++... +++.||||++.+. .....+.+..|+.++.+++||||+++++++.. ....
T Consensus 6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~ 85 (328)
T cd07856 6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDI 85 (328)
T ss_pred eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcE
Confidence 446788999999999999999999865 7899999988542 22345778899999999999999999999876 5578
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++|+||+ +++|.+++. ...+++.....++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+++.
T Consensus 86 ~lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~ 157 (328)
T cd07856 86 YFVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI 157 (328)
T ss_pred EEEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccc
Confidence 9999998 568988874 345788888899999999999999987 99999999999999999999999999986
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
..
T Consensus 158 ~~ 159 (328)
T cd07856 158 QD 159 (328)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.9e-19 Score=191.57 Aligned_cols=145 Identities=28% Similarity=0.473 Sum_probs=124.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------e
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------E 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 551 (649)
++|...+.||+|+||.||+|+.. +++.||||++.+.. ......+.+|+.++++++|+||+++++++.... +
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 94 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQD 94 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCce
Confidence 67888899999999999999865 68999999986532 223456889999999999999999999987543 4
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++|+||+.. +|..++ ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||+++
T Consensus 95 ~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~ 165 (342)
T cd07879 95 FYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLAR 165 (342)
T ss_pred EEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCc
Confidence 6899999964 776665 235789999999999999999999987 9999999999999999999999999998
Q ss_pred eeC
Q 006347 632 IFG 634 (649)
Q Consensus 632 ~~~ 634 (649)
...
T Consensus 166 ~~~ 168 (342)
T cd07879 166 HAD 168 (342)
T ss_pred CCC
Confidence 753
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=189.86 Aligned_cols=144 Identities=22% Similarity=0.241 Sum_probs=124.2
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.+.+|.|+++.||+++. +++.||||++... .....+.+..|+.++++++|+||+++++++.+.+..+++|||++++
T Consensus 6 i~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 6 IGKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hhHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 345566667777777666 5899999998654 3445678999999999999999999999999999999999999999
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+|.+++... ....+++.....++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+..+
T Consensus 85 ~l~~~l~~~-~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~ 151 (314)
T cd08216 85 SCEDLLKTH-FPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSM 151 (314)
T ss_pred CHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceee
Confidence 999998653 2345788889999999999999999987 999999999999999999999999998765
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.81 E-value=9.9e-20 Score=192.50 Aligned_cols=148 Identities=29% Similarity=0.478 Sum_probs=130.9
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKM 553 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~ 553 (649)
+|.+.+.||+|+||.||+++.. +++.+|||++.... ....+.+.+|+.+++.++|+||+++++++.+.+ ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 4778899999999999999976 58999999987543 345578999999999999999999999998875 789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||++ ++|.+++.. ...+++..+..++.++++||+|||+.+ |+|+||||+|||+++++.+||+|||++...
T Consensus 81 lv~e~~~-~~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELME-TDLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchh-hhHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 9999997 589888853 337899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 154 ~~~ 156 (330)
T cd07834 154 DPD 156 (330)
T ss_pred ccc
Confidence 544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.1e-19 Score=185.80 Aligned_cols=147 Identities=20% Similarity=0.320 Sum_probs=111.0
Q ss_pred cCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccccccH-----------HHHHHHHHHHhcCCCCCccceEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGL-----------EEFMNEVMVISKLQHRNLVRLLGC 545 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~~~-----------~~f~~E~~~l~~l~H~niv~l~g~ 545 (649)
++|.+.+.||+|+||.||+|...+ +..+|+|.......... .....+...+..+.|+|+++++++
T Consensus 12 ~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~ 91 (294)
T PHA02882 12 KEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGC 91 (294)
T ss_pred CceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEe
Confidence 578899999999999999999764 34566665432221111 112233345567789999999998
Q ss_pred EEeCC----eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 546 CVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 546 ~~~~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
+.... ..++++|++. .++.+.+.. ....++..+..|+.|+++||+|||+.+ |+||||||+|||++.++.
T Consensus 92 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~ 164 (294)
T PHA02882 92 GSFKRCRMYYRFILLEKLV-ENTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNR 164 (294)
T ss_pred eeEecCCceEEEEEEehhc-cCHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCc
Confidence 76554 3478888774 466666532 223567888999999999999999987 999999999999999999
Q ss_pred eEEEecCCceeeC
Q 006347 622 PKISDFGMAKIFG 634 (649)
Q Consensus 622 ~Ki~DFGla~~~~ 634 (649)
+||+|||+|+.+.
T Consensus 165 ~~l~DFGla~~~~ 177 (294)
T PHA02882 165 GYIIDYGIASHFI 177 (294)
T ss_pred EEEEEcCCceeec
Confidence 9999999999874
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.5e-19 Score=186.22 Aligned_cols=148 Identities=30% Similarity=0.509 Sum_probs=130.0
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
|+..+.||+|++|.||++... +++.+++|++..... .....+..|+.++++++|+||+++++++.+++..++|+||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456689999999999999876 688999999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++ +|.+++... ...+++..+..++.+++.||.|||+.+ |+|+||||+||++++++.+||+|||.+..+...
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~ 151 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSP 151 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCC
Confidence 75 888887542 256899999999999999999999987 999999999999999999999999999887544
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=8.2e-21 Score=216.08 Aligned_cols=162 Identities=32% Similarity=0.420 Sum_probs=135.3
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++.-..+||.|.||.||-+... +|+..|||-+... .....+...+|..++..|+|||+|+.+|+-.+++..+|.|||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEy 1315 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEY 1315 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHH
Confidence 4555679999999999999855 7889999977532 234567788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
|++|+|.+.+.. ....++.....+-.|++.|++|||+++ ||||||||.||+|+.++.+|+.|||.|+.+.+...
T Consensus 1316 C~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1316 CEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred hccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 999999999842 334566666677899999999999998 99999999999999999999999999999865521
Q ss_pred --ccccCceeecC
Q 006347 639 --QADTGRVVGTL 649 (649)
Q Consensus 639 --~~~~~~~~GT~ 649 (649)
.......+||+
T Consensus 1390 ~~~~el~~~~GT~ 1402 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTP 1402 (1509)
T ss_pred cCCHHHHhhcCCc
Confidence 12234567774
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.1e-19 Score=188.06 Aligned_cols=150 Identities=27% Similarity=0.372 Sum_probs=124.3
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+|...++||+|+||.||++... +++.+|||.+.... ......+.+|+.++.++. |+||+++++++.+....+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 3455678999999999999876 68999999986532 234567899999999996 99999999999999999999999
Q ss_pred CCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ ++|.++... ......+++.....++.+++.||+|||+.. +|+||||||+||++++++.+||+|||+++.+.
T Consensus 85 ~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~ 159 (288)
T cd06616 85 MD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159 (288)
T ss_pred cc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhc
Confidence 86 455544321 112356899999999999999999999752 39999999999999999999999999998654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.5e-19 Score=187.83 Aligned_cols=148 Identities=34% Similarity=0.550 Sum_probs=127.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.|+..+.||+|+||.||+|... +++.+|||.+... .....+++.+|++++++++|+|++++++++.+....++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 3666689999999999999976 6788999988642 22344678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+. |+|.+++.. ....+++.++..++.+++.||.|||+.+ ++||||||+||+++.++.+||+|||++.....
T Consensus 96 ~~~-~~l~~~~~~--~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 96 YCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred ccC-CCHHHHHHH--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 996 688777643 2345889999999999999999999987 99999999999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.81 E-value=3.9e-19 Score=183.43 Aligned_cols=148 Identities=30% Similarity=0.504 Sum_probs=125.2
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcC---CCCCccceEEEEEeCCe-----
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEE----- 551 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~----- 551 (649)
|++.+.||+|+||.||+|+.. +++.+|||++..... .....+.+|+.++.++ .|+|++++++++.+.+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 566789999999999999987 489999999964322 2234567788777665 59999999999998776
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.+++|||++ ++|.+++... ....+++..+..++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||+++
T Consensus 81 ~~l~~e~~~-~~l~~~l~~~-~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVD-QDLATYLSKC-PKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhcc-cCHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 899999997 5898888542 2235899999999999999999999987 9999999999999999999999999998
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 156 ~~~~ 159 (287)
T cd07838 156 IYSF 159 (287)
T ss_pred eccC
Confidence 8743
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.7e-19 Score=190.77 Aligned_cols=141 Identities=27% Similarity=0.360 Sum_probs=122.8
Q ss_pred eeeccC--CcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G--~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
++||+| +||+||++... +++.||||.+.... ....+.+.+|+.+++.++|+||+++++++..++..++|+||+++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 467766 89999999875 78999999986432 23346788999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+.
T Consensus 84 ~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~ 149 (328)
T cd08226 84 GSANSLLKTY-FPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLY 149 (328)
T ss_pred CCHHHHHHhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHh
Confidence 9999998653 2345889999999999999999999887 9999999999999999999999998654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.2e-20 Score=193.50 Aligned_cols=157 Identities=26% Similarity=0.381 Sum_probs=132.6
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCC---CCCccceEEEEEeC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--------GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEG 549 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~ 549 (649)
+|+..+.+|+|+||.|..+.++ +..+|+||.+.+.. ....-..-.|+.+|..++ |+||++++.++.++
T Consensus 562 ~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd 641 (772)
T KOG1152|consen 562 DYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD 641 (772)
T ss_pred cceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC
Confidence 4788899999999999999987 46789999987642 112234567999999997 99999999999999
Q ss_pred CeEEEEEecC-CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 550 EEKMLIYEYM-PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 550 ~~~~lV~Ey~-~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
+..||+||-. ++-+|.+++. .+..+++.+..-|.+||+.|+++||+++ |||||||-+|+.++.+|-+||+|||
T Consensus 642 d~yyl~te~hg~gIDLFd~IE---~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidfg 715 (772)
T KOG1152|consen 642 DYYYLETEVHGEGIDLFDFIE---FKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDFG 715 (772)
T ss_pred CeeEEEecCCCCCcchhhhhh---ccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeecc
Confidence 9999999976 5667888883 4567899999999999999999999998 9999999999999999999999999
Q ss_pred CceeeCCCCCccccCceeec
Q 006347 629 MAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 629 la~~~~~~~~~~~~~~~~GT 648 (649)
-|....... ....+||
T Consensus 716 saa~~ksgp----fd~f~gt 731 (772)
T KOG1152|consen 716 SAAYTKSGP----FDVFVGT 731 (772)
T ss_pred chhhhcCCC----cceeeee
Confidence 998764433 3346666
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.2e-19 Score=187.73 Aligned_cols=150 Identities=32% Similarity=0.531 Sum_probs=127.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------ 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (649)
.++|++.++||+|+||.||+|+.. +++.+|||++..... .....+.+|++++.+++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 468999999999999999999976 688999998864322 22356788999999999999999999886544
Q ss_pred --eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 551 --EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 551 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
..++|+||++. +|...+.. ....+++..+..++.|+++||.|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35999999964 67777643 2346899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+++....
T Consensus 161 ~~~~~~~ 167 (311)
T cd07866 161 LARPYDG 167 (311)
T ss_pred cchhccC
Confidence 9987643
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=1.4e-19 Score=205.61 Aligned_cols=158 Identities=30% Similarity=0.459 Sum_probs=134.5
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec----C----CcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK----D----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCC 546 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~----~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 546 (649)
+...++..+.+.||+|.||.|++|... . ...||||+++... ..+.+.+..|+.+|..+ +|+||+.++|+|
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~ 371 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGAC 371 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeee
Confidence 333444555679999999999999854 1 3579999997543 34678899999999999 699999999999
Q ss_pred EeCCeEEEEEecCCCCChhhhhcCCC-----------CC--CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006347 547 VEGEEKMLIYEYMPNRSLDALLFDPL-----------KK--ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN 613 (649)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 613 (649)
.+++..++|+||++.|+|.+||+... .. ..++..+++.++.|||.||+||++.. +|||||.++|
T Consensus 372 t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRN 448 (609)
T KOG0200|consen 372 TQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARN 448 (609)
T ss_pred ccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhh
Confidence 99999999999999999999997643 01 23889999999999999999999887 9999999999
Q ss_pred EEEcCCCceEEEecCCceeeCCCC
Q 006347 614 ILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 614 ILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
||+.++..+||+||||||......
T Consensus 449 VLi~~~~~~kIaDFGlar~~~~~~ 472 (609)
T KOG0200|consen 449 VLITKNKVIKIADFGLARDHYNKD 472 (609)
T ss_pred EEecCCCEEEEccccceeccCCCC
Confidence 999999999999999999754433
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=191.11 Aligned_cols=146 Identities=28% Similarity=0.471 Sum_probs=126.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC----------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG---------- 549 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~---------- 549 (649)
.+|...+.||+|+||.||+|... +++.||+|.+........+.+.+|++++++++|+||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~ 84 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGS 84 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhccccccccccccc
Confidence 67888999999999999999875 6889999998765556677899999999999999999999776543
Q ss_pred ----CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEE
Q 006347 550 ----EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKI 624 (649)
Q Consensus 550 ----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki 624 (649)
...++||||++ ++|.+++. ...+++.....++.||+.||.|||+.+ |+||||||+||+++ ++..+||
T Consensus 85 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~kl 156 (342)
T cd07854 85 LTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLKI 156 (342)
T ss_pred ccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEEE
Confidence 35789999997 58888873 235889999999999999999999987 99999999999998 4567999
Q ss_pred EecCCceeeC
Q 006347 625 SDFGMAKIFG 634 (649)
Q Consensus 625 ~DFGla~~~~ 634 (649)
+|||+++.+.
T Consensus 157 ~dfg~~~~~~ 166 (342)
T cd07854 157 GDFGLARIVD 166 (342)
T ss_pred CCcccceecC
Confidence 9999998763
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.1e-19 Score=185.00 Aligned_cols=147 Identities=32% Similarity=0.506 Sum_probs=129.8
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
|+..+.||+|++|.||+|+.. +++.+|+|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 455678999999999999987 58999999987643 334567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+ ++|.+++... ...+++..+..++.++++||+|||+.+ |+||||+|+||++++++.+||+|||+++....
T Consensus 81 ~-~~l~~~i~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~ 150 (282)
T cd07829 81 D-MDLKKYLDKR--PGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGI 150 (282)
T ss_pred C-cCHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCC
Confidence 7 5899998542 146899999999999999999999987 99999999999999999999999999987643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.80 E-value=1.8e-19 Score=183.47 Aligned_cols=150 Identities=31% Similarity=0.463 Sum_probs=124.8
Q ss_pred CcccceeeccCCcEEEEEEEecC-CcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
+|.+.++||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778999999999999998763 444555555431 123345677899999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 556 YEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++|+||||+||++++ ..+||+|||+++.+.
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999988542 23456899999999999999999999987 999999999999986 469999999998764
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 157 ~ 157 (260)
T cd08222 157 G 157 (260)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.2e-19 Score=179.34 Aligned_cols=141 Identities=35% Similarity=0.458 Sum_probs=126.5
Q ss_pred eccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 489 LGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 489 LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
||+|+||.||++... +++.+|+|.+..... .....+..|+.++++++|+||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999976 588999999865432 2456889999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
.+++.. ...+++.....++.|+++||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~ 145 (250)
T cd05123 81 FSHLSK---EGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSS 145 (250)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceeccc
Confidence 999853 346899999999999999999999977 99999999999999999999999999988644
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.6e-21 Score=185.24 Aligned_cols=151 Identities=26% Similarity=0.435 Sum_probs=128.0
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eEEEEEe
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EKMLIYE 557 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~~lV~E 557 (649)
.+.||-|+||.||.++.+ +|+.||.|++...- -...+.+.+|+..+.-++|.|++..++...-.. +.|+|+|
T Consensus 58 DRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TE 137 (449)
T KOG0664|consen 58 DRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTE 137 (449)
T ss_pred CCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHH
Confidence 468999999999999976 79999999886432 234578999999999999999999988765433 5678999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
.| .-+|.+++- ....++.....-+..||++||.|||+.+ |.||||||.|.|++.+...||+||||||....++
T Consensus 138 Lm-QSDLHKIIV---SPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~ 210 (449)
T KOG0664|consen 138 LM-QSDLHKIIV---SPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD 210 (449)
T ss_pred HH-Hhhhhheec---cCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccchhh
Confidence 88 457888773 4567888888889999999999999988 9999999999999999999999999999988777
Q ss_pred CccccC
Q 006347 638 DQADTG 643 (649)
Q Consensus 638 ~~~~~~ 643 (649)
...+|.
T Consensus 211 ~~hMTq 216 (449)
T KOG0664|consen 211 RLNMTH 216 (449)
T ss_pred hhhhHH
Confidence 665554
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.80 E-value=4.7e-20 Score=188.48 Aligned_cols=155 Identities=28% Similarity=0.356 Sum_probs=128.6
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-------cccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~ 551 (649)
++|-++..||+|||..|||+..- ..+-||||+-.... +.-.+...+|..+-+.|.||.||+++.++.- .+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 45777789999999999999854 57789999643211 1122446688899999999999999999875 456
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecC
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFG 628 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFG 628 (649)
.+-|+||+++.+|+-||. ..+.+++.+...|+.||..||.||.+. ++||||=||||.||||.+ .+.+||+|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecc
Confidence 789999999999999995 356789999999999999999999987 489999999999999965 4679999999
Q ss_pred CceeeCCCCCc
Q 006347 629 MAKIFGGNQDQ 639 (649)
Q Consensus 629 la~~~~~~~~~ 639 (649)
|++++.++...
T Consensus 619 LSKIMdddSy~ 629 (775)
T KOG1151|consen 619 LSKIMDDDSYN 629 (775)
T ss_pred hhhhccCCccC
Confidence 99999776544
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.80 E-value=1e-19 Score=193.12 Aligned_cols=155 Identities=25% Similarity=0.377 Sum_probs=131.3
Q ss_pred HHHHHHHh---cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEE
Q 006347 473 FEELATAT---NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGC 545 (649)
Q Consensus 473 ~~~l~~~~---~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~ 545 (649)
|..|+.+. .-|..++.||-|+||.|..+... +...+|+|.|++.+ +......+.|..||+.-..+=||+|+-.
T Consensus 618 YiRLkRaKMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyyS 697 (1034)
T KOG0608|consen 618 YIRLKRAKMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYS 697 (1034)
T ss_pred HHHHHHhhccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEE
Confidence 44444443 34667789999999999998754 45678999997653 3455667889999999999999999999
Q ss_pred EEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 546 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
|.+.+.+|+||||+++|++-.+|. +.+.+.+.....++.++..|+++.|.-+ +|||||||+|||||.+|++||+
T Consensus 698 FQDkdnLYFVMdYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLT 771 (1034)
T KOG0608|consen 698 FQDKDNLYFVMDYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLT 771 (1034)
T ss_pred eccCCceEEEEeccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeee
Confidence 999999999999999999999883 4566777777788889999999999877 9999999999999999999999
Q ss_pred ecCCceee
Q 006347 626 DFGMAKIF 633 (649)
Q Consensus 626 DFGla~~~ 633 (649)
||||+.=+
T Consensus 772 DFGLCTGf 779 (1034)
T KOG0608|consen 772 DFGLCTGF 779 (1034)
T ss_pred eccccccc
Confidence 99998643
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.5e-19 Score=190.83 Aligned_cols=148 Identities=30% Similarity=0.471 Sum_probs=129.1
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe----
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE---- 551 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 551 (649)
..++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++|+|++++++++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 4567889999999999999999986 5789999998643 22344677889999999999999999998876655
Q ss_pred --EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 552 --KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 552 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 6799988843 46899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeC
Q 006347 630 AKIFG 634 (649)
Q Consensus 630 a~~~~ 634 (649)
++...
T Consensus 165 ~~~~~ 169 (343)
T cd07851 165 ARHTD 169 (343)
T ss_pred ccccc
Confidence 98764
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=9.3e-20 Score=170.15 Aligned_cols=151 Identities=26% Similarity=0.364 Sum_probs=127.2
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.....+.||+|++|.|-|-++. +|+.+|+|++... ..+..++.+.|+.+..+. ..|.+|+++|........+|.||.
T Consensus 47 ~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~ 126 (282)
T KOG0984|consen 47 DLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMEL 126 (282)
T ss_pred hhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHH
Confidence 3344578999999999888765 7999999999753 345667888999987776 689999999998888899999999
Q ss_pred CCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
| ..||+.+-.+- .+...+++..+-+||..|.+||.|||++ +.+||||+||+|||++.++++||+|||.+..+.+
T Consensus 127 M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~k--L~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 127 M-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSK--LSVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred h-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHH--hhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9 56888776432 2345678888889999999999999985 5699999999999999999999999999988744
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=5.6e-21 Score=182.97 Aligned_cols=147 Identities=31% Similarity=0.601 Sum_probs=122.0
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--------Ce
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--------EE 551 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--------~~ 551 (649)
|.-..++|+|.||.|||++.. +|+.||+|++-.. .+......++|+.+|..++|+|++.++..|... ..
T Consensus 19 yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t 98 (376)
T KOG0669|consen 19 YEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRAT 98 (376)
T ss_pred HHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccce
Confidence 444568999999999999876 5778898876322 222335567899999999999999999988642 24
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.+||+++|++ +|..+|.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+||
T Consensus 99 ~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar 172 (376)
T KOG0669|consen 99 FYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR 172 (376)
T ss_pred eeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence 7899999965 78888854 3356889999999999999999999887 9999999999999999999999999999
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 173 ~fs~ 176 (376)
T KOG0669|consen 173 AFST 176 (376)
T ss_pred ceec
Confidence 8753
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.7e-20 Score=181.04 Aligned_cols=147 Identities=30% Similarity=0.400 Sum_probs=123.2
Q ss_pred cceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
....||.|+||+|+|-.++ .|+.+|||+++... +.+.++++.|.++..+- +.||||+++|.+...+..||.||.| .
T Consensus 68 dlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d 146 (361)
T KOG1006|consen 68 DLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-D 146 (361)
T ss_pred HHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-h
Confidence 3468999999999999876 69999999997543 46778899999977666 6899999999999999999999999 4
Q ss_pred CChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 562 RSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 562 gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.||+.+... ..++..+++.-+-.|..-+.+||.||.++- .|||||+||+|||||..|.+|++|||.+..+.
T Consensus 147 ~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv 219 (361)
T KOG1006|consen 147 ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLV 219 (361)
T ss_pred hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHH
Confidence 577665431 123456788888888888999999998753 69999999999999999999999999987653
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.3e-18 Score=196.01 Aligned_cols=149 Identities=26% Similarity=0.355 Sum_probs=106.1
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-C----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEE------EE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-D----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGC------CV 547 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~------~~ 547 (649)
..++|.+.++||+|+||.||+|++. + +..||||++..... .+.+..| . +....+.+++.+... +.
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e-~-l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE-R-VRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH-H-HHhhchhhHHHHHHhhhcccccc
Confidence 4578999999999999999999986 4 68999998854321 1112222 1 122222222222211 24
Q ss_pred eCCeEEEEEecCCCCChhhhhcCCCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006347 548 EGEEKMLIYEYMPNRSLDALLFDPLKK-----------------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK 610 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 610 (649)
++.+.+|||||+++++|.+++...... .......+..|+.|+++||+|||+.+ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566889999999999999988542110 01112345578999999999999987 9999999
Q ss_pred CCcEEEcC-CCceEEEecCCceeeC
Q 006347 611 ASNILLDE-ELNPKISDFGMAKIFG 634 (649)
Q Consensus 611 p~NILl~~-~~~~Ki~DFGla~~~~ 634 (649)
|+|||+++ ++.+||+|||+|+.+.
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~ 307 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLR 307 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCccccc
Confidence 99999996 5799999999998653
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.78 E-value=1.1e-18 Score=175.81 Aligned_cols=132 Identities=23% Similarity=0.189 Sum_probs=115.5
Q ss_pred CCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChhhhhcC
Q 006347 492 GGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570 (649)
Q Consensus 492 G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 570 (649)
|.||.||++... +++.+|+|++.... ++..|...+....|||++++++++.+.+..++||||+++|+|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999976 68899999996542 334555666666799999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 571 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
...+++.....++.|++.||+|||+.+ |+||||||+||++++++.+|++|||+++.+.
T Consensus 79 ---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~ 136 (237)
T cd05576 79 ---FLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVE 136 (237)
T ss_pred ---hcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccc
Confidence 345899999999999999999999987 9999999999999999999999999887654
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.6e-18 Score=168.62 Aligned_cols=137 Identities=22% Similarity=0.270 Sum_probs=106.4
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-----CCCCccceEEEEEeCC---e-EEEE
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-----QHRNLVRLLGCCVEGE---E-KMLI 555 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-----~H~niv~l~g~~~~~~---~-~~lV 555 (649)
..+.||+|+||.||. ...++.. +||++........+.+.+|+.++..+ .||||++++|++.++. . ..+|
T Consensus 6 ~~~~LG~G~~~~Vy~-hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I 83 (210)
T PRK10345 6 EQSPLGTGRHRKCYA-HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI 83 (210)
T ss_pred CcceecCCCceEEEE-CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence 347899999999996 2224444 79988654444667899999999999 5799999999998874 3 3378
Q ss_pred Eec--CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCceEecCCCCCcEEEcC----CCceEEEecC
Q 006347 556 YEY--MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL-LYLHRDSRLRIIHRDLKASNILLDE----ELNPKISDFG 628 (649)
Q Consensus 556 ~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~iiHrDlkp~NILl~~----~~~~Ki~DFG 628 (649)
+|| +++|+|.+++.+ ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||+
T Consensus 84 ~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~ 154 (210)
T PRK10345 84 ADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI 154 (210)
T ss_pred ecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence 999 668999999943 235544 35677888777 8999998 999999999999974 3479999954
Q ss_pred Ccee
Q 006347 629 MAKI 632 (649)
Q Consensus 629 la~~ 632 (649)
.++.
T Consensus 155 G~~~ 158 (210)
T PRK10345 155 GEST 158 (210)
T ss_pred CCcc
Confidence 4443
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.8e-18 Score=168.94 Aligned_cols=149 Identities=37% Similarity=0.556 Sum_probs=132.8
Q ss_pred cccceeeccCCcEEEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
|++.+.||+|++|.||++...+ ++.+|+|.+...... ..+.+.+|++.+.+++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4566899999999999999875 889999999765444 67889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++|.+++.... ..+++.....++.++++++.|||+.+ ++|+||+|+||+++.++.++|+|||++..+...
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~ 151 (225)
T smart00221 81 GGDLFDYLRKKG--GKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRD 151 (225)
T ss_pred CCCHHHHHHhcc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCc
Confidence 999999985421 11789999999999999999999986 999999999999999999999999999987544
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.2e-19 Score=185.03 Aligned_cols=162 Identities=25% Similarity=0.372 Sum_probs=136.8
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEec--ccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLS--KASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~--~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (649)
..|++.++||.||...|||+...+.+.+|+|++. ..+.+....|.+|+.+|.+|+ |.+||+|+.|-..++..|||||
T Consensus 361 ~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE 440 (677)
T KOG0596|consen 361 REYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVME 440 (677)
T ss_pred chhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEee
Confidence 4578889999999999999999988899998774 335667889999999999995 9999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|= .-+|..+|.... .....| .+..+..|++.++.++|+++ |||.||||.|+|+-+ |.+||+|||.|..+..+.
T Consensus 441 ~G-d~DL~kiL~k~~-~~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~~DT 513 (677)
T KOG0596|consen 441 CG-DIDLNKILKKKK-SIDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQPDT 513 (677)
T ss_pred cc-cccHHHHHHhcc-CCCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccCccc
Confidence 76 568999996532 223345 66778999999999999998 999999999999986 489999999999987766
Q ss_pred CccccCceeecC
Q 006347 638 DQADTGRVVGTL 649 (649)
Q Consensus 638 ~~~~~~~~~GT~ 649 (649)
....-...+||+
T Consensus 514 TsI~kdsQvGT~ 525 (677)
T KOG0596|consen 514 TSIVKDSQVGTV 525 (677)
T ss_pred cceeeccccCcc
Confidence 555444567774
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=1.7e-19 Score=176.99 Aligned_cols=147 Identities=27% Similarity=0.330 Sum_probs=122.5
Q ss_pred HhcCcccc-eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEe----CCe
Q 006347 479 ATNNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE----GEE 551 (649)
Q Consensus 479 ~~~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~ 551 (649)
.+++|++. ++||-|-.|.|..+..+ +++.+|+|++.. ....++|+++--.. .|+|||+++.++.. ..-
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-----s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc 133 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-----SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC 133 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-----CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence 34566654 68999999999999876 788999998843 24567888876666 69999999998764 335
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecC
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFG 628 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFG 628 (649)
.++|||.|+||.|.+.+.++ ....+++++.-.|+.||+.|+.|||+.. |.||||||+|+|... +...|++|||
T Consensus 134 LLiVmE~meGGeLfsriq~~-g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfG 209 (400)
T KOG0604|consen 134 LLIVMECMEGGELFSRIQDR-GDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFG 209 (400)
T ss_pred eEeeeecccchHHHHHHHHc-ccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccc
Confidence 68999999999999988653 4457999999999999999999999987 999999999999964 5568999999
Q ss_pred CceeeC
Q 006347 629 MAKIFG 634 (649)
Q Consensus 629 la~~~~ 634 (649)
+|+.-.
T Consensus 210 FAK~t~ 215 (400)
T KOG0604|consen 210 FAKETQ 215 (400)
T ss_pred cccccC
Confidence 999754
|
|
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.77 E-value=3.5e-19 Score=172.60 Aligned_cols=147 Identities=29% Similarity=0.421 Sum_probs=123.9
Q ss_pred ccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecCC
Q 006347 484 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
..+..||.|..|.|+|.+.. .|..+|||.+.+.. ..+.++++..+.++.+-+ .|.||+.+|+++.+...++.||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 34568999999999999987 68999999997653 345678888888888776 8999999999999999999999983
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
--++.+|+. ..+++++.-+-++...+.+||.||.+++ .|||||+||+|||+|+.|++|++|||++..+..
T Consensus 175 -~C~ekLlkr--ik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvd 244 (391)
T KOG0983|consen 175 -TCAEKLLKR--IKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVD 244 (391)
T ss_pred -HHHHHHHHH--hcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeec
Confidence 345566543 3456888888889999999999999876 699999999999999999999999999988743
|
|
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.1e-19 Score=180.39 Aligned_cols=161 Identities=30% Similarity=0.370 Sum_probs=133.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
.+|..+..||+|+||.|-.+..+ +.+.+|||++++.. ..+.+--+.|-++|+.. +-|.+++|..++..-+.+|.|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 46777899999999999999877 45679999998643 23344456777888877 568999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+.+|+|-.++. +-..+.+.....+|..||-||-+||+++ ||.||||.+||+||.++++||+|||+++.-.-
T Consensus 429 MEyvnGGDLMyhiQ---Q~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQ---QVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHH---HhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 99999999988873 3455777788889999999999999998 99999999999999999999999999996322
Q ss_pred CCCccccCceeecC
Q 006347 636 NQDQADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~~~~~~~~GT~ 649 (649)
+ ...|.+..|||
T Consensus 503 ~--~~TTkTFCGTP 514 (683)
T KOG0696|consen 503 D--GVTTKTFCGTP 514 (683)
T ss_pred C--CcceeeecCCC
Confidence 2 12345578885
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=8.9e-19 Score=192.30 Aligned_cols=158 Identities=31% Similarity=0.445 Sum_probs=123.2
Q ss_pred cccceeeccCCcEE-EEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCC
Q 006347 483 FQLSSKLGQGGFGP-VYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 483 f~~~~~LG~G~fG~-Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
|...+.+|.|+-|+ ||+|.+. |++||||++-. ....-..+|+..++.- .||||||+++.-.+++..||..|.|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~ye-~R~VAVKrll~---e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC- 585 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVYE-GREVAVKRLLE---EFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC- 585 (903)
T ss_pred eccHHHcccCCCCcEEEEEeeC-CceehHHHHhh---HhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-
Confidence 44456789999875 7999998 89999999843 3344567899999988 6999999999999999999999999
Q ss_pred CCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---C--CceEEEecCCceeeC
Q 006347 561 NRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---E--LNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~--~~~Ki~DFGla~~~~ 634 (649)
.-+|++++... .......-.....+..|+++||++||+-+ ||||||||+||||+. + .+++|+|||+++.+.
T Consensus 586 ~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 586 ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 56999999653 11111111344667899999999999866 999999999999976 2 579999999999997
Q ss_pred CCCCcc-ccCceeec
Q 006347 635 GNQDQA-DTGRVVGT 648 (649)
Q Consensus 635 ~~~~~~-~~~~~~GT 648 (649)
.+++.. ......||
T Consensus 663 ~~~sS~~r~s~~sGt 677 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGT 677 (903)
T ss_pred CCcchhhcccCCCCc
Confidence 766543 22334454
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.75 E-value=3.3e-17 Score=159.28 Aligned_cols=143 Identities=40% Similarity=0.677 Sum_probs=127.1
Q ss_pred eccCCcEEEEEEEecC-CcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChhh
Q 006347 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA 566 (649)
Q Consensus 489 LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 566 (649)
||+|.+|.||++...+ ++++++|++...... ..+.+.+|+..+.+++|++++++++++......++++||+++++|.+
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999874 899999998654322 35789999999999999999999999999999999999999999999
Q ss_pred hhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeCCC
Q 006347 567 LLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 567 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~~~ 636 (649)
++... ...+++..+..++.++++++.|||+.+ ++|+||+|.||+++. +..++|+|||.+......
T Consensus 81 ~~~~~--~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~ 146 (215)
T cd00180 81 LLKEN--EGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSD 146 (215)
T ss_pred HHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCC
Confidence 98542 146889999999999999999999987 999999999999999 899999999999977543
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=2.5e-17 Score=164.44 Aligned_cols=137 Identities=36% Similarity=0.537 Sum_probs=124.0
Q ss_pred CcEEEEEEEec-CCcEEEEEEeccccccc-HHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChhhhhcC
Q 006347 493 GFGPVYWGRLK-DGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD 570 (649)
Q Consensus 493 ~fG~Vykg~~~-~g~~vAVK~l~~~~~~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 570 (649)
+||.||+|+.. +++.+|+|++....... .+.+.+|++.+++++|+|++++++++......++++||+++++|.+++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 58999999987 48999999997655444 78999999999999999999999999999999999999999999999854
Q ss_pred CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 571 PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 571 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
. ..+++..+..++.++++++.|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 ~---~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~ 139 (244)
T smart00220 81 R---GRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDP 139 (244)
T ss_pred c---cCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecc
Confidence 2 23889999999999999999999987 99999999999999999999999999998754
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.8e-17 Score=162.40 Aligned_cols=135 Identities=22% Similarity=0.308 Sum_probs=114.6
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccc--------cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+.||+|++|.||+|.. .+..++||+....... ....+.+|+.++..++|++++....++.+.+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 5778999976432211 124678899999999999998888888888889999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++++|.+++... .+ .+..++.+++.+|.+||+.+ ++|+|++|+|||++ ++.++|+|||+++..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~ 144 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEFS 144 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence 9999999998431 22 78899999999999999987 99999999999999 788999999999864
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.4e-17 Score=161.46 Aligned_cols=147 Identities=18% Similarity=0.200 Sum_probs=113.3
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccc----------------------cHHHHHHHHHHHh
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ----------------------GLEEFMNEVMVIS 532 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~----------------------~~~~f~~E~~~l~ 532 (649)
++......|.+.+.||+|+||.||++...+|+.||||++...... ....+..|..++.
T Consensus 9 ~~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~ 88 (198)
T cd05144 9 TLVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALK 88 (198)
T ss_pred HHHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHH
Confidence 333333447777899999999999999888999999987542200 1123667888999
Q ss_pred cCCCC--CccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006347 533 KLQHR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK 610 (649)
Q Consensus 533 ~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 610 (649)
++.|+ .+++.++ ....++||||+++++|.+.... .....++.++++++.++|+.+ |+|||||
T Consensus 89 ~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~---------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~ 152 (198)
T cd05144 89 ALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL---------EDPEEVLDEILEEIVKAYKHG---IIHGDLS 152 (198)
T ss_pred HHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc---------ccHHHHHHHHHHHHHHHHHCC---CCcCCCC
Confidence 99877 4455544 2456899999999999765420 234568899999999999977 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 611 ASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 611 p~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+||++++++.+||+|||+|+....+.
T Consensus 153 p~Nill~~~~~~~liDfg~~~~~~~~~ 179 (198)
T cd05144 153 EFNILVDDDEKIYIIDWPQMVSTDHPN 179 (198)
T ss_pred cccEEEcCCCcEEEEECCccccCCCcc
Confidence 999999999999999999998775543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=2.6e-17 Score=165.27 Aligned_cols=146 Identities=18% Similarity=0.197 Sum_probs=113.0
Q ss_pred CcccceeeccCCcEEEEEEE--ecCCcEEEEEEecccccc------------------------cHHHHHHHHHHHhcCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGR--LKDGQEIAVKRLSKASGQ------------------------GLEEFMNEVMVISKLQ 535 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~--~~~g~~vAVK~l~~~~~~------------------------~~~~f~~E~~~l~~l~ 535 (649)
.|++.+.||+|+||.||+|. ..+|+.||||.++..... ....+..|+..+.++.
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~ 108 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY 108 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 47788999999999999998 568999999988643210 0123568999999997
Q ss_pred CC--CccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCc
Q 006347 536 HR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASN 613 (649)
Q Consensus 536 H~--niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~N 613 (649)
|. .+.+++++ ...+|||||+++.+|..... ....+...+...++.|++.+|.+||+.+ .|+||||||+|
T Consensus 109 ~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Dikp~N 179 (237)
T smart00090 109 EAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDLSEYN 179 (237)
T ss_pred hcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCCChhh
Confidence 53 34444443 23589999999988876542 2234556667889999999999999875 39999999999
Q ss_pred EEEcCCCceEEEecCCceeeCCCC
Q 006347 614 ILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 614 ILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+++ ++.+||+|||+|+..+...
T Consensus 180 Ili~-~~~i~LiDFg~a~~~~~~~ 202 (237)
T smart00090 180 ILVH-DGKVVIIDVSQSVELDHPM 202 (237)
T ss_pred EEEE-CCCEEEEEChhhhccCCcc
Confidence 9999 8899999999999765543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.73 E-value=3.6e-17 Score=184.20 Aligned_cols=142 Identities=20% Similarity=0.271 Sum_probs=115.3
Q ss_pred HHhcCcccceeeccCCcEEEEEEEecCCcEEEEEE-ecccc-------cccHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR-LSKAS-------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG 549 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~-l~~~~-------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (649)
.....|...+.||+|+||.||+|.+.+.. +++|+ +.+.. ....+++.+|++++.+++|++++....++.+.
T Consensus 330 ~~~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~ 408 (535)
T PRK09605 330 EVKRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP 408 (535)
T ss_pred ccccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC
Confidence 33445566789999999999999887443 44443 22211 11235688999999999999999988888888
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
...++||||+++++|.+++. ....++.+++++|.|||+.+ ++||||||+|||+ +++.++|+|||+
T Consensus 409 ~~~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGl 473 (535)
T PRK09605 409 EEKTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGL 473 (535)
T ss_pred CCCEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcc
Confidence 88899999999999998873 35678999999999999987 9999999999999 678999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
|+....
T Consensus 474 a~~~~~ 479 (535)
T PRK09605 474 GKYSDL 479 (535)
T ss_pred cccCCc
Confidence 998543
|
|
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.73 E-value=5.8e-19 Score=183.60 Aligned_cols=158 Identities=28% Similarity=0.376 Sum_probs=135.4
Q ss_pred cccceeeccCCcEEEEEEEecCCc-EEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKDGQ-EIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~g~-~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++....||-|+||.|-.+..+... .+|+|.+++. ...+.+....|-.+|...+.+.||+||..+.+....|+.||-
T Consensus 422 l~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEa 501 (732)
T KOG0614|consen 422 LKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEA 501 (732)
T ss_pred hhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHh
Confidence 344568999999999999877433 4788887654 334567788999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
|-+|.|...|++ ++.++..+...++..+.+|++|||.++ ||.|||||+|.+||.+|-+||.|||+|+.++....
T Consensus 502 ClGGElWTiLrd---Rg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~K 575 (732)
T KOG0614|consen 502 CLGGELWTILRD---RGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRK 575 (732)
T ss_pred hcCchhhhhhhh---cCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccCCc
Confidence 999999999965 356777888889999999999999998 99999999999999999999999999999965542
Q ss_pred ccccCceeecC
Q 006347 639 QADTGRVVGTL 649 (649)
Q Consensus 639 ~~~~~~~~GT~ 649 (649)
|-+..|||
T Consensus 576 ---TwTFcGTp 583 (732)
T KOG0614|consen 576 ---TWTFCGTP 583 (732)
T ss_pred ---eeeecCCc
Confidence 45578885
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=1.3e-18 Score=186.44 Aligned_cols=162 Identities=27% Similarity=0.456 Sum_probs=141.5
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
..+|...+.+|.|.+|.|||++.. .++..|||.++-.......-...|+-+++..+|+|||.++|-+.-.+..+++|||
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEy 93 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEY 93 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEe
Confidence 456888899999999999999976 7889999999877667778888999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
+.+|+|++.-+- ..++++.+.-..++...+||+|||..+ -+|||||-.|||+.+.+.+|++|||.+..++..-.
T Consensus 94 cgggslQdiy~~---TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~ 167 (829)
T KOG0576|consen 94 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA 167 (829)
T ss_pred cCCCcccceeee---cccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh
Confidence 999999988753 467888888888999999999999988 89999999999999999999999999988754333
Q ss_pred ccccCceeecC
Q 006347 639 QADTGRVVGTL 649 (649)
Q Consensus 639 ~~~~~~~~GT~ 649 (649)
+. ....|||
T Consensus 168 Kr--ksfiGtp 176 (829)
T KOG0576|consen 168 KR--KSFIGTP 176 (829)
T ss_pred hh--hcccCCc
Confidence 22 3366664
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=7.3e-17 Score=155.88 Aligned_cols=132 Identities=23% Similarity=0.245 Sum_probs=106.5
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEeccccccc----HHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecC
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG----LEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~----~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+...|++|+||+||.+.- ++..++.+.+....... ...|.+|+++|.+++ |+++++++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 457899999999997766 57888888776543211 225889999999995 5889999886 4579999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC-CCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL-KASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl-kp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++.+|...+. . ....++.+++++|.++|+.+ |+|||| ||+|||+++++.++|+|||+|....
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~ 143 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGN 143 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecC
Confidence 9999865431 1 11347789999999999998 999999 7999999999999999999999654
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=8.8e-18 Score=166.67 Aligned_cols=162 Identities=29% Similarity=0.383 Sum_probs=134.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~l 554 (649)
.++|.+...||+|+++.|..+.+. +.+.+|+|++++. ...+..-...|-.+...- +||.+|.|..++......++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 357888999999999999999876 5778999998764 233455566777777766 79999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|.||.++|+|--++ .+...+++.....+...|+-||.|||+.+ ||.||||.+|+|||.++++|++|+|+++.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999996555 34556888888888999999999999998 9999999999999999999999999999753
Q ss_pred CCCCccccCceeecC
Q 006347 635 GNQDQADTGRVVGTL 649 (649)
Q Consensus 635 ~~~~~~~~~~~~GT~ 649 (649)
++.. .|.+..|||
T Consensus 403 ~~gd--~tstfcgtp 415 (593)
T KOG0695|consen 403 GPGD--TTSTFCGTP 415 (593)
T ss_pred CCCc--ccccccCCC
Confidence 3332 244578885
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.6e-17 Score=157.18 Aligned_cols=149 Identities=25% Similarity=0.409 Sum_probs=126.5
Q ss_pred hcCcccceeeccCCcEEEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||.|+||.+|.|.. .+|++||||.-+... .-.++..|..+...++| ..|.++.-+..+...-.+|||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a--~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKA--KHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccC--CCcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 36799999999999999999985 479999999764332 33567789999999975 788899999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~DFGla~~~~ 634 (649)
.+ +.||.+.+.- -...++..+.+-+|.|+..-++|+|.++ .|||||||+|+|+.-+ ..+.++|||||+.+-
T Consensus 92 LL-GPsLEdLfnf--C~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNF--CSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHH--HhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 88 8999988732 3456889999999999999999999998 9999999999999754 458899999999875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
+.
T Consensus 166 d~ 167 (341)
T KOG1163|consen 166 DI 167 (341)
T ss_pred cc
Confidence 43
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.72 E-value=5.4e-17 Score=160.01 Aligned_cols=141 Identities=12% Similarity=0.129 Sum_probs=115.2
Q ss_pred HHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHH---------HHHHHHHHhcCCCCCccceEEEEEe
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE---------FMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~---------f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
...++|+..+.||.|+||.||.... ++..+|||.+........+. +.+|+..+.+++|++|..+..+...
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~ 106 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLL 106 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeee
Confidence 3457899999999999999999665 57789999996543322222 6789999999999999999988664
Q ss_pred C--------CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006347 549 G--------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620 (649)
Q Consensus 549 ~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 620 (649)
. ...+|||||++|.+|.++.. ++. ....+++.+|..||+.+ ++|||+||+||++++++
T Consensus 107 ~~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g 172 (232)
T PRK10359 107 AERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG 172 (232)
T ss_pred cccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC
Confidence 4 35789999999999987741 222 24568999999999988 99999999999999988
Q ss_pred ceEEEecCCceeeC
Q 006347 621 NPKISDFGMAKIFG 634 (649)
Q Consensus 621 ~~Ki~DFGla~~~~ 634 (649)
++|+|||..+...
T Consensus 173 -i~liDfg~~~~~~ 185 (232)
T PRK10359 173 -LRIIDLSGKRCTA 185 (232)
T ss_pred -EEEEECCCccccc
Confidence 9999999988763
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.71 E-value=6.6e-17 Score=158.26 Aligned_cols=132 Identities=23% Similarity=0.349 Sum_probs=108.9
Q ss_pred eeccCCcEEEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASG--------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.||+|+||.||+|... +..+++|....... ....++.+|++++..++|+++.....++.+.+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~~-~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDFL-GLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeecC-CccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 4899999999999964 78899998643211 12356788999999999887776666677777889999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++++|.+++... . . .++.+++++|.+||+.+ ++|+|++|+||+++ ++.++++|||+++...
T Consensus 80 ~g~~l~~~~~~~---~-~------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~~ 140 (199)
T TIGR03724 80 EGKPLKDVIEEG---N-D------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYSD 140 (199)
T ss_pred CCccHHHHHhhc---H-H------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCCC
Confidence 999999887431 1 0 78999999999999987 99999999999999 8899999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=2e-17 Score=160.47 Aligned_cols=146 Identities=20% Similarity=0.418 Sum_probs=121.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEE-EEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGC-CVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~-~~~~~~~~lV~E 557 (649)
+.|.+.+.||+|.||.+-.+.++ ..+.+++|-+.+. ....++|.+|...--.| .|.||+.-+.. +...+....++|
T Consensus 24 d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE 102 (378)
T KOG1345|consen 24 DVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQE 102 (378)
T ss_pred hhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeec
Confidence 45788899999999999999987 5778999988653 34568899998765555 69999988765 455667789999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~Ki~DFGla~~~~ 634 (649)
|+|.|+|.+-+. ...+.+....+++.|++.|+.|||++. +||||||.+|||+- +..++|++|||+.+..+
T Consensus 103 ~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 103 FAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred cCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 999999987773 345778888899999999999999998 99999999999983 34589999999998764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.70 E-value=9e-18 Score=159.04 Aligned_cols=145 Identities=24% Similarity=0.466 Sum_probs=124.4
Q ss_pred cCcccceeeccCCcEEEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCe--EEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEE--KMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~--~~lV~ 556 (649)
++|++.+++|+|.++.||.|.. .+.+.++||.++.. ..+.+.+|+.+|..|. ||||++|+....++.. ..||+
T Consensus 38 ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiF 114 (338)
T KOG0668|consen 38 DDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIF 114 (338)
T ss_pred chHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHh
Confidence 5788889999999999999974 46788999999643 4578899999999996 9999999999987664 46999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla~~~~~ 635 (649)
||..+.+...+. +.++-.++...+.++++||.|+|+.+ |.|||+||.|+++|.. -..+|+|.|||..+-.
T Consensus 115 E~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp 185 (338)
T KOG0668|consen 115 EYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHP 185 (338)
T ss_pred hhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcCC
Confidence 999998876554 44677778889999999999999988 9999999999999965 5699999999998855
Q ss_pred CC
Q 006347 636 NQ 637 (649)
Q Consensus 636 ~~ 637 (649)
.+
T Consensus 186 ~~ 187 (338)
T KOG0668|consen 186 GK 187 (338)
T ss_pred Cc
Confidence 44
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=8e-17 Score=160.37 Aligned_cols=151 Identities=23% Similarity=0.409 Sum_probs=128.3
Q ss_pred cCcccceeeccCCcEEEEEEE-ecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~-~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
-+|++.++||+|.||.++.|+ +-+++.||||.-.. .....+++.|.+..+.|. -++|...+-|-.++-+..||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPr--kS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPR--KSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccc--cCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468899999999999999998 44799999996533 345567888888888884 69999999999999999999998
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-----LNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~Ki~DFGla~~~ 633 (649)
+ +.||++++. .-...++..++..+|.|++.-++|+|++. +|.|||||+|+||... ..+.|+|||||+.+
T Consensus 106 L-GPSLEDLFD--~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFD--LCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHH--HhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 8 899998863 24566899999999999999999999998 9999999999999743 45899999999998
Q ss_pred CCCCCc
Q 006347 634 GGNQDQ 639 (649)
Q Consensus 634 ~~~~~~ 639 (649)
.+..++
T Consensus 180 rDp~Tk 185 (449)
T KOG1165|consen 180 RDPKTK 185 (449)
T ss_pred cCcccc
Confidence 655443
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=6.6e-17 Score=174.01 Aligned_cols=146 Identities=25% Similarity=0.397 Sum_probs=122.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (649)
+..|.....+|.|+|+.|-++... +++..+||++.+.. .+-.+|+.++.+. +|+|++++.+.+.++.+.++|||
T Consensus 321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~----~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e 396 (612)
T KOG0603|consen 321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA----DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVME 396 (612)
T ss_pred chhhccccccCCCCccceeeeeccccccchhheeccccc----cccccccchhhhhcCCCcceeecceecCCceeeeeeh
Confidence 445667778999999999999865 68889999997642 2334577666666 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-cCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-~~~~~~Ki~DFGla~~~~~~ 636 (649)
++.++-|.+.++. .+... .++..|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++...++
T Consensus 397 ~l~g~ell~ri~~---~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~ 469 (612)
T KOG0603|consen 397 LLDGGELLRRIRS---KPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS 469 (612)
T ss_pred hccccHHHHHHHh---cchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence 9999988777643 22233 777789999999999999988 9999999999999 58999999999999988655
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.7e-16 Score=160.84 Aligned_cols=158 Identities=25% Similarity=0.433 Sum_probs=134.5
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEE
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGC 545 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~ 545 (649)
..++.....+++....+.+|.||+||+|.+. +.++|-||.++.. ++-+...++.|..++..+.|||+..+.++
T Consensus 276 ~~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V 355 (563)
T KOG1024|consen 276 LQELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGV 355 (563)
T ss_pred HHhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEE
Confidence 3455555567777888999999999999654 4566788888653 34466789999999999999999999999
Q ss_pred EEeCC-eEEEEEecCCCCChhhhhc-----CCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 006347 546 CVEGE-EKMLIYEYMPNRSLDALLF-----DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 619 (649)
Q Consensus 546 ~~~~~-~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 619 (649)
+++.. ..+++|.++.-|+|..||. +....+.++-.+...++.|++.|++|||.++ |||.||.++|.+||+.
T Consensus 356 ~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~ 432 (563)
T KOG1024|consen 356 SIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQ 432 (563)
T ss_pred EeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhh
Confidence 98754 5789999999999999997 4444566888889999999999999999988 9999999999999999
Q ss_pred CceEEEecCCceee
Q 006347 620 LNPKISDFGMAKIF 633 (649)
Q Consensus 620 ~~~Ki~DFGla~~~ 633 (649)
.++||+|=.|+|-+
T Consensus 433 LqVkltDsaLSRDL 446 (563)
T KOG1024|consen 433 LQVKLTDSALSRDL 446 (563)
T ss_pred eeEEeccchhcccc
Confidence 99999999999975
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=5.1e-16 Score=163.80 Aligned_cols=145 Identities=27% Similarity=0.401 Sum_probs=122.2
Q ss_pred CcccceeeccCCcEEEEEEEecCC--cEEEEEEecccccccHHHHHHHHHHHhcCCC----CCccceEEEE-EeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDG--QEIAVKRLSKASGQGLEEFMNEVMVISKLQH----RNLVRLLGCC-VEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g--~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H----~niv~l~g~~-~~~~~~~l 554 (649)
+|++.++||+|+||.||++..... ..+|+|............+..|+.++..+.+ +++.+++... ......++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 799999999999999999997643 4788887755433333378889999998863 5888888888 47778899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-----CceEEEecCC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-----LNPKISDFGM 629 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-----~~~Ki~DFGl 629 (649)
||+.+ +.+|.++..... .+.++..+.++|+.|++.+|.+||+.+ ++||||||+|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99987 899999875543 567999999999999999999999988 9999999999999854 4699999999
Q ss_pred ce
Q 006347 630 AK 631 (649)
Q Consensus 630 a~ 631 (649)
|+
T Consensus 174 ar 175 (322)
T KOG1164|consen 174 AR 175 (322)
T ss_pred Cc
Confidence 99
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.8e-16 Score=159.45 Aligned_cols=153 Identities=21% Similarity=0.257 Sum_probs=127.5
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-C-C----CccceEEEEEeCCe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-R----NLVRLLGCCVEGEE 551 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H-~----niv~l~g~~~~~~~ 551 (649)
.+++|.+...+|+|.||.|.++... .+..||||+++.. ..-.+.-+.|++++.+|. + | -+|++.+++...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 3678999999999999999999876 4689999988643 445567788999999994 3 2 26788888889999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE------------- 618 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~------------- 618 (649)
.+||+|.| +.|+.++|..+ ...+++...+..|+.|++++++|||+.. ++|-||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999988 77999999653 4567888999999999999999999987 999999999999842
Q ss_pred -------CCceEEEecCCceeeCCCC
Q 006347 619 -------ELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 619 -------~~~~Ki~DFGla~~~~~~~ 637 (649)
...+||+|||-|+.-....
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~h 266 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEHH 266 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccCc
Confidence 2347999999999865444
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.65 E-value=2.3e-16 Score=162.19 Aligned_cols=146 Identities=23% Similarity=0.477 Sum_probs=127.7
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
....+.|...++||+|.|++||++++.. .+.||+|.+... +......+|++.|..+ -|.||+++.+++..++.
T Consensus 32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~t--s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRT--SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccc--cCchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 3445678889999999999999998653 578999998654 3456789999999999 59999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCc
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMA 630 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla 630 (649)
..+|+||+++-...++++. ++..+...++..+.+||.++|..+ ||||||||+|+|.+. -+.-.|.|||||
T Consensus 110 v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 110 VAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhH
Confidence 9999999999999999843 678888889999999999999998 999999999999985 467899999999
Q ss_pred eee
Q 006347 631 KIF 633 (649)
Q Consensus 631 ~~~ 633 (649)
...
T Consensus 181 ~~~ 183 (418)
T KOG1167|consen 181 QRY 183 (418)
T ss_pred HHH
Confidence 854
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.5e-15 Score=140.41 Aligned_cols=136 Identities=23% Similarity=0.223 Sum_probs=116.6
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CCccceEEEEEeCCeEEEEEecCCCC
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
+.+.||+|.++.||++...+ ..++||....... ...+..|+.++..++| .++++++++...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 34789999999999999874 7899998865432 5689999999999976 58999999988888899999999887
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
.+..+ +......++.+++++|++||.....+++|+|++|+||++++.+.++++|||+++..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 77433 55677788999999999999875567999999999999999999999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.3e-15 Score=147.48 Aligned_cols=140 Identities=21% Similarity=0.261 Sum_probs=100.3
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccc--cHHHH----------------------HHHHHHHhcCCCC--Cc
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--GLEEF----------------------MNEVMVISKLQHR--NL 539 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--~~~~f----------------------~~E~~~l~~l~H~--ni 539 (649)
.+.||+|+||+||++...++++||||++...... ....+ ..|...+.++.+. .+
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 3689999999999999888999999988643211 11111 3455666666433 34
Q ss_pred cceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcC
Q 006347 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 540 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~ 618 (649)
.+.+++ ...++||||++++.+....... .... .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~---~~~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKD---VRLL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhh---hhhc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 455543 3468999999995543221110 0011 5567889999999999998 66 99999999999999
Q ss_pred CCceEEEecCCceeeCCCC
Q 006347 619 ELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~~~~ 637 (649)
++.++|+|||+|+....+.
T Consensus 150 ~~~~~liDfg~a~~~~~~~ 168 (187)
T cd05119 150 DGKVYIIDVPQAVEIDHPN 168 (187)
T ss_pred CCcEEEEECcccccccCcc
Confidence 8999999999998775543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-15 Score=159.78 Aligned_cols=155 Identities=23% Similarity=0.311 Sum_probs=133.1
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC------CCCccceEEEEEeCCe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ------HRNLVRLLGCCVEGEE 551 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~------H~niv~l~g~~~~~~~ 551 (649)
....|.+....|+|-|++|.+|... .|++||||+|... +...+.=+.|+++|.+|+ .-+.++|+..|...++
T Consensus 430 LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnN-E~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH 508 (752)
T KOG0670|consen 430 LDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNN-EVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH 508 (752)
T ss_pred hcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecc-hHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence 3467877788999999999999876 5789999999653 444566678999999996 3578999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCc
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMA 630 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla 630 (649)
++||+|-+ .-+|.+.|.....+-.|....+..++.|+.-||..|...+ |+|.||||.|||+++. ...||||||-|
T Consensus 509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA 584 (752)
T KOG0670|consen 509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA 584 (752)
T ss_pred eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence 99999988 5689999988777778888999999999999999999877 9999999999999976 45899999999
Q ss_pred eeeCCCCC
Q 006347 631 KIFGGNQD 638 (649)
Q Consensus 631 ~~~~~~~~ 638 (649)
...+.++.
T Consensus 585 ~~~~enei 592 (752)
T KOG0670|consen 585 SFASENEI 592 (752)
T ss_pred cccccccc
Confidence 98766553
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=8.4e-16 Score=152.69 Aligned_cols=144 Identities=28% Similarity=0.412 Sum_probs=116.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------e
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------E 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~ 551 (649)
.+|.....+|.|.- .|.-+... .+++||+|++... .....+...+|..++..++|+|+++++.++.-+. +
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 34555567777776 55555443 5889999987543 2345677889999999999999999999987544 5
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.|+||||| ..+|...+. -.++-.+...|..|++.|+.|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m-~~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELM-DANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhh-hhHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 68999999 568877774 23677788899999999999999988 9999999999999999999999999999
Q ss_pred eeC
Q 006347 632 IFG 634 (649)
Q Consensus 632 ~~~ 634 (649)
.-+
T Consensus 167 ~e~ 169 (369)
T KOG0665|consen 167 TED 169 (369)
T ss_pred ccC
Confidence 643
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.59 E-value=4.6e-15 Score=154.51 Aligned_cols=134 Identities=25% Similarity=0.409 Sum_probs=112.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----C---CCccceEEEEEe---
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----H---RNLVRLLGCCVE--- 548 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H---~niv~l~g~~~~--- 548 (649)
.+|.+.++||-|.|.+||.+... ..+-||+|+.+. ...-.+..+.||.+|++++ | ..||+|+.+|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS-AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS-AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh-hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 56888899999999999999865 577899998854 3445567789999999884 2 369999999975
Q ss_pred -CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 006347 549 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 619 (649)
Q Consensus 549 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 619 (649)
+.+.++|+|++ +-+|..+|... .-+.++...+.+|++||+.||.|||.++ +|||-||||+||||..+
T Consensus 157 NG~HVCMVfEvL-GdnLLklI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~~~ 224 (590)
T KOG1290|consen 157 NGQHVCMVFEVL-GDNLLKLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLCST 224 (590)
T ss_pred CCcEEEEEehhh-hhHHHHHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeeecc
Confidence 55899999999 77888888653 4456899999999999999999999987 69999999999999654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.59 E-value=3.3e-14 Score=147.15 Aligned_cols=150 Identities=35% Similarity=0.565 Sum_probs=128.5
Q ss_pred cccceeeccCCcEEEEEEEecCCcEEEEEEecccccc---cHHHHHHHHHHHhcCCCC-CccceEEEEEeCCeEEEEEec
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ---GLEEFMNEVMVISKLQHR-NLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~---~~~~f~~E~~~l~~l~H~-niv~l~g~~~~~~~~~lV~Ey 558 (649)
|...+.||.|+||.||++... ..+++|.+...... ..+.|.+|+.+++.+.|+ +++++...+......++++||
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 566789999999999999988 78999998764332 377899999999999887 799999999777778999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceeeCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~~~~~ 637 (649)
+.+++|.+++........+.......++.+++.++.|+|+.+ ++|||+||+||+++... .+|++|||+++.+....
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999977743211126888999999999999999999988 99999999999999988 79999999999765443
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.4e-14 Score=145.81 Aligned_cols=136 Identities=22% Similarity=0.305 Sum_probs=107.0
Q ss_pred eeec-cCCcEEEEEEEecCCcEEEEEEecccc-------------cccHHHHHHHHHHHhcCCCCCc--cceEEEEEeCC
Q 006347 487 SKLG-QGGFGPVYWGRLKDGQEIAVKRLSKAS-------------GQGLEEFMNEVMVISKLQHRNL--VRLLGCCVEGE 550 (649)
Q Consensus 487 ~~LG-~G~fG~Vykg~~~~g~~vAVK~l~~~~-------------~~~~~~f~~E~~~l~~l~H~ni--v~l~g~~~~~~ 550 (649)
..|| .|+.|+||++... +..++||+..... ......+.+|++++.+++|+++ ++.+++.....
T Consensus 37 ~~lg~~~g~gtv~~v~~~-~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP-GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEeC-CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4787 8999999999886 7789999875311 1233567889999999988775 77777755432
Q ss_pred e----EEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 551 E----KMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 551 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
. .++||||+++ .+|.+++.+ ..++.. .+.+|+++|.+||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 3599999997 689888743 234433 3568999999999998 9999999999999998899999
Q ss_pred ecCCceeeC
Q 006347 626 DFGMAKIFG 634 (649)
Q Consensus 626 DFGla~~~~ 634 (649)
|||.++...
T Consensus 185 Dfg~~~~~~ 193 (239)
T PRK01723 185 DFDRGELRT 193 (239)
T ss_pred ECCCcccCC
Confidence 999999864
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.56 E-value=4.3e-15 Score=117.63 Aligned_cols=58 Identities=50% Similarity=1.109 Sum_probs=51.9
Q ss_pred CCCeeeeccccCCCCcc--ccCCCChhHHHHHhhccCCeEEEEec---CCceEEEeeccccccc
Q 006347 337 EDGFSKLNKMKVPDFTE--WTSPATEDECREQCLKNCSCIAYAFD---GGIGCMVWRSINLIDI 395 (649)
Q Consensus 337 ~~~f~~~~~~~~p~~~~--~~~~~~~~~C~~~Cl~nCsC~a~~~~---~g~gC~~w~~~~l~~~ 395 (649)
+|+|++|++|++|+++. +..+.++++|+++||+||||+||+|. ++++|++|.+ +|+|+
T Consensus 4 ~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~~~~~C~lW~~-~L~d~ 66 (66)
T PF08276_consen 4 GDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLSGGGGCLLWYG-DLVDL 66 (66)
T ss_pred CCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccCCCCEEEEEcC-EeecC
Confidence 78999999999999976 44679999999999999999999998 4677999999 99874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.51 E-value=3.5e-14 Score=163.28 Aligned_cols=147 Identities=24% Similarity=0.341 Sum_probs=117.1
Q ss_pred HHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~l 554 (649)
.....|.+..+||+|+||+||+|+..+|+.||+|.-+..... +|.--.+++.+|+ -+-|..+.....-.+..+|
T Consensus 695 ~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~W---EfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~l 771 (974)
T KOG1166|consen 695 VGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPW---EFYICLQVMERLKPQMLPSIMHISSAHVFQNASVL 771 (974)
T ss_pred ecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCce---eeeehHHHHHhhchhhhcchHHHHHHHccCCccee
Confidence 334568888999999999999999988999999987665554 2232333344443 2345555555666788899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CCceEEEec
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-------ELNPKISDF 627 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------~~~~Ki~DF 627 (649)
|+||.+.|+|.+++. ..+.++|.....++.|+++-+++||..+ |||+||||+|.||.. ...+||+||
T Consensus 772 v~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lIDf 845 (974)
T KOG1166|consen 772 VSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLIDF 845 (974)
T ss_pred eeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEec
Confidence 999999999999994 5677999999999999999999999988 999999999999953 345899999
Q ss_pred CCceee
Q 006347 628 GMAKIF 633 (649)
Q Consensus 628 Gla~~~ 633 (649)
|-+--+
T Consensus 846 G~siDm 851 (974)
T KOG1166|consen 846 GRSIDM 851 (974)
T ss_pred ccceee
Confidence 988654
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.47 E-value=1.5e-13 Score=150.18 Aligned_cols=141 Identities=24% Similarity=0.276 Sum_probs=101.0
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEeccccccc----------------------------------------HHHHHH
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG----------------------------------------LEEFMN 526 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~----------------------------------------~~~f~~ 526 (649)
+.||.|++|+||+|++.+|+.||||+.+...... +-.|.+
T Consensus 123 ~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~ 202 (437)
T TIGR01982 123 KPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRR 202 (437)
T ss_pred cceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHH
Confidence 6799999999999999999999999986431110 012455
Q ss_pred HHHHHhcCC----CCCccceEEEEE-eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHHHHHhCC
Q 006347 527 EVMVISKLQ----HRNLVRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-GLLYLHRDS 600 (649)
Q Consensus 527 E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~~ 600 (649)
|+..+.+++ |.+-+.+-..+. .....+|||||+++++|.++.... .... .+..++..+++ .+..+|..+
T Consensus 203 Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~--~~~~---~~~~ia~~~~~~~l~ql~~~g 277 (437)
T TIGR01982 203 EAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALD--EAGL---DRKALAENLARSFLNQVLRDG 277 (437)
T ss_pred HHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHH--hcCC---CHHHHHHHHHHHHHHHHHhCC
Confidence 665555552 333333333332 234679999999999998876321 1112 24456776666 467888877
Q ss_pred CCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 601 ~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++|+|+||.||++++++.++++|||+++.+..
T Consensus 278 ---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 278 ---FFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred ---ceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 99999999999999999999999999998854
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=2.9e-13 Score=110.72 Aligned_cols=67 Identities=25% Similarity=0.382 Sum_probs=59.7
Q ss_pred CCCeeeeccccCCCCccccCCCChhHHHHHhhc---cCCeEEEEec-CCceEEEeecccc-ccccccCCCccceEEE
Q 006347 337 EDGFSKLNKMKVPDFTEWTSPATEDECREQCLK---NCSCIAYAFD-GGIGCMVWRSINL-IDIQRLPFGGTDLYIR 408 (649)
Q Consensus 337 ~~~f~~~~~~~~p~~~~~~~~~~~~~C~~~Cl~---nCsC~a~~~~-~g~gC~~w~~~~l-~~~~~~~~~~~~lyvr 408 (649)
..+|+++.++++|++.. .+++||+++|++ ||||+||+|. .+.||.+|.+ +| .+++..++.+.++|+|
T Consensus 8 ~g~fl~~~~~klpd~~~----~s~~eC~~~Cl~~~~nCsC~Aya~~~~~~gC~~W~~-~l~~d~~~~~~~g~~Ly~r 79 (80)
T cd00129 8 AGTTLIKIALKIKTTKA----NTADECANRCEKNGLPFSCKAFVFAKARKQCLWFPF-NSMSGVRKEFSHGFDLYEN 79 (80)
T ss_pred CCeEEEeecccCCcccc----cCHHHHHHHHhcCCCCCCceeeeccCCCCCeEEecC-cchhhHHhccCCCceeEeE
Confidence 56899999999999763 689999999999 9999999997 3568999999 99 9998887778999998
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.3e-13 Score=112.08 Aligned_cols=73 Identities=44% Similarity=0.914 Sum_probs=60.8
Q ss_pred CCCeeeeccccCCCCccccCCCChhHHHHHhhccCCeEEEEecC-CceEEEeeccccccccccCCCccceEEEEe
Q 006347 337 EDGFSKLNKMKVPDFTEWTSPATEDECREQCLKNCSCIAYAFDG-GIGCMVWRSINLIDIQRLPFGGTDLYIRVA 410 (649)
Q Consensus 337 ~~~f~~~~~~~~p~~~~~~~~~~~~~C~~~Cl~nCsC~a~~~~~-g~gC~~w~~~~l~~~~~~~~~~~~lyvrv~ 410 (649)
.++|.++.++++|++.+.....++++|+++||+||+|+||+|.+ +.+|++|.+ ++.+.+.....+.++||||+
T Consensus 11 ~~~f~~~~~~~~~~~~~~~~~~s~~~C~~~Cl~nCsC~a~~~~~~~~~C~~~~~-~~~~~~~~~~~~~~~yiKv~ 84 (84)
T cd01098 11 TDGFLKLPDVKLPDNASAITAISLEECREACLSNCSCTAYAYNNGSGGCLLWNG-LLNNLRSLSSGGGTLYLRLA 84 (84)
T ss_pred CCEEEEeCCeeCCCchhhhccCCHHHHHHHHhcCCCcceeeecCCCCeEEEEec-eecceEeecCCCcEEEEEeC
Confidence 46899999999998876336789999999999999999999985 455999998 88887664444678999985
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.33 E-value=7e-12 Score=119.11 Aligned_cols=132 Identities=22% Similarity=0.157 Sum_probs=98.9
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEecCCCCCh
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
.+.|+.|.++.||++... +..+++|....... ....+..|+.++..+.+.++ .+++.+. .+..++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 367899999999999876 77899998754321 23456789999998865554 4555543 3446899999999887
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
.... . ....++.+++++|+.||... ...++|+|++|.||+++ ++.++++||+.|..-
T Consensus 79 ~~~~--------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~~ 137 (170)
T cd05151 79 LTED--------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGMN 137 (170)
T ss_pred cccc--------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccCC
Confidence 5320 0 11235678999999999876 33479999999999999 668999999999863
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.28 E-value=1.7e-11 Score=135.69 Aligned_cols=146 Identities=21% Similarity=0.280 Sum_probs=94.8
Q ss_pred CcccceeeccCCcEEEEEEEecC-CcEEEEEEecccccc----------------------------------cH-----
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQ----------------------------------GL----- 521 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~----------------------------------~~----- 521 (649)
.|+. +.||.|++|+||+|++++ |++||||++++.... ..
T Consensus 121 ~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~~ 199 (537)
T PRK04750 121 DFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLHD 199 (537)
T ss_pred hcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHHH
Confidence 4665 789999999999999987 999999998643110 00
Q ss_pred -HHHHHHHHHHhcCC----CCCccceEEEEEe-CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH-HHH
Q 006347 522 -EEFMNEVMVISKLQ----HRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR-GLL 594 (649)
Q Consensus 522 -~~f~~E~~~l~~l~----H~niv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~ 594 (649)
-.|.+|+.-+.+++ +.+.+.+-..+.+ ..+.+|||||++|+.+.++-.- .....+.. .++...++ -+.
T Consensus 200 ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l--~~~g~d~~---~la~~~v~~~~~ 274 (537)
T PRK04750 200 ELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAAL--RAAGTDMK---LLAERGVEVFFT 274 (537)
T ss_pred hhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHH--HhcCCCHH---HHHHHHHHHHHH
Confidence 12445555444442 4444444343333 4567899999999999875311 11122222 12222221 122
Q ss_pred HHHhCCCCceEecCCCCCcEEEcCCC----ceEEEecCCceeeCCC
Q 006347 595 YLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFGMAKIFGGN 636 (649)
Q Consensus 595 yLH~~~~~~iiHrDlkp~NILl~~~~----~~Ki~DFGla~~~~~~ 636 (649)
-++..+ ++|+|+||.||+++.++ .+++.|||++..+...
T Consensus 275 Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~~ 317 (537)
T PRK04750 275 QVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNKE 317 (537)
T ss_pred HHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCHH
Confidence 233455 99999999999999988 9999999999988543
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.19 E-value=2e-10 Score=113.81 Aligned_cols=143 Identities=18% Similarity=0.273 Sum_probs=113.6
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCC--CCccceEEEEEeCC---eEEEEEecCC
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE---EKMLIYEYMP 560 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 560 (649)
+.|+.|..+.||+++..+|+.+++|....... ....++..|++++..+++ .++.+++.+..+.. ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999987778999998754322 245678999999999975 45678888876543 5689999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS---------------------------------------- 600 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 600 (649)
+.++.+.+.. ..++...+..++.+++++|.+||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988765521 34677888889999999999998531
Q ss_pred -------------CCceEecCCCCCcEEEcC--CCceEEEecCCceee
Q 006347 601 -------------RLRIIHRDLKASNILLDE--ELNPKISDFGMAKIF 633 (649)
Q Consensus 601 -------------~~~iiHrDlkp~NILl~~--~~~~Ki~DFGla~~~ 633 (649)
...++|+|++|.||++++ +..+.|+||+.+..-
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~g 207 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATLG 207 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccccC
Confidence 245899999999999998 667899999998863
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.19 E-value=1.4e-11 Score=145.70 Aligned_cols=95 Identities=18% Similarity=0.263 Sum_probs=74.8
Q ss_pred cCCC-CCccceEEEE-------EeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006347 533 KLQH-RNLVRLLGCC-------VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604 (649)
Q Consensus 533 ~l~H-~niv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 604 (649)
.++| +||+++++++ .+....++++||+ .++|.++|.. ....+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDN--PDRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhc--ccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5888888877 3334567889988 6699999964 2356899999999999999999999987 9
Q ss_pred EecCCCCCcEEEcC-------------------CCceEEEecCCceee
Q 006347 605 IHRDLKASNILLDE-------------------ELNPKISDFGMAKIF 633 (649)
Q Consensus 605 iHrDlkp~NILl~~-------------------~~~~Ki~DFGla~~~ 633 (649)
+||||||+||||+. ++.+||+|||+++..
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~ 149 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRRE 149 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCccccccccccccc
Confidence 99999999999954 455667777777653
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.6e-11 Score=138.63 Aligned_cols=144 Identities=28% Similarity=0.378 Sum_probs=110.9
Q ss_pred cceeeccCCcEEEEEEEec-CCcEEEEEEec----c-cccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 485 LSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS----K-ASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~----~-~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
..+.+|.|++|.|+..... .....+.|... . ..+. ....+..|..+-..++|+|++..+..+.+....+-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 3468999999977766543 23333333221 1 1111 11225567777788899999888888777777777799
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|++. +|..++.. ...+...++..+..|+.+|+.|||+.+ |.|||+|++|+++..++.+||+|||.+..+.-
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~ 472 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRY 472 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeecc
Confidence 9999 99988843 346788889999999999999999998 99999999999999999999999999998743
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.17 E-value=5.2e-10 Score=108.18 Aligned_cols=137 Identities=14% Similarity=0.097 Sum_probs=100.4
Q ss_pred eeeccCCcEEEEEEEecC-------CcEEEEEEecccc----------------------cccHHHHH----HHHHHHhc
Q 006347 487 SKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKAS----------------------GQGLEEFM----NEVMVISK 533 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~-------g~~vAVK~l~~~~----------------------~~~~~~f~----~E~~~l~~ 533 (649)
..||.|.-+.||.|.-.+ +..+|||..+... ....+.+. +|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 478999999999998653 4799999654210 01122344 79999999
Q ss_pred CC--CCCccceEEEEEeCCeEEEEEecCCCCChhh-hhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCC
Q 006347 534 LQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDA-LLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDL 609 (649)
Q Consensus 534 l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~-~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDl 609 (649)
++ ..++.+++++ ...+|||||+.+..+.. .+. ...++..+...+..+++.+|..| |+.+ |||+||
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lk----d~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDL 151 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLK----DAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADL 151 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhh----ccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCC
Confidence 95 3567777765 56789999997654422 221 22344455667889999999999 7776 999999
Q ss_pred CCCcEEEcCCCceEEEecCCceeeCC
Q 006347 610 KASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 610 kp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++.|||+++ +.++|+|||-|.....
T Consensus 152 s~~NIL~~~-~~v~iIDF~qav~~~h 176 (197)
T cd05146 152 SEYNMLWHD-GKVWFIDVSQSVEPTH 176 (197)
T ss_pred CHHHEEEEC-CcEEEEECCCceeCCC
Confidence 999999974 6799999999987754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=6.4e-10 Score=104.10 Aligned_cols=133 Identities=23% Similarity=0.327 Sum_probs=103.8
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEE-ecccc--c-----ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKR-LSKAS--G-----QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~-l~~~~--~-----~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
..+++|+-+.+|.+.+. |.++.+|. +++.= + --.....+|+.+|.+++--.|.--.-+..+.+...|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35789999999999775 44455552 32211 1 1234577899999999766666666677888899999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++..|.+.+... +..++..+-+-+.-||..+ |+|+||.++||++..+. +.++||||++.-.
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~s~ 142 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEFSD 142 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccccc
Confidence 9999998888432 3567888888999999998 99999999999998876 9999999999643
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.6e-09 Score=101.01 Aligned_cols=149 Identities=21% Similarity=0.291 Sum_probs=110.5
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEE-eccc-------ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKR-LSKA-------SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~-l~~~-------~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
..+.+-||+-+.|+++... |+...||. ..+. ..-..++.++|++++.+++--.|.--.-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~~-Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS-GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeeccC-CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 3578999999999999988 67666663 2221 1123467889999999997666665556677888888999
Q ss_pred ecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEecCCcee
Q 006347 557 EYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKI 632 (649)
Q Consensus 557 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DFGla~~ 632 (649)
||+++ .++.+++.........+ .....++..|-+.+.-||.++ |||+||..+||+|..++. +.++||||+..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~~d-~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDESED-EGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcccc-hhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99977 46788875433333222 223678889999999999998 999999999999976654 58999999887
Q ss_pred eCCCCC
Q 006347 633 FGGNQD 638 (649)
Q Consensus 633 ~~~~~~ 638 (649)
-...+.
T Consensus 166 s~~~ED 171 (229)
T KOG3087|consen 166 SRLPED 171 (229)
T ss_pred ccCccc
Confidence 544443
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.01 E-value=1.7e-09 Score=110.16 Aligned_cols=148 Identities=26% Similarity=0.339 Sum_probs=99.3
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecc---cccccHHHHHHHHHHHhcCCC-----------CCccceEEEEE
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH-----------RNLVRLLGCCV 547 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~---~~~~~~~~f~~E~~~l~~l~H-----------~niv~l~g~~~ 547 (649)
+...+.||.|+++.||.++.. +++++|||.... ......+++++|...+..+.+ .-++.+--.-.
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 445678999999999999987 589999997742 233466788888877766543 12222211111
Q ss_pred e--------CC--------eEEEEEecCCCCChhhhhc---CCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006347 548 E--------GE--------EKMLIYEYMPNRSLDALLF---DPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607 (649)
Q Consensus 548 ~--------~~--------~~~lV~Ey~~~gsL~~~l~---~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 607 (649)
. .. +.+++|+-+ .++|.+++. ... ....+....++.+..|+.+.+++||..+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 1 11 235677777 678877753 211 1233455667778899999999999998 9999
Q ss_pred CCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 608 DLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 608 Dlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+|++++++|.++++||+-++..+
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g 196 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAG 196 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETT
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecC
Confidence 999999999999999999999887654
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=8.4e-11 Score=114.60 Aligned_cols=136 Identities=26% Similarity=0.457 Sum_probs=112.7
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
.+|.+...|..|+|+++ |..+++|.+.-. ...--+.|..|.-.++-+.||||..++|.|....+..++..|||.|||
T Consensus 196 tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gsl 274 (448)
T KOG0195|consen 196 TKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSL 274 (448)
T ss_pred hhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHH
Confidence 47888899999999998 556666776432 223446888999899999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
...|++. ..-.++-.+..+++.+||+|++|||+-. +-|..-.|.+..+++|++.+++|+
T Consensus 275 ynvlhe~-t~vvvd~sqav~faldiargmaflhsle-p~ipr~~lns~hvmidedltaris 333 (448)
T KOG0195|consen 275 YNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLE-PMIPRFYLNSKHVMIDEDLTARIS 333 (448)
T ss_pred HHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcc-hhhhhhhcccceEEecchhhhhee
Confidence 9999763 3345678889999999999999999875 224444788999999999998875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.95 E-value=9e-11 Score=127.14 Aligned_cols=142 Identities=27% Similarity=0.287 Sum_probs=115.7
Q ss_pred eeccCCcEEEEEEEe----cCCcEEEEEEeccccc--ccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecCC
Q 006347 488 KLGQGGFGPVYWGRL----KDGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.+|+|.||.|+.+.- ..+..+|+|.+++... ........|..++..++ ||.+|++.-.+......+++++|..
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r 80 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR 80 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence 378999999987642 3467788888865432 12225667888889997 9999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+|.|...+.+ ....+..........++-+++++|+.+ |+|||+|++||+++.+|++|+.|||+.+..-.
T Consensus 81 gg~lft~l~~---~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~ 149 (612)
T KOG0603|consen 81 GGDLFTRLSK---EVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVK 149 (612)
T ss_pred cchhhhcccc---CCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHh
Confidence 9999777743 344566666667788999999999887 99999999999999999999999999998643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.87 E-value=4.6e-08 Score=99.83 Aligned_cols=142 Identities=18% Similarity=0.095 Sum_probs=102.4
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEeccccc-----------ccHHHHHHHHHHHhcCC--CCCccceEEEEEe-----
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-----------QGLEEFMNEVMVISKLQ--HRNLVRLLGCCVE----- 548 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-----------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~----- 548 (649)
+.+-+..-..|++..+. |+.+.||+...... .....+.+|...+.++. .-..+.++++...
T Consensus 28 e~v~~~~~rrvvr~~~~-g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~ 106 (268)
T PRK15123 28 EVFRELEGRRTLRFELA-GKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPA 106 (268)
T ss_pred cEEecCCCceEEEEEEC-CEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCc
Confidence 34444444457777664 77899997643210 11124789999998885 3445566667654
Q ss_pred CCeEEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------CC
Q 006347 549 GEEKMLIYEYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-------EL 620 (649)
Q Consensus 549 ~~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-------~~ 620 (649)
....+||+|++++- +|.+++.+.. ....+...+..++.++++.+.-||+.+ |+|+|++++|||++. +.
T Consensus 107 ~~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 107 TRTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred cceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCc
Confidence 23578999999886 8998874321 234456677789999999999999998 999999999999985 46
Q ss_pred ceEEEecCCceee
Q 006347 621 NPKISDFGMAKIF 633 (649)
Q Consensus 621 ~~Ki~DFGla~~~ 633 (649)
.+.++||+.++..
T Consensus 183 ~~~LIDl~r~~~~ 195 (268)
T PRK15123 183 KLSVIDLHRAQIR 195 (268)
T ss_pred eEEEEECCccccc
Confidence 8999999998753
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.2e-09 Score=113.44 Aligned_cols=100 Identities=35% Similarity=0.600 Sum_probs=90.8
Q ss_pred HhcCCCCCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006347 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK 610 (649)
Q Consensus 531 l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 610 (649)
|+.+.|.|+.+++|.+.++...++|.+|++.|+|.+.+.. ....++|.-...++++|++||+|||... -..|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999975 4556899999999999999999999864 12999999
Q ss_pred CCcEEEcCCCceEEEecCCceeeC
Q 006347 611 ASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 611 p~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++|.++|....+||+|||+..+..
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~ 100 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLE 100 (484)
T ss_pred cccceeeeeEEEEechhhhccccc
Confidence 999999999999999999998874
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.82 E-value=5.3e-09 Score=107.32 Aligned_cols=89 Identities=27% Similarity=0.485 Sum_probs=70.5
Q ss_pred CCCCccceEEEEEeC---------------------------CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHH
Q 006347 535 QHRNLVRLLGCCVEG---------------------------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIE 587 (649)
Q Consensus 535 ~H~niv~l~g~~~~~---------------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 587 (649)
+|||||++.+++.+. ...|+||.-++ -+|.+++-. ...+...+.-|+.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 588888888877542 23588988874 488888843 3456677777899
Q ss_pred HHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCCc--eEEEecCCce
Q 006347 588 GISRGLLYLHRDSRLRIIHRDLKASNILL--DEELN--PKISDFGMAK 631 (649)
Q Consensus 588 ~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~~--~Ki~DFGla~ 631 (649)
|+++|+.|||.++ |.|||+|++|||+ |+|.. ..|+|||.+-
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcL 393 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCL 393 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceee
Confidence 9999999999998 9999999999998 45544 5799999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.79 E-value=3.2e-08 Score=95.37 Aligned_cols=127 Identities=25% Similarity=0.301 Sum_probs=83.3
Q ss_pred EEEEEEecCCcEEEEEEecccc--------------c-------c-----cHHHHHHHHHHHhcCCCC--CccceEEEEE
Q 006347 496 PVYWGRLKDGQEIAVKRLSKAS--------------G-------Q-----GLEEFMNEVMVISKLQHR--NLVRLLGCCV 547 (649)
Q Consensus 496 ~Vykg~~~~g~~vAVK~l~~~~--------------~-------~-----~~~~f~~E~~~l~~l~H~--niv~l~g~~~ 547 (649)
-||.|...+|..+|||.-+... . . ......+|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 3899999889999999754210 0 0 123467899999999755 56777655
Q ss_pred eCCeEEEEEecCC--CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 548 EGEEKMLIYEYMP--NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL-HRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 548 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
....|||||++ +..+..+... .++......++.+++..+..+ |..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~-----~~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDV-----DLSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHC-----GGGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhc-----cccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999998 5555443311 111234456777777766664 5666 9999999999999998 9999
Q ss_pred EecCCceeeCC
Q 006347 625 SDFGMAKIFGG 635 (649)
Q Consensus 625 ~DFGla~~~~~ 635 (649)
+|||.|.....
T Consensus 148 IDf~qav~~~~ 158 (188)
T PF01163_consen 148 IDFGQAVDSSH 158 (188)
T ss_dssp --GTTEEETTS
T ss_pred EecCcceecCC
Confidence 99999987653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.2e-09 Score=124.26 Aligned_cols=143 Identities=20% Similarity=0.227 Sum_probs=112.8
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEecccc-cccHHHHHHHHHH--HhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS-GQGLEEFMNEVMV--ISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~-~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++...+.||.+.|=+|.+++.++|. |+||++-+.. .-..+.|.++++- ...++|||.+.+.-+-..+...|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4555689999999999999999887 8889875443 3455666655544 4445899999887776666677888888
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
..+ +|.+.|. -+.-+...+..-|+.|+..||.-+|..+ |.|+|||.+|||+..-.=+.|+||.--|.
T Consensus 103 vkh-nLyDRlS---TRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKP 169 (1431)
T KOG1240|consen 103 VKH-NLYDRLS---TRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKP 169 (1431)
T ss_pred Hhh-hhhhhhc---cchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCC
Confidence 843 6766662 2344677788889999999999999988 99999999999999999999999986554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.67 E-value=3.2e-09 Score=120.00 Aligned_cols=163 Identities=26% Similarity=0.376 Sum_probs=123.0
Q ss_pred cCcccceeeccCCcEEEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 555 (649)
..|.+.+.||+|+|+.|-..... ....+|+|.+.... .........|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 45666778999999999887764 34456777665432 223344455777777776 99999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH-RDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~ 633 (649)
+||..++++.+.+... .....+....-.+..|+..++.|+| +.+ +.||||||+|.+++..+ ..|++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~~-~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISHP-DSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCcccccccccccccC-CccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 9999999998777321 1113445556678899999999999 776 99999999999999999 9999999999988
Q ss_pred CC-CCCccccCceee
Q 006347 634 GG-NQDQADTGRVVG 647 (649)
Q Consensus 634 ~~-~~~~~~~~~~~G 647 (649)
.. +..........|
T Consensus 176 ~~~~g~~~~~~~~~g 190 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCG 190 (601)
T ss_pred cccCCcceeeecccC
Confidence 66 333333333333
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.62 E-value=1.2e-07 Score=83.95 Aligned_cols=89 Identities=28% Similarity=0.461 Sum_probs=63.6
Q ss_pred eEEEeeCCcEEEEcCC-ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCc
Q 006347 88 IITISEDGNLVLVNGQ-KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK 166 (649)
Q Consensus 88 ~l~~~~~G~L~l~~~~-~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~ 166 (649)
++.++.||+||+++.. +.++|++++.........+.|.++|||||++. .+.++|+|= + . +
T Consensus 23 ~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S~--t-~---~------------ 83 (114)
T smart00108 23 TLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDG-DGRVVWSSN--T-T---G------------ 83 (114)
T ss_pred ccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeC-CCCEEEEec--c-c---C------------
Confidence 3556689999999875 58999999863333346889999999999985 467899981 1 0 1
Q ss_pred eeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecC
Q 006347 167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSG 209 (649)
Q Consensus 167 ~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg 209 (649)
..+.|.+.++.+|+..++-. .+.+.|.|.
T Consensus 84 -------------~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 84 -------------ANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred -------------CCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 24567888999998655422 346788764
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.61 E-value=2.9e-07 Score=98.08 Aligned_cols=140 Identities=21% Similarity=0.319 Sum_probs=113.7
Q ss_pred EEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEEEEEecCCC-CChhhhh
Q 006347 495 GPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLIYEYMPN-RSLDALL 568 (649)
Q Consensus 495 G~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~l 568 (649)
.+.||+... +|..+++|+++....+.....-.-++..+++.|.|+|++..++.. +....+||+|+|+ ++|.++.
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~ 369 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY 369 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence 578999876 899999999955444444344556788999999999999998873 4467899999985 6787776
Q ss_pred cCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 569 FDPL------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 569 ~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+... ....+++..++.++.|+..||.++|+.+ +.-+-|.|++||++.+.+++|+..|...++..+
T Consensus 370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d 446 (655)
T KOG3741|consen 370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQED 446 (655)
T ss_pred ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence 5421 2234678899999999999999999998 888999999999999999999999999888655
Q ss_pred C
Q 006347 637 Q 637 (649)
Q Consensus 637 ~ 637 (649)
.
T Consensus 447 ~ 447 (655)
T KOG3741|consen 447 P 447 (655)
T ss_pred C
Confidence 5
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.57 E-value=2e-07 Score=82.91 Aligned_cols=89 Identities=26% Similarity=0.443 Sum_probs=63.8
Q ss_pred EEEee-CCcEEEEcCC-ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCc
Q 006347 89 ITISE-DGNLVLVNGQ-KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK 166 (649)
Q Consensus 89 l~~~~-~G~L~l~~~~-~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~ 166 (649)
+.++. ||+|++++.. ++++|++++.........+.|.++|||||++. ++.++|+|=-.
T Consensus 24 ~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~S~~~------------------- 83 (116)
T cd00028 24 LIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDG-SGTVVWSSNTT------------------- 83 (116)
T ss_pred CCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcC-CCcEEEEeccc-------------------
Confidence 44565 9999999765 58999999863223456799999999999985 46789997210
Q ss_pred eeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 167 ~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
.+.+.+.+.|+.+|+..++-. .+.+.|.|..
T Consensus 84 ------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf~ 114 (116)
T cd00028 84 ------------RVNGNYVLVLLDDGNLVLYDS-DGNFLWQSFD 114 (116)
T ss_pred ------------CCCCceEEEEeCCCCEEEECC-CCCEEEcCCC
Confidence 024567888999998555432 3567888754
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.53 E-value=2.8e-07 Score=75.30 Aligned_cols=71 Identities=39% Similarity=0.889 Sum_probs=55.4
Q ss_pred CCCeeeeccccCCCCcc-ccCCCChhHHHHHhhc-cCCeEEEEecC-CceEEEee-ccccccccccCCCccceEEE
Q 006347 337 EDGFSKLNKMKVPDFTE-WTSPATEDECREQCLK-NCSCIAYAFDG-GIGCMVWR-SINLIDIQRLPFGGTDLYIR 408 (649)
Q Consensus 337 ~~~f~~~~~~~~p~~~~-~~~~~~~~~C~~~Cl~-nCsC~a~~~~~-g~gC~~w~-~~~l~~~~~~~~~~~~lyvr 408 (649)
...|..++++.+++... .....++++|++.|++ +|+|.||.|.. +.+|.+|. + ++.+.+..+..+.++|.|
T Consensus 3 ~~~f~~~~~~~l~~~~~~~~~~~s~~~C~~~C~~~~~~C~s~~y~~~~~~C~l~~~~-~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 3 DDCFVRLPNTKLPGFSRIVISVASLEECASKCLNSNCSCRSFTYNNGTKGCLLWSES-SLGDARLFPSGGVDLYEK 77 (78)
T ss_pred CceeEEecCccCCCCcceeEcCCCHHHHHHHhCCCCCceEEEEEcCCCCEEEEeeCC-ccccceecccCCceeEEe
Confidence 45789999999986654 3456799999999999 99999999974 55699999 6 777776444555566665
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.52 E-value=9.5e-07 Score=86.98 Aligned_cols=109 Identities=24% Similarity=0.260 Sum_probs=88.0
Q ss_pred cHHHHHHHHHHHhcCC--CCCccceEEEEEeCC----eEEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 006347 520 GLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGE----EKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRG 592 (649)
Q Consensus 520 ~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 592 (649)
......+|...+.++. .-..++.+++..... ..+||+|++++ .+|.+++.+. ...+......++.++++.
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~---~~~~~~~~~~ll~~l~~~ 130 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQW---EQLDPSQRRELLRALARL 130 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhh---cccchhhHHHHHHHHHHH
Confidence 3456788888888884 455678888877643 45899999987 4799998532 125666778899999999
Q ss_pred HHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEecCCceeeC
Q 006347 593 LLYLHRDSRLRIIHRDLKASNILLDEEL---NPKISDFGMAKIFG 634 (649)
Q Consensus 593 L~yLH~~~~~~iiHrDlkp~NILl~~~~---~~Ki~DFGla~~~~ 634 (649)
++-||+.+ |+|+|+++.|||++.+. .+.++||+-++...
T Consensus 131 i~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~~ 172 (206)
T PF06293_consen 131 IAKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFRP 172 (206)
T ss_pred HHHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhceeCC
Confidence 99999998 99999999999999887 89999999988754
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=8.2e-07 Score=88.30 Aligned_cols=137 Identities=21% Similarity=0.235 Sum_probs=94.9
Q ss_pred cccceeeccCCcEEEEEEEecCCcEEEEEEeccc--------------------c--cccHHHHHHHHHHHhcCCCC--C
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--------------------S--GQGLEEFMNEVMVISKLQHR--N 538 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--------------------~--~~~~~~f~~E~~~l~~l~H~--n 538 (649)
..+.++||-|.-+.||.|..+.|.++|||.=+.. + .-......+|.++|.+|+-. .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 3456799999999999999999999999942110 0 01123466888999999644 6
Q ss_pred ccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC
Q 006347 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 539 iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~ 618 (649)
+.+.+++ +...+||||+++-.|...-- ..-+..+ |+..|++-+.-+-..+ |||+|+.+=||++++
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~-----~~en~~~---il~~il~~~~~~~~~G---iVHGDlSefNIlV~~ 237 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL-----DVENPDE---ILDKILEEVRKAYRRG---IVHGDLSEFNILVTE 237 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC-----cccCHHH---HHHHHHHHHHHHHHcC---ccccCCchheEEEec
Confidence 7666655 56679999998866643310 1122333 3333444444333444 999999999999999
Q ss_pred CCceEEEecCCceeeC
Q 006347 619 ELNPKISDFGMAKIFG 634 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~ 634 (649)
++.+.++||-=+...+
T Consensus 238 dg~~~vIDwPQ~v~~~ 253 (304)
T COG0478 238 DGDIVVIDWPQAVPIS 253 (304)
T ss_pred CCCEEEEeCcccccCC
Confidence 9999999997666543
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.47 E-value=4.4e-07 Score=100.22 Aligned_cols=142 Identities=19% Similarity=0.255 Sum_probs=94.2
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccc--------------------------c--------------HHHHHH
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ--------------------------G--------------LEEFMN 526 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~--------------------------~--------------~~~f~~ 526 (649)
+.|+.++-|+||+|++++|++||||+.+..-.. . +-.+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 578899999999999999999999987542110 0 012444
Q ss_pred HHHHHhcCC----CCCccceEEEEE-eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHH-HHHHhCC
Q 006347 527 EVMVISKLQ----HRNLVRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL-LYLHRDS 600 (649)
Q Consensus 527 E~~~l~~l~----H~niv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~ 600 (649)
|..-+.+++ +..-+++-..+. -..+..|+|||++|-.+.++..- +....+.. .|+..++++. .-+-..+
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l--~~~g~d~k---~ia~~~~~~f~~q~~~dg 285 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAAL--KSAGIDRK---ELAELLVRAFLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHH--HhcCCCHH---HHHHHHHHHHHHHHHhcC
Confidence 555444442 222233333333 34677899999999999888532 22344533 3343333322 2222234
Q ss_pred CCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 601 ~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+.|.|..|.||+++.++.+-+.|||+...+...
T Consensus 286 ---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~ 318 (517)
T COG0661 286 ---FFHADPHPGNILVRSDGRIVLLDFGIVGRLDPK 318 (517)
T ss_pred ---ccccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence 999999999999999999999999999887543
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1e-07 Score=103.54 Aligned_cols=148 Identities=23% Similarity=0.263 Sum_probs=118.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec--CCcEEEEEEecccccccHH--HHHHHHHHHhcC-CCCCccceEEEEEeCCeEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASGQGLE--EFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~~~~~~--~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (649)
.+.+|.++..||.|.|+.|++...+ ++..+++|.+.+....... .-..|+.+...+ .|.++++....+.+..+.+
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ 342 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGY 342 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccccccc
Confidence 3457888899999999999998755 5778999987654322222 223456555555 5888999888888888889
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCcee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKI 632 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla~~ 632 (649)
+=.||++++++...+ .-...++...++++..+++.++.++|+.. ++|+|+||+||++..+ +..++.|||.+..
T Consensus 343 ip~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 343 IPLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred CchhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhccccccccc
Confidence 999999999987665 22345778888999999999999999877 9999999999999886 8899999999874
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.44 E-value=5.5e-06 Score=80.56 Aligned_cols=140 Identities=16% Similarity=0.139 Sum_probs=105.0
Q ss_pred eccCCcEEEEEEEecCCcEEEEEEeccc------ccccHHHHHHHHHHHhcCC--CCCccceEEEEEeCC----eEEEEE
Q 006347 489 LGQGGFGPVYWGRLKDGQEIAVKRLSKA------SGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGE----EKMLIY 556 (649)
Q Consensus 489 LG~G~fG~Vykg~~~~g~~vAVK~l~~~------~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~----~~~lV~ 556 (649)
-|+||-+.|++-.+. |..+-+|+-..- .+.+...|.+|...|.++. ...+.+.+.+..... ..+||+
T Consensus 26 ~~rgG~SgV~r~~~~-g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVT 104 (216)
T PRK09902 26 YRRNGMSGVQCVERN-GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVT 104 (216)
T ss_pred cCCCCcceEEEEEeC-CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEE
Confidence 456888889988776 446888876511 1457789999999999995 344556663322222 357999
Q ss_pred ecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--eEEEecCCceee
Q 006347 557 EYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--PKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~Ki~DFGla~~~ 633 (649)
|-+++ .+|.+++.+. ...+.+...+..++.++++.+.-||+.+ +.|+|+-+.||+++.++. ++++||--++..
T Consensus 105 e~L~g~~~L~~~l~~~-~~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~~ 180 (216)
T PRK09902 105 EDMAGFISIADWYAQH-AVSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRRR 180 (216)
T ss_pred EeCCCCccHHHHHhcC-CcCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccchh
Confidence 97753 6898888442 1234577778899999999999999998 999999999999986666 999999877653
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=98.36 E-value=8.8e-07 Score=84.39 Aligned_cols=62 Identities=26% Similarity=0.199 Sum_probs=54.3
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+|.+++.+ ....+++.++..|+.||++||.|||+.+ ||+|||+++++.+|+ ||+++.....
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~ 62 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE 62 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc
Confidence 689999954 2456999999999999999999999875 999999999999999 9999987543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.1e-06 Score=94.56 Aligned_cols=142 Identities=18% Similarity=0.239 Sum_probs=91.6
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEeccccccc-------------------------------------HHHHHHHHH
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-------------------------------------LEEFMNEVM 529 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~-------------------------------------~~~f~~E~~ 529 (649)
+.|+.-+.|+||+|++++|+.||||+-+..-+.. +-.|.+|++
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 6899999999999999999999999865421110 112555554
Q ss_pred HHhcC----CCCCc---cceEEEEE-eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006347 530 VISKL----QHRNL---VRLLGCCV-EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601 (649)
Q Consensus 530 ~l~~l----~H~ni---v~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 601 (649)
-..++ .|-++ |++-.++. -...+.|+||||+|..+.+... ..+..++...+..-+.++..-+-+- .
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~--i~~~gi~~~~i~~~l~~~~~~qIf~--~-- 320 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDA--IDKRGISPHDILNKLVEAYLEQIFK--T-- 320 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHH--HHHcCCCHHHHHHHHHHHHHHHHHh--c--
Confidence 44333 35551 11222222 2346889999999998877643 2334455554433333322222222 2
Q ss_pred CceEecCCCCCcEEEcC----CCceEEEecCCceeeCC
Q 006347 602 LRIIHRDLKASNILLDE----ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 602 ~~iiHrDlkp~NILl~~----~~~~Ki~DFGla~~~~~ 635 (649)
+++|+|-.|.||++.. +..+.+-|||+.+.+..
T Consensus 321 -GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~ 357 (538)
T KOG1235|consen 321 -GFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH 357 (538)
T ss_pred -CCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence 3999999999999983 67899999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.32 E-value=2e-06 Score=94.74 Aligned_cols=122 Identities=19% Similarity=0.257 Sum_probs=98.9
Q ss_pred cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHH
Q 006347 503 KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR 582 (649)
Q Consensus 503 ~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~ 582 (649)
.++.+|.|...+...+.......+-++.++.++||||++++.........|||+|-+. -|..++.. +.....
T Consensus 35 ~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~v 106 (690)
T KOG1243|consen 35 ADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEEV 106 (690)
T ss_pred ccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHHH
Confidence 3688899988876554334556777889999999999999999999999999999873 46666633 234444
Q ss_pred HHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 583 ~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
.-.+.||+.||.|||+.+ .++|++|.-.-|++++.|.-||.+|-++....
T Consensus 107 ~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~ 156 (690)
T KOG1243|consen 107 CLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKAS 156 (690)
T ss_pred HHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccc
Confidence 556899999999999776 59999999999999999999999998876543
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.30 E-value=1.2e-05 Score=80.35 Aligned_cols=133 Identities=16% Similarity=0.182 Sum_probs=86.9
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--CccceEEEEEeCCeEEEEEecCCCCC-
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLGCCVEGEEKMLIYEYMPNRS- 563 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~~~~~~~~~lV~Ey~~~gs- 563 (649)
..||+|..+.||+. .+..+++|..... .......+|.+++..+..- .+.+.+++..+.+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~--~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPG--FDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCC--CCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 58999999999984 2456778876542 2345578899999988643 35778888888888889999998863
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHH---------------------------------------HHHHh-CCCCc
Q 006347 564 LDALLFDPLKKERLDWRKRFNIIEGISRGL---------------------------------------LYLHR-DSRLR 603 (649)
Q Consensus 564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL---------------------------------------~yLH~-~~~~~ 603 (649)
+...+.. +......++..+++.+ .+|.. .....
T Consensus 82 ~~~~~~~-------~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~ 154 (226)
T TIGR02172 82 FSRIISD-------NPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTST 154 (226)
T ss_pred hhhhhcC-------CHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCc
Confidence 2211110 0111111111122211 22221 12345
Q ss_pred eEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 604 IIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 604 iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++|+|+.|.||++++++ +.|+||+.|..
T Consensus 155 ~~HgD~~~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 155 CLHGDFQIGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred eEecCCCCCcEEEcCCC-cEEEechhcCc
Confidence 78999999999999888 99999998875
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.26 E-value=7.1e-07 Score=97.16 Aligned_cols=149 Identities=25% Similarity=0.332 Sum_probs=116.8
Q ss_pred cccceeecc--CCcEEEEEEEe--c-CCcEEEEEEecc--cccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEE
Q 006347 483 FQLSSKLGQ--GGFGPVYWGRL--K-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 483 f~~~~~LG~--G~fG~Vykg~~--~-~g~~vAVK~l~~--~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~l 554 (649)
|-....+|. |.+|.||++.. . ++..+|+|+-+. ..++....=.+|.....+++ |+|.++....+..++..++
T Consensus 116 ~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfi 195 (524)
T KOG0601|consen 116 FPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFI 195 (524)
T ss_pred cccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCccee
Confidence 445578999 99999999987 3 688899998432 22334444456777777774 9999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGM 629 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGl 629 (649)
-+|++ +.+|.++.... ...+.....+.+..+..+ ||.++|... |+|-|+||.||++.++ ..+|+.|||+
T Consensus 196 qtE~~-~~sl~~~~~~~--~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 196 QTELC-GESLQSYCHTP--CNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred eeccc-cchhHHhhhcc--cccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcce
Confidence 99988 57888887542 222445555666666666 999999987 9999999999999999 8999999999
Q ss_pred ceeeCCCC
Q 006347 630 AKIFGGNQ 637 (649)
Q Consensus 630 a~~~~~~~ 637 (649)
...++...
T Consensus 270 v~~i~~~~ 277 (524)
T KOG0601|consen 270 VSKISDGN 277 (524)
T ss_pred eEEccCCc
Confidence 99886554
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.5e-05 Score=80.52 Aligned_cols=141 Identities=16% Similarity=0.152 Sum_probs=88.6
Q ss_pred eeccCCc-EEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecCCCCChh
Q 006347 488 KLGQGGF-GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565 (649)
Q Consensus 488 ~LG~G~f-G~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~ 565 (649)
.|-.|.. ..||+.... +..+.||...... .....+|++++..+. +--+.+++++....+..++|||+++|.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 4555655 789999875 4678888775432 346778999888883 455678888877776789999999998876
Q ss_pred hhh-------------------cCCCC-CCCCC--HHHHHHHHH--------------------HHHHHHHHHHh----C
Q 006347 566 ALL-------------------FDPLK-KERLD--WRKRFNIIE--------------------GISRGLLYLHR----D 599 (649)
Q Consensus 566 ~~l-------------------~~~~~-~~~l~--~~~~~~i~~--------------------~ia~gL~yLH~----~ 599 (649)
... +.... ..+.. ...++.... .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 442 11000 00111 001110000 01111222211 1
Q ss_pred CCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 600 ~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
..+.++|+|+.|.|||++++....|+||+.|..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999988889999999875
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.21 E-value=6.2e-06 Score=79.78 Aligned_cols=105 Identities=20% Similarity=0.229 Sum_probs=83.5
Q ss_pred HHHHHHHhcCCC-CCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCc
Q 006347 525 MNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603 (649)
Q Consensus 525 ~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 603 (649)
..|..++..+++ +++++++|+| ..++|.||.+.+++...-..-.+-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~C----G~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSC----GRFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeEC----CCEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 357888888876 6999999999 34789999987766422100011123589999999999999999999865556
Q ss_pred eEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 604 IIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 604 iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+.-+|++|+|+-+++++++|++|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 888999999999999999999999887665
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=3e-05 Score=77.09 Aligned_cols=145 Identities=25% Similarity=0.221 Sum_probs=88.5
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CCccceEEEEEeCC---eEEEEEecCC
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGE---EKMLIYEYMP 560 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~---~~~lV~Ey~~ 560 (649)
++.|+.|..+.||+....+ ..+++|..... .....+..|..++..+.. ..+.+++.+..... ..+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3688999999999999987 69999987543 456778899999888853 34677887654433 4689999999
Q ss_pred CCChhh----------------hh---cCC-CCCCCCCHHH---------HHHH------------HHHHHH-HHHHHHh
Q 006347 561 NRSLDA----------------LL---FDP-LKKERLDWRK---------RFNI------------IEGISR-GLLYLHR 598 (649)
Q Consensus 561 ~gsL~~----------------~l---~~~-~~~~~l~~~~---------~~~i------------~~~ia~-gL~yLH~ 598 (649)
+..+.. .+ +.. .......+.. .... ...+.+ .+..+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 988877 11 011 0111111111 0000 111222 2333332
Q ss_pred ----CCCCceEecCCCCCcEEEc-CCCceEEEecCCceee
Q 006347 599 ----DSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIF 633 (649)
Q Consensus 599 ----~~~~~iiHrDlkp~NILl~-~~~~~Ki~DFGla~~~ 633 (649)
.....++|+|+.|.|||++ +++.+.|+||+.+..-
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~~ 198 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGWG 198 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EEE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceEC
Confidence 2445699999999999999 6666689999998764
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=98.12 E-value=5.5e-07 Score=96.38 Aligned_cols=81 Identities=25% Similarity=0.375 Sum_probs=72.0
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
..+|.|+++...+|.++|.++......++...+.++.|++.|+.| ++ .+|||+||.||....+..+||.||||.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 468999999999999999766566677899999999999999999 44 999999999999999999999999999
Q ss_pred eeeCCCC
Q 006347 631 KIFGGNQ 637 (649)
Q Consensus 631 ~~~~~~~ 637 (649)
.......
T Consensus 404 ts~~~~~ 410 (516)
T KOG1033|consen 404 TSQDKDE 410 (516)
T ss_pred eecccCC
Confidence 8875544
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.12 E-value=6.4e-05 Score=73.52 Aligned_cols=139 Identities=16% Similarity=0.196 Sum_probs=90.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHH---------HHHHHHHhcCC---CCCccceEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF---------MNEVMVISKLQ---HRNLVRLLGCC 546 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f---------~~E~~~l~~l~---H~niv~l~g~~ 546 (649)
..++|+..+.+-....-.|.+-..+ |....+|.........++.| .+++..+.+++ -...+.++.+.
T Consensus 29 ~~~~~~~~kv~k~~~r~~ValIei~-~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ 107 (229)
T PF06176_consen 29 LDNNYKIIKVFKNTKRNYVALIEID-GKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAA 107 (229)
T ss_pred HhCCceEEEeecCCCccEEEEEEEC-CcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeee
Confidence 4467777777777666666665555 68888887654332222222 23333333332 22333333332
Q ss_pred Ee-----CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 547 VE-----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 547 ~~-----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
.- ....+|+|||++|..|.++.. ++. .++..+.+++.-||+.+ +.|+|..|.|+++.+++
T Consensus 108 ekk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~~- 172 (229)
T PF06176_consen 108 EKKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNNG- 172 (229)
T ss_pred eeeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECCc-
Confidence 21 234568999999988866541 222 25566788899999998 99999999999999655
Q ss_pred eEEEecCCceee
Q 006347 622 PKISDFGMAKIF 633 (649)
Q Consensus 622 ~Ki~DFGla~~~ 633 (649)
++++||+..+..
T Consensus 173 i~iID~~~k~~~ 184 (229)
T PF06176_consen 173 IRIIDTQGKRMS 184 (229)
T ss_pred EEEEECcccccc
Confidence 999999988764
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=98.11 E-value=3e-05 Score=68.57 Aligned_cols=100 Identities=27% Similarity=0.452 Sum_probs=67.2
Q ss_pred CeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEe-cCCCCCCCCcceEEEeeCCcEEEEcCCceEEEEecCcc
Q 006347 36 DAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVA-NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSN 114 (649)
Q Consensus 36 ~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~A-nr~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~ 114 (649)
+.+.+.+|.+.|-|...|+ -+.|.. ..+++|.. +...... ..+.+.|..||||||+|..+.++|+|...
T Consensus 12 ~p~~~~s~~~~L~l~~dGn------Lvl~~~--~~~~iWss~~t~~~~~-~~~~~~L~~~GNlvl~d~~~~~lW~Sf~~- 81 (114)
T PF01453_consen 12 SPLTSSSGNYTLILQSDGN------LVLYDS--NGSVIWSSNNTSGRGN-SGCYLVLQDDGNLVLYDSSGNVLWQSFDY- 81 (114)
T ss_dssp EEEEECETTEEEEEETTSE------EEEEET--TTEEEEE--S-TTSS--SSEEEEEETTSEEEEEETTSEEEEESTTS-
T ss_pred cccccccccccceECCCCe------EEEEcC--CCCEEEEecccCCccc-cCeEEEEeCCCCEEEEeecceEEEeecCC-
Confidence 4565655889998887764 244543 25779999 4444332 45789999999999999999999998443
Q ss_pred cccccccceeec--ccCeEEeeCCCCceEeeecCCCc
Q 006347 115 LVNNSTSAQLLD--SGNLVLRDNINRAIVWESFQEPT 149 (649)
Q Consensus 115 ~~~~~~~a~Lld--sGNlVl~~~~~~~~~WqSFD~PT 149 (649)
...+.+..++ .||++ +.. ...+.|.|=+.|+
T Consensus 82 --ptdt~L~~q~l~~~~~~-~~~-~~~~sw~s~~dps 114 (114)
T PF01453_consen 82 --PTDTLLPGQKLGDGNVT-GKN-DSLTSWSSNTDPS 114 (114)
T ss_dssp --SS-EEEEEET--TSEEE-EES-TSSEEEESS----
T ss_pred --CccEEEeccCcccCCCc-ccc-ceEEeECCCCCCC
Confidence 2346677777 89999 653 3568899876663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.06 E-value=8.6e-05 Score=73.41 Aligned_cols=156 Identities=19% Similarity=0.242 Sum_probs=100.5
Q ss_pred CCHHHHHHHhcCcccce---eeccCCcEEEEEEEecCCcEEEEEEecccccc-------------------cHH-----H
Q 006347 471 FQFEELATATNNFQLSS---KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-------------------GLE-----E 523 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~---~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~-------------------~~~-----~ 523 (649)
.+.+.+....+...+.+ .|.+|.-+.||+|.-.++..+|||+....... ..+ -
T Consensus 35 ~t~~~l~~L~~rg~i~~~~g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W 114 (268)
T COG1718 35 RTLETLRRLLSRGVITELVGCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAW 114 (268)
T ss_pred HHHHHHHHHhcCCceeeeEeeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHH
Confidence 44555555555554444 45678889999999888999999987532111 111 1
Q ss_pred HHHHHHHHhcCC--CCCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 006347 524 FMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601 (649)
Q Consensus 524 f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~ 601 (649)
..+|..-|.++. +-.+.+-+++ .+..|||||+....+..-. .+.-.+...+...+..++.+.+.-|-...
T Consensus 115 ~~kEf~NL~R~~eAGVrvP~Pi~~----~~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a- 186 (268)
T COG1718 115 ARKEFRNLKRAYEAGVRVPEPIAF----RNNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA- 186 (268)
T ss_pred HHHHHHHHHHHHHcCCCCCCceee----cCCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc-
Confidence 234565566653 4455555554 2457999999654221111 11222333355667777888888887632
Q ss_pred CceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 602 ~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++||+||..=|||+. ++.+.|+|||=|.....+
T Consensus 187 -~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~hp 219 (268)
T COG1718 187 -GLVHGDLSEYNILVH-DGEPYIIDVSQAVTIDHP 219 (268)
T ss_pred -CcccccchhhheEEE-CCeEEEEECccccccCCC
Confidence 399999999999999 889999999998876533
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.3e-06 Score=96.89 Aligned_cols=110 Identities=27% Similarity=0.446 Sum_probs=74.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.+|..++.+..|++|.||...++ ..+.+|+| +++.. -+.+. ++.....|.+|
T Consensus 83 ~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~-----lilRn--ilt~a~npfvv------------------- 135 (1205)
T KOG0606|consen 83 SDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQN-----LILRN--ILTFAGNPFVV------------------- 135 (1205)
T ss_pred cccceeEeeccCCCCceeeeeccccccchhhc-ccccc-----hhhhc--cccccCCccee-------------------
Confidence 56788899999999999999887 45678884 43321 01110 22222333333
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+-...+.. ....+. +++.+++|||+.+ |+|||+||+|.||..=+++|+.||||.++.
T Consensus 136 --gDc~tllk~-~g~lPv----------dmvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~G 193 (1205)
T KOG0606|consen 136 --GDCATLLKN-IGPLPV----------DMVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKG 193 (1205)
T ss_pred --chhhhhccc-CCCCcc----------hhhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhh
Confidence 343334422 111122 2278899999887 999999999999999999999999999864
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.93 E-value=5.3e-06 Score=83.88 Aligned_cols=94 Identities=28% Similarity=0.333 Sum_probs=78.4
Q ss_pred HhcCCCCCccceEEEEEeCC-----eEEEEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006347 531 ISKLQHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604 (649)
Q Consensus 531 l~~l~H~niv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 604 (649)
|-.+-|.|||+++.|+.+.. +..++.|||+.|+|..+|++..+ ...+......+++.||..||.|||+. .++|
T Consensus 121 llqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~-~Ppi 199 (458)
T KOG1266|consen 121 LLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC-DPPI 199 (458)
T ss_pred HHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-CCcc
Confidence 34456999999999987543 46799999999999999975322 34567777788999999999999986 5899
Q ss_pred EecCCCCCcEEEcCCCceEEE
Q 006347 605 IHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 605 iHrDlkp~NILl~~~~~~Ki~ 625 (649)
+|+++..+-|++..++-+||.
T Consensus 200 ihgnlTc~tifiq~ngLIkig 220 (458)
T KOG1266|consen 200 IHGNLTCDTIFIQHNGLIKIG 220 (458)
T ss_pred ccCCcchhheeecCCceEEec
Confidence 999999999999999988875
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.92 E-value=0.00013 Score=86.69 Aligned_cols=147 Identities=18% Similarity=0.344 Sum_probs=92.2
Q ss_pred ceeeccCCcEEEEEEEecCC---cEEEEEEecccc-cccHHHHHHHHHHHhcCC-CCCc--cceEEEEEeC---CeEEEE
Q 006347 486 SSKLGQGGFGPVYWGRLKDG---QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ-HRNL--VRLLGCCVEG---EEKMLI 555 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g---~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~-H~ni--v~l~g~~~~~---~~~~lV 555 (649)
.+.++.|.+..+|+....++ ..+++|+..... ......+.+|.+++..+. |.++ .+++++|.+. +..++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999887653 367777764322 123457889999999995 6654 8888888764 357899
Q ss_pred EecCCCCChhhh-----------------------hcCCC-C-------CCCCC--------HHHHHHH---------HH
Q 006347 556 YEYMPNRSLDAL-----------------------LFDPL-K-------KERLD--------WRKRFNI---------IE 587 (649)
Q Consensus 556 ~Ey~~~gsL~~~-----------------------l~~~~-~-------~~~l~--------~~~~~~i---------~~ 587 (649)
|||+++..+.+- |+.-. . ..+.. |...+.- ..
T Consensus 123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~ 202 (822)
T PLN02876 123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP 202 (822)
T ss_pred EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence 999988653211 11100 0 00111 1111100 01
Q ss_pred HHHHHHHHHHhCC--------CCceEecCCCCCcEEEcC-C-CceEEEecCCcee
Q 006347 588 GISRGLLYLHRDS--------RLRIIHRDLKASNILLDE-E-LNPKISDFGMAKI 632 (649)
Q Consensus 588 ~ia~gL~yLH~~~--------~~~iiHrDlkp~NILl~~-~-~~~Ki~DFGla~~ 632 (649)
.+.+.+.+|..+- ++.+||+|+++.|||++. + ..+-|.|+.++.+
T Consensus 203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~ 257 (822)
T PLN02876 203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL 257 (822)
T ss_pred hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence 2334456664421 235999999999999985 3 3367999998875
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00021 Score=71.77 Aligned_cols=140 Identities=19% Similarity=0.189 Sum_probs=78.2
Q ss_pred eeeccCCcE-EEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC---CccceEEEEEeCC---eEEEEEecC
Q 006347 487 SKLGQGGFG-PVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR---NLVRLLGCCVEGE---EKMLIYEYM 559 (649)
Q Consensus 487 ~~LG~G~fG-~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~~~~---~~~lV~Ey~ 559 (649)
+.++.|+.. .||+. +..+.+|..+. ......+..|.+++..+... .+.++++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~--~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSA--AGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCc--cchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 567777665 58875 23466775433 22345788999999887532 3455555443322 348899999
Q ss_pred CCCChhhhh------------------cCCCCCC-C------------C-CHHHHH--HHH-------HHHHHHH-H-HH
Q 006347 560 PNRSLDALL------------------FDPLKKE-R------------L-DWRKRF--NII-------EGISRGL-L-YL 596 (649)
Q Consensus 560 ~~gsL~~~l------------------~~~~~~~-~------------l-~~~~~~--~i~-------~~ia~gL-~-yL 596 (649)
+|.++.+.. +.-.... . + .|.... .+. .+....+ . ++
T Consensus 77 ~G~~l~~~~~~~~~~l~~~la~~l~~LH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 156 (235)
T cd05155 77 EGETATAAALSDPSEFAEDLADFLAALRQIDPSGGPPAGRHNFLRGGDLAVRDAETREAIEALEGVIDVDAARALWEAAL 156 (235)
T ss_pred cCCCCCccccCCHHHHHHHHHHHHHHHhCCCcccCCccCCccccCCCChhHhhHHHHHHHHHcccccChHHHHHHHHHHh
Confidence 987774321 1100000 0 0 121110 000 0111111 1 11
Q ss_pred Hh--CCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 597 HR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 597 H~--~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+. .....++|+|+.+.|||++++....|+||+.|..
T Consensus 157 ~~~~~~~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 157 RAPWWGPPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred cccccCCceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 11 1334589999999999999877678999998875
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00054 Score=71.42 Aligned_cols=76 Identities=11% Similarity=0.043 Sum_probs=57.2
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-C--CCccceEEEEEeC---CeEEEEEecC
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H--RNLVRLLGCCVEG---EEKMLIYEYM 559 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~---~~~~lV~Ey~ 559 (649)
.+.||.|..+.||+....+++ +.+|..+. ......|..|.+.++.+. + ..+.+++++|... +..+||||++
T Consensus 19 ~~~i~~G~~~~vy~~~~~~~~-~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i 95 (297)
T PRK10593 19 VECISEQPYAALWALYDSQGN-PMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL 95 (297)
T ss_pred eeecCCccceeEEEEEcCCCC-EEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence 468999999999998876564 55666422 113468899999999885 2 4688999988653 5689999999
Q ss_pred CCCCh
Q 006347 560 PNRSL 564 (649)
Q Consensus 560 ~~gsL 564 (649)
+++++
T Consensus 96 ~G~~~ 100 (297)
T PRK10593 96 RGVSV 100 (297)
T ss_pred CCEec
Confidence 98765
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.74 E-value=0.00032 Score=67.82 Aligned_cols=125 Identities=25% Similarity=0.402 Sum_probs=90.0
Q ss_pred cCcccceeeccCCc-EEEEEEEecCCcEEEEEEecc---cc---------c---------ccHHHHHHHHHHHhcCC---
Q 006347 481 NNFQLSSKLGQGGF-GPVYWGRLKDGQEIAVKRLSK---AS---------G---------QGLEEFMNEVMVISKLQ--- 535 (649)
Q Consensus 481 ~~f~~~~~LG~G~f-G~Vykg~~~~g~~vAVK~l~~---~~---------~---------~~~~~f~~E~~~l~~l~--- 535 (649)
.+++..+.||.|.- |.|||+.+. |+.+|+|.... .. . ....-|..|.+..++|+
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~-g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID-GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC-CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 67888899999999 999999998 77999998321 00 0 11235889999888885
Q ss_pred CCCc--cceEEEEEeCC------------------eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHH
Q 006347 536 HRNL--VRLLGCCVEGE------------------EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595 (649)
Q Consensus 536 H~ni--v~l~g~~~~~~------------------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 595 (649)
+.++ |+.+||..-.. .+-||.||.+... .+.- +=+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~~----~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQI----RDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccch----hHHHHHHHHHHH
Confidence 4566 99999974321 1347777765432 1222 234566777888
Q ss_pred HHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 596 LH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
+|..+ |+-+|++++|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99877 999999999985 5689999864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00042 Score=67.46 Aligned_cols=134 Identities=19% Similarity=0.248 Sum_probs=90.3
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccc----------------cccHHHHHHHHHHHhcCC------CCCccceE
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----------------GQGLEEFMNEVMVISKLQ------HRNLVRLL 543 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~----------------~~~~~~f~~E~~~l~~l~------H~niv~l~ 543 (649)
...||+|+.=.||. +++.....||+..... ....+++.+|+.-...+. +..|.+++
T Consensus 6 ~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~ 83 (199)
T PF10707_consen 6 SDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY 83 (199)
T ss_pred CcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence 35799999988884 4444556788776543 123466777776555544 88999999
Q ss_pred EEEEeCCeEEEEEecCC------CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006347 544 GCCVEGEEKMLIYEYMP------NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617 (649)
Q Consensus 544 g~~~~~~~~~lV~Ey~~------~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 617 (649)
|+..++...-+|+|.+. ..+|.+++. ...++. ...+.+. +-..||-+.. |+.+|++|.||++.
T Consensus 84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~~ 152 (199)
T PF10707_consen 84 GFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVVQ 152 (199)
T ss_pred EEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEEE
Confidence 99999999999999764 245777773 334555 3333333 4445666555 99999999999996
Q ss_pred CCC----ceEEEe-cCCcee
Q 006347 618 EEL----NPKISD-FGMAKI 632 (649)
Q Consensus 618 ~~~----~~Ki~D-FGla~~ 632 (649)
... .+.|+| ||-..+
T Consensus 153 ~~~~~~~~lvlIDG~G~~~~ 172 (199)
T PF10707_consen 153 RRDSGEFRLVLIDGLGEKEL 172 (199)
T ss_pred ecCCCceEEEEEeCCCCccc
Confidence 432 466666 555443
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.00091 Score=72.07 Aligned_cols=75 Identities=13% Similarity=0.183 Sum_probs=55.1
Q ss_pred eeeccCCcEEEEEEEecCC-cEEEEEEeccc-----c--cccHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEEE
Q 006347 487 SKLGQGGFGPVYWGRLKDG-QEIAVKRLSKA-----S--GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g-~~vAVK~l~~~-----~--~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 555 (649)
+.||.|.+..||++...+| +.+.||.-... . +...+++..|.+.|..+. -..+++++.+ +.+..++|
T Consensus 32 ~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~lV 109 (401)
T PRK09550 32 REIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVTV 109 (401)
T ss_pred eEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEEE
Confidence 6899999999999999877 48999974311 1 224567788888888763 2457777777 44567899
Q ss_pred EecCCCCC
Q 006347 556 YEYMPNRS 563 (649)
Q Consensus 556 ~Ey~~~gs 563 (649)
|||+++..
T Consensus 110 ME~L~~~~ 117 (401)
T PRK09550 110 MEDLSDHK 117 (401)
T ss_pred EecCCCcc
Confidence 99998643
|
|
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=97.55 E-value=8.2e-05 Score=60.12 Aligned_cols=46 Identities=13% Similarity=0.408 Sum_probs=34.2
Q ss_pred ccccCCCCcc-ccCCCChhHHHHHhhccCCeEEEEecCCce-EEEeec
Q 006347 344 NKMKVPDFTE-WTSPATEDECREQCLKNCSCIAYAFDGGIG-CMVWRS 389 (649)
Q Consensus 344 ~~~~~p~~~~-~~~~~~~~~C~~~Cl~nCsC~a~~~~~g~g-C~~w~~ 389 (649)
+++.++..+. .....+.++|+++|+.||+|.||.|..+.+ |+++..
T Consensus 10 ~~~~~~g~d~~~~~~~s~~~Cq~~C~~~~~C~afT~~~~~~~C~lk~~ 57 (73)
T cd01100 10 SNVDFRGGDLSTVFASSAEQCQAACTADPGCLAFTYNTKSKKCFLKSS 57 (73)
T ss_pred CCCccccCCcceeecCCHHHHHHHcCCCCCceEEEEECCCCeEEcccC
Confidence 3455555443 223568999999999999999999985444 999776
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.49 E-value=0.0016 Score=65.15 Aligned_cols=141 Identities=18% Similarity=0.229 Sum_probs=82.0
Q ss_pred eeeccCCcEEEEEEEecC--CcEEEEEEecccccccHHHHHHHHHHHhcCCC-CCccceEEEEEeCCeEEEEEecCCCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD--GQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYEYMPNRS 563 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~--g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (649)
+.|..|-...+|+....+ +..+++|....... ....-.+|+.++..+.. .-.+++++... ..+||||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 567778888999998764 67888887643221 11223468888888843 33445554432 248999999877
Q ss_pred hhhh-------h----------cCCCCC--------CCCC-HHHHHHHHH----------------------HHHHHHHH
Q 006347 564 LDAL-------L----------FDPLKK--------ERLD-WRKRFNIIE----------------------GISRGLLY 595 (649)
Q Consensus 564 L~~~-------l----------~~~~~~--------~~l~-~~~~~~i~~----------------------~ia~gL~y 595 (649)
+... + +..... .... |.....+.. .+.+.+..
T Consensus 79 l~~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 158 (235)
T cd05157 79 LEPEDLRNPKIYRLIARELAKLHSIKPPEAISSPGTPKPILWPTIRKWINLVPTEFKKPEKFQKKTKAISFEQLRDEISW 158 (235)
T ss_pred CCHHHccChHHHHHHHHHHHHHhcccccccccccCCCCCcHHHHHHHHHHHhHHhhccccchhhhhccccHHHHHHHHHH
Confidence 6322 1 111000 1111 222111111 11111122
Q ss_pred H----HhC-CCCceEecCCCCCcEEEcC-CCceEEEecCCcee
Q 006347 596 L----HRD-SRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI 632 (649)
Q Consensus 596 L----H~~-~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~ 632 (649)
| ... ....++|+|+.+.|||+++ +..+.++||-.|..
T Consensus 159 l~~~l~~~~~~~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~~ 201 (235)
T cd05157 159 LKELLSALNSPIVFCHNDLLSGNIIYNEEKNSVKFIDYEYAGY 201 (235)
T ss_pred HHHHhcccCCCEEEEcCCCCcCcEEEeCCCCCEEEEEcccCCc
Confidence 2 111 2346999999999999998 57899999998875
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.48 E-value=0.00088 Score=68.19 Aligned_cols=139 Identities=15% Similarity=0.070 Sum_probs=79.6
Q ss_pred eeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEecCCCCChhh
Q 006347 488 KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPNRSLDA 566 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL~~ 566 (649)
.+..|-...+|+... ++..+++|..........-...+|..++..+....+ .++++... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 355677788998874 466788887543322211235778888888854333 45554432 368999999877642
Q ss_pred h-----------------hcCCC-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCceEecCCCCCc
Q 006347 567 L-----------------LFDPL-KKERLDWRKR-FNIIEG---------ISRGLLYLHRD-----SRLRIIHRDLKASN 613 (649)
Q Consensus 567 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~iiHrDlkp~N 613 (649)
- |+... ...+++...+ .....+ +.+.+..+-.. .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11110 1112222211 111111 11112222211 13458999999999
Q ss_pred EEEcCCCceEEEecCCcee
Q 006347 614 ILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 614 ILl~~~~~~Ki~DFGla~~ 632 (649)
|++++++ ++|+||..|..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999877 78999998875
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.45 E-value=0.00098 Score=62.62 Aligned_cols=129 Identities=22% Similarity=0.311 Sum_probs=88.0
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCcc-ceEEEEEeCCeEEEEEecCCCCC
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV-RLLGCCVEGEEKMLIYEYMPNRS 563 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv-~l~g~~~~~~~~~lV~Ey~~~gs 563 (649)
..+.|++|.+|.||+|.+. |.++|+|.-..+ .....+..|++++..++-.++- +++.+- +-.+.|||+.+..
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg----~~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYG----EDFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEec----hhhhhhhhhcCcc
Confidence 3468999999999999988 568999976543 4567899999999998765543 444442 3345699999988
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC-CCcEEEcCCCceEEEecCCceee
Q 006347 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK-ASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk-p~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|.+.-.. .+..+.+.++.. |-. |-.. +|-|..|. |..++|..+..+.|+||--|++-
T Consensus 99 L~~~~~~------~~rk~l~~vlE~-a~~---LD~~---GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIG------GDRKHLLRVLEK-AYK---LDRL---GIEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhc------ccHHHHHHHHHH-HHH---HHHh---ccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 8666421 133333333332 222 2222 37787775 55666666669999999999854
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.0011 Score=68.90 Aligned_cols=143 Identities=17% Similarity=0.173 Sum_probs=87.7
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC--CccceEEE------EEeCCeEEEEEe
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR--NLVRLLGC------CVEGEEKMLIYE 557 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~--niv~l~g~------~~~~~~~~lV~E 557 (649)
.+.|..|....+|+....+ ..+++|+... ....+...|+.++..+++. .+.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 3567778778999987654 4688887753 3345667788888877433 34555442 123445689999
Q ss_pred cCCCCChhh----hh----------cCC----C----CCCCCCHHHHHH----------HHHHHHHHHHHHHh----CCC
Q 006347 558 YMPNRSLDA----LL----------FDP----L----KKERLDWRKRFN----------IIEGISRGLLYLHR----DSR 601 (649)
Q Consensus 558 y~~~gsL~~----~l----------~~~----~----~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~ 601 (649)
|++|..+.. .. +.. . ......|..... ....+...+.++.+ .-.
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877632 11 100 0 011123332210 11223344555543 123
Q ss_pred CceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 602 LRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 602 ~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
..++|+|+.|.|||++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 4599999999999999988889999988764
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.10 E-value=0.0041 Score=64.88 Aligned_cols=141 Identities=26% Similarity=0.318 Sum_probs=84.5
Q ss_pred eeeccCCcEEEEEEEecC-------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCC-ccceEEEEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKD-------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~-------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey 558 (649)
+.|..|-...+|+....+ ++.+++|...... .......+|.+++..+.... ..++++++.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456666677899988765 4788888865432 23345567888887774322 3456666532 368999
Q ss_pred CCCCChhhh-h----------------cCCCCCC------CC--CHHHHHH--------------------------HHH
Q 006347 559 MPNRSLDAL-L----------------FDPLKKE------RL--DWRKRFN--------------------------IIE 587 (649)
Q Consensus 559 ~~~gsL~~~-l----------------~~~~~~~------~l--~~~~~~~--------------------------i~~ 587 (649)
++|..+... + +...... .. -|..... +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 998776432 1 1110000 01 1111111 111
Q ss_pred HHHHHHHHHHh------CCCCceEecCCCCCcEEEcCC----CceEEEecCCcee
Q 006347 588 GISRGLLYLHR------DSRLRIIHRDLKASNILLDEE----LNPKISDFGMAKI 632 (649)
Q Consensus 588 ~ia~gL~yLH~------~~~~~iiHrDlkp~NILl~~~----~~~Ki~DFGla~~ 632 (649)
.+.+-+.+|.. ..+..++|+|+.|.|||++++ ..++++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22233334432 245679999999999999985 8899999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.06 E-value=0.016 Score=61.01 Aligned_cols=142 Identities=15% Similarity=0.163 Sum_probs=78.2
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CCccceEE------EEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLG------CCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g------~~~~~~~~~lV~Ey 558 (649)
+.|..|....+|+....+| .+++|+.+. ...+....|+.++..|.. -.+.+.+. +....+..++++||
T Consensus 28 ~~l~~G~~n~~y~v~t~~g-~~vLK~~~~---~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~ 103 (319)
T PRK05231 28 KGIAEGIENSNFFLTTTQG-EYVLTLFER---LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTF 103 (319)
T ss_pred chhccccccceEEEEeCCC-cEEEEEecc---CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEe
Confidence 4566677778999887655 688887752 123344445555555532 22334442 11234567899999
Q ss_pred CCCCChhh-----h------h---cCCC--------CCCCCCH-HHHHHH------------H-HHHHHHHHHHHhC---
Q 006347 559 MPNRSLDA-----L------L---FDPL--------KKERLDW-RKRFNI------------I-EGISRGLLYLHRD--- 599 (649)
Q Consensus 559 ~~~gsL~~-----~------l---~~~~--------~~~~l~~-~~~~~i------------~-~~ia~gL~yLH~~--- 599 (649)
++|..+.. . | +... ....+.| .....- . ..+...+..+...
T Consensus 104 l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~ 183 (319)
T PRK05231 104 LEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWP 183 (319)
T ss_pred cCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccc
Confidence 99875421 1 1 1100 0111222 221111 1 1111222333211
Q ss_pred -CCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 600 -SRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 600 -~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
-...++|+|+.|.|||++.+...-|+||+.+..
T Consensus 184 ~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 184 ALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234699999999999999776678999998853
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.93 E-value=0.017 Score=60.46 Aligned_cols=142 Identities=17% Similarity=0.174 Sum_probs=82.4
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CCccceEEEE------EeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLGCC------VEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~------~~~~~~~lV~Ey 558 (649)
+.++.|--..+|+....++ .+.+|..... ....+...|++++..|.. -.+.+++... ...+..++++||
T Consensus 28 ~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~--~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~ 104 (307)
T TIGR00938 28 KGIAEGVENSNYLLTTDVG-RYILTLYEKR--VKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF 104 (307)
T ss_pred cccCCccccceEEEEeCCC-cEEEEEecCC--CCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence 4566676678998876545 5677876432 123455567777777642 2244544421 123456899999
Q ss_pred CCCCChhhh--------------hcCCCC----C-----CCCCHHHHHH------------HHHHHHHHHHHHHh----C
Q 006347 559 MPNRSLDAL--------------LFDPLK----K-----ERLDWRKRFN------------IIEGISRGLLYLHR----D 599 (649)
Q Consensus 559 ~~~gsL~~~--------------l~~~~~----~-----~~l~~~~~~~------------i~~~ia~gL~yLH~----~ 599 (649)
++|..+... ++.... . ..-.|..... ....+.+.++++.. .
T Consensus 105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~ 184 (307)
T TIGR00938 105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD 184 (307)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence 988654210 111000 0 0112222111 11223445555543 2
Q ss_pred CCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 600 ~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
....++|+|+.+.||+++++....|+||+.+.
T Consensus 185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23569999999999999998877999999885
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.81 E-value=0.01 Score=61.19 Aligned_cols=32 Identities=31% Similarity=0.505 Sum_probs=26.9
Q ss_pred CceEecCCCCCcEEEcCCCc-eEEEecCCceee
Q 006347 602 LRIIHRDLKASNILLDEELN-PKISDFGMAKIF 633 (649)
Q Consensus 602 ~~iiHrDlkp~NILl~~~~~-~Ki~DFGla~~~ 633 (649)
..++|+|++|.|||+++++. .-|.||+.|.+-
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~iG 217 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKVG 217 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhcccC
Confidence 45899999999999998554 579999998863
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.75 E-value=0.018 Score=61.32 Aligned_cols=141 Identities=21% Similarity=0.290 Sum_probs=81.2
Q ss_pred eeeccCCcEEEEEEEecC-----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEecCC
Q 006347 487 SKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~ 560 (649)
+.|-.|-.-.+|+....+ ++.+.+|........... -.+|..++..+...++ .++++.+..+ .|+||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeec-hHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 345456677889887542 357888877544332222 2678888888753333 3566665332 5899998
Q ss_pred CCChhhh-----------------hcCCC-C--CCCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 006347 561 NRSLDAL-----------------LFDPL-K--KERLDWRKRFNIIEG-----------------ISRGLLYL----HR- 598 (649)
Q Consensus 561 ~gsL~~~-----------------l~~~~-~--~~~l~~~~~~~i~~~-----------------ia~gL~yL----H~- 598 (649)
+.+|..- ++... . ....-|.+...+..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8777422 11100 0 111113322222211 11122222 21
Q ss_pred CCCCceEecCCCCCcEEEcC-CCceEEEecCCcee
Q 006347 599 DSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI 632 (649)
Q Consensus 599 ~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~ 632 (649)
.....++|+|+++.|||+++ +..++++||..|..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 23346899999999999986 47899999998875
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.74 E-value=0.017 Score=59.63 Aligned_cols=73 Identities=18% Similarity=0.242 Sum_probs=48.8
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
.+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. -..+++.+++....+..+||+||++.+
T Consensus 22 ~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 22 IEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred eEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 4678889999999988 557889999764 334467888888777773 456889999988888889999999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.046 Score=57.93 Aligned_cols=72 Identities=15% Similarity=0.187 Sum_probs=47.8
Q ss_pred eeccCCcEEEEEEEecCC-cEEEEEEecc-------cccccHHHHHHHHHHHhcCC--CC-CccceEEEEEeCCeEEEEE
Q 006347 488 KLGQGGFGPVYWGRLKDG-QEIAVKRLSK-------ASGQGLEEFMNEVMVISKLQ--HR-NLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~~~g-~~vAVK~l~~-------~~~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV~ 556 (649)
+||.|-...||++..++| +.|+||.-.. .-+-...+...|.+.|.... -| .+++++.+ +.+...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 678899999999998754 5899996431 11233455667777776653 23 35555544 555667999
Q ss_pred ecCCC
Q 006347 557 EYMPN 561 (649)
Q Consensus 557 Ey~~~ 561 (649)
|+++.
T Consensus 80 EdL~~ 84 (370)
T TIGR01767 80 EDLSH 84 (370)
T ss_pred hhCcc
Confidence 99964
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.27 E-value=0.0078 Score=61.83 Aligned_cols=144 Identities=15% Similarity=0.204 Sum_probs=95.7
Q ss_pred CCCHHHHHHHhcC---cccceeeccCCcEEEEEEEecCCcEEEEEEecc-----------------ccc-----ccHHHH
Q 006347 470 LFQFEELATATNN---FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK-----------------ASG-----QGLEEF 524 (649)
Q Consensus 470 ~~~~~~l~~~~~~---f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~-----------------~~~-----~~~~~f 524 (649)
-+.|..|+...++ +++.+.||-|.-+-||.+...+|++.++|.=.- ... -..-..
T Consensus 78 GyDyLAlktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa 157 (465)
T KOG2268|consen 78 GYDYLALKTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAA 157 (465)
T ss_pred cchHHHHHHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHH
Confidence 3555555555443 567889999999999999999999999883110 000 012234
Q ss_pred HHHHHHHhcCC-CC-CccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 006347 525 MNEVMVISKLQ-HR-NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602 (649)
Q Consensus 525 ~~E~~~l~~l~-H~-niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~ 602 (649)
.+|...|..|+ |- -+.+.+ +.+..++|||++.+-.|...- ...+..+++.- +..-+.-|..++
T Consensus 158 ~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~---lm~~Iv~la~~G-- 222 (465)
T KOG2268|consen 158 TKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVR------HVEDPPTLYDD---LMGLIVRLANHG-- 222 (465)
T ss_pred HHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeee------ecCChHHHHHH---HHHHHHHHHHcC--
Confidence 57888888884 32 233433 345678999999887774432 12334443333 333344555666
Q ss_pred ceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 603 RIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 603 ~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
+||+|..-=||+++++..++++||-=
T Consensus 223 -lIHgDFNEFNimv~dd~~i~vIDFPQ 248 (465)
T KOG2268|consen 223 -LIHGDFNEFNIMVKDDDKIVVIDFPQ 248 (465)
T ss_pred -ceecccchheeEEecCCCEEEeechH
Confidence 99999999999999999999999953
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.16 E-value=0.00067 Score=78.59 Aligned_cols=150 Identities=17% Similarity=0.175 Sum_probs=103.0
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecc---cccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~---~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
.....+.+.+-+..|.++.++...-. .|...++|.... ......+..+.+-.+....+||-+++...-+......+
T Consensus 801 sS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~ 880 (1205)
T KOG0606|consen 801 SSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLP 880 (1205)
T ss_pred CCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcc
Confidence 34456666777888999999877644 233333333221 11223334444444444455677776665566778899
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|+++|+.+++|...|+... ..+..-....+..+.+.++|||... ++|||++|.|+|...++..+++|||+.+..
T Consensus 881 L~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v 954 (1205)
T KOG0606|consen 881 LVGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKV 954 (1205)
T ss_pred hhhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCcccccccc
Confidence 9999999999988886432 3333333445666788999999865 899999999999999999999999966554
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.07 E-value=0.078 Score=55.38 Aligned_cols=129 Identities=17% Similarity=0.293 Sum_probs=76.2
Q ss_pred CcEEEEEEec-ccccccHHHHHHHHHHHhcCC--CCCccceEEEEEeCC--eEEEEEecCCCCChhhh------------
Q 006347 505 GQEIAVKRLS-KASGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGE--EKMLIYEYMPNRSLDAL------------ 567 (649)
Q Consensus 505 g~~vAVK~l~-~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~--~~~lV~Ey~~~gsL~~~------------ 567 (649)
++++++++-. ...........+|..+|+.+. -.-+.+.++.|.++. ..+.||||.++..+.+.
T Consensus 48 ~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~ 127 (321)
T COG3173 48 GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFAL 127 (321)
T ss_pred CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHH
Confidence 6777777221 112234455667777887774 344567778887776 56899999987332211
Q ss_pred ------hc---C----------C----CCCCCCCHHHHHHHH--------HHHHHHHHHHHhC-----CCCceEecCCCC
Q 006347 568 ------LF---D----------P----LKKERLDWRKRFNII--------EGISRGLLYLHRD-----SRLRIIHRDLKA 611 (649)
Q Consensus 568 ------l~---~----------~----~~~~~l~~~~~~~i~--------~~ia~gL~yLH~~-----~~~~iiHrDlkp 611 (649)
|. . . ...+.-.|...++.+ -...+-..+|+++ +++.++|+|+.+
T Consensus 128 ~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~ 207 (321)
T COG3173 128 DALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRP 207 (321)
T ss_pred HHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCccc
Confidence 11 0 0 000111222222111 1122334455443 335699999999
Q ss_pred CcEEEcCCCceEEEecCCceee
Q 006347 612 SNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 612 ~NILl~~~~~~Ki~DFGla~~~ 633 (649)
.||+++.+.-.-|.||+++.+-
T Consensus 208 gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 208 GNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred CCEEEeCCCeeEEEeccccccC
Confidence 9999999888999999999863
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.12 Score=55.70 Aligned_cols=73 Identities=11% Similarity=0.091 Sum_probs=49.8
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEeccc----cc---ccHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEEE
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA----SG---QGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~----~~---~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV 555 (649)
.+.||.|..-.||+.... +..++||+-... .. ....+-..|...|..+. ...+.+++.++. +...++
T Consensus 37 ~~eiggGn~N~VyrV~~~-~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVSS-SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEcC-CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 468999999999998875 556889975411 11 13334444566665553 357888998877 446789
Q ss_pred EecCCC
Q 006347 556 YEYMPN 561 (649)
Q Consensus 556 ~Ey~~~ 561 (649)
|||+++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999976
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=95.78 E-value=0.0015 Score=72.08 Aligned_cols=136 Identities=18% Similarity=0.129 Sum_probs=94.3
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCC-ccceEEEEEeCCeEEEEEecCCCC-
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYEYMPNR- 562 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~Ey~~~g- 562 (649)
....+++++.+.++|.+-...+....+.+... ....-++++|.+++||| .++.++-+...+..+++++++..+
T Consensus 246 ~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~r 320 (829)
T KOG0576|consen 246 FFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGR 320 (829)
T ss_pred HHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCc
Confidence 34568899999999887553444445555332 45567899999999999 777777766677788999999876
Q ss_pred C-hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 563 S-LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 563 s-L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+ ..... .....+...+...+.+.-.++++|||+.. -+|+| ||+..+ ...|..||+.+..+...
T Consensus 321 s~~~~~~---~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 321 SSALEMT---VSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred cccccCC---hhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 2 21111 11222334444456667788999999864 58998 777766 67899999998877543
|
|
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.69 E-value=0.11 Score=54.86 Aligned_cols=137 Identities=23% Similarity=0.297 Sum_probs=81.3
Q ss_pred CcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCC------ccceEEEEE--eC--CeEEEEEecCCCC
Q 006347 493 GFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN------LVRLLGCCV--EG--EEKMLIYEYMPNR 562 (649)
Q Consensus 493 ~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~--~~--~~~~lV~Ey~~~g 562 (649)
.--.+|+....+|.. ++|..+.. ....+...|+..+..+.-.. |..+=|-.. -. ...+-++||++|.
T Consensus 37 ~eN~~f~~~~~~g~~-iLki~~~~--~~~~~i~~el~~l~~La~~~i~v~~Pl~~~dG~~l~~~~~~~r~a~lf~~l~G~ 113 (331)
T COG2334 37 EENSNFRVQTEDGRY-ILKIYRPG--WTRAEIPFELALLQHLAERGIPVPAPLPSLDGELLEALSGGPRPAALFEYLPGR 113 (331)
T ss_pred ccCceEEEEecCCCe-EEEEecCC--CCHHHHHHHHHHHHHHHHcCCCCCCCccCCCcchhhhccCCceeEEEEEecCCc
Confidence 445688888887776 77876543 45567777777777763111 222222211 12 3678899999998
Q ss_pred Chhh-h----h--------------cCCC-----CCCCCCHHH-------------HHHHHHHHHHHHHHHHhC------
Q 006347 563 SLDA-L----L--------------FDPL-----KKERLDWRK-------------RFNIIEGISRGLLYLHRD------ 599 (649)
Q Consensus 563 sL~~-~----l--------------~~~~-----~~~~l~~~~-------------~~~i~~~ia~gL~yLH~~------ 599 (649)
.+.. . + .+.. ......|.. ......++...+..+.+.
T Consensus 114 ~~~~~~~~~~~~~lG~~LgrlH~a~~~f~~~~p~~~~~~~w~~~~~~~~~~~~~~~~~~l~a~~~~~~~~~~~~~~~~lp 193 (331)
T COG2334 114 PLERDDNAEQLEELGRMLGRLHLALRGFPFERPNALRRLEWDILEPRALLRLDLVEPEDLRAALLAALDRLLARLPAHLP 193 (331)
T ss_pred CcCCCCcHHHHHHHHHHHHHHHHHhCcCCccCCCcccccchhhhcchhhhhhcccCchhhHHHHHHHHHHHHhhchhhCC
Confidence 8872 1 1 0110 111233430 011233344445554432
Q ss_pred -CCCceEecCCCCCcEEEcCCCc-eEEEecCCcee
Q 006347 600 -SRLRIIHRDLKASNILLDEELN-PKISDFGMAKI 632 (649)
Q Consensus 600 -~~~~iiHrDlkp~NILl~~~~~-~Ki~DFGla~~ 632 (649)
.+..+||+|+.|.||+++.+.. +.+.||+-+..
T Consensus 194 ~~~~~iIH~D~~~~NVl~d~~~~~~g~iDFdDa~~ 228 (331)
T COG2334 194 ALGDQIIHGDLHPDNVLFDDDTDVSGFIDFDDAGY 228 (331)
T ss_pred cccceeeecCCCccceeEcCCCCeeeEEEcccccc
Confidence 1122999999999999999885 99999998763
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=95.57 E-value=0.21 Score=52.05 Aligned_cols=30 Identities=30% Similarity=0.408 Sum_probs=25.8
Q ss_pred CceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 602 LRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 602 ~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
..++|+|+.+.||+++. ..+.|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~~ 216 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCTI 216 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECccccc
Confidence 46899999999999998 5789999997653
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.45 E-value=0.11 Score=54.58 Aligned_cols=139 Identities=19% Similarity=0.232 Sum_probs=91.9
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccc------c---cc-------------HHH----HHHHHHHHhcCCCCCcc
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS------G---QG-------------LEE----FMNEVMVISKLQHRNLV 540 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~------~---~~-------------~~~----f~~E~~~l~~l~H~niv 540 (649)
..|..|.-+-||.++-.+|..+|||+.+... . .+ .+. ...|++-|.+|+...|.
T Consensus 150 GCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aGIP 229 (520)
T KOG2270|consen 150 GCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAGIP 229 (520)
T ss_pred cccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcCCC
Confidence 4678899999999999999999999765310 0 00 111 23466666666544433
Q ss_pred ceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006347 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620 (649)
Q Consensus 541 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 620 (649)
.---... ....|||+|+..-. +-.-..+...++...+..+-.++++-|.-|.+.| ++||.||.-=|+|+.+ +
T Consensus 230 ~PePIlL--k~hVLVM~FlGrdg---w~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyhd-G 301 (520)
T KOG2270|consen 230 CPEPILL--KNHVLVMEFLGRDG---WAAPKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYHD-G 301 (520)
T ss_pred CCCceee--ecceEeeeeccCCC---CcCcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEEC-C
Confidence 2111111 12359999984321 1111123455777777788888889999998877 5999999999998865 5
Q ss_pred ceEEEecCCceee
Q 006347 621 NPKISDFGMAKIF 633 (649)
Q Consensus 621 ~~Ki~DFGla~~~ 633 (649)
.+.|+|.+=+...
T Consensus 302 ~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 302 KLYIIDVSQSVEH 314 (520)
T ss_pred EEEEEEccccccC
Confidence 7889998766654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.29 E-value=0.07 Score=57.26 Aligned_cols=74 Identities=11% Similarity=0.103 Sum_probs=50.1
Q ss_pred ceeeccCCcEEEEEEEecC-CcEEEEEEecc------cccccHHHHHHHHHHHhcCC--CC-CccceEEEEEeCCeEEEE
Q 006347 486 SSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK------ASGQGLEEFMNEVMVISKLQ--HR-NLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~------~~~~~~~~f~~E~~~l~~l~--H~-niv~l~g~~~~~~~~~lV 555 (649)
.+.||-|--.-||++...+ ++.|+||.-.. .-+-..++...|.+.|+... -| .+++++.+ +.+...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 3689999999999999853 56799985421 11234566777888777663 23 45556655 45556789
Q ss_pred EecCCC
Q 006347 556 YEYMPN 561 (649)
Q Consensus 556 ~Ey~~~ 561 (649)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999864
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.31 Score=48.14 Aligned_cols=75 Identities=19% Similarity=0.283 Sum_probs=53.0
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC---CCCCccceEEEEEeCCeEEEEEecCCCCC
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL---QHRNLVRLLGCCVEGEEKMLIYEYMPNRS 563 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (649)
+++.-|.--..|.... +..++-||+- .......|..|+.-|..+ +..++.+.+.+-.+.++.+||+||++-|.
T Consensus 22 ~~v~gG~inea~~v~d-g~~~~FvK~n---~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~ 97 (286)
T COG3001 22 EEVSGGDINEAWRLRD-GTDPFFVKCN---QREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGP 97 (286)
T ss_pred cccCCccccceeEeec-CCcceEEEec---chhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCC
Confidence 3455454444454433 3567888864 334567888888765555 45678899999999999999999999877
Q ss_pred hh
Q 006347 564 LD 565 (649)
Q Consensus 564 L~ 565 (649)
++
T Consensus 98 ~d 99 (286)
T COG3001 98 LD 99 (286)
T ss_pred CC
Confidence 75
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.13 E-value=0.27 Score=52.06 Aligned_cols=141 Identities=20% Similarity=0.296 Sum_probs=79.2
Q ss_pred eeeccCCcEEEEEEEecC----CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
+.|..|=.-.+|+....+ +..+.+|........ .-.-.+|..++..+...++ .++++++..+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 455556667889887653 237888876543322 2223578888888864444 4666665322 58999987
Q ss_pred CChhhh-------h----------cCCC-C--CCCCCHHHHHHHHHHH----------------------HHHHHHHHh-
Q 006347 562 RSLDAL-------L----------FDPL-K--KERLDWRKRFNIIEGI----------------------SRGLLYLHR- 598 (649)
Q Consensus 562 gsL~~~-------l----------~~~~-~--~~~l~~~~~~~i~~~i----------------------a~gL~yLH~- 598 (649)
..|..- + +... . ...--|....++..++ .+-+..+.+
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 1 1110 0 1111233322222111 111222111
Q ss_pred ----CCCCceEecCCCCCcEEEcC-CCceEEEecCCcee
Q 006347 599 ----DSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKI 632 (649)
Q Consensus 599 ----~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~ 632 (649)
.......|.|+-+.|||+++ +..++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 12234789999999999975 57899999988875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=94.93 E-value=0.084 Score=51.89 Aligned_cols=30 Identities=33% Similarity=0.504 Sum_probs=21.7
Q ss_pred ceEecCCCCCcEEE-cCCCceEEEecCCcee
Q 006347 603 RIIHRDLKASNILL-DEELNPKISDFGMAKI 632 (649)
Q Consensus 603 ~iiHrDlkp~NILl-~~~~~~Ki~DFGla~~ 632 (649)
.+.|.|+.|.|||+ +.++.++++||-.|..
T Consensus 144 v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 144 VFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred eEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 47899999999999 8899999999998875
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 649 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 7e-36 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 7e-36 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 5e-29 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 3e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-26 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-26 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-26 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-25 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 1e-18 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 4e-18 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 2e-17 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-17 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 3e-17 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-17 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-17 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-17 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-17 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-17 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-17 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-17 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-17 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 3e-17 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 3e-17 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-17 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 5e-17 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 8e-17 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 8e-17 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 9e-17 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 9e-17 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 1e-16 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-16 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 1e-16 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 1e-16 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-16 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-16 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 1e-16 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 1e-16 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-16 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 2e-16 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-16 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-16 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 2e-16 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 2e-16 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 3e-16 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 3e-16 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 3e-16 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 3e-16 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 3e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 3e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 3e-16 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-16 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 4e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 4e-16 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 4e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 4e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 4e-16 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 5e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 5e-16 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-16 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 5e-16 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 6e-16 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 6e-16 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 6e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 6e-16 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-16 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 8e-16 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 9e-16 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 9e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 1e-15 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 1e-15 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-15 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 2e-15 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 3e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 4e-15 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 4e-15 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 7e-15 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 9e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-14 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-14 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-14 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-14 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-14 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-14 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-14 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-14 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-14 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 2e-14 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-14 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 3e-14 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-14 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-14 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 4e-14 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 5e-14 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-14 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 6e-14 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 8e-14 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 8e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-13 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-13 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 1e-13 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 1e-13 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-13 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-13 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-13 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 1e-13 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 1e-13 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 1e-13 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 2e-13 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 2e-13 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-13 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-13 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-13 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-13 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-13 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 2e-13 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-13 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-13 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-13 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-13 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 2e-13 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 2e-13 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 2e-13 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 2e-13 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 2e-13 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-13 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-13 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 2e-13 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-13 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-13 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-13 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-13 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 3e-13 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-13 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 4e-13 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 4e-13 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 4e-13 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 4e-13 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 4e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 4e-13 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 5e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 5e-13 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-13 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 6e-13 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 7e-13 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 7e-13 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 8e-13 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 8e-13 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-13 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-13 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 8e-13 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 9e-13 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 9e-13 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 9e-13 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 9e-13 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 9e-13 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-13 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-13 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 9e-13 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-12 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 1e-12 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-12 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-12 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 1e-12 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-12 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-12 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 1e-12 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-12 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-12 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-12 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-12 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 1e-12 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-12 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 1e-12 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 1e-12 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-12 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 1e-12 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 1e-12 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 1e-12 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 1e-12 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-12 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 1e-12 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 1e-12 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 1e-12 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 1e-12 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 1e-12 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 1e-12 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 1e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 1e-12 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-12 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 2e-12 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 2e-12 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 2e-12 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 2e-12 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 2e-12 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-12 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 2e-12 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-12 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-12 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-12 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 2e-12 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 2e-12 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-12 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-12 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-12 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-12 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 2e-12 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 2e-12 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-12 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-12 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 2e-12 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-12 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-12 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 3e-12 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 3e-12 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 3e-12 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-12 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-12 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-12 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 3e-12 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-12 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 3e-12 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 3e-12 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 3e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 3e-12 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 3e-12 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 3e-12 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 4e-12 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 4e-12 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 4e-12 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 4e-12 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 4e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 5e-12 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 5e-12 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 5e-12 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 6e-12 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 6e-12 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 6e-12 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 6e-12 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 6e-12 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 6e-12 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 6e-12 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 6e-12 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 6e-12 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 6e-12 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 6e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-12 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 7e-12 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 7e-12 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 7e-12 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 7e-12 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 8e-12 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 8e-12 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 9e-12 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 9e-12 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 9e-12 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 9e-12 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-12 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 9e-12 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 9e-12 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 9e-12 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-12 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-11 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-11 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-11 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 1e-11 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-11 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-11 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 1e-11 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 1e-11 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 1e-11 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 1e-11 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 1e-11 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 1e-11 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 1e-11 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-11 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-11 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-11 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-11 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 1e-11 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 1e-11 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 1e-11 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 1e-11 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-11 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-11 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-11 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 1e-11 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-11 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 1e-11 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-11 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 1e-11 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 1e-11 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-11 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-11 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-11 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-11 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-11 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-11 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-11 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 2e-11 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 2e-11 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 2e-11 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 2e-11 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-11 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-11 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 2e-11 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 2e-11 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-11 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-11 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-11 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-11 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 2e-11 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 2e-11 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-11 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 2e-11 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 2e-11 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 2e-11 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-11 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-11 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-11 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-11 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-11 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 3e-11 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-11 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-11 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-11 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 4e-11 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 4e-11 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 4e-11 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 4e-11 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 4e-11 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 4e-11 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 4e-11 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 4e-11 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 5e-11 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 5e-11 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 5e-11 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 5e-11 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-11 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 5e-11 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 5e-11 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-11 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 5e-11 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-11 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 5e-11 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 6e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 6e-11 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 6e-11 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 7e-11 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 7e-11 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-11 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 8e-11 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 8e-11 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-10 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 1e-10 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-10 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-10 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 1e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-10 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-10 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 2e-10 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-10 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-10 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-10 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-10 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-10 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-10 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-10 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-10 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 2e-10 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 3e-10 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-10 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-10 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 3e-10 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-10 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-10 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 3e-10 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-10 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 3e-10 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-10 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-10 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 3e-10 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 3e-10 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-10 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-10 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-10 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 3e-10 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-10 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-10 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 3e-10 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 4e-10 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 4e-10 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 4e-10 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-10 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-10 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 4e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 5e-10 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 6e-10 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-10 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 6e-10 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 6e-10 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 6e-10 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-10 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 7e-10 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-10 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 8e-10 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 8e-10 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 8e-10 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-10 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 9e-10 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-10 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-10 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-09 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-09 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-09 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-09 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-09 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 1e-09 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 1e-09 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-09 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 1e-09 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-09 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-09 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-09 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-09 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-09 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-09 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-09 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-09 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-09 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-09 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-09 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-09 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-09 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-09 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-09 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-09 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 3e-09 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 3e-09 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 3e-09 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 3e-09 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 3e-09 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 3e-09 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 3e-09 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 3e-09 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-09 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 3e-09 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 3e-09 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 4e-09 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 4e-09 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-09 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 5e-09 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 5e-09 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 6e-09 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 6e-09 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 6e-09 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 6e-09 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 6e-09 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 6e-09 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-09 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 7e-09 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 7e-09 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 7e-09 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 7e-09 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 7e-09 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 7e-09 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-09 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 7e-09 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 7e-09 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-09 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 8e-09 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 8e-09 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 9e-09 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 9e-09 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-08 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-08 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-08 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-08 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-08 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-08 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-08 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-08 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-08 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-08 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-08 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-08 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-08 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-08 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-08 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-08 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-08 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-08 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-08 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-08 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-08 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-08 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-08 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-08 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-08 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-08 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-08 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-08 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-08 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-08 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 1e-08 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-08 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-08 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-08 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-08 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-08 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-08 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 2e-08 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 2e-08 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 2e-08 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-08 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 2e-08 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 2e-08 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-08 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-08 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-08 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 2e-08 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 3e-08 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 3e-08 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 3e-08 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 3e-08 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 3e-08 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 3e-08 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-08 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-08 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 3e-08 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-08 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 3e-08 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 3e-08 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 4e-08 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 4e-08 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-08 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 4e-08 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 4e-08 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 5e-08 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 5e-08 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 5e-08 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 5e-08 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 5e-08 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 5e-08 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 6e-08 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-08 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 6e-08 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-08 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-08 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-08 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 6e-08 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-08 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 6e-08 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 6e-08 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 7e-08 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 7e-08 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-08 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 7e-08 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 7e-08 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 7e-08 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-08 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 7e-08 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 7e-08 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-08 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 7e-08 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 7e-08 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-08 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 8e-08 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 8e-08 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 9e-08 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 9e-08 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 9e-08 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 9e-08 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 9e-08 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 9e-08 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-07 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-07 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 1e-07 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-07 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-07 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-07 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 1e-07 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 1e-07 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-07 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-07 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-07 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-07 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-07 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 1e-07 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 2e-07 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 2e-07 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 2e-07 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-07 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 2e-07 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 2e-07 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 2e-07 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-07 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 2e-07 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 2e-07 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-07 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-07 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 2e-07 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 2e-07 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-07 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-07 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 2e-07 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 2e-07 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-07 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-07 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-07 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 2e-07 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-07 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-07 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-07 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 2e-07 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-07 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-07 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 2e-07 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-07 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 3e-07 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 3e-07 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 3e-07 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 4e-07 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-07 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 4e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 4e-07 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 5e-07 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 5e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 5e-07 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 5e-07 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-07 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 5e-07 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 5e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 5e-07 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-07 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 5e-07 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 5e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 5e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 6e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 6e-07 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 6e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 6e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 6e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-07 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 6e-07 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 6e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 6e-07 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 6e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-07 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 6e-07 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 7e-07 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 7e-07 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-07 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 7e-07 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 7e-07 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 8e-07 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 8e-07 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 8e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 8e-07 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 8e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 8e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 9e-07 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 9e-07 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 9e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 9e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 9e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-06 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-06 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 1e-06 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-06 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-06 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-06 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-06 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 1e-06 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 1e-06 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 2e-06 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 2e-06 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-06 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 2e-06 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 2e-06 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 3e-06 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 3e-06 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 3e-06 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 3e-06 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 3e-06 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 3e-06 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-06 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 3e-06 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 3e-06 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 3e-06 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 3e-06 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 3e-06 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 3e-06 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 4e-06 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 4e-06 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 4e-06 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 4e-06 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 4e-06 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-06 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 5e-06 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 6e-06 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 6e-06 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-06 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 7e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-06 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 7e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 7e-06 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-06 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 7e-06 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 7e-06 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 7e-06 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 7e-06 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 8e-06 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-06 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-06 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 8e-06 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 8e-06 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 8e-06 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 9e-06 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 9e-06 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 9e-06 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 9e-06 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 9e-06 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-05 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-05 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 1e-05 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 1e-05 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 1e-05 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 1e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 1e-05 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-05 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-05 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 1e-05 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 1e-05 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 1e-05 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-05 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-05 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-05 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-05 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-05 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-05 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 2e-05 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 2e-05 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 2e-05 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 2e-05 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-05 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 2e-05 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-05 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 2e-05 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 2e-05 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 2e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-05 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-05 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-05 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-05 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 2e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 3e-05 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 3e-05 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 3e-05 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 3e-05 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 3e-05 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 3e-05 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-05 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 3e-05 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-05 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-05 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-05 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 4e-05 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 4e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 4e-05 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 4e-05 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 4e-05 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 4e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 4e-05 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 4e-05 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 4e-05 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-05 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-05 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-05 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 5e-05 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 5e-05 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 5e-05 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 5e-05 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 5e-05 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 5e-05 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 5e-05 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 5e-05 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 5e-05 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 5e-05 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 5e-05 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 6e-05 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-05 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 6e-05 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-05 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 6e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 6e-05 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 6e-05 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 6e-05 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 7e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 7e-05 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 7e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 7e-05 | ||
| 2rio_A | 434 | Structure Of The Dual Enzyme Ire1 Reveals The Basis | 7e-05 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 8e-05 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 8e-05 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-05 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 8e-05 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 8e-05 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 8e-05 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 8e-05 | ||
| 3lj0_A | 434 | Ire1 Complexed With Adp And Quercetin Length = 434 | 8e-05 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 8e-05 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 8e-05 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 9e-05 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-05 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 9e-05 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 9e-05 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 9e-05 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 9e-05 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-05 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 9e-05 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 1e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 1e-04 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 1e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 1e-04 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 1e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 1e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 1e-04 | ||
| 3sdj_A | 448 | Structure Of Rnase-Inactive Point Mutant Of Oligome | 1e-04 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 1e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 1e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 1e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 1e-04 | ||
| 3fbv_A | 448 | Crystal Structure Of The Oligomer Formed By The Kin | 1e-04 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 1e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 1e-04 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 1e-04 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 1e-04 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 1e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 1e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 2e-04 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 2e-04 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 2e-04 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 2e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-04 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-04 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 2e-04 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 2e-04 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 2e-04 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 2e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-04 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 3e-04 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 3e-04 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 3e-04 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 3e-04 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 3e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 5e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 5e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 5e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 5e-04 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 7e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 649 | |||
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 1e-96 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 2e-96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 7e-85 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-64 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 2e-54 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-46 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 6e-45 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 3e-43 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 3e-42 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 6e-42 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 7e-42 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 7e-42 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 9e-42 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 7e-41 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 4e-40 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 9e-40 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 3e-39 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 7e-38 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 4e-37 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 2e-36 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 2e-36 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 4e-36 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 4e-35 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 5e-35 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 5e-35 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 6e-35 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 7e-35 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 8e-35 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 3e-34 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 4e-34 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-34 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 5e-34 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 6e-34 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 6e-34 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 8e-34 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 1e-33 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 3e-33 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 4e-33 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 4e-33 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 4e-33 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 5e-33 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 5e-33 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 6e-33 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 9e-33 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-32 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 1e-32 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 2e-32 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 3e-32 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 4e-32 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 5e-32 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 5e-32 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 6e-32 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 6e-32 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 6e-32 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 8e-32 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 9e-32 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 9e-32 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 9e-32 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 9e-32 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 1e-31 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-31 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-31 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 5e-31 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 6e-31 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-31 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 8e-31 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 1e-30 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 1e-30 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-30 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 6e-30 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 8e-30 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 1e-29 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-29 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 2e-29 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 3e-29 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 4e-29 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 4e-29 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 4e-29 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 5e-29 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 9e-29 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 9e-29 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 1e-28 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 3e-28 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 3e-28 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 7e-28 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 8e-28 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 9e-28 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 2e-27 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 2e-27 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 2e-27 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 3e-27 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 4e-27 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-27 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 5e-26 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 5e-26 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 6e-26 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-25 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 2e-25 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 4e-25 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 5e-25 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 1e-24 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 2e-24 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-24 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 2e-24 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 4e-24 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 8e-24 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 9e-24 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 9e-24 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 1e-23 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-23 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-23 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 4e-23 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 5e-23 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 9e-23 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-22 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 3e-22 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 3e-22 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 3e-22 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 5e-22 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-22 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 7e-22 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 8e-22 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 1e-21 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 1e-21 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 1e-21 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 1e-21 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 2e-21 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 2e-21 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 2e-21 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 2e-21 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 2e-21 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 3e-21 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 3e-21 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 3e-21 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 3e-21 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 4e-21 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 4e-21 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 4e-21 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 5e-21 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 5e-21 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 7e-21 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 9e-21 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 1e-20 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 1e-20 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 1e-20 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 1e-20 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 2e-20 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-20 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 2e-20 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 2e-20 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 3e-20 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 3e-20 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 3e-20 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 4e-20 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 4e-20 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 4e-20 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 4e-20 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 5e-20 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 5e-20 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 5e-20 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 7e-20 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 8e-20 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 9e-20 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 9e-20 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 1e-19 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 1e-19 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-19 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 2e-19 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 2e-19 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 2e-19 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 3e-19 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 3e-19 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 3e-19 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 4e-19 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 6e-19 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 9e-19 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 1e-18 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 1e-18 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 2e-18 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 3e-18 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 3e-18 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 3e-18 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 3e-18 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 7e-18 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 8e-18 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 3e-17 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 3e-17 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 5e-17 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 8e-17 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 9e-17 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 1e-16 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 1e-16 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 2e-16 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 5e-16 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 8e-16 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 1e-15 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-15 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 3e-15 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 3e-15 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 3e-15 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 4e-15 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 5e-15 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 5e-15 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 6e-15 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 8e-15 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 9e-15 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 9e-15 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-14 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 2e-14 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 3e-14 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-14 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 3e-14 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 6e-14 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 8e-14 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 1e-13 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 1e-13 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 3e-13 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-13 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 1e-12 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 1e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-12 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 1e-07 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 6e-12 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 5e-11 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 1e-10 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 1e-10 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 2e-10 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 4e-10 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 6e-10 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 1e-09 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 2e-09 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 2e-09 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 2e-05 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 5e-09 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 6e-09 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 7e-09 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 1e-08 | |
| 1kj1_A | 109 | Lectin I, lecgna 1; BULB lectin, mannose, plant pr | 2e-08 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 4e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 6e-08 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 2e-07 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 2e-07 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 5e-07 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 2e-06 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 2e-04 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 4e-06 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 5e-06 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 1e-05 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 6e-06 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 1e-05 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 1e-04 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 9e-06 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-05 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 3e-05 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 3e-05 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 2e-04 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 4e-05 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 1e-04 |
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 1e-96
Identities = 74/192 (38%), Positives = 104/192 (54%), Gaps = 14/192 (7%)
Query: 467 DLPLFQFEELATATNNF------QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK----A 516
F F EL TNNF +K+G+GGFG VY G + + +AVK+L+
Sbjct: 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDIT 69
Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 576
+ + ++F E+ V++K QH NLV LLG +G++ L+Y YMPN SL L
Sbjct: 70 TEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPP 129
Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
L W R I +G + G+ +LH + IHRD+K++NILLDE KISDFG+A+
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKF 186
Query: 637 QDQADTGRVVGT 648
T R+VGT
Sbjct: 187 AQTVMTSRIVGT 198
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 298 bits (765), Expect = 2e-96
Identities = 84/181 (46%), Positives = 110/181 (60%), Gaps = 3/181 (1%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLE-EFMNEVM 529
F EL A++NF + LG+GGFG VY GRL DG +AVKRL + QG E +F EV
Sbjct: 20 FSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVE 79
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEG 588
+IS HRNL+RL G C+ E++L+Y YM N S+ + L + + + LDW KR I G
Sbjct: 80 MISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALG 139
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+RGL YLH +IIHRD+KA+NILLDEE + DFG+AK+ T V GT
Sbjct: 140 SARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRGT 198
Query: 649 L 649
+
Sbjct: 199 I 199
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 268 bits (687), Expect = 7e-85
Identities = 78/180 (43%), Positives = 105/180 (58%), Gaps = 6/180 (3%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 530
+L ATNNF +G G FG VY G L+DG ++A+KR + S QG+EEF E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGI 589
+S +H +LV L+G C E E +LIY+YM N +L L+ L + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF-GGNQDQADTGRVVGT 648
+RGL YLH + IIHRD+K+ NILLDE PKI+DFG++K +Q T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 213 bits (545), Expect = 4e-64
Identities = 56/189 (29%), Positives = 84/189 (44%), Gaps = 17/189 (8%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV 530
E L + QL +G FG V+ +L + +AVK Q + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQL-LNEYVAVKIFPIQDKQS-WQNEYEVYS 71
Query: 531 ISKLQHRNLVRLLGCCVEGE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII 586
+ ++H N+++ +G G + LI + SL D LK + W + +I
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL----SDFLKANVVSWNELCHIA 127
Query: 587 EGISRGLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
E ++RGL YLH D + I HRD+K+ N+LL L I+DFG+A F +
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 640 ADTGRVVGT 648
DT VGT
Sbjct: 188 GDTHGQVGT 196
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 2e-54
Identities = 57/197 (28%), Positives = 88/197 (44%), Gaps = 27/197 (13%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--V 528
E + +N +L +G+G +G VY G L D + +AVK S A+ Q F+NE +
Sbjct: 3 AAASEPSLDLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQ---NFINEKNI 58
Query: 529 MVISKLQHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
+ ++H N+ R + E +L+ EY PN SL L DW
Sbjct: 59 YRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX----KYLSLHTSDWVSSC 114
Query: 584 NIIEGISRGLLYLHRD------SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN- 636
+ ++RGL YLH + + I HRDL + N+L+ + ISDFG++ GN
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174
Query: 637 -----QDQADTGRVVGT 648
++ VGT
Sbjct: 175 LVRPGEEDNAAISEVGT 191
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 2e-46
Identities = 51/196 (26%), Positives = 96/196 (48%), Gaps = 6/196 (3%)
Query: 456 SATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL-- 513
T L +++ + + K+G G FG V+ G ++AVK L
Sbjct: 12 DYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILME 70
Query: 514 SKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLK 573
+ + EF+ EV ++ +L+H N+V +G + ++ EY+ SL LL
Sbjct: 71 QDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130
Query: 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
+E+LD R+R ++ +++G+ YLH I+HR+LK+ N+L+D++ K+ DFG++++
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189
Query: 634 GGNQDQADTGRVVGTL 649
+ + GT
Sbjct: 190 ASTFLSSKSA--AGTP 203
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 6e-45
Identities = 43/163 (26%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
LG+G FG ++ G+ + +K L + + F+ EV V+ L+H N+++
Sbjct: 12 LIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLK 71
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
+G + + I EY+ +L ++ + W +R + + I+ G+ YLH
Sbjct: 72 FIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSFAKDIASGMAYLH---S 126
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
+ IIHRDL + N L+ E N ++DFG+A++ + Q + R
Sbjct: 127 MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLR 169
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 3e-43
Identities = 55/183 (30%), Positives = 85/183 (46%), Gaps = 24/183 (13%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL----SKASGQGLEEFMNEV 528
F EL L +G GGFG VY G E+AVK + Q +E E
Sbjct: 6 FAEL-------TLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEA 57
Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
+ + L+H N++ L G C++ L+ E+ L L +R+ N
Sbjct: 58 KLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPL----NRVLSGKRIPPDILVNWAVQ 113
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP--------KISDFGMAKIFGGNQDQA 640
I+RG+ YLH ++ + IIHRDLK+SNIL+ +++ KI+DFG+A+ + +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMS 173
Query: 641 DTG 643
G
Sbjct: 174 AAG 176
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-42
Identities = 43/153 (28%), Positives = 71/153 (46%), Gaps = 6/153 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
++ +G+G FG V + + +++A+K++ S + F+ E+ +S++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L G C+ L+ EY SL +L + S+G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 601 RLRIIHRDLKASNILLDEELN-PKISDFGMAKI 632
+IHRDLK N+LL KI DFG A
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 151 bits (385), Expect = 7e-42
Identities = 38/157 (24%), Positives = 68/157 (43%), Gaps = 7/157 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMVISKLQHRN 538
+KL + G ++ GR + G +I VK L S + +F E + H N
Sbjct: 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPN 68
Query: 539 LVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
++ +LG C LI +MP SL +L + +D + ++RG+ +L
Sbjct: 69 VLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFL 127
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
H L I L + ++++DE++ +IS + F
Sbjct: 128 HTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF 163
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 7e-42
Identities = 49/182 (26%), Positives = 85/182 (46%), Gaps = 23/182 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQG-------LEEFMNEVMVIS 532
N + ++G+GGFG V+ GRL D +A+K L +G +EF EV ++S
Sbjct: 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS 78
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
L H N+V+L G ++ E++P L L D K + W + ++ I+ G
Sbjct: 79 NLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALG 134
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFGGNQDQADTGRVVG 647
+ Y+ + I+HRDL++ NI L + K++DFG+++ ++G
Sbjct: 135 IEYMQ-NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ-----SVHSVSGLLG 188
Query: 648 TL 649
Sbjct: 189 NF 190
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 9e-42
Identities = 50/171 (29%), Positives = 84/171 (49%), Gaps = 10/171 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
+ ++G G FG VY G+ ++AVK L+ + Q L+ F NEV V+ K +H N
Sbjct: 24 GQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVN 81
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
++ +G + ++ ++ SL L + + + +K +I +RG+ YLH
Sbjct: 82 ILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHAS--ETKFEMKKLIDIARQTARGMDYLHA 138
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
IIHRDLK++NI L E+ KI DFG+A ++ G++
Sbjct: 139 ---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSI 186
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 7e-41
Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 21/184 (11%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQ 535
T + L +G+G +G V+ G + G+ +AVK S + + + E + L+
Sbjct: 5 TVARDITLLECVGKGRYGEVWRGSWQ-GENVAVKIFSS---RDEKSWFRETELYNTVMLR 60
Query: 536 HRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
H N++ + + LI Y SL +D L+ LD I+ I+
Sbjct: 61 HENILGFIASDMTSRHSSTQLWLITHYHEMGSL----YDYLQLTTLDTVSCLRIVLSIAS 116
Query: 592 GLLYLHRDSRLR-----IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR-- 644
GL +LH + I HRDLK+ NIL+ + I+D G+A + + +Q D G
Sbjct: 117 GLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP 176
Query: 645 VVGT 648
VGT
Sbjct: 177 RVGT 180
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-40
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 21/185 (11%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQ 535
T Q+ ++G+G +G V+ G+ + G+++AVK + E + ++
Sbjct: 34 TIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFT---TEEASWFRETEIYQTVLMR 89
Query: 536 HRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
H N++ + ++G LI +Y N SL +D LK LD + +
Sbjct: 90 HENILGFIAADIKGTGSWTQLYLITDYHENGSL----YDYLKSTTLDAKSMLKLAYSSVS 145
Query: 592 GLLYLHRDSRLR-----IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TGR 644
GL +LH + I HRDLK+ NIL+ + I+D G+A F + ++ D
Sbjct: 146 GLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNT 205
Query: 645 VVGTL 649
VGT
Sbjct: 206 RVGTK 210
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 3e-39
Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 20/182 (10%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--SKASGQGLEEFMNEVMV 530
FE+L ++ +G+G FG VY GR E+A++ + + + L+ F EVM
Sbjct: 32 FEQL-------EIGELIGKGRFGQVYHGRWH--GEVAIRLIDIERDNEDQLKAFKREVMA 82
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
+ +H N+V +G C+ +I R+L +++ D K LD K I + I
Sbjct: 83 YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDA--KIVLDVNKTRQIAQEIV 140
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR---VVG 647
+G+ YLH I+H+DLK+ N+ D I+DFG+ I G Q + G
Sbjct: 141 KGMGYLH---AKGILHKDLKSKNVFYDNG-KVVITDFGLFSISGVLQAGRREDKLRIQNG 196
Query: 648 TL 649
L
Sbjct: 197 WL 198
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 7e-38
Identities = 50/195 (25%), Positives = 81/195 (41%), Gaps = 24/195 (12%)
Query: 468 LPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE 527
LPL +A L +G+G FG V+ G+ + G+E+AVK S + + E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFRE 84
Query: 528 --VMVISKLQHRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRK 581
+ L+H N++ + + L+ +Y + SL FD L + +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140
Query: 582 RFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
+ + GL +LH + + I HRDLK+ NIL+ + I+D G+A
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 637 QDQADTGR--VVGTL 649
D D VGT
Sbjct: 201 TDTIDIAPNHRVGTK 215
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 139 bits (353), Expect = 4e-37
Identities = 50/166 (30%), Positives = 74/166 (44%), Gaps = 15/166 (9%)
Query: 481 NNFQLSSKLGQGGFGPVY---WGRLKDGQEI--AVKRL-SKASGQGLEEFMNEVMVISKL 534
+ LG+G FG V + DG AVK L + A Q + E+ ++ L
Sbjct: 31 RYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTL 90
Query: 535 QHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
H ++++ GCC + L+ EY+P SL D L + + + + I G
Sbjct: 91 YHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR----DYLPRHSIGLAQLLLFAQQICEG 146
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+ YLH IHRDL A N+LLD + KI DFG+AK +
Sbjct: 147 MAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE 189
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 2e-36
Identities = 47/165 (28%), Positives = 76/165 (46%), Gaps = 7/165 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRN 538
+ L ++G+G FG V+ GRL+ D +AVK +F+ E ++ + H N
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPN 173
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+VRL+G C + + ++ E + L + RL + ++ + G+ YL
Sbjct: 174 IVRLIGVCTQKQPIYIVMELVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLE- 230
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
IHRDL A N L+ E+ KISDFGM++ A G
Sbjct: 231 --SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGG 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-36
Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
+ + +LG+G FG V R G+ +AVK+L ++ + L +F E+ ++ LQ
Sbjct: 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 100
Query: 536 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
H N+V+ G C + LI EY+P SL L KER+D K I +G+
Sbjct: 101 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 158
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
YL R IHRDL NIL++ E KI DFG+ K+ +++
Sbjct: 159 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 200
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-36
Identities = 55/165 (33%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
+ + +LG+G FG V R G+ +AVK+L ++ + L +F E+ ++ LQ
Sbjct: 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ 69
Query: 536 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
H N+V+ G C + LI EY+P SL L KER+D K I +G+
Sbjct: 70 HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL--QKHKERIDHIKLLQYTSQICKGM 127
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
YL R IHRDL NIL++ E KI DFG+ K+ +++
Sbjct: 128 EYL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE 169
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 134 bits (340), Expect = 4e-35
Identities = 49/165 (29%), Positives = 79/165 (47%), Gaps = 12/165 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ 535
+ + S+LG+G FG V R G +AVK+L + +F E+ ++ L
Sbjct: 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH 82
Query: 536 HRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
+V+ G + L+ EY+P+ L L + RLD + I +G+
Sbjct: 83 SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL--QRHRARLDASRLLLYSSQICKGM 140
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
YL R +HRDL A NIL++ E + KI+DFG+AK+ ++D
Sbjct: 141 EYL---GSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD 182
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 5e-35
Identities = 48/166 (28%), Positives = 82/166 (49%), Gaps = 13/166 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL 534
+ LG+G FG V R G+++AVK L ++ G + + E+ ++ L
Sbjct: 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL 80
Query: 535 QHRNLVRLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
H N+V+ G C E LI E++P+ SL L P K +++ +++ I +G
Sbjct: 81 YHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYL--PKNKNKINLKQQLKYAVQICKG 138
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+ YL + +HRDL A N+L++ E KI DFG+ K +++
Sbjct: 139 MDYL---GSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE 181
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 5e-35
Identities = 47/163 (28%), Positives = 76/163 (46%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ ++G G FG V+ G + ++A+K + + E+F+ E V+ KL H LV
Sbjct: 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTI-REGAMSEEDFIEEAEVMMKLSHPKLV 66
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L G C+E L+ E+M + L L ++ + + G+ YL
Sbjct: 67 QLYGVCLEQAPICLVTEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYL---E 121
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+IHRDL A N L+ E K+SDFGM + +Q + TG
Sbjct: 122 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG 164
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 6e-35
Identities = 49/163 (30%), Positives = 75/163 (46%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
L +LG G FG V G+ K ++AVK + K +EF E + KL H LV
Sbjct: 8 EEITLLKELGSGQFGVVKLGKWKGQYDVAVKMI-KEGSMSEDEFFQEAQTMMKLSHPKLV 66
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+ G C + ++ EY+ N L L + L+ + + + G+ +L
Sbjct: 67 KFYGVCSKEYPIYIVTEYISNGCLLNYLRS--HGKGLEPSQLLEMCYDVCEGMAFL---E 121
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL A N L+D +L K+SDFGM + +Q + G
Sbjct: 122 SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVG 164
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 133 bits (338), Expect = 7e-35
Identities = 47/168 (27%), Positives = 81/168 (48%), Gaps = 21/168 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSKASGQGLEEFMNEVMVISKL 534
+ L +LG+G FG V+ + +AVK L +AS ++F E +++ L
Sbjct: 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML 100
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL------------FDPLKKERLDWRKR 582
QH+++VR G C EG ++++EYM + L+ L + + L +
Sbjct: 101 QHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ ++ G++YL + L +HRDL N L+ + L KI DFGM+
Sbjct: 161 LAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMS 205
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 132 bits (334), Expect = 8e-35
Identities = 44/163 (26%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +LG G FG V +G+ + ++A+K + K +EF+ E V+ L H LV
Sbjct: 24 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMI-KEGSMSEDEFIEEAKVMMNLSHEKLV 82
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L G C + +I EYM N L L + + R ++ + + + + YL
Sbjct: 83 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYL---E 137
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ +HRDL A N L++++ K+SDFG+++ ++ + G
Sbjct: 138 SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG 180
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 131 bits (333), Expect = 3e-34
Identities = 52/173 (30%), Positives = 87/173 (50%), Gaps = 14/173 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSK-ASGQGLEEFMNEVMVISKL 534
F+ LG G FG VY G E +A+K L + S + +E ++E V++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
+ ++ RLLG C+ LI + MP L + + K+ + + N I++G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRV 645
YL R++HRDL A N+L+ + KI+DFG+AK+ G + A+ G+V
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 4e-34
Identities = 51/164 (31%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
+ + KLG G +G VY G K +AVK L K +EEF+ E V+ +++H NL
Sbjct: 220 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 278
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
V+LLG C +I E+M +L L + ++ + + IS + YL
Sbjct: 279 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 334
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHR+L A N L+ E K++DFG++++ G+ A G
Sbjct: 335 EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 378
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 4e-34
Identities = 45/169 (26%), Positives = 77/169 (45%), Gaps = 22/169 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSKASGQGLEEFMNEVMVISKL 534
+ L +LG+G FG V+ + +AVK L + ++F E +++ L
Sbjct: 15 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNL 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWRK 581
QH ++V+ G C +G+ ++++EYM + L+ L K L +
Sbjct: 75 QHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQ 134
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+I I+ G++YL + +HRDL N L+ L KI DFGM+
Sbjct: 135 MLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 5e-34
Identities = 52/164 (31%), Positives = 81/164 (49%), Gaps = 6/164 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
+ + KLG G +G VY G K +AVK L K +EEF+ E V+ +++H NL
Sbjct: 13 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNL 71
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
V+LLG C +I E+M +L L + ++ + + IS + YL
Sbjct: 72 VQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYL--- 127
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL A N L+ E K++DFG++++ G+ A G
Sbjct: 128 EKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG 171
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-34
Identities = 51/170 (30%), Positives = 81/170 (47%), Gaps = 23/170 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
+ + +LG+ FG VY G L Q +A+K L A G EEF +E M+ ++
Sbjct: 9 SAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRAR 68
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWR 580
LQH N+V LLG + + +I+ Y + L L D K L+
Sbjct: 69 LQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPP 128
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+++ I+ G+ YL S ++H+DL N+L+ ++LN KISD G+
Sbjct: 129 DFVHLVAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLF 175
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 131 bits (331), Expect = 6e-34
Identities = 49/165 (29%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQ 535
+ + +G G G V +GRL+ +++ A+K L + + + +F++E ++ +
Sbjct: 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD 108
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H N++RL G G M++ EYM N SLD L + + ++ G+ G+ Y
Sbjct: 109 HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRY 166
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
L S L +HRDL A N+L+D L K+SDFG++++ + D A
Sbjct: 167 L---SDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAA 208
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 8e-34
Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +L KLG G FG V+ ++AVK + K +E F+ E V+ LQH LV
Sbjct: 188 ESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTM-KPGSMSVEAFLAEANVMKTLQHDKLV 246
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L + E +I E+M SL L + + K + I+ G+ ++
Sbjct: 247 KLHAVVTK-EPIYIITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFI---E 301
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ IHRDL+A+NIL+ L KI+DFG+A++ N+ A G
Sbjct: 302 QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 344
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-33
Identities = 44/167 (26%), Positives = 77/167 (46%), Gaps = 21/167 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVIS 532
+ + LGQG F ++ G ++ E+ +K L KA E F ++S
Sbjct: 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMS 67
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
KL H++LV G CV G+E +L+ E++ SLD L K ++ + + + ++
Sbjct: 68 KLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKK--NKNCINILWKLEVAKQLAAA 125
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNP--------KISDFGMAK 631
+ +L +IH ++ A NILL E + K+SD G++
Sbjct: 126 MHFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISI 169
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 3e-33
Identities = 52/163 (31%), Positives = 82/163 (50%), Gaps = 9/163 (5%)
Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547
LG+G +G VY GR L + IA+K + + + + E+ + L+H+N+V+ LG
Sbjct: 30 LGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFS 89
Query: 548 EGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606
E + I+ E +P SL ALL + + + + I GL YLH + +I+H
Sbjct: 90 E-NGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDN---QIVH 145
Query: 607 RDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGT 648
RD+K N+L++ KISDFG +K G +T GT
Sbjct: 146 RDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET--FTGT 186
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-33
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L +G+G FG V G + G ++AVK + + + F+ E V+++L+H NLV
Sbjct: 193 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCI--KNDATAQAFLAEASVMTQLRHSNLV 249
Query: 541 RLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+LLG VE + ++ EYM SL L + L + + YL
Sbjct: 250 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 305
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+HRDL A N+L+ E+ K+SDFG+ K
Sbjct: 306 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 337
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 4e-33
Identities = 48/164 (29%), Positives = 83/164 (50%), Gaps = 11/164 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSK-ASGQGLEEFMNEVMVISKL 534
+ +G G FG VY G LK +A+K L + + +F+ E ++ +
Sbjct: 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 103
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
H N++RL G + + M+I EYM N +LD L + K + ++ GI+ G+
Sbjct: 104 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 161
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
YL + + +HRDL A NIL++ L K+SDFG++++ + +
Sbjct: 162 YL---ANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE 202
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 4e-33
Identities = 52/165 (31%), Positives = 86/165 (52%), Gaps = 10/165 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 535
N + +G G FG V GRLK +EI A+K L + + +F+ E ++ +
Sbjct: 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD 104
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H N++RL G + + M++ EYM N SLD+ L + + ++ GI+ G+ Y
Sbjct: 105 HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKY 162
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
L S + +HRDL A NIL++ L K+SDFG+ ++ + + A
Sbjct: 163 L---SDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA 204
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 5e-33
Identities = 50/165 (30%), Positives = 80/165 (48%), Gaps = 17/165 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRLSK-ASGQGLEEFMNEVMVISK 533
+S +LGQG FG VY G K + +A+K +++ AS + EF+NE V+ +
Sbjct: 25 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 84
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNII 586
++VRLLG +G+ ++I E M RSL + + K +
Sbjct: 85 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 144
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I+ G+ YL + + +HRDL A N ++ E+ KI DFGM +
Sbjct: 145 GEIADGMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-33
Identities = 55/163 (33%), Positives = 85/163 (52%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L +LG G FG V+ G ++AVK L K + F+ E ++ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSL-KQGSMSPDAFLAEANLMKQLQHQRLV 71
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
RL + E +I EYM N SL L P +L K ++ I+ G+ ++
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFI---E 126
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
IHRDL+A+NIL+ + L+ KI+DFG+A++ N+ A G
Sbjct: 127 ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG 169
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 6e-33
Identities = 50/166 (30%), Positives = 72/166 (43%), Gaps = 13/166 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL---SKASGQGLEEFMNEVMVISK 533
+ +L KLG G FG V G G+ + AVK L + + +++F+ EV +
Sbjct: 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 77
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
L HRNL+RL G + ++ E P SL L + ++ G+
Sbjct: 78 LDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGM 134
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
YL R IHRDL A N+LL KI DFG+ + N D
Sbjct: 135 GYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH 177
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 9e-33
Identities = 47/152 (30%), Positives = 74/152 (48%), Gaps = 8/152 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L +G+G FG V G + G ++AVK + + + F+ E V+++L+H NLV
Sbjct: 21 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIK--NDATAQAFLAEASVMTQLRHSNLV 77
Query: 541 RLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+LLG VE + ++ EYM SL L + L + + YL
Sbjct: 78 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYL--- 133
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+HRDL A N+L+ E+ K+SDFG+ K
Sbjct: 134 EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK 165
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 52/173 (30%), Positives = 86/173 (49%), Gaps = 14/173 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRL-SKASGQGLEEFMNEVMVISKL 534
F+ LG G FG VY G E +A+K L S + +E ++E V++ +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
+ ++ RLLG C+ LI + MP L + + K+ + + N I++G+
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMN 131
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD--QADTGRV 645
YL R++HRDL A N+L+ + KI+DFG+AK+ G + A+ G+V
Sbjct: 132 YL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 181
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 1e-32
Identities = 48/155 (30%), Positives = 74/155 (47%), Gaps = 10/155 (6%)
Query: 488 KLGQGGFGPVYWGRLKDGQE---IAVKRLSK-ASGQGLEEFMNEVMVISKLQHRNLVRLL 543
+LG G FG V G + ++ +A+K L + EE M E ++ +L + +VRL+
Sbjct: 17 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 76
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G C + E ML+ E L L K+E + ++ +S G+ YL
Sbjct: 77 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 130
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+HRDL A N+LL KISDFG++K G +
Sbjct: 131 FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS 165
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (319), Expect = 2e-32
Identities = 52/169 (30%), Positives = 78/169 (46%), Gaps = 21/169 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE---IAVKRL-SKASGQGLEEFMNEVMVISKL-Q 535
N+ + +G+G FG V R+K A+KR+ AS +F E+ V+ KL
Sbjct: 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 84
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------FDPLKKERLDWRKRFNIIE- 587
H N++ LLG C L EY P+ +L L DP + +
Sbjct: 85 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144
Query: 588 -----GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++RG+ YL S+ + IHRDL A NIL+ E KI+DFG+++
Sbjct: 145 LHFAADVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSR 190
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 48/165 (29%), Positives = 78/165 (47%), Gaps = 17/165 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSK--ASGQGLEEFMNEVMVISKL 534
N L LG+G FG V G LK +AVK + +S + +EEF++E +
Sbjct: 34 NLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF 93
Query: 535 QHRNLVRLLGCCVEGE-----EKMLIYEYMPNRSLDALL---FDPLKKERLDWRKRFNII 586
H N++RLLG C+E + M+I +M L L + + + +
Sbjct: 94 SHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFM 153
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I+ G+ YL S +HRDL A N +L +++ ++DFG++K
Sbjct: 154 VDIALGMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 4e-32
Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
N L LG G FG VY G++ ++AVK L + S Q +F+ E ++ISK
Sbjct: 30 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 89
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGI 589
H+N+VR +G ++ + ++ E M L + L P + L ++ I
Sbjct: 90 FNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 149
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAK 631
+ G YL IHRD+ A N LL KI DFGMA+
Sbjct: 150 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 42/154 (27%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 484 QLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
+ +G+G FG VY G L D AVK L++ + +F+ E +++ H N
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 87
Query: 539 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
++ LLG C+ E +++ YM + L + + + +++G+ YL
Sbjct: 88 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKYL- 144
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + +HRDL A N +LDE+ K++DFG+A+
Sbjct: 145 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 5e-32
Identities = 44/154 (28%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 484 QLSSKLGQGGFGPVYWGRLKDGQE----IAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
+G+G FG VY G D + A+K LS+ Q +E F+ E +++ L H N
Sbjct: 24 HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPN 83
Query: 539 LVRLLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
++ L+G + E ++ YM + L + P + + + ++RG+ YL
Sbjct: 84 VLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSP--QRNPTVKDLISFGLQVARGMEYL- 140
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + +HRDL A N +LDE K++DFG+A+
Sbjct: 141 --AEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 6e-32
Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +L KLGQG FG V+ G +A+K L K E F+ E V+ KL+H LV
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 242
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L E E ++ EYM SL L + L + ++ I+ G+ Y+
Sbjct: 243 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 297
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
R+ +HRDL+A+NIL+ E L K++DFG+A++ N+ A G
Sbjct: 298 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 340
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 6e-32
Identities = 55/163 (33%), Positives = 84/163 (51%), Gaps = 6/163 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +L KLGQG FG V+ G +A+K L K E F+ E V+ KL+H LV
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTL-KPGTMSPEAFLQEAQVMKKLRHEKLV 325
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L E E ++ EYM SL L + L + ++ I+ G+ Y+
Sbjct: 326 QLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYV---E 380
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
R+ +HRDL+A+NIL+ E L K++DFG+A++ N+ A G
Sbjct: 381 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQG 423
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 6e-32
Identities = 45/156 (28%), Positives = 74/156 (47%), Gaps = 12/156 (7%)
Query: 488 KLGQGGFGPVYWGRLKDG---QEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRL 542
+LG G FG V G + + +AVK L +E + E V+ +L + +VR+
Sbjct: 24 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 83
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
+G C E E ML+ E L+ L + + + ++ +S G+ YL
Sbjct: 84 IGIC-EAESWMLVMEMAELGPLNKYL---QQNRHVKDKNIIELVHQVSMGMKYL---EES 136
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+HRDL A N+LL + KISDFG++K +++
Sbjct: 137 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 172
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 8e-32
Identities = 51/165 (30%), Positives = 75/165 (45%), Gaps = 17/165 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
N L LG G FG VY G++ ++AVK L + S Q +F+ E ++ISK
Sbjct: 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISK 130
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL----FDPLKKERLDWRKRFNIIEGI 589
H+N+VR +G ++ + ++ E M L + L P + L ++ I
Sbjct: 131 FNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI 190
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAK 631
+ G YL IHRD+ A N LL KI DFGMA+
Sbjct: 191 ACGCQYL---EENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 9e-32
Identities = 51/212 (24%), Positives = 87/212 (41%), Gaps = 31/212 (14%)
Query: 448 RKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDG-- 505
E++ N ++ L + L NN + +G+G FG V+ R
Sbjct: 14 PSELLLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLP 73
Query: 506 ----QEIAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560
+AVK L +AS +F E ++++ + N+V+LLG C G+ L++EYM
Sbjct: 74 YEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133
Query: 561 NRSLDALL---------------------FDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
L+ L L ++ I ++ G+ YL
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYL--- 190
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
S + +HRDL N L+ E + KI+DFG+++
Sbjct: 191 SERKFVHRDLATRNCLVGENMVVKIADFGLSR 222
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 9e-32
Identities = 41/154 (26%), Positives = 76/154 (49%), Gaps = 11/154 (7%)
Query: 484 QLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK-ASGQGLEEFMNEVMVISKLQHRN 538
+ +G+G FG VY G L D AVK L++ + +F+ E +++ H N
Sbjct: 92 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 151
Query: 539 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
++ LLG C+ E +++ YM + L + + + +++G+ +L
Sbjct: 152 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE--THNPTVKDLIGFGLQVAKGMKFL- 208
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + +HRDL A N +LDE+ K++DFG+A+
Sbjct: 209 --ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 9e-32
Identities = 48/187 (25%), Positives = 85/187 (45%), Gaps = 18/187 (9%)
Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDG----QEIAVKRLSK 515
++++ + D + E++ F L LG+G FG V +LK ++AVK L
Sbjct: 2 LDSLGISDELKEKLEDVLIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKA 61
Query: 516 --ASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK------MLIYEYMPNRSLDAL 567
+ +EEF+ E + + H ++ +L+G + K M+I +M + L A
Sbjct: 62 DIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAF 121
Query: 568 LFD---PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624
L L + + I+ G+ YL S IHRDL A N +L E++ +
Sbjct: 122 LLASRIGENPFNLPLQTLVRFMVDIACGMEYL---SSRNFIHRDLAARNCMLAEDMTVCV 178
Query: 625 SDFGMAK 631
+DFG+++
Sbjct: 179 ADFGLSR 185
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 9e-32
Identities = 44/163 (26%), Positives = 74/163 (45%), Gaps = 12/163 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKASG-QGLEEFMNEVMVISKL 534
+ LG G FG V+ G E + +K + SG Q + + ++ I L
Sbjct: 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSL 72
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
H ++VRLLG C G L+ +Y+P SL + + L + N I++G+
Sbjct: 73 DHAHIVRLLGLC-PGSSLQLVTQYLPLGSLLDHVRQ--HRGALGPQLLLNWGVQIAKGMY 129
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
YL ++HR+L A N+LL +++DFG+A + +
Sbjct: 130 YL---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD 169
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 1e-31
Identities = 38/178 (21%), Positives = 77/178 (43%), Gaps = 20/178 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRL---SKASGQGLEEFMNEVMVISKLQH 536
NF++ K+G+G F VY L DG +A+K++ + + + E+ ++ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
N+++ +E E ++ E L ++ K ++ +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMI-----KHFKKQKRLIPERTVWKYFVQLC 146
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
L ++H R++HRD+K +N+ + K+ D G+ + F A + +VGT
Sbjct: 147 SALEHMHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGT 199
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 40/171 (23%), Positives = 79/171 (46%), Gaps = 9/171 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 537
+ K+G+G FG + +DG++ +K +S+ S + EE EV V++ ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V+ E ++ +Y L + + K + + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+I+HRD+K+ NI L ++ ++ DFG+A++ + A +GT
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGT 188
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 3e-31
Identities = 46/162 (28%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 535
+ L+ LG+G FG VY G G++I AVK K + E+FM+E +++ L
Sbjct: 12 EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD 71
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H ++V+L+G E E +I E P L L K L I + + Y
Sbjct: 72 HPHIVKLIGII-EEEPTWIIMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAY 128
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
L + +HRD+ NIL+ K+ DFG+++
Sbjct: 129 L---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED 167
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 5e-31
Identities = 47/155 (30%), Positives = 73/155 (47%), Gaps = 10/155 (6%)
Query: 488 KLGQGGFGPVYWGRLKDGQE---IAVKRL-SKASGQGLEEFMNEVMVISKLQHRNLVRLL 543
+LG G FG V G + ++ +A+K L EE M E ++ +L + +VRL+
Sbjct: 343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLI 402
Query: 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLR 603
G C + E ML+ E L L K+E + ++ +S G+ YL
Sbjct: 403 GVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYL---EEKN 456
Query: 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+HR+L A N+LL KISDFG++K G +
Sbjct: 457 FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS 491
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 6e-31
Identities = 40/157 (25%), Positives = 68/157 (43%), Gaps = 11/157 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRLSK-ASGQGLEEFMNEVMVISKLQ 535
+L +G+G FG V+ G + + A+K S E+F+ E + + +
Sbjct: 15 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 74
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H ++V+L+G E +I E L + L +K LD +S L Y
Sbjct: 75 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 131
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
L R +HRD+ A N+L+ K+ DFG+++
Sbjct: 132 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRY 165
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 122 bits (309), Expect = 6e-31
Identities = 51/169 (30%), Positives = 72/169 (42%), Gaps = 22/169 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 533
NN Q LG G FG V + +AVK L S A E M+E+ ++S
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPN-----------RSLDALLFDPLKKERLDWRK 581
L QH N+V LLG C G ++I EY R L+ + R
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ +++G+ +L + IHRD+ A N+LL KI DFG+A
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 211
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 8e-31
Identities = 47/179 (26%), Positives = 75/179 (41%), Gaps = 31/179 (17%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG------QEIAVKRL-SKASGQGLEEFMNEVMVISK 533
N L LG+G FG V +AVK L AS L + ++E V+ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPN-------RSLDALLFDPLKKERLDWRKRFNII 586
+ H ++++L G C + +LI EY R + L +
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 587 EG--------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ IS+G+ YL + ++++HRDL A NIL+ E KISDFG+++
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR 198
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 1e-30
Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 531
+ L LG+G FG V +AVK L A+ + L + ++E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
+ +H+N++ LLG C + +I EY +L L + + +E++
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++ + ++RG+ YL + + IHRDL A N+L+ E KI+DFG+A+
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 251
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-30
Identities = 45/174 (25%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 531
+ L LG+G FG V +AVK L A+ + L + ++E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERL 577
+ +H+N++ LLG C + +I EY +L L + + +E++
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
++ + ++RG+ YL + + IHRDL A N+L+ E KI+DFG+A+
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR 205
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 53/180 (29%), Positives = 85/180 (47%), Gaps = 24/180 (13%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
++F+ + LGQG FG V R D + A+K++ + L ++EVM+++ L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 539 LVRLLGCCVEG----------EEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRF-- 583
+VR +E ++K ++ EY N +L +D + E L+ ++
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL----YDLIHSENLNQQRDEYW 119
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ I L Y+H IIHRDLK NI +DE N KI DFG+AK + D
Sbjct: 120 RLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLD 176
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 6e-30
Identities = 51/173 (29%), Positives = 68/173 (39%), Gaps = 26/173 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 533
N LG G FG V + +AVK L A E M+E+ V+S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL---------------FDPLKKERL 577
L H N+V LLG C G ++I EY L L + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
D + +++G+ +L + IHRDL A NILL KI DFG+A
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLA 192
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 8e-30
Identities = 44/162 (27%), Positives = 68/162 (41%), Gaps = 19/162 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
++ KLG+GGF V L DG A+KR+ Q EE E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 541 RLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
RL+ C+ L+ + +L ++ +++ D ++ GI
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTL----WNEIER-LKDKGNFLTEDQILWLLLGIC 144
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
RGL +H HRDLK +NILL +E P + D G
Sbjct: 145 RGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQ 183
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 1e-29
Identities = 46/174 (26%), Positives = 82/174 (47%), Gaps = 26/174 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRL-SKASGQGLEEFMNEVMVI 531
+ L LG+G FG V ++AVK L S A+ + L + ++E+ ++
Sbjct: 69 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 128
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL-------------DALLFDPLKKERL 577
+ +H+N++ LLG C + +I EY +L + +E+L
Sbjct: 129 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 188
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+ + ++RG+ YL + + IHRDL A N+L+ E+ KI+DFG+A+
Sbjct: 189 SSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR 239
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 2e-29
Identities = 40/156 (25%), Positives = 69/156 (44%), Gaps = 11/156 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEI--AVKRL-SKASGQGLEEFMNEVMVISKLQ 535
+L +G+G FG V+ G + + A+K + S E+F+ E + + +
Sbjct: 390 ERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD 449
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H ++V+L+G E +I E L + L +K LD +S L Y
Sbjct: 450 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAY 506
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L R +HRD+ A N+L+ K+ DFG+++
Sbjct: 507 L---ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSR 539
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 2e-29
Identities = 49/173 (28%), Positives = 76/173 (43%), Gaps = 25/173 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
+ +L LG+G FG V + +AVK L A+ M+E+ ++
Sbjct: 27 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 86
Query: 534 L-QHRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLD 578
+ H N+V LLG C G M+I E+ +L L + L K+ L
Sbjct: 87 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 146
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+++G+ +L + + IHRDL A NILL E+ KI DFG+A+
Sbjct: 147 LEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 196
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 43/176 (24%), Positives = 75/176 (42%), Gaps = 17/176 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
+F+ LG+GGFG V+ + K D A+KR+ E+ M EV ++KL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 539 LVRLLGCCVEGEE---------KMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNII 586
+VR +E K+ +Y + +L + E + +I
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
I+ + +LH ++HRDLK SNI + K+ DFG+ ++++
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 177
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 48/185 (25%), Positives = 82/185 (44%), Gaps = 28/185 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
+F+ +G GGFG V+ + DG+ +KR+ + E+ EV ++KL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 540 VRLLGCCVEGEEKM----------------LIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
V GC + + E+ +L+ + + + E+LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ E I++G+ Y+H ++I+RDLK SNI L + KI DFG+ + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRT--- 179
Query: 644 RVVGT 648
R GT
Sbjct: 180 RSKGT 184
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 4e-29
Identities = 45/167 (26%), Positives = 85/167 (50%), Gaps = 8/167 (4%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+++ +LG G FG VY + + G A K + S + LE+++ E+ +++ H +V+
Sbjct: 21 WEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVK 80
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
LLG + ++ E+ P ++DA++ L + + + L +LH
Sbjct: 81 LLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHSK-- 136
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
RIIHRDLKA N+L+ E + +++DFG++ + D+ +GT
Sbjct: 137 -RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGT 180
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 4e-29
Identities = 47/167 (28%), Positives = 87/167 (52%), Gaps = 10/167 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+ K+GQG G VY + GQE+A+++++ E +NE++V+ + ++ N+V
Sbjct: 22 YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVN 81
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
L + G+E ++ EY+ SL D + + +D + + + L +LH +
Sbjct: 82 YLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALEFLHSN-- 135
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
++IHRD+K+ NILL + + K++DFG Q + T +VGT
Sbjct: 136 -QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGT 179
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 5e-29
Identities = 49/215 (22%), Positives = 86/215 (40%), Gaps = 23/215 (10%)
Query: 442 WRWIAKRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR 501
W + + + + + N + + L +E + ++G+G FG V+ +
Sbjct: 20 WSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREE-VHWMTHQPRVGRGSFGEVHRMK 78
Query: 502 -LKDGQEIAVKRLSKASGQGLEEF-MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559
+ G + AVK++ LE F + E++ + L +V L G EG + E +
Sbjct: 79 DKQTGFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELL 132
Query: 560 PNRSLDALL--FDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617
SL L+ L ++R + GL YLH RI+H D+KA N+LL
Sbjct: 133 EGGSLGQLIKQMGCLPEDRAL-----YYLGQALEGLEYLHTR---RILHGDVKADNVLLS 184
Query: 618 EELNP-KISDFGMAKIFGGNQDQADTGR---VVGT 648
+ + + DFG A + + GT
Sbjct: 185 SDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGT 219
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 9e-29
Identities = 48/167 (28%), Positives = 82/167 (49%), Gaps = 10/167 (5%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
K+G+G G V R G+++AVK + Q E NEV+++ QH N+V
Sbjct: 47 LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVE 106
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
+ + GEE ++ E++ +L D + + RL+ + + E + + L YLH
Sbjct: 107 MYKSYLVGEELWVLMEFLQGGALT----DIVSQVRLNEEQIATVCEAVLQALAYLHAQ-- 160
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+IHRD+K+ +ILL + K+SDFG + + + +VGT
Sbjct: 161 -GVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKS--LVGT 204
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 42/181 (23%), Positives = 80/181 (44%), Gaps = 20/181 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHR 537
++++ +G G +G R DG+ + K + + ++EV ++ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 538 NLVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGI 589
N+VR ++ L + EY L +++ + R+ ++ +
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI-----TKGTKERQYLDEEFVLRVMTQL 120
Query: 590 SRGLLYLH--RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
+ L H D ++HRDLK +N+ LD + N K+ DFG+A+I + A T VG
Sbjct: 121 TLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVG 178
Query: 648 T 648
T
Sbjct: 179 T 179
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 46/178 (25%), Positives = 71/178 (39%), Gaps = 31/178 (17%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE------IAVKRL-SKASGQGLEEFMNEVMVISK 533
N + LG G FG V + +AVK L KA E M+E+ ++++
Sbjct: 45 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 104
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSL--------DALLFDPLKKERLDWRKRFN 584
L H N+V LLG C LI+EY L + D ++ E +
Sbjct: 105 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 164
Query: 585 IIEG------------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ +++G+ +L +HRDL A N+L+ KI DFG+A
Sbjct: 165 DLNVLTFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLA 219
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 3e-28
Identities = 45/169 (26%), Positives = 74/169 (43%), Gaps = 16/169 (9%)
Query: 488 KLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLG 544
++G+G F VY G + E+A + K + + F E ++ LQH N+VR
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 545 CCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+ L+ E M + +L L + + + + + I +GL +LH
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLH-TR 148
Query: 601 RLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVVGT 648
IIHRDLK NI + + KI D G+A + + +A V+GT
Sbjct: 149 TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGT 193
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-28
Identities = 43/181 (23%), Positives = 84/181 (46%), Gaps = 12/181 (6%)
Query: 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMV 530
F+ ++ + + ++G GG V+ + Q A+K L +A Q L+ + NE+
Sbjct: 20 FQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAY 79
Query: 531 ISKLQHRNL--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
++KLQ + +RL + + ++ E N L++ L KK+ +D +R + +
Sbjct: 80 LNKLQQHSDKIIRLYDYEITDQYIYMVMECG-NIDLNSWL---KKKKSIDPWERKSYWKN 135
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ + +H + I+H DLK +N L+ + K+ DFG+A + VGT
Sbjct: 136 MLEAVHTIH---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGT 191
Query: 649 L 649
+
Sbjct: 192 V 192
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 7e-28
Identities = 45/160 (28%), Positives = 68/160 (42%), Gaps = 24/160 (15%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHR 537
+ LG+GGF + + A K + K+ E E+ + L H+
Sbjct: 16 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 75
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
++V G E + + ++ E RSL + K+ RK + I
Sbjct: 76 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 125
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
G YLHR R+IHRDLK N+ L+E+L KI DFG+A
Sbjct: 126 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 162
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 8e-28
Identities = 45/160 (28%), Positives = 68/160 (42%), Gaps = 24/160 (15%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQHR 537
+ LG+GGF + + A K + K+ E E+ + L H+
Sbjct: 42 RYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQ 101
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
++V G E + + ++ E RSL + K+ RK + I
Sbjct: 102 HVVGFHGF-FEDNDFVFVVLELCRRRSL----LELHKR-----RKALTEPEARYYLRQIV 151
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
G YLHR R+IHRDLK N+ L+E+L KI DFG+A
Sbjct: 152 LGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLA 188
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 9e-28
Identities = 50/168 (29%), Positives = 85/168 (50%), Gaps = 11/168 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRNLV 540
F K+G+G FG V+ G + + +A+K + + +E+ E+ V+S+ +
Sbjct: 24 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 83
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+ G ++ + +I EY+ S D L+ LD + I+ I +GL YLH +
Sbjct: 84 KYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLDYLHSE- 138
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ IHRD+KA+N+LL E K++DFG+A Q + +T VGT
Sbjct: 139 --KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGT 182
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 2e-27
Identities = 41/173 (23%), Positives = 80/173 (46%), Gaps = 12/173 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRN 538
+ + ++G GG V+ + Q A+K ++ A Q L+ + NE+ ++KLQ +
Sbjct: 9 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 68
Query: 539 L--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+RL + + ++ E N L++ L KK+ +D +R + + + + +
Sbjct: 69 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 124
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
H + I+H DLK +N L+ + K+ DFG+A + VGT+
Sbjct: 125 H---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTV 173
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 2e-27
Identities = 41/173 (23%), Positives = 79/173 (45%), Gaps = 12/173 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKLQHRN 538
+ + ++G GG V+ + Q A+K L +A Q L+ + NE+ ++KLQ +
Sbjct: 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS 115
Query: 539 L--VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+RL + + ++ E N L++ L KK+ +D +R + + + + +
Sbjct: 116 DKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTI 171
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
H + I+H DLK +N L+ + K+ DFG+A + VG +
Sbjct: 172 H---QHGIVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAV 220
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 13/169 (7%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ 535
T+ + + LS LGQG V+ GR K G A+K + S + ++ M E V+ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 536 HRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
H+N+V+L E E+ P SL +L +P L + ++ + G
Sbjct: 66 HKNIVKLFAI-EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQ 637
+ +L I+HR++K NI+ D + K++DFG A+ ++
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 49/161 (30%), Positives = 78/161 (48%), Gaps = 23/161 (14%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS--GQGLEE-FMNEVMVISKLQH 536
+F++ + LG+G F VY + G E+A+K + K + G+ + NEV + +L+H
Sbjct: 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKH 70
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 589
+++ L E + L+ E N + LK K F+ + I
Sbjct: 71 PSILELYNY-FEDSNYVYLVLEMCHNGEM----NRYLKNRV----KPFSENEARHFMHQI 121
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
G+LYLH I+HRDL SN+LL +N KI+DFG+A
Sbjct: 122 ITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLA 159
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 46/169 (27%), Positives = 78/169 (46%), Gaps = 13/169 (7%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQ 535
T+ + + LS LGQG V+ GR K G A+K + S + ++ M E V+ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 536 HRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
H+N+V+L E E+ P SL +L +P L + ++ + G
Sbjct: 66 HKNIVKLF-AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGG 124
Query: 593 LLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKIFGGNQ 637
+ +L I+HR++K NI+ D + K++DFG A+ ++
Sbjct: 125 MNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE 170
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 55/197 (27%), Positives = 102/197 (51%), Gaps = 16/197 (8%)
Query: 459 NVNTVKLQDLPLFQFEELATATNN------FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK 511
++ TV+L++ P Q ++L + F + KLG+G +G VY + GQ +A+K
Sbjct: 1 SLETVQLRNPPRRQLKKLDEDSLTKQPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIK 60
Query: 512 RLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
++ L+E + E+ ++ + ++V+ G + + ++ EY S+ ++
Sbjct: 61 QVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDII--R 116
Query: 572 LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L+ + L + I++ +GL YLH R IHRD+KA NILL+ E + K++DFG+A
Sbjct: 117 LRNKTLTEDEIATILQSTLKGLEYLHFM---RKIHRDIKAGNILLNTEGHAKLADFGVAG 173
Query: 632 IFGGNQDQADTGRVVGT 648
+ +T V+GT
Sbjct: 174 QLTDTMAKRNT--VIGT 188
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 5e-26
Identities = 44/179 (24%), Positives = 85/179 (47%), Gaps = 15/179 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
++++L +G G V +++A+KR++ + ++E + E+ +S+ H N
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 592
+V V +E L+ + + S+ ++ + + + I+ + G
Sbjct: 75 IVSYYTSFVVKDELWLVMKLLSGGSVLDII-KHIVAKGEHKSGVLDESTIATILREVLEG 133
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM-AKIFGGNQDQADTGR--VVGT 648
L YLH++ IHRD+KA NILL E+ + +I+DFG+ A + G + R VGT
Sbjct: 134 LEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGT 189
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 5e-26
Identities = 52/156 (33%), Positives = 78/156 (50%), Gaps = 12/156 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEE-FMNEVMVISKLQH 536
+F++ LG+G FG VY R K +A+K L KA G+E EV + S L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
N++RL G + LI EY P ++ + L+K + D ++ I ++ L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
H R+IHRD+K N+LL KI+DFG +
Sbjct: 125 CHS---KRVIHRDIKPENLLLGSAGELKIADFGWSV 157
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 6e-26
Identities = 42/183 (22%), Positives = 76/183 (41%), Gaps = 35/183 (19%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA-----------------SGQGLEE 523
N++++ L QG F + KD + A+K+ K+ ++
Sbjct: 31 NDYRIIRTLNQGKFNKIILCE-KDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDD 89
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERLDWRK 581
F NE+ +I+ +++ + G + +++ +IYEYM N S+ LD
Sbjct: 90 FKNELQIITDIKNEYCLTCEGI-ITNYDEVYIIYEYMENDSI----LKFDEYFFVLDKNY 144
Query: 582 RFNIIEGISR--------GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
I + + Y+H + I HRD+K SNIL+D+ K+SDFG ++
Sbjct: 145 TCFIPIQVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202
Query: 634 GGN 636
Sbjct: 203 VDK 205
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 54/170 (31%), Positives = 86/170 (50%), Gaps = 16/170 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS---KASGQGLEEFMNEVMVISKLQHRN 538
F ++G G FG VY+ R +++ + +A+K++S K S + ++ + EV + KL+H N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
++ GC + L+ EY + D L + K+ L + + G +GL YLH
Sbjct: 116 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLHS 172
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+IHRD+KA NILL E K+ DFG A A++ VGT
Sbjct: 173 H---NMIHRDVKAGNILLSEPGLVKLGDFGSA----SIMAPANS--FVGT 213
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 45/173 (26%), Positives = 65/173 (37%), Gaps = 17/173 (9%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHR 537
+FQ S+LG G +G V+ R K DG+ AVKR + + EV K+ QH
Sbjct: 58 SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE--RLDWRKRFNIIEGISRGLLY 595
VRL EG L E L + L + + + L +
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-----GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
LH ++H D+K +NI L K+ DFG+ G + G
Sbjct: 173 LHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVEL-GTAGAGEV--QEGD 219
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 4e-25
Identities = 45/177 (25%), Positives = 73/177 (41%), Gaps = 10/177 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNL 539
++ L +GGF VY + + G+E A+KRL + + EV + KL H N+
Sbjct: 29 RLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNI 88
Query: 540 VRLLGCCVEGEEKM-------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
V+ G+E+ L+ + L L + L I R
Sbjct: 89 VQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA 148
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+ ++HR + IIHRDLK N+LL + K+ DFG A D + + + +
Sbjct: 149 VQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALV 204
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 107 bits (268), Expect = 5e-25
Identities = 42/167 (25%), Positives = 74/167 (44%), Gaps = 25/167 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLV 540
+F LG G G + + + D +++AVKR+ + EV ++ + +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECFSFAD---REVQLLRESDEHPNVI 81
Query: 541 RLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLY 595
R C E +++ Y E A L + + K + +++ + GL +
Sbjct: 82 RYF--CTE-KDRQFQYIAIELCA-----ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH 133
Query: 596 LHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIFGGNQ 637
LH L I+HRDLK NIL+ ++ ISDFG+ K +
Sbjct: 134 LH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 108 bits (270), Expect = 1e-24
Identities = 54/180 (30%), Positives = 78/180 (43%), Gaps = 19/180 (10%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 539
+++ +LG GGFG V +D G+++A+K+ + E + E+ ++ KL H N+
Sbjct: 15 PWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNV 74
Query: 540 VRLLGCCVEGEEKM-------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
V +G +K+ L EY L L L ++ IS
Sbjct: 75 VSAR-EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSA 133
Query: 593 LLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
L YLH RIIHRDLK NI+L + L KI D G AK + VGTL
Sbjct: 134 LRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-LCTE--FVGTL 187
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 2e-24
Identities = 46/161 (28%), Positives = 80/161 (49%), Gaps = 12/161 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEE-FMNEVMVISKLQH 536
++F + LG+G FG VY R K +A+K L K+ +G+E E+ + S L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE-RLDWRKRFNIIEGISRGLLY 595
N++R+ + + L+ E+ P L + L+K R D ++ +E ++ L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
H ++IHRD+K N+L+ + KI+DFG +
Sbjct: 130 CHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL 167
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 34/180 (18%), Positives = 67/180 (37%), Gaps = 14/180 (7%)
Query: 480 TNNFQLSSKLGQG--GFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKL 534
++L + +G+G V R G+ + V+R L S + + E+ V
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
H N+V + E ++ +M S L+ + ++ I++G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKDLI-CTHFMDGMNELAIAYILQGVLKALD 142
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT-----GRVVGTL 649
Y+H +HR +KAS+IL+ + +S + + V L
Sbjct: 143 YIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVL 199
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 54/196 (27%), Positives = 85/196 (43%), Gaps = 15/196 (7%)
Query: 461 NTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQ 519
+ + L L F+L +G G +G VY GR +K GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 520 GLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPL 572
EE E+ ++ K HRN+ G ++ L+ E+ S+ L+
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLI-KNT 121
Query: 573 KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
K L I I RGL +LH+ ++IHRD+K N+LL E K+ DFG++
Sbjct: 122 KGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSAQ 178
Query: 633 FGGNQDQADTGRVVGT 648
+ +T +GT
Sbjct: 179 LDRTVGRRNT--FIGT 192
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-24
Identities = 43/178 (24%), Positives = 77/178 (43%), Gaps = 18/178 (10%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHR 537
+ F KLG G FG V+ + G E +K ++K Q +E+ E+ V+ L H
Sbjct: 21 DDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHP 80
Query: 538 NLVRLLGCCVEGEEKMLIY---EYMPNRSL-DALLFDPLKKERLDWRKRFNIIEGISRGL 593
N++++ E+ +Y E L + ++ + + L +++ + L
Sbjct: 81 NIIKIFEVF---EDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 594 LYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
Y H ++H+DLK NIL KI DFG+A++F ++ + GT
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTN---AAGT 189
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 8e-24
Identities = 44/182 (24%), Positives = 74/182 (40%), Gaps = 31/182 (17%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ L + +G+G +G V K A K++ K + ++ F E+ ++ L H N
Sbjct: 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPN 67
Query: 539 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 589
++RL E+ IY E LF+ R+ ++ F I++ +
Sbjct: 68 IIRLYETF---EDNTDIYLVMELCTGGE----LFE-----RVVHKRVFRESDAARIMKDV 115
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 646
+ Y H +L + HRDLK N L + K+ DFG+A F + V
Sbjct: 116 LSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRT---KV 169
Query: 647 GT 648
GT
Sbjct: 170 GT 171
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 9e-24
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
+ + LG+G FG V + + QE AVK ++KA + + EV ++ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
N+++L + ++ E LFD + RKRF+ II+ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----EIIKRKRFSEHDAARIIKQVF 131
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
G+ Y+H + I+HRDLK NILL +++ + KI DFG++ F N D +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185
Query: 648 T 648
T
Sbjct: 186 T 186
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 9e-24
Identities = 42/169 (24%), Positives = 73/169 (43%), Gaps = 22/169 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536
+ + LG+G +G V + AVK L K G E+ ++ +L+H
Sbjct: 6 KYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRH 65
Query: 537 RNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERL---DWRKRFN-IIEGI 589
+N+++L+ + EEK +Y EY + + D + ++R F +I+G+
Sbjct: 66 KNVIQLVDV-LYNEEKQKMYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGL 122
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
YLH I+H+D+K N+LL KIS G+A+
Sbjct: 123 E----YLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA 164
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 1e-23
Identities = 52/181 (28%), Positives = 82/181 (45%), Gaps = 27/181 (14%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
+ +Q KLG G +G V R K E A+K + K S + + EV V+ L H
Sbjct: 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDH 95
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
N+++L + L+ E LFD + R +FN II+ +
Sbjct: 96 PNIMKLYDFFEDKRNYYLVMECYKGGE----LFD-----EIIHRMKFNEVDAAVIIKQVL 146
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
G+ YLH + I+HRDLK N+LL +++ KI DFG++ +F + + +G
Sbjct: 147 SGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE---RLG 200
Query: 648 T 648
T
Sbjct: 201 T 201
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 48/188 (25%), Positives = 67/188 (35%), Gaps = 39/188 (20%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKR--LSKASGQGLEEFMNEVMVISKL-Q 535
T F K+G G FG V+ DG A+KR A + + EV + L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 536 HRNLVRLLGCCVEGEEKMLIY-EYMPNRSLDALLFDPLKKERLDWRKRF------NIIEG 588
H ++VR E + MLI EY SL + E F +++
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAI-----SENYRIMSYFKEAELKDLLLQ 123
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-------------------KISDFGM 629
+ RGL Y+H ++H D+K SNI + P KI D G
Sbjct: 124 VGRGLRYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGH 180
Query: 630 AKIFGGNQ 637
Q
Sbjct: 181 VTRISSPQ 188
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-23
Identities = 54/182 (29%), Positives = 87/182 (47%), Gaps = 28/182 (15%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ 535
++ ++ LG+G FG V + K GQE AVK +SK E + EV ++ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGI 589
H N+++L + L+ E LFD + RKRF+ II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGE----LFD-----EIISRKRFSEVDAARIIRQV 135
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVV 646
G+ Y+H + +I+HRDLK N+LL ++ N +I DFG++ F ++ D +
Sbjct: 136 LSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD---KI 189
Query: 647 GT 648
GT
Sbjct: 190 GT 191
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 4e-23
Identities = 53/181 (29%), Positives = 85/181 (46%), Gaps = 27/181 (14%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
+ + LG+G FG V + + QE AVK ++KA + + EV ++ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGIS 590
N+++L + ++ E LFD + RKRF+ II+ +
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGE----LFD-----EIIKRKRFSEHDAARIIKQVF 131
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
G+ Y+H + I+HRDLK NILL +++ + KI DFG++ F N D +G
Sbjct: 132 SGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD---RIG 185
Query: 648 T 648
T
Sbjct: 186 T 186
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 5e-23
Identities = 49/181 (27%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGL---------EEFMNEVM 529
N++ LG+G V K +E AVK + G E + EV
Sbjct: 16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVD 75
Query: 530 VISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIE 587
++ K+ H N+++L L+++ M L FD L +K L ++ I+
Sbjct: 76 ILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTLSEKETRKIMR 131
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
+ + LH+ L I+HRDLK NILLD+++N K++DFG + + + V G
Sbjct: 132 ALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE---VCG 185
Query: 648 T 648
T
Sbjct: 186 T 186
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 9e-23
Identities = 47/195 (24%), Positives = 74/195 (37%), Gaps = 41/195 (21%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNL 539
N LG G G V + G+ +AVKR+ + + E+ ++++ H N+
Sbjct: 15 NLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALMEIKLLTESDDHPNV 71
Query: 540 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFD--------PLKKERLDWRKRFNIIEG 588
+R C E +Y E + L D + +++
Sbjct: 72 IRYY--CSE-TTDRFLYIALELC-----NLNLQDLVESKNVSDENLKLQKEYNPISLLRQ 123
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLD-------------EELNPKISDFGMAKIFGG 635
I+ G+ +LH L+IIHRDLK NIL+ E L ISDFG+ K
Sbjct: 124 IASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDS 180
Query: 636 NQD--QADTGRVVGT 648
Q + + GT
Sbjct: 181 GQSSFRTNLNNPSGT 195
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 54/174 (31%), Positives = 74/174 (42%), Gaps = 14/174 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKAS---GQGLEEFMNEVMVISKLQH 536
+F+ LG+G F V R A+K L K + E V+S+L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRGLL 594
V+L + E+ Y N L ++K + RF E I L
Sbjct: 90 PFFVKLYFTFQDDEKLYFGLSYAKNGEL----LKYIRKIGSFDETCTRFYTAE-IVSALE 144
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
YLH IIHRDLK NILL+E+++ +I+DFG AK+ QA VGT
Sbjct: 145 YLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGT 195
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 3e-22
Identities = 40/180 (22%), Positives = 75/180 (41%), Gaps = 21/180 (11%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQG--------LEEFMNEVMV 530
+ +G+G V + G E AVK + + + E E +
Sbjct: 93 YQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHI 152
Query: 531 ISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEG 588
+ ++ H +++ L+ L+++ M L FD L +K L ++ +I+
Sbjct: 153 LRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----FDYLTEKVALSEKETRSIMRS 208
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ + +LH I+HRDLK NILLD+ + ++SDFG + + + + GT
Sbjct: 209 LLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE---LCGT 262
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 3e-22
Identities = 48/196 (24%), Positives = 82/196 (41%), Gaps = 46/196 (23%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK-------------------ASGQG 520
N + L ++G+G +G V D A+K LSK + G
Sbjct: 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 521 LEEFMN-------EVMVISKLQHRNLVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFD 570
+ E+ ++ KL H N+V+L+ ++ + +Y E + + +
Sbjct: 73 CIQPRGPIEQVYQEIAILKKLDHPNVVKLV-EVLDDPNEDHLYMVFELVNQGPV----ME 127
Query: 571 PLKKERLD---WRKRFN-IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 626
+ L R F +I+GI YLH +IIHRD+K SN+L+ E+ + KI+D
Sbjct: 128 VPTLKPLSEDQARFYFQDLIKGIE----YLHY---QKIIHRDIKPSNLLVGEDGHIKIAD 180
Query: 627 FGMAKIFGGNQDQADT 642
FG++ F G+
Sbjct: 181 FGVSNEFKGSDALLSN 196
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 96.1 bits (240), Expect = 3e-22
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
++N+ + +LG+G F V K G E A K ++ S + ++ E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLY 595
N+VRL E L+++ + LF+ + +E + I+ I + Y
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H I+HR+LK N+LL + K++DFG+A ++ GT
Sbjct: 121 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGT 170
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 97.9 bits (244), Expect = 5e-22
Identities = 39/174 (22%), Positives = 73/174 (41%), Gaps = 15/174 (8%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ + + +LG G FG V+ K G+ K ++ NE+ ++++L H
Sbjct: 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPK 109
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 596
L+ L + E +LI E++ LFD + + ++ + N + GL ++
Sbjct: 110 LINLHDAFEDKYEMVLILEFLSGGE----LFDRIAAEDYKMSEAEVINYMRQACEGLKHM 165
Query: 597 HRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H I+H D+K NI+ + + KI DFG+A ++ T
Sbjct: 166 H---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTAT 213
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 97.4 bits (242), Expect = 5e-22
Identities = 23/202 (11%), Positives = 48/202 (23%), Gaps = 36/202 (17%)
Query: 466 QDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK---ASGQGL 521
Q+ L+ +L L G V+ R + ++ A+K + S L
Sbjct: 47 QNAETTVDSLLSQGERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSEL 106
Query: 522 EEFMNEVMVISKLQHRNLVRLLGCC----------VEGEEKM----------------LI 555
E ++L + V+ + L+
Sbjct: 107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLL 166
Query: 556 YEYMP---NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS 612
L F + + + + R L ++H
Sbjct: 167 MPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPD 223
Query: 613 NILLDEELNPKISDFGMAKIFG 634
N+ + + + D G
Sbjct: 224 NLFIMPDGRLMLGDVSALWKVG 245
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 96.8 bits (241), Expect = 7e-22
Identities = 50/203 (24%), Positives = 87/203 (42%), Gaps = 21/203 (10%)
Query: 448 RKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQ 506
++ +L A K+ +L FE++ S+LG G G V+ K G
Sbjct: 10 DEQQRKRLEAFLTQKQKVGELKDDDFEKI----------SELGAGNGGVVFKVSHKPSGL 59
Query: 507 EIAVKRLS-KASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD 565
+A K + + + + E+ V+ + +V G E + E+M SLD
Sbjct: 60 VMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLD 119
Query: 566 ALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625
+L K R+ + + + +GL YL + +I+HRD+K SNIL++ K+
Sbjct: 120 QVL---KKAGRIPEQILGKVSIAVIKGLTYLR--EKHKIMHRDVKPSNILVNSRGEIKLC 174
Query: 626 DFGMAKIFGGNQDQADTGRVVGT 648
DFG++ A++ VGT
Sbjct: 175 DFGVSGQL--IDSMANS--FVGT 193
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 98.8 bits (246), Expect = 8e-22
Identities = 40/174 (22%), Positives = 70/174 (40%), Gaps = 15/174 (8%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+++ + +LG G FG V+ + G A K + E E+ +S L+H
Sbjct: 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPT 215
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 596
LV L + E ++IYE+M LF+ + + ++ + + + +GL ++
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGE----LFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 597 HRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H +H DLK NI+ K+ DFG+ Q GT
Sbjct: 272 H---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGT 319
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 98.3 bits (245), Expect = 1e-21
Identities = 49/175 (28%), Positives = 84/175 (48%), Gaps = 14/175 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
+ F LG+GGFG V+ ++K ++ A K+L+K +G + M E +++K+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
R +V L E + + L+ M + +++ + + R F + I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQ-IVSGL 302
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+LH+ II+RDLK N+LLD++ N +ISD G+A Q + GT
Sbjct: 303 EHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGT 352
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-21
Identities = 45/172 (26%), Positives = 77/172 (44%), Gaps = 15/172 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ LG G FG V+ G ++A K + + EE NE+ V+++L H NL+
Sbjct: 90 TVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLI 149
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYLHR 598
+L + +L+ EY+ LFD + + L ++ I G+ ++H
Sbjct: 150 QLYDAFESKNDIVLVMEYVDGGE----LFDRIIDESYNLTELDTILFMKQICEGIRHMH- 204
Query: 599 DSRLRIIHRDLKASNILL-DEELNP-KISDFGMAKIFGGNQDQADTGRVVGT 648
++ I+H DLK NIL + + KI DFG+A+ + + GT
Sbjct: 205 --QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKV---NFGT 251
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 44/183 (24%), Positives = 75/183 (40%), Gaps = 21/183 (11%)
Query: 455 LSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL 513
+S + +K+ + F + + ++G+G +G V K GQ +AVKR+
Sbjct: 1 MSIESSGKLKISPEQHWDFT-----AEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI 55
Query: 514 -SKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDP 571
S + ++ + ++ V+ + +V+ G + + E M + S D
Sbjct: 56 RSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELM-STSFDKFY--- 111
Query: 572 LKKERLDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625
K I + L +L L+IIHRD+K SNILLD N K+
Sbjct: 112 -KYVYSVLDDVIPEEILGKITLATVKALNHLK--ENLKIIHRDIKPSNILLDRSGNIKLC 168
Query: 626 DFG 628
DFG
Sbjct: 169 DFG 171
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 1e-21
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 539
++ L LG+G +G V + +AVK + E E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 540 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
V+ G E + Y EY L FD + + D ++ F+ ++ G+
Sbjct: 68 VKFYGHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV- 119
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
YLH + I HRD+K N+LLDE N KISDFG+A +F
Sbjct: 120 ---YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 2e-21
Identities = 54/161 (33%), Positives = 86/161 (53%), Gaps = 21/161 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRN 538
N++L +G+G F V R + G+E+A+K + K + L++ EV ++ L H N
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPN 75
Query: 539 LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISRG 592
+V+L +E E+ + LI EY + FD L R+ + R +F I+ +
Sbjct: 76 IVKLFEV-IETEKTLYLIMEYASGGEV----FDYLVAHGRMKEKEARSKFRQIVSAVQ-- 128
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
Y H+ RI+HRDLKA N+LLD ++N KI+DFG + F
Sbjct: 129 --YCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEF 164
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 97.5 bits (243), Expect = 2e-21
Identities = 51/192 (26%), Positives = 85/192 (44%), Gaps = 38/192 (19%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-------------SGQGLEEFM 525
++ KLG G +G V + K E A+K + K+ + EE
Sbjct: 35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIY 94
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN- 584
NE+ ++ L H N+++L + + L+ E+ L F+ ++ R +F+
Sbjct: 95 NEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGEL----FE-----QIINRHKFDE 145
Query: 585 -----IIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGN 636
I++ I G+ YLH+ I+HRD+K NILL + LN KI DFG++ F +
Sbjct: 146 CDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD 202
Query: 637 QDQADTGRVVGT 648
D +GT
Sbjct: 203 YKLRD---RLGT 211
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.2 bits (237), Expect = 2e-21
Identities = 41/166 (24%), Positives = 69/166 (41%), Gaps = 24/166 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--------SGQGLEEFMNEVMVIS 532
+ S LG G FG V+ + +E+ VK + K L + E+ ++S
Sbjct: 25 KYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS 84
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-IIE 587
+++H N++++L E + M LF + + RLD F ++
Sbjct: 85 RVEHANIIKVLDIF---ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVS 141
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
+ YL IIHRD+K NI++ E+ K+ DFG A
Sbjct: 142 AVG----YLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 2e-21
Identities = 44/171 (25%), Positives = 73/171 (42%), Gaps = 21/171 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--------FMNEVMV 530
+ + +S LG G G V + +++A+K +SK E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGI 589
+ KL H ++++ + E+ ++ E M L FD + +RL +
Sbjct: 69 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 123
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQ 637
+ YLH IIHRDLK N+LL +E+ KI+DFG +KI G
Sbjct: 124 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 171
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 95.0 bits (237), Expect = 2e-21
Identities = 46/160 (28%), Positives = 79/160 (49%), Gaps = 12/160 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-----EVMVISKL 534
++ LG+G F VY R Q +A+K++ ++ +N E+ ++ +L
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
H N++ LL L++++M L+ ++ D K + + +GL
Sbjct: 70 SHPNIIGLLDAFGHKSNISLVFDFME-TDLEVIIKDNSLVLTPSHIKAY--MLMTLQGLE 126
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
YLH+ I+HRDLK +N+LLDE K++DFG+AK FG
Sbjct: 127 YLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG 163
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 94.2 bits (235), Expect = 3e-21
Identities = 43/162 (26%), Positives = 81/162 (50%), Gaps = 20/162 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF--------MNEVMVIS 532
+Q K+G+G +G VY + G+ +A+KR+ L+ + E+ ++
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
+L H N+V L+ L++E+M L +L + + K + + + RG
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIY--LYQLLRG 131
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+ + H+ RI+HRDLK N+L++ + K++DFG+A+ FG
Sbjct: 132 VAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG 170
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 3e-21
Identities = 48/162 (29%), Positives = 73/162 (45%), Gaps = 24/162 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRNL 539
++ L LG+G +G V + +AVK + E E+ + L H N+
Sbjct: 8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENV 67
Query: 540 VRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
V+ G E + Y EY L FD + + D ++ F+ ++ G+
Sbjct: 68 VKFYGHR---REGNIQYLFLEYCSGGEL----FDRIEPDIGMPEPDAQRFFHQLMAGVV- 119
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
YLH + I HRD+K N+LLDE N KISDFG+A +F
Sbjct: 120 ---YLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVF 155
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 93.8 bits (234), Expect = 3e-21
Identities = 44/179 (24%), Positives = 72/179 (40%), Gaps = 26/179 (14%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
F LG G F V+ + + G+ A+K + K+ NE+ V+ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGISRG 592
+V L L+ + + LFD R+ R + +I+ +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGE----LFD-----RILERGVYTEKDASLVIQQVLSA 118
Query: 593 LLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ YLH I+HRDLK N+L +E I+DFG++K+ GT
Sbjct: 119 VKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGT 170
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 94.7 bits (236), Expect = 3e-21
Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 25/181 (13%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISKLQH 536
++L +G+G F V ++ GQ+ AVK + + + G E+ E + L+H
Sbjct: 26 YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKH 85
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
++V LL +++E+M A L + +R D + + + I
Sbjct: 86 PHIVELLETYSSDGMLYMVFEFMDG----ADLCFEI-VKRADAGFVYSEAVASHYMRQIL 140
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
L Y H IIHRD+K +LL + K+ FG+A G + A VG
Sbjct: 141 EALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVG 195
Query: 648 T 648
T
Sbjct: 196 T 196
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 97.2 bits (242), Expect = 4e-21
Identities = 36/175 (20%), Positives = 71/175 (40%), Gaps = 25/175 (14%)
Query: 483 FQLSSKLGQGGFGPVYWG---RLKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHRN 538
+++ + GG G +Y + +G+ + +K L + + M E ++++ H +
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNV-NGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPS 140
Query: 539 LVRLL--GCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
+V++ + + Y EY+ +SL ++L + + I L
Sbjct: 141 IVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSK-----GQKLPVAEAIAYLLEILPAL 195
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
YLH + +++ DLK NI+L EE K+ D G G + GT
Sbjct: 196 SYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRIN------SFGYLYGT 240
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 93.0 bits (232), Expect = 4e-21
Identities = 44/162 (27%), Positives = 79/162 (48%), Gaps = 20/162 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEF--------MNEVMVIS 532
+ K+G+G +G VY + G+ A+K++ LE+ + E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
+L+H N+V+L + +L++E++ L LL K F + + G
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSF--LLQLLNG 112
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+ Y H R++HRDLK N+L++ E KI+DFG+A+ FG
Sbjct: 113 IAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG 151
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 93.1 bits (232), Expect = 4e-21
Identities = 41/157 (26%), Positives = 72/157 (45%), Gaps = 17/157 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHR 537
++ + +LG+G +G V R GQ +AVKR+ + + Q + + ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISR 591
V G + + E M + SLD K+ +D + I I +
Sbjct: 67 FTVTFYGALFREGDVWICMELM-DTSLDKFY-----KQVIDKGQTIPEDILGKIAVSIVK 120
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628
L +LH S+L +IHRD+K SN+L++ K+ DFG
Sbjct: 121 ALEHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFG 155
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 95.1 bits (237), Expect = 5e-21
Identities = 43/171 (25%), Positives = 73/171 (42%), Gaps = 21/171 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--------FMNEVMV 530
+ + +S LG G G V + +++A++ +SK E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGI 589
+ KL H ++++ + E+ ++ E M L FD + +RL +
Sbjct: 194 LKKLNHPCIIKIKNF-FDAEDYYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQ 637
+ YLH IIHRDLK N+LL +E+ KI+DFG +KI G
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS 296
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 94.9 bits (236), Expect = 5e-21
Identities = 44/182 (24%), Positives = 83/182 (45%), Gaps = 24/182 (13%)
Query: 485 LSSKLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQGLE-EFMNEVMVISKLQHRNLV 540
K+G+G +G VY + KD ++ A+K++ G+ E+ ++ +L+H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEG---TGISMSACREIALLRELKHPNVI 81
Query: 541 RLLGCCVEGEEK--MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRG 592
L + ++ L+++Y L ++ + + ++ I G
Sbjct: 82 SLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGG-NQDQADTGRVVG 647
+ YLH + ++HRDLK +NIL+ E KI+D G A++F + AD VV
Sbjct: 141 IHYLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVV 197
Query: 648 TL 649
T
Sbjct: 198 TF 199
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 56/187 (29%), Positives = 97/187 (51%), Gaps = 29/187 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEF----MNEVMVISK 533
+ ++ +K+GQG FG V+ R K GQ++A+K + E F + E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK----EGFPITALREIKILQL 72
Query: 534 LQHRNLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
L+H N+V L+ C L++++ + L LL + L K L KR
Sbjct: 73 LKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRV-- 129
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD---T 642
++ + GL Y+HR+ +I+HRD+KA+N+L+ + K++DFG+A+ F ++ T
Sbjct: 130 MQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYT 186
Query: 643 GRVVGTL 649
RVV TL
Sbjct: 187 NRVV-TL 192
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 91.9 bits (229), Expect = 9e-21
Identities = 52/181 (28%), Positives = 83/181 (45%), Gaps = 22/181 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 532
+++++ +LG G F V R K G+E A K + K G EE EV ++
Sbjct: 4 EDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR 63
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
+++H N++ L + +LI E + LFD L +KE L + ++ I
Sbjct: 64 EIRHPNIITLHDIFENKTDVVLILELVSGGE----LFDFLAEKESLTEDEATQFLKQILD 119
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
G+ YLH RI H DLK NI+L ++ P K+ DFG+A + + + G
Sbjct: 120 GVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN---IFG 173
Query: 648 T 648
T
Sbjct: 174 T 174
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 1e-20
Identities = 45/176 (25%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
++N+ + +LG+G F V K G E A K ++ S + ++ E + KLQH
Sbjct: 28 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 87
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLY 595
N+VRL E L+++ + LF+ + +E + I+ I + Y
Sbjct: 88 PNIVRLHDSIQEESFHYLVFDLVTGGE----LFEDIVAREFYSEADASHCIQQILESIAY 143
Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H I+HR+LK N+LL + K++DFG+A ++ GT
Sbjct: 144 CH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG---FAGT 193
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 92.6 bits (231), Expect = 1e-20
Identities = 54/192 (28%), Positives = 88/192 (45%), Gaps = 41/192 (21%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQGLEEFMN-----EVM 529
++++ F+ KLG G + VY G G +A+K +L EE E+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS------EEGTPSTAIREIS 55
Query: 530 VISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
++ +L+H N+VRL + L++E+M D LKK +D R N G+
Sbjct: 56 LMKELKHENIVRLYDVIHTENKLTLVFEFM---DND------LKKY-MDSRTVGNTPRGL 105
Query: 590 S------------RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
+GL + H + +I+HRDLK N+L+++ K+ DFG+A+ F G
Sbjct: 106 ELNLVKYFQWQLLQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIP 161
Query: 638 DQADTGRVVGTL 649
+ VV TL
Sbjct: 162 VNTFSSEVV-TL 172
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 1e-20
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 532
+ + + +LG G F V R K G E A K + K G EE EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR 70
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
++ H N++ L + +LI E + LFD L +KE L + + I+ I
Sbjct: 71 QVLHHNVITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
G+ YLH +I H DLK NI+L ++ P K+ DFG+A + + + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 648 T 648
T
Sbjct: 181 T 181
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 91.5 bits (228), Expect = 1e-20
Identities = 50/173 (28%), Positives = 75/173 (43%), Gaps = 17/173 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQG-LEEFMNEVMVISKLQHRN 538
+++ KLG GG VY ++A+K + + L+ F EV S+L H+N
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQN 72
Query: 539 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
+V ++ EE Y EY+ +L + L N I G+ +
Sbjct: 73 IVSMI---DVDEEDDCYYLVMEYIEGPTLSEYI---ESHGPLSVDTAINFTNQILDGIKH 126
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
H +RI+HRD+K NIL+D KI DFG+AK T V+GT
Sbjct: 127 AHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETS-LTQTNHVLGT 175
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 2e-20
Identities = 52/181 (28%), Positives = 80/181 (44%), Gaps = 22/181 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKAS------GQGLEEFMNEVMVIS 532
+ + + +LG G F V R K G E A K + K G EE EV ++
Sbjct: 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR 70
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
++ H N++ L + +LI E + LFD L +KE L + + I+ I
Sbjct: 71 QVLHPNIITLHDVYENRTDVVLILELVSGGE----LFDFLAQKESLSEEEATSFIKQILD 126
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
G+ YLH +I H DLK NI+L ++ P K+ DFG+A + + + G
Sbjct: 127 GVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKN---IFG 180
Query: 648 T 648
T
Sbjct: 181 T 181
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 91.6 bits (228), Expect = 2e-20
Identities = 45/176 (25%), Positives = 70/176 (39%), Gaps = 28/176 (15%)
Query: 489 LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCC 546
LG+G V QE AVK + K G EV ++ + Q HRN++ L+
Sbjct: 21 LGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFF 80
Query: 547 VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRDS 600
E + L++E M S+ + R+ FN +++ ++ L +LH
Sbjct: 81 EEEDRFYLVFEKMRGGSI----LS-----HIHKRRHFNELEASVVVQDVASALDFLHN-- 129
Query: 601 RLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGR-----VVGT 648
I HRDLK NIL ++ KI DF + N D + G+
Sbjct: 130 -KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGS 184
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 93.2 bits (231), Expect = 2e-20
Identities = 30/194 (15%), Positives = 55/194 (28%), Gaps = 38/194 (19%)
Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH-------- 536
LGQ + G+ V +++ EV+ + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 537 --------RNLVRLLGCC-----VEGEEKMLIYEY---MPNRS------LDALLFDPLKK 574
+LV+ E M + P + LL
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+ L R + + R L LH ++H L+ +I+LD+ ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 635 GNQDQADTGRVVGT 648
+ + GR
Sbjct: 263 ASA-VSPIGRGFAP 275
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 94.2 bits (234), Expect = 3e-20
Identities = 52/178 (29%), Positives = 81/178 (45%), Gaps = 23/178 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMV---ISK 533
N+F + +G+GGFG VY R D ++ A+K L K QG +NE ++ +S
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGIS 590
+V + +K+ I + M L L + + + RF E I
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDL----HYHLSQHGVFSEADMRFYAAE-II 302
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
GL ++H +++RDLK +NILLDE + +ISD G+A F + VGT
Sbjct: 303 LGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGT 353
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 3e-20
Identities = 42/171 (24%), Positives = 73/171 (42%), Gaps = 34/171 (19%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRN 538
+ +G G FG V+ +L + E+A+K++ + + F N E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 539 LVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG---- 588
+V L +K L+ EY+P + + + + K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP---------ETVYRASRHYAKLKQTMPMLLIK 144
Query: 589 -----ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIF 633
+ R L Y+H + I HRD+K N+LLD K+ DFG AKI
Sbjct: 145 LYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 50/166 (30%), Positives = 75/166 (45%), Gaps = 18/166 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
N F+ LG+GGFG V +++ ++ A K+L K +G +NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW----RKRFNIIEGISR 591
R +V L E ++ + L+ M L + R F E I
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDL----KFHIYHMGQAGFPEARAVFYAAE-ICC 297
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
GL LHR RI++RDLK NILLD+ + +ISD G+A Q
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ 340
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 47/167 (28%), Positives = 74/167 (44%), Gaps = 25/167 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN------EVMVISKL 534
+Q+ LG GGFG VY G + D +A+K + K E N EV+++ K+
Sbjct: 44 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 103
Query: 535 QHR--NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-IIE 587
++RLL + +LI E P D LFD + ++ L R F ++E
Sbjct: 104 SSGFSGVIRLLDWFERPDSFVLILER-PEPVQD--LFDFITERGALQEELARSFFWQVLE 160
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIF 633
+ + H ++HRD+K NIL+D K+ DFG +
Sbjct: 161 AVR----HCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL 200
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 44/163 (26%), Positives = 82/163 (50%), Gaps = 20/163 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 531
NFQ K+G+G +G VY R G+ +A+K++ L+ + E+ ++
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
+L H N+V+LL + L++E++ + L + D + + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFM-DASALTGIPLPLIKSYLFQLLQ 114
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
GL + H R++HRDLK N+L++ E K++DFG+A+ FG
Sbjct: 115 GLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG 154
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 4e-20
Identities = 37/163 (22%), Positives = 79/163 (48%), Gaps = 21/163 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 531
++ K+G+G +G V+ + + + +A+KR+ L++ + E+ ++
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
+L+H+N+VRL ++ L++E+ L + K F + + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSF--LFQLLK 112
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
GL + H ++HRDLK N+L++ K+++FG+A+ FG
Sbjct: 113 GLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG 152
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 46/162 (28%), Positives = 77/162 (47%), Gaps = 20/162 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE-------FMNEVMVIS 532
+ KLG+G + VY G+ K +A+K + LE + EV ++
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIR------LEHEEGAPCTAIREVSLLK 55
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592
L+H N+V L + L++EY+ ++ L L D + K F + + RG
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNIINMHNVKLF--LFQLLRG 112
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
L Y HR +++HRDLK N+L++E K++DFG+A+
Sbjct: 113 LAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS 151
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 5e-20
Identities = 43/217 (19%), Positives = 70/217 (32%), Gaps = 52/217 (23%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK-----RLSKASGQGLEEFMNEVMVISK 533
+ L +GQG +G V A+K ++ + + + +E EV ++ K
Sbjct: 25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKK 84
Query: 534 LQHRNLVRLLGCCVEGEEKM-LIYEYM-------------------------------PN 561
L H N+ RL E E+ + L+ E
Sbjct: 85 LHHPNIARLYEVY-EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCP 143
Query: 562 RSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615
+ + + R I+ I L YLH I HRD+K N L
Sbjct: 144 ECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPENFL 200
Query: 616 L--DEELNPKISDFGMAKIFGGNQ--DQADTGRVVGT 648
++ K+ DFG++K F + GT
Sbjct: 201 FSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGT 237
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 90.8 bits (226), Expect = 5e-20
Identities = 33/174 (18%), Positives = 69/174 (39%), Gaps = 16/174 (9%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ ++ LG+G FG V+ + K + G E+ +++ +HRN
Sbjct: 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL--KKERLDWRKRFNIIEGISRGLLYL 596
++ L EE ++I+E++ +F+ + L+ R+ + + + L +L
Sbjct: 63 ILHLHESFESMEELVMIFEFISGLD----IFERINTSAFELNEREIVSYVHQVCEALQFL 118
Query: 597 HRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQDQADTGRVVGT 648
H I H D++ NI+ + KI +FG A+ + +
Sbjct: 119 H---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL---LFTA 166
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 91.2 bits (226), Expect = 5e-20
Identities = 25/175 (14%), Positives = 49/175 (28%), Gaps = 30/175 (17%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQGLEEFMNEVMVISK 533
+ + LG+G F VY D Q+ +K A+ + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIE 587
++ + +L+ E + L + + + K
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGT----LLNAINLYKNTPEKVMPQGLVISFAM 179
Query: 588 GISRGLLYLHRDSRLRIIHRDLKASNILL-----------DEELNPKISDFGMAK 631
+ + +H IIH D+K N +L D + D G +
Sbjct: 180 RMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 7e-20
Identities = 45/162 (27%), Positives = 78/162 (48%), Gaps = 22/162 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
++ L LG G FG V G G ++AVK L++ S + + E+ + +H
Sbjct: 12 HYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHP 71
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
++++L + ++ EY+ L FD + K R+ + R+ F I+ +
Sbjct: 72 HIIKLYQV-ISTPTDFFMVMEYVSGGEL----FDYICKHGRVEEMEARRLFQQILSAVD- 125
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
Y HR ++HRDLK N+LLD +N KI+DFG++ +
Sbjct: 126 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 161
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 89.9 bits (224), Expect = 8e-20
Identities = 38/157 (24%), Positives = 76/157 (48%), Gaps = 9/157 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN--EVMVISKLQHR 537
++ K+G+G +G V+ R +D GQ +A+K+ ++ + + + E+ ++ +L+H
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
NLV LL L++EY + ++ L + + +I + + + H
Sbjct: 63 NLVNLLEVFRRKRRLHLVFEYC-DHTVLHELDR--YQRGVPEHLVKSITWQTLQAVNFCH 119
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+ IHRD+K NIL+ + K+ DFG A++
Sbjct: 120 KH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT 153
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 9e-20
Identities = 52/181 (28%), Positives = 79/181 (43%), Gaps = 22/181 (12%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA------SGQGLEEFMNEVMVIS 532
+ + +LG G F V R K G + A K + K G E+ EV ++
Sbjct: 10 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK 69
Query: 533 KLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISR 591
++QH N++ L + +LI E + LFD L +KE L + ++ I
Sbjct: 70 EIQHPNVITLHEVYENKTDVILILELVAGGE----LFDFLAEKESLTEEEATEFLKQILN 125
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVG 647
G+ YLH L+I H DLK NI+L + P KI DFG+A + + + G
Sbjct: 126 GVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN---IFG 179
Query: 648 T 648
T
Sbjct: 180 T 180
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 9e-20
Identities = 47/176 (26%), Positives = 77/176 (43%), Gaps = 17/176 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK--RLSKASGQG-LEEFMNEVMVISKLQHRN 538
++L LG GG V+ R L+D +++AVK R A F E + L H
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPA 73
Query: 539 LVRLL--GCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
+V + G E L Y EY+ +L ++ + + ++ +I + L
Sbjct: 74 IVAVYDTGE-AETPAGPLPYIVMEYVDGVTLRDIV---HTEGPMTPKRAIEVIADACQAL 129
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK-IFGGNQDQADTGRVVGT 648
+ H+ IIHRD+K +NI++ K+ DFG+A+ I T V+GT
Sbjct: 130 NFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 182
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 91.2 bits (227), Expect = 1e-19
Identities = 45/181 (24%), Positives = 75/181 (41%), Gaps = 26/181 (14%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEE--FMNEVMVISKLQH 536
T +QL +LG+G F V GQE A ++ + E + L+H
Sbjct: 10 TEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKH 69
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGIS 590
N+VRL E LI++ + LF+ + R+ + + I+ I
Sbjct: 70 PNIVRLHDSISEEGHHYLIFDLVTGGE----LFE-----DIVAREYYSEADASHCIQQIL 120
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
+L+ H ++ ++HR+LK N+LL + K++DFG+A G Q G
Sbjct: 121 EAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FAG 175
Query: 648 T 648
T
Sbjct: 176 T 176
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 91.4 bits (227), Expect = 1e-19
Identities = 47/162 (29%), Positives = 81/162 (50%), Gaps = 22/162 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
++ L LG G FG V G+ G ++AVK L++ S + + E+ + +H
Sbjct: 17 HYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHP 76
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
++++L + + ++ EY+ L FD + K RL + R+ F I+ G+
Sbjct: 77 HIIKLYQV-ISTPSDIFMVMEYVSGGEL----FDYICKNGRLDEKESRRLFQQILSGVD- 130
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
Y HR ++HRDLK N+LLD +N KI+DFG++ +
Sbjct: 131 ---YCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMM 166
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 90.5 bits (225), Expect = 2e-19
Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 37/185 (20%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHR 537
++ + +G G FG VY +L D G+ +A+K++ + + F N E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 538 NLVRLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG--- 588
N+VRL EK L+ +Y+P + + + + + +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP---------ETVYRVARHYSRAKQTLPVIYV 158
Query: 589 ------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQDQAD 641
+ R L Y+H I HRD+K N+LLD + K+ DFG AK + + +
Sbjct: 159 KLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPN 213
Query: 642 TGRVV 646
+
Sbjct: 214 VSYIC 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 89.2 bits (222), Expect = 2e-19
Identities = 45/176 (25%), Positives = 79/176 (44%), Gaps = 19/176 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVK--RLSKASGQGLEEF----MNEVMVISK 533
++ +G+G +G V R KD G+ +A+K S + M E+ ++ +
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDD----KMVKKIAMREIKLLKQ 80
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
L+H NLV LL C + + L++E++ + ++ L LD++ + I G+
Sbjct: 81 LRHENLVNLLEVCKKKKRWYLVFEFV-DHTILDDLEL--FPNGLDYQVVQKYLFQIINGI 137
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+ H IIHRD+K NIL+ + K+ DFG A+ + V T
Sbjct: 138 GFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAA-PGEVYDDEVA-TR 188
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 88.8 bits (221), Expect = 2e-19
Identities = 49/174 (28%), Positives = 75/174 (43%), Gaps = 39/174 (22%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEF--------MNEVMVI 531
+ ++ +KLG+G +G VY + +A+KR+ LE + EV ++
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 532 SKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS- 590
+LQHRN++ L LI+EY D LKK +D ++ S
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA---END------LKK-YMDKNPDVSMRVIKSF 137
Query: 591 -----RGLLYLHRDSRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIFG 634
G+ + H R +HRDLK N+LL KI DFG+A+ FG
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG 188
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 2e-19
Identities = 50/200 (25%), Positives = 82/200 (41%), Gaps = 28/200 (14%)
Query: 460 VNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASG 518
+ TV + + T+ +++ +G G + K E AVK + K+
Sbjct: 1 MQTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR 60
Query: 519 QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
EE E++ + QH N++ L +G+ ++ E M L D ++
Sbjct: 61 DPTEE--IEIL-LRYGQHPNIITLKDVYDDGKYVYVVTELMKGGEL----LD-----KIL 108
Query: 579 WRKRFN------IIEGISRGLLYLHRDSRLRIIHRDLKASNILL-DEELNP---KISDFG 628
+K F+ ++ I++ + YLH ++HRDLK SNIL DE NP +I DFG
Sbjct: 109 RQKFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFG 165
Query: 629 MAKIFGGNQDQADTGRVVGT 648
AK T T
Sbjct: 166 FAKQLRAENGLLMT--PCYT 183
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 88.2 bits (219), Expect = 3e-19
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 8/153 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRL-SKASGQGLEEFMNEVMVISKL-QHR 537
N+ + ++G G G V+ R + G IAVK++ + + + + ++ V+ K
Sbjct: 25 NDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCP 84
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
+V+ G + + + E M + + + R + I + L YL
Sbjct: 85 YIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRMQGPIPERILGKMTVAIVKALYYLK 141
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
+ +IHRD+K SNILLDE K+ DFG++
Sbjct: 142 --EKHGVIHRDVKPSNILLDERGQIKLCDFGIS 172
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 3e-19
Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 23/162 (14%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
+ + LG+G FG V K Q++A+K +S+ E+ + L+H
Sbjct: 10 PYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHP 69
Query: 538 NLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISR 591
++++L + + ++ EY LFD + +K+R+ + R+ F II I
Sbjct: 70 HIIKLYDV-ITTPTDIVMVIEYAGGE-----LFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
Y HR +I+HRDLK N+LLD+ LN KI+DFG++ I
Sbjct: 123 ---YCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIM 158
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 88.5 bits (219), Expect = 4e-19
Identities = 25/180 (13%), Positives = 52/180 (28%), Gaps = 37/180 (20%)
Query: 489 LGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQ--------- 535
LGQ + G+ V +++ EV+ + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 536 ----------------HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-----KK 574
+ ++R+ + + Y +S + L
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 200
Query: 575 ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+ L R + + R L LH ++H L+ +I+LD+ ++ F G
Sbjct: 201 KSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 6e-19
Identities = 44/164 (26%), Positives = 76/164 (46%), Gaps = 16/164 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
++F++ +G+G FG V + D +++ A+K ++K E E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
LV L + EE M ++ + + L L++ + + I E + L
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDL----RYHLQQNVHFKEETVKLFICE-LVMAL 128
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
YL RIIHRD+K NILLDE + I+DF +A +
Sbjct: 129 DYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRET 169
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 9e-19
Identities = 48/169 (28%), Positives = 74/169 (43%), Gaps = 27/169 (15%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN------EV----MV 530
++L LG+GGFG V+ G L D ++A+K + + G + EV V
Sbjct: 32 EYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV 91
Query: 531 ISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLD---WRKRFN-I 585
+ H ++RLL E ML+ E P + D LFD + +K L R F +
Sbjct: 92 GAGGGHPGVIRLLDWFETQEGFMLVLER-PLPAQD--LFDYITEKGPLGEGPSRCFFGQV 148
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIF 633
+ I + H ++HRD+K NIL+D K+ DFG +
Sbjct: 149 VAAIQ----HCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALL 190
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 86.6 bits (215), Expect = 1e-18
Identities = 47/179 (26%), Positives = 79/179 (44%), Gaps = 27/179 (15%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
++ F++ S+LG+G VY + K + A+K L K + + E+ V+ +L H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF------NIIEGISRG 592
+++L E L+ E + L FD R+ + + + ++ I
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGEL----FD-----RIVEKGYYSERDAADAVKQILEA 160
Query: 593 LLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ YLH I+HRDLK N+L + KI+DFG++KI V GT
Sbjct: 161 VAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKT---VCGT 213
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 86.1 bits (214), Expect = 1e-18
Identities = 48/170 (28%), Positives = 83/170 (48%), Gaps = 19/170 (11%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEF----MNEVMVIS 532
AT+ ++ +++G G +G VY R G +A+K + G G + EV ++
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 533 KLQ---HRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFN 584
+L+ H N+VRL+ C L++E++ ++ L L D L +
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 585 IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
++ RGL +LH + I+HRDLK NIL+ K++DFG+A+I+
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYS 171
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 42/174 (24%), Positives = 69/174 (39%), Gaps = 17/174 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQG-LEEFMNEVMVISKLQHRN 538
++L +G+GG G VY + +A+K +S+ +S E +LQ +
Sbjct: 36 YRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPH 95
Query: 539 LVRLLGCCVEGEEKMLIY---EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
+V + GE +Y + L A+L ++ L + I+ I L
Sbjct: 96 VVPIHD---FGEIDGQLYVDMRLINGVDLAAML---RRQGPLAPPRAVAIVRQIGSALDA 149
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
H HRD+K NIL+ + + DFG+A + G VGTL
Sbjct: 150 AHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEK-LTQLGNTVGTL 199
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 54/213 (25%), Positives = 83/213 (38%), Gaps = 32/213 (15%)
Query: 447 KRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSK-LGQGGFGPVYWGRLKD- 504
L N+ +++ N + L+SK LG+G F V K
Sbjct: 5 HHHSSGVDLGTENLYFQSMENF-----------NNFYILTSKELGRGKFAVVRQCISKST 53
Query: 505 GQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR-NLVRLLGCCVEGEEKMLIYEYMPN 561
GQE A K L K E ++E+ V+ + ++ L E +LI EY
Sbjct: 54 GQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAG 113
Query: 562 RSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-- 616
+ F E + +I+ I G+ YLH+ I+H DLK NILL
Sbjct: 114 GEI----FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSS 166
Query: 617 -DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ KI DFGM++ G + + ++GT
Sbjct: 167 IYPLGDIKIVDFGMSRKIGHACELRE---IMGT 196
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 3e-18
Identities = 48/196 (24%), Positives = 84/196 (42%), Gaps = 29/196 (14%)
Query: 447 KRKEVIAKLSATNVNTVKLQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQ 506
+++ + K + NT +L F+ + T LG G FG V + K+
Sbjct: 22 AKEDFLKKWETPSQNTAQLDQ-----FDRIKT----------LGTGSFGRVMLVKHKESG 66
Query: 507 EI-AVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNR 562
A+K L K + +E +NE ++ + LV+L + ++ EY+
Sbjct: 67 NHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 563 SLDALLFDPLKKERL--DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620
+ F L++ + RF + I YLH L +I+RDLK N+L+D++
Sbjct: 127 EM----FSHLRRIGRFSEPHARFYAAQ-IVLTFEYLHS---LDLIYRDLKPENLLIDQQG 178
Query: 621 NPKISDFGMAKIFGGN 636
+++DFG AK G
Sbjct: 179 YIQVTDFGFAKRVKGR 194
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 85.0 bits (211), Expect = 3e-18
Identities = 41/172 (23%), Positives = 69/172 (40%), Gaps = 28/172 (16%)
Query: 488 KLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGC 545
LG+G F K Q AVK +SK E+ + + H N+V+L
Sbjct: 18 PLGEGSFSICRKCVHKKSNQAFAVKIISKRM---EANTQKEITALKLCEGHPNIVKLHEV 74
Query: 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------IIEGISRGLLYLHRD 599
+ L+ E + L F+ R+ +K F+ I+ + + ++H
Sbjct: 75 FHDQLHTFLVMELLNGGEL----FE-----RIKKKKHFSETEASYIMRKLVSAVSHMHD- 124
Query: 600 SRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ ++HRDLK N+L ++ L KI DFG A++ + T T
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFT 172
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 84.9 bits (211), Expect = 3e-18
Identities = 49/161 (30%), Positives = 79/161 (49%), Gaps = 14/161 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
+FQ+ LG G FG V+ R + A+K L K L++ +E +++S + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGLL 594
++R+ G + ++ +I +Y+ L F L+K + + +F E + L
Sbjct: 66 PFIIRMWGTFQDAQQIFMIMDYIEGGEL----FSLLRKSQRFPNPVAKFYAAE-VCLALE 120
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635
YLH II+RDLK NILLD+ + KI+DFG AK
Sbjct: 121 YLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 84.5 bits (209), Expect = 7e-18
Identities = 41/218 (18%), Positives = 68/218 (31%), Gaps = 56/218 (25%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
+F+ +G+GGFG V+ + K D A+KR+ E+ M EV ++KL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNII------------ 586
+VR +E + E D PL I
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 587 ---------------EGISRGLLYLHRDSRL---------------------------RI 604
+ + L + R +
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 605 IHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+HRDLK SNI + K+ DFG+ ++++
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTV 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 85.1 bits (211), Expect = 8e-18
Identities = 42/173 (24%), Positives = 73/173 (42%), Gaps = 14/173 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
++++ +G+G FG V R K +++ A+K LSK + F E +++
Sbjct: 69 EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 128
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD-WRKRFNIIEGISRGLLY 595
+V+L + ++ EYMP L + + + RF E + L
Sbjct: 129 PWVVQLFYAFQDDRYLYMVMEYMPGGDL----VNLMSNYDVPEKWARFYTAEVVL-ALDA 183
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+H + IHRD+K N+LLD+ + K++DFG VGT
Sbjct: 184 IHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE-GMVRCDTAVGT 232
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 3e-17
Identities = 44/161 (27%), Positives = 69/161 (42%), Gaps = 22/161 (13%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN-EVMVISKLQHRNL 539
+ +G G FG R + +AVK + + G ++E + E++ L+H N+
Sbjct: 21 RYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIER--GAAIDENVQREIINHRSLRHPNI 78
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERL---DWRKRFN-IIEGISRGLL 594
VR + +I EY L ++ + R + R F ++ G+S
Sbjct: 79 VRFKEVILTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS---- 130
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMAKIF 633
Y H ++I HRDLK N LLD P KI DFG +K
Sbjct: 131 YCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 3e-17
Identities = 50/169 (29%), Positives = 78/169 (46%), Gaps = 15/169 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
N F+ LG+G FG V + K A+K L K +E + E V+ +H
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRH 207
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
L L + +++ + EY L F L +ER+ + R RF E +S L
Sbjct: 208 PFLTALK-YSFQTHDRLCFVMEYANGGEL----FFHLSRERVFSEDRARFYGAEIVS-AL 261
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
YLH S +++RDLK N++LD++ + KI+DFG+ K + T
Sbjct: 262 DYLH--SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT 308
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 5e-17
Identities = 42/173 (24%), Positives = 77/173 (44%), Gaps = 12/173 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
++F++ +G+G F V ++K ++ A+K ++K + F E V+
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
R + +L + E + L+ EY L LL ++ + RF + E + +
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAE-MARFYLAEIVM-AIDS 177
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+HR L +HRD+K NILLD + +++DFG + + VGT
Sbjct: 178 VHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGT 226
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 8e-17
Identities = 46/172 (26%), Positives = 84/172 (48%), Gaps = 29/172 (16%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEI-AVKRLSKASGQGLEEFMN--------EVMV 530
++ +++G+G +G V+ R LK+G A+KR+ ++ EV V
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 531 ISKLQ---HRNLVRLLGCCVEGEEK-----MLIYEYMPNRSLDALLFDPLKKERLDWRKR 582
+ L+ H N+VRL C L++E++ ++ L L D + + +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
+++ + RGL +LH R++HRDLK NIL+ K++DFG+A+I+
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 9e-17
Identities = 44/177 (24%), Positives = 75/177 (42%), Gaps = 29/177 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ FQ+ GQG FG V G+ K G +A+K++ + E + ++ L H N
Sbjct: 22 MDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQ-IMQDLAVLHHPN 80
Query: 539 LVRLLGC-CVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG--- 588
+V+L GE ++ EY+P D L + ++ +R
Sbjct: 81 IVQLQSYFYTLGERDRRDIYLNVVMEYVP---------DTLHRCCRNYYRRQVAPPPILI 131
Query: 589 ------ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP-KISDFGMAKIFGGNQD 638
+ R + LH S + + HRD+K N+L++E K+ DFG AK ++
Sbjct: 132 KVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP 187
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 81.7 bits (202), Expect = 1e-16
Identities = 43/175 (24%), Positives = 77/175 (44%), Gaps = 16/175 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEE---FMNEVMVISKLQH 536
+F++ +G+G FG V +LK+ ++ A+K L+K E F E V+
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
+ + L + + + L+ +Y L LL K E + RF + E + +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLL---SKFEDRLPEEMARFYLAEMVI-AI 188
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+H+ L +HRD+K NIL+D + +++DFG + + VGT
Sbjct: 189 DSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGT 239
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 80.7 bits (200), Expect = 1e-16
Identities = 49/169 (28%), Positives = 76/169 (44%), Gaps = 16/169 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISKLQH 536
N+F LG+G FG V R K A+K L K +E + E V+ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRGL 593
L L + +++ + EY L F L +ER+ + R RF E I L
Sbjct: 65 PFLTALK-YAFQTHDRLCFVMEYANGGEL----FFHLSRERVFTEERARFYGAE-IVSAL 118
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
YLH +++RD+K N++LD++ + KI+DFG+ K + T
Sbjct: 119 EYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT 164
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 15/154 (9%), Positives = 49/154 (31%), Gaps = 16/154 (10%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD---GQEIAVKRL---SKASGQGLEEFMNEVMVISKLQH 536
++L G + D +++A+ + L+E ++ + +S++
Sbjct: 33 YRLLIFHGGVPPLQFWQAL--DTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDK 90
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+ R+L +++ E++ SL + ++ ++
Sbjct: 91 PGVARVLDVVHTRAGGLVVAEWIRGGSLQEVA-----DTSPSPVGAIRAMQSLAAAADAA 145
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
HR + S + + + + ++
Sbjct: 146 HRAG---VALSIDHPSRVRVSIDGDVVLAYPATM 176
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 5e-16
Identities = 50/173 (28%), Positives = 84/173 (48%), Gaps = 20/173 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVIS 532
F+L LG+GG+G V+ R + +I A+K L KA + E ++
Sbjct: 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE 76
Query: 533 KLQHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGI 589
+++H +V L+ + K+ LI EY+ L F L++E + + F + E I
Sbjct: 77 EVKHPFIVDLI-YAFQTGGKLYLILEYLSGGEL----FMQLEREGIFMEDTACFYLAE-I 130
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
S L +LH+ II+RDLK NI+L+ + + K++DFG+ K + T
Sbjct: 131 SMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT 180
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 78.0 bits (193), Expect = 8e-16
Identities = 53/171 (30%), Positives = 91/171 (53%), Gaps = 18/171 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS--GQGLEEFMNEVMVISKL 534
+ F+L LGQG FG V+ + D +++ A+K L KA+ + E ++ ++
Sbjct: 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEV 83
Query: 535 QHRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISR 591
H +V+L + E K+ LI +++ L F L KE + + +F + E ++
Sbjct: 84 NHPFIVKLH-YAFQTEGKLYLILDFLRGGDL----FTRLSKEVMFTEEDVKFYLAE-LAL 137
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L +LH L II+RDLK NILLDEE + K++DFG++K ++ +A +
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 185
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 78.1 bits (193), Expect = 1e-15
Identities = 54/159 (33%), Positives = 82/159 (51%), Gaps = 17/159 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISK-LQ 535
++F +G+G FG V R K + AVK L K + +E M+E V+ K ++
Sbjct: 38 SDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK 97
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
H LV L + +K+ + +Y+ L F L++ER L+ R RF E I+
Sbjct: 98 HPFLVGLH-FSFQTADKLYFVLDYINGGEL----FYHLQRERCFLEPRARFYAAE-IASA 151
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
L YLH L I++RDLK NILLD + + ++DFG+ K
Sbjct: 152 LGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCK 187
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.7 bits (192), Expect = 1e-15
Identities = 40/186 (21%), Positives = 69/186 (37%), Gaps = 30/186 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEE--FMN---------EV 528
+ + + + G +G V G +G +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 529 MVISKLQHRNLVRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL---DWR 580
+++ H N++ L E M L+ E M L + +R+
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-----RTDLAQVIHDQRIVISPQH 135
Query: 581 KRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQA 640
++ + I GL LH ++HRDL NILL + + I DF +A+ D
Sbjct: 136 IQY-FMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAR--EDTADAN 189
Query: 641 DTGRVV 646
T V
Sbjct: 190 KTHYVT 195
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 55/170 (32%), Positives = 83/170 (48%), Gaps = 17/170 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
+NF+ LG+G FG V R+K+ ++ AVK L K +E M E ++S
Sbjct: 23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
H L +L CC + +++ + E++ L ++K R + R RF E I
Sbjct: 83 HPFLTQLF-CCFQTPDRLFFVMEFVNGGDL----MFHIQKSRRFDEARARFYAAE-IISA 136
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L++LH II+RDLK N+LLD E + K++DFGM K N T
Sbjct: 137 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT 183
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 50/170 (29%), Positives = 76/170 (44%), Gaps = 17/170 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKASGQGLEEF---MNEVMVISK-LQ 535
+F L LG+G FG V+ K + A+K L K ++ M E V+S +
Sbjct: 17 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 76
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
H L + C + +E + + EY+ L ++ R F E I G
Sbjct: 77 HPFLTHMF-CTFQTKENLFFVMEYLNGGDL----MYHIQSCHKFDLSRATFYAAE-IILG 130
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L +LH I++RDLK NILLD++ + KI+DFGM K + +T
Sbjct: 131 LQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT 177
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 3e-15
Identities = 51/170 (30%), Positives = 77/170 (45%), Gaps = 17/170 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
+F L +G+G + V RLK I A+K + K + ++ E V +
Sbjct: 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASN 68
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
H LV L C + E ++ + EY+ L ++++R + RF E IS
Sbjct: 69 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAE-ISLA 122
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L YLH II+RDLK N+LLD E + K++D+GM K D T
Sbjct: 123 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 169
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 4e-15
Identities = 34/180 (18%), Positives = 79/180 (43%), Gaps = 33/180 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+ +++ +G G +G V + + +A+K++ + F + E+
Sbjct: 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-------FEDLIDCKRILREIA 104
Query: 530 VISKLQHRNLVRLLG-CCVEGEEKM----LIYEYMPNRSLDALL--FDPLKKERLDWRKR 582
++++L H ++V++L + EK ++ E L L + +
Sbjct: 105 ILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SDFKKLFRTPVYLTELH----IK 159
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
++ + G+ Y+H S I+HRDLK +N L++++ + K+ DFG+A+ ++
Sbjct: 160 T-LLYNLLVGVKYVH--SA-GILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQ 215
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 36/173 (20%), Positives = 77/173 (44%), Gaps = 32/173 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+ + +G G +G V + G+++A+K+LS+ F + E++
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRP-------FQSEIFAKRAYRELL 75
Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
++ +QH N++ LL + L+ +M L + + + + ++
Sbjct: 76 LLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFM-----QTDLQKIMGLKFSEEKIQY 130
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
++ + +GL Y+H ++HRDLK N+ ++E+ KI DFG+A+
Sbjct: 131 -LVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 50/170 (29%), Positives = 77/170 (45%), Gaps = 17/170 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
+F L +G+G + V RLK I A++ + K + ++ E V +
Sbjct: 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASN 111
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
H LV L C + E ++ + EY+ L ++++R + RF E IS
Sbjct: 112 HPFLVGLH-SCFQTESRLFFVIEYVNGGDL----MFHMQRQRKLPEEHARFYSAE-ISLA 165
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L YLH II+RDLK N+LLD E + K++D+GM K D T
Sbjct: 166 LNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST 212
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 6e-15
Identities = 42/174 (24%), Positives = 70/174 (40%), Gaps = 31/174 (17%)
Query: 480 TNNFQLSSK-LGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H 536
T+++QLS + LG G G V + GQ+ A+K L + + EV +
Sbjct: 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-----PKARQEVDHHWQASGG 81
Query: 537 RNLVRLLGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDWRKRFN------II 586
++V +L +I E M L F +++ + F I+
Sbjct: 82 PHIVCILDVYENMHHGKRCLLIIMECMEGGEL----FSRIQERG---DQAFTEREAAEIM 134
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQ 637
I + +LH I HRD+K N+L +++ K++DFG AK N
Sbjct: 135 RDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA 185
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 77.0 bits (189), Expect = 8e-15
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
+F LG+G FG V K E+ AVK L K +E M E V++ +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 400
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKER--LDWRKRFNIIEGISRG 592
L +L C + +++ + EY+ L +++ + F E I+ G
Sbjct: 401 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAE-IAIG 454
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L +L II+RDLK N++LD E + KI+DFGM K + T
Sbjct: 455 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 501
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 75.5 bits (186), Expect = 9e-15
Identities = 37/176 (21%), Positives = 62/176 (35%), Gaps = 27/176 (15%)
Query: 485 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRL 542
S LG G G V K ++ A+K L + EV + + ++VR+
Sbjct: 66 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 120
Query: 543 LGCCVEGEEKM----LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLY 595
+ ++ E + L F ++ R+ I++ I + Y
Sbjct: 121 VDVYENLYAGRKCLLIVMECLDGGEL----FSRIQDRGDQAFTEREASEIMKSIGEAIQY 176
Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
LH + I HRD+K N+L K++DFG AK + T
Sbjct: 177 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT---PCYT 226
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 48/170 (28%), Positives = 74/170 (43%), Gaps = 17/170 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI-AVKRLSKA---SGQGLEEFMNEVMVISK-LQ 535
+F LG+G FG V K E+ AVK L K +E M E V++ +
Sbjct: 20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGK 79
Query: 536 HRNLVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEGISRG 592
L +L C + +++ + EY+ L +++ + F E I+ G
Sbjct: 80 PPFLTQLH-SCFQTMDRLYFVMEYVNGGDL----MYHIQQVGRFKEPHAVFYAAE-IAIG 133
Query: 593 LLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
L +L II+RDLK N++LD E + KI+DFGM K + T
Sbjct: 134 LFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT 180
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 74.3 bits (183), Expect = 2e-14
Identities = 44/174 (25%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+Q +G G G V + +A+K+LS+ F N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRP-------FQNQTHAKRAYRELV 76
Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
++ + H+N++ LL E ++ ++ E M DA L ++ E R +
Sbjct: 77 LMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELM-----DANLCQVIQMELDHERMSY 131
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
++ + G+ +LH IIHRDLK SNI++ + KI DFG+A+ G +
Sbjct: 132 -LLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 44/185 (23%), Positives = 82/185 (44%), Gaps = 35/185 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+ S +G+G +G V + +A+K++S F + E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 530 VISKLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRF 583
++ + +H N++ + E+M ++ + M + L+ LK + L + +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLM-----ETDLYKLLKTQHLSNDHICY 132
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-- 641
+ I RGL Y+H S ++HRDLK SN+LL+ + KI DFG+A++ + D
Sbjct: 133 -FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFL 188
Query: 642 TGRVV 646
T V
Sbjct: 189 TEYVA 193
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 3e-14
Identities = 45/174 (25%), Positives = 77/174 (44%), Gaps = 32/174 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+Q +G G G V + +A+K+LS+ F N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRP-------FQNQTHAKRAYRELV 113
Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRF 583
++ + H+N++ LL E ++ L+ E M DA L ++ E R +
Sbjct: 114 LMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELM-----DANLCQVIQMELDHERMSY 168
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
+ + + G+ +LH IIHRDLK SNI++ + KI DFG+A+ G +
Sbjct: 169 LLYQ-MLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 218
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 41/172 (23%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HR 537
+++QL KLG+G + V+ + + +++ VK L + + E+ ++ L+
Sbjct: 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKK---KIKREIKILENLRGGP 91
Query: 538 NLVRLLGCCVEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
N++ L + + L++E++ N L + L + RF + E I + L Y
Sbjct: 92 NIITLADIVKDPVSRTPALVFEHVNNTDFKQL-YQTLTDYDI----RFYMYE-ILKALDY 145
Query: 596 LHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQDQADTGRVV 646
H S I+HRD+K N+++D E ++ D+G+A+ + Q RV
Sbjct: 146 CH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAE--FYHPGQEYNVRVA 192
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 49/163 (30%), Positives = 77/163 (47%), Gaps = 21/163 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR---LKDGQEI-AVKRLSKAS----GQGLEEFMNEVMVIS 532
NF+L LG G +G V+ R D ++ A+K L KA+ + E E V+
Sbjct: 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 113
Query: 533 KLQHRN-LVRLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERL--DWRKRFNIIEG 588
++ LV L + E K+ LI +Y+ L F L + + + + E
Sbjct: 114 HIRQSPFLVTLH-YAFQTETKLHLILDYINGGEL----FTHLSQRERFTEHEVQIYVGE- 167
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
I L +LH+ L II+RD+K NILLD + ++DFG++K
Sbjct: 168 IVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSK 207
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 71.9 bits (177), Expect = 6e-14
Identities = 38/159 (23%), Positives = 64/159 (40%), Gaps = 24/159 (15%)
Query: 485 LSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRL 542
S LG G G V K ++ A+K L + EV + + Q ++VR+
Sbjct: 22 TSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCPHIVRI 76
Query: 543 LGCC---VEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDW---RKRFNIIEGISRGLLY 595
+ G + + ++ E + LF ++ R+ I++ I + Y
Sbjct: 77 VDVYENLYAGRKCLLIVMECLD----GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQY 132
Query: 596 LHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAK 631
LH + I HRD+K N+L K++DFG AK
Sbjct: 133 LHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 72.4 bits (178), Expect = 8e-14
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 33/174 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
++ +G G +G V + G ++A+K+L + F + E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRP-------FQSELFAKRAYRELR 76
Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKR 582
++ ++H N++ LL + + L+ +M L +K E+L + R +
Sbjct: 77 LLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-----GTDLGKLMKHEKLGEDRIQ 131
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
F ++ + +GL Y+H IIHRDLK N+ ++E+ KI DFG+A+
Sbjct: 132 F-LVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 44/195 (22%), Positives = 82/195 (42%), Gaps = 46/195 (23%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+ + LG GG G V+ + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 530 VISKLQHRNLVRLL--------------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE 575
+I +L H N+V++ G E ++ EYM + L + L++
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYM-----ETDLANVLEQG 115
Query: 576 RL-DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIF 633
L + R + + RGL Y+H + ++HRDLK +N+ ++ E+L KI DFG+A+I
Sbjct: 116 PLLEEHARL-FMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 634 GGNQDQAD--TGRVV 646
+ + +V
Sbjct: 172 DPHYSHKGHLSEGLV 186
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 1e-13
Identities = 40/189 (21%), Positives = 82/189 (43%), Gaps = 33/189 (17%)
Query: 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN--- 526
FQ + +N+ + +G+G +G VY + +A+K++++ F +
Sbjct: 16 FQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-------FEDLID 68
Query: 527 ------EVMVISKLQHRNLVRLLGCCV-EGEEKM----LIYEYMPNRSLDALL--FDPLK 573
E+ ++++L+ ++RL + + K ++ E L L L
Sbjct: 69 CKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLT 127
Query: 574 KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633
+E + I+ + G ++H IIHRDLK +N LL+++ + K+ DFG+A+
Sbjct: 128 EEH----IKT-ILYNLLLGENFIH--ES-GIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 634 GGNQDQADT 642
+D
Sbjct: 180 NSEKDTNIV 188
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 3e-13
Identities = 36/202 (17%), Positives = 72/202 (35%), Gaps = 49/202 (24%)
Query: 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMN-EVMVISKLQ 535
T++ + L LG G FG V + G+ A+K++ + + N E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 536 HRNLVRLLGC----CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN------- 584
H N+++L+ E + + + K + +
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 585 --------IIEGIS-------------------RGLLYLHRDSRLRIIHRDLKASNILLD 617
+++ R + ++H L I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 618 EELNP-KISDFGMAKIFGGNQD 638
+ N K+ DFG AK ++
Sbjct: 176 SKDNTLKLCDFGSAKKLIPSEP 197
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 51/168 (30%), Positives = 79/168 (47%), Gaps = 33/168 (19%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+Q S +G G +G V K G +AVK+LS+ F + E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRP-------FQSIIHAKRTYRELR 80
Query: 530 VISKLQHRNLVRLL------GCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKR 582
++ ++H N++ LL E + L+ M A L + +K ++L D +
Sbjct: 81 LLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-----GADLNNIVKCQKLTDDHVQ 135
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630
F +I I RGL Y+H IIHRDLK SN+ ++E+ KI DFG+A
Sbjct: 136 F-LIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 42/179 (23%), Positives = 76/179 (42%), Gaps = 33/179 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
+++FQL S LG+G +G V G+ +A+K++ F E+
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALRTLREIK 61
Query: 530 VISKLQHRNLVRLLGC-CVEGEEKM----LIYEYMPNRSLDALLFDPLKKERL-DWRKRF 583
++ +H N++ + + E +I E M L + + L D ++
Sbjct: 62 ILKHFKHENIITIFNIQRPDSFENFNEVYIIQELM-----QTDLHRVISTQMLSDDHIQY 116
Query: 584 NIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
I R + LH + +IHRDLK SN+L++ + K+ DFG+A+I +
Sbjct: 117 -FIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSE 171
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 47/179 (26%), Positives = 89/179 (49%), Gaps = 30/179 (16%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMN---------EVM 529
++L KLG+G +G V+ + G+ +AVK++ A F N E+M
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQRTFREIM 60
Query: 530 VISKLQ-HRNLVRLLGCCV--EGEEKMLIYEYMPNRSLDALLFDPLKKERL-DWRKRFNI 585
++++L H N+V LL + L+++YM + L ++ L K++ +
Sbjct: 61 ILTELSGHENIVNLLNVLRADNDRDVYLVFDYM-----ETDLHAVIRANILEPVHKQY-V 114
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR 644
+ + + + YLH S ++HRD+K SNILL+ E + K++DFG+++ F + +
Sbjct: 115 VYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIP 170
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.4 bits (167), Expect = 1e-12
Identities = 37/168 (22%), Positives = 62/168 (36%), Gaps = 19/168 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRL-SKASGQGLEEFMNEVMVISK 533
+ +L LG+G FG V + +AVK L A+ M+E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 534 L-QHRNLVRLLGCC-VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
+ H N+V LLG C G M+I E+ +L L KR + ++
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
G + + I DLK + + S F K +++
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEE 179
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 1e-07
Identities = 19/43 (44%), Positives = 29/43 (67%), Gaps = 3/43 (6%)
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631
+++G+ +L + + IHRDL A NILL E+ KI DFG+A+
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR 241
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 66.4 bits (161), Expect = 6e-12
Identities = 35/199 (17%), Positives = 67/199 (33%), Gaps = 46/199 (23%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRL--------SKASGQGLEEFMNEVMV 530
T Q K+G+G FG V+ +A+K + + + + EE + E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIAD-HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 531 ISKLQ---------HRNLVRLLGC-CVEG---EEKMLIYEYM----------PNRSLDAL 567
+L + L CV+G + +++ P+ D
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 568 LF------------DPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615
LF + ++ + +I+ ++ L LR HRDL N+L
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 616 LDEELNPKISDFGMAKIFG 634
L + K+ K
Sbjct: 195 LKKTSLKKLHYTLNGKSST 213
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 5e-11
Identities = 22/121 (18%), Positives = 46/121 (38%), Gaps = 17/121 (14%)
Query: 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLK 83
+S++S + L G +++L + + YD +W +N
Sbjct: 2 NSLSSPNSLF-TGHSLEVGPSYRLIMQGDCNF------VLYD---SGKPVWASNTGG--L 49
Query: 84 DSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWE 143
S +T+ +GNLV+ + V+W + + + L N+V+ +VW
Sbjct: 50 GSGCRLTLHNNGNLVIYDQSNRVIWQTKTNG-KEDHYVLVLQQDRNVVIYGP----VVWA 104
Query: 144 S 144
+
Sbjct: 105 T 105
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 63.1 bits (153), Expect = 1e-10
Identities = 42/166 (25%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQHRN 538
N F+L K+G G FG +Y G ++ +E+A+K + K L E + LQ
Sbjct: 7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLL---YESKIYRILQGGT 63
Query: 539 LV-RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
+ + VEG+ +L+ + + SL+ LF+ ++ ++ + I+
Sbjct: 64 GIPNVRWFGVEGDYNVLVMDLL-GPSLED-LFNFCS-------RKLSLKTVLMLADQMIN 114
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK---ISDFGMAKIF 633
R + ++H S +HRD+K N L+ I DFG+AK +
Sbjct: 115 R-VEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKY 156
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 1e-10
Identities = 41/168 (24%), Positives = 72/168 (42%), Gaps = 31/168 (18%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 537
NF++ K+G G FG + G+ L + +A+K K+ L E +L
Sbjct: 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQL---HLEYRFYKQLGSGD 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
+ ++ G+ ++ E + SL+ LFD + F++ I+ IS
Sbjct: 66 GIPQVYYFGPCGKYNAMVLELL-GPSLED-LFDLCD-------RTFSLKTVLMIAIQLIS 116
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK-----ISDFGMAKIF 633
R + Y+H + +I+RD+K N L+ N I DF +AK +
Sbjct: 117 R-MEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 2e-10
Identities = 44/166 (26%), Positives = 75/166 (45%), Gaps = 29/166 (17%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 537
N ++L K+G G FG +Y G + G+E+A+K K L E + +Q
Sbjct: 9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLH---IESKIYKMMQGGV 65
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
+ + C EG+ +++ E + SL+ LF+ ++F++ + IS
Sbjct: 66 GIPTIRWCGAEGDYNVMVMELL-GPSLED-LFNFCS-------RKFSLKTVLLLADQMIS 116
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK---ISDFGMAKIF 633
R + Y+H + IHRD+K N L+ I DFG+AK +
Sbjct: 117 R-IEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 62.2 bits (150), Expect = 4e-10
Identities = 71/520 (13%), Positives = 148/520 (28%), Gaps = 132/520 (25%)
Query: 191 QNIPEIFVWNVSRP-Y-WRSGPWNGQIFIGIPELKSV-YLFRHNFTFGFANDWTFFA--- 244
+ + + FV V R Y + P + P + + Y+ + + + ND FA
Sbjct: 76 EEMVQKFVEEVLRINYKFLMSPIKTEQ--RQPSMMTRMYIEQRDRLY---NDNQVFAKYN 130
Query: 245 LT-AQGILEERIWIKWKDNWEVGFLNLRTECDV--YGKCGAFGICNSQEKPICSCL---- 297
++ Q L+ R + L LR +V G G G K + +
Sbjct: 131 VSRLQPYLKLRQAL----------LELRPAKNVLIDGVLG-SG------K---TWVALDV 170
Query: 298 ---EGFEPKNAEEWNRGNW-TSGCIRRSKLQCER-RNITGKVGKEDGFSKLNKMKVPDFT 352
+ K + W + E + + ++ + +
Sbjct: 171 CLSYKVQCKMD---FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRI 227
Query: 353 EWTSPATEDECREQCLKNC---------SCIAYAFDGGIGC---MVWRSINLIDI----- 395
+ + +NC + AF+ + C + R + D
Sbjct: 228 HSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFN--LSCKILLTTRFKQVTDFLSAAT 285
Query: 396 --------QRLPFG---GTDLYIRVANSDVDEKGKKDVFVSPLIKGMFALAICTLFLWRW 444
+ L ++ + + ++ + +P + A L W
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIA-ESIRDGLATW 344
Query: 445 IAKRKEVIAKLSATNVNTVKLQDLPLFQ--FEELATATNNFQLSSKLGQGGFGP-----V 497
+ KL+ +++ + + ++ F+ L+ F S+ + P +
Sbjct: 345 DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSV----FPPSAHI------PTILLSL 394
Query: 498 YWGRLK--DGQEIAVK--RLSKASGQGLEE--FMNEVMVISKLQHRNLVRLLGCCVEGEE 551
W + D + K + S Q E + + + K++ N L
Sbjct: 395 IWFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYAL--------H 446
Query: 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA 611
+ ++ Y ++ D D L LD Y H I H
Sbjct: 447 RSIVDHYNIPKTFD---SDDLIPPYLD-------------QYFYSH------IGHHLKNI 484
Query: 612 SNILLDEELNPKISDFGM--AKIFGGNQDQADTGRVVGTL 649
+ DF KI + +G ++ TL
Sbjct: 485 EHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTL 524
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 59.7 bits (145), Expect = 6e-10
Identities = 33/168 (19%), Positives = 73/168 (43%), Gaps = 31/168 (18%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLS-KASGQGLEEFMNEVMVISKLQH-R 537
++++ ++G+G FG ++ G L + Q++A+K ++ L +E L
Sbjct: 10 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLR---DEYRTYKLLAGCT 66
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI-------IEGIS 590
+ + EG +L+ + + SL+ L D ++F++ + ++
Sbjct: 67 GIPNVYYFGQEGLHNVLVIDLLG-PSLED-LLDLCG-------RKFSVKTVAMAAKQMLA 117
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPK-----ISDFGMAKIF 633
R + +H S +++RD+K N L+ + + DFGM K +
Sbjct: 118 R-VQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 161
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 55.3 bits (133), Expect = 1e-09
Identities = 23/127 (18%), Positives = 40/127 (31%), Gaps = 17/127 (13%)
Query: 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMG-----IWYDMPSEKAVIWVAN 77
++ I S Q + IL + L M + YD IW N
Sbjct: 1 NNIIFSKQPDDNHPQILHATES--LEILFGTHVYRFIMQTDCNLVLYD---NNNPIWATN 55
Query: 78 RDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNIN 137
+ + DG LV++ + +W S V+ L N+V+ +
Sbjct: 56 TGG--LGNGCRAVLQPDGVLVVITNENVTVWQSPVAG-KAGHYVLVLQPDRNVVIYGD-- 110
Query: 138 RAIVWES 144
+W +
Sbjct: 111 --ALWAT 115
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 58.6 bits (142), Expect = 2e-09
Identities = 28/183 (15%), Positives = 58/183 (31%), Gaps = 43/183 (23%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR---------LKDGQEIAVKRLSKASGQGLEEFMNEVMVI 531
++L S + G +Y Q+ ++K L G+ E
Sbjct: 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAA 100
Query: 532 SKLQHRNLVRLLGC------------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
LQ +L + + + L+ + RSL + L +
Sbjct: 101 KPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSAL-------DVSP 152
Query: 580 RKRFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMA 630
+ + + L +LH + +H ++ A NI +D E ++ + +G A
Sbjct: 153 KHVLSERSVLQVACRLLDA-LEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFA 208
Query: 631 KIF 633
+
Sbjct: 209 FRY 211
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 27/123 (21%), Positives = 45/123 (36%), Gaps = 18/123 (14%)
Query: 22 IDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNP 81
+D+ + S Q + D L G + L N + + Y IW +N D
Sbjct: 1 MDNVLLSGQTLH-ADHSLQAG-AYTLTIQNKCNL------VKYQ---NGRQIWASNTDR- 48
Query: 82 LKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141
+ S +T+ DGNLV+ + +W S N + L G V+ ++
Sbjct: 49 -RGSGCRLTLLSDGNLVIYDHNNNDVWGSACWG-DNGKYALVLQKDGRFVIYGP----VL 102
Query: 142 WES 144
W
Sbjct: 103 WSL 105
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 18/76 (23%), Positives = 32/76 (42%), Gaps = 2/76 (2%)
Query: 77 NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
+ D+ L+ + +TI NLV + +W+SN + LL GNLV+ D+
Sbjct: 12 HADHSLQAGAYTLTIQNKCNLVKYQNGR-QIWASNTDRRGSGCR-LTLLSDGNLVIYDHN 69
Query: 137 NRAIVWESFQEPTDSF 152
N + + +
Sbjct: 70 NNDVWGSACWGDNGKY 85
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 40/176 (22%), Positives = 77/176 (43%), Gaps = 39/176 (22%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ------ 535
+ L KLG G F V+ + + + +A+K + + E +E+ ++ ++
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIV-RGDKVYTEAAEDEIKLLQRVNDADNTK 79
Query: 536 -----HRNLVRLLGC-CVEGEEKM---LIYEYMPNRSLDALLFDPLKKERLDWRKRFNI- 585
++++LL +G + +++E L L +KK + +
Sbjct: 80 EDSMGANHILKLLDHFNHKGPNGVHVVMVFE-----VLGENLLALIKKYEH---RGIPLI 131
Query: 586 -IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP------KISDFGMA 630
++ IS+ GL Y+HR R IIH D+K N+L++ +P KI+D G A
Sbjct: 132 YVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA 185
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 6e-09
Identities = 35/181 (19%), Positives = 65/181 (35%), Gaps = 42/181 (23%)
Query: 481 NNFQLSSKLGQGGFGPVYWG-RLKDGQEIA---VKRLSKASGQGLEEF-----MNEVMVI 531
N + L K+G GGFG +Y ++ A VK + +G E + + I
Sbjct: 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCI 96
Query: 532 SKLQHRNLVRLLG----------CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRK 581
K R + LG + ++ E + L +
Sbjct: 97 KKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKI---------SGQNG 146
Query: 582 RFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMAKI 632
F I + L Y+H + +H D+KA+N+LL + ++ +D+G++
Sbjct: 147 TFKKSTVLQLGIRMLDV-LEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYR 202
Query: 633 F 633
+
Sbjct: 203 Y 203
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.1 bits (138), Expect = 7e-09
Identities = 33/183 (18%), Positives = 70/183 (38%), Gaps = 43/183 (23%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEI------AVKRLSKASGQ-----------GLEE 523
+++ +GQGGFG +Y + + + VK +G E
Sbjct: 35 AAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPE 94
Query: 524 FMNEVMVISKLQHRNLVRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDW 579
+ + + KL++ + + G + + +I + L + ++ K
Sbjct: 95 QIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKI-YEANAK----- 147
Query: 580 RKRFNI-------IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI--SDFGMA 630
RF+ + + L Y+H +H D+KASN+LL+ + ++ D+G+A
Sbjct: 148 --RFSRKTVLQLSLRILDI-LEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLA 201
Query: 631 KIF 633
+
Sbjct: 202 YRY 204
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 52.2 bits (125), Expect = 1e-08
Identities = 16/74 (21%), Positives = 31/74 (41%), Gaps = 6/74 (8%)
Query: 72 VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
+W +N K + DGN V+ + + LW+S+ N + L + GN+V
Sbjct: 39 SVWASNTGILGKKGC-KAVLQSDGNFVVYDAEGRSLWASHSVR-GNGNYVLVLQEDGNVV 96
Query: 132 LRDNINRAIVWESF 145
+ + +W +
Sbjct: 97 IYGS----DIWSTG 106
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 51.8 bits (124), Expect = 2e-08
Identities = 20/68 (29%), Positives = 27/68 (39%), Gaps = 2/68 (2%)
Query: 77 NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
L + ED NLVL + +W+SN L A L GN V+ D
Sbjct: 11 YAGQSLDVEPYHFIMQEDCNLVLYDHST-SVWASNTGILGKKGCKAVLQSDGNFVVYDAE 69
Query: 137 NRAIVWES 144
R+ +W S
Sbjct: 70 GRS-LWAS 76
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 50.6 bits (121), Expect = 4e-08
Identities = 25/122 (20%), Positives = 45/122 (36%), Gaps = 18/122 (14%)
Query: 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPL 82
D+ + S + + P L+NG + + + YD IW N
Sbjct: 1 DNILYSGETLS-PGEFLNNG-RYVFIMQEDCNL------VLYD---VDKPIWATNTGG-- 47
Query: 83 KDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVW 142
D +++ DGNLV+ + + +W+SN N + L N+V+ W
Sbjct: 48 LDRRCHLSMQSDGNLVVYSPRNNPIWASNTGG-ENGNYVCVLQKDRNVVIYGT----ARW 102
Query: 143 ES 144
+
Sbjct: 103 AT 104
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 6e-08
Identities = 38/179 (21%), Positives = 64/179 (35%), Gaps = 51/179 (28%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVIS 532
+ +++ S +G+G FG V + + +A+K + EV ++
Sbjct: 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQA-------QIEVRLLE 105
Query: 533 KLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDW 579
+ +V L C L++E L L+D L+
Sbjct: 106 LMNKHDTEMKYYIVHLKRHFMFRNHLC-------LVFE-----MLSYNLYDLLRNTN--- 150
Query: 580 RKRFNI--IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMA 630
+ ++ ++ LL+L L IIH DLK NILL KI DFG +
Sbjct: 151 FRGVSLNLTRKFAQQMCTALLFLAT-PELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.0 bits (127), Expect = 2e-07
Identities = 41/188 (21%), Positives = 76/188 (40%), Gaps = 34/188 (18%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--- 535
+ + KLG G F V+ ++ + +A+K + K++ E ++E+ ++ ++
Sbjct: 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEIRLLKSVRNSD 94
Query: 536 -----HRNLVRLLGC-CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFN----- 584
+V+LL + G N + ++F+ L L W + N
Sbjct: 95 PNDPNREMVVQLLDDFKISG----------VNGTHICMVFEVLGHHLLKWIIKSNYQGLP 144
Query: 585 ------IIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
II+ + +GL YLH ++ RIIH D+K NILL A + +
Sbjct: 145 LPCVKKIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGA 202
Query: 639 QADTGRVV 646
+G V
Sbjct: 203 PPPSGSAV 210
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 49.2 bits (117), Expect = 2e-07
Identities = 28/119 (23%), Positives = 50/119 (42%), Gaps = 16/119 (13%)
Query: 26 ITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDS 85
+ S + L+ G + N + + YD +W + + K S
Sbjct: 4 LNSGHQLD-TGGSLAEG-GYLFIIQNDCNL------VLYD---NNRAVWASGTNG--KAS 50
Query: 86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
++ + DGNLV+ +G + +W+SN + N + L N+V+ DN N AI W +
Sbjct: 51 GCVLKMQNDGNLVIYSGSR-AIWASNTNR-QNGNYYLILQRDRNVVIYDNSNNAI-WAT 106
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 5e-07
Identities = 39/177 (22%), Positives = 73/177 (41%), Gaps = 55/177 (31%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVISKLQ 535
+++ +G+G FG V K Q +A+K R + + E+ ++ L+
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQA-------AEEIRILEHLR 151
Query: 536 HR------NLVRLLGC-------CVEGEEKMLIYEYM-PNRSLDALLFDPLKKERLDWRK 581
+ N++ +L C + +E + N L++ +KK + +
Sbjct: 152 KQDKDNTMNVIHMLENFTFRNHIC-------MTFELLSMN------LYELIKKNKF---Q 195
Query: 582 RFNI--IEGISR----GLLYLHRDSRLRIIHRDLKASNILLDEELNP--KISDFGMA 630
F++ + + L LH+ RIIH DLK NILL ++ K+ DFG +
Sbjct: 196 GFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSS 249
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 45.6 bits (108), Expect = 2e-06
Identities = 19/82 (23%), Positives = 34/82 (41%), Gaps = 12/82 (14%)
Query: 74 WVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLR 133
W +N N +T+++ G LV+ NG +W S + V + +A + G LV+
Sbjct: 40 WQSNTAN--NGRDCKLTLTDYGELVIKNGDGSTVWKSGAQS-VKGNYAAVVHPDGRLVVF 96
Query: 134 DNINRAIVWESFQEPTDSFLPG 155
V+ D ++ G
Sbjct: 97 GP----SVF-----KIDPWVRG 109
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 2e-04
Identities = 21/68 (30%), Positives = 32/68 (47%), Gaps = 6/68 (8%)
Query: 77 NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
+ + LK+ + + +D NLVL NG W SN +N L D G LV+++
Sbjct: 13 DTEGHLKNGDFDLVMQDDCNLVLYNGN----WQSNTANN-GRDCKLTLTDYGELVIKNGD 67
Query: 137 NRAIVWES 144
VW+S
Sbjct: 68 GST-VWKS 74
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-06
Identities = 33/197 (16%), Positives = 66/197 (33%), Gaps = 71/197 (36%)
Query: 480 TNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVK------RLSKASGQGLEEFMNEVMVI 531
+++ LG+G FG V + ++A+K + +A+ E+ V+
Sbjct: 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAA-------RLEINVL 70
Query: 532 SKLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
K++ + V + C + +E L F+ LK+
Sbjct: 71 KKIKEKDKENKFLCVLMSDWFNFHGHMC-------IAFE-----LLGKNTFEFLKENN-- 116
Query: 579 WRKRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNP---------- 622
+ + + + ++ L +LH ++ H DLK NIL
Sbjct: 117 -FQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCE 172
Query: 623 ---------KISDFGMA 630
+++DFG A
Sbjct: 173 EKSVKNTSIRVADFGSA 189
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 5e-06
Identities = 17/68 (25%), Positives = 28/68 (41%), Gaps = 4/68 (5%)
Query: 77 NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
D L + + + D NLVL + W SN + +L G L+++D+
Sbjct: 16 YGDGRLTAKNHQLVMQGDCNLVLYG--GKYGWQSNTHGNGEHCF-LRLNHKGELIIKDDD 72
Query: 137 NRAIVWES 144
+ I W S
Sbjct: 73 FKTI-WSS 79
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 17/110 (15%), Positives = 38/110 (34%), Gaps = 15/110 (13%)
Query: 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPL 82
++ + S Q++ + + N +L + + Y W +N
Sbjct: 6 NNLLFSGQVLYGDGRLTA--KNHQLVMQGDCNL------VLYGG----KYGWQSNTHG-- 51
Query: 83 KDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVL 132
+ ++ G L++ + + +WSS S+ L D G V+
Sbjct: 52 NGEHCFLRLNHKGELIIKDDDFKTIWSSR-SSSKQGEYVLILQDDGFGVI 100
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 46.8 bits (110), Expect = 6e-06
Identities = 18/142 (12%), Positives = 40/142 (28%), Gaps = 8/142 (5%)
Query: 71 AVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNL 130
+W +N + + DG LV++ Q + WSS + L +
Sbjct: 45 VRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIRWSSGTKG-SIGNYVLVLQPDRTV 100
Query: 131 VLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIH 190
I +W+S S + + + + + S L
Sbjct: 101 T----IYGPGLWDSGTSNKGSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSM 156
Query: 191 QNIPEIFVWNVSRPYWRSGPWN 212
+ + +++ W +
Sbjct: 157 ETDCNLVLFDRDDRVWSTNTAG 178
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 46.1 bits (108), Expect = 1e-05
Identities = 30/153 (19%), Positives = 47/153 (30%), Gaps = 10/153 (6%)
Query: 62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
I + + E + + L+ SS T+ D NLVL + +W+SN +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDV-RVWASNTAG--ATGCR 59
Query: 122 AQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPST 181
A L G LV+ I W S G + + Q L D T
Sbjct: 60 AVLQSDGLLVILTA-QNTIRWSS----GTKGSIGNYVLVLQPDRTVT--IYGPGLWDSGT 112
Query: 182 GSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQ 214
+ + ++ N I Q
Sbjct: 113 SNKGSVVVANNGNSILYSTQGNDNHPQTLHATQ 145
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 Length = 236 | Back alignment and structure |
|---|
Score = 43.0 bits (100), Expect = 1e-04
Identities = 11/75 (14%), Positives = 23/75 (30%), Gaps = 7/75 (9%)
Query: 70 KAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGN 129
+W N ++ +G + ++ Q +W+S S L N
Sbjct: 168 DDRVWSTNTAGKGTGCRAVLQ--PNGRMDVLTNQNIAVWTSGNSRSAGRYV-FVLQPDRN 224
Query: 130 LVLRDNINRAIVWES 144
L + +W +
Sbjct: 225 LAIYGG----ALWTT 235
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 9e-06
Identities = 41/190 (21%), Positives = 70/190 (36%), Gaps = 50/190 (26%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVK------RLSKASGQGLEEFMNEVMVIS 532
N F + K+G G FG V + + + + AVK + ++++ E ++
Sbjct: 34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSA-------KIEADILK 86
Query: 533 KLQHR-----NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWR 580
K+Q+ N+V+ G C LI+E L L++ + +
Sbjct: 87 KIQNDDINNNNIVKYHGKFMYYDHMC-------LIFE-----PLGPSLYEIITRNN---Y 131
Query: 581 KRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634
F+I I+ +L YL + + + H DLK NILLD+ K G
Sbjct: 132 NGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDG 188
Query: 635 GNQDQADTGR 644
T
Sbjct: 189 KKIQIYRTKS 198
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 2e-05
Identities = 33/166 (19%), Positives = 61/166 (36%), Gaps = 52/166 (31%)
Query: 480 TNNFQLSSKLGQGGFGPVY--WGRLKDGQEIAVK------RLSKASGQGLEEFMNEVMVI 531
+ +++ LG+G FG V G+ +AVK R +A+ +E+ V+
Sbjct: 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAA-------RSEIQVL 65
Query: 532 SKLQHR------NLVRLLGC-------CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLD 578
L V++L C +++E L +D +K+
Sbjct: 66 EHLNTTDPNSTFRCVQMLEWFEHHGHIC-------IVFE-----LLGLSTYDFIKENG-- 111
Query: 579 WRKRFNI--IEGISRGLL----YLHRDSRLRIIHRDLKASNILLDE 618
F + I ++ + +LH ++ H DLK NIL +
Sbjct: 112 -FLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQ 153
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.4 bits (106), Expect = 3e-05
Identities = 20/123 (16%), Positives = 36/123 (29%), Gaps = 5/123 (4%)
Query: 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAV--IWVANRDNP 81
S+ TS+ +L + N L + + + + +
Sbjct: 101 STFTSNDQWNRTHLVLQDDGNIVLVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVV 160
Query: 82 LKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141
+ + DGNLV W++ + A GNLV+ N +
Sbjct: 161 YGAGASKLVFQGDGNLVAYGPNGAATWNAGTQG--KGAVRAVFQGDGNLVVYGAGNAVL- 217
Query: 142 WES 144
W S
Sbjct: 218 WHS 220
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 45.4 bits (106), Expect = 3e-05
Identities = 29/144 (20%), Positives = 46/144 (31%), Gaps = 17/144 (11%)
Query: 35 PDAILSNGSNFKLGFFNPADSPYRYMGIWYDM---PSEKAVIWVANRDNPLKDSSGIITI 91
+L+ GS G A + ++ A W A +
Sbjct: 145 DSLLLAPGSELVQGVVYGAGASKLVFQGDGNLVAYGPNGAATWNAGTQGK---GAVRAVF 201
Query: 92 SEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDS 151
DGNLV+ VLW S+ + S +L +G++ + D VW F
Sbjct: 202 QGDGNLVVYGAGNAVLWHSHTGG--HASAVLRLQANGSIAILDE---KPVWARF-----G 251
Query: 152 FLPGMHHG-IDQRTGKKVQLTSWK 174
F P H K + + +W
Sbjct: 252 FQPTYRHIRKINPDQKPIDIWTWH 275
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 42.7 bits (99), Expect = 2e-04
Identities = 30/202 (14%), Positives = 62/202 (30%), Gaps = 18/202 (8%)
Query: 15 CLDFAVAIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSP--YRYMGIWYDMPSEKAV 72
+ F S + + Q + +LS FKL + +W +
Sbjct: 6 RIPFNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGNLVIQDNGATVWVANEQQPFS 65
Query: 73 IWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVL 132
+ R+ + L + + +W ++ S +N + +LVL
Sbjct: 66 STIPLRNKK-----APLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQW----NRTHLVL 116
Query: 133 RDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSL-SDPSTGSFSAGLIHQ 191
+D+ N +V +P + ID L L G+ ++ L+ Q
Sbjct: 117 QDDGNIVLVDSLALWNGTPAIPLVPGAIDSL-----LLAPGSELVQGVVYGAGASKLVFQ 171
Query: 192 NIPEIFVWNVS-RPYWRSGPWN 212
+ + + W +G
Sbjct: 172 GDGNLVAYGPNGAATWNAGTQG 193
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 111 | Back alignment and structure |
|---|
Score = 42.1 bits (99), Expect = 4e-05
Identities = 17/68 (25%), Positives = 25/68 (36%), Gaps = 3/68 (4%)
Query: 77 NRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNI 136
+ DN L S + D NLVL N + SN + +L + G L +
Sbjct: 12 HTDNQLSYESAAFVMQGDCNLVLYNEA--GGFQSNTHGR-GVDCTLRLNNRGQLEIHSAN 68
Query: 137 NRAIVWES 144
+ VW
Sbjct: 69 SNTPVWVY 76
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 7/77 (9%)
Query: 68 SEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDS 127
S+ ++W + + + + G L + + + ++ SN L +
Sbjct: 42 SKTNIVWESGTSG--RGQHCFMRLGHSGELDITDDRLNTVFVSNTVG-QEGDYVLILQIN 98
Query: 128 GNLVLRDNINRAIVWES 144
G V+ VW +
Sbjct: 99 GQAVVYGP----AVWST 111
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 649 | |||
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 100.0 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.98 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 99.98 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.98 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 99.97 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 99.97 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 99.97 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 99.97 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 99.96 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 99.96 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 99.96 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 99.96 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 99.95 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 99.95 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 99.95 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.94 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.94 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.94 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 99.94 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 99.94 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.94 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 99.94 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 99.94 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 99.94 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 99.94 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 99.94 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 99.94 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 99.94 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 99.93 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 99.93 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 99.93 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.93 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 99.93 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 99.93 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 99.93 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.93 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 99.93 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 99.93 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 99.93 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.93 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.93 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.93 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.93 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.93 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 99.93 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 99.93 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.93 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.93 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.93 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.93 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 99.93 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.93 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.93 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.93 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.93 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.93 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.93 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.93 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.93 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 99.93 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.93 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.93 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.93 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.92 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.92 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.92 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.92 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 99.92 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.92 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.92 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.92 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 99.92 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 99.92 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.92 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 99.92 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.92 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.92 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.92 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.92 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.92 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.92 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.92 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.92 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 99.92 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.92 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.92 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.92 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.92 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 99.92 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.92 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.92 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.92 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.92 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.92 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 99.92 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.92 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.92 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.92 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.92 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.92 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.92 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.92 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.92 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.92 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.92 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.92 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.92 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.92 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.92 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.92 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.92 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.92 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.92 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.92 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.92 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.92 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 99.92 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.92 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.91 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.91 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.91 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.91 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 99.91 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.91 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.91 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.91 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.91 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.91 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.91 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.91 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.91 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.91 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.91 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.91 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.91 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.91 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.91 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.91 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.91 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.91 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.91 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.91 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.91 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.91 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.91 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.91 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.91 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.91 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.91 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.91 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.91 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.91 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.91 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.91 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.91 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.91 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.91 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.91 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.91 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.91 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.91 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.91 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.91 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.91 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.91 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.91 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.91 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.91 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.91 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.91 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.91 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.91 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.91 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.91 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.91 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.91 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.91 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.9 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.9 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.9 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.9 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.9 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.9 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.9 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.9 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.9 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.9 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.9 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.9 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.9 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.9 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.9 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.9 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.9 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.9 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.9 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.9 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.9 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.9 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.9 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.9 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.9 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.9 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.9 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.9 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.9 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.9 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.89 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.89 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.89 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.89 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.89 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.89 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.89 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.89 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.89 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.89 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.89 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.89 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.89 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.89 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.89 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.88 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.88 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.88 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.88 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.88 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.88 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.88 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.88 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.88 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.88 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.88 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.87 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.87 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.87 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.87 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.87 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.87 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.87 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.86 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.86 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.85 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.85 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.85 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.83 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.82 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.81 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.79 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.77 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.69 | |
| 1xd5_A | 112 | Gastrodianin-1, antifungal protein GAFP-1; monocot | 99.69 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.67 | |
| 3a0c_A | 110 | Mannose/sialic acid-binding lectin; beta-prism II, | 99.66 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.65 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.64 | |
| 1b2p_A | 119 | Protein (lectin); mannose-binding lectin, monocot, | 99.61 | |
| 2dpf_A | 115 | Curculin; sweet taste, taste modifying, plant prot | 99.6 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.54 | |
| 3mez_B | 113 | Mannose-specific lectin 3 chain 2; heterotetramer, | 99.38 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.37 | |
| 3mez_A | 111 | Mannose-specific lectin 3 chain 1; heterotetramer, | 99.34 | |
| 3m7h_A | 276 | Putidacin L1; monocot mannose-binding lectin, bact | 99.25 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.19 | |
| 3dzw_A | 109 | Agglutinin; lectin, mannobiose, mannose-alpha1, 3- | 99.18 | |
| 3r0e_B | 110 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.15 | |
| 3r0e_A | 109 | Lectin; carbohydrate binding, carbohydrate, sugar | 99.13 | |
| 4h3o_A | 105 | Lectin; cadmium, plant protein; 2.17A {Allium sati | 99.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.04 | |
| 1dlp_A | 236 | Lectin scafet precursor; two-domain lectin, beta p | 98.9 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.65 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 98.65 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.45 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.45 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 98.34 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.33 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.0 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.99 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.86 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.76 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.6 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.5 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.21 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.14 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 97.12 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.1 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 97.08 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.03 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.69 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 96.65 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.05 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 94.01 | |
| 2ll3_A | 82 | Micronemal protein 4; cell adhesion; NMR {Toxoplas | 92.18 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 89.22 | |
| 3cxl_A | 463 | N-chimerin; SH2, RHO-GAP, structural genomics cons | 81.61 |
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=361.39 Aligned_cols=215 Identities=17% Similarity=0.212 Sum_probs=167.8
Q ss_pred cccccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCC----cceEEEeeCCc
Q 006347 21 AIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDS----SGIITISEDGN 96 (649)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~----~~~l~~~~~G~ 96 (649)
++.|+|.+|++|++|++|+|++|.|+||||+++ ++|+ |+ +.+ |||+||||+|+.++ +++|+|+.||+
T Consensus 12 ~~~~~l~~g~~l~~~~~l~S~~g~F~lgf~~~~---~~~l---y~--~~~-vvW~Anr~~p~~~~~~~~~~~l~l~~~G~ 82 (276)
T 3m7h_A 12 VGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDG---NLVI---QD--NGA-TVWVANEQQPFSSTIPLRNKKAPLAFYVQ 82 (276)
T ss_dssp TTSSEECTTEEBCTTCEEECTTSSEEEEECTTS---CEEE---EE--TTE-EEEECSTTSTTEEEEECCCTTCCSEEEES
T ss_pred ccCCEecCCCEecCCCEEEcCCCcEEEEEECCC---CeEE---EC--CCC-eEEECCCCCCcCCcccccceEEEEeCCCc
Confidence 348999999999999999999999999999543 4676 76 667 99999999999875 78999999999
Q ss_pred EEE--EcCCceEEEEecCcccc----cccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCceeEE
Q 006347 97 LVL--VNGQKEVLWSSNVSNLV----NNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKKVQL 170 (649)
Q Consensus 97 L~l--~~~~~~~~Wss~~~~~~----~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~~~~L 170 (649)
|+| .|++|++||+++++... ..+++|+|+|+|||||+| +.+|||| ||||||||||+++.+..+|. .|
T Consensus 83 Lvl~~~~~~~~~vWst~~~~~~~~~~~~~~~a~L~d~GNlVl~~---~~~lWqS--~ptdtlLpg~~~~~~l~~g~--~L 155 (276)
T 3m7h_A 83 YGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIVLVD---SLALWNG--TPAIPLVPGAIDSLLLAPGS--EL 155 (276)
T ss_dssp SSEEEEEGGGTEEEEECCCCCCCTTHHHHEEEEECTTSCEEEEE---EEEEEES--CTTSCCCCSCTTCEEECSSE--EE
T ss_pred EEEEEeCCCCCEEEEeCCCcccccccCCceEEEEeCCCCEEecC---CceeeCc--ccccccccccccccccccCc--cc
Confidence 999 78889999999986311 345789999999999997 5789999 99999999999998888774 47
Q ss_pred EEcccCCCCCCceeEEeeeCCCccEEEEEc-CCeeeeecCCCCCccccccccceee-eEEee----eEEe-ccCCeEEEE
Q 006347 171 TSWKSLSDPSTGSFSAGLIHQNIPEIFVWN-VSRPYWRSGPWNGQIFIGIPELKSV-YLFRH----NFTF-GFANDWTFF 243 (649)
Q Consensus 171 ~S~~s~~dps~G~f~l~~~~~~~~~~~~~~-~~~~yw~sg~~~~~~~~~~~~~~~~-~~~~~----~~~~-~~~~~~~~~ 243 (649)
++.+||++|.|+++++++|. +++++ +..+||++|+|++.......+.... ..+.. .... ......+|+
T Consensus 156 ---~S~~dps~G~fsl~l~~dGn--lvLy~~~~~~yW~Sgt~~~~~~~l~l~~dGnLvl~d~~~~~vWsS~t~~~~~~rl 230 (276)
T 3m7h_A 156 ---VQGVVYGAGASKLVFQGDGN--LVAYGPNGAATWNAGTQGKGAVRAVFQGDGNLVVYGAGNAVLWHSHTGGHASAVL 230 (276)
T ss_dssp ---CTTCEEEETTEEEEECTTSC--EEEECTTSSEEEECCCTTTTCCEEEECTTSCEEEECTTSCEEEECSCTTCTTCEE
T ss_pred ---ccCCCCCCceEEEeecCCce--EEEEeCCCeEEEECCCCCCccEEEEEcCCCeEEEEeCCCcEEEEecCCCCCCEEE
Confidence 56889999999999999985 44555 4689999999975432111110111 11100 0011 112234799
Q ss_pred EEccCCcEEEEEE
Q 006347 244 ALTAQGILEERIW 256 (649)
Q Consensus 244 ~l~~~G~l~~~~~ 256 (649)
+|+.||+|++|.|
T Consensus 231 ~Ld~dGnLvly~~ 243 (276)
T 3m7h_A 231 RLQANGSIAILDE 243 (276)
T ss_dssp EECTTSCEEEEEE
T ss_pred EEcCCccEEEEcC
Confidence 9999999999998
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-36 Score=302.50 Aligned_cols=208 Identities=13% Similarity=0.173 Sum_probs=157.8
Q ss_pred cccccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEE
Q 006347 21 AIDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLV 100 (649)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~ 100 (649)
++.|+|.+|++|.+|++| ++|.|+|||+.+++. ++|.. +++||+|||+.| .+++|+|+.||||||+
T Consensus 6 ~~~~~i~~g~~L~~g~~l--~~g~f~l~f~~~gnl------~ly~~---~~~vW~an~~~~---~~~~l~l~~dGnLvl~ 71 (236)
T 1dlp_A 6 GLSHEGSHPQTLHAAQSL--ELSSFRFTMQSDCNL------VLFDS---DVRVWASNTAGA---TGCRAVLQSDGLLVIL 71 (236)
T ss_dssp CSSSSSCSCSCCCTTCEE--CSTTEEEEECTTSCE------EEEES---SSEEECCCCCSC---SCCBCCBCSSSCBCCB
T ss_pred eccceeCCCCEECCCCEE--EcCCEEEEECCCCcE------EEEEC---CEEEEECCCCCC---CCeEEEEcCCCcEEEE
Confidence 347899999999999999 599999999976641 34543 799999999988 4578999999999999
Q ss_pred cCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccc-cCCCcccccc-cCCc-----eeEEEEc
Q 006347 101 NGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSF-LPGMHHGIDQ-RTGK-----KVQLTSW 173 (649)
Q Consensus 101 ~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTl-Lpg~~l~~~~-~~g~-----~~~L~S~ 173 (649)
|++|++||+|++.. ......|+|+|+|||||++. ++||||||||||+ |||| +.+. .+|+ +++|+
T Consensus 72 d~~~~~vW~s~~~~-~~~~~~~~l~d~Gnlvl~~~----~~W~S~~~p~~t~~lp~~--g~d~L~~gq~~~~~~~~L~-- 142 (236)
T 1dlp_A 72 TAQNTIRWSSGTKG-SIGNYVLVLQPDRTVTIYGP----GLWDSGTSNKGSVVVANN--GNSILYSTQGNDNHPQTLH-- 142 (236)
T ss_dssp CTTTCCSCCCCCCC-CSSCCEEEECSSSCEEEECS----EEEECSCCCSSCCCCSSC--CCEECCCC--CCCCCCEEC--
T ss_pred cCCCcEEEeCCccc-cCCcEEEEEeCCCCEEEecC----CEEECCCCCCcccccCCc--cceEEecCCcCCCccceEE--
Confidence 99999999998862 23346899999999999952 7999999998776 5554 3333 3333 46887
Q ss_pred ccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCCCCccccccccceeee-EEeeeE------Ee-cc-CCeEEEEE
Q 006347 174 KSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQIFIGIPELKSVY-LFRHNF------TF-GF-ANDWTFFA 244 (649)
Q Consensus 174 ~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~~~~~~~~~~~~~~~~-~~~~~~------~~-~~-~~~~~~~~ 244 (649)
+..||++|.|+|+++++| +++++++..+||++++|++. +...+.+.... .+.+.. .. .. ....+|++
T Consensus 143 -s~~d~s~G~~~l~l~~dG--~LvL~~~~~~~W~s~~~~~~-~~~~~~L~~~Gnl~ly~~~~~~vw~s~~~~~~~~~rl~ 218 (236)
T 1dlp_A 143 -ATQSLQLSPYRLSMETDC--NLVLFDRDDRVWSTNTAGKG-TGCRAVLQPNGRMDVLTNQNIAVWTSGNSRSAGRYVFV 218 (236)
T ss_dssp -SSCCCBCSSCEEEEETTT--EEEEEBTTBCCSCCCCCSSC-SSCEEEEETTTEEEEEETTTEEEEECCCCCSSSCCEEE
T ss_pred -cCcEeecCcEEEEECCCC--cEEEEcCCEeEEeCCCcCCC-CceEEEECCCCcEEEEeCCCcEEEEeCCCCCCCCEEEE
Confidence 478999999999999998 57778888899999999653 44445543111 111111 10 11 23457999
Q ss_pred EccCCcEEEEE
Q 006347 245 LTAQGILEERI 255 (649)
Q Consensus 245 l~~~G~l~~~~ 255 (649)
||+||++++|.
T Consensus 219 Ld~dG~l~ly~ 229 (236)
T 1dlp_A 219 LQPDRNLAIYG 229 (236)
T ss_dssp ECSSSCEEEEC
T ss_pred EcCCCcEEEeC
Confidence 99999999994
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-35 Score=306.95 Aligned_cols=166 Identities=31% Similarity=0.546 Sum_probs=143.6
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus 13 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 92 (299)
T 4asz_A 13 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 92 (299)
T ss_dssp GGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence 46788899999999999999864 477899999987766778899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCC----------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 555 IYEYMPNRSLDALLFDP----------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~----------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
|||||++|+|.++|+.. .....++|.++++|+.|||+||+|||+++ ||||||||+||||++++++||
T Consensus 93 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~Ki 169 (299)
T 4asz_A 93 VFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 169 (299)
T ss_dssp EEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcEEE
Confidence 99999999999999642 12357999999999999999999999987 999999999999999999999
Q ss_pred EecCCceeeCCCCCccccCceeecC
Q 006347 625 SDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 625 ~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
+|||+|+..........+....||+
T Consensus 170 ~DFGla~~~~~~~~~~~~~~~~gt~ 194 (299)
T 4asz_A 170 GDFGMSRDVYSTDYYRVGGHTMLPI 194 (299)
T ss_dssp CCCSCHHHHTGGGCEEETTTEEECG
T ss_pred CCcccceecCCCCceeecCceecCh
Confidence 9999999876554444445567773
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-35 Score=308.66 Aligned_cols=166 Identities=30% Similarity=0.516 Sum_probs=135.2
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|.+.++||+|+||+||+|++. +++.||||+++.......++|.+|++++++++|||||+++|+|.+++..+|
T Consensus 41 ~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~l 120 (329)
T 4aoj_A 41 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLM 120 (329)
T ss_dssp GGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence 45777899999999999999864 478899999987777778899999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 555 IYEYMPNRSLDALLFDPL------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
|||||++|+|.++|+... ...+++|.+++.|+.|||+||+|||+.+ ||||||||+||||++++++
T Consensus 121 V~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~~~ 197 (329)
T 4aoj_A 121 VFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGLVV 197 (329)
T ss_dssp EEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEE
T ss_pred EEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCCcE
Confidence 999999999999997532 1246999999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeeCCCCCccccCceeecC
Q 006347 623 KISDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 623 Ki~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
||+|||+|+.+........++...||+
T Consensus 198 Ki~DFGla~~~~~~~~~~~~~~~~gt~ 224 (329)
T 4aoj_A 198 KIGDFGMSRDIYSTDYYRVGGRTMLPI 224 (329)
T ss_dssp EECCCC----------------CCCCG
T ss_pred EEcccccceeccCCCcceecCcccccc
Confidence 999999999876554444444566763
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-34 Score=301.99 Aligned_cols=165 Identities=30% Similarity=0.470 Sum_probs=140.4
Q ss_pred CcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++++.++||+|+||+||+|++. +++.||||+++... ....++|.+|+.++++++|||||+++|+|.+++..+|
T Consensus 27 ~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~l 106 (308)
T 4gt4_A 27 AVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSM 106 (308)
T ss_dssp GEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEE
T ss_pred HCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEE
Confidence 3566789999999999999863 46789999997543 3456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 555 IYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
|||||++|+|.++|.... ....++|.++++|+.|||+||+|||+.+ ||||||||+||||+++++
T Consensus 107 V~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK~~NILl~~~~~ 183 (308)
T 4gt4_A 107 IFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLN 183 (308)
T ss_dssp EEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGC
T ss_pred EEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCccccceEECCCCC
Confidence 999999999999996432 1346899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCceeeCCCCCccccCceeecC
Q 006347 622 PKISDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
+||+|||+|+.+........++...||+
T Consensus 184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~ 211 (308)
T 4gt4_A 184 VKISDLGLFREVYAADYYKLLGNSLLPI 211 (308)
T ss_dssp EEECCSCCBCGGGGGGCBCSSSSSCBCG
T ss_pred EEECCcccceeccCCCceeEecccccCC
Confidence 9999999999875544444444566763
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-34 Score=294.79 Aligned_cols=163 Identities=32% Similarity=0.426 Sum_probs=146.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|++++++++|||||++++++.+.+..||||
T Consensus 32 ~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivm 111 (311)
T 4aw0_A 32 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 111 (311)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 46999999999999999999976 7899999999753 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.++|.+ ...+++.+...++.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+...
T Consensus 112 Ey~~gG~L~~~i~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~ 185 (311)
T 4aw0_A 112 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 185 (311)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCC
Confidence 99999999999953 456999999999999999999999998 999999999999999999999999999998766
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
.....+.+.+||+
T Consensus 186 ~~~~~~~~~~GTp 198 (311)
T 4aw0_A 186 SKQARANSFVGTA 198 (311)
T ss_dssp TTCCCBCCCCSCG
T ss_pred CCcccccCcccCc
Confidence 5555566688985
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-34 Score=298.42 Aligned_cols=160 Identities=26% Similarity=0.445 Sum_probs=143.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
..|+..++||+|+||+||+|+.. +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..|||||||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~ 153 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 153 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCC
Confidence 46888999999999999999986 79999999997666666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCc
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 639 (649)
++|+|.+++.+ ..+++.++..|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+......
T Consensus 154 ~gg~L~~~l~~----~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 226 (346)
T 4fih_A 154 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 226 (346)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC
T ss_pred CCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCCCc
Confidence 99999999843 45899999999999999999999998 999999999999999999999999999988654432
Q ss_pred cccCceeecC
Q 006347 640 ADTGRVVGTL 649 (649)
Q Consensus 640 ~~~~~~~GT~ 649 (649)
....+||+
T Consensus 227 --~~~~~GTp 234 (346)
T 4fih_A 227 --RKSLVGTP 234 (346)
T ss_dssp --BCCCCSCG
T ss_pred --ccccccCc
Confidence 33467884
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-34 Score=294.23 Aligned_cols=161 Identities=30% Similarity=0.536 Sum_probs=132.9
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+++.+.++||+|+||+||+|++.+ .||||+++.. .....++|.+|+.++++++|||||+++|+|.+ ++.+|||||
T Consensus 36 ~~l~l~~~iG~G~fG~Vy~~~~~~--~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy 112 (307)
T 3omv_A 36 SEVMLSTRIGSGSFGTVYKGKWHG--DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQW 112 (307)
T ss_dssp TSCCEEEECCCCSSSEEEEEESSS--EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEEC
T ss_pred HHeEEeeEEeeCCCcEEEEEEECC--cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEc
Confidence 567788999999999999999763 6999998643 33456789999999999999999999998864 568999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
|++|+|.++|+. .+..++|.+++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+.......
T Consensus 113 ~~gGsL~~~l~~--~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~ 187 (307)
T 3omv_A 113 CEGSSLYKHLHV--QETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG 187 (307)
T ss_dssp CSSCBHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred CCCCCHHHHHhh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence 999999999965 3456999999999999999999999987 99999999999999999999999999998765444
Q ss_pred ccccCceeecC
Q 006347 639 QADTGRVVGTL 649 (649)
Q Consensus 639 ~~~~~~~~GT~ 649 (649)
...+....||+
T Consensus 188 ~~~~~~~~GT~ 198 (307)
T 3omv_A 188 SQQVEQPTGSV 198 (307)
T ss_dssp ------CCCCT
T ss_pred ceeecccccCC
Confidence 44445577875
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-33 Score=299.87 Aligned_cols=160 Identities=26% Similarity=0.445 Sum_probs=144.6
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+.|++.++||+|+||.||+|+.. +|+.||||+++.......+.+.+|+.+|++++|||||++++++.+.+..|||||||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~ 230 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFL 230 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCC
Confidence 56889999999999999999976 69999999998766666778999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCc
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 639 (649)
++|+|.+++.. ..+++.++..|+.||+.||+|||+++ ||||||||+||||++++.+||+|||+|+.+......
T Consensus 231 ~gG~L~~~i~~----~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~ 303 (423)
T 4fie_A 231 EGGALTDIVTH----TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPR 303 (423)
T ss_dssp TTEEHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCC
T ss_pred CCCcHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCCCcc
Confidence 99999999843 45899999999999999999999998 999999999999999999999999999998654433
Q ss_pred cccCceeecC
Q 006347 640 ADTGRVVGTL 649 (649)
Q Consensus 640 ~~~~~~~GT~ 649 (649)
....+||+
T Consensus 304 --~~~~~GTp 311 (423)
T 4fie_A 304 --RKSLVGTP 311 (423)
T ss_dssp --BCCCEECT
T ss_pred --ccccccCc
Confidence 34578985
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-33 Score=297.53 Aligned_cols=163 Identities=23% Similarity=0.385 Sum_probs=136.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.++||+|+||+||+|+.. +|+.||||++++. .....+.|.+|+.++++++|||||++++++.+++..|||||
T Consensus 24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE 103 (350)
T 4b9d_A 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD 103 (350)
T ss_dssp CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence 57999999999999999999976 7999999999654 23456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+++|+|.++|... +...+++.+...|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+....
T Consensus 104 y~~gg~L~~~i~~~-~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~ 179 (350)
T 4b9d_A 104 YCEGGDLFKRINAQ-KGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV 179 (350)
T ss_dssp CCTTCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred CCCCCcHHHHHHHc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence 99999999999642 3445789999999999999999999988 9999999999999999999999999999874322
Q ss_pred CccccCceeecC
Q 006347 638 DQADTGRVVGTL 649 (649)
Q Consensus 638 ~~~~~~~~~GT~ 649 (649)
..+...+||+
T Consensus 180 --~~~~~~~GT~ 189 (350)
T 4b9d_A 180 --ELARACIGTP 189 (350)
T ss_dssp --HHHHHHHSCC
T ss_pred --ccccccCCCc
Confidence 1223456774
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=286.11 Aligned_cols=161 Identities=27% Similarity=0.410 Sum_probs=130.7
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHH--HHHHHHhcCCCCCccceEEEEEeCC----eEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFM--NEVMVISKLQHRNLVRLLGCCVEGE----EKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~--~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 554 (649)
++|.+.++||+|+||+||+|++. |+.||||+++.. ..+++. .|+..+.+++|||||+++|+|.+.+ +.+|
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~~-g~~VAvK~l~~~---~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~l 78 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEE
Confidence 35777899999999999999985 899999999653 233344 4556667889999999999998764 5799
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
|||||++|+|.++|+. ..++|..+.+|+.|+|+||+|||++ ..++||||||||+||||++++++||+|||+
T Consensus 79 V~Ey~~~gsL~~~l~~----~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGl 154 (303)
T 3hmm_A 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EecCCCCCcHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCC
Confidence 9999999999999953 4689999999999999999999986 234699999999999999999999999999
Q ss_pred ceeeCCCCCcc--ccCceeecC
Q 006347 630 AKIFGGNQDQA--DTGRVVGTL 649 (649)
Q Consensus 630 a~~~~~~~~~~--~~~~~~GT~ 649 (649)
|+......... .+...+||+
T Consensus 155 a~~~~~~~~~~~~~~~~~~GT~ 176 (303)
T 3hmm_A 155 AVRHDSATDTIDIAPNHRVGTK 176 (303)
T ss_dssp CEEEETTTTEESCC-----CCG
T ss_pred CccccCCCCceeeecccccccc
Confidence 99986544322 233467774
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.8e-32 Score=284.02 Aligned_cols=154 Identities=27% Similarity=0.438 Sum_probs=128.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC--------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-------- 550 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-------- 550 (649)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+
T Consensus 5 ~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~ 84 (299)
T 4g31_A 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPS 84 (299)
T ss_dssp HHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC--------
T ss_pred hhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCcccccccc
Confidence 45889999999999999999976 78999999996543 334578999999999999999999999998654
Q ss_pred ----eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006347 551 ----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 626 (649)
Q Consensus 551 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~D 626 (649)
..+|||||+++|+|.+++.........++.....|+.||++||+|||+++ ||||||||+||||+.++.+||+|
T Consensus 85 ~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~D 161 (299)
T 4g31_A 85 SPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 161 (299)
T ss_dssp --CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC
T ss_pred CCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEcc
Confidence 36899999999999999976544445677888999999999999999998 99999999999999999999999
Q ss_pred cCCceeeCCCC
Q 006347 627 FGMAKIFGGNQ 637 (649)
Q Consensus 627 FGla~~~~~~~ 637 (649)
||+|+.+..+.
T Consensus 162 FGla~~~~~~~ 172 (299)
T 4g31_A 162 FGLVTAMDQDE 172 (299)
T ss_dssp CCCC-------
T ss_pred CccceecCCCc
Confidence 99999886543
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.98 E-value=2.2e-32 Score=281.41 Aligned_cols=158 Identities=28% Similarity=0.389 Sum_probs=134.2
Q ss_pred ccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEEEEE
Q 006347 484 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLIY 556 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 556 (649)
++.++||+|+||+||+|... +++.||||++... .....+.|.+|+.++++++|||||++++++.+ .+..+|||
T Consensus 29 ~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvm 108 (290)
T 3fpq_A 29 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 108 (290)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEE
Confidence 55678999999999999976 6889999999643 23456789999999999999999999999875 24579999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~~ 635 (649)
|||++|+|.++|.+ ...+++..+..|+.||++||+|||+++ ++||||||||+||||+. ++.+||+|||+|+....
T Consensus 109 Ey~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~ylH~~~-~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~ 184 (290)
T 3fpq_A 109 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 184 (290)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEecccChhheeEECCCCCEEEEeCcCCEeCCC
Confidence 99999999999953 456899999999999999999999874 46999999999999984 78999999999987533
Q ss_pred CCCccccCceeecC
Q 006347 636 NQDQADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~~~~~~~~GT~ 649 (649)
. .+..++|||
T Consensus 185 ~----~~~~~~GTp 194 (290)
T 3fpq_A 185 S----FAKAVIGTP 194 (290)
T ss_dssp T----SBEESCSSC
T ss_pred C----ccCCcccCc
Confidence 2 233467885
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-32 Score=291.24 Aligned_cols=176 Identities=28% Similarity=0.402 Sum_probs=147.7
Q ss_pred CCHHHHHHHhcCcccceeeccCCcEEEEEEEecC------CcEEEEEEeccccc-ccHHHHHHHHHHHhcCC-CCCccce
Q 006347 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQ-HRNLVRL 542 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~-H~niv~l 542 (649)
++..+.+...++|++.++||+|+||+||+|.... ++.||||+++.... ...++|.+|+.+|.++. |||||++
T Consensus 54 ~~~~~wEi~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l 133 (353)
T 4ase_A 54 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 133 (353)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred CCCcccEecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence 3444555566789999999999999999998652 35899999976433 34678999999999995 5999999
Q ss_pred EEEEEeC-CeEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 006347 543 LGCCVEG-EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 608 (649)
Q Consensus 543 ~g~~~~~-~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 608 (649)
+|+|.+. +..+||||||++|+|.++|+... ....++|.+++.|+.|||+||+|||+++ |||||
T Consensus 134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD 210 (353)
T 4ase_A 134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 210 (353)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence 9999875 56899999999999999996421 1345899999999999999999999987 99999
Q ss_pred CCCCcEEEcCCCceEEEecCCceeeCCCCCccccCceeecC
Q 006347 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 609 lkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
|||+|||+++++++||+|||+|+.+..+.....++...||+
T Consensus 211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~ 251 (353)
T 4ase_A 211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251 (353)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECG
T ss_pred cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccc
Confidence 99999999999999999999999886666555556678874
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.2e-32 Score=285.19 Aligned_cols=159 Identities=26% Similarity=0.339 Sum_probs=134.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.+.|++.++||+|+||.||+|+.. +|+.||||+++... .+.+|+.++++++|||||++++++.+++..+|||||
T Consensus 57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-----~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy 131 (336)
T 4g3f_A 57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-----FRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMEL 131 (336)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-----CCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-----hHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEec
Confidence 356788889999999999999976 68999999996532 224799999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceeeCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~~~~~ 637 (649)
|++|+|.++|.+ ...+++.+...|+.||+.||+|||+++ ||||||||+||||+.++ ++||+|||+|+.+..+.
T Consensus 132 ~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~ 205 (336)
T 4g3f_A 132 LEGGSLGQLIKQ---MGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDG 205 (336)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC----
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCC
Confidence 999999999953 356999999999999999999999987 99999999999999987 69999999999986543
Q ss_pred Ccc---ccCceeecC
Q 006347 638 DQA---DTGRVVGTL 649 (649)
Q Consensus 638 ~~~---~~~~~~GT~ 649 (649)
... ....++||+
T Consensus 206 ~~~~~~~~~~~~GT~ 220 (336)
T 4g3f_A 206 LGKSLLTGDYIPGTE 220 (336)
T ss_dssp --------CCCCCCG
T ss_pred cccceecCCccccCc
Confidence 221 223467885
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-32 Score=275.35 Aligned_cols=159 Identities=28% Similarity=0.498 Sum_probs=127.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||+|... +|+.||||++++.. ....+.+.+|+.++++++|||||++++++.+.+..+|||
T Consensus 13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 92 (275)
T 3hyh_A 13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVI 92 (275)
T ss_dssp -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEE
Confidence 58999999999999999999975 79999999996532 234567999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+ +|+|.+++.+ ...+++.+...++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+.....
T Consensus 93 Ey~-~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 165 (275)
T 3hyh_A 93 EYA-GNELFDYIVQ---RDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG 165 (275)
T ss_dssp ECC-CEEHHHHHHH---SCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC------
T ss_pred eCC-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC
Confidence 999 6899999853 456999999999999999999999998 999999999999999999999999999987543
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
.. ..+..||+
T Consensus 166 ~~---~~~~~GT~ 175 (275)
T 3hyh_A 166 NF---LKTSCGSP 175 (275)
T ss_dssp ------------C
T ss_pred Cc---cCCeeECc
Confidence 22 23467875
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-32 Score=284.49 Aligned_cols=161 Identities=29% Similarity=0.321 Sum_probs=132.5
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|++.+.||+|+||+||+|+.. +++.||||++++.. .....++.+|+.++++++|||||++++++.+.+..+|
T Consensus 24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i 103 (304)
T 3ubd_A 24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL 103 (304)
T ss_dssp GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence 46999999999999999999863 47899999997542 2344578899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.++|.+ ...+++.+...++.||+.||+|||+++ ||||||||+|||+++++++||+|||+|+...
T Consensus 104 vmEy~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~ 177 (304)
T 3ubd_A 104 ILDFLRGGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESI 177 (304)
T ss_dssp EECCCTTCEEHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC--
T ss_pred EEEcCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceecc
Confidence 9999999999999953 456999999999999999999999998 9999999999999999999999999999764
Q ss_pred CCCCccccCceeecC
Q 006347 635 GNQDQADTGRVVGTL 649 (649)
Q Consensus 635 ~~~~~~~~~~~~GT~ 649 (649)
..... ..+..||+
T Consensus 178 ~~~~~--~~~~~GT~ 190 (304)
T 3ubd_A 178 DHEKK--AYSFCGTV 190 (304)
T ss_dssp ---CC--CCSCCCCG
T ss_pred CCCcc--ccccccCc
Confidence 43332 23467874
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=272.85 Aligned_cols=162 Identities=25% Similarity=0.453 Sum_probs=136.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC------Ce
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------EE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~~ 551 (649)
++|++.++||+|+||+||+|... +|+.||||++++.. ....+.+.+|+.+|++++|||||++++++... +.
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~ 133 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKS 133 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCE
Confidence 57999999999999999999976 79999999997542 23456789999999999999999999997643 57
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.|||||||+ |+|.+++.. ...+++.++..++.||+.||+|||+++ ||||||||+|||++.++.+||+|||+|+
T Consensus 134 ~~ivmE~~~-g~L~~~i~~---~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~ 206 (398)
T 4b99_A 134 VYVVLDLME-SDLHQIIHS---SQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMAR 206 (398)
T ss_dssp EEEEEECCS-EEHHHHHTS---SSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCB
T ss_pred EEEEEeCCC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceee
Confidence 899999995 789999853 467999999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCCCC--ccccCceeecC
Q 006347 632 IFGGNQD--QADTGRVVGTL 649 (649)
Q Consensus 632 ~~~~~~~--~~~~~~~~GT~ 649 (649)
.+..... .......+||+
T Consensus 207 ~~~~~~~~~~~~~~~~~GT~ 226 (398)
T 4b99_A 207 GLCTSPAEHQYFMTEYVATR 226 (398)
T ss_dssp CC-------CCCCCSSCCCC
T ss_pred ecccCccccccccccceeCh
Confidence 8754322 22334567874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-29 Score=263.56 Aligned_cols=146 Identities=23% Similarity=0.391 Sum_probs=131.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (649)
..++|++.++||+|+||+||+|+.+ +++.||||++.+. ....++.+|++++.++ +|||||++++++.+.++.+
T Consensus 19 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~--~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~ 96 (361)
T 4f9c_A 19 LSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPT--SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVV 96 (361)
T ss_dssp GGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTT--SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEE
T ss_pred ccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccc--cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEE
Confidence 4578999999999999999999853 4678999998653 3456788999999998 6999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCcee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKI 632 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla~~ 632 (649)
|||||+++|+|.+++. .+++.+...++.||++||+|||+++ ||||||||+|||++.+ +.+||+|||+|+.
T Consensus 97 lvmE~~~g~~L~~~~~------~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~ 167 (361)
T 4f9c_A 97 IAMPYLEHESFLDILN------SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQG 167 (361)
T ss_dssp EEEECCCCCCHHHHHT------TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred EEEeCCCcccHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcc
Confidence 9999999999999982 3889999999999999999999998 9999999999999977 7999999999997
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
...
T Consensus 168 ~~~ 170 (361)
T 4f9c_A 168 THD 170 (361)
T ss_dssp CTT
T ss_pred cCC
Confidence 654
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=99.96 E-value=7.5e-29 Score=278.78 Aligned_cols=159 Identities=30% Similarity=0.348 Sum_probs=136.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHH---HHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMN---EVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|++.+.||+|+||+||+|+.. +|+.||||++++.. ......+.+ ++.++..++|||||++++++.+.+..|
T Consensus 189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly 268 (689)
T 3v5w_A 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 268 (689)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence 56899999999999999999976 68999999996531 222333334 466777889999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||||+++|+|.++|.+ ...+++.....++.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+
T Consensus 269 lVmEy~~GGdL~~~l~~---~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~ 342 (689)
T 3v5w_A 269 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 342 (689)
T ss_dssp EEECCCCSCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred EEEecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeec
Confidence 99999999999999953 456999999999999999999999988 999999999999999999999999999988
Q ss_pred CCCCCccccCceeecC
Q 006347 634 GGNQDQADTGRVVGTL 649 (649)
Q Consensus 634 ~~~~~~~~~~~~~GT~ 649 (649)
.... +.+.+||+
T Consensus 343 ~~~~----~~t~~GTp 354 (689)
T 3v5w_A 343 SKKK----PHASVGTH 354 (689)
T ss_dssp SSCC----CCSCCSCG
T ss_pred CCCC----CCCccCCc
Confidence 5543 23467885
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-28 Score=276.65 Aligned_cols=161 Identities=25% Similarity=0.432 Sum_probs=142.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.+.||+|+||.||+|... +|+.||||.+........+.+.+|+.+|++++|||||++++++.+.+..+||||||
T Consensus 157 ~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~ 236 (573)
T 3uto_A 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 236 (573)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred cccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeec
Confidence 57999999999999999999976 78999999997766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE--LNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~Ki~DFGla~~~~~~~ 637 (649)
++|+|.++|.+ +...+++.+...++.||+.||.|||+++ |+||||||+|||++.+ +.+||+|||+|+.+....
T Consensus 237 ~gg~L~~~i~~--~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~ 311 (573)
T 3uto_A 237 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311 (573)
T ss_dssp CCCBHHHHHTC--TTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred CCCcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence 99999999854 3356899999999999999999999998 9999999999999854 899999999999986543
Q ss_pred CccccCceeecC
Q 006347 638 DQADTGRVVGTL 649 (649)
Q Consensus 638 ~~~~~~~~~GT~ 649 (649)
. .....||+
T Consensus 312 ~---~~~~~GT~ 320 (573)
T 3uto_A 312 S---VKVTTGTA 320 (573)
T ss_dssp E---EEEECSSG
T ss_pred c---eeeeEECc
Confidence 2 22356763
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=9.3e-28 Score=251.23 Aligned_cols=175 Identities=43% Similarity=0.683 Sum_probs=151.0
Q ss_pred CCHHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 006347 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE 550 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (649)
+.+.++...+++|++.+.||+|+||.||+|+..+++.||||++........+++.+|+.++.+++||||+++++++.+.+
T Consensus 29 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 108 (321)
T 2qkw_B 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERN 108 (321)
T ss_dssp -CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTT
T ss_pred ecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCC
Confidence 44445566788999999999999999999998889999999997766667789999999999999999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 109 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~ 185 (321)
T 2qkw_B 109 EMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGI 185 (321)
T ss_dssp CCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEECCCTT
T ss_pred eEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEEeeccc
Confidence 99999999999999999965322 346899999999999999999999987 99999999999999999999999999
Q ss_pred ceeeCCCCCccccCceeec
Q 006347 630 AKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 630 a~~~~~~~~~~~~~~~~GT 648 (649)
++...............||
T Consensus 186 ~~~~~~~~~~~~~~~~~gt 204 (321)
T 2qkw_B 186 SKKGTELDQTHLSTVVKGT 204 (321)
T ss_dssp CEECSSSSCCCCBCCCEEE
T ss_pred ccccccccccccccccCCC
Confidence 9986543333223334555
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=7e-27 Score=244.94 Aligned_cols=162 Identities=29% Similarity=0.462 Sum_probs=145.4
Q ss_pred CCCCCHHHHHHHhcC----------cccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC
Q 006347 468 LPLFQFEELATATNN----------FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH 536 (649)
Q Consensus 468 ~~~~~~~~l~~~~~~----------f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H 536 (649)
.+.+++++++.+++. |+..+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|
T Consensus 22 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h 101 (321)
T 2c30_A 22 SGVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQH 101 (321)
T ss_dssp ---CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCC
T ss_pred CCcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCC
Confidence 356888888888764 666789999999999999987 799999999977666677889999999999999
Q ss_pred CCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 537 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+||+++++++...+..++||||+++++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||+
T Consensus 102 ~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll 174 (321)
T 2c30_A 102 FNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ----VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILL 174 (321)
T ss_dssp TTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEE
T ss_pred CCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999843 46899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCC
Q 006347 617 DEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~ 636 (649)
+.++.+||+|||+++.+...
T Consensus 175 ~~~~~~kl~Dfg~~~~~~~~ 194 (321)
T 2c30_A 175 TLDGRVKLSDFGFCAQISKD 194 (321)
T ss_dssp CTTCCEEECCCTTCEECCSS
T ss_pred CCCCcEEEeeeeeeeecccC
Confidence 99999999999999987544
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.1e-27 Score=261.21 Aligned_cols=172 Identities=22% Similarity=0.288 Sum_probs=146.0
Q ss_pred CHHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEE
Q 006347 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547 (649)
Q Consensus 472 ~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 547 (649)
.+.++....++|++.++||+|+||+||+|+.. +++.||||++++.. ....+.+.+|+.++.+++||||+++++++.
T Consensus 65 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 144 (437)
T 4aw2_A 65 KVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQ 144 (437)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhcccCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence 34555666789999999999999999999987 57899999996522 223345899999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
+.+..+|||||+++|+|.+++.. ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+||
T Consensus 145 ~~~~~~lV~Ey~~gg~L~~~l~~--~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DF 219 (437)
T 4aw2_A 145 DDNNLYLVMDYYVGGDLLTLLSK--FEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219 (437)
T ss_dssp CSSEEEEEECCCTTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEecCCCCcHHHHHHH--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcch
Confidence 99999999999999999999964 2356899999999999999999999988 999999999999999999999999
Q ss_pred CCceeeCCCCCccccCceeecC
Q 006347 628 GMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 628 Gla~~~~~~~~~~~~~~~~GT~ 649 (649)
|+|+.+....... .....||+
T Consensus 220 Gla~~~~~~~~~~-~~~~~GT~ 240 (437)
T 4aw2_A 220 GSCLKLMEDGTVQ-SSVAVGTP 240 (437)
T ss_dssp TTCEECCTTSCEE-CCSCCSCG
T ss_pred hhhhhcccCCCcc-cccccCCc
Confidence 9999875543322 22345663
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=8e-27 Score=242.17 Aligned_cols=178 Identities=42% Similarity=0.661 Sum_probs=153.7
Q ss_pred CCCCCCHHHHHHHhcCcccc------eeeccCCcEEEEEEEecCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCC
Q 006347 467 DLPLFQFEELATATNNFQLS------SKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH 536 (649)
Q Consensus 467 ~~~~~~~~~l~~~~~~f~~~------~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~H 536 (649)
..+.|++.++..++++|... +.||+|+||.||+|.. +++.||||++.... ....+.+.+|+.++.+++|
T Consensus 11 ~~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h 89 (307)
T 2nru_A 11 RFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQH 89 (307)
T ss_dssp CCEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEES-SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCC
T ss_pred CCCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEE-CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCC
Confidence 45679999999999999877 8899999999999997 48899999986432 3346789999999999999
Q ss_pred CCccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 537 ~niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
|||+++++++.+.+..++||||+++++|.+++........+++..+..++.|+++||+|||+.+ |+||||||+||++
T Consensus 90 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili 166 (307)
T 2nru_A 90 ENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILL 166 (307)
T ss_dssp TTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEE
Confidence 9999999999999999999999999999999975444567999999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCCCCccccCceeec
Q 006347 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
++++.+||+|||+++...............||
T Consensus 167 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~ 198 (307)
T 2nru_A 167 DEAFTAKISDFGLARASEKFAQTVMTSRIVGT 198 (307)
T ss_dssp CTTCCEEECCCTTCEECCSCSSCEECSSCCSC
T ss_pred cCCCcEEEeecccccccccccccccccccCCC
Confidence 99999999999999987554333223334444
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.7e-27 Score=247.97 Aligned_cols=172 Identities=47% Similarity=0.751 Sum_probs=151.0
Q ss_pred cCCCCCCCHHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceE
Q 006347 465 LQDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLL 543 (649)
Q Consensus 465 ~~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~ 543 (649)
...+..+++.++....++|++.+.||+|+||.||+|...+++.||||++..... .....+.+|+.++.+++||||++++
T Consensus 14 ~~~~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~ 93 (326)
T 3uim_A 14 LGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLR 93 (326)
T ss_dssp -CCCEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCC
T ss_pred cCccceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceE
Confidence 345668899999999999999999999999999999988899999999975432 2344789999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
+++.+.+..++||||+++|+|.+++.... ....+++..+..|+.|++.||+|||+.+..+|+||||||+|||+++++.+
T Consensus 94 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~ 173 (326)
T 3uim_A 94 GFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEA 173 (326)
T ss_dssp EEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCE
T ss_pred EEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCE
Confidence 99999999999999999999999997643 23459999999999999999999999833349999999999999999999
Q ss_pred EEEecCCceeeCCC
Q 006347 623 KISDFGMAKIFGGN 636 (649)
Q Consensus 623 Ki~DFGla~~~~~~ 636 (649)
||+|||+++.+...
T Consensus 174 kl~Dfg~~~~~~~~ 187 (326)
T 3uim_A 174 VVGDFGLAKLMDYK 187 (326)
T ss_dssp EECCCSSCEECCSS
T ss_pred EeccCccccccCcc
Confidence 99999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=9.8e-27 Score=242.11 Aligned_cols=151 Identities=27% Similarity=0.519 Sum_probs=138.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|.+.+.||+|+||+||++... +++.||+|++........+.|.+|+.++.+++||||+++++++.+++..++||||+
T Consensus 10 ~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 89 (310)
T 3s95_A 10 SDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYI 89 (310)
T ss_dssp GGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEec
Confidence 56888899999999999999986 68999999997766677789999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++++|.+++... ...+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 90 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~ 161 (310)
T 3s95_A 90 KGGTLRGIIKSM--DSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161 (310)
T ss_dssp TTCBHHHHHHHC--CTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC--
T ss_pred CCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceecccc
Confidence 999999999642 456899999999999999999999988 999999999999999999999999999987543
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=1.1e-26 Score=240.61 Aligned_cols=150 Identities=28% Similarity=0.471 Sum_probs=137.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.+.||+|+||+||+|... +++.||||++........+.+.+|+.++++++||||+++++++.+++..++||||+
T Consensus 20 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~ 99 (297)
T 3fxz_A 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (297)
T ss_dssp GTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred hceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECC
Confidence 57889999999999999999964 78999999997666666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
++|+|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+....
T Consensus 100 ~~~~L~~~~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 170 (297)
T 3fxz_A 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (297)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred CCCCHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence 99999999953 35899999999999999999999987 9999999999999999999999999999876544
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=5.6e-27 Score=253.75 Aligned_cols=168 Identities=24% Similarity=0.315 Sum_probs=143.3
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
+.+++...++|.+.+.||+|+||+||+++.. +++.||||++++. .....+.+.+|+.++..++|||||++++++.+
T Consensus 61 ~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~ 140 (410)
T 3v8s_A 61 IRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQD 140 (410)
T ss_dssp HHHHSCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred HHhcccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEE
Confidence 3445556678999999999999999999987 6889999998652 12344568899999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
.+..+|||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 141 ~~~~~lV~E~~~gg~L~~~l~~----~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG 213 (410)
T 3v8s_A 141 DRYLYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213 (410)
T ss_dssp SSEEEEEECCCTTEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEeCCCCCcHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccc
Confidence 9999999999999999999853 35899999999999999999999988 9999999999999999999999999
Q ss_pred CceeeCCCCCccccCceeec
Q 006347 629 MAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 629 la~~~~~~~~~~~~~~~~GT 648 (649)
+|+.+...... ......||
T Consensus 214 ~a~~~~~~~~~-~~~~~~gt 232 (410)
T 3v8s_A 214 TCMKMNKEGMV-RCDTAVGT 232 (410)
T ss_dssp TCEECCTTSEE-ECCSCCSC
T ss_pred eeEeeccCCcc-cccCCcCC
Confidence 99987544321 22235565
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.3e-26 Score=240.81 Aligned_cols=153 Identities=26% Similarity=0.434 Sum_probs=135.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe-------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE------- 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------- 551 (649)
++|++.+.||+|+||.||+|+.. +++.||||+++... ....+.+.+|+.++++++||||+++++++.+...
T Consensus 6 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 85 (332)
T 3qd2_B 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEM 85 (332)
T ss_dssp HHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHH
T ss_pred hcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhh
Confidence 56888999999999999999987 79999999996433 3456789999999999999999999999976542
Q ss_pred --------------------------------------------------EEEEEecCCCCChhhhhcCCCCCCCCCHHH
Q 006347 552 --------------------------------------------------KMLIYEYMPNRSLDALLFDPLKKERLDWRK 581 (649)
Q Consensus 552 --------------------------------------------------~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 581 (649)
.++||||+++++|.+++.........++..
T Consensus 86 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~ 165 (332)
T 3qd2_B 86 DEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGV 165 (332)
T ss_dssp HC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHH
T ss_pred hhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHH
Confidence 799999999999999998765555678888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 582 RFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 582 ~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 166 ~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~ 217 (332)
T 3qd2_B 166 CLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQD 217 (332)
T ss_dssp HHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC
T ss_pred HHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccc
Confidence 9999999999999999988 999999999999999999999999999988654
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=99.94 E-value=1.8e-26 Score=243.56 Aligned_cols=160 Identities=27% Similarity=0.326 Sum_probs=139.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||+++.. +++.||||.+++. .....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~ 84 (337)
T 1o6l_A 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence 57889999999999999999976 6899999999753 2345678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 85 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 158 (337)
T 1o6l_A 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC
Confidence 99999999999853 356899999999999999999999987 999999999999999999999999999975333
Q ss_pred CCccccCceeec
Q 006347 637 QDQADTGRVVGT 648 (649)
Q Consensus 637 ~~~~~~~~~~GT 648 (649)
... .....||
T Consensus 159 ~~~--~~~~~gt 168 (337)
T 1o6l_A 159 GAT--MKTFCGT 168 (337)
T ss_dssp TCC--BCCCEEC
T ss_pred CCc--ccccccC
Confidence 222 2235666
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=1e-26 Score=251.82 Aligned_cols=171 Identities=25% Similarity=0.308 Sum_probs=145.1
Q ss_pred CHHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEE
Q 006347 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCV 547 (649)
Q Consensus 472 ~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 547 (649)
.++++....++|++.+.||+|+||+||+++.. +++.||||++++.. ....+.+.+|..++.+++|+||+++++++.
T Consensus 52 ~~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~ 131 (412)
T 2vd5_A 52 RLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQ 131 (412)
T ss_dssp HHHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEE
T ss_pred hhhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEe
Confidence 34455556688999999999999999999986 78999999996532 234456889999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
+.+..+|||||+++|+|.+++.+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++++||+||
T Consensus 132 ~~~~~~lVmE~~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DF 206 (412)
T 2vd5_A 132 DENYLYLVMEYYVGGDLLTLLSKF--GERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206 (412)
T ss_dssp CSSEEEEEECCCCSCBHHHHHHHH--SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCC
T ss_pred eCCEEEEEEcCCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeec
Confidence 999999999999999999999542 246899999999999999999999987 999999999999999999999999
Q ss_pred CCceeeCCCCCccccCceeec
Q 006347 628 GMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 628 Gla~~~~~~~~~~~~~~~~GT 648 (649)
|+|+.+...... ......||
T Consensus 207 Gla~~~~~~~~~-~~~~~~Gt 226 (412)
T 2vd5_A 207 GSCLKLRADGTV-RSLVAVGT 226 (412)
T ss_dssp TTCEECCTTSCE-ECSSCCSC
T ss_pred hhheeccCCCcc-ccceeccc
Confidence 999987554322 12234565
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=242.48 Aligned_cols=151 Identities=31% Similarity=0.525 Sum_probs=136.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 93 (328)
T 3fe3_A 14 IGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIM 93 (328)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEE
Confidence 467999999999999999999974 7999999999654 2345677899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 94 e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 167 (328)
T 3fe3_A 94 EYASGGEVFDYLVA---HGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG 167 (328)
T ss_dssp CCCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS
T ss_pred ECCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC
Confidence 99999999999853 356899999999999999999999988 999999999999999999999999999876543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.9e-26 Score=246.63 Aligned_cols=155 Identities=28% Similarity=0.515 Sum_probs=136.0
Q ss_pred hcCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG 549 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (649)
.++|.+.+.||+|+||.||+|+.. ++..||||+++... ....+++.+|+.++.++ +||||+++++++.+.
T Consensus 80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 159 (370)
T 2psq_A 80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 159 (370)
T ss_dssp GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS
T ss_pred HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC
Confidence 367888999999999999999852 35679999997543 34567899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+..++||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 160 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll 236 (370)
T 2psq_A 160 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 236 (370)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEE
T ss_pred CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhEEE
Confidence 99999999999999999996432 1245899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCCC
Q 006347 617 DEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~~ 637 (649)
++++.+||+|||+|+.+....
T Consensus 237 ~~~~~~kl~DFG~a~~~~~~~ 257 (370)
T 2psq_A 237 TENNVMKIADFGLARDINNID 257 (370)
T ss_dssp CTTCCEEECCCSSCEETTCCC
T ss_pred CCCCCEEEccccCCcccCccc
Confidence 999999999999999875443
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.4e-26 Score=241.15 Aligned_cols=162 Identities=30% Similarity=0.445 Sum_probs=137.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 86 (323)
T 3tki_A 7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 86 (323)
T ss_dssp TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEc
Confidence 67999999999999999999977 78999999986432 23346789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 87 ~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 160 (323)
T 3tki_A 87 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 160 (323)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred CCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCc
Confidence 999999999853 345899999999999999999999988 99999999999999999999999999998753333
Q ss_pred ccccCceeec
Q 006347 639 QADTGRVVGT 648 (649)
Q Consensus 639 ~~~~~~~~GT 648 (649)
........||
T Consensus 161 ~~~~~~~~gt 170 (323)
T 3tki_A 161 ERLLNKMCGT 170 (323)
T ss_dssp ECCBCSCCSC
T ss_pred ccccCCCccC
Confidence 2222334454
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=99.94 E-value=2.1e-26 Score=241.26 Aligned_cols=163 Identities=31% Similarity=0.493 Sum_probs=136.7
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC----eEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----EKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~lV 555 (649)
.++|++.+.||+|+||.||+|+.. ++.||||++... ......+..|+.++.+++||||+++++++.+.. ..++|
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv 100 (322)
T 3soc_A 23 SMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPIQ-DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLI 100 (322)
T ss_dssp TEEEEEEEEEECSTTCEEEEEEET-TEEEEEEEECGG-GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred hhhchhhheecccCceEEEEEEEC-CCEEEEEEeecC-chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEE
Confidence 367899999999999999999887 789999999653 334455667999999999999999999998854 46999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------CCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
|||+++|+|.+++.. ..+++..+..++.|+++||+|||+. ...+|+||||||+|||+++++.+||+|||
T Consensus 101 ~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg 176 (322)
T 3soc_A 101 TAFHEKGSLSDFLKA----NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFG 176 (322)
T ss_dssp EECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCT
T ss_pred EecCCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCC
Confidence 999999999999953 4589999999999999999999987 01139999999999999999999999999
Q ss_pred CceeeCCCCCccccCceeec
Q 006347 629 MAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 629 la~~~~~~~~~~~~~~~~GT 648 (649)
+|+.+.............||
T Consensus 177 ~a~~~~~~~~~~~~~~~~gt 196 (322)
T 3soc_A 177 LALKFEAGKSAGDTHGQVGT 196 (322)
T ss_dssp TCEEECTTSCCCCCTTCCCC
T ss_pred cccccccccCccccccCccC
Confidence 99988655443333334555
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.94 E-value=2.2e-26 Score=244.41 Aligned_cols=150 Identities=33% Similarity=0.460 Sum_probs=134.1
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (649)
..++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 21 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~ 100 (353)
T 3txo_A 21 GIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLF 100 (353)
T ss_dssp --CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred chhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEE
Confidence 3468999999999999999999976 6899999999753 234567788999999988 7999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 101 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~ 174 (353)
T 3txo_A 101 FVMEFVNGGDLMFHIQK---SRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEG 174 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCS
T ss_pred EEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeec
Confidence 99999999999999853 356899999999999999999999988 999999999999999999999999999964
Q ss_pred C
Q 006347 634 G 634 (649)
Q Consensus 634 ~ 634 (649)
.
T Consensus 175 ~ 175 (353)
T 3txo_A 175 I 175 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-26 Score=244.56 Aligned_cols=167 Identities=16% Similarity=0.154 Sum_probs=138.7
Q ss_pred HHHHhcCcccceeeccCCcEEEEEEE------ecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCCccceEEEE
Q 006347 476 LATATNNFQLSSKLGQGGFGPVYWGR------LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCC 546 (649)
Q Consensus 476 l~~~~~~f~~~~~LG~G~fG~Vykg~------~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~ 546 (649)
+....++|.+.+.||+|+||+||+|. ..+++.||||+++.. ...++..|+.++.+++ |+||+++++++
T Consensus 60 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~ 136 (365)
T 3e7e_A 60 FQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---NPWEFYIGTQLMERLKPSMQHMFMKFYSAH 136 (365)
T ss_dssp EECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---CHHHHHHHHHHHHHSCGGGGGGBCCEEEEE
T ss_pred EEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---ChhHHHHHHHHHHHhhhhhhhhhhhhheee
Confidence 33445779999999999999999994 346889999999653 4567888888888886 99999999999
Q ss_pred EeCCeEEEEEecCCCCChhhhhcCC--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC------
Q 006347 547 VEGEEKMLIYEYMPNRSLDALLFDP--LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE------ 618 (649)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~------ 618 (649)
.+++..+|||||+++|+|.+++... .....+++..+..|+.||++||+|||+.+ ||||||||+|||++.
T Consensus 137 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~~~~~~~~ 213 (365)
T 3e7e_A 137 LFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQD 213 (365)
T ss_dssp ECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECGGGTCC-
T ss_pred ecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEecccccCcc
Confidence 9999999999999999999999632 13456999999999999999999999987 999999999999998
Q ss_pred -----CCceEEEecCCceeeCCCCCccccCceeec
Q 006347 619 -----ELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 619 -----~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
++.+||+|||+|+.+.............||
T Consensus 214 ~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt 248 (365)
T 3e7e_A 214 DEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCET 248 (365)
T ss_dssp -----CTTEEECCCTTCEEGGGSCTTEEECCSSCT
T ss_pred ccccccCCEEEeeCchhhhhhccCCCceeeeecCC
Confidence 899999999999876433222223334565
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=234.27 Aligned_cols=149 Identities=29% Similarity=0.493 Sum_probs=128.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--------------------------ccHHHHHHHHHHHhc
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--------------------------QGLEEFMNEVMVISK 533 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------------------------~~~~~f~~E~~~l~~ 533 (649)
++|++.+.||+|+||.||+|... +++.||||++..... ...+++.+|+.++++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 92 (298)
T 2zv2_A 13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK 92 (298)
T ss_dssp TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence 67899999999999999999875 688999999864321 123568999999999
Q ss_pred CCCCCccceEEEEEe--CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 006347 534 LQHRNLVRLLGCCVE--GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA 611 (649)
Q Consensus 534 l~H~niv~l~g~~~~--~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 611 (649)
++||||+++++++.+ .+..++||||+++++|.+++ ....+++..+..++.||++||+|||+.+ |+||||||
T Consensus 93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~----~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp 165 (298)
T 2zv2_A 93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP----TLKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKP 165 (298)
T ss_dssp CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS----CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCG
T ss_pred CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh----hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCH
Confidence 999999999999987 56789999999999998765 3457999999999999999999999987 99999999
Q ss_pred CcEEEcCCCceEEEecCCceeeCCC
Q 006347 612 SNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 612 ~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+|||++.++.+||+|||+++.+...
T Consensus 166 ~Nil~~~~~~~kl~Dfg~~~~~~~~ 190 (298)
T 2zv2_A 166 SNLLVGEDGHIKIADFGVSNEFKGS 190 (298)
T ss_dssp GGEEECTTSCEEECCCTTCEECSSS
T ss_pred HHEEECCCCCEEEecCCCccccccc
Confidence 9999999999999999999987543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=7e-26 Score=237.74 Aligned_cols=151 Identities=30% Similarity=0.598 Sum_probs=134.3
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|... .+..||||+++.. .....++|.+|+.++.+++||||+++++++.+++..++|
T Consensus 49 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 128 (325)
T 3kul_A 49 SRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIV 128 (325)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEE
T ss_pred hHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEE
Confidence 46788899999999999999975 3456999999754 334567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ....+++..+..|+.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 129 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 203 (325)
T 3kul_A 129 TEYMENGSLDTFLRT--HDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVLED 203 (325)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEECC-
T ss_pred eeCCCCCcHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccccc
Confidence 999999999999964 2356899999999999999999999988 99999999999999999999999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 204 ~ 204 (325)
T 3kul_A 204 D 204 (325)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.4e-26 Score=246.32 Aligned_cols=160 Identities=29% Similarity=0.383 Sum_probs=136.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||+||+++.. +++.||||++++.. ....+.+..|..++.++ +|||||++++++.+.+..+||
T Consensus 52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV 131 (396)
T 4dc2_A 52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 131 (396)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence 57899999999999999999987 57899999997542 23445688999999887 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 132 ~E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~ 205 (396)
T 4dc2_A 132 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 205 (396)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEcCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeeccc
Confidence 999999999999853 356899999999999999999999988 99999999999999999999999999997433
Q ss_pred CCCccccCceeec
Q 006347 636 NQDQADTGRVVGT 648 (649)
Q Consensus 636 ~~~~~~~~~~~GT 648 (649)
.... +....||
T Consensus 206 ~~~~--~~~~~gt 216 (396)
T 4dc2_A 206 PGDT--TSTFCGT 216 (396)
T ss_dssp TTCC--BCCCCBC
T ss_pred CCCc--cccccCC
Confidence 2222 2335566
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=238.47 Aligned_cols=151 Identities=30% Similarity=0.415 Sum_probs=135.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|.+.+.||+|+||.||++... +|+.||||.+++... ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence 467899999999999999999986 689999999975432 1357899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEecC
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFG 628 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~Ki~DFG 628 (649)
++||||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG 164 (361)
T 2yab_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (361)
T ss_dssp EEEEECCCSCBHHHHHTT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCS
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecC
Confidence 999999999999999943 456899999999999999999999987 99999999999998877 79999999
Q ss_pred CceeeCCC
Q 006347 629 MAKIFGGN 636 (649)
Q Consensus 629 la~~~~~~ 636 (649)
+++.+...
T Consensus 165 ~a~~~~~~ 172 (361)
T 2yab_A 165 LAHEIEDG 172 (361)
T ss_dssp SCEECCTT
T ss_pred CceEcCCC
Confidence 99987543
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=99.93 E-value=5.2e-26 Score=235.14 Aligned_cols=150 Identities=29% Similarity=0.460 Sum_probs=134.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||++... +++.||||.+.... ....+.|.+|+.++.+++||||+++++++.+++..++|
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 89 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLV 89 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEE
Confidence 357899999999999999999976 68999999985432 23457899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 90 ~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 163 (294)
T 4eqm_A 90 MEYIEGPTLSEYIES---HGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSE 163 (294)
T ss_dssp EECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC--
T ss_pred EeCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccc
Confidence 999999999999953 346899999999999999999999988 99999999999999999999999999987743
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-26 Score=238.66 Aligned_cols=157 Identities=30% Similarity=0.588 Sum_probs=132.5
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
....++|++.+.||+|+||+||+|+.. ++.||||++.... ....++|.+|+.++.+++||||+++++++.+.+..++
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l 111 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEWH-GSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSI 111 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEE
T ss_pred cCChhHceeeeEeecCCCeEEEEEEEC-CCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEE
Confidence 344567899999999999999999874 8899999986543 3345689999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++........+++..++.++.|+++||+|||+.+ .+|+||||||+|||+++++.+||+|||+++...
T Consensus 112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~-~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~ 190 (309)
T 3p86_A 112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRN-PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKA 190 (309)
T ss_dssp EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSS-SCCCCTTCCGGGEEECTTCCEEECCCC------
T ss_pred EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCC-CCEECCCCChhhEEEeCCCcEEECCCCCCcccc
Confidence 9999999999999975433345899999999999999999999874 359999999999999999999999999998754
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 191 ~ 191 (309)
T 3p86_A 191 S 191 (309)
T ss_dssp -
T ss_pred c
Confidence 3
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.7e-26 Score=241.12 Aligned_cols=152 Identities=32% Similarity=0.426 Sum_probs=134.7
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
....++|.+.+.||+|+||.||+|+.. +++.||||++++.. ....+.+..|..++.++ +||||+++++++.+.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 344578999999999999999999986 68899999997532 34567788999999887 89999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 93 ~~lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~ 166 (345)
T 1xjd_A 93 LFFVMEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCK 166 (345)
T ss_dssp EEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCB
T ss_pred EEEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhh
Confidence 9999999999999999953 356899999999999999999999988 9999999999999999999999999999
Q ss_pred eeC
Q 006347 632 IFG 634 (649)
Q Consensus 632 ~~~ 634 (649)
...
T Consensus 167 ~~~ 169 (345)
T 1xjd_A 167 ENM 169 (345)
T ss_dssp CCC
T ss_pred hcc
Confidence 753
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=7.8e-26 Score=236.72 Aligned_cols=149 Identities=32% Similarity=0.465 Sum_probs=135.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+++.. +|+.||||.+++.. ....+.+.+|+.++..++||||+++++++.+.+..++||
T Consensus 6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~ 85 (318)
T 1fot_A 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 85 (318)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence 56889999999999999999986 68999999996532 245677889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+....
T Consensus 86 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~ 158 (318)
T 1fot_A 86 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD 158 (318)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC
Confidence 99999999999953 356899999999999999999999987 99999999999999999999999999998643
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=8.2e-26 Score=242.50 Aligned_cols=150 Identities=25% Similarity=0.393 Sum_probs=136.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||++... +++.||||.+.+. .....+.+.+|+.++.+++|||||++++++.+.+..++||
T Consensus 15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~ 94 (384)
T 4fr4_A 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV 94 (384)
T ss_dssp GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence 56889999999999999999976 6889999998653 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 95 e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~ 168 (384)
T 4fr4_A 95 DLLLGGDLRYHLQQ---NVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE 168 (384)
T ss_dssp CCCTTEEHHHHHHT---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred ecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccCC
Confidence 99999999999954 356899999999999999999999988 999999999999999999999999999987543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=3.7e-26 Score=244.61 Aligned_cols=151 Identities=32% Similarity=0.600 Sum_probs=128.3
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|+.. ++..||||+++.. .....++|.+|+.++.+++||||+++++++.+.+..++|
T Consensus 45 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 124 (373)
T 2qol_A 45 TNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIV 124 (373)
T ss_dssp GGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred hhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEE
Confidence 46888999999999999999875 5678999999754 334567899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|.+++.. ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 125 ~e~~~~~sL~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~ 199 (373)
T 2qol_A 125 TEYMENGSLDSFLRK--HDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLED 199 (373)
T ss_dssp EECCTTCBHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccccc
Confidence 999999999999964 2346899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 200 ~ 200 (373)
T 2qol_A 200 D 200 (373)
T ss_dssp -
T ss_pred C
Confidence 4
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.1e-26 Score=244.41 Aligned_cols=176 Identities=27% Similarity=0.398 Sum_probs=144.6
Q ss_pred CCCHHHHHHHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccc
Q 006347 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVR 541 (649)
Q Consensus 470 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~ 541 (649)
.+...+.....++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++.++ +||||++
T Consensus 11 ~~~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~ 90 (359)
T 3vhe_A 11 PYDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVN 90 (359)
T ss_dssp CCCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred CCCcccccccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceee
Confidence 3455666667789999999999999999999742 46789999997643 33457799999999999 7999999
Q ss_pred eEEEEEeCCe-EEEEEecCCCCChhhhhcCCCC-----------------------------------------------
Q 006347 542 LLGCCVEGEE-KMLIYEYMPNRSLDALLFDPLK----------------------------------------------- 573 (649)
Q Consensus 542 l~g~~~~~~~-~~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------- 573 (649)
+++++.+.+. .++||||+++|+|.+++.....
T Consensus 91 ~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (359)
T 3vhe_A 91 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEE 170 (359)
T ss_dssp EEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------
T ss_pred eeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccc
Confidence 9999988654 8999999999999999975422
Q ss_pred ----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 574 ----------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 574 ----------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
...+++..++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 171 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~ 247 (359)
T 3vhe_A 171 KSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDP 247 (359)
T ss_dssp -------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCT
T ss_pred cccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccc
Confidence 122889999999999999999999987 9999999999999999999999999999875444
Q ss_pred CccccCceeec
Q 006347 638 DQADTGRVVGT 648 (649)
Q Consensus 638 ~~~~~~~~~GT 648 (649)
.........||
T Consensus 248 ~~~~~~~~~~t 258 (359)
T 3vhe_A 248 DYVRKGDARLP 258 (359)
T ss_dssp TCEEC--CEEC
T ss_pred cchhccccCCC
Confidence 33333334554
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=3.1e-26 Score=245.57 Aligned_cols=151 Identities=30% Similarity=0.528 Sum_probs=135.5
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|.+.+.||+|+||.||+|... +++.||||.++... ....++|.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 113 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 192 (377)
T 3cbl_A 113 HEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVME 192 (377)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred hHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEE
Confidence 457888999999999999999987 78999999987543 2344678999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++|+|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+....
T Consensus 193 ~~~~g~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~ 265 (377)
T 3cbl_A 193 LVQGGDFLTFLRT--EGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGMSREEAD 265 (377)
T ss_dssp CCTTCBHHHHHHH--HGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECTT
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCCceecCC
Confidence 9999999999964 2345899999999999999999999988 99999999999999999999999999997643
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=233.49 Aligned_cols=151 Identities=21% Similarity=0.334 Sum_probs=135.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|++.+.||+|+||.||++... +++.+|+|.+... ......+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 82 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK-GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC-THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC-cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEe
Confidence 367899999999999999999976 6889999998643 34556789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--ELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~Ki~DFGla~~~~~~ 636 (649)
+++|+|.+++.. ....+++.++..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++.+...
T Consensus 83 ~~g~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~ 157 (321)
T 1tki_A 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence 999999999954 2346899999999999999999999987 999999999999997 789999999999987543
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=1.6e-25 Score=233.98 Aligned_cols=154 Identities=31% Similarity=0.472 Sum_probs=136.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC--eEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE--EKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 556 (649)
++|.+.+.||+|+||+||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (319)
T 4euu_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (319)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEE
Confidence 56889999999999999999987 58999999997543 345678899999999999999999999998766 779999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEecCCcee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKI 632 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~Ki~DFGla~~ 632 (649)
||+++++|.+++........+++..+..++.||++||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~ 165 (319)
T 4euu_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (319)
T ss_dssp ECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCTTCEE
T ss_pred eCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCCCcee
Confidence 99999999999976544455999999999999999999999987 9999999999999 7888899999999998
Q ss_pred eCCCC
Q 006347 633 FGGNQ 637 (649)
Q Consensus 633 ~~~~~ 637 (649)
+....
T Consensus 166 ~~~~~ 170 (319)
T 4euu_A 166 LEDDE 170 (319)
T ss_dssp CCTTC
T ss_pred cCCCC
Confidence 75443
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6.9e-26 Score=239.89 Aligned_cols=147 Identities=30% Similarity=0.396 Sum_probs=132.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+.+|..++.++ +||||+++++++.+.+..++|
T Consensus 9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv 88 (345)
T 3a8x_A 9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV 88 (345)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence 56888999999999999999986 68899999997542 23456788999999988 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+|+..
T Consensus 89 ~e~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~ 160 (345)
T 3a8x_A 89 IEYVNGGDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEG 160 (345)
T ss_dssp ECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCS
T ss_pred EeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccc
Confidence 999999999999853 346899999999999999999999987 999999999999999999999999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=238.26 Aligned_cols=149 Identities=28% Similarity=0.375 Sum_probs=135.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+++.. +++.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 120 (350)
T 1rdq_E 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence 57888999999999999999976 68999999986532 245678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 121 e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~ 193 (350)
T 1rdq_E 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG 193 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSS
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccC
Confidence 99999999999953 346899999999999999999999988 99999999999999999999999999998754
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=3.2e-25 Score=232.81 Aligned_cols=150 Identities=30% Similarity=0.408 Sum_probs=135.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|.+.+.||+|+||.||++... +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+.+..+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~ 90 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 90 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence 46888999999999999999986 689999999865322 24678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEecCC
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFGM 629 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~Ki~DFGl 629 (649)
+||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++ .+||+|||+
T Consensus 91 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~ 164 (326)
T 2y0a_A 91 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 164 (326)
T ss_dssp EEEECCCSCBHHHHHTT---SSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCCCHHHHHHh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCC
Confidence 99999999999999953 456899999999999999999999987 99999999999999887 799999999
Q ss_pred ceeeCCC
Q 006347 630 AKIFGGN 636 (649)
Q Consensus 630 a~~~~~~ 636 (649)
|+.+...
T Consensus 165 a~~~~~~ 171 (326)
T 2y0a_A 165 AHKIDFG 171 (326)
T ss_dssp CEECCTT
T ss_pred CeECCCC
Confidence 9987543
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=233.14 Aligned_cols=150 Identities=28% Similarity=0.476 Sum_probs=132.6
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||+|+||+||+|...+++.||||++.... ....+.+.+|+.++++++||||+++++++.+.+..++|||
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 99 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFE 99 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEc
Confidence 36799999999999999999999889999999986432 2335788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|++ ++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 100 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~ 171 (311)
T 3niz_A 100 FME-KDLKKVLDE--NKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGI 171 (311)
T ss_dssp CCS-EEHHHHHHT--CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTS
T ss_pred CCC-CCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCC
Confidence 997 488888754 3345899999999999999999999987 99999999999999999999999999998753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1.3e-25 Score=228.53 Aligned_cols=149 Identities=30% Similarity=0.534 Sum_probs=136.0
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||.||+|...+++.||||++... ....+++.+|+.++.+++||||+++++++.+.+..++||||++
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 88 (269)
T 4hcu_A 10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 88 (269)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCT
T ss_pred hhceeeheecCCCccEEEEEEecCCCeEEEEEeccc-ccCHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCC
Confidence 568888999999999999999988899999999754 3456789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 89 ~~~L~~~l~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 158 (269)
T 4hcu_A 89 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLD 158 (269)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCC
T ss_pred CCcHHHHHHh--cCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccc
Confidence 9999999964 3456899999999999999999999988 99999999999999999999999999987643
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.93 E-value=2.5e-25 Score=229.47 Aligned_cols=149 Identities=24% Similarity=0.458 Sum_probs=131.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.++||+|+||+||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 81 (292)
T 3o0g_A 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence 57889999999999999999986 68999999996533 2345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 82 ~~~~-~l~~~~~~--~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~ 153 (292)
T 3o0g_A 82 FCDQ-DLKKYFDS--CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGI 153 (292)
T ss_dssp CCSE-EHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCS
T ss_pred cCCC-CHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCC
Confidence 9976 55555432 2456899999999999999999999997 99999999999999999999999999998753
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=1e-25 Score=239.29 Aligned_cols=150 Identities=30% Similarity=0.377 Sum_probs=134.4
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (649)
..++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +||||+++++++.+.+..+
T Consensus 18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~ 97 (353)
T 2i0e_A 18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 97 (353)
T ss_dssp -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence 3468999999999999999999987 4789999999753 234567788999999988 8999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+..
T Consensus 98 lv~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~ 171 (353)
T 2i0e_A 98 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 171 (353)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCC
T ss_pred EEEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCccccc
Confidence 99999999999999953 346899999999999999999999987 999999999999999999999999999975
Q ss_pred C
Q 006347 634 G 634 (649)
Q Consensus 634 ~ 634 (649)
.
T Consensus 172 ~ 172 (353)
T 2i0e_A 172 I 172 (353)
T ss_dssp C
T ss_pred c
Confidence 3
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=8.8e-26 Score=237.19 Aligned_cols=148 Identities=30% Similarity=0.391 Sum_probs=125.1
Q ss_pred cCcccceeeccCCcEEEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
++|++.+.||+|+||.||+++. .+++.||||++++.. ......+.+|+.++.+++||||+++++++.+.+..
T Consensus 17 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~ 96 (327)
T 3a62_A 17 ECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKL 96 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCE
T ss_pred HHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEE
Confidence 5789999999999999999987 478999999997542 23456788999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 97 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~ 170 (327)
T 3a62_A 97 YLILEYLSGGELFMQLER---EGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKE 170 (327)
T ss_dssp EEEEECCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC--
T ss_pred EEEEeCCCCCcHHHHHHh---CCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccc
Confidence 999999999999999853 346889999999999999999999987 99999999999999999999999999987
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
..
T Consensus 171 ~~ 172 (327)
T 3a62_A 171 SI 172 (327)
T ss_dssp --
T ss_pred cc
Confidence 53
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=3.6e-25 Score=237.98 Aligned_cols=152 Identities=24% Similarity=0.378 Sum_probs=136.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|++.+.||+|+||.||+|... +++.||+|.+..........+.+|+.++.+++||||+++++++.+....++||||
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~ 129 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 129 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEc
Confidence 357999999999999999999976 6889999999765555667899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--ELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~Ki~DFGla~~~~~~ 636 (649)
+++|+|.+++.. ....+++.++..++.||+.||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+...
T Consensus 130 ~~gg~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~ 204 (387)
T 1kob_A 130 LSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 204 (387)
T ss_dssp CCCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCcHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence 999999999854 2346899999999999999999999987 999999999999974 578999999999987554
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.93 E-value=1.4e-25 Score=238.10 Aligned_cols=153 Identities=26% Similarity=0.379 Sum_probs=134.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+.|++.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++||||+++++++.+.+..++
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 103 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM 103 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence 56889999999999999999876 68999999986421 2246789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEecCCc
Q 006347 555 IYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMA 630 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DFGla 630 (649)
||||+++++|.+++.... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||++
T Consensus 104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a 180 (351)
T 3c0i_A 104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA 180 (351)
T ss_dssp EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence 999999999988875422 2345899999999999999999999987 999999999999987654 999999999
Q ss_pred eeeCCC
Q 006347 631 KIFGGN 636 (649)
Q Consensus 631 ~~~~~~ 636 (649)
+.+...
T Consensus 181 ~~~~~~ 186 (351)
T 3c0i_A 181 IQLGES 186 (351)
T ss_dssp EECCTT
T ss_pred eEecCC
Confidence 987654
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2.3e-25 Score=226.50 Aligned_cols=152 Identities=31% Similarity=0.521 Sum_probs=137.4
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|++.+.||+|+||.||++...++..||||++... ....+++.+|+.++.+++||||+++++++.+.+..++||||+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 85 (268)
T 3sxs_A 7 REEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEG-SMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYI 85 (268)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBT-TBCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECC
T ss_pred hhheeeeeeeccCCCceEEEEEecCceeEEEEEeccC-CCcHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEcc
Confidence 3578889999999999999999998889999999754 345678999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
++++|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 86 ~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 158 (268)
T 3sxs_A 86 SNGCLLNYLRSH--GKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQ 158 (268)
T ss_dssp TTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTTC
T ss_pred CCCcHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchhh
Confidence 999999999542 345899999999999999999999987 9999999999999999999999999999875443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=4.6e-26 Score=240.14 Aligned_cols=157 Identities=29% Similarity=0.520 Sum_probs=137.6
Q ss_pred HHHHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 476 LATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 476 l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
+....++|++.+.||+|+||.||+|+.. +++.||||.++... ....++|.+|+.++.+++||||+++++++.+
T Consensus 42 ~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~ 121 (343)
T 1luf_A 42 LEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAV 121 (343)
T ss_dssp TBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECS
T ss_pred eEecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcc
Confidence 3445578999999999999999999975 34789999997543 3345789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEec
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLK---------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHR 607 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHr 607 (649)
++..++||||+++|+|.+++..... ...+++.+++.++.||++||.|||+.+ |+||
T Consensus 122 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH~ 198 (343)
T 1luf_A 122 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHR 198 (343)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred CCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecC
Confidence 9999999999999999999964211 256899999999999999999999987 9999
Q ss_pred CCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 608 DLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 608 Dlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||||+|||+++++.+||+|||+++.+..
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 226 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYS 226 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTG
T ss_pred CCCcceEEECCCCeEEEeecCCCccccc
Confidence 9999999999999999999999987643
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.93 E-value=6.5e-26 Score=234.03 Aligned_cols=151 Identities=36% Similarity=0.627 Sum_probs=132.1
Q ss_pred cCcccceeeccCCcEEEEEEEe-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~ 553 (649)
++|++.+.||+|+||.||++++ .+++.||||++........+++.+|+.++.+++||||+++++++.+. ...+
T Consensus 10 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 89 (295)
T 3ugc_A 10 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 89 (295)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCE
T ss_pred HHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceE
Confidence 5788899999999999999984 26889999999876666678899999999999999999999998654 4589
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++|+|.+++... ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 90 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~ 164 (295)
T 3ugc_A 90 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 164 (295)
T ss_dssp EEEECCTTCBHHHHHHHC--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSCC--
T ss_pred EEEEeCCCCCHHHHHHhc--ccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCcccccc
Confidence 999999999999999642 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 165 ~~~ 167 (295)
T 3ugc_A 165 PQD 167 (295)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=7.9e-26 Score=235.16 Aligned_cols=156 Identities=31% Similarity=0.480 Sum_probs=136.6
Q ss_pred HhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
..++|.+.+.||+|+||.||++... +++.||||.+.... ....+++.+|+.++.+++||||+++++++.+.+.
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~ 100 (314)
T 2ivs_A 21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGP 100 (314)
T ss_dssp CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCc
Confidence 3467889999999999999999862 45789999997543 3456789999999999999999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCC---------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCC
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK---------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLK 610 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~---------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlk 610 (649)
.++||||+++++|.+++..... ...+++.+++.++.||++||+|||+.+ |+|||||
T Consensus 101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dik 177 (314)
T 2ivs_A 101 LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLA 177 (314)
T ss_dssp CEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT---EECCCCS
T ss_pred eEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC---Ccccccc
Confidence 9999999999999999965322 234889999999999999999999987 9999999
Q ss_pred CCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 611 ASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 611 p~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+|||+++++.+||+|||+++.+....
T Consensus 178 p~NIli~~~~~~kl~Dfg~~~~~~~~~ 204 (314)
T 2ivs_A 178 ARNILVAEGRKMKISDFGLSRDVYEED 204 (314)
T ss_dssp GGGEEEETTTEEEECCCTTCEECTTTS
T ss_pred hheEEEcCCCCEEEccccccccccccc
Confidence 999999999999999999999875543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.93 E-value=1.8e-25 Score=235.88 Aligned_cols=168 Identities=28% Similarity=0.421 Sum_probs=138.9
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG 549 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (649)
...++|.+.+.||+|+||.||+|... ++..||||.+... .....+.+.+|+.++.++ +||||+++++++.+.
T Consensus 42 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 121 (344)
T 1rjb_A 42 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS 121 (344)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred cCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC
Confidence 34578899999999999999999962 4568999999753 234567899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCC--------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKK--------------------ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDL 609 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~--------------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDl 609 (649)
+..++||||+++|+|.+++...... ..+++..++.++.||++||+|||+.+ |+||||
T Consensus 122 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Di 198 (344)
T 1rjb_A 122 GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDL 198 (344)
T ss_dssp SSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTC
T ss_pred CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCC
Confidence 9999999999999999999753221 34899999999999999999999987 999999
Q ss_pred CCCcEEEcCCCceEEEecCCceeeCCCCCccccCceeec
Q 006347 610 KASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 610 kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
||+|||++.++.+||+|||+++.+.............||
T Consensus 199 kp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t 237 (344)
T 1rjb_A 199 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLP 237 (344)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEEC
T ss_pred ChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCc
Confidence 999999999999999999999987554433333334444
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=6e-26 Score=248.83 Aligned_cols=149 Identities=28% Similarity=0.324 Sum_probs=125.0
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||++... +++.||||++... .......+.+|+.++.+++||||+++++++.+.+..+||
T Consensus 147 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv 226 (446)
T 4ejn_A 147 MNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFV 226 (446)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEE
T ss_pred hHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEE
Confidence 357899999999999999999976 6899999999753 234456788999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|||+++|+|.+++.. ...+++..+..++.||++||+|||+ .+ |+||||||+|||++.++.+||+|||+|+...
T Consensus 227 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~ 300 (446)
T 4ejn_A 227 MEYANGGELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGI 300 (446)
T ss_dssp ECCCSSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTC
T ss_pred EeeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceecc
Confidence 999999999999853 3568999999999999999999997 76 9999999999999999999999999998643
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.93 E-value=2.8e-25 Score=237.81 Aligned_cols=146 Identities=29% Similarity=0.421 Sum_probs=127.0
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
.+.||+|+||.||+|... +|+.||||+++.......+++.+|+.++.+++||||+++++++.+.+..+|||||+++++|
T Consensus 94 ~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L 173 (373)
T 2x4f_A 94 TEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL 173 (373)
T ss_dssp EEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEE
T ss_pred ceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcH
Confidence 568999999999999875 6899999999776556678899999999999999999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE--cCCCceEEEecCCceeeCCC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL--DEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--~~~~~~Ki~DFGla~~~~~~ 636 (649)
.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.+...
T Consensus 174 ~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~ 242 (373)
T 2x4f_A 174 FDRIID--ESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR 242 (373)
T ss_dssp HHHHHH--TGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT
T ss_pred HHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc
Confidence 998854 2345899999999999999999999988 9999999999999 56789999999999987544
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.93 E-value=4e-25 Score=235.60 Aligned_cols=152 Identities=27% Similarity=0.427 Sum_probs=134.9
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
..++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 27 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 27 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEE
Confidence 3467999999999999999999976 68999999996532 33557889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEecCCcee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAKI 632 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~DFGla~~ 632 (649)
|||+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+.
T Consensus 107 ~e~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~ 180 (362)
T 2bdw_A 107 FDLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIE 180 (362)
T ss_dssp ECCCCSCBHHHHHTT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBC
T ss_pred EecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceE
Confidence 999999999999853 456899999999999999999999987 9999999999999865 4599999999998
Q ss_pred eCCC
Q 006347 633 FGGN 636 (649)
Q Consensus 633 ~~~~ 636 (649)
+...
T Consensus 181 ~~~~ 184 (362)
T 2bdw_A 181 VNDS 184 (362)
T ss_dssp CTTC
T ss_pred ecCC
Confidence 7543
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=4.2e-25 Score=228.21 Aligned_cols=147 Identities=29% Similarity=0.455 Sum_probs=127.5
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCCccceEEEEEeC----CeEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK--LQHRNLVRLLGCCVEG----EEKM 553 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~----~~~~ 553 (649)
.++|++.+.||+|+||+||+|+. +++.||||++.. ...+.+..|.+++.. ++||||+++++++.+. ...+
T Consensus 7 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~ 82 (301)
T 3q4u_A 7 ARDITLLECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLW 82 (301)
T ss_dssp GGGCEEEEEEEECSSEEEEEEEE-TTEEEEEEEECG---GGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred cCcEEEEEeeccCCCcEEEEEEE-CCEEEEEEEecc---ccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeE
Confidence 46789999999999999999998 589999999854 344566777777666 7999999999997753 4578
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH--------RDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
+||||+++|+|.+++. ...+++..++.++.|+++||+||| +.+ |+||||||+|||++.++.+||+
T Consensus 83 lv~e~~~~g~L~~~l~----~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~ 155 (301)
T 3q4u_A 83 LITHYHEMGSLYDYLQ----LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIA 155 (301)
T ss_dssp EEECCCTTCBHHHHHT----TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEEC
T ss_pred EehhhccCCCHHHHHh----hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEe
Confidence 9999999999999993 346899999999999999999999 555 9999999999999999999999
Q ss_pred ecCCceeeCCCC
Q 006347 626 DFGMAKIFGGNQ 637 (649)
Q Consensus 626 DFGla~~~~~~~ 637 (649)
|||+|+......
T Consensus 156 Dfg~a~~~~~~~ 167 (301)
T 3q4u_A 156 DLGLAVMHSQST 167 (301)
T ss_dssp CCTTCEEEETTT
T ss_pred eCCCeeeccccc
Confidence 999999875543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=225.58 Aligned_cols=151 Identities=24% Similarity=0.400 Sum_probs=137.6
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|++.+.||+|+||.||+|... ++..+|+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (277)
T 3f3z_A 8 NQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMEL 87 (277)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred hhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEec
Confidence 456899999999999999999986 5779999999876666788999999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||+ +.++.+||+|||+++.+..
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~ 161 (277)
T 3f3z_A 88 CTGGELFERVVH---KRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKP 161 (277)
T ss_dssp CCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCT
T ss_pred cCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccC
Confidence 999999998853 355899999999999999999999988 9999999999999 7889999999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 162 ~ 162 (277)
T 3f3z_A 162 G 162 (277)
T ss_dssp T
T ss_pred c
Confidence 3
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=2.2e-25 Score=239.32 Aligned_cols=155 Identities=29% Similarity=0.493 Sum_probs=136.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE 548 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~ 548 (649)
..++|.+.++||+|+||.||+|+.. .+..||||++.... ....+++.+|++++.++ +||||+++++++.+
T Consensus 67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 146 (382)
T 3tt0_A 67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ 146 (382)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence 3467889999999999999999863 23579999997543 34557899999999999 89999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 615 (649)
++..++||||+++|+|.+++..... ...+++.+++.|+.||++||+|||+.+ |+||||||+|||
T Consensus 147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIl 223 (382)
T 3tt0_A 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVL 223 (382)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEE
T ss_pred CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceEE
Confidence 9999999999999999999964321 245899999999999999999999987 999999999999
Q ss_pred EcCCCceEEEecCCceeeCCC
Q 006347 616 LDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 616 l~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++++.+||+|||+|+.+...
T Consensus 224 l~~~~~~kL~DFG~a~~~~~~ 244 (382)
T 3tt0_A 224 VTEDNVMKIADFGLARDIHHI 244 (382)
T ss_dssp ECTTCCEEECSCSCCCCSSCC
T ss_pred EcCCCcEEEcccCcccccccc
Confidence 999999999999999987544
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.92 E-value=3e-25 Score=227.51 Aligned_cols=151 Identities=28% Similarity=0.539 Sum_probs=134.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
..++|++.+.||+|+||.||++...++..||||++... ....+++.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 100 (283)
T 3gen_A 22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY 100 (283)
T ss_dssp CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECC
T ss_pred CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCC-CCCHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEec
Confidence 34678889999999999999999998889999999754 34567899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 101 ~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 172 (283)
T 3gen_A 101 MANGCLLNYLREM--RHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD 172 (283)
T ss_dssp CTTCBHHHHHHCG--GGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCC
T ss_pred cCCCcHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccc
Confidence 9999999999652 356899999999999999999999987 99999999999999999999999999987643
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=229.11 Aligned_cols=149 Identities=27% Similarity=0.467 Sum_probs=133.6
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||.||+|...+++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (288)
T 1ob3_A 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (288)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred ccchhhhhcccCCCEEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence 4688899999999999999999889999999986432 23457889999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 82 ~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 152 (288)
T 1ob3_A 82 LDQ-DLKKLLDV--CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGI 152 (288)
T ss_dssp CSE-EHHHHHHT--STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC
T ss_pred cCC-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCc
Confidence 975 89888854 2356899999999999999999999987 99999999999999999999999999987643
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-25 Score=248.97 Aligned_cols=153 Identities=31% Similarity=0.537 Sum_probs=138.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
...+|++.++||+|+||.||+|... ++..||||.++.. ....++|.+|+.++.+++|||||+++++|.+.+..+||||
T Consensus 218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E 296 (495)
T 1opk_A 218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE 296 (495)
T ss_dssp CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCc-ccchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEE
Confidence 4467888899999999999999987 4889999999754 3457889999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+++|+|.+++... ....+++..++.|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+...
T Consensus 297 ~~~~g~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~ 371 (495)
T 1opk_A 297 FMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD 371 (495)
T ss_dssp CCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred ccCCCCHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence 99999999999643 2356899999999999999999999988 999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.3e-25 Score=247.25 Aligned_cols=153 Identities=29% Similarity=0.406 Sum_probs=137.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|.+.+.||+|+||.||++... +|+.||||++.+. .......+.+|+.++.+++|||||++++++.+.+..++|
T Consensus 183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV 262 (576)
T 2acx_A 183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV 262 (576)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence 356888999999999999999986 7899999999653 234567789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 263 mEy~~gg~L~~~l~~~-~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~ 338 (576)
T 2acx_A 263 LTLMNGGDLKFHIYHM-GQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPE 338 (576)
T ss_dssp ECCCCSCBHHHHHHSS-SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EEcCCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceeccc
Confidence 9999999999999653 2345899999999999999999999987 99999999999999999999999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 339 ~ 339 (576)
T 2acx_A 339 G 339 (576)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=245.86 Aligned_cols=155 Identities=30% Similarity=0.515 Sum_probs=137.6
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
+.+...++|++.+.||+|+||.||+|...++..||||+++.. ....++|.+|+.++++++|||||++++++. .+..++
T Consensus 182 ~~~i~~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~l 259 (454)
T 1qcf_A 182 AWEIPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG-SMSVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYI 259 (454)
T ss_dssp CSBCCGGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTT-SBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEE
T ss_pred ceeechHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCC-CccHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEE
Confidence 334455778899999999999999999988899999999764 346789999999999999999999999986 667899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 260 v~e~~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~ 335 (454)
T 1qcf_A 260 ITEFMAKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIE 335 (454)
T ss_dssp EECCCTTCBHHHHHHSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGGGGBC
T ss_pred EEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCceEcC
Confidence 99999999999999642 2235889999999999999999999987 9999999999999999999999999999874
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 336 ~ 336 (454)
T 1qcf_A 336 D 336 (454)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=5.8e-26 Score=238.61 Aligned_cols=160 Identities=31% Similarity=0.470 Sum_probs=137.6
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEecC------CcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCC 546 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 546 (649)
+.+...++|.+.+.||+|+||.||+|.... ...||||.+.... ....+.+.+|+.++.++ +||||+++++++
T Consensus 40 ~~~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 40 KWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp GGBCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 344456789999999999999999998752 2479999997543 23567899999999999 899999999999
Q ss_pred EeCCeEEEEEecCCCCChhhhhcCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006347 547 VEGEEKMLIYEYMPNRSLDALLFDPL-----------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615 (649)
Q Consensus 547 ~~~~~~~lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 615 (649)
.+.+..++||||+++|+|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl 196 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVL 196 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCE
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEE
Confidence 99999999999999999999986421 1345899999999999999999999987 999999999999
Q ss_pred EcCCCceEEEecCCceeeCCCC
Q 006347 616 LDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 616 l~~~~~~Ki~DFGla~~~~~~~ 637 (649)
+++++.+||+|||+++.+....
T Consensus 197 ~~~~~~~kl~Dfg~~~~~~~~~ 218 (333)
T 2i1m_A 197 LTNGHVAKIGDFGLARDIMNDS 218 (333)
T ss_dssp EEGGGEEEBCCCGGGCCGGGCT
T ss_pred ECCCCeEEECcccccccccccc
Confidence 9999999999999999775443
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.92 E-value=8.5e-26 Score=236.29 Aligned_cols=156 Identities=29% Similarity=0.522 Sum_probs=123.0
Q ss_pred HHhcCcccceeeccCCcEEEEEEEecC-C---cEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLKD-G---QEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~~-g---~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
...++|++.+.||+|+||.||+|.... + ..||||.++.. .....+++.+|+.++++++||||+++++++.+.+.
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 99 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRA 99 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC--
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeecccc
Confidence 344679999999999999999998763 2 27999998654 34456889999999999999999999999988776
Q ss_pred E------EEEEecCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 552 K------MLIYEYMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 552 ~------~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
. ++||||+++|+|.+++.... ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+
T Consensus 100 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~~ 176 (323)
T 3qup_A 100 KGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTV 176 (323)
T ss_dssp -----CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCE
T ss_pred ccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCCE
Confidence 5 99999999999999985321 1235899999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeeCCC
Q 006347 623 KISDFGMAKIFGGN 636 (649)
Q Consensus 623 Ki~DFGla~~~~~~ 636 (649)
||+|||+|+.+...
T Consensus 177 kl~Dfg~a~~~~~~ 190 (323)
T 3qup_A 177 CVADFGLSRKIYSG 190 (323)
T ss_dssp EECCCCC-------
T ss_pred EEeecccccccccc
Confidence 99999999987443
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=239.33 Aligned_cols=149 Identities=28% Similarity=0.347 Sum_probs=124.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHH-HhcCCCCCccceEEEEEeCCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMV-ISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~-l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.++|++.+.||+|+||.||+++.. +++.||||++++.. ....+.+..|..+ ++.++||||+++++++.+.+..++
T Consensus 37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l 116 (373)
T 2r5t_A 37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF 116 (373)
T ss_dssp GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence 357999999999999999999987 58899999997543 2344566777776 567899999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++++||+|||+|+...
T Consensus 117 v~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~ 190 (373)
T 2r5t_A 117 VLDYINGGELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENI 190 (373)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGB
T ss_pred EEeCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccc
Confidence 9999999999999853 356889999999999999999999988 9999999999999999999999999998743
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.6e-26 Score=234.91 Aligned_cols=151 Identities=24% Similarity=0.410 Sum_probs=129.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe----
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE---- 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~---- 551 (649)
.++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~ 90 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 90 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence 367999999999999999999974 78999999997542 2334678999999999999999999999886553
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 91 ~~lv~e~~~g~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~ 164 (311)
T 3ork_A 91 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 164 (311)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC-
T ss_pred cEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCcc
Confidence 3999999999999999953 346899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCC
Q 006347 632 IFGGN 636 (649)
Q Consensus 632 ~~~~~ 636 (649)
.+...
T Consensus 165 ~~~~~ 169 (311)
T 3ork_A 165 AIADS 169 (311)
T ss_dssp -----
T ss_pred ccccc
Confidence 87543
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.92 E-value=5.4e-25 Score=242.54 Aligned_cols=150 Identities=28% Similarity=0.533 Sum_probs=136.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||+|+.. +|+.||||++.... ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~ 95 (476)
T 2y94_A 16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM 95 (476)
T ss_dssp TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence 57888999999999999999986 79999999996532 234568999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 96 E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~ 169 (476)
T 2y94_A 96 EYVSGGELFDYICK---NGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169 (476)
T ss_dssp ECCSSEEHHHHTTS---SSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc
Confidence 99999999999953 456899999999999999999999987 999999999999999999999999999987543
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=245.12 Aligned_cols=164 Identities=29% Similarity=0.403 Sum_probs=141.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||+||+++.. +|+.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 185 ~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVm 264 (543)
T 3c4z_A 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVM 264 (543)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEE
Confidence 56888899999999999999986 68999999996532 245678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++..... ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 265 E~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~~ 341 (543)
T 3c4z_A 265 TIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKA 341 (543)
T ss_dssp CCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCT
T ss_pred EeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeeccC
Confidence 99999999999875422 456899999999999999999999988 99999999999999999999999999998754
Q ss_pred CCCccccCceeecC
Q 006347 636 NQDQADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~~~~~~~~GT~ 649 (649)
.... +....||+
T Consensus 342 ~~~~--~~~~~GT~ 353 (543)
T 3c4z_A 342 GQTK--TKGYAGTP 353 (543)
T ss_dssp TCCC--BCCCCSCT
T ss_pred CCcc--cccccCCc
Confidence 4322 22346663
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.92 E-value=5.1e-25 Score=231.78 Aligned_cols=155 Identities=28% Similarity=0.521 Sum_probs=135.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec--------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG 549 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (649)
.++|.+.+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++.++ +||||+++++++.+.
T Consensus 34 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~ 113 (334)
T 2pvf_A 34 RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD 113 (334)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC
Confidence 467899999999999999999863 46789999997543 34567899999999999 899999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+..++||||+++|+|.+++..... ...+++.+++.++.||++||+|||+.+ |+||||||+|||+
T Consensus 114 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll 190 (334)
T 2pvf_A 114 GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNVLV 190 (334)
T ss_dssp SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEE
T ss_pred CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCccceEEE
Confidence 999999999999999999975321 235899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCCC
Q 006347 617 DEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~~ 637 (649)
+.++.+||+|||+++.+....
T Consensus 191 ~~~~~~kL~Dfg~~~~~~~~~ 211 (334)
T 2pvf_A 191 TENNVMKIADFGLARDINNID 211 (334)
T ss_dssp CTTCCEEECCCTTCEECTTTS
T ss_pred cCCCCEEEccccccccccccc
Confidence 999999999999999876543
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5e-25 Score=241.80 Aligned_cols=148 Identities=32% Similarity=0.534 Sum_probs=133.1
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-eEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 558 (649)
.++|++.+.||+|+||.||+|... ++.||||+++... ..++|.+|+.++.+++||||+++++++.+.+ ..+|||||
T Consensus 192 ~~~~~~~~~lG~G~fg~V~~~~~~-~~~vavK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~ 268 (450)
T 1k9a_A 192 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDA--TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 268 (450)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEET-TEEEEEEEESSCT--TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEEC
T ss_pred hHHeEEEeeecCcCCeeEEEEEec-CCeEEEEEeCCch--HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEe
Confidence 356888899999999999999987 7899999997543 5688999999999999999999999998776 78999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++|+|.+++... ....+++..++.++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 269 ~~~g~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~ 340 (450)
T 1k9a_A 269 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEAS 340 (450)
T ss_dssp CTTCBHHHHHHHH-CTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred cCCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccc
Confidence 9999999999653 2334799999999999999999999988 9999999999999999999999999999754
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=230.53 Aligned_cols=150 Identities=30% Similarity=0.330 Sum_probs=129.6
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.++||+|+||+||+|... +++.||||++.... .....++..|+..+.++ +|+||+++++++.+++..+|||
T Consensus 57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~ 136 (311)
T 3p1a_A 57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQT 136 (311)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEE
Confidence 57999999999999999999987 79999999986532 23344566677666666 8999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+ +++|.+++... ...+++..+..|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 137 e~~-~~~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~ 210 (311)
T 3p1a_A 137 ELC-GPSLQQHCEAW--GASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA 210 (311)
T ss_dssp ECC-CCBHHHHHHHH--CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC--
T ss_pred ecc-CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC
Confidence 999 77998888542 356999999999999999999999987 999999999999999999999999999987543
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-25 Score=234.94 Aligned_cols=152 Identities=32% Similarity=0.578 Sum_probs=128.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|++.+.||+|+||+||+|+.. +++ .||+|.+... .....++|.+|+.++.+++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~ 93 (327)
T 3poz_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEE
T ss_pred HHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEE
Confidence 56888999999999999999865 344 4688888543 3356688999999999999999999999998765 789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+||+++|+|.+++... ...+++..++.|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 94 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~ 168 (327)
T 3poz_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EEECCTTCBHHHHHHHS--TTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHHHT
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeEcc
Confidence 99999999999999652 456899999999999999999999987 9999999999999999999999999999876
Q ss_pred CCCC
Q 006347 635 GNQD 638 (649)
Q Consensus 635 ~~~~ 638 (649)
....
T Consensus 169 ~~~~ 172 (327)
T 3poz_A 169 AEEK 172 (327)
T ss_dssp TTCC
T ss_pred CCcc
Confidence 5443
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=230.92 Aligned_cols=167 Identities=31% Similarity=0.446 Sum_probs=140.9
Q ss_pred HhcCcccceeeccCCcEEEEEEEe------cCCcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCCccceEEEEEeCC
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGE 550 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~ 550 (649)
..++|++.+.||+|+||.||+|+. .+++.||||++..... ...+.+.+|+.++.++ +||||+++++++.+++
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 100 (313)
T 1t46_A 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG 100 (313)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence 346789999999999999999985 2467899999975432 3457899999999999 8999999999999999
Q ss_pred eEEEEEecCCCCChhhhhcCCCC---------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLK---------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~---------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 615 (649)
..++||||+++|+|.+++..... ...+++..++.++.|+++||+|||+.+ |+||||||+|||
T Consensus 101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil 177 (313)
T 1t46_A 101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNIL 177 (313)
T ss_dssp SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEE
T ss_pred CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEE
Confidence 99999999999999999964321 225899999999999999999999987 999999999999
Q ss_pred EcCCCceEEEecCCceeeCCCCCccccCceeec
Q 006347 616 LDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 616 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
+++++.+||+|||+++.+.............||
T Consensus 178 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 210 (313)
T 1t46_A 178 LTHGRITKICDFGLARDIKNDSNYVVKGNARLP 210 (313)
T ss_dssp EETTTEEEECCCGGGSCTTSCTTSEECSSSEEC
T ss_pred EcCCCCEEEccccccccccccccceeccCCCCc
Confidence 999999999999999987655443333333343
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.4e-25 Score=228.18 Aligned_cols=152 Identities=28% Similarity=0.474 Sum_probs=120.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.+.||+|+||.||+|... +++.||||+++... ....+.+.+|+.++++++||||+++++++.+++..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 83 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFE 83 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEE
Confidence 457888999999999999999876 68999999986543 3345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPL---KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|++ ++|.+++.... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 84 ~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~ 159 (317)
T 2pmi_A 84 FMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAFG 159 (317)
T ss_dssp CCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEETT
T ss_pred ecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceecC
Confidence 998 69999885321 2245899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 160 ~ 160 (317)
T 2pmi_A 160 I 160 (317)
T ss_dssp S
T ss_pred C
Confidence 3
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.9e-25 Score=241.83 Aligned_cols=153 Identities=27% Similarity=0.388 Sum_probs=134.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
..++|++.+.||+|+||.||++... +|+.+|+|.+.... ....+.+.+|+.++++++||||+++++++.+.+..++|
T Consensus 9 ~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 9 FTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEE
T ss_pred ccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEE
Confidence 3467999999999999999999875 78999999986532 33456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEecCCcee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKI 632 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~Ki~DFGla~~ 632 (649)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+|+.
T Consensus 89 ~E~~~gg~L~~~i~~---~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~ 162 (444)
T 3soa_A 89 FDLVTGGELFEDIVA---REYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIE 162 (444)
T ss_dssp ECCCBCCBHHHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBC
T ss_pred EEeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEE
Confidence 999999999998854 356899999999999999999999998 99999999999998 467899999999998
Q ss_pred eCCCC
Q 006347 633 FGGNQ 637 (649)
Q Consensus 633 ~~~~~ 637 (649)
+....
T Consensus 163 ~~~~~ 167 (444)
T 3soa_A 163 VEGEQ 167 (444)
T ss_dssp CCTTC
T ss_pred ecCCC
Confidence 75543
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.1e-26 Score=242.37 Aligned_cols=150 Identities=33% Similarity=0.546 Sum_probs=131.8
Q ss_pred cCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|++.+.||+|+||.||+|+.. +++.||||+++.. ......++.+|+.++.+++||||+++++++.+....+
T Consensus 71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 150 (367)
T 3l9p_A 71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRF 150 (367)
T ss_dssp GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCE
T ss_pred hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCE
Confidence 57888999999999999999853 4678999999653 3445668999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEe
Q 006347 554 LIYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL---NPKISD 626 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~Ki~D 626 (649)
+||||+++|+|.+++.... ....+++.+++.++.||++||+|||+.+ |+||||||+|||++.++ .+||+|
T Consensus 151 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL~D 227 (367)
T 3l9p_A 151 ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGD 227 (367)
T ss_dssp EEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred EEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEECC
Confidence 9999999999999996421 2246899999999999999999999998 99999999999999544 599999
Q ss_pred cCCceee
Q 006347 627 FGMAKIF 633 (649)
Q Consensus 627 FGla~~~ 633 (649)
||+|+.+
T Consensus 228 FG~a~~~ 234 (367)
T 3l9p_A 228 FGMARDI 234 (367)
T ss_dssp CHHHHHH
T ss_pred Ccccccc
Confidence 9999865
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=233.87 Aligned_cols=149 Identities=28% Similarity=0.477 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||+|... +++.||||++.+.. ....+.+.+|+.+++.++||||+++++++.+.+..++||
T Consensus 9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~ 88 (336)
T 3h4j_B 9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI 88 (336)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence 57899999999999999999974 78999999986431 233467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+ +|+|.+++.. ...+++.++..++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 89 E~~-~g~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~ 161 (336)
T 3h4j_B 89 EYA-GGELFDYIVE---KKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG 161 (336)
T ss_dssp CCC-CEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS
T ss_pred ECC-CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC
Confidence 999 7899888853 356899999999999999999999988 999999999999999999999999999976543
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=234.01 Aligned_cols=148 Identities=19% Similarity=0.297 Sum_probs=126.0
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--------cccHHHHHHHHHHHhcCC---------CCCccce
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--------GQGLEEFMNEVMVISKLQ---------HRNLVRL 542 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~---------H~niv~l 542 (649)
.++|++.+.||+|+||+||+|+. +|+.||||++.... ....+.+.+|+.++++++ |+|||++
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~-~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l 97 (336)
T 2vuw_A 19 TEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGL 97 (336)
T ss_dssp HHHHHTCEEEEEETTEEEEEEEE-TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCE
T ss_pred cccchheeeecccCceEEEEEEe-CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhh
Confidence 35688889999999999999998 58999999997542 233478899999998885 8888888
Q ss_pred EEEEE------------------------------eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHH
Q 006347 543 LGCCV------------------------------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRG 592 (649)
Q Consensus 543 ~g~~~------------------------------~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~g 592 (649)
.+.+. +.+..+|||||+++|++.+.+.+ ..+++..+..|+.||+.|
T Consensus 98 ~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~----~~~~~~~~~~i~~qi~~a 173 (336)
T 2vuw_A 98 NSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT----KLSSLATAKSILHQLTAS 173 (336)
T ss_dssp EEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT----TCCCHHHHHHHHHHHHHH
T ss_pred cceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh----cCCCHHHHHHHHHHHHHH
Confidence 87754 26789999999999977666632 468999999999999999
Q ss_pred HHHHH-hCCCCceEecCCCCCcEEEcCCC--------------------ceEEEecCCceeeCC
Q 006347 593 LLYLH-RDSRLRIIHRDLKASNILLDEEL--------------------NPKISDFGMAKIFGG 635 (649)
Q Consensus 593 L~yLH-~~~~~~iiHrDlkp~NILl~~~~--------------------~~Ki~DFGla~~~~~ 635 (649)
|+||| +.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 174 L~~lH~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~ 234 (336)
T 2vuw_A 174 LAVAEASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERD 234 (336)
T ss_dssp HHHHHHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEET
T ss_pred HHHHHHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCC
Confidence 99999 887 99999999999999887 899999999998753
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=223.33 Aligned_cols=150 Identities=30% Similarity=0.450 Sum_probs=135.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+++..++|||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 85 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 85 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence 357889999999999999999986 68999999986433 3445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 86 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 157 (276)
T 2yex_A 86 YCSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRY 157 (276)
T ss_dssp CCTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEE
T ss_pred ecCCCcHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCC
Confidence 9999999999853 346899999999999999999999987 99999999999999999999999999987643
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=226.66 Aligned_cols=149 Identities=26% Similarity=0.424 Sum_probs=134.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.++||+|+||.||+|... +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (311)
T 4agu_A 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE 82 (311)
T ss_dssp CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred ccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence 57899999999999999999986 589999999865432 235678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+..
T Consensus 83 ~~~~~~l~~~~~~---~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 154 (311)
T 4agu_A 83 YCDHTVLHELDRY---QRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTG 154 (311)
T ss_dssp CCSEEHHHHHHHT---SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC-
T ss_pred eCCCchHHHHHhh---hcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccC
Confidence 9999999998853 356899999999999999999999988 99999999999999999999999999998754
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=222.49 Aligned_cols=150 Identities=29% Similarity=0.504 Sum_probs=135.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (278)
T 3cok_A 11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL 90 (278)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence 56888999999999999999974 78999999986432 233578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~ 164 (278)
T 3cok_A 91 EMCHNGEMNRYLKN--RVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM 164 (278)
T ss_dssp ECCTTEEHHHHHHT--CSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred ecCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccC
Confidence 99999999999964 2356899999999999999999999987 99999999999999999999999999998753
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.2e-25 Score=230.25 Aligned_cols=149 Identities=22% Similarity=0.310 Sum_probs=132.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||.||+|... +++.||||.+.... ..+++.+|+.++.++ +|+||+++++++.+++..++||||
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~ 86 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKS--RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL 86 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTC--SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence 57899999999999999999964 78999999986532 335788999999999 899999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----eEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-----PKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~Ki~DFGla~~~ 633 (649)
+ +++|.+++... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+|+.+
T Consensus 87 ~-~~~L~~~~~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~ 160 (330)
T 2izr_A 87 L-GPSLEDLFDLC--DRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEY 160 (330)
T ss_dssp C-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCEES
T ss_pred C-CCCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccceee
Confidence 9 99999999642 457999999999999999999999987 999999999999999887 999999999987
Q ss_pred CCCC
Q 006347 634 GGNQ 637 (649)
Q Consensus 634 ~~~~ 637 (649)
....
T Consensus 161 ~~~~ 164 (330)
T 2izr_A 161 IDPE 164 (330)
T ss_dssp BCTT
T ss_pred ecCC
Confidence 5443
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.2e-25 Score=236.98 Aligned_cols=153 Identities=31% Similarity=0.471 Sum_probs=135.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC--eEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE--EKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~lV~ 556 (649)
++|.+.+.||+|+||.||+|... +++.||||++.... ....+.+.+|++++.+++||||+++++++.+.+ ..++||
T Consensus 9 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~ 88 (396)
T 4eut_A 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIM 88 (396)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEE
Confidence 56889999999999999999987 58999999997543 345678889999999999999999999998766 679999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEecCCcee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISDFGMAKI 632 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~Ki~DFGla~~ 632 (649)
||+++|+|.+++........+++..++.++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 89 e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~ 165 (396)
T 4eut_A 89 EFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARE 165 (396)
T ss_dssp CCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGGGCEE
T ss_pred ecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCCCceE
Confidence 99999999999976444445999999999999999999999988 9999999999999 7788899999999998
Q ss_pred eCCC
Q 006347 633 FGGN 636 (649)
Q Consensus 633 ~~~~ 636 (649)
+...
T Consensus 166 ~~~~ 169 (396)
T 4eut_A 166 LEDD 169 (396)
T ss_dssp CCCG
T ss_pred ccCC
Confidence 7543
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-25 Score=235.50 Aligned_cols=163 Identities=31% Similarity=0.497 Sum_probs=140.1
Q ss_pred CCHHHHHHHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceE
Q 006347 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLL 543 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~ 543 (649)
+..++.....++|.+.+.||+|+||.||+|+.. +++.||||.+.... .....++.+|+.++.+++|+||++++
T Consensus 15 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~ 94 (322)
T 1p4o_A 15 YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLL 94 (322)
T ss_dssp CCCCTTBCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEE
T ss_pred cChhhhcchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeE
Confidence 444455566788999999999999999999864 36789999997543 23456799999999999999999999
Q ss_pred EEEEeCCeEEEEEecCCCCChhhhhcCCC-------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 544 GCCVEGEEKMLIYEYMPNRSLDALLFDPL-------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 544 g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~-------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+++.+++..++||||+++|+|.+++.... ....+++..++.++.||++||.|||+.+ |+||||||+|||+
T Consensus 95 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli 171 (322)
T 1p4o_A 95 GVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMV 171 (322)
T ss_dssp EEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEE
T ss_pred EEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEE
Confidence 99999999999999999999999986421 1245789999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCC
Q 006347 617 DEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~ 636 (649)
++++.+||+|||+++.....
T Consensus 172 ~~~~~~kl~Dfg~~~~~~~~ 191 (322)
T 1p4o_A 172 AEDFTVKIGDFGMTRDIYET 191 (322)
T ss_dssp CTTCCEEECCTTCCCGGGGG
T ss_pred cCCCeEEECcCccccccccc
Confidence 99999999999999876443
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.92 E-value=5.2e-25 Score=234.59 Aligned_cols=147 Identities=27% Similarity=0.385 Sum_probs=131.0
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|.+.+.||+|+||.||++... +++.||||++.... ...+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 97 (361)
T 3uc3_A 19 SDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGA-AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEY 97 (361)
T ss_dssp TTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESST-TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCc-cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEe
Confidence 467999999999999999999987 78999999997533 3446789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--eEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--PKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~Ki~DFGla~~~ 633 (649)
+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++. +||+|||+|+..
T Consensus 98 ~~~~~L~~~l~~---~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~ 168 (361)
T 3uc3_A 98 ASGGELYERICN---AGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS 168 (361)
T ss_dssp CCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC---
T ss_pred CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCccccc
Confidence 999999999853 346899999999999999999999988 999999999999987765 999999999854
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=8.6e-25 Score=226.13 Aligned_cols=152 Identities=31% Similarity=0.580 Sum_probs=132.2
Q ss_pred cCcccceeeccCCcEEEEEEEe-----cCCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~ 552 (649)
+.|++.+.||+|+||.||++++ .+++.||||++... .....+.+.+|+.++.+++|+||+++++++.+. +..
T Consensus 21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 100 (302)
T 4e5w_A 21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 100 (302)
T ss_dssp GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCE
T ss_pred hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceE
Confidence 4588889999999999999984 36889999999743 234568899999999999999999999999876 568
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ....+++..++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 101 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 175 (302)
T 4e5w_A 101 KLIMEFLPSGSLKEYLPK--NKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 175 (302)
T ss_dssp EEEEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence 999999999999999954 2345899999999999999999999988 99999999999999999999999999998
Q ss_pred eCCCC
Q 006347 633 FGGNQ 637 (649)
Q Consensus 633 ~~~~~ 637 (649)
+....
T Consensus 176 ~~~~~ 180 (302)
T 4e5w_A 176 IETDK 180 (302)
T ss_dssp CCTTC
T ss_pred ccCCC
Confidence 75543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=4.7e-25 Score=233.12 Aligned_cols=161 Identities=24% Similarity=0.365 Sum_probs=132.7
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCC--CCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH--RNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H--~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||++...+++.||||++... .....+.+.+|+.++.+++| +||+++++++.+++..+||
T Consensus 8 ~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv 87 (343)
T 3dbq_A 8 GRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV 87 (343)
T ss_dssp SCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred cCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEE
Confidence 3568999999999999999999988999999998643 23445789999999999976 9999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|| +.+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+|+.+..
T Consensus 88 ~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~ 159 (343)
T 3dbq_A 88 ME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP 159 (343)
T ss_dssp EC-CCSEEHHHHHHH---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC--
T ss_pred Ee-CCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeecccccccCc
Confidence 99 568899999954 456899999999999999999999987 99999999999997 57899999999998755
Q ss_pred CCCccccCceeec
Q 006347 636 NQDQADTGRVVGT 648 (649)
Q Consensus 636 ~~~~~~~~~~~GT 648 (649)
...........||
T Consensus 160 ~~~~~~~~~~~gt 172 (343)
T 3dbq_A 160 DTTSVVKDSQVGT 172 (343)
T ss_dssp ----------CCC
T ss_pred ccccccCCCCcCC
Confidence 4433333344555
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=2.5e-25 Score=233.28 Aligned_cols=162 Identities=27% Similarity=0.462 Sum_probs=132.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|++.+.||+|+||.||+|... +++ .||+|.+.... ....+++.+|+.++.+++||||+++++++. ++..++
T Consensus 13 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~ 91 (325)
T 3kex_A 13 TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQL 91 (325)
T ss_dssp TTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEE
T ss_pred hHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEE
Confidence 56888899999999999999865 444 38888875432 344567889999999999999999999986 566889
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 92 v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 166 (325)
T 3kex_A 92 VTQYLPLGSLLDHVRQH--RGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLP 166 (325)
T ss_dssp EEECCTTCBSHHHHHSS--GGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGGSC
T ss_pred EEEeCCCCCHHHHHHHc--cccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccccC
Confidence 99999999999999652 346889999999999999999999998 9999999999999999999999999999876
Q ss_pred CCCCccccCceeec
Q 006347 635 GNQDQADTGRVVGT 648 (649)
Q Consensus 635 ~~~~~~~~~~~~GT 648 (649)
............||
T Consensus 167 ~~~~~~~~~~~~~~ 180 (325)
T 3kex_A 167 PDDKQLLYSEAKTP 180 (325)
T ss_dssp CCTTCCC-----CC
T ss_pred cccccccccCCCCc
Confidence 54433333333443
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.6e-25 Score=233.62 Aligned_cols=157 Identities=27% Similarity=0.357 Sum_probs=134.2
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-----ccccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-----SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-----~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
++....++|.+.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++.+++||||+++++++.+
T Consensus 20 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~ 99 (345)
T 3hko_A 20 SLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYED 99 (345)
T ss_dssp CHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEEC
T ss_pred hhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhcc
Confidence 34556678999999999999999999975 6889999998643 23556789999999999999999999999999
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCC-------------------------------------CCCCCHHHHHHHHHHHHH
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLK-------------------------------------KERLDWRKRFNIIEGISR 591 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------------------------------~~~l~~~~~~~i~~~ia~ 591 (649)
.+..++||||+++|+|.+++..... ...+++..+..|+.||++
T Consensus 100 ~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~ 179 (345)
T 3hko_A 100 EQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFS 179 (345)
T ss_dssp SSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHH
Confidence 9999999999999999999842100 112356778889999999
Q ss_pred HHHHHHhCCCCceEecCCCCCcEEEcCCC--ceEEEecCCceeeC
Q 006347 592 GLLYLHRDSRLRIIHRDLKASNILLDEEL--NPKISDFGMAKIFG 634 (649)
Q Consensus 592 gL~yLH~~~~~~iiHrDlkp~NILl~~~~--~~Ki~DFGla~~~~ 634 (649)
||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+.
T Consensus 180 ~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~ 221 (345)
T 3hko_A 180 ALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFY 221 (345)
T ss_dssp HHHHHHHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGG
T ss_pred HHHHHHHCC---ccccCCChhhEEEecCCCceEEEeecccccccc
Confidence 999999987 99999999999998776 89999999999764
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=4.6e-25 Score=226.67 Aligned_cols=148 Identities=30% Similarity=0.514 Sum_probs=133.8
Q ss_pred cCcccceeeccCCcEEEEEEEecC-C-------cEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-G-------QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-g-------~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
++|.+.+.||+|+||.||+|.... + ..||+|.+........+.+.+|+.++.+++||||+++++++.+++..
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 87 (289)
T 4fvq_A 8 EDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDEN 87 (289)
T ss_dssp GGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCC
T ss_pred hHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCC
Confidence 568888999999999999998762 3 47999999776667778999999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--------eEE
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--------PKI 624 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--------~Ki 624 (649)
++||||+++++|.+++... ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||
T Consensus 88 ~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~kl 162 (289)
T 4fvq_A 88 ILVQEFVKFGSLDTYLKKN--KNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKL 162 (289)
T ss_dssp EEEEECCTTCBHHHHHHHT--GGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEEEE
T ss_pred EEEEECCCCCCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCcccccccceeee
Confidence 9999999999999999642 334899999999999999999999988 999999999999998887 999
Q ss_pred EecCCceee
Q 006347 625 SDFGMAKIF 633 (649)
Q Consensus 625 ~DFGla~~~ 633 (649)
+|||+++..
T Consensus 163 ~Dfg~~~~~ 171 (289)
T 4fvq_A 163 SDPGISITV 171 (289)
T ss_dssp CCCCSCTTT
T ss_pred ccCcccccc
Confidence 999999765
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=7.6e-25 Score=232.23 Aligned_cols=149 Identities=29% Similarity=0.428 Sum_probs=122.5
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
..++|++.+.||+|+||.||+|+.. +++.||||+++.. ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 51 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 128 (349)
T 2w4o_A 51 LSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKT--VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLE 128 (349)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC------------CHHHHHCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccc--hhHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEE
Confidence 4467999999999999999999987 5789999999753 245678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFGla~~~~ 634 (649)
|+++++|.+++.. ...+++.++..++.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+++...
T Consensus 129 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~ 202 (349)
T 2w4o_A 129 LVTGGELFDRIVE---KGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE 202 (349)
T ss_dssp CCCSCBHHHHHTT---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC------
T ss_pred eCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccC
Confidence 9999999999953 356899999999999999999999987 999999999999975 8899999999999874
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 203 ~ 203 (349)
T 2w4o_A 203 H 203 (349)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=223.02 Aligned_cols=150 Identities=31% Similarity=0.436 Sum_probs=132.4
Q ss_pred cccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
|.....||+|+||.||+|... +++.||||.+........+.+.+|+.++.+++||||+++++++.+.+..++||||+++
T Consensus 24 ~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~ 103 (295)
T 2clq_A 24 NGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPG 103 (295)
T ss_dssp TSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSE
T ss_pred CCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCC
Confidence 444568999999999999975 6889999999776666678899999999999999999999999999999999999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCCceeeCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGla~~~~~ 635 (649)
++|.+++........+++..+..++.|+++||.|||+.+ |+||||||+||+++. ++.+||+|||+++.+..
T Consensus 104 ~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~ 175 (295)
T 2clq_A 104 GSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175 (295)
T ss_dssp EEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC
T ss_pred CCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCC
Confidence 999999975434446778999999999999999999987 999999999999997 89999999999998754
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.92 E-value=3.8e-25 Score=243.19 Aligned_cols=148 Identities=22% Similarity=0.440 Sum_probs=122.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC-----CeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 552 (649)
++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+.++.+++|+|||++++++... ...
T Consensus 53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~ 132 (458)
T 3rp9_A 53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDEL 132 (458)
T ss_dssp TTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCE
T ss_pred CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceE
Confidence 67999999999999999999876 7899999999653 233567899999999999999999999999543 468
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+ +++|.+++.. ...+++..+..++.||++||+|||+.+ ||||||||+||||+.++.+||+|||+|+.
T Consensus 133 ~lv~e~~-~~~L~~~~~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~ 205 (458)
T 3rp9_A 133 YVVLEIA-DSDFKKLFRT---PVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLART 205 (458)
T ss_dssp EEEECCC-SEEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBC
T ss_pred EEEEecc-ccchhhhccc---CCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchh
Confidence 9999998 5789999853 356899999999999999999999988 99999999999999999999999999998
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 206 ~~~ 208 (458)
T 3rp9_A 206 VDY 208 (458)
T ss_dssp TTS
T ss_pred ccC
Confidence 753
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=233.93 Aligned_cols=150 Identities=21% Similarity=0.324 Sum_probs=135.3
Q ss_pred hcCcccceeeccC--CcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 480 TNNFQLSSKLGQG--GFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G--~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.++|++.++||+| +||.||+++.. +++.||||++.... ....+.+.+|+.++++++|||||++++++.+++..++
T Consensus 24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 103 (389)
T 3gni_B 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWV 103 (389)
T ss_dssp GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEE
Confidence 3578999999999 99999999987 78999999997543 3345778899999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||||+++|+|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||++...
T Consensus 104 v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~dfg~~~~~ 178 (389)
T 3gni_B 104 VTSFMAYGSAKDLICTH-FMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSM 178 (389)
T ss_dssp EEECCTTCBHHHHHHHT-CTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred EEEccCCCCHHHHHhhh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccccceee
Confidence 99999999999998643 2355899999999999999999999988 999999999999999999999999998765
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.92 E-value=2.8e-25 Score=236.13 Aligned_cols=149 Identities=32% Similarity=0.404 Sum_probs=133.8
Q ss_pred cCcccceeeccCCcEEEEEEEe----cCCcEEEEEEecccc----cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~----~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
++|++.+.||+|+||.||+++. .+++.||||++++.. ....+.+.+|+.++.++ +|+||+++++++.+.+.
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~ 133 (355)
T 1vzo_A 54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 133 (355)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence 5789999999999999999987 368999999986532 23456788899999999 79999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.+|||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 134 ~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~ 207 (355)
T 1vzo_A 134 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 207 (355)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred EEEEeecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCe
Confidence 9999999999999999953 346899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 208 ~~~~ 211 (355)
T 1vzo_A 208 EFVA 211 (355)
T ss_dssp ECCG
T ss_pred eccc
Confidence 8743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=7.7e-25 Score=239.02 Aligned_cols=150 Identities=24% Similarity=0.459 Sum_probs=132.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC-----Ce
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 551 (649)
.++|.+.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++|+||+++++++... ..
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~ 104 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDE 104 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCe
Confidence 368999999999999999999976 6889999999753 234567899999999999999999999999876 57
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||++ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 105 ~~lv~e~~~-~~L~~~~~~---~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~ 177 (432)
T 3n9x_A 105 LYIVLEIAD-SDLKKLFKT---PIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLAR 177 (432)
T ss_dssp EEEEEECCS-EEHHHHHHS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEEecCC-cCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcc
Confidence 899999986 699999953 356899999999999999999999998 9999999999999999999999999999
Q ss_pred eeCCC
Q 006347 632 IFGGN 636 (649)
Q Consensus 632 ~~~~~ 636 (649)
.+...
T Consensus 178 ~~~~~ 182 (432)
T 3n9x_A 178 TINSE 182 (432)
T ss_dssp EC---
T ss_pred ccccc
Confidence 87543
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.7e-24 Score=223.33 Aligned_cols=150 Identities=28% Similarity=0.383 Sum_probs=134.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++++++|+||+++++++.+.+..++|
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 93 (294)
T 2rku_A 14 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 93 (294)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEE
Confidence 357888999999999999999987 57899999986532 23457789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ...+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 94 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~ 167 (294)
T 2rku_A 94 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 167 (294)
T ss_dssp EECCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEeccCceeccc
Confidence 999999999998843 356899999999999999999999987 99999999999999999999999999998753
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=3.2e-25 Score=243.48 Aligned_cols=152 Identities=34% Similarity=0.567 Sum_probs=132.9
Q ss_pred HHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
...++|++.++||+|+||.||+|...++..||||+++... ...++|.+|+.++++++||||+++++++.+ +..+||||
T Consensus 181 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e 258 (452)
T 1fmk_A 181 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 258 (452)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cChhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEeh
Confidence 3456788899999999999999999888889999997543 456789999999999999999999999876 67899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++|+|.+++... ....+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 259 ~~~~gsL~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 332 (452)
T 1fmk_A 259 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 332 (452)
T ss_dssp CCTTCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC----
T ss_pred hhcCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCC
Confidence 99999999999531 2245899999999999999999999988 99999999999999999999999999998754
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.92 E-value=6.3e-25 Score=231.51 Aligned_cols=152 Identities=28% Similarity=0.386 Sum_probs=134.8
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCCccceEEEEEeC
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEG 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~ 549 (649)
..++|++.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.
T Consensus 22 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~ 101 (335)
T 3dls_A 22 YSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ 101 (335)
T ss_dssp HHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS
T ss_pred cccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC
Confidence 3467999999999999999999865 688999999875421 1345678899999999999999999999999
Q ss_pred CeEEEEEecCCCC-ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 550 EEKMLIYEYMPNR-SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 550 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
+..++||||+..| +|.+++.. ...+++..+..|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 102 ~~~~lv~e~~~~g~~l~~~~~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg 175 (335)
T 3dls_A 102 GFFQLVMEKHGSGLDLFAFIDR---HPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFG 175 (335)
T ss_dssp SEEEEEEECCTTSCBHHHHHHT---CCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCT
T ss_pred CEEEEEEEeCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecc
Confidence 9999999999777 99999854 346899999999999999999999987 9999999999999999999999999
Q ss_pred CceeeCCC
Q 006347 629 MAKIFGGN 636 (649)
Q Consensus 629 la~~~~~~ 636 (649)
+++.+...
T Consensus 176 ~a~~~~~~ 183 (335)
T 3dls_A 176 SAAYLERG 183 (335)
T ss_dssp TCEECCTT
T ss_pred cceECCCC
Confidence 99987544
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9.1e-25 Score=229.08 Aligned_cols=152 Identities=31% Similarity=0.526 Sum_probs=135.6
Q ss_pred cCcccceeeccCCcEEEEEEEe-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~ 553 (649)
++|++.+.||+|+||.||++++ .+++.||||++........+.+.+|+.++.+++|+||+++++++.. ....+
T Consensus 23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 102 (327)
T 3lxl_A 23 RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLR 102 (327)
T ss_dssp GGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEE
T ss_pred hhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEE
Confidence 5688899999999999999984 3688999999987666667889999999999999999999999874 55689
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++++|.+++... ...+++..++.|+.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 103 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~ 177 (327)
T 3lxl_A 103 LVMEYLPSGCLRDFLQRH--RARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLL 177 (327)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGGCEEC
T ss_pred EEEeecCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEcccccceec
Confidence 999999999999999542 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCC
Q 006347 634 GGNQ 637 (649)
Q Consensus 634 ~~~~ 637 (649)
....
T Consensus 178 ~~~~ 181 (327)
T 3lxl_A 178 PLDK 181 (327)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 5443
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-24 Score=226.14 Aligned_cols=148 Identities=27% Similarity=0.383 Sum_probs=131.0
Q ss_pred cCcccc-eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (649)
+.|.+. +.||+|+||.||++... +++.||||++........+.+.+|+.++.++ +||||+++++++.+.+..++|||
T Consensus 12 ~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 91 (316)
T 2ac3_A 12 DVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFE 91 (316)
T ss_dssp TSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred eeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEE
Confidence 457664 67999999999999965 7899999999776666678899999999985 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DFGla~~~~ 634 (649)
|+++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+++.+.
T Consensus 92 ~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~ 165 (316)
T 2ac3_A 92 KMRGGSILSHIHK---RRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIK 165 (316)
T ss_dssp CCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC---
T ss_pred cCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCccccc
Confidence 9999999999954 346899999999999999999999987 999999999999998776 9999999998764
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.6e-24 Score=228.21 Aligned_cols=150 Identities=28% Similarity=0.383 Sum_probs=135.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|.+.+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|+.++.+++|+||+++++++.+.+..++|
T Consensus 40 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 119 (335)
T 2owb_A 40 RRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVV 119 (335)
T ss_dssp TEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEE
Confidence 357888999999999999999986 57899999986532 23567889999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 120 ~e~~~~~~L~~~~~~---~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 193 (335)
T 2owb_A 120 LELCRRRSLLELHKR---RKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY 193 (335)
T ss_dssp ECCCTTCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCS
T ss_pred EecCCCCCHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeeccCceeccc
Confidence 999999999999853 356899999999999999999999987 99999999999999999999999999998753
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1e-24 Score=237.02 Aligned_cols=151 Identities=26% Similarity=0.422 Sum_probs=129.1
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
...++|.+.+.||+|+||.||+|... +++.||||++.+.. ......+.+|+.++++++||||+++++++ +
T Consensus 132 ~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~-~ 210 (419)
T 3i6u_A 132 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-D 210 (419)
T ss_dssp HHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEE-E
T ss_pred hhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEE-e
Confidence 34578999999999999999999876 68999999986431 12234588999999999999999999997 4
Q ss_pred CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEE
Q 006347 549 GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKIS 625 (649)
Q Consensus 549 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~ 625 (649)
.+..++||||+++|+|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.+ ..+||+
T Consensus 211 ~~~~~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~ 284 (419)
T 3i6u_A 211 AEDYYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKIT 284 (419)
T ss_dssp SSEEEEEEECCTTCBGGGGTSS---SCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEEC
T ss_pred cCceEEEEEcCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEe
Confidence 5668999999999999998853 456899999999999999999999987 9999999999999754 459999
Q ss_pred ecCCceeeCC
Q 006347 626 DFGMAKIFGG 635 (649)
Q Consensus 626 DFGla~~~~~ 635 (649)
|||+|+.+..
T Consensus 285 DFG~a~~~~~ 294 (419)
T 3i6u_A 285 DFGHSKILGE 294 (419)
T ss_dssp CSSTTTSCC-
T ss_pred ecccceecCC
Confidence 9999998754
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.8e-24 Score=226.32 Aligned_cols=151 Identities=30% Similarity=0.422 Sum_probs=135.6
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|.+.+.||+|+||.||++... +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+.+..
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 90 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV 90 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence 356889999999999999999976 689999999865322 1367899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEecC
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFG 628 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~Ki~DFG 628 (649)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||+++++ .+||+|||
T Consensus 91 ~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg 164 (321)
T 2a2a_A 91 VLILELVSGGELFDFLAQ---KESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFG 164 (321)
T ss_dssp EEEECCCCSCBHHHHHHT---CSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCT
T ss_pred EEEEEcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCc
Confidence 999999999999999954 356899999999999999999999987 99999999999999888 79999999
Q ss_pred CceeeCCC
Q 006347 629 MAKIFGGN 636 (649)
Q Consensus 629 la~~~~~~ 636 (649)
+++.+...
T Consensus 165 ~~~~~~~~ 172 (321)
T 2a2a_A 165 LAHEIEDG 172 (321)
T ss_dssp TCEECCTT
T ss_pred cceecCcc
Confidence 99987543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=221.31 Aligned_cols=151 Identities=34% Similarity=0.541 Sum_probs=125.8
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|... ++.||||++.... ....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 7 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 85 (271)
T 3dtc_A 7 AELTLEEIIGIGGFGKVYRAFWI-GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM 85 (271)
T ss_dssp TSEEEEEEEEEETTEEEEEEEET-TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred hheeeeeeeccCCCeEEEEEEEc-CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence 57888999999999999999986 8899999986532 234578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--------CCceEEEecC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--------ELNPKISDFG 628 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--------~~~~Ki~DFG 628 (649)
||+++++|.+++. ...+++..+..++.|+++||+|||+.+..+|+||||||+|||+++ ++.+||+|||
T Consensus 86 e~~~~~~L~~~~~----~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg 161 (271)
T 3dtc_A 86 EFARGGPLNRVLS----GKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG 161 (271)
T ss_dssp ECCTTEEHHHHHT----SSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred EcCCCCCHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence 9999999999984 346899999999999999999999987666999999999999986 6789999999
Q ss_pred CceeeCCC
Q 006347 629 MAKIFGGN 636 (649)
Q Consensus 629 la~~~~~~ 636 (649)
+++.+...
T Consensus 162 ~~~~~~~~ 169 (271)
T 3dtc_A 162 LAREWHRT 169 (271)
T ss_dssp C-------
T ss_pred cccccccc
Confidence 99876543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.5e-24 Score=222.02 Aligned_cols=154 Identities=27% Similarity=0.425 Sum_probs=134.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||+|... +++.||||++... ......++.+|+..+.++ +||||+++++++.+.+..++|
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv 89 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ 89 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence 467889999999999999999987 7899999998753 234567889999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC----------------
Q 006347 556 YEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---------------- 618 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---------------- 618 (649)
|||+++++|.+++..... ...+++.++..|+.||++||+|||+.+ |+||||||+|||++.
T Consensus 90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~ 166 (289)
T 1x8b_A 90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW 166 (289)
T ss_dssp EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence 999999999999964211 256899999999999999999999987 999999999999984
Q ss_pred ---CCceEEEecCCceeeCCC
Q 006347 619 ---ELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 619 ---~~~~Ki~DFGla~~~~~~ 636 (649)
...+||+|||+++.....
T Consensus 167 ~~~~~~~kl~Dfg~~~~~~~~ 187 (289)
T 1x8b_A 167 ASNKVMFKIGDLGHVTRISSP 187 (289)
T ss_dssp ---CCCEEECCCTTCEETTCS
T ss_pred cCCceEEEEcccccccccCCc
Confidence 447999999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.92 E-value=1.2e-24 Score=228.35 Aligned_cols=141 Identities=26% Similarity=0.346 Sum_probs=125.8
Q ss_pred eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 487 SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
+.||+|+||.||++... +++.||||++.+ .....+.+|+.++.++. ||||+++++++.+....++||||+++|+|
T Consensus 17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L 93 (325)
T 3kn6_A 17 KPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL 93 (325)
T ss_dssp CCSEEETTEEEEEEEETTTCCEEEEEEEEG---GGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBH
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEECh---hhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcH
Confidence 68999999999999986 689999999854 34567889999999997 99999999999999999999999999999
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---ceEEEecCCceeeCCC
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL---NPKISDFGMAKIFGGN 636 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~~Ki~DFGla~~~~~~ 636 (649)
.+++.. ...+++.++..|+.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+++.....
T Consensus 94 ~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~ 162 (325)
T 3kn6_A 94 FERIKK---KKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD 162 (325)
T ss_dssp HHHHHH---CSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC-
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC
Confidence 999954 356899999999999999999999987 99999999999998765 8999999999976443
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.92 E-value=2.6e-25 Score=228.43 Aligned_cols=155 Identities=32% Similarity=0.534 Sum_probs=139.0
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
...++|++.+.||+|+||.||+|... ++..||||.+... ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 88 (288)
T 3kfa_A 10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 88 (288)
T ss_dssp CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC-STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEE
T ss_pred ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEE
Confidence 34567899999999999999999987 4889999999653 445688999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+++.....
T Consensus 89 e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~ 164 (288)
T 3kfa_A 89 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 164 (288)
T ss_dssp ECCTTEEHHHHHHHC-CTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCSS
T ss_pred EcCCCCcHHHHHHhc-ccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccCC
Confidence 999999999999652 3456899999999999999999999988 999999999999999999999999999987544
Q ss_pred C
Q 006347 637 Q 637 (649)
Q Consensus 637 ~ 637 (649)
.
T Consensus 165 ~ 165 (288)
T 3kfa_A 165 T 165 (288)
T ss_dssp S
T ss_pred c
Confidence 3
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=99.92 E-value=9.9e-25 Score=250.74 Aligned_cols=163 Identities=29% Similarity=0.352 Sum_probs=140.0
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~ 553 (649)
..++|++.+.||+|+||.||+++.. +++.||||++++. .....+.+..|..++..+ +|++|+++++++.+.+..+
T Consensus 339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~ 418 (674)
T 3pfq_A 339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY 418 (674)
T ss_dssp -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence 4467999999999999999999976 6889999999753 234567888999999988 7999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ ||||||||+||||++++++||+|||+|+..
T Consensus 419 lV~E~~~gg~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~ 492 (674)
T 3pfq_A 419 FVMEYVNGGDLMYHIQQ---VGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEN 492 (674)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEEC
T ss_pred EEEeCcCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeecc
Confidence 99999999999999953 356899999999999999999999987 999999999999999999999999999975
Q ss_pred CCCCCccccCceeecC
Q 006347 634 GGNQDQADTGRVVGTL 649 (649)
Q Consensus 634 ~~~~~~~~~~~~~GT~ 649 (649)
...... +....||+
T Consensus 493 ~~~~~~--~~~~~GT~ 506 (674)
T 3pfq_A 493 IWDGVT--TKTFCGTP 506 (674)
T ss_dssp CCTTCC--BCCCCSCS
T ss_pred ccCCcc--cccccCCC
Confidence 433322 23356663
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=3.7e-24 Score=221.70 Aligned_cols=149 Identities=30% Similarity=0.470 Sum_probs=135.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
+.|+..+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 101 (303)
T 3a7i_A 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY 101 (303)
T ss_dssp GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEe
Confidence 56888999999999999999875 68999999986543 34568899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+++++|.+++. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+...
T Consensus 102 ~~~~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~ 172 (303)
T 3a7i_A 102 LGGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 172 (303)
T ss_dssp CTTEEHHHHHT----TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTT
T ss_pred CCCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCcc
Confidence 99999999984 356899999999999999999999987 999999999999999999999999999987544
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=220.95 Aligned_cols=148 Identities=30% Similarity=0.523 Sum_probs=135.3
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||.||++...+++.||||.+.... ...+++.+|+.++.+++||||+++++++.+++..++||||++
T Consensus 8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 86 (267)
T 3t9t_A 8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFME 86 (267)
T ss_dssp GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTT-BCHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCT
T ss_pred hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCC
Confidence 5688889999999999999999888899999997643 345789999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 87 ~~~L~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~ 155 (267)
T 3t9t_A 87 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVL 155 (267)
T ss_dssp TCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBC
T ss_pred CCcHHHHHhh--CcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEcccccccccc
Confidence 9999999964 2346899999999999999999999988 9999999999999999999999999998764
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-25 Score=228.60 Aligned_cols=175 Identities=27% Similarity=0.411 Sum_probs=143.7
Q ss_pred CCHHHHHHHhcCcccceeeccCCcEEEEEEEe------cCCcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCCccce
Q 006347 471 FQFEELATATNNFQLSSKLGQGGFGPVYWGRL------KDGQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRL 542 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~------~~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l 542 (649)
+...+.....++|++.+.||+|+||.||+|.. .+++.||||.+..... ...+.+.+|+.++.++ +||||+++
T Consensus 17 ~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 96 (316)
T 2xir_A 17 YDASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNL 96 (316)
T ss_dssp CCHHHHBCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred ccccceecchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeE
Confidence 34455555668899999999999999999984 2468899999975432 3456899999999999 79999999
Q ss_pred EEEEEeCC-eEEEEEecCCCCChhhhhcCCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecC
Q 006347 543 LGCCVEGE-EKMLIYEYMPNRSLDALLFDPLK-------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRD 608 (649)
Q Consensus 543 ~g~~~~~~-~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrD 608 (649)
++++.+.+ ..++||||+++++|.+++..... ...+++..+..++.|+++||.|||+.+ |+|||
T Consensus 97 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~d 173 (316)
T 2xir_A 97 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD 173 (316)
T ss_dssp EEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred EEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---ccccc
Confidence 99998765 48999999999999999975322 123789999999999999999999987 99999
Q ss_pred CCCCcEEEcCCCceEEEecCCceeeCCCCCccccCceeec
Q 006347 609 LKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 609 lkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
|||+||++++++.+||+|||+++.+.............||
T Consensus 174 ikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t 213 (316)
T 2xir_A 174 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 213 (316)
T ss_dssp CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEEC
T ss_pred CccceEEECCCCCEEECCCccccccccCccceeccCCCcc
Confidence 9999999999999999999999987554433333334444
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=230.61 Aligned_cols=164 Identities=26% Similarity=0.327 Sum_probs=142.7
Q ss_pred CCCCCCCHHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----CCCc
Q 006347 466 QDLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----HRNL 539 (649)
Q Consensus 466 ~~~~~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----H~ni 539 (649)
.+...+++.+.....++|.+.++||+|+||.||+|+.. +++.||||+++. .....+.+..|+.++.+++ |+||
T Consensus 20 ~~~~~~~~~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~-~~~~~~~~~~e~~~l~~l~~~~~~h~~i 98 (360)
T 3llt_A 20 DEIVHFSWKKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN-IKKYTRSAKIEADILKKIQNDDINNNNI 98 (360)
T ss_dssp CGGGSCCCCTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS-CHHHHHHHHHHHHHHHHTCCCSTTGGGB
T ss_pred ccceeeeeecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc-chhhhhhhHHHHHHHHHhcccCCCCCCe
Confidence 34456667776777889999999999999999999985 688999999964 2345567888999999986 9999
Q ss_pred cceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-
Q 006347 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE- 618 (649)
Q Consensus 540 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~- 618 (649)
+++++++.+.+..++||||+ +++|.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++
T Consensus 99 v~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~ 173 (360)
T 3llt_A 99 VKYHGKFMYYDHMCLIFEPL-GPSLYEIITRN-NYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDP 173 (360)
T ss_dssp CCEEEEEEETTEEEEEECCC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCT
T ss_pred ecccceeeECCeeEEEEcCC-CCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccc
Confidence 99999999999999999999 99999999653 2345899999999999999999999988 999999999999976
Q ss_pred ------------------------CCceEEEecCCceeeCC
Q 006347 619 ------------------------ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 619 ------------------------~~~~Ki~DFGla~~~~~ 635 (649)
++.+||+|||+|+....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~ 214 (360)
T 3llt_A 174 YFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSD 214 (360)
T ss_dssp TCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTS
T ss_pred cccccccchhcccccccccccccCCCCEEEEeccCceecCC
Confidence 78999999999997643
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.7e-24 Score=221.38 Aligned_cols=151 Identities=34% Similarity=0.603 Sum_probs=134.2
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|++.+.||+|+||.||+|...++..||||.+... ....+.+.+|+.++.+++||||+++++++. .+..++||||+
T Consensus 12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 89 (279)
T 1qpc_A 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYM 89 (279)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECC
T ss_pred HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCC-cccHHHHHHHHHHHHhCCCcCcceEEEEEc-CCCcEEEEecC
Confidence 3578889999999999999999988889999999653 345688999999999999999999999976 55689999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++++|.+++... ....+++.++..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.....
T Consensus 90 ~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~ 162 (279)
T 1qpc_A 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (279)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred CCCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCc
Confidence 999999999532 1236899999999999999999999988 999999999999999999999999999987543
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=233.18 Aligned_cols=150 Identities=29% Similarity=0.562 Sum_probs=124.8
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCC--e
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGE--E 551 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~--~ 551 (649)
...++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++.++. |+||+++++++...+ .
T Consensus 6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~ 85 (388)
T 3oz6_A 6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD 85 (388)
T ss_dssp HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence 34578999999999999999999875 7899999998643 2345677889999999997 999999999998654 6
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||++ ++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 86 ~~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~ 157 (388)
T 3oz6_A 86 VYLVFDYME-TDLHAVIRA----NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSR 157 (388)
T ss_dssp EEEEEECCS-EEHHHHHHH----TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred EEEEecccC-cCHHHHHHc----CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccc
Confidence 899999997 689998843 46899999999999999999999988 9999999999999999999999999999
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 158 ~~~~ 161 (388)
T 3oz6_A 158 SFVN 161 (388)
T ss_dssp ESSS
T ss_pred cccc
Confidence 8743
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.1e-24 Score=234.70 Aligned_cols=160 Identities=24% Similarity=0.362 Sum_probs=132.7
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC--CCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||++...+++.||||++... .....+++.+|+.++.+++ |+||+++++++.+.+..+|||
T Consensus 56 ~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~ 135 (390)
T 2zmd_A 56 RIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVM 135 (390)
T ss_dssp EEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred CceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEE
Confidence 458999999999999999999888999999998643 2345678999999999996 599999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
| +.+++|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+|+.+...
T Consensus 136 E-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~ 207 (390)
T 2zmd_A 136 E-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQPD 207 (390)
T ss_dssp E-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC---
T ss_pred e-cCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccCC
Confidence 9 568999999964 346889999999999999999999987 99999999999996 578999999999987554
Q ss_pred CCccccCceeec
Q 006347 637 QDQADTGRVVGT 648 (649)
Q Consensus 637 ~~~~~~~~~~GT 648 (649)
..........||
T Consensus 208 ~~~~~~~~~~gt 219 (390)
T 2zmd_A 208 TTSVVKDSQVGA 219 (390)
T ss_dssp ------CCSCCC
T ss_pred CccccCCCCCcC
Confidence 433223334555
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.4e-24 Score=230.11 Aligned_cols=149 Identities=34% Similarity=0.544 Sum_probs=131.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
+.|+..+.||+|+||.||+|... +++.||||++.... ....+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 133 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 133 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence 45888899999999999999964 78999999986432 233467899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||++ |+|.+++.. ....+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 134 e~~~-g~l~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~ 206 (348)
T 1u5q_A 134 EYCL-GSASDLLEV--HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 206 (348)
T ss_dssp ECCS-EEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCC-CCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC
Confidence 9997 688887743 2356899999999999999999999987 99999999999999999999999999987643
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.7e-24 Score=225.87 Aligned_cols=153 Identities=27% Similarity=0.465 Sum_probs=129.5
Q ss_pred HHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC--CCCCccceEEEEEeC----
Q 006347 476 LATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL--QHRNLVRLLGCCVEG---- 549 (649)
Q Consensus 476 l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l--~H~niv~l~g~~~~~---- 549 (649)
.....++|++.+.||+|+||.||+|+.. ++.||||++... ....+..|.+++..+ +|+||+++++++.+.
T Consensus 32 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 32 QRTIAKQIQMVKQIGKGRYGEVWMGKWR-GEKVAVKVFFTT---EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HTTHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccccccceEEEeEeecCCCeEEEEEEEC-CceEEEEEEecc---ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 3445578999999999999999999987 899999998542 334556666666655 899999999999988
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCceEecCCCCCcEEEcCCCceEE
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS-----RLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
...++||||+++|+|.+++.. ..+++..++.++.|++.||+|||+.. +.+|+||||||+|||++.++.+||
T Consensus 108 ~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl 183 (337)
T 3mdy_A 108 TQLYLITDYHENGSLYDYLKS----TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCI 183 (337)
T ss_dssp CEEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEE
T ss_pred CceEEEEeccCCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEE
Confidence 788999999999999999943 35899999999999999999999871 123999999999999999999999
Q ss_pred EecCCceeeCCC
Q 006347 625 SDFGMAKIFGGN 636 (649)
Q Consensus 625 ~DFGla~~~~~~ 636 (649)
+|||+|+.+...
T Consensus 184 ~Dfg~a~~~~~~ 195 (337)
T 3mdy_A 184 ADLGLAVKFISD 195 (337)
T ss_dssp CCCTTCEECC--
T ss_pred EeCCCceeeccc
Confidence 999999887543
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-25 Score=246.78 Aligned_cols=152 Identities=34% Similarity=0.567 Sum_probs=135.2
Q ss_pred HHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
...++|++.++||+|+||.||+|.+.++..||||+++... ...++|.+|+.++++++|+||+++++++.+ +..+||||
T Consensus 264 i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e 341 (535)
T 2h8h_A 264 IPRESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTE 341 (535)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTS-SCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEC
T ss_pred cchhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCC-CCHHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeee
Confidence 3456788899999999999999999888899999997543 456789999999999999999999999866 67899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++|+|.++|... ....+++.+++.|+.||++||+|||+++ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 342 ~~~~gsL~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~ 415 (535)
T 2h8h_A 342 YMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIED 415 (535)
T ss_dssp CCTTEEHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTSTTTCCC
T ss_pred hhcCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccceecCC
Confidence 99999999999532 2245899999999999999999999988 99999999999999999999999999997643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=223.32 Aligned_cols=148 Identities=34% Similarity=0.571 Sum_probs=123.7
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||+|+||.||+|+.. ..||||+++... ....+.|.+|+.++++++|+||+++++++ .....++|||
T Consensus 23 ~~~y~~~~~lG~G~~g~Vy~~~~~--~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e 99 (289)
T 3og7_A 23 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQ 99 (289)
T ss_dssp TTSCEEEEEEEECSSEEEEEEESS--SEEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEE
T ss_pred ccceeeeeEecCCCCeEEEEEEEc--CceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEE
Confidence 467999999999999999999875 359999986432 34567899999999999999999999965 5567899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.+++.. ....+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 100 ~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 172 (289)
T 3og7_A 100 WCEGSSLYHHLHA--SETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSR 172 (289)
T ss_dssp CCCEEEHHHHHTT--C---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred ecCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecccccc
Confidence 9999999999954 3456899999999999999999999988 99999999999999999999999999987654
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.3e-24 Score=223.37 Aligned_cols=153 Identities=25% Similarity=0.433 Sum_probs=133.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|.+.++||+|+||.||++... ++..+|||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~ 101 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMET 101 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEe
Confidence 56888999999999999999976 68899999986543 34568899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~~~ 634 (649)
+++|+|.+++.... ....+++..+..|+.|+++||+|||+.+ |+||||||+|||+ +.++.+||+|||+++.+.
T Consensus 102 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~ 178 (285)
T 3is5_A 102 CEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFK 178 (285)
T ss_dssp CSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC--
T ss_pred CCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeecceecC
Confidence 99999999885421 2356899999999999999999999987 9999999999999 456789999999998765
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 179 ~~ 180 (285)
T 3is5_A 179 SD 180 (285)
T ss_dssp --
T ss_pred Cc
Confidence 43
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=225.71 Aligned_cols=151 Identities=36% Similarity=0.624 Sum_probs=134.3
Q ss_pred cCcccceeeccCCcEEEEEEEe-----cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC--eEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRL-----KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE--EKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~-----~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~--~~~ 553 (649)
++|++.+.||+|+||.||++.. .+++.||||++........+++.+|+.++.+++|+||+++++++...+ ..+
T Consensus 41 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 120 (326)
T 2w1i_A 41 RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLK 120 (326)
T ss_dssp GGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCE
T ss_pred HHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceE
Confidence 4688889999999999999984 368899999998766666788999999999999999999999987654 679
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++++|.+++... ...+++.+++.++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+
T Consensus 121 lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~~~~ 195 (326)
T 2w1i_A 121 LIMEYLPYGSLRDYLQKH--KERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVL 195 (326)
T ss_dssp EEECCCTTCBHHHHHHHS--TTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEECCCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcchhhc
Confidence 999999999999999642 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 196 ~~~ 198 (326)
T 2w1i_A 196 PQD 198 (326)
T ss_dssp CSS
T ss_pred ccc
Confidence 544
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=4.2e-24 Score=218.93 Aligned_cols=151 Identities=28% Similarity=0.442 Sum_probs=134.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++.+++||||+++++++.+++..++||
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 84 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF 84 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEE
Confidence 468999999999999999999976 6899999998643 2334577889999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DFGla~~~ 633 (649)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||+++.++. +||+|||+++..
T Consensus 85 e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~ 158 (284)
T 3kk8_A 85 DLVTGGELFEDIVA---REFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEV 158 (284)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEEC
T ss_pred ecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEc
Confidence 99999999888853 356899999999999999999999988 999999999999986655 999999999887
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 159 ~~~ 161 (284)
T 3kk8_A 159 NDS 161 (284)
T ss_dssp CSS
T ss_pred ccC
Confidence 543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.2e-25 Score=227.36 Aligned_cols=158 Identities=30% Similarity=0.543 Sum_probs=127.4
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEec----CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
++....++|.+.+.||+|+||.||+|... .+..||||.++.. .....+++.+|+.++.+++||||+++++++.+
T Consensus 28 ~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~ 107 (313)
T 3brb_A 28 DVVIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIE 107 (313)
T ss_dssp TTBCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC
T ss_pred hcccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEee
Confidence 33445567889999999999999999865 3458999998653 23445789999999999999999999999987
Q ss_pred CCe-----EEEEEecCCCCChhhhhcCC---CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC
Q 006347 549 GEE-----KMLIYEYMPNRSLDALLFDP---LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL 620 (649)
Q Consensus 549 ~~~-----~~lV~Ey~~~gsL~~~l~~~---~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~ 620 (649)
.+. .++||||+++++|.+++... .....+++..++.++.||++||.|||+.+ |+||||||+|||+++++
T Consensus 108 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~ 184 (313)
T 3brb_A 108 MSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDM 184 (313)
T ss_dssp -------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTS
T ss_pred ccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCC
Confidence 654 49999999999999998432 23456899999999999999999999987 99999999999999999
Q ss_pred ceEEEecCCceeeCC
Q 006347 621 NPKISDFGMAKIFGG 635 (649)
Q Consensus 621 ~~Ki~DFGla~~~~~ 635 (649)
.+||+|||+++.+..
T Consensus 185 ~~kl~Dfg~~~~~~~ 199 (313)
T 3brb_A 185 TVCVADFGLSKKIYS 199 (313)
T ss_dssp CEEECSCSCC-----
T ss_pred cEEEeecCcceeccc
Confidence 999999999987744
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=228.97 Aligned_cols=157 Identities=24% Similarity=0.382 Sum_probs=133.2
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccc-----------cHHHHHHHHHHHhcCCCCCccc
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQ-----------GLEEFMNEVMVISKLQHRNLVR 541 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~ 541 (649)
..++....++|.+.+.||+|+||.||+|...+++.||||++...... ..+.+.+|+.++.+++||||++
T Consensus 14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~ 93 (362)
T 3pg1_A 14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG 93 (362)
T ss_dssp HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence 45677888999999999999999999999888999999998643211 2378999999999999999999
Q ss_pred eEEEEEeCC-----eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 542 LLGCCVEGE-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 542 l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+++++...+ ..++||||++ |+|.+++.. ....+++..+..++.||++||.|||+.+ |+||||||+|||+
T Consensus 94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~ 167 (362)
T 3pg1_A 94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHD--QRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILL 167 (362)
T ss_dssp CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEE
T ss_pred eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEE
Confidence 999996533 5799999997 688888864 3456899999999999999999999987 9999999999999
Q ss_pred cCCCceEEEecCCceeeCC
Q 006347 617 DEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~ 635 (649)
+.++.+||+|||+++....
T Consensus 168 ~~~~~~kl~Dfg~~~~~~~ 186 (362)
T 3pg1_A 168 ADNNDITICDFNLAREDTA 186 (362)
T ss_dssp CTTCCEEECCTTC------
T ss_pred cCCCCEEEEecCccccccc
Confidence 9999999999999986543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=222.35 Aligned_cols=150 Identities=25% Similarity=0.425 Sum_probs=124.2
Q ss_pred hcCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.++|++.+.||+|+||.||+|.... +..||||++.... ....+.+.+|+.++.+++||||+++++++ ..+..++
T Consensus 14 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~~~~~l 92 (281)
T 1mp8_A 14 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TENPVWI 92 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CSSSCEE
T ss_pred hHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-ccCccEE
Confidence 3578889999999999999998752 4579999986533 34457899999999999999999999997 4567899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 93 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 167 (281)
T 1mp8_A 93 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 167 (281)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEecCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECccccccccC
Confidence 9999999999999964 2346899999999999999999999987 9999999999999999999999999999875
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 168 ~ 168 (281)
T 1mp8_A 168 D 168 (281)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=236.91 Aligned_cols=152 Identities=30% Similarity=0.508 Sum_probs=132.8
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-------------ccHHHHHHHHHHHhcCCCCCccceEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-------------QGLEEFMNEVMVISKLQHRNLVRLLG 544 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-------------~~~~~f~~E~~~l~~l~H~niv~l~g 544 (649)
..++|.+.++||+|+||+||+|... +++.||||++..... ...+++.+|+.++.+++||||+++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~ 113 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFD 113 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence 3467999999999999999999976 678999999865321 34578999999999999999999999
Q ss_pred EEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC---c
Q 006347 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL---N 621 (649)
Q Consensus 545 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~---~ 621 (649)
++.+....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .
T Consensus 114 ~~~~~~~~~lv~e~~~gg~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~ 187 (504)
T 3q5i_A 114 VFEDKKYFYLVTEFYEGGELFEQIIN---RHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLN 187 (504)
T ss_dssp EEECSSEEEEEEECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSS
T ss_pred EEEcCCEEEEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCcc
Confidence 99999999999999999999998853 356899999999999999999999987 99999999999998775 6
Q ss_pred eEEEecCCceeeCCC
Q 006347 622 PKISDFGMAKIFGGN 636 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~ 636 (649)
+||+|||+|+.+...
T Consensus 188 ~kl~Dfg~a~~~~~~ 202 (504)
T 3q5i_A 188 IKIVDFGLSSFFSKD 202 (504)
T ss_dssp EEECCCTTCEECCTT
T ss_pred EEEEECCCCEEcCCC
Confidence 999999999987554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=6.2e-24 Score=218.38 Aligned_cols=151 Identities=32% Similarity=0.595 Sum_probs=132.5
Q ss_pred cCcccce-eeccCCcEEEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|.+.+ .||+|+||.||+|+.. ++..||||.++... ....+++.+|+.++.+++||||+++++++ +.+..++|
T Consensus 9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv 87 (287)
T 1u59_A 9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLV 87 (287)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEE
T ss_pred HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEE
Confidence 4566665 8999999999999864 57889999997643 34567899999999999999999999999 56678999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+||++++++.+||+|||+++.+..
T Consensus 88 ~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~ 162 (287)
T 1u59_A 88 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 162 (287)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCCHHHHHHh--CCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence 999999999999954 3456899999999999999999999988 99999999999999999999999999998854
Q ss_pred CC
Q 006347 636 NQ 637 (649)
Q Consensus 636 ~~ 637 (649)
..
T Consensus 163 ~~ 164 (287)
T 1u59_A 163 DD 164 (287)
T ss_dssp CS
T ss_pred Cc
Confidence 43
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=2.1e-24 Score=220.84 Aligned_cols=149 Identities=32% Similarity=0.474 Sum_probs=132.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (279)
T 3fdn_A 8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI 87 (279)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence 467889999999999999999876 57799999985432 23456789999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 88 ~e~~~~~~l~~~l~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~ 160 (279)
T 3fdn_A 88 LEYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP 160 (279)
T ss_dssp ECCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCC
Confidence 999999999999853 345899999999999999999999887 9999999999999999999999999987653
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=227.40 Aligned_cols=158 Identities=23% Similarity=0.380 Sum_probs=138.9
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--------ccHHHHHHHHHHHhcC-CCCCccce
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--------QGLEEFMNEVMVISKL-QHRNLVRL 542 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l-~H~niv~l 542 (649)
........++|.+.+.||+|+||.||+|... +|+.||||++..... ...+.+.+|+.++.++ +||||+++
T Consensus 86 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~ 165 (365)
T 2y7j_A 86 WAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITL 165 (365)
T ss_dssp HHHHHHHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCE
T ss_pred chhhhhhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEE
Confidence 3344555678999999999999999999986 799999999865321 1245688999999999 79999999
Q ss_pred EEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
++++......++||||+++++|.+++.+ ...+++..+..++.||++||.|||+.+ |+||||||+|||+++++.+
T Consensus 166 ~~~~~~~~~~~lv~e~~~g~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~i 239 (365)
T 2y7j_A 166 IDSYESSSFMFLVFDLMRKGELFDYLTE---KVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQI 239 (365)
T ss_dssp EEEEEBSSEEEEEECCCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCE
T ss_pred EEEEeeCCEEEEEEEeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCE
Confidence 9999999999999999999999999953 356899999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeeCCC
Q 006347 623 KISDFGMAKIFGGN 636 (649)
Q Consensus 623 Ki~DFGla~~~~~~ 636 (649)
||+|||+++.+...
T Consensus 240 kl~DfG~~~~~~~~ 253 (365)
T 2y7j_A 240 RLSDFGFSCHLEPG 253 (365)
T ss_dssp EECCCTTCEECCTT
T ss_pred EEEecCcccccCCC
Confidence 99999999987543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.2e-24 Score=223.59 Aligned_cols=151 Identities=30% Similarity=0.394 Sum_probs=132.7
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 554 (649)
.++|++.+.||+|+||.||++... +++.||||++........+.+.+|+.++.+++||||+++++++.. ....++
T Consensus 28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 107 (317)
T 2buj_A 28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWL 107 (317)
T ss_dssp TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEE
T ss_pred CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEE
Confidence 467999999999999999999974 789999999876556677889999999999999999999999973 347789
Q ss_pred EEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||||+++|+|.+++... .....+++.+++.++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 108 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~ 184 (317)
T 2buj_A 108 LLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGSMNQA 184 (317)
T ss_dssp EEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSSCEES
T ss_pred EEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCcchhc
Confidence 99999999999998642 12456899999999999999999999987 999999999999999999999999998875
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=237.66 Aligned_cols=150 Identities=30% Similarity=0.480 Sum_probs=129.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.++||+|+||+||+|... ++..||||++.+.. ......+.+|+.++++++|||||++++++.+....++|||
T Consensus 37 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e 116 (494)
T 3lij_A 37 EMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME 116 (494)
T ss_dssp HHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred cCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence 46899999999999999999986 68899999987542 3446789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFGla~~~~ 634 (649)
|+++|+|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+|+.+.
T Consensus 117 ~~~~g~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~ 190 (494)
T 3lij_A 117 CYKGGELFDEIIH---RMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFE 190 (494)
T ss_dssp CCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECB
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECC
Confidence 9999999988853 356899999999999999999999987 999999999999976 4559999999999875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 191 ~~ 192 (494)
T 3lij_A 191 NQ 192 (494)
T ss_dssp TT
T ss_pred CC
Confidence 44
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=229.33 Aligned_cols=152 Identities=30% Similarity=0.478 Sum_probs=127.4
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc-----cHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
...++|.+.+.||+|+||.||+|... +|+.||||++...... ..+.+.+|+.++.+++||||+++++++.+.+.
T Consensus 7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~ 86 (346)
T 1ua2_A 7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN 86 (346)
T ss_dssp ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence 34568999999999999999999986 6899999998643221 23578899999999999999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+++ +|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+
T Consensus 87 ~~lv~e~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~ 160 (346)
T 1ua2_A 87 ISLVFDFMET-DLEVIIKD--NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAK 160 (346)
T ss_dssp CEEEEECCSE-EHHHHHTT--CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGS
T ss_pred eEEEEEcCCC-CHHHHHHh--cCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccce
Confidence 9999999975 89888854 2346888999999999999999999998 9999999999999999999999999999
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 161 ~~~~ 164 (346)
T 1ua2_A 161 SFGS 164 (346)
T ss_dssp TTTS
T ss_pred eccC
Confidence 8743
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.3e-24 Score=220.67 Aligned_cols=147 Identities=32% Similarity=0.532 Sum_probs=131.4
Q ss_pred cccceeeccCCcEEEEEEEec-----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEE
Q 006347 483 FQLSSKLGQGGFGPVYWGRLK-----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKML 554 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~-----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~l 554 (649)
|++.++||+|+||.||++.+. +++.||||++.... ....+.+.+|+.++++++||||+++++++.+. ...++
T Consensus 33 ~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~l 112 (318)
T 3lxp_A 33 LKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQL 112 (318)
T ss_dssp EEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEE
T ss_pred HhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEE
Confidence 488899999999999998753 57899999997543 34467899999999999999999999999984 57899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 113 v~e~~~~~~L~~~l~~----~~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~ 185 (318)
T 3lxp_A 113 VMEYVPLGSLRDYLPR----HSIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 185 (318)
T ss_dssp EECCCTTCBHHHHGGG----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred EEecccCCcHHHHHhh----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence 9999999999999943 34899999999999999999999988 9999999999999999999999999999875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 186 ~~ 187 (318)
T 3lxp_A 186 EG 187 (318)
T ss_dssp TT
T ss_pred cc
Confidence 44
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=221.60 Aligned_cols=149 Identities=33% Similarity=0.539 Sum_probs=132.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe----------
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE---------- 548 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~---------- 548 (649)
.++|++.+.||+|+||.||+|+.. +++.||||++.. .....+.+.+|+.++.+++||||+++++++.+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (303)
T 1zy4_A 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH-TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTA 83 (303)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE-EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC----
T ss_pred cccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec-cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcc
Confidence 457889999999999999999975 789999999964 33456789999999999999999999999876
Q ss_pred ---CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 549 ---GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 549 ---~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
.+..++||||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+
T Consensus 84 ~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~ 158 (303)
T 1zy4_A 84 VKKKSTLFIQMEYCENGTLYDLIHS--ENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIG 158 (303)
T ss_dssp --CEEEEEEEEECCCSCBHHHHHHH--SCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEEC
T ss_pred cccCCceEEEEecCCCCCHHHhhhc--cccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEe
Confidence 3467899999999999999964 2345788999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeeC
Q 006347 626 DFGMAKIFG 634 (649)
Q Consensus 626 DFGla~~~~ 634 (649)
|||+++.+.
T Consensus 159 dfg~~~~~~ 167 (303)
T 1zy4_A 159 DFGLAKNVH 167 (303)
T ss_dssp CCCCCSCTT
T ss_pred eCcchhhcc
Confidence 999998764
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=219.00 Aligned_cols=150 Identities=30% Similarity=0.525 Sum_probs=132.3
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe---------
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--------- 548 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--------- 548 (649)
..++|++.+.||+|+||.||+|... +++.||||++.... +.+.+|+.++.+++||||+++++++..
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~----~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~ 84 (284)
T 2a19_B 9 FGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS 84 (284)
T ss_dssp HHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS----GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred hccccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc----HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence 3456899999999999999999987 78999999986533 467789999999999999999999865
Q ss_pred -------CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 549 -------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 549 -------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
....++||||+++++|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.
T Consensus 85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~ 160 (284)
T 2a19_B 85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKR-RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQ 160 (284)
T ss_dssp ----CCEEEEEEEEECCCCSCBHHHHHHHG-GGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTE
T ss_pred ccccccCcceEEEEEeccCCCCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCC
Confidence 34579999999999999999642 2356899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCceeeCCC
Q 006347 622 PKISDFGMAKIFGGN 636 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~ 636 (649)
+||+|||+++.+...
T Consensus 161 ~kl~Dfg~~~~~~~~ 175 (284)
T 2a19_B 161 VKIGDFGLVTSLKND 175 (284)
T ss_dssp EEECCCTTCEESSCC
T ss_pred EEECcchhheecccc
Confidence 999999999987554
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=226.86 Aligned_cols=151 Identities=28% Similarity=0.416 Sum_probs=134.8
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccccccc-----------------HHHHHHHHHHHhcCCCCCccce
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQG-----------------LEEFMNEVMVISKLQHRNLVRL 542 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~-----------------~~~f~~E~~~l~~l~H~niv~l 542 (649)
.++|.+.+.||+|+||.||+|.. +++.||||.+....... .+.+.+|+.++.+++||||+++
T Consensus 30 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~ 108 (348)
T 2pml_X 30 INDYRIIRTLNQGKFNKIILCEK-DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTC 108 (348)
T ss_dssp ETTEEEEEEEECCSSCCEEEEEE-TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCC
T ss_pred cCceEEEEEEcCCCCeEEEEEEc-CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceE
Confidence 46799999999999999999999 89999999986432111 1889999999999999999999
Q ss_pred EEEEEeCCeEEEEEecCCCCChhhh------hcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEE
Q 006347 543 LGCCVEGEEKMLIYEYMPNRSLDAL------LFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNIL 615 (649)
Q Consensus 543 ~g~~~~~~~~~lV~Ey~~~gsL~~~------l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NIL 615 (649)
++++.+.+..++||||+++++|.++ +.. .....+++..+..++.|+++||+|||+ .+ |+||||||+|||
T Consensus 109 ~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~-~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil 184 (348)
T 2pml_X 109 EGIITNYDEVYIIYEYMENDSILKFDEYFFVLDK-NYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNIL 184 (348)
T ss_dssp SEEEESSSEEEEEEECCTTCBSSEESSSEESSCS-SSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEE
T ss_pred EEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhh-ccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEE
Confidence 9999999999999999999999998 532 125679999999999999999999998 76 999999999999
Q ss_pred EcCCCceEEEecCCceeeCC
Q 006347 616 LDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 616 l~~~~~~Ki~DFGla~~~~~ 635 (649)
++.++.+||+|||+++....
T Consensus 185 ~~~~~~~kl~dfg~~~~~~~ 204 (348)
T 2pml_X 185 MDKNGRVKLSDFGESEYMVD 204 (348)
T ss_dssp ECTTSCEEECCCTTCEECBT
T ss_pred EcCCCcEEEecccccccccc
Confidence 99999999999999998644
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.9e-24 Score=220.86 Aligned_cols=152 Identities=30% Similarity=0.523 Sum_probs=128.3
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-----cccHHHHHHHHHHHhcCC---CCCccceEEEEEeC
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-----GQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEG 549 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-----~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~ 549 (649)
..++|++.++||+|+||+||+|+.. +++.||||++.... ......+.+|+.++++++ ||||+++++++.+.
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 4578999999999999999999975 78999999986432 122456778888777764 99999999999886
Q ss_pred C-----eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEE
Q 006347 550 E-----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKI 624 (649)
Q Consensus 550 ~-----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki 624 (649)
. ..++||||++ ++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||
T Consensus 87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl 161 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD-QDLRTYLDKA-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKL 161 (308)
T ss_dssp CSSSEEEEEEEEECCC-CBHHHHHHTC-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEE
T ss_pred CCCCceeEEEEehhhh-cCHHHHHhhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEE
Confidence 5 4789999996 6999999653 2344899999999999999999999998 999999999999999999999
Q ss_pred EecCCceeeCC
Q 006347 625 SDFGMAKIFGG 635 (649)
Q Consensus 625 ~DFGla~~~~~ 635 (649)
+|||+|+.+..
T Consensus 162 ~Dfg~a~~~~~ 172 (308)
T 3g33_A 162 ADFGLARIYSY 172 (308)
T ss_dssp CSCSCTTTSTT
T ss_pred eeCccccccCC
Confidence 99999997754
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-24 Score=217.85 Aligned_cols=149 Identities=30% Similarity=0.438 Sum_probs=133.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|.+.+.||+|+||.||++... +++.||||.++.... ...+++.+|+.++.+++||||+++++++.+.+..+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVV 84 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEE
Confidence 46888999999999999999987 689999999865321 24678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEecCC
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFGM 629 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~Ki~DFGl 629 (649)
+||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||++++++ .+||+|||+
T Consensus 85 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~ 158 (283)
T 3bhy_A 85 LILELVSGGELFDFLAE---KESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158 (283)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEeecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEeccc
Confidence 99999999999999953 356899999999999999999999987 99999999999999877 899999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
++.+..
T Consensus 159 ~~~~~~ 164 (283)
T 3bhy_A 159 AHKIEA 164 (283)
T ss_dssp CEECC-
T ss_pred ceeccC
Confidence 998754
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=245.03 Aligned_cols=149 Identities=32% Similarity=0.583 Sum_probs=129.7
Q ss_pred Ccccce-eeccCCcEEEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++.+.+ +||+|+||.||+|.+. ++..||||+++... ....++|.+|+.++.+++|||||++++++.+ +..+|||
T Consensus 336 ~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~ 414 (613)
T 2ozo_A 336 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVM 414 (613)
T ss_dssp SEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEE
T ss_pred ceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEE
Confidence 344444 7999999999999875 46689999997643 3467889999999999999999999999876 5689999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ....+++..+..|+.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 415 E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~ 489 (613)
T 2ozo_A 415 EMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGAD 489 (613)
T ss_dssp ECCTTCBHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC--
T ss_pred EeCCCCcHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCC
Confidence 99999999999964 3456899999999999999999999987 999999999999999999999999999987543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.91 E-value=5.2e-24 Score=225.18 Aligned_cols=147 Identities=27% Similarity=0.427 Sum_probs=128.7
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.+.||+|+||.||++... +++.||||.+++... .+.+|++++.++ +||||+++++++.+++..++|||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~----~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E 96 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKR----DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTE 96 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTC----CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccC----ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEe
Confidence 457899999999999999999986 688999999975432 345688888888 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC----CceEEEecCCceee
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE----LNPKISDFGMAKIF 633 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~----~~~Ki~DFGla~~~ 633 (649)
|+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+.++ ..+||+|||+++.+
T Consensus 97 ~~~gg~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~ 170 (342)
T 2qr7_A 97 LMKGGELLDKILR---QKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQL 170 (342)
T ss_dssp CCCSCBHHHHHHT---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEEC
T ss_pred CCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccC
Confidence 9999999999854 356899999999999999999999998 9999999999998543 35999999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 171 ~~~ 173 (342)
T 2qr7_A 171 RAE 173 (342)
T ss_dssp BCT
T ss_pred cCC
Confidence 544
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=2.3e-24 Score=226.29 Aligned_cols=151 Identities=32% Similarity=0.581 Sum_probs=126.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|++.+.||+|+||.||+|... +++ .||+|.+... .....+++.+|+.++.+++||||+++++++.++. .++
T Consensus 15 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~ 93 (327)
T 3lzb_A 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQL 93 (327)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEE
T ss_pred hHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceE
Confidence 57899999999999999999965 444 4688877543 3456788999999999999999999999998765 789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+||+++|+|.+++... ...+++..++.|+.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 94 v~~~~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~ 168 (327)
T 3lzb_A 94 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 168 (327)
T ss_dssp EECCCSSCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC-----
T ss_pred EEEecCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeEcc
Confidence 99999999999999642 456899999999999999999999988 9999999999999999999999999999875
Q ss_pred CCC
Q 006347 635 GNQ 637 (649)
Q Consensus 635 ~~~ 637 (649)
...
T Consensus 169 ~~~ 171 (327)
T 3lzb_A 169 AEE 171 (327)
T ss_dssp ---
T ss_pred Ccc
Confidence 443
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.1e-24 Score=220.66 Aligned_cols=151 Identities=25% Similarity=0.390 Sum_probs=129.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc----cccHHHHHHHHHHHhcCCCCCccceEEEEE--eCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQHRNLVRLLGCCV--EGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~H~niv~l~g~~~--~~~~~ 552 (649)
.++|.+.+.||+|+||.||++... +++.||||.+.... ....+.+.+|+.++.+++|+||+++++++. +.+..
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKM 83 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CE
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeE
Confidence 368999999999999999999976 68899999996532 345678999999999999999999999985 44578
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||++++ |.+++... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 84 ~lv~e~~~~~-l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~ 158 (305)
T 2wtk_C 84 YMVMEYCVCG-MQEMLDSV-PEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEA 158 (305)
T ss_dssp EEEEECCSEE-HHHHHHHS-TTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEehhccCC-HHHHHHhC-cccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccc
Confidence 9999999877 76766542 3456899999999999999999999987 99999999999999999999999999998
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 159 ~~~ 161 (305)
T 2wtk_C 159 LHP 161 (305)
T ss_dssp CCT
T ss_pred cCc
Confidence 754
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.91 E-value=2.5e-24 Score=229.45 Aligned_cols=151 Identities=22% Similarity=0.367 Sum_probs=126.6
Q ss_pred HhcCcccceeeccCCcEEEEEEEecC------CcEEEEEEeccccccc-----------HHHHHHHHHHHhcCCCCCccc
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQG-----------LEEFMNEVMVISKLQHRNLVR 541 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~~~~~-----------~~~f~~E~~~l~~l~H~niv~ 541 (649)
..++|++.+.||+|+||.||+|.... ++.||||++....... ...+..|+..+..++|+||++
T Consensus 33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~ 112 (364)
T 3op5_A 33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK 112 (364)
T ss_dssp TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence 34689999999999999999998864 4789999986543211 123445666778889999999
Q ss_pred eEEEEEeC----CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006347 542 LLGCCVEG----EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617 (649)
Q Consensus 542 l~g~~~~~----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 617 (649)
+++++.+. ...+|||||+ +++|.+++.. ....+++..++.|+.||++||+|||+.+ |+||||||+|||++
T Consensus 113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~--~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~ 186 (364)
T 3op5_A 113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEA--NAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLN 186 (364)
T ss_dssp EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEE
T ss_pred EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEe
Confidence 99999875 4579999999 9999999964 2356999999999999999999999987 99999999999999
Q ss_pred --CCCceEEEecCCceeeCC
Q 006347 618 --EELNPKISDFGMAKIFGG 635 (649)
Q Consensus 618 --~~~~~Ki~DFGla~~~~~ 635 (649)
.++.+||+|||+|+.+..
T Consensus 187 ~~~~~~~kl~DFG~a~~~~~ 206 (364)
T 3op5_A 187 YKNPDQVYLVDYGLAYRYCP 206 (364)
T ss_dssp SSCTTCEEECCCTTCEESSG
T ss_pred cCCCCeEEEEECCcceeccc
Confidence 889999999999998754
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-24 Score=219.07 Aligned_cols=152 Identities=28% Similarity=0.375 Sum_probs=135.5
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---------cccHHHHHHHHHHHhcCC-CCCccceEEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---------GQGLEEFMNEVMVISKLQ-HRNLVRLLGCCV 547 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---------~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~ 547 (649)
..++|++.+.||+|+||.||+|... +++.||||.++... ....+.+.+|+.++.++. ||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3468999999999999999999986 68899999986432 123467889999999995 999999999999
Q ss_pred eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
+.+..++||||+++++|.+++.. ...+++..+..++.||+.||.|||+.+ |+||||||+||++++++.+||+||
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df 168 (298)
T 1phk_A 95 TNTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDF 168 (298)
T ss_dssp CSSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCC
T ss_pred cCCeEEEEEeccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecc
Confidence 99999999999999999999953 356899999999999999999999988 999999999999999999999999
Q ss_pred CCceeeCCC
Q 006347 628 GMAKIFGGN 636 (649)
Q Consensus 628 Gla~~~~~~ 636 (649)
|+++.+...
T Consensus 169 g~~~~~~~~ 177 (298)
T 1phk_A 169 GFSCQLDPG 177 (298)
T ss_dssp TTCEECCTT
T ss_pred cchhhcCCC
Confidence 999987543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=7.4e-24 Score=218.49 Aligned_cols=150 Identities=19% Similarity=0.324 Sum_probs=132.8
Q ss_pred hcCcccceeeccCCcEEEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.+.||+|+||.||+|.. .+++.||||++... ...+++.+|+.++.++ +|+|++++++++.+....++|||
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e 86 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 86 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECC--TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccC--CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEE
Confidence 35799999999999999999996 47899999998643 2345788999999999 79999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----eEEEecCCcee
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-----PKISDFGMAKI 632 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~Ki~DFGla~~ 632 (649)
|+ +++|.+++... ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +||+|||+|+.
T Consensus 87 ~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~ 160 (298)
T 1csn_A 87 LL-GPSLEDLLDLC--GRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 160 (298)
T ss_dssp CC-CCBHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred ec-CCCHHHHHHHh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECccccc
Confidence 99 99999999642 345899999999999999999999987 999999999999987776 99999999998
Q ss_pred eCCCC
Q 006347 633 FGGNQ 637 (649)
Q Consensus 633 ~~~~~ 637 (649)
+....
T Consensus 161 ~~~~~ 165 (298)
T 1csn_A 161 YRDPV 165 (298)
T ss_dssp SBCTT
T ss_pred ccccc
Confidence 76543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.1e-24 Score=223.72 Aligned_cols=154 Identities=26% Similarity=0.410 Sum_probs=134.4
Q ss_pred HHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhc--CCCCCccceEEEEEeCC
Q 006347 473 FEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISK--LQHRNLVRLLGCCVEGE 550 (649)
Q Consensus 473 ~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~--l~H~niv~l~g~~~~~~ 550 (649)
...-....++|.+.+.||+|+||.||+|+.. ++.||||.+.. ...+.+.+|++++.. ++||||+++++++.+..
T Consensus 34 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~vavK~~~~---~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~ 109 (342)
T 1b6c_B 34 LLVQRTIARTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSS---REERSWFREAEIYQTVMLRHENILGFIAADNKDN 109 (342)
T ss_dssp HHHHHHHHHHCEEEEEEEEETTEEEEEEEET-TEEEEEEEECG---GGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCC
T ss_pred eeecccccccEEEEeeecCCCCcEEEEEEEc-CccEEEEEeCc---hhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccC
Confidence 3333455578999999999999999999985 89999999854 345678889988887 78999999999999876
Q ss_pred ----eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCceEecCCCCCcEEEcC
Q 006347 551 ----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH--------RDSRLRIIHRDLKASNILLDE 618 (649)
Q Consensus 551 ----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH--------~~~~~~iiHrDlkp~NILl~~ 618 (649)
..++||||+++|+|.+++.. ..+++..++.++.|+++||+||| +.+ |+||||||+|||+++
T Consensus 110 ~~~~~~~lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~ 182 (342)
T 1b6c_B 110 GTWTQLWLVSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKK 182 (342)
T ss_dssp SSCCCEEEEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECT
T ss_pred CccceeEEEEeecCCCcHHHHHhc----cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECC
Confidence 78999999999999999953 45899999999999999999999 555 999999999999999
Q ss_pred CCceEEEecCCceeeCCCC
Q 006347 619 ELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 619 ~~~~Ki~DFGla~~~~~~~ 637 (649)
++.+||+|||+++......
T Consensus 183 ~~~~kL~Dfg~~~~~~~~~ 201 (342)
T 1b6c_B 183 NGTCCIADLGLAVRHDSAT 201 (342)
T ss_dssp TSCEEECCCTTCEEEETTT
T ss_pred CCCEEEEECCCceeccccc
Confidence 9999999999999875543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=218.50 Aligned_cols=149 Identities=32% Similarity=0.598 Sum_probs=129.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc-------cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-------GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-------~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
++|++.+.||+|+||.||+|+.. +++.||||++...... ..+++.+|+.++.+++||||+++++++.+..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-- 96 (287)
T 4f0f_A 19 NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP-- 96 (287)
T ss_dssp TTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT--
T ss_pred ccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC--
Confidence 67888999999999999999985 7899999998643221 1278999999999999999999999986554
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-----eEEEec
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-----PKISDF 627 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-----~Ki~DF 627 (649)
++||||+++++|.+++.+ ....+++..+..++.|+++||+|||+.+ .+|+||||||+|||++.++. +||+||
T Consensus 97 ~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df 173 (287)
T 4f0f_A 97 RMVMEFVPCGDLYHRLLD--KAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF 173 (287)
T ss_dssp EEEEECCTTCBHHHHHHC--TTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred eEEEEecCCCCHHHHHhc--ccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence 799999999999998865 3456899999999999999999999874 35999999999999988776 999999
Q ss_pred CCceeeC
Q 006347 628 GMAKIFG 634 (649)
Q Consensus 628 Gla~~~~ 634 (649)
|+|+...
T Consensus 174 g~~~~~~ 180 (287)
T 4f0f_A 174 GLSQQSV 180 (287)
T ss_dssp TTCBCCS
T ss_pred Ccccccc
Confidence 9998653
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=226.69 Aligned_cols=161 Identities=30% Similarity=0.491 Sum_probs=137.0
Q ss_pred CCCHHHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEE
Q 006347 470 LFQFEELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCV 547 (649)
Q Consensus 470 ~~~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~ 547 (649)
.+++.++....++|++.+.||+|+||.||+|... +++.||||++... ....+++.+|+.++.++ +||||+++++++.
T Consensus 13 ~~~~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 91 (326)
T 2x7f_A 13 EIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVT-GDEEEEIKQEINMLKKYSHHRNIATYYGAFI 91 (326)
T ss_dssp ---CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-SSTTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred hccchhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecC-cccHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence 3444455566788999999999999999999975 7899999998653 34567899999999999 7999999999998
Q ss_pred e------CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc
Q 006347 548 E------GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN 621 (649)
Q Consensus 548 ~------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~ 621 (649)
. .+..++||||+++++|.+++... ....+++..+..++.||+.||.|||+.+ |+||||||+|||+++++.
T Consensus 92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~ 167 (326)
T 2x7f_A 92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAE 167 (326)
T ss_dssp ECC--CCCCEEEEEEECCTTEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCC
T ss_pred eccCccccceEEEEEEcCCCCcHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCC
Confidence 7 46789999999999999999643 2356899999999999999999999987 999999999999999999
Q ss_pred eEEEecCCceeeCC
Q 006347 622 PKISDFGMAKIFGG 635 (649)
Q Consensus 622 ~Ki~DFGla~~~~~ 635 (649)
+||+|||+++.+..
T Consensus 168 ~kl~Dfg~~~~~~~ 181 (326)
T 2x7f_A 168 VKLVDFGVSAQLDR 181 (326)
T ss_dssp EEECCCTTTC----
T ss_pred EEEeeCcCceecCc
Confidence 99999999987643
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=1.5e-24 Score=227.80 Aligned_cols=152 Identities=30% Similarity=0.471 Sum_probs=127.7
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
....++|++.++||+|+||+||++... +++.||||++..... ...+.+.+|+.++++++||||+++++++.+.+..+
T Consensus 30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 109 (329)
T 3gbz_A 30 ATSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLH 109 (329)
T ss_dssp --CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEETTEEE
T ss_pred ccchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEE
Confidence 334568999999999999999999865 789999999965432 23467889999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE-----cCCCceEEEecC
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL-----DEELNPKISDFG 628 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl-----~~~~~~Ki~DFG 628 (649)
+||||++ |+|.+++.. ...+++..+..|+.||++||+|||+.+ |+||||||+|||+ ++++.+||+|||
T Consensus 110 lv~e~~~-~~L~~~~~~---~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg 182 (329)
T 3gbz_A 110 LIFEYAE-NDLKKYMDK---NPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFG 182 (329)
T ss_dssp EEEECCS-EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTT
T ss_pred EEEecCC-CCHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCC
Confidence 9999997 599999853 345899999999999999999999987 9999999999999 455669999999
Q ss_pred CceeeCC
Q 006347 629 MAKIFGG 635 (649)
Q Consensus 629 la~~~~~ 635 (649)
+|+.+..
T Consensus 183 ~a~~~~~ 189 (329)
T 3gbz_A 183 LARAFGI 189 (329)
T ss_dssp HHHHHC-
T ss_pred CccccCC
Confidence 9987753
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=3.3e-24 Score=225.29 Aligned_cols=149 Identities=29% Similarity=0.494 Sum_probs=130.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc--ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG--QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~--~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||++... +++.||||++..... ...+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 104 (331)
T 4aaa_A 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFE 104 (331)
T ss_dssp GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEe
Confidence 46888999999999999999986 589999999864332 234668899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 105 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 176 (331)
T 4aaa_A 105 FVDHTILDDLELF---PNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAA 176 (331)
T ss_dssp CCSEEHHHHHHHS---TTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred cCCcchHHHHHhh---ccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecC
Confidence 9999999988743 346899999999999999999999988 99999999999999999999999999987644
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=222.67 Aligned_cols=150 Identities=22% Similarity=0.271 Sum_probs=131.0
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||++... +++.||||.+..... ...+++.+|+.++.+++||||+++++++.+++..++|
T Consensus 33 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv 112 (309)
T 2h34_A 33 FGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVD 112 (309)
T ss_dssp -CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred eccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEE
Confidence 468999999999999999999976 688999999975432 2347899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 113 ~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 186 (309)
T 2h34_A 113 MRLINGVDLAAMLRR---QGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTD 186 (309)
T ss_dssp EECCCCEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC------
T ss_pred EEecCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccc
Confidence 999999999999953 346899999999999999999999987 99999999999999999999999999987654
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=1.6e-24 Score=227.24 Aligned_cols=148 Identities=28% Similarity=0.477 Sum_probs=128.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|.+.++||+|+||.||+|... +++.||||++...... ....+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 81 (324)
T 3mtl_A 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 81 (324)
T ss_dssp CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecc
Confidence 57889999999999999999986 7899999998653322 223566899999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++ |+|.+++... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++...
T Consensus 82 ~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~ 151 (324)
T 3mtl_A 82 LD-KDLKQYLDDC--GNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKS 151 (324)
T ss_dssp CS-EEHHHHHHHT--TTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC-
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCccccccc
Confidence 97 5898888542 346899999999999999999999988 9999999999999999999999999998764
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.8e-24 Score=223.17 Aligned_cols=163 Identities=30% Similarity=0.422 Sum_probs=138.5
Q ss_pred CCCHHHHHHHhcCcccc-eeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcC-CCCCccceEE
Q 006347 470 LFQFEELATATNNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL-QHRNLVRLLG 544 (649)
Q Consensus 470 ~~~~~~l~~~~~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l-~H~niv~l~g 544 (649)
...+...+...+.|.+. +.||+|+||.||+|... +++.||||++.... .....++.+|+.++.++ +||||+++++
T Consensus 17 n~~~~~~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~ 96 (327)
T 3lm5_A 17 NLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHE 96 (327)
T ss_dssp CCCSBCHHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEE
T ss_pred hhHHHHHHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEE
Confidence 33444455556677776 88999999999999977 68999999987532 33467899999999999 5799999999
Q ss_pred EEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCc
Q 006347 545 CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELN 621 (649)
Q Consensus 545 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~ 621 (649)
++.+.+..++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.
T Consensus 97 ~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~ 172 (327)
T 3lm5_A 97 VYENTSEIILILEYAAGGEIFSLCLPE-LAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGD 172 (327)
T ss_dssp EEECSSEEEEEEECCTTEEGGGGGSSC-C-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCC
T ss_pred EEEeCCeEEEEEEecCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCc
Confidence 999999999999999999999998542 3456899999999999999999999987 999999999999998 789
Q ss_pred eEEEecCCceeeCCC
Q 006347 622 PKISDFGMAKIFGGN 636 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~ 636 (649)
+||+|||+++.+...
T Consensus 173 ~kL~Dfg~a~~~~~~ 187 (327)
T 3lm5_A 173 IKIVDFGMSRKIGHA 187 (327)
T ss_dssp EEECCGGGCEEC---
T ss_pred EEEeeCccccccCCc
Confidence 999999999987543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=236.50 Aligned_cols=147 Identities=27% Similarity=0.419 Sum_probs=125.0
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC------C
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------E 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 550 (649)
.++|++.+.||+|+||+||+|... +++.||||++... .....+++.+|+.+++.++||||+++++++... .
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 140 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 140 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence 467999999999999999999876 6889999999754 334567889999999999999999999999754 3
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
+.+|||||++++ |.+.+. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 141 ~~~lv~E~~~~~-l~~~~~-----~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a 211 (464)
T 3ttj_A 141 DVYLVMELMDAN-LCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 211 (464)
T ss_dssp EEEEEEECCSEE-HHHHHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC
T ss_pred eEEEEEeCCCCC-HHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEee
Confidence 579999999764 666663 23889999999999999999999998 999999999999999999999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 212 ~~~~~ 216 (464)
T 3ttj_A 212 RTAGT 216 (464)
T ss_dssp -----
T ss_pred eecCC
Confidence 98754
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=6.3e-24 Score=217.89 Aligned_cols=149 Identities=29% Similarity=0.468 Sum_probs=133.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|... +++.||||.+.... ....+.+.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 93 (284)
T 2vgo_A 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML 93 (284)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence 56888999999999999999986 57899999986432 234578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 94 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~ 166 (284)
T 2vgo_A 94 EFAPRGELYKELQK---HGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPS 166 (284)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSS
T ss_pred EeCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCcc
Confidence 99999999999853 346899999999999999999999987 99999999999999999999999999987643
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.3e-24 Score=221.27 Aligned_cols=152 Identities=22% Similarity=0.442 Sum_probs=127.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|... +++.||||++... .....+++.+|+.++.+++|+||+++++++.+.+..++||
T Consensus 32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 111 (310)
T 2wqm_A 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 111 (310)
T ss_dssp GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence 56899999999999999999975 7899999998642 2345578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~ 188 (310)
T 2wqm_A 112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 188 (310)
T ss_dssp ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence 9999999999985321 2456899999999999999999999987 99999999999999999999999999987754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=2.6e-24 Score=222.51 Aligned_cols=148 Identities=28% Similarity=0.520 Sum_probs=132.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|++.+.||+|+||.||+|... +++.||+|.+........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 97 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEF 97 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEEC
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEe
Confidence 367899999999999999999987 5899999999776666778999999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 98 ~~~~~l~~~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~ 166 (302)
T 2j7t_A 98 CPGGAVDAIMLE--LDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAK 166 (302)
T ss_dssp CTTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHH
T ss_pred CCCCcHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCcc
Confidence 999999999854 2356899999999999999999999987 99999999999999999999999999764
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.91 E-value=5.4e-24 Score=229.95 Aligned_cols=146 Identities=25% Similarity=0.333 Sum_probs=124.6
Q ss_pred cCcccc-eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhc-CCCCCccceEEEEEe----CCeEE
Q 006347 481 NNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISK-LQHRNLVRLLGCCVE----GEEKM 553 (649)
Q Consensus 481 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~-l~H~niv~l~g~~~~----~~~~~ 553 (649)
++|.+. +.||+|+||+||++... +++.||||+++. ...+.+|+.++.+ .+|+||+++++++.. ....+
T Consensus 61 ~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-----~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~ 135 (400)
T 1nxk_A 61 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 135 (400)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred ccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-----chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence 456665 68999999999999976 689999999853 2467788888754 489999999999876 55789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecCCc
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMA 630 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFGla 630 (649)
|||||+++|+|.+++... ....+++.++..|+.||++||.|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 136 lv~E~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~a 211 (400)
T 1nxk_A 136 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 211 (400)
T ss_dssp EEEECCCSEEHHHHHHCC----CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEEeCCCCcHHHHHHHh-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEecccc
Confidence 999999999999999653 2346899999999999999999999987 999999999999998 789999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 212 ~~~~~ 216 (400)
T 1nxk_A 212 KETTS 216 (400)
T ss_dssp EECC-
T ss_pred cccCC
Confidence 98653
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=8.5e-24 Score=220.01 Aligned_cols=151 Identities=29% Similarity=0.503 Sum_probs=131.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
..++|++.+.||+|+||.||+|... +|+.||||.+... ...+++.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 27 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 104 (314)
T 3com_A 27 PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVE--SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVME 104 (314)
T ss_dssp ---CEEEEEECC----CEEEEEEETTTCCEEEEEEEETT--SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCch--HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEee
Confidence 4467999999999999999999986 5899999998653 345789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+++++|.+++.. ....+++..+..++.+++.||.|||+.+ |+|+||||+||+++.++.+||+|||+++.+...
T Consensus 105 ~~~~~~L~~~~~~--~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (314)
T 3com_A 105 YCGAGSVSDIIRL--RNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDT 178 (314)
T ss_dssp CCTTEEHHHHHHH--HTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTT
T ss_pred cCCCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhh
Confidence 9999999999852 2456899999999999999999999988 999999999999999999999999999987543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=9.2e-24 Score=223.67 Aligned_cols=148 Identities=28% Similarity=0.557 Sum_probs=130.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-------- 549 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 549 (649)
++|++.++||+|+||.||+|... +++.||||++.... ......+.+|+.++.+++||||+++++++.+.
T Consensus 17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 96 (351)
T 3mi9_A 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 96 (351)
T ss_dssp GGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------
T ss_pred cceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCC
Confidence 57999999999999999999985 78999999986433 23456788999999999999999999999874
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
+..++||||+++ +|.+.+... ...+++.++..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 97 ~~~~lv~e~~~~-~l~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~ 170 (351)
T 3mi9_A 97 GSIYLVFDFCEH-DLAGLLSNV--LVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 170 (351)
T ss_dssp CEEEEEEECCSE-EHHHHHHCT--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCC-CHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence 468999999975 777777542 345899999999999999999999988 99999999999999999999999999
Q ss_pred ceeeC
Q 006347 630 AKIFG 634 (649)
Q Consensus 630 a~~~~ 634 (649)
|+.+.
T Consensus 171 a~~~~ 175 (351)
T 3mi9_A 171 ARAFS 175 (351)
T ss_dssp CEECC
T ss_pred ccccc
Confidence 99875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=4.9e-24 Score=219.84 Aligned_cols=149 Identities=29% Similarity=0.477 Sum_probs=129.9
Q ss_pred CcccceeeccCCcEEEEEEEecC----CcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE-EEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK-MLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~-~lV 555 (649)
.|...+.||+|+||.||+|...+ +..+|||.+..... ...+.+.+|+.++++++||||+++++++.+.+.. ++|
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v 101 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVL 101 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEE
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEE
Confidence 35566899999999999998642 23799999875433 4567899999999999999999999999877665 999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++.+..
T Consensus 102 ~e~~~~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~ 176 (298)
T 3pls_A 102 LPYMCHGDLLQFIRS--PQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILD 176 (298)
T ss_dssp ECCCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECCTTSSCTTTT
T ss_pred EecccCCCHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEEeCcCCCcccccC
Confidence 999999999999965 3456899999999999999999999987 99999999999999999999999999987643
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.91 E-value=3.8e-24 Score=221.01 Aligned_cols=150 Identities=27% Similarity=0.520 Sum_probs=130.4
Q ss_pred cCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEe-CCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE-GEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~-~~~~~l 554 (649)
.+|++.+.||+|+||.||+|+..+ ...+|||.+.... ....+++.+|+.++++++||||+++++++.+ .+..++
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 104 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLV 104 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEE
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEE
Confidence 457888999999999999998652 2368999987533 3455789999999999999999999999765 457799
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.
T Consensus 105 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~ 179 (298)
T 3f66_A 105 VLPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMY 179 (298)
T ss_dssp EEECCTTCBHHHHHHC--TTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSCGGGCCCS
T ss_pred EEeCCCCCCHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEECccccccccc
Confidence 9999999999999965 3456899999999999999999999987 9999999999999999999999999999774
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 180 ~ 180 (298)
T 3f66_A 180 D 180 (298)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.91 E-value=5.5e-24 Score=221.45 Aligned_cols=147 Identities=29% Similarity=0.472 Sum_probs=125.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEE------------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCV------------ 547 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~------------ 547 (649)
++|.+.+.||+|+||.||+|... +++.||||++........+++.+|+.++++++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~ 90 (320)
T 2i6l_A 11 SRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGS 90 (320)
T ss_dssp TTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----
T ss_pred CceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccccccc
Confidence 57889999999999999999987 58999999997666667788999999999999999999999873
Q ss_pred --eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEE
Q 006347 548 --EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKI 624 (649)
Q Consensus 548 --~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki 624 (649)
+....++||||++ |+|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++ +++.+||
T Consensus 91 ~~~~~~~~lv~e~~~-~~L~~~~~----~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl 162 (320)
T 2i6l_A 91 LTELNSVYIVQEYME-TDLANVLE----QGPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLKI 162 (320)
T ss_dssp CCSCSEEEEEEECCS-EEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEEE
T ss_pred ccccCceeEEeeccC-CCHHHHhh----cCCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEEE
Confidence 4467899999997 69999984 356899999999999999999999987 99999999999997 5779999
Q ss_pred EecCCceeeCC
Q 006347 625 SDFGMAKIFGG 635 (649)
Q Consensus 625 ~DFGla~~~~~ 635 (649)
+|||+++.+..
T Consensus 163 ~Dfg~~~~~~~ 173 (320)
T 2i6l_A 163 GDFGLARIMDP 173 (320)
T ss_dssp CCCTTCBCC--
T ss_pred ccCccccccCC
Confidence 99999998743
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=3.7e-24 Score=225.29 Aligned_cols=151 Identities=32% Similarity=0.556 Sum_probs=128.5
Q ss_pred cCcccceeeccCCcEEEEEEEecC-----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD-----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~-----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
++|+..+.||+|+||.||+|.... +..||||.++... .....++.+|+.++.+++||||+++++++.+.+..++
T Consensus 44 ~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 123 (333)
T 1mqb_A 44 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 123 (333)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEE
Confidence 457778999999999999998752 2469999997542 3345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++++|.+++.. ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 124 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~ 198 (333)
T 1mqb_A 124 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 198 (333)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEeCCCCCcHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchhhc
Confidence 9999999999999964 2356899999999999999999999987 9999999999999999999999999999875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 199 ~~ 200 (333)
T 1mqb_A 199 DD 200 (333)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.91 E-value=2.9e-24 Score=229.88 Aligned_cols=149 Identities=28% Similarity=0.544 Sum_probs=123.3
Q ss_pred CcccceeeccCCcEEEEEEEec--CC--cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeC-CeEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK--DG--QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-EEKMLI 555 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~--~g--~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV 555 (649)
.|.+.+.||+|+||.||+|+.. ++ ..||||.++... ....++|.+|+.++++++||||+++++++.+. +..++|
T Consensus 90 ~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv 169 (373)
T 3c1x_A 90 IVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 169 (373)
T ss_dssp EEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEE
T ss_pred eeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEE
Confidence 4667789999999999999864 22 468999986533 34567899999999999999999999998654 578999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|.+++.. ....+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 170 ~e~~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~ 244 (373)
T 3c1x_A 170 LPYMKHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYD 244 (373)
T ss_dssp EECCTTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EECCCCCCHHHHHhh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEEEeeccccccccc
Confidence 999999999999964 3345889999999999999999999987 99999999999999999999999999997643
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=5.6e-24 Score=217.06 Aligned_cols=149 Identities=26% Similarity=0.497 Sum_probs=135.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|.+.+.||+|+||.||+|+.. +++.||||.+.... ....+.+.+|+.++.+++||||+++++++.+.+..++||
T Consensus 11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 90 (276)
T 2h6d_A 11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM 90 (276)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence 57889999999999999999987 78999999986432 234578999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++....
T Consensus 91 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~ 163 (276)
T 2h6d_A 91 EYVSGGELFDYICK---HGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSD 163 (276)
T ss_dssp ECCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC
T ss_pred eccCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCC
Confidence 99999999999953 345899999999999999999999988 99999999999999999999999999988754
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=7.9e-24 Score=221.91 Aligned_cols=150 Identities=34% Similarity=0.585 Sum_probs=130.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcE--EEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQE--IAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~--vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.+.||+|+||.||+|... ++.. +|||.+... .....+.+.+|+.++.++ +||||+++++++.+.+..++|
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 104 (327)
T 1fvr_A 25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 104 (327)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEE
Confidence 46888899999999999999876 5554 499988643 234556799999999999 899999999999999999999
Q ss_pred EecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 556 YEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
|||+++++|.+++.... ....+++..++.++.||++||+|||+.+ |+||||||+|||++.++.+
T Consensus 105 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~ 181 (327)
T 1fvr_A 105 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 181 (327)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCCeE
Confidence 99999999999997532 2346899999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceee
Q 006347 623 KISDFGMAKIF 633 (649)
Q Consensus 623 Ki~DFGla~~~ 633 (649)
||+|||+++..
T Consensus 182 kL~Dfg~~~~~ 192 (327)
T 1fvr_A 182 KIADFGLSRGQ 192 (327)
T ss_dssp EECCTTCEESS
T ss_pred EEcccCcCccc
Confidence 99999999853
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.2e-24 Score=223.09 Aligned_cols=149 Identities=28% Similarity=0.455 Sum_probs=126.4
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||.||+++.. ++.||||++.. ....+.|.+|+.++.+++||||+++++++. +..++||||++
T Consensus 8 ~~~~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~--~~~~lv~e~~~ 82 (307)
T 2eva_A 8 KEIEVEEVVGRGAFGVVCKAKWR-AKDVAIKQIES--ESERKAFIVELRQLSRVNHPNIVKLYGACL--NPVCLVMEYAE 82 (307)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEECSS--TTHHHHHHHHHHHHHHCCCTTBCCEEEBCT--TTTEEEEECCT
T ss_pred hHeeeeeEeecCCCceEEEEEEC-CeeEEEEEecC--hhHHHHHHHHHHHHhcCCCCCcCeEEEEEc--CCcEEEEEcCC
Confidence 46888899999999999999986 78999999864 345678999999999999999999999876 45799999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc-eEEEecCCceeeC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFG 634 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~-~Ki~DFGla~~~~ 634 (649)
+++|.+++........+++..++.++.|+++||+|||+.+..+|+||||||+|||+++++. +||+|||+++.+.
T Consensus 83 ~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~ 157 (307)
T 2eva_A 83 GGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ 157 (307)
T ss_dssp TCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred CCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence 9999999976544446889999999999999999999943334999999999999998876 7999999998764
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.5e-23 Score=219.79 Aligned_cols=144 Identities=24% Similarity=0.409 Sum_probs=129.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEe--CCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVE--GEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~--~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|... +++.||||+++. ...+.+.+|+.++.+++ |+||+++++++.+ ....++||
T Consensus 36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~---~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~ 112 (330)
T 3nsz_A 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP---VKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 112 (330)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS---CCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEE
T ss_pred CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecc---cchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEE
Confidence 56889999999999999999864 789999999864 34578999999999997 9999999999998 56789999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~~~ 635 (649)
||+++++|.+++. .+++.++..++.||++||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 113 e~~~~~~l~~~~~------~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~ 183 (330)
T 3nsz_A 113 EHVNNTDFKQLYQ------TLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 183 (330)
T ss_dssp ECCCCCCHHHHGG------GCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred eccCchhHHHHHH------hCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence 9999999999983 3789999999999999999999988 99999999999999776 899999999998754
Q ss_pred C
Q 006347 636 N 636 (649)
Q Consensus 636 ~ 636 (649)
.
T Consensus 184 ~ 184 (330)
T 3nsz_A 184 G 184 (330)
T ss_dssp T
T ss_pred C
Confidence 3
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.7e-24 Score=236.97 Aligned_cols=151 Identities=30% Similarity=0.501 Sum_probs=135.7
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.++|++.+.||+|+||.||++... +++.||||++.+.. ....+.+.+|+.++.+++||||+++++++.+.+..++|
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv 104 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLV 104 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEE
Confidence 356888999999999999999986 78999999986432 34568899999999999999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCcee
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKI 632 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~ 632 (649)
|||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||+|+.
T Consensus 105 ~e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~ 178 (484)
T 3nyv_A 105 GEVYTGGELFDEIIS---RKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTH 178 (484)
T ss_dssp ECCCCSCBHHHHHHT---CSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHH
T ss_pred EecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEE
Confidence 999999999999854 356899999999999999999999988 9999999999999 5678999999999998
Q ss_pred eCCC
Q 006347 633 FGGN 636 (649)
Q Consensus 633 ~~~~ 636 (649)
+...
T Consensus 179 ~~~~ 182 (484)
T 3nyv_A 179 FEAS 182 (484)
T ss_dssp BCCC
T ss_pred cccc
Confidence 7544
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=221.52 Aligned_cols=147 Identities=35% Similarity=0.590 Sum_probs=122.3
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHH--HhcCCCCCccceEEEEEe-----CCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMV--ISKLQHRNLVRLLGCCVE-----GEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~--l~~l~H~niv~l~g~~~~-----~~~~~ 553 (649)
++|++.+.||+|+||.||+|+. +++.||||++... ..+.+..|.++ +..++|+||+++++.+.. ....+
T Consensus 13 ~~y~~~~~lg~G~~g~Vy~~~~-~~~~vavK~~~~~---~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~ 88 (336)
T 3g2f_A 13 DNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFA---NRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYL 88 (336)
T ss_dssp TSEEEEEEEEECSSEEEEEEEE-TTEEEEEEEEEGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEE
T ss_pred HHhheeeecccCCCeEEEEEEE-CCeEEEEEEeecc---chhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEE
Confidence 5788999999999999999987 4899999998643 33455555555 445899999999987653 22568
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCceEecCCCCCcEEEcCCCceEEEec
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS------RLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
+||||+++|+|.+++.. ...++..+..|+.||++||+|||+.. +.+|+||||||+|||++.++.+||+||
T Consensus 89 lv~e~~~~g~L~~~l~~----~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DF 164 (336)
T 3g2f_A 89 LVMEYYPNGSLXKYLSL----HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164 (336)
T ss_dssp EEECCCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCC
T ss_pred EEEecCCCCcHHHHHhh----cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeec
Confidence 99999999999999943 34589999999999999999999881 113999999999999999999999999
Q ss_pred CCceeeCC
Q 006347 628 GMAKIFGG 635 (649)
Q Consensus 628 Gla~~~~~ 635 (649)
|+|+.+..
T Consensus 165 G~a~~~~~ 172 (336)
T 3g2f_A 165 GLSMRLTG 172 (336)
T ss_dssp TTCEECSS
T ss_pred cceeeccc
Confidence 99998754
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=220.12 Aligned_cols=149 Identities=27% Similarity=0.413 Sum_probs=127.7
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--------cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~ 550 (649)
.++|.+.+.||+|+||.||+|... +++.||||.+.... ......+.+|+.++.+++||||+++++++...+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS
T ss_pred hhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc
Confidence 457999999999999999999976 68899999986432 123356889999999999999999999987654
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEec
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDF 627 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DF 627 (649)
.++||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++.++. +||+||
T Consensus 89 -~~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Df 161 (322)
T 2ycf_A 89 -YYIVLELMEGGELFDKVVG---NKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDF 161 (322)
T ss_dssp -EEEEEECCTTEETHHHHST---TCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCC
T ss_pred -eEEEEecCCCCcHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccC
Confidence 8999999999999999853 456899999999999999999999987 999999999999987654 999999
Q ss_pred CCceeeCC
Q 006347 628 GMAKIFGG 635 (649)
Q Consensus 628 Gla~~~~~ 635 (649)
|+++.+..
T Consensus 162 g~~~~~~~ 169 (322)
T 2ycf_A 162 GHSKILGE 169 (322)
T ss_dssp TTCEECCC
T ss_pred ccceeccc
Confidence 99998754
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.8e-24 Score=219.66 Aligned_cols=151 Identities=30% Similarity=0.510 Sum_probs=130.9
Q ss_pred hcCcccce-eeccCCcEEEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 480 TNNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 480 ~~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
.++|.+.+ .||+|+||.||+|... .++.||||.++... ....+++.+|+.++.+++||||+++++++ +.+..+
T Consensus 15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~ 93 (291)
T 1xbb_A 15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWM 93 (291)
T ss_dssp GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEE
T ss_pred chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcE
Confidence 35677777 9999999999999643 46789999997543 23367899999999999999999999999 677889
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+++.+
T Consensus 94 lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~ 167 (291)
T 1xbb_A 94 LVMEMAELGPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKAL 167 (291)
T ss_dssp EEEECCTTEEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEeCCCCCHHHHHHh---CcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcceee
Confidence 99999999999999954 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCC
Q 006347 634 GGNQ 637 (649)
Q Consensus 634 ~~~~ 637 (649)
....
T Consensus 168 ~~~~ 171 (291)
T 1xbb_A 168 RADE 171 (291)
T ss_dssp CTTC
T ss_pred ccCC
Confidence 5443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=226.92 Aligned_cols=147 Identities=27% Similarity=0.369 Sum_probs=133.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++.+++||||+++++++.+++..++||||
T Consensus 33 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 112 (360)
T 3eqc_A 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEH 112 (360)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECC
T ss_pred ccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEEC
Confidence 46888999999999999999987 68999999987542 34457899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+++++|.+++.. ...+++..+..++.++++||+|||+. + |+||||||+|||++.++.+||+|||+++.+
T Consensus 113 ~~~~~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~ 182 (360)
T 3eqc_A 113 MDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQL 182 (360)
T ss_dssp CTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHH
T ss_pred CCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCccc
Confidence 999999999953 34689999999999999999999985 6 999999999999999999999999999765
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-24 Score=223.21 Aligned_cols=154 Identities=27% Similarity=0.448 Sum_probs=120.7
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
..++|.+.+.||+|+||.||++... +++.||||++.... ....+++.+|+.++.+++||||+++++++.+.+..++||
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 92 (303)
T 2vwi_A 13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVM 92 (303)
T ss_dssp CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESSSCEEEEE
T ss_pred chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEe
Confidence 3578999999999999999999865 68899999886432 344678899999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcC-----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 557 EYMPNRSLDALLFD-----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 557 Ey~~~gsL~~~l~~-----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
||+++++|.+++.. ......+++..+..++.||++||.|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 93 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~ 169 (303)
T 2vwi_A 93 KLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSA 169 (303)
T ss_dssp ECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCHHHH
T ss_pred hhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEeccchh
Confidence 99999999999853 112456899999999999999999999987 9999999999999999999999999998
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 170 ~~~~ 173 (303)
T 2vwi_A 170 FLAT 173 (303)
T ss_dssp HCC-
T ss_pred eecc
Confidence 7643
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=225.09 Aligned_cols=157 Identities=28% Similarity=0.378 Sum_probs=135.2
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEe-------
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVE------- 548 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~------- 548 (649)
....+|++.+.||+|+||.||++... +++.||||++........+.+.+|+.++.++. ||||+++++++..
T Consensus 25 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 104 (337)
T 3ll6_A 25 LGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDT 104 (337)
T ss_dssp ETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTT
T ss_pred ccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhcccccccccccccc
Confidence 34457899999999999999999975 68999999987665566788999999999996 9999999999953
Q ss_pred -CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 549 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 549 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
....++||||++ |+|.+++........+++.+++.|+.||+.||+|||+.+ .+|+||||||+|||+++++.+||+||
T Consensus 105 ~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~-~~ivH~Dikp~NIl~~~~~~~kl~Df 182 (337)
T 3ll6_A 105 GQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQK-PPIIHRDLKVENLLLSNQGTIKLCDF 182 (337)
T ss_dssp SSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCCCCCGGGCEECTTSCEEBCCC
T ss_pred CCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-CCEEEccCCcccEEECCCCCEEEecC
Confidence 334789999995 799998864334456999999999999999999999864 35999999999999999999999999
Q ss_pred CCceeeCCC
Q 006347 628 GMAKIFGGN 636 (649)
Q Consensus 628 Gla~~~~~~ 636 (649)
|+++.+...
T Consensus 183 g~~~~~~~~ 191 (337)
T 3ll6_A 183 GSATTISHY 191 (337)
T ss_dssp TTCBCCSSC
T ss_pred ccceecccc
Confidence 999987543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.90 E-value=5.6e-24 Score=220.62 Aligned_cols=149 Identities=26% Similarity=0.434 Sum_probs=131.6
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
.++|.+.+.||+|+||.||+++.. +++.||||.+........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 87 (304)
T 2jam_A 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQL 87 (304)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECC
T ss_pred hccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEc
Confidence 357889999999999999999976 7899999999765544567789999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCceeeC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFG 634 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~~~ 634 (649)
+++++|.+++.. ...+++..+..++.|++.||.|||+.+ |+||||||+||++ ++++.+||+|||+++...
T Consensus 88 ~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 160 (304)
T 2jam_A 88 VSGGELFDRILE---RGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160 (304)
T ss_dssp CCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCC
T ss_pred CCCccHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecC
Confidence 999999999853 346899999999999999999999987 9999999999999 788999999999998754
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.4e-24 Score=236.59 Aligned_cols=151 Identities=30% Similarity=0.518 Sum_probs=134.6
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.++|++.+.||+|+||+||++... +++.||||++.+. .....+.+.+|+.++.+++||||+++++++.+....++||
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~ 100 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG 100 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEE
Confidence 357999999999999999999986 7899999998643 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+|||++ .++.+||+|||+|+.+
T Consensus 101 e~~~~~~L~~~~~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~ 174 (486)
T 3mwu_A 101 ELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCF 174 (486)
T ss_dssp CCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTB
T ss_pred EcCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeEC
Confidence 99999999988853 356899999999999999999999988 99999999999995 4567999999999877
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 175 ~~~ 177 (486)
T 3mwu_A 175 QQN 177 (486)
T ss_dssp CCC
T ss_pred CCC
Confidence 543
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=226.29 Aligned_cols=152 Identities=25% Similarity=0.357 Sum_probs=125.9
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC------
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------ 549 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------ 549 (649)
....++|++.+.||+|+||.||+|... +++.||||++.... +...+|+.++++++|+||+++++++...
T Consensus 3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~----~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~ 78 (383)
T 3eb0_A 3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP----RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPK 78 (383)
T ss_dssp ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHTTCCCTTBCCEEEEEEEC------
T ss_pred ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHHcCCCCccchhheeeecCccccc
Confidence 455678999999999999999999875 78999999986432 2234799999999999999999998543
Q ss_pred --------------------------------CeEEEEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHH
Q 006347 550 --------------------------------EEKMLIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYL 596 (649)
Q Consensus 550 --------------------------------~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yL 596 (649)
...++||||++ ++|.+.+... .....+++..+..++.||++||+||
T Consensus 79 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~L 157 (383)
T 3eb0_A 79 PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFI 157 (383)
T ss_dssp -------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 33789999998 5887777531 1345689999999999999999999
Q ss_pred HhCCCCceEecCCCCCcEEEc-CCCceEEEecCCceeeCCC
Q 006347 597 HRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 597 H~~~~~~iiHrDlkp~NILl~-~~~~~Ki~DFGla~~~~~~ 636 (649)
|+.+ |+||||||+|||++ +++.+||+|||+|+.+...
T Consensus 158 H~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~ 195 (383)
T 3eb0_A 158 HSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS 195 (383)
T ss_dssp HTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT
T ss_pred HHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC
Confidence 9987 99999999999998 6899999999999987543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.90 E-value=6.6e-24 Score=226.59 Aligned_cols=148 Identities=27% Similarity=0.454 Sum_probs=125.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------ 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (649)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+++.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~ 103 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 103 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence 367999999999999999999975 7899999999643 2334578899999999999999999999998763
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
..++||||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 104 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a 175 (367)
T 1cm8_A 104 DFYLVMPFM-GTDLGKLMKH----EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 175 (367)
T ss_dssp CCEEEEECC-SEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeecc
Confidence 459999999 8899999853 46899999999999999999999988 999999999999999999999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 176 ~~~~~ 180 (367)
T 1cm8_A 176 RQADS 180 (367)
T ss_dssp EECCS
T ss_pred ccccc
Confidence 98653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2.3e-24 Score=225.97 Aligned_cols=152 Identities=33% Similarity=0.534 Sum_probs=129.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|++.+.||+|+||.||+|+.. +++.||||.+... ......++.+|+.++.+++||||+++++++.+.+..
T Consensus 29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 108 (327)
T 2yfx_A 29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPR 108 (327)
T ss_dssp GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCc
Confidence 357889999999999999999842 5778999999643 334567899999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEE
Q 006347 553 MLIYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKIS 625 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~ 625 (649)
++||||+++++|.+++.... ....+++..++.++.|+++||.|||+.+ |+||||||+|||++. +..+||+
T Consensus 109 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~kl~ 185 (327)
T 2yfx_A 109 FILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIG 185 (327)
T ss_dssp EEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred EEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEEEC
Confidence 99999999999999996532 1245899999999999999999999987 999999999999994 4569999
Q ss_pred ecCCceeeC
Q 006347 626 DFGMAKIFG 634 (649)
Q Consensus 626 DFGla~~~~ 634 (649)
|||+++.+.
T Consensus 186 Dfg~~~~~~ 194 (327)
T 2yfx_A 186 DFGMARDIY 194 (327)
T ss_dssp CCHHHHHHH
T ss_pred ccccccccc
Confidence 999998653
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1e-23 Score=224.71 Aligned_cols=149 Identities=25% Similarity=0.422 Sum_probs=131.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-----eE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-----EK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-----~~ 552 (649)
.++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.... ..
T Consensus 26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 105 (364)
T 3qyz_A 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 105 (364)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceE
Confidence 357999999999999999999876 68899999997533 234578999999999999999999999997653 68
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||++ ++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 106 ~iv~e~~~-~~L~~~l~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~ 177 (364)
T 3qyz_A 106 YIVQDLME-TDLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARV 177 (364)
T ss_dssp EEEEECCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEcccC-cCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEe
Confidence 99999997 599998843 45899999999999999999999988 99999999999999999999999999998
Q ss_pred eCCC
Q 006347 633 FGGN 636 (649)
Q Consensus 633 ~~~~ 636 (649)
....
T Consensus 178 ~~~~ 181 (364)
T 3qyz_A 178 ADPD 181 (364)
T ss_dssp CCGG
T ss_pred cCCC
Confidence 7543
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=1.2e-23 Score=217.17 Aligned_cols=150 Identities=28% Similarity=0.506 Sum_probs=131.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||+|... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++|||
T Consensus 3 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 82 (299)
T 2r3i_A 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 82 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred chhhhhhhhccCCCeeEEEEEEcCCCceEEEEEeecCccchhhHHHHHHHHHHHHHcCCCCeeeEEEEEecCCceEEEEE
Confidence 57889999999999999999986 68999999986532 2345788999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|++ ++|.+++... ....+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+..
T Consensus 83 ~~~-~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 155 (299)
T 2r3i_A 83 FLH-QDLKKFMDAS-ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGV 155 (299)
T ss_dssp CCS-EEHHHHHHHT-TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECSTTHHHHHCC
T ss_pred ccc-CCHHHHHHhh-hccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHeEEcCCCCEEECcchhhhhccC
Confidence 997 6999998643 2345889999999999999999999987 99999999999999999999999999987653
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.3e-24 Score=232.75 Aligned_cols=151 Identities=16% Similarity=0.215 Sum_probs=124.6
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHH---HHHhcCCCCCccceE-------EE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEV---MVISKLQHRNLVRLL-------GC 545 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~---~~l~~l~H~niv~l~-------g~ 545 (649)
.++|.+.+.||+|+||+||+|+.. +|+.||||++... .....+.+.+|+ .++++++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 467888899999999999999974 6899999999642 334567899999 556666899999998 66
Q ss_pred EEeCCe-----------------EEEEEecCCCCChhhhhcCCC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006347 546 CVEGEE-----------------KMLIYEYMPNRSLDALLFDPL----KKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604 (649)
Q Consensus 546 ~~~~~~-----------------~~lV~Ey~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 604 (649)
+.+.+. .+|||||+ +|+|.+++.... ....+++..++.|+.||++||+|||+.+ |
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 227 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 227 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred hhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 665532 78999999 689999996421 1123446888999999999999999988 9
Q ss_pred EecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 605 IHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 605 iHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
+||||||+|||++.++.+||+|||+|+..+
T Consensus 228 vHrDikp~NIll~~~~~~kL~DFG~a~~~~ 257 (377)
T 3byv_A 228 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 257 (377)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ecCCCCHHHEEEcCCCCEEEEechhheecC
Confidence 999999999999999999999999999743
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.7e-24 Score=243.45 Aligned_cols=143 Identities=31% Similarity=0.512 Sum_probs=126.4
Q ss_pred eeeccCCcEEEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
++||+|+||.||+|.+. .++.||||+++... ....++|.+|+.++.+++|||||++++++. .+..+|||||+++
T Consensus 375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~~~~~lv~E~~~~ 453 (635)
T 4fl3_A 375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 453 (635)
T ss_dssp EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCCEEEEEEccCC
Confidence 47999999999999653 46789999997543 234688999999999999999999999986 4568899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+|.+++.. ...+++..+..|+.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+...
T Consensus 454 g~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~ 522 (635)
T 4fl3_A 454 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRAD 522 (635)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-
T ss_pred CCHHHHHhh---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccC
Confidence 999999953 356899999999999999999999988 999999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=215.44 Aligned_cols=150 Identities=27% Similarity=0.389 Sum_probs=130.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~l 554 (649)
.|.+.+.||+|+||.||+|... ++..||+|.+... .....+.+.+|+.++.+++||||+++++++.. ....++
T Consensus 27 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~l 106 (290)
T 1t4h_A 27 FLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 106 (290)
T ss_dssp EEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred eEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEE
Confidence 4677789999999999999876 6889999998643 23456789999999999999999999999876 356899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki~DFGla~~~ 633 (649)
||||+++++|.+++.. ...+++..+..++.|+++||.|||+.+ .+|+||||||+|||++ +++.+||+|||+++..
T Consensus 107 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~ 182 (290)
T 1t4h_A 107 VTELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK 182 (290)
T ss_dssp EEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGC
T ss_pred EEEecCCCCHHHHHHH---ccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEeeCCCcccc
Confidence 9999999999999953 356899999999999999999999874 3599999999999998 7899999999999865
Q ss_pred CC
Q 006347 634 GG 635 (649)
Q Consensus 634 ~~ 635 (649)
..
T Consensus 183 ~~ 184 (290)
T 1t4h_A 183 RA 184 (290)
T ss_dssp CT
T ss_pred cc
Confidence 43
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=214.83 Aligned_cols=143 Identities=10% Similarity=0.069 Sum_probs=127.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|... +++.||||.+..... ...++|.+|+.++.+++|+||+++++++.+++..++||
T Consensus 31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 110 (286)
T 3uqc_A 31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA 110 (286)
T ss_dssp TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence 67999999999999999999986 589999999975432 33478999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
||+++++|.+++.. . ....+..+|+.|+++||+|||+.+ |+||||||+|||+++++.+||+++|...
T Consensus 111 e~~~g~~L~~~l~~----~-~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~~~~ 177 (286)
T 3uqc_A 111 EWIRGGSLQEVADT----S-PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPATMP 177 (286)
T ss_dssp ECCCEEEHHHHHTT----C-CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCCCCT
T ss_pred EecCCCCHHHHHhc----C-CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEeccccC
Confidence 99999999999943 2 355678899999999999999998 9999999999999999999999887643
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.1e-24 Score=214.79 Aligned_cols=150 Identities=24% Similarity=0.406 Sum_probs=132.4
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC--CeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG--EEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~--~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|+.. ++.||||++.... ....++|.+|+.++.+++||||+++++++.+. +..++||
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~-~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 88 (271)
T 3kmu_A 10 KQLNFLTKLNENHSGELWKGRWQ-GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT 88 (271)
T ss_dssp GGCEEEEEEEEETTEEEEEEEET-TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred HHhHHHHHhcCCCcceEEEEEEC-CeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence 46888899999999999999986 8899999987542 34457899999999999999999999999887 6789999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
||+++|+|.+++... ....+++..+..++.|+++||+|||+.+ .+|+||||||+|||+++++.+||+|||++...
T Consensus 89 e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~ 163 (271)
T 3kmu_A 89 HWMPYGSLYNVLHEG-TNFVVDQSQAVKFALDMARGMAFLHTLE-PLIPRHALNSRSVMIDEDMTARISMADVKFSF 163 (271)
T ss_dssp ECCTTCBHHHHHHSC-SSCCCCHHHHHHHHHHHHHHHHHHTTSS-SCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT
T ss_pred cccCCCcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCC-CceecCCCccceEEEcCCcceeEEeccceeee
Confidence 999999999999753 3346899999999999999999999864 45999999999999999999999999987654
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.90 E-value=7.7e-24 Score=223.95 Aligned_cols=148 Identities=19% Similarity=0.326 Sum_probs=123.6
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccccc-----------cHHHHHHHHHHHhcCCCCCccceEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKASGQ-----------GLEEFMNEVMVISKLQHRNLVRLLGC 545 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~~~-----------~~~~f~~E~~~l~~l~H~niv~l~g~ 545 (649)
++|.+.+.||+|+||.||+|... ++..+|||++...... ..+.+.+|+..+..++|+||++++++
T Consensus 37 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~ 116 (345)
T 2v62_A 37 NQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGS 116 (345)
T ss_dssp CEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEE
T ss_pred ceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecc
Confidence 57999999999999999999986 5678999998654321 22346788899999999999999999
Q ss_pred EEe----CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-
Q 006347 546 CVE----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL- 620 (649)
Q Consensus 546 ~~~----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~- 620 (649)
+.+ ....++||||+ +++|.+++.. ...+++.+++.|+.||++||+|||+.+ |+||||||+|||++.++
T Consensus 117 ~~~~~~~~~~~~lv~e~~-~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~ 189 (345)
T 2v62_A 117 GLTEFKGRSYRFMVMERL-GIDLQKISGQ---NGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNP 189 (345)
T ss_dssp EEEESSSCEEEEEEEECE-EEEHHHHCBG---GGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSST
T ss_pred cccccCCCcEEEEEEecc-CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCC
Confidence 998 77899999999 9999999954 237899999999999999999999987 99999999999999887
Q ss_pred -ceEEEecCCceeeCC
Q 006347 621 -NPKISDFGMAKIFGG 635 (649)
Q Consensus 621 -~~Ki~DFGla~~~~~ 635 (649)
.+||+|||+|+.+..
T Consensus 190 ~~~kL~Dfg~a~~~~~ 205 (345)
T 2v62_A 190 DQVYLADYGLSYRYCP 205 (345)
T ss_dssp TSEEECCCTTCEESSG
T ss_pred CcEEEEeCCCceeccc
Confidence 999999999998743
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.90 E-value=6.4e-24 Score=218.10 Aligned_cols=153 Identities=26% Similarity=0.334 Sum_probs=121.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-c-cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-Q-GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~-~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.++|++.+.||+|+||.||++... +++.||||++..... . ..+.+.++...++.++||||+++++++.+.+..++||
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~ 85 (290)
T 3fme_A 6 ADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICM 85 (290)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEE
T ss_pred HHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEE
Confidence 467899999999999999999975 789999999965422 2 2334445555688889999999999999999999999
Q ss_pred ecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 557 EYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||++ |+|.+++... .....+++..+..++.|+++||+|||++ + |+||||||+|||++.++.+||+|||+|+.+.
T Consensus 86 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 161 (290)
T 3fme_A 86 ELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGISGYLV 161 (290)
T ss_dssp ECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC-------
T ss_pred ehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCccccc
Confidence 9997 5888777431 1345789999999999999999999997 6 9999999999999999999999999998875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 162 ~~ 163 (290)
T 3fme_A 162 DD 163 (290)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=3.1e-24 Score=241.56 Aligned_cols=150 Identities=19% Similarity=0.229 Sum_probs=115.3
Q ss_pred eeccCCcEEEEEEEe-cCCcEEEEEEecccc----------cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 488 KLGQGGFGPVYWGRL-KDGQEIAVKRLSKAS----------GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 488 ~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~----------~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
..+.|++|.+.++.. ..|+.+|||.+.+.. +...++|.+|+++|+++ +|+||+++++++.+++..|||
T Consensus 241 ~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLV 320 (569)
T 4azs_A 241 QPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLV 320 (569)
T ss_dssp C-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEE
T ss_pred ccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEE
Confidence 456677776665542 358889999986431 23457899999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||++|++|.++|.+ ..+++.. +|+.||+.||+|||+++ ||||||||+||||++++++||+|||+|+.+..
T Consensus 321 MEyv~G~~L~d~i~~---~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~ 391 (569)
T 4azs_A 321 MEKLPGRLLSDMLAA---GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQ 391 (569)
T ss_dssp EECCCSEEHHHHHHT---TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC-
T ss_pred EecCCCCcHHHHHHh---CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCC
Confidence 999999999999964 3456654 48899999999999998 99999999999999999999999999998755
Q ss_pred CCCccccCceeec
Q 006347 636 NQDQADTGRVVGT 648 (649)
Q Consensus 636 ~~~~~~~~~~~GT 648 (649)
+... +...+||
T Consensus 392 ~~~~--~~t~vGT 402 (569)
T 4azs_A 392 DCSW--PTNLVQS 402 (569)
T ss_dssp --CC--SHHHHHH
T ss_pred CCcc--ccCceec
Confidence 4332 2235565
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=8.3e-24 Score=225.82 Aligned_cols=148 Identities=30% Similarity=0.458 Sum_probs=116.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC------C
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG------E 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~------~ 550 (649)
.++|++.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++++++||||+++++++... .
T Consensus 28 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~ 107 (367)
T 2fst_X 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 107 (367)
T ss_dssp ETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred CCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence 367999999999999999999865 6899999999653 233567889999999999999999999998764 5
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
..++|+||+ +++|.+++.. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 108 ~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a 179 (367)
T 2fst_X 108 DVYLVTHLM-GADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 179 (367)
T ss_dssp CCEEEEECC-CEECC---------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC----
T ss_pred eEEEEeccc-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeecccc
Confidence 679999999 7899888843 56899999999999999999999988 999999999999999999999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 180 ~~~~~ 184 (367)
T 2fst_X 180 RHTAD 184 (367)
T ss_dssp -----
T ss_pred ccccc
Confidence 97643
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=4.3e-23 Score=213.54 Aligned_cols=147 Identities=25% Similarity=0.347 Sum_probs=128.1
Q ss_pred cCcccc-eeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHH-hcCCCCCccceEEEEEe----CCeEE
Q 006347 481 NNFQLS-SKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVI-SKLQHRNLVRLLGCCVE----GEEKM 553 (649)
Q Consensus 481 ~~f~~~-~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l-~~l~H~niv~l~g~~~~----~~~~~ 553 (649)
++|.+. +.||+|+||.||++... +++.||||+++. ...+.+|+.++ +.++||||+++++++.+ ....+
T Consensus 17 ~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-----~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 91 (299)
T 3m2w_A 17 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 91 (299)
T ss_dssp GTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-----cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence 567766 77999999999999975 689999999853 25677888887 55589999999999987 66789
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecCCc
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMA 630 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFGla 630 (649)
+||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||+|
T Consensus 92 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a 167 (299)
T 3m2w_A 92 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 167 (299)
T ss_dssp EEECCCCSCBHHHHHHHC-TTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTC
T ss_pred EEEeecCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEeccccc
Confidence 999999999999999653 2346899999999999999999999988 999999999999998 789999999999
Q ss_pred eeeCCC
Q 006347 631 KIFGGN 636 (649)
Q Consensus 631 ~~~~~~ 636 (649)
+...+.
T Consensus 168 ~~~~~~ 173 (299)
T 3m2w_A 168 KETTGE 173 (299)
T ss_dssp EECTTC
T ss_pred cccccc
Confidence 987543
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=2e-23 Score=221.00 Aligned_cols=148 Identities=28% Similarity=0.453 Sum_probs=131.0
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeC-----CeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~~ 552 (649)
.++|.+.+.||+|+||.||+|... +|+.||||++.... .....++.+|+.++.+++||||+++++++... ...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 89 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEV 89 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCE
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceE
Confidence 467999999999999999999976 68999999996432 33456788999999999999999999998764 678
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||++ ++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 90 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~ 161 (353)
T 2b9h_A 90 YIIQELMQ-TDLHRVIST----QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARI 161 (353)
T ss_dssp EEEECCCS-EEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred EEEEeccC-ccHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEecccccc
Confidence 99999997 689998843 46899999999999999999999987 99999999999999999999999999998
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 162 ~~~ 164 (353)
T 2b9h_A 162 IDE 164 (353)
T ss_dssp CC-
T ss_pred ccc
Confidence 753
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=1.1e-23 Score=215.65 Aligned_cols=151 Identities=29% Similarity=0.448 Sum_probs=130.0
Q ss_pred hcCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.++|.+.+.||+|+||.||+|.... +..||||.+.... ....+.+.+|+.++.+++||||+++++++.+ +..++
T Consensus 11 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~ 89 (281)
T 3cc6_A 11 REDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-EPTWI 89 (281)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-SSCEE
T ss_pred ccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCCEE
Confidence 4678889999999999999998652 3469999987542 3456789999999999999999999999764 56789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++++|.+++.. ....+++..+..++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 90 v~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 164 (281)
T 3cc6_A 90 IMELYPYGELGHYLER--NKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYIE 164 (281)
T ss_dssp EEECCTTCBHHHHHHH--HTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGCC-
T ss_pred EEecCCCCCHHHHHHh--ccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcccc
Confidence 9999999999999954 2345899999999999999999999988 9999999999999999999999999999775
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 165 ~~ 166 (281)
T 3cc6_A 165 DE 166 (281)
T ss_dssp --
T ss_pred cc
Confidence 43
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.90 E-value=8.4e-24 Score=216.09 Aligned_cols=156 Identities=26% Similarity=0.457 Sum_probs=132.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~l 554 (649)
.++|++.+.||+|+||.||++... +++.||+|.+.... ....+.+.+|+.++.+++||||+++++++.+ ....++
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 84 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 84 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEE
Confidence 357889999999999999999986 68999999996532 3456789999999999999999999999875 567899
Q ss_pred EEecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 555 IYEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
||||+++++|.+++.... ....+++..++.++.|+++||+|||+.+ ..+|+||||||+|||+++++.+||+|||+++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~ 164 (279)
T 2w5a_A 85 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 164 (279)
T ss_dssp EEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHH
T ss_pred EEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchhe
Confidence 999999999999986422 2345899999999999999999999875 2349999999999999999999999999998
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
.+..
T Consensus 165 ~~~~ 168 (279)
T 2w5a_A 165 ILNH 168 (279)
T ss_dssp HC--
T ss_pred eecc
Confidence 7654
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.90 E-value=2.1e-23 Score=222.94 Aligned_cols=147 Identities=27% Similarity=0.412 Sum_probs=125.3
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------ 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (649)
.++|++.+.||+|+||.||+|... +++.||||++... .....+.+.+|+.++++++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~ 103 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 103 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence 367999999999999999999876 6889999998653 2334577899999999999999999999998765
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
..++||||++ ++|.+++. ..+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+|
T Consensus 104 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a 174 (371)
T 2xrw_A 104 DVYIVMELMD-ANLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 174 (371)
T ss_dssp EEEEEEECCS-EEHHHHHH-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC-
T ss_pred ceEEEEEcCC-CCHHHHHh-----hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeecc
Confidence 7899999997 57888874 24889999999999999999999987 999999999999999999999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 175 ~~~~~ 179 (371)
T 2xrw_A 175 RTAGT 179 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 98753
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.90 E-value=1.6e-23 Score=241.50 Aligned_cols=146 Identities=22% Similarity=0.394 Sum_probs=127.7
Q ss_pred cCcccceeeccCCcEEEEEEEec--CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe-----E
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE-----K 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~-----~ 552 (649)
++|++.+.||+|+||.||++... +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+. .
T Consensus 80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~ 159 (681)
T 2pzi_A 80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVG 159 (681)
T ss_dssp TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEE
T ss_pred CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCcee
Confidence 67999999999999999999975 58999999986432 3445678999999999999999999999988665 6
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
+|||||+++++|.+++.. .+++.+++.|+.||++||.|||+.+ ||||||||+|||++++ .+||+|||+++.
T Consensus 160 ~lv~E~~~g~~L~~~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~ 230 (681)
T 2pzi_A 160 YIVMEYVGGQSLKRSKGQ-----KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSR 230 (681)
T ss_dssp EEEEECCCCEECC----C-----CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred EEEEEeCCCCcHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchh
Confidence 999999999999887632 6899999999999999999999988 9999999999999986 899999999998
Q ss_pred eCC
Q 006347 633 FGG 635 (649)
Q Consensus 633 ~~~ 635 (649)
+..
T Consensus 231 ~~~ 233 (681)
T 2pzi_A 231 INS 233 (681)
T ss_dssp TTC
T ss_pred ccc
Confidence 754
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.89 E-value=1.5e-23 Score=225.98 Aligned_cols=149 Identities=27% Similarity=0.378 Sum_probs=124.2
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe------EEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE------KML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------~~l 554 (649)
.+|++.+.||+|+||.||+|+...+..+|+|++..... ...+|+.++++++|+||+++++++..... .++
T Consensus 40 ~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~----~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l 115 (394)
T 4e7w_A 40 IAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR----FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNL 115 (394)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT----SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEE
T ss_pred ceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc----hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEE
Confidence 46888999999999999999998777799998854322 22369999999999999999999976443 789
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki~DFGla~~~ 633 (649)
||||++++.+............+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+|||+|+.+
T Consensus 116 v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~ 192 (394)
T 4e7w_A 116 VLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL 192 (394)
T ss_dssp EEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred EeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeCCCcccc
Confidence 9999987544443321123457899999999999999999999987 99999999999999 7999999999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 193 ~~~ 195 (394)
T 4e7w_A 193 IAG 195 (394)
T ss_dssp CTT
T ss_pred cCC
Confidence 443
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.6e-24 Score=216.57 Aligned_cols=149 Identities=32% Similarity=0.529 Sum_probs=125.7
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC-eEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE-EKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~-~~~lV~Ey 558 (649)
.++|++.+.||+|+||.||++... ++.||||.++.. ...+.+.+|+.++.+++||||+++++++.+.+ ..++||||
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~vavK~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 96 (278)
T 1byg_A 20 MKELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 96 (278)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred hhhceEEeEEecCCCceEEEEEEc-CCEEEEEEecch--hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEec
Confidence 357889999999999999999886 889999998653 35678999999999999999999999987654 68999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++....
T Consensus 97 ~~~~~L~~~l~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~ 169 (278)
T 1byg_A 97 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 169 (278)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCCHHHHHHhc-ccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeeccccccccc
Confidence 9999999999542 1223789999999999999999999987 99999999999999999999999999987643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-24 Score=220.73 Aligned_cols=158 Identities=23% Similarity=0.373 Sum_probs=133.7
Q ss_pred CHHHHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCC--CCCccceEEEEE
Q 006347 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCV 547 (649)
Q Consensus 472 ~~~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~ 547 (649)
.++.+....++|++.+.||+|+||.||++...+++.||||.+... .....+.+.+|+.++.+++ |+||+++++++.
T Consensus 19 ~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~ 98 (313)
T 3cek_A 19 YFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEI 98 (313)
T ss_dssp -CCEEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEE
T ss_pred CeeeeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEee
Confidence 334444455779999999999999999999988999999998643 2345678999999999996 599999999999
Q ss_pred eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 548 EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
+.+..++||| +.+++|.+++.. ...+++..+..++.|+++||.|||+.+ |+||||||+|||+++ +.+||+||
T Consensus 99 ~~~~~~lv~e-~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Df 170 (313)
T 3cek_A 99 TDQYIYMVME-CGNIDLNSWLKK---KKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDF 170 (313)
T ss_dssp CSSEEEEEEC-CCSEEHHHHHHH---CSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCC
T ss_pred cCCEEEEEEe-cCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeec
Confidence 9999999999 568999999954 346899999999999999999999987 999999999999975 89999999
Q ss_pred CCceeeCCCC
Q 006347 628 GMAKIFGGNQ 637 (649)
Q Consensus 628 Gla~~~~~~~ 637 (649)
|+++.+....
T Consensus 171 g~~~~~~~~~ 180 (313)
T 3cek_A 171 GIANQMQPDT 180 (313)
T ss_dssp SSSCC-----
T ss_pred cccccccCcc
Confidence 9999875443
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.89 E-value=2.2e-23 Score=226.67 Aligned_cols=148 Identities=28% Similarity=0.402 Sum_probs=122.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC----C--eEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG----E--EKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~----~--~~~ 553 (649)
.+|++.+.||+|+||.||+|+.. +++.||||++.... +.+.+|++++++++|+|||++++++... + ..+
T Consensus 54 ~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~ 129 (420)
T 1j1b_A 54 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLN 129 (420)
T ss_dssp EEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCT----TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEE
T ss_pred ceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccc----hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEE
Confidence 45888899999999999999986 68999999986432 2334799999999999999999998652 2 357
Q ss_pred EEEecCCCCChhhhhcCC-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-CceEEEecCCce
Q 006347 554 LIYEYMPNRSLDALLFDP-LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAK 631 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-~~~Ki~DFGla~ 631 (649)
+||||+++ +|.+.+... .....+++..+..++.||++||+|||+.+ |+||||||+|||++.+ +.+||+|||+|+
T Consensus 130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~DFG~a~ 205 (420)
T 1j1b_A 130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAK 205 (420)
T ss_dssp EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEeccchhhh
Confidence 99999975 565555321 13456899999999999999999999987 9999999999999965 678999999999
Q ss_pred eeCCC
Q 006347 632 IFGGN 636 (649)
Q Consensus 632 ~~~~~ 636 (649)
.+...
T Consensus 206 ~~~~~ 210 (420)
T 1j1b_A 206 QLVRG 210 (420)
T ss_dssp ECCTT
T ss_pred hcccC
Confidence 87543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.9e-23 Score=214.60 Aligned_cols=151 Identities=32% Similarity=0.492 Sum_probs=124.6
Q ss_pred cCcccceeeccCCcEEEEEEEec--CCc--EEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--DGQ--EIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--~g~--~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|++.+.||+|+||+||+|+.. +++ .||||.++.. .....+++.+|+.++.+++||||+++++++.+.. .+
T Consensus 18 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~ 96 (291)
T 1u46_A 18 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MK 96 (291)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CE
T ss_pred hHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ce
Confidence 57889999999999999999864 333 6899988653 2345678999999999999999999999988765 88
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++++|.+++... ...+++..+..++.|+++||.|||+.+ |+||||||+||+++.++.+||+|||+++.+
T Consensus 97 ~v~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~ 171 (291)
T 1u46_A 97 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 171 (291)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeEecccCCCHHHHHHhc--cCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence 999999999999998642 345899999999999999999999987 999999999999999999999999999987
Q ss_pred CCCC
Q 006347 634 GGNQ 637 (649)
Q Consensus 634 ~~~~ 637 (649)
....
T Consensus 172 ~~~~ 175 (291)
T 1u46_A 172 PQND 175 (291)
T ss_dssp CC-C
T ss_pred cccc
Confidence 5443
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.89 E-value=2.6e-23 Score=220.71 Aligned_cols=159 Identities=25% Similarity=0.344 Sum_probs=121.4
Q ss_pred HHHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe-
Q 006347 474 EELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE- 551 (649)
Q Consensus 474 ~~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~- 551 (649)
.+.....++|++.+.||+|+||.||+|+.. +++.||||++... ......+.+|+..+..++||||+++++++.....
T Consensus 16 ~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~ 94 (360)
T 3e3p_A 16 ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQD-PRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGER 94 (360)
T ss_dssp HHHHHHHTTEEEC----------CEEEEETTTCCEEEEEEEECC-TTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS
T ss_pred hhchhhccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecC-ccccHHHHHHHHHHHhcCCCCcccHHHhhhccccc
Confidence 455667789999999999999999999986 6899999998653 3334567788888999999999999999976443
Q ss_pred ------EEEEEecCCCCChhhhhcC-CCCCCCCCHHHHHHHHHHHHHHHHHHH--hCCCCceEecCCCCCcEEEcC-CCc
Q 006347 552 ------KMLIYEYMPNRSLDALLFD-PLKKERLDWRKRFNIIEGISRGLLYLH--RDSRLRIIHRDLKASNILLDE-ELN 621 (649)
Q Consensus 552 ------~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH--~~~~~~iiHrDlkp~NILl~~-~~~ 621 (649)
.++||||+++ +|...+.. ......+++..+..++.|++.||.||| +.+ |+||||||+|||++. ++.
T Consensus 95 ~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~ 170 (360)
T 3e3p_A 95 DRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGT 170 (360)
T ss_dssp CTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTE
T ss_pred cccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCc
Confidence 7899999986 44443321 123456889999999999999999999 766 999999999999997 899
Q ss_pred eEEEecCCceeeCCCC
Q 006347 622 PKISDFGMAKIFGGNQ 637 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~~ 637 (649)
+||+|||+|+.+....
T Consensus 171 ~kl~Dfg~a~~~~~~~ 186 (360)
T 3e3p_A 171 LKLCDFGSAKKLSPSE 186 (360)
T ss_dssp EEECCCTTCBCCCTTS
T ss_pred EEEeeCCCceecCCCC
Confidence 9999999999875443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=8.5e-24 Score=224.17 Aligned_cols=145 Identities=21% Similarity=0.293 Sum_probs=127.8
Q ss_pred cCcccceeeccCCcEEEEEEEecC---------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccc----------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKD---------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR---------- 541 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~---------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~---------- 541 (649)
++|.+.+.||+|+||.||+|.... ++.||||.+... +.+.+|+.++.+++||||++
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~ 116 (352)
T 2jii_A 42 RQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-----GRLFNEQNFFQRAAKPLQVNKWKKLYSTPL 116 (352)
T ss_dssp CEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-----STHHHHHHHHHHHCCHHHHHHHHHHTTCTT
T ss_pred CeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-----chHHHHHHHHHHhcccchhhhhhhhccCCc
Confidence 679999999999999999999763 789999998643 46889999999999999987
Q ss_pred -----eEEEEEe-CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEE
Q 006347 542 -----LLGCCVE-GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNIL 615 (649)
Q Consensus 542 -----l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NIL 615 (649)
+++++.. +...++||||+ +++|.+++... ....+++.+++.|+.||++||.|||+.+ |+||||||+|||
T Consensus 117 ~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~-~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIl 191 (352)
T 2jii_A 117 LAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVS-PKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIF 191 (352)
T ss_dssp CSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHS-GGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCGGGEE
T ss_pred cCccchhhccccCCcEEEEEecCC-CcCHHHHHHhC-CcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEE
Confidence 6788877 77889999999 99999999642 2357999999999999999999999987 999999999999
Q ss_pred EcCCC--ceEEEecCCceeeCC
Q 006347 616 LDEEL--NPKISDFGMAKIFGG 635 (649)
Q Consensus 616 l~~~~--~~Ki~DFGla~~~~~ 635 (649)
++.++ .+||+|||+|+.+..
T Consensus 192 ~~~~~~~~~kl~Dfg~a~~~~~ 213 (352)
T 2jii_A 192 VDPEDQSQVTLAGYGFAFRYCP 213 (352)
T ss_dssp EETTEEEEEEECCGGGCBCSSG
T ss_pred EcCCCCceEEEecCcceeeccC
Confidence 99998 999999999998753
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.89 E-value=7.1e-23 Score=210.77 Aligned_cols=151 Identities=25% Similarity=0.439 Sum_probs=126.2
Q ss_pred HhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEE-EeCCeEEEEE
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC-VEGEEKMLIY 556 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~ 556 (649)
..++|++.+.||+|+||.||+|+.. +++.||||.+.... ..+++.+|+.++.+++|++++..++.+ .+++..++||
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~ 84 (296)
T 4hgt_A 7 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM 84 (296)
T ss_dssp ----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC-----CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEE
T ss_pred cCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccc--cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEE
Confidence 4478999999999999999999974 78899999875432 334688999999999888777766665 6677889999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCceee
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIF 633 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~~ 633 (649)
||+ +++|.+++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+|+.+
T Consensus 85 e~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~ 158 (296)
T 4hgt_A 85 ELL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 158 (296)
T ss_dssp ECC-CCBHHHHHHH--TTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred Ecc-CCCHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceec
Confidence 999 9999999853 2346899999999999999999999998 9999999999999 78999999999999987
Q ss_pred CCCC
Q 006347 634 GGNQ 637 (649)
Q Consensus 634 ~~~~ 637 (649)
....
T Consensus 159 ~~~~ 162 (296)
T 4hgt_A 159 RDAR 162 (296)
T ss_dssp BCTT
T ss_pred cCcc
Confidence 5543
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=7.2e-23 Score=210.42 Aligned_cols=153 Identities=31% Similarity=0.510 Sum_probs=135.2
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
...++|++.+.||+|+||.||+++.. +++.||||++.... ....+.+.+|+.++.+++||||+++++++.+.+..++
T Consensus 19 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEE
T ss_pred HHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEE
Confidence 34467999999999999999999986 68999999986532 3456789999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC---CceEEEecCCce
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE---LNPKISDFGMAK 631 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~---~~~Ki~DFGla~ 631 (649)
||||+++++|.+++.. ...+++..+..++.||++||.|||+.+ |+||||||+||+++.+ ..+||+|||+++
T Consensus 99 v~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~ 172 (287)
T 2wei_A 99 VGELYTGGELFDEIIK---RKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLST 172 (287)
T ss_dssp EECCCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGG
T ss_pred EEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcce
Confidence 9999999999988853 346899999999999999999999987 9999999999999764 479999999998
Q ss_pred eeCCC
Q 006347 632 IFGGN 636 (649)
Q Consensus 632 ~~~~~ 636 (649)
.....
T Consensus 173 ~~~~~ 177 (287)
T 2wei_A 173 CFQQN 177 (287)
T ss_dssp TBCCC
T ss_pred eecCC
Confidence 77543
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.89 E-value=1.4e-22 Score=208.78 Aligned_cols=150 Identities=25% Similarity=0.445 Sum_probs=129.0
Q ss_pred hcCcccceeeccCCcEEEEEEEe-cCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEE-EeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRL-KDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCC-VEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~-~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~-~~~~~~~lV~E 557 (649)
.++|++.+.||+|+||.||+|+. .+++.||||++.... ..+++.+|+.++.+++|++++..+.++ .+++..++|||
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e 85 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 85 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCS--SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCc--chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence 46799999999999999999997 478999999986533 335789999999999988766666555 56778899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~~~ 634 (649)
|+ +++|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||+ ++++.+||+|||+++.+.
T Consensus 86 ~~-~~~L~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~ 159 (296)
T 3uzp_A 86 LL-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 159 (296)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred ec-CCCHHHHHHh--hccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCccccc
Confidence 99 9999999953 2346899999999999999999999988 9999999999999 588999999999999876
Q ss_pred CCC
Q 006347 635 GNQ 637 (649)
Q Consensus 635 ~~~ 637 (649)
...
T Consensus 160 ~~~ 162 (296)
T 3uzp_A 160 DAR 162 (296)
T ss_dssp CTT
T ss_pred ccc
Confidence 543
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.89 E-value=4.4e-23 Score=215.65 Aligned_cols=151 Identities=28% Similarity=0.504 Sum_probs=128.7
Q ss_pred HhcCcccceeeccCCcEEEEEEEec--CCcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCCccceEEEEE----
Q 006347 479 ATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCV---- 547 (649)
Q Consensus 479 ~~~~f~~~~~LG~G~fG~Vykg~~~--~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~---- 547 (649)
+.++|++.+.||+|+||.||+|... +++.||||++.... ......+.+|+.+++.+ +||||+++++++.
T Consensus 9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~ 88 (326)
T 1blx_A 9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 88 (326)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence 4578999999999999999999973 68899999986432 22234677788777766 8999999999997
Q ss_pred -eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEe
Q 006347 548 -EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISD 626 (649)
Q Consensus 548 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~D 626 (649)
.....++||||++ |+|.+++... ....+++..+..++.||++||.|||+.+ |+||||||+|||++.++.+||+|
T Consensus 89 ~~~~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D 163 (326)
T 1blx_A 89 DRETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 163 (326)
T ss_dssp SSEEEEEEEEECCS-CBHHHHHHHS-CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCceEEEEEecCC-CCHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence 4557899999997 6999998643 2345899999999999999999999987 99999999999999999999999
Q ss_pred cCCceeeC
Q 006347 627 FGMAKIFG 634 (649)
Q Consensus 627 FGla~~~~ 634 (649)
||+++.+.
T Consensus 164 fg~~~~~~ 171 (326)
T 1blx_A 164 FGLARIYS 171 (326)
T ss_dssp CCSCCCCC
T ss_pred Cccccccc
Confidence 99998764
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.89 E-value=1.3e-22 Score=221.03 Aligned_cols=150 Identities=23% Similarity=0.293 Sum_probs=130.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC------CCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL------QHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l------~H~niv~l~g~~~~~~~~ 552 (649)
..+|++.+.||+|+||+||+|... +++.||||++... ....+++.+|+.++..+ +|+||+++++++...+..
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~ 174 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE-KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHI 174 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEE
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc-cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeE
Confidence 457999999999999999999876 5889999999653 33456778888888877 577999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc--eEEEecCCc
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN--PKISDFGMA 630 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~--~Ki~DFGla 630 (649)
++||||++ ++|.+++... ....+++..+..|+.||++||+|||+.+ |+||||||+|||++.++. +||+|||+|
T Consensus 175 ~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG~a 249 (429)
T 3kvw_A 175 CMTFELLS-MNLYELIKKN-KFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFGSS 249 (429)
T ss_dssp EEEECCCC-CBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCTTC
T ss_pred EEEEeccC-CCHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecccc
Confidence 99999996 6899888643 3345899999999999999999999987 999999999999999887 999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 250 ~~~~~ 254 (429)
T 3kvw_A 250 CYEHQ 254 (429)
T ss_dssp EETTC
T ss_pred eecCC
Confidence 87643
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.89 E-value=2e-23 Score=217.11 Aligned_cols=156 Identities=26% Similarity=0.398 Sum_probs=125.4
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcC----CCCCccceE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKL----QHRNLVRLL 543 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l----~H~niv~l~ 543 (649)
+.....++|++.+.||+|+||.||+|... +++.||||++..... .....+.+|+.++.++ +|+||++++
T Consensus 25 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~ 104 (312)
T 2iwi_A 25 DREAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLL 104 (312)
T ss_dssp --------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEE
T ss_pred chhhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEE
Confidence 34455678999999999999999999875 688999999965432 1234566789988888 899999999
Q ss_pred EEEEeCCeEEEEEec-CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCc
Q 006347 544 GCCVEGEEKMLIYEY-MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELN 621 (649)
Q Consensus 544 g~~~~~~~~~lV~Ey-~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~ 621 (649)
+++.+.+..++|||| +++++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+||+++ +++.
T Consensus 105 ~~~~~~~~~~~v~e~~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~ 178 (312)
T 2iwi_A 105 DWFETQEGFMLVLERPLPAQDLFDYITE---KGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGC 178 (312)
T ss_dssp EEC-----CEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTE
T ss_pred EEEecCCeEEEEEEecCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCe
Confidence 999999999999999 789999999954 346899999999999999999999987 99999999999999 8899
Q ss_pred eEEEecCCceeeCCC
Q 006347 622 PKISDFGMAKIFGGN 636 (649)
Q Consensus 622 ~Ki~DFGla~~~~~~ 636 (649)
+||+|||+++.+...
T Consensus 179 ~kl~dfg~~~~~~~~ 193 (312)
T 2iwi_A 179 AKLIDFGSGALLHDE 193 (312)
T ss_dssp EEECCCSSCEECCSS
T ss_pred EEEEEcchhhhcccC
Confidence 999999999987543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.89 E-value=5.9e-23 Score=219.47 Aligned_cols=147 Identities=25% Similarity=0.464 Sum_probs=127.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE----
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK---- 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~---- 552 (649)
.++|.+.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+.++++++||||+++++++...+..
T Consensus 41 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 120 (371)
T 4exu_A 41 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY 120 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred cccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence 367889999999999999999876 68999999997532 23457889999999999999999999999887755
Q ss_pred --EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 553 --MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 553 --~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
++||||++ ++|.+++. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+|
T Consensus 121 ~~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a 191 (371)
T 4exu_A 121 DFYLVMPFMQ-TDLQKIMG-----MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLA 191 (371)
T ss_dssp CCEEEEECCC-EEHHHHTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC
T ss_pred eEEEEEcccc-ccHHHHhh-----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCcc
Confidence 99999997 68888873 34899999999999999999999987 999999999999999999999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 192 ~~~~~ 196 (371)
T 4exu_A 192 RHADA 196 (371)
T ss_dssp -----
T ss_pred ccccc
Confidence 97643
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=4.7e-23 Score=236.06 Aligned_cols=154 Identities=24% Similarity=0.410 Sum_probs=133.0
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~ 551 (649)
....++|.+.+.||+|+||.||+|... .+..||||+++... ....++|.+|+.++.+++||||+++++++. .+.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~ 464 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP 464 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSS
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCc
Confidence 334567888999999999999999875 24679999986533 334578999999999999999999999984 567
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+++|+|.+++.. ....+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 465 ~~lv~E~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~ 539 (656)
T 2j0j_A 465 VWIIMELCTLGELRSFLQV--RKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSR 539 (656)
T ss_dssp CEEEEECCTTCBHHHHHHH--TTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCC
T ss_pred eEEEEEcCCCCcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCe
Confidence 8999999999999999964 2346899999999999999999999987 9999999999999999999999999999
Q ss_pred eeCCC
Q 006347 632 IFGGN 636 (649)
Q Consensus 632 ~~~~~ 636 (649)
.+...
T Consensus 540 ~~~~~ 544 (656)
T 2j0j_A 540 YMEDS 544 (656)
T ss_dssp SCCC-
T ss_pred ecCCC
Confidence 87543
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.88 E-value=1.4e-22 Score=223.62 Aligned_cols=150 Identities=25% Similarity=0.439 Sum_probs=130.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||+|+||.||+|+.. +++.||||++.... ..+++..|++++..++| ++++.+..++.+.+..+||||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme 83 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKT--KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD 83 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTC--SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccc--ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence 367999999999999999999974 78999999876433 33468899999999976 667777778888899999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---cCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl---~~~~~~Ki~DFGla~~~~ 634 (649)
|+ +++|.+++.. ....+++.+++.|+.||+.||+|||+.+ ||||||||+|||| ++++.+||+|||+|+.+.
T Consensus 84 ~~-g~sL~~ll~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~ 157 (483)
T 3sv0_A 84 LL-GPSLEDLFNF--CSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR 157 (483)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred CC-CCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence 99 9999999953 2356999999999999999999999988 9999999999999 688999999999999876
Q ss_pred CCC
Q 006347 635 GNQ 637 (649)
Q Consensus 635 ~~~ 637 (649)
...
T Consensus 158 ~~~ 160 (483)
T 3sv0_A 158 DTS 160 (483)
T ss_dssp CTT
T ss_pred CCc
Confidence 543
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=9.1e-23 Score=220.60 Aligned_cols=147 Identities=28% Similarity=0.473 Sum_probs=115.5
Q ss_pred ccc-ceeeccCCcEEEEEEEec---CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEEEE
Q 006347 483 FQL-SSKLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLIY 556 (649)
Q Consensus 483 f~~-~~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV~ 556 (649)
|.+ .++||+|+||+||+|... +++.||||++... ...+.+.+|+.++++++||||+++++++.+ ....+|||
T Consensus 22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~ 99 (405)
T 3rgf_A 22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGT--GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLF 99 (405)
T ss_dssp EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSS--SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEE
T ss_pred hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCC--CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEE
Confidence 443 358999999999999965 5789999999653 234678899999999999999999999975 66889999
Q ss_pred ecCCCCChhhhhcCC------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE----cCCCceEEEe
Q 006347 557 EYMPNRSLDALLFDP------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL----DEELNPKISD 626 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl----~~~~~~Ki~D 626 (649)
||++ ++|.+++... .....+++..+..|+.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|
T Consensus 100 e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~D 175 (405)
T 3rgf_A 100 DYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIAD 175 (405)
T ss_dssp ECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEEECC
T ss_pred eCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEEEEE
Confidence 9996 5787776421 12235899999999999999999999988 9999999999999 7789999999
Q ss_pred cCCceeeCC
Q 006347 627 FGMAKIFGG 635 (649)
Q Consensus 627 FGla~~~~~ 635 (649)
||+|+.+..
T Consensus 176 fg~a~~~~~ 184 (405)
T 3rgf_A 176 MGFARLFNS 184 (405)
T ss_dssp TTCCC----
T ss_pred CCCceecCC
Confidence 999998754
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=3.2e-23 Score=221.42 Aligned_cols=150 Identities=14% Similarity=0.157 Sum_probs=113.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcC--CCCCccceE-------EEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKL--QHRNLVRLL-------GCC 546 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l--~H~niv~l~-------g~~ 546 (649)
..+|.+.+.||+|+||.||+|... +++.||||++..... ...+.+.+|+.++..+ +||||++++ +++
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~ 140 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV 140 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence 345888999999999999999976 789999999976432 3456777885544444 699987755 444
Q ss_pred EeC-----------------CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHH------HHHHHHHHHHHHHHHhCCCCc
Q 006347 547 VEG-----------------EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKR------FNIIEGISRGLLYLHRDSRLR 603 (649)
Q Consensus 547 ~~~-----------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ 603 (649)
... ...+|||||++ |+|.+++... ...+.+..+ +.++.||++||+|||+.+
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~--~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~--- 214 (371)
T 3q60_A 141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTL--DFVYVFRGDEGILALHILTAQLIRLAANLQSKG--- 214 (371)
T ss_dssp EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHH--HHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---
T ss_pred ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHh--ccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---
Confidence 433 33799999998 8999999642 223455556 788899999999999988
Q ss_pred eEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 604 IIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 604 iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+||||||+|||+++++.+||+|||+|+..+.
T Consensus 215 ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~ 246 (371)
T 3q60_A 215 LVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246 (371)
T ss_dssp EEETTCSGGGEEECTTSCEEECCGGGEEETTC
T ss_pred CccCcCCHHHEEECCCCCEEEEecceeeecCC
Confidence 99999999999999999999999999998743
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.1e-22 Score=213.02 Aligned_cols=151 Identities=25% Similarity=0.353 Sum_probs=126.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHH-HHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVM-VISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~-~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.+.||+|+||.||++... +++.||||++.... .....++..|+. +++.++||||+++++++.+.+..++|||
T Consensus 22 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e 101 (327)
T 3aln_A 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICME 101 (327)
T ss_dssp CSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred HHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEe
Confidence 67888899999999999999986 78999999997542 234456666666 7777899999999999999999999999
Q ss_pred cCCCCChhhhhcC--CCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFD--PLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|+++ +|.+++.. ......+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.+.
T Consensus 102 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~ 177 (327)
T 3aln_A 102 LMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177 (327)
T ss_dssp CCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred ecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence 9975 88777642 11245689999999999999999999997 7 9999999999999999999999999998774
Q ss_pred C
Q 006347 635 G 635 (649)
Q Consensus 635 ~ 635 (649)
.
T Consensus 178 ~ 178 (327)
T 3aln_A 178 D 178 (327)
T ss_dssp -
T ss_pred c
Confidence 4
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=8.5e-23 Score=216.48 Aligned_cols=146 Identities=25% Similarity=0.468 Sum_probs=127.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCe------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEE------ 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~------ 551 (649)
++|.+.+.||+|+||.||+|... +|+.||||++.... ....+++.+|+.++.+++||||+++++++...+.
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~ 103 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYD 103 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEeccccccccee
Confidence 57888999999999999999976 68999999996532 2345788999999999999999999999987654
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||++ ++|.+++. ..+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++
T Consensus 104 ~~lv~e~~~-~~l~~~~~-----~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~ 174 (353)
T 3coi_A 104 FYLVMPFMQ-TDLQKIMG-----LKFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLAR 174 (353)
T ss_dssp CEEEEECCS-EEGGGTTT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTT
T ss_pred EEEEecccc-CCHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeeccccc
Confidence 499999997 68888773 24899999999999999999999988 9999999999999999999999999998
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
....
T Consensus 175 ~~~~ 178 (353)
T 3coi_A 175 HADA 178 (353)
T ss_dssp C---
T ss_pred CCCC
Confidence 7643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=9e-23 Score=219.07 Aligned_cols=135 Identities=25% Similarity=0.383 Sum_probs=114.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC--------CCCccceEEEEE---
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--------HRNLVRLLGCCV--- 547 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~--------H~niv~l~g~~~--- 547 (649)
.++|++.++||+|+||+||+|+.. +++.||||+++.. ....+.+.+|+.++.+++ |+||+++++++.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~ 114 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA-EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISG 114 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC-CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecC
Confidence 367999999999999999999865 6889999999643 345678899999999985 788999999988
Q ss_pred -eCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCC
Q 006347 548 -EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEEL 620 (649)
Q Consensus 548 -~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~ 620 (649)
++...+|||||+ +++|.+++... ....+++..+..|+.||++||+|||++ + |+||||||+|||++.++
T Consensus 115 ~~~~~~~lv~e~~-~~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~ 184 (397)
T 1wak_A 115 VNGTHICMVFEVL-GHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNE 184 (397)
T ss_dssp TTEEEEEEEECCC-CCBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCH
T ss_pred CCCceEEEEEecc-CccHHHHHHhc-ccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccc
Confidence 455789999999 55666655432 235689999999999999999999998 6 99999999999999775
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=2.2e-22 Score=210.98 Aligned_cols=150 Identities=23% Similarity=0.331 Sum_probs=130.7
Q ss_pred hcCcccceeeccCCcEEEEEEEe-c-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCC------CccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRL-K-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR------NLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~-~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~------niv~l~g~~~~~~~ 551 (649)
.++|++.+.||+|+||.||++.. . +++.||||+++.. ....+.+.+|+.++..++|+ +++++++++.+.+.
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~ 91 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV-DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGH 91 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC-CchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCc
Confidence 35799999999999999999987 3 6889999999653 34567888999999988765 49999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE------------- 618 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~------------- 618 (649)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||++.
T Consensus 92 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~~~ 166 (339)
T 1z57_A 92 ICIVFELL-GLSTYDFIKEN-GFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKIKR 166 (339)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC----C
T ss_pred EEEEEcCC-CCCHHHHHHhc-CCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcccc
Confidence 99999999 89999998643 2346899999999999999999999987 999999999999987
Q ss_pred ------CCceEEEecCCceeeCC
Q 006347 619 ------ELNPKISDFGMAKIFGG 635 (649)
Q Consensus 619 ------~~~~Ki~DFGla~~~~~ 635 (649)
++.+||+|||+++....
T Consensus 167 ~~~~~~~~~~kl~Dfg~~~~~~~ 189 (339)
T 1z57_A 167 DERTLINPDIKVVDFGSATYDDE 189 (339)
T ss_dssp EEEEESCCCEEECCCSSCEETTS
T ss_pred ccccccCCCceEeeCcccccCcc
Confidence 67899999999998643
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.88 E-value=2.1e-23 Score=217.40 Aligned_cols=152 Identities=32% Similarity=0.553 Sum_probs=129.4
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
+.....++|++.+.||+|+||.||+|.... .+|||.++... ....+.+.+|+.++.+++|+||+++++++.+.+..
T Consensus 27 ~~~i~~~~~~~~~~lg~G~~g~V~~~~~~~--~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 104 (319)
T 2y4i_B 27 EWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHL 104 (319)
T ss_dssp GSSSCCSCEECCCBCCCSSSSEEEEEEESS--SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCE
T ss_pred cccCCHHHeEEeeEeccCCceEEEEEEEcC--eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCce
Confidence 333445788899999999999999999863 49999986432 33456788999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
++||||+++++|.+++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++ ++.+||+|||+++.
T Consensus 105 ~iv~e~~~~~~L~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~ 178 (319)
T 2y4i_B 105 AIITSLCKGRTLYSVVRD--AKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSI 178 (319)
T ss_dssp EEECBCCCSEEHHHHTTS--SCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC-
T ss_pred EEEeecccCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccc
Confidence 999999999999999954 2346899999999999999999999987 99999999999998 67999999999887
Q ss_pred eC
Q 006347 633 FG 634 (649)
Q Consensus 633 ~~ 634 (649)
..
T Consensus 179 ~~ 180 (319)
T 2y4i_B 179 SG 180 (319)
T ss_dssp --
T ss_pred cc
Confidence 63
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.88 E-value=7.5e-23 Score=214.02 Aligned_cols=154 Identities=25% Similarity=0.370 Sum_probs=133.7
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccc------cHHHHHHHHHHHhcCC--CCCccceEEEEE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ------GLEEFMNEVMVISKLQ--HRNLVRLLGCCV 547 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~------~~~~f~~E~~~l~~l~--H~niv~l~g~~~ 547 (649)
....++|++.+.||+|+||.||+|... +++.||||.+...... ..+.+.+|+.++.+++ |+||+++++++.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~ 118 (320)
T 3a99_A 39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE 118 (320)
T ss_dssp -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence 344578999999999999999999865 6899999998654221 2356778999999996 599999999999
Q ss_pred eCCeEEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEE
Q 006347 548 EGEEKMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKIS 625 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki~ 625 (649)
+.+..++||||+.+ ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++ +++.+||+
T Consensus 119 ~~~~~~lv~e~~~~~~~L~~~l~~---~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~ 192 (320)
T 3a99_A 119 RPDSFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI 192 (320)
T ss_dssp CSSEEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred cCCcEEEEEEcCCCCccHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence 99999999999976 899999853 356899999999999999999999987 99999999999999 78999999
Q ss_pred ecCCceeeCCC
Q 006347 626 DFGMAKIFGGN 636 (649)
Q Consensus 626 DFGla~~~~~~ 636 (649)
|||+++.+...
T Consensus 193 Dfg~~~~~~~~ 203 (320)
T 3a99_A 193 DFGSGALLKDT 203 (320)
T ss_dssp CCTTCEECCSS
T ss_pred eCccccccccc
Confidence 99999987543
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.88 E-value=1.5e-22 Score=221.04 Aligned_cols=149 Identities=27% Similarity=0.326 Sum_probs=120.3
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEecCC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
.|...+.||+|+||+||.+...+|+.||||++... ..+.+.+|+.++.++ +|||||++++++.+++..+|||||++
T Consensus 16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~---~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~ 92 (434)
T 2rio_A 16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLID---FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN 92 (434)
T ss_dssp CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGG---GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS
T ss_pred eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHH---HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC
Confidence 34556789999999998776667999999998542 345778999999886 89999999999999999999999995
Q ss_pred CCChhhhhcCCCCC-C---CCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC-------------CceE
Q 006347 561 NRSLDALLFDPLKK-E---RLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE-------------LNPK 623 (649)
Q Consensus 561 ~gsL~~~l~~~~~~-~---~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~-------------~~~K 623 (649)
|+|.+++...... . ..++..+..++.||+.||+|||+.+ |+||||||+|||++.+ +.+|
T Consensus 93 -gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~k 168 (434)
T 2rio_A 93 -LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENLRIL 168 (434)
T ss_dssp -EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSCEEE
T ss_pred -CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCceEEE
Confidence 6999999653221 1 1133356789999999999999987 9999999999999754 5899
Q ss_pred EEecCCceeeCCCC
Q 006347 624 ISDFGMAKIFGGNQ 637 (649)
Q Consensus 624 i~DFGla~~~~~~~ 637 (649)
|+|||+|+.+....
T Consensus 169 L~DFG~a~~~~~~~ 182 (434)
T 2rio_A 169 ISDFGLCKKLDSGQ 182 (434)
T ss_dssp ECCCTTCEECCC--
T ss_pred EcccccceecCCCC
Confidence 99999999886543
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=6.2e-22 Score=208.58 Aligned_cols=148 Identities=26% Similarity=0.313 Sum_probs=121.2
Q ss_pred hcCcccce-eeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEE
Q 006347 480 TNNFQLSS-KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKM 553 (649)
Q Consensus 480 ~~~f~~~~-~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~ 553 (649)
.++|.+.+ .||+|+||.||+|... +++.||||++... . +........+..+.|+||+++++++.. +...+
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~-~---~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~ 102 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS-P---KARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLL 102 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS-H---HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc-H---HHHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEE
Confidence 46788754 6999999999999987 6899999998542 1 222222334566799999999999986 44579
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecCCc
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMA 630 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFGla 630 (649)
+||||+++|+|.+++... ....+++.++..++.|+++||.|||+.+ |+||||||+|||++. ++.+||+|||++
T Consensus 103 lv~e~~~gg~L~~~l~~~-~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~ 178 (336)
T 3fhr_A 103 IIMECMEGGELFSRIQER-GDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFGFA 178 (336)
T ss_dssp EEEECCTTEEHHHHHHTC--CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEeccCCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccccc
Confidence 999999999999999753 2346899999999999999999999997 999999999999986 455999999999
Q ss_pred eeeCC
Q 006347 631 KIFGG 635 (649)
Q Consensus 631 ~~~~~ 635 (649)
+....
T Consensus 179 ~~~~~ 183 (336)
T 3fhr_A 179 KETTQ 183 (336)
T ss_dssp EEC--
T ss_pred eeccc
Confidence 97653
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.7e-22 Score=226.11 Aligned_cols=135 Identities=19% Similarity=0.260 Sum_probs=110.0
Q ss_pred cceeeccCCcEEEEEEEecCCcEEEEEEeccccc--------ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 485 LSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG--------QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 485 ~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--------~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
..+.||+|+||.||++... ++.+++|+...... ...+.|.+|++++.+++||||+++..++.+.++.+|||
T Consensus 340 ~~~~LG~G~fg~Vy~~~~~-~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVm 418 (540)
T 3en9_A 340 PEHLIGKGAEADIKRDSYL-DFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMM 418 (540)
T ss_dssp --------CCEEEEEEECS-SCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEE
T ss_pred CCCEEeeCCCEEEEEEEEC-CCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEE
Confidence 3568999999999999554 78899998643211 12356899999999999999998877778888899999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++++|.+++.. +..++.|+++||.|||+++ |+||||||+|||+++ ++||+|||+|+.+...
T Consensus 419 E~~~ggsL~~~l~~-----------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~ 482 (540)
T 3en9_A 419 SYINGKLAKDVIED-----------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLD 482 (540)
T ss_dssp ECCCSEEHHHHSTT-----------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCH
T ss_pred ECCCCCCHHHHHHH-----------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCc
Confidence 99999999999843 5579999999999999988 999999999999999 9999999999998554
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=3.2e-22 Score=208.18 Aligned_cols=150 Identities=26% Similarity=0.409 Sum_probs=116.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-cc-HHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QG-LEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-~~-~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
.++|++.+.||+|+||.||+|... +++.||||++..... .. .+.+..+..++..++||||+++++++.+.+..++||
T Consensus 24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~ 103 (318)
T 2dyl_A 24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAM 103 (318)
T ss_dssp GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred hccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEE
Confidence 357888899999999999999986 789999999965432 22 234445556788889999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
||+ ++.+..+... ....+++..+..++.|+++||.|||+. + |+||||||+|||++.++.+||+|||+++.+..
T Consensus 104 e~~-~~~~~~l~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 177 (318)
T 2dyl_A 104 ELM-GTCAEKLKKR--MQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVD 177 (318)
T ss_dssp CCC-SEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC-----
T ss_pred ecc-CCcHHHHHHH--hccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccC
Confidence 999 4555555432 235689999999999999999999985 6 99999999999999999999999999987644
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.87 E-value=1.4e-22 Score=220.94 Aligned_cols=148 Identities=24% Similarity=0.345 Sum_probs=121.2
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEEEec
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
..+|...+.||+|+||+|+.....+++.||||++..... ..+.+|+.++.++ +|||||++++++.+.+..+|||||
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~---~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~ 99 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF---SFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIEL 99 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE---EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH---HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEEC
Confidence 346888899999999996655556789999999965332 3456899999999 799999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~Ki~DFGla~~~ 633 (649)
++ |+|.+++... ...+.+..+..++.||++||+|||+.+ |+||||||+|||++. ...+||+|||+|+.+
T Consensus 100 ~~-g~L~~~l~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~ 173 (432)
T 3p23_A 100 CA-ATLQEYVEQK--DFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKL 173 (432)
T ss_dssp CS-EEHHHHHHSS--SCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC
T ss_pred CC-CCHHHHHHhc--CCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccceeec
Confidence 96 6999999653 223444556789999999999999988 999999999999953 346889999999987
Q ss_pred CCC
Q 006347 634 GGN 636 (649)
Q Consensus 634 ~~~ 636 (649)
...
T Consensus 174 ~~~ 176 (432)
T 3p23_A 174 AVG 176 (432)
T ss_dssp ---
T ss_pred cCC
Confidence 543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=1.1e-21 Score=210.55 Aligned_cols=155 Identities=25% Similarity=0.350 Sum_probs=130.7
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CC-----CccceEEEEEeC
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HR-----NLVRLLGCCVEG 549 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~-----niv~l~g~~~~~ 549 (649)
....++|++.+.||+|+||+||+|... +++.||||+++.. ....+++..|+.++..++ |+ +++++++++...
T Consensus 50 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 50 EKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK-KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp CEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS-HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred CEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc-HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 344678999999999999999999876 6889999999643 344577888999988884 55 499999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCceEEEec
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDF 627 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~Ki~DF 627 (649)
+..+|||||++ ++|.+++... ....+++..+..++.|++.||.|||.+ ..+|+||||||+|||++ .++.+||+||
T Consensus 129 ~~~~lv~e~~~-~~L~~~l~~~-~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DF 205 (382)
T 2vx3_A 129 NHLCLVFEMLS-YNLYDLLRNT-NFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDF 205 (382)
T ss_dssp TEEEEEEECCC-CBHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCC
T ss_pred CceEEEEecCC-CCHHHHHhhc-CcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEec
Confidence 99999999996 5999998653 234589999999999999999999953 23499999999999994 5788999999
Q ss_pred CCceeeCC
Q 006347 628 GMAKIFGG 635 (649)
Q Consensus 628 Gla~~~~~ 635 (649)
|+|+.+..
T Consensus 206 G~a~~~~~ 213 (382)
T 2vx3_A 206 GSSCQLGQ 213 (382)
T ss_dssp TTCEETTC
T ss_pred cCceeccc
Confidence 99998754
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=9.2e-22 Score=207.72 Aligned_cols=150 Identities=21% Similarity=0.322 Sum_probs=128.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CC-cEEEEEEecccccccHHHHHHHHHHHhcCCCCC------ccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DG-QEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN------LVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g-~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n------iv~l~g~~~~~~~ 551 (649)
.++|++.+.||+|+||.||++... ++ +.||||+++.. ....+.+.+|+.++.+++|++ ++.+++++...+.
T Consensus 18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~-~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~ 96 (355)
T 2eu9_A 18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV-GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGH 96 (355)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTE
T ss_pred cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc-ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCe
Confidence 468999999999999999999975 34 68999999653 345678889999999997665 9999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE---------------
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL--------------- 616 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl--------------- 616 (649)
.++||||+ +++|.+++... ....+++..+..++.||++||+|||+.+ |+||||||+|||+
T Consensus 97 ~~lv~e~~-~~~l~~~l~~~-~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~~ 171 (355)
T 2eu9_A 97 MCIAFELL-GKNTFEFLKEN-NFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHKSC 171 (355)
T ss_dssp EEEEEECC-CCBHHHHHHHT-TTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-CC
T ss_pred EEEEEecc-CCChHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccccc
Confidence 99999999 66776666442 2346899999999999999999999987 9999999999999
Q ss_pred ----cCCCceEEEecCCceeeCC
Q 006347 617 ----DEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 617 ----~~~~~~Ki~DFGla~~~~~ 635 (649)
+.++.+||+|||+++....
T Consensus 172 ~~~~~~~~~~kl~Dfg~~~~~~~ 194 (355)
T 2eu9_A 172 EEKSVKNTSIRVADFGSATFDHE 194 (355)
T ss_dssp CEEEESCCCEEECCCTTCEETTS
T ss_pred cccccCCCcEEEeecCccccccc
Confidence 6788999999999997543
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.87 E-value=7.1e-23 Score=231.80 Aligned_cols=153 Identities=30% Similarity=0.414 Sum_probs=132.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEe------CCeE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE------GEEK 552 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~~ 552 (649)
++|.+.+.||+|+||.||+|... +|+.||||++... .....+.+.+|+.++.+++||||+++++++.. ++..
T Consensus 14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~ 93 (676)
T 3qa8_A 14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLP 93 (676)
T ss_dssp ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSC
T ss_pred CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeE
Confidence 67999999999999999999975 6899999998653 33456789999999999999999999999765 6678
Q ss_pred EEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCc---eEEEecCC
Q 006347 553 MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELN---PKISDFGM 629 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~---~Ki~DFGl 629 (649)
++||||+++|+|.+++........+++..+..|+.+++.||+|||+.+ |+||||||+|||++.++. +||+|||+
T Consensus 94 ~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DFG~ 170 (676)
T 3qa8_A 94 LLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGY 170 (676)
T ss_dssp CCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred EEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccccc
Confidence 999999999999999976544456899999999999999999999987 999999999999997664 99999999
Q ss_pred ceeeCCC
Q 006347 630 AKIFGGN 636 (649)
Q Consensus 630 a~~~~~~ 636 (649)
++.+...
T Consensus 171 a~~~~~~ 177 (676)
T 3qa8_A 171 AKELDQG 177 (676)
T ss_dssp CCBTTSC
T ss_pred ccccccc
Confidence 9987543
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.86 E-value=5.8e-22 Score=211.18 Aligned_cols=149 Identities=23% Similarity=0.383 Sum_probs=128.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----------CCCccceEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----------HRNLVRLLGCCVE 548 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~ 548 (649)
++|.+.+.||+|+||.||+|+.. +++.||||.+... ....+.+.+|+.++.+++ |+||+++++++..
T Consensus 19 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~ 97 (373)
T 1q8y_A 19 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD-KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 97 (373)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC-HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCC-ccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhc
Confidence 57999999999999999999975 7899999999643 345577889999999886 8899999999987
Q ss_pred CC----eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEc------
Q 006347 549 GE----EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLD------ 617 (649)
Q Consensus 549 ~~----~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~------ 617 (649)
.+ ..++||||+ +++|.+++... ....+++..+..++.||+.||+|||++ + |+||||||+|||++
T Consensus 98 ~~~~~~~~~lv~e~~-~~~L~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~~~~~ 172 (373)
T 1q8y_A 98 KGPNGVHVVMVFEVL-GENLLALIKKY-EHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPE 172 (373)
T ss_dssp EETTEEEEEEEECCC-CEEHHHHHHHT-TTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTT
T ss_pred cCCCCceEEEEEecC-CCCHHHHHHHh-hccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEeccCCCc
Confidence 54 789999999 89999998643 234589999999999999999999997 7 99999999999994
Q ss_pred CCCceEEEecCCceeeCC
Q 006347 618 EELNPKISDFGMAKIFGG 635 (649)
Q Consensus 618 ~~~~~Ki~DFGla~~~~~ 635 (649)
..+.+||+|||+|+.+..
T Consensus 173 ~~~~~kl~Dfg~a~~~~~ 190 (373)
T 1q8y_A 173 NLIQIKIADLGNACWYDE 190 (373)
T ss_dssp TEEEEEECCCTTCEETTB
T ss_pred CcceEEEcccccccccCC
Confidence 445899999999998754
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.86 E-value=7.3e-22 Score=202.88 Aligned_cols=142 Identities=19% Similarity=0.181 Sum_probs=115.1
Q ss_pred HHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccccc------------------ccHHHHHHHHHHHhcCCCC
Q 006347 476 LATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG------------------QGLEEFMNEVMVISKLQHR 537 (649)
Q Consensus 476 l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~ 537 (649)
+......|++.+.||+|+||.||+|...+|+.||||.++.... .....+.+|+.++.+++
T Consensus 85 ~~~~~~~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-- 162 (282)
T 1zar_A 85 LVRSGKVDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-- 162 (282)
T ss_dssp HHHTTSCSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--
T ss_pred HHhCCeEEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--
Confidence 3344455777799999999999999997799999999864321 13467899999999999
Q ss_pred CccceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc
Q 006347 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD 617 (649)
Q Consensus 538 niv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~ 617 (649)
| +++.+++. .+..++||||+++++|.+ +.. .....++.|+++||.|||+.+ |+||||||+|||++
T Consensus 163 ~-~~v~~~~~-~~~~~lvmE~~~g~~L~~-l~~---------~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~ 227 (282)
T 1zar_A 163 G-LAVPKVYA-WEGNAVLMELIDAKELYR-VRV---------ENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS 227 (282)
T ss_dssp T-SSSCCEEE-EETTEEEEECCCCEEGGG-CCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE
T ss_pred C-CCcCeEEe-ccceEEEEEecCCCcHHH-cch---------hhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE
Confidence 4 66666543 356699999999999988 421 123469999999999999988 99999999999999
Q ss_pred CCCceEEEecCCceeeCC
Q 006347 618 EELNPKISDFGMAKIFGG 635 (649)
Q Consensus 618 ~~~~~Ki~DFGla~~~~~ 635 (649)
++.+||+|||+|+....
T Consensus 228 -~~~vkl~DFG~a~~~~~ 244 (282)
T 1zar_A 228 -EEGIWIIDFPQSVEVGE 244 (282)
T ss_dssp -TTEEEECCCTTCEETTS
T ss_pred -CCcEEEEECCCCeECCC
Confidence 99999999999997643
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-21 Score=166.76 Aligned_cols=110 Identities=20% Similarity=0.395 Sum_probs=94.3
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
+|+|.+|+.|.+|++|+ ++|.|+|+|+.+++ -++|+ ..++||.||++.|. .++.++|..||||||+|.
T Consensus 1 ~d~l~~g~~L~~g~~l~-~~~~~~l~~~~dGn------lvl~~---~~~~vW~sn~~~~~--~~~~l~l~~dGNLVl~~~ 68 (110)
T 3a0c_A 1 VNSLSSPNSLFTGHSLE-VGPSYRLIMQGDCN------FVLYD---SGKPVWASNTGGLG--SGCRLTLHNNGNLVIYDQ 68 (110)
T ss_dssp CCEEETTCEECTTCEEE-ETTTEEEEECTTSC------EEEEE---TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE-ECCCEEEEEcCCCc------EEEEE---CCEEEEECCCCCCC--CcEEEEEeCCCCEEEECC
Confidence 47899999999999999 99999999998775 37787 37999999998764 357899999999999999
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCc
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPT 149 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PT 149 (649)
++.++|+|++.. ..+...++|+|+|||||++. ++||||+||.
T Consensus 69 ~~~~~W~S~t~~-~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~ 110 (110)
T 3a0c_A 69 SNRVIWQTKTNG-KEDHYVLVLQQDRNVVIYGP----VVWATGSGPA 110 (110)
T ss_dssp TCCEEEECCCCC-SSSCCEEEECTTSCEEEECS----EEEECSCCC-
T ss_pred CCcEEEecCCCC-CCCCEEEEEeCCccEEEECC----CEecCCCcCC
Confidence 999999999863 33455899999999999962 7999999984
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.85 E-value=6.1e-21 Score=165.07 Aligned_cols=104 Identities=17% Similarity=0.371 Sum_probs=88.7
Q ss_pred ccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCC
Q 006347 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ 103 (649)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~ 103 (649)
++|.+||.|.+|++|.| |.|.|.|..+++ |.+ |. ..++||+|||+.|.. ..+.|+|+.||||+|+|++
T Consensus 2 n~L~~g~~L~~g~~L~s--g~y~l~~q~DgN-----Lvl-y~---~~~~vW~ant~~~~~-~~~~L~l~~dGnLvL~d~~ 69 (105)
T 4h3o_A 2 NILDNNEGLYAGQSLDV--EPYHFIMQDDCN-----LVL-YD---HSTSTWASNTEIGGK-SGCSAVLQSDGNFVVYDSS 69 (105)
T ss_dssp CEECTTEEECTTCEEEE--TTEEEEECTTSC-----EEE-EE---TTEEEEECCCCCTTC-CSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEEcCCCEEEE--CCEEEEECCCCe-----EEE-EE---CCEEEEEecCCCCCC-ccEEEEEeCCccEEEECCC
Confidence 68999999999999998 889999988775 334 43 368999999999986 4578999999999999999
Q ss_pred ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeee
Q 006347 104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144 (649)
Q Consensus 104 ~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqS 144 (649)
+.+||+|++.. .....+|+|+|+|||||++. +||||
T Consensus 70 ~~~vWss~t~~-~~~~~~l~L~ddGNlVly~~----~~W~S 105 (105)
T 4h3o_A 70 GRSLWASHSTR-GSGNYILILQDDGNVIIYGS----DIWST 105 (105)
T ss_dssp CCEEEECCCCC-CSSCEEEEECTTSCEEEEES----EEEEC
T ss_pred cEEEEEecCCC-CCCCEEEEEeCCCeEEEECC----cEecC
Confidence 99999999873 33456899999999999963 59998
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.85 E-value=7.3e-21 Score=168.48 Aligned_cols=108 Identities=16% Similarity=0.306 Sum_probs=93.3
Q ss_pred cccccccCCCCcCCCCeEE--eCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEE
Q 006347 21 AIDSSITSSQLIRDPDAIL--SNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLV 98 (649)
Q Consensus 21 ~~~~~l~~g~~l~~~~~l~--S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~ 98 (649)
++.++|.+|++|.+|++|+ |++|.|+|+|+.+++ -+||++ .++||+|||+.|- .++.++|+.|||||
T Consensus 6 ~~~~~l~~g~~L~~g~~l~~~S~~g~~~L~~~~dgn------lvly~~---~~~vW~sn~~~~~--~~~~l~l~~dGNLV 74 (119)
T 1b2p_A 6 SKQPDDNHPQILHATESLEILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGLG--NGCRAVLQPDGVLV 74 (119)
T ss_dssp CSCSSSCCCCEEETTCEEEEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTSC--SSCEEEECTTSCEE
T ss_pred ecCcccCCCCEEcCCCEEEEeCCCCCEEEEEecCCC------EEEEEC---CEEEEeCCCccCC--CceEEEEccCCEEE
Confidence 3478999999999999999 999999999998775 368876 7999999998763 45789999999999
Q ss_pred EEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeee
Q 006347 99 LVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144 (649)
Q Consensus 99 l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqS 144 (649)
|+|.++.++|+|++.. ..+...++|+|+|||||++ .++|||
T Consensus 75 l~d~~~~~lW~S~~~~-~~g~~~l~l~~~Gnlvl~~----~~~W~S 115 (119)
T 1b2p_A 75 VITNENVTVWQSPVAG-KAGHYVLVLQPDRNVVIYG----DALWAT 115 (119)
T ss_dssp EECTTCCEEEECSCCC-CSSCEEEEECTTSCEEEEE----SEEEEC
T ss_pred EEeCCCcEEEcCCCCC-CCCCEEEEEECCCcEEEEC----ccEeCC
Confidence 9999999999998763 2345689999999999997 279998
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.83 E-value=2.7e-20 Score=164.18 Aligned_cols=110 Identities=22% Similarity=0.368 Sum_probs=92.7
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
.|+|.+||+|.+|++|+ +|.|+|+|+.+++ -++|. ..++||+|||+.|. .++.|+|+.||||+|+|.
T Consensus 2 ~dtl~~gq~L~~g~~L~--~g~~~L~~~~dgn------lvly~---~~~~vW~sn~~~~~--~~~~l~l~~~GnLvl~d~ 68 (115)
T 2dpf_A 2 DNVLLSGQTLHADHSLQ--AGAYTLTIQNKCN------LVKYQ---NGRQIWASNTDRRG--SGCRLTLLSDGNLVIYDH 68 (115)
T ss_dssp CCEEETTCEEETTEEEE--ETTEEEEECTTSC------EEEEE---TTEEEEECSCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEEE--CCCEEEEEcCCCc------EEEEe---CCEEEEeCCCCCCC--CceEEEECCCCcEEEECC
Confidence 47999999999999998 7999999987764 23465 37899999999884 357899999999999999
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcc
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD 150 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTD 150 (649)
++.++|+|++.. +....+|+|+|+|||||++. ++||||.+++.
T Consensus 69 ~~~~vW~S~~~~-~~g~~~l~l~~dGnlvl~~~----~~W~S~~~~~~ 111 (115)
T 2dpf_A 69 NNNDVWGSACWG-DNGKYALVLQKDGRFVIYGP----VLWSLGPNGCR 111 (115)
T ss_dssp TCCEEEECCCCC-SSSCCEEEECTTSCEEEECS----EEECSSTTCBC
T ss_pred CceEEEEcCCCC-CCCCEEEEEeCCCeEEEECC----CEEECCCCCCc
Confidence 899999998862 23456799999999999952 79999988754
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.82 E-value=2e-20 Score=202.85 Aligned_cols=151 Identities=17% Similarity=0.193 Sum_probs=115.4
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCC-CCccc---------eE--
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQH-RNLVR---------LL-- 543 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H-~niv~---------l~-- 543 (649)
..+|+..+.||+|+||.||+|+.. +|+.||||++.... ....+.|.+|+.++..++| +|... ..
T Consensus 77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEE
T ss_pred ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhh
Confidence 345777889999999999999965 78999999987332 2346889999999999987 32111 11
Q ss_pred ----------EEEEe-----CCeEEEEEecCCCCChhhhhcC----CCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCce
Q 006347 544 ----------GCCVE-----GEEKMLIYEYMPNRSLDALLFD----PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRI 604 (649)
Q Consensus 544 ----------g~~~~-----~~~~~lV~Ey~~~gsL~~~l~~----~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 604 (649)
.+... ....+++|+++ +++|.+++.. ......+++..++.|+.||++||+|||+.+ |
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i 232 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG---L 232 (413)
T ss_dssp EECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred cccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC---c
Confidence 11111 12346677765 7899988841 123456788999999999999999999988 9
Q ss_pred EecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 605 IHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 605 iHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
|||||||+|||++.++.+||+|||+|+..+
T Consensus 233 iHrDiKp~NILl~~~~~~kL~DFG~a~~~~ 262 (413)
T 3dzo_A 233 VHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262 (413)
T ss_dssp ECSCCCGGGEEECTTCCEEECCGGGCEETT
T ss_pred ccCCcccceEEEecCCeEEEEeccceeecC
Confidence 999999999999999999999999998764
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.81 E-value=8.5e-20 Score=160.23 Aligned_cols=110 Identities=19% Similarity=0.424 Sum_probs=92.4
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
+|+|.+||.|.+|++| ++|.|+|+|+.+++ -++|.+ .++||+||++.+ +.++.++|..+|||||+|
T Consensus 1 tdtl~~gq~L~~g~~L--~~~~~~L~~~~dgn------lvl~~~---~~~vW~sn~~~~--~~~~~l~l~~~GNLvl~d- 66 (112)
T 1xd5_A 1 SDRLNSGHQLDTGGSL--AEGGYLFIIQNDCN------LVLYDN---NRAVWASGTNGK--ASGCVLKMQNDGNLVIYS- 66 (112)
T ss_dssp CCEEETTEEECTTCEE--EETTEEEEECTTSC------EEEEET---TEEEEECCCTTS--CSSEEEEECTTSCEEEEE-
T ss_pred CCCCCCCCEECCCCEE--eCCCEEEEEcCCCc------EEEEEC---CEEEEeCCCcCC--CCCEEEEEeCCCCEEEEc-
Confidence 4899999999999999 57999999998876 356765 689999999764 345789999999999999
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCC
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEP 148 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~P 148 (649)
++.++|+|.+.. ..+...++|+++|||||++. .+.++||||++.
T Consensus 67 ~~~~~W~S~~~~-~~g~~~l~l~~dGnlvl~~~-~~~~~W~S~~~~ 110 (112)
T 1xd5_A 67 GSRAIWASNTNR-QNGNYYLILQRDRNVVIYDN-SNNAIWATHTNV 110 (112)
T ss_dssp TTEEEEECCCCC-SCCCCEEEECTTSCEEEECT-TSCEEEECCCCC
T ss_pred CCEEEEECCccC-CCCCEEEEEeCCCcEEEECC-CCceEEECCCcc
Confidence 789999998762 23356899999999999974 467899999985
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.79 E-value=1.6e-19 Score=182.88 Aligned_cols=139 Identities=17% Similarity=0.196 Sum_probs=108.0
Q ss_pred cccceeeccCCcEEEEEEEe-cCCcE--EEEEEecccccc------------------------cHHHHHHHHHHHhcCC
Q 006347 483 FQLSSKLGQGGFGPVYWGRL-KDGQE--IAVKRLSKASGQ------------------------GLEEFMNEVMVISKLQ 535 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~-~~g~~--vAVK~l~~~~~~------------------------~~~~f~~E~~~l~~l~ 535 (649)
|.+.+.||+|+||.||+|.. .+|+. ||||.++..... ....+.+|+..+.+++
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~ 128 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK 128 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence 56778999999999999998 67888 999987542111 1136889999999998
Q ss_pred CCCc--cceEEEEEeCCeEEEEEecCCC-C----ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCceEec
Q 006347 536 HRNL--VRLLGCCVEGEEKMLIYEYMPN-R----SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH-RDSRLRIIHR 607 (649)
Q Consensus 536 H~ni--v~l~g~~~~~~~~~lV~Ey~~~-g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~iiHr 607 (649)
|+++ +.++.+ +..+|||||+.+ | +|.++... .++.....++.|++.||.||| +.+ |+||
T Consensus 129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~------~~~~~~~~i~~qi~~~l~~lH~~~g---ivHr 195 (258)
T 1zth_A 129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE------LKELDVEGIFNDVVENVKRLYQEAE---LVHA 195 (258)
T ss_dssp HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG------GGGSCHHHHHHHHHHHHHHHHHTSC---EECS
T ss_pred hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc------cChHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence 8764 444432 356899999942 4 67666422 224456789999999999999 777 9999
Q ss_pred CCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 608 DLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 608 Dlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||||+|||+++ .+||+|||+|+.....
T Consensus 196 Dlkp~NILl~~--~~~liDFG~a~~~~~~ 222 (258)
T 1zth_A 196 DLSEYNIMYID--KVYFIDMGQAVTLRHP 222 (258)
T ss_dssp SCSTTSEEESS--SEEECCCTTCEETTST
T ss_pred CCCHHHEEEcC--cEEEEECcccccCCCc
Confidence 99999999998 9999999999987443
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.77 E-value=1.2e-18 Score=151.90 Aligned_cols=104 Identities=19% Similarity=0.376 Sum_probs=87.0
Q ss_pred ccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCC
Q 006347 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ 103 (649)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~ 103 (649)
++|.+||.|.+|++|+ +|.|+|+|+.+++ . +.|.. .++||++|++.+ +.++.|+|+.||||+|+|.+
T Consensus 2 ntL~~gq~L~~g~~L~--~g~~~L~~q~dGn---L---vly~~---~~~vW~snt~~~--~~~~~l~l~~dGNLvl~~~~ 68 (109)
T 3dzw_A 2 NILYSGETLSPGEFLN--NGRYVFIMQEDCN---L---VLYDV---DKPIWATNTGGL--DRRCHLSMQSDGNLVVYSPR 68 (109)
T ss_dssp CEEETTEEECTTCEEE--ETTEEEEECTTSC---E---EEEET---TEEEEECCCTTS--SSSCEEEECTTSCEEEECTT
T ss_pred CCcCCCCEeCCCCEEE--CCCEEEEEcCCCc---E---EEEeC---CEEEEECCcccC--CCCEEEEEeCCCCEEEECCC
Confidence 6899999999999997 6999999988775 2 34655 589999999876 34578999999999999999
Q ss_pred ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeec
Q 006347 104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145 (649)
Q Consensus 104 ~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSF 145 (649)
+.++|++++.. .....+|+|+|+|||||++. ++|||=
T Consensus 69 ~~~~W~S~t~~-~~~~~~~~L~ddGNlvly~~----~~W~s~ 105 (109)
T 3dzw_A 69 NNPIWASNTGG-ENGNYVCVLQKDRNVVIYGT----ARWATG 105 (109)
T ss_dssp SCEEEECCCCC-SSSCEEEEECTTSCEEEEES----CCCCCC
T ss_pred CCEEEECCCCC-CCCCEEEEEeCCCEEEEECC----CEEeCC
Confidence 99999999863 22346799999999999973 699983
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.69 E-value=5.5e-17 Score=141.46 Aligned_cols=104 Identities=17% Similarity=0.328 Sum_probs=84.3
Q ss_pred ccccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEc
Q 006347 22 IDSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVN 101 (649)
Q Consensus 22 ~~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~ 101 (649)
+.|+|.+||.|..|+.|+| |.|.|-|...++ | +.|.. ++||.+|++.. +.++.|+|+.||||+|+|
T Consensus 5 ~~dtL~~gq~L~~g~~L~s--g~~~L~~q~dGn-----L-vl~~~----~~vW~snt~~~--~~~~~l~l~~dGNLvl~d 70 (110)
T 3r0e_B 5 TNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----L-VLYGG----KYGWQSNTHGN--GEHCFLRLNHKGELIIKD 70 (110)
T ss_dssp BTTEEETTCEEETTEEEEC--SSCEEEECTTSC-----E-EEECS----SSCEECCCTTS--SSSCEEEECTTSCEEEEC
T ss_pred ccCEECCCCEecCCCEEEe--CCEEEEEcCCCe-----E-EEECC----eEEEECCCcCC--CcCEEEEEeCCCcEEEEe
Confidence 3689999999999999998 569997766554 2 33654 48999999863 345789999999999999
Q ss_pred CCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeee
Q 006347 102 GQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144 (649)
Q Consensus 102 ~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqS 144 (649)
.++.++|++++.. .....+|+|+|+|||||++ .++|+|
T Consensus 71 ~~~~~iW~S~t~~-~~~~~~~~L~~dGNlvly~----~~~W~t 108 (110)
T 3r0e_B 71 DDFKTIWSSRSSS-KQGEYVLILQDDGFGVIYG----PAIFET 108 (110)
T ss_dssp TTCCEEEECCCCC-SSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCCEEEEcCCcC-CCCCEEEEEcCCccEEEec----CCEecC
Confidence 9999999999863 2334689999999999996 379997
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A | Back alignment and structure |
|---|
Probab=99.69 E-value=9.6e-17 Score=140.70 Aligned_cols=97 Identities=20% Similarity=0.432 Sum_probs=78.9
Q ss_pred CCCCCCcceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCccc
Q 006347 80 NPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHG 159 (649)
Q Consensus 80 ~pv~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~ 159 (649)
.|+.+...+|.|+.||+|+|++. ++++|++++.. ......|+|+|+|||||++ ++.++||||+
T Consensus 14 ~~L~~~~~~L~~~~dgnlvl~~~-~~~vW~sn~~~-~~~~~~l~l~~~GNLvl~d--~~~~~W~S~~------------- 76 (112)
T 1xd5_A 14 GSLAEGGYLFIIQNDCNLVLYDN-NRAVWASGTNG-KASGCVLKMQNDGNLVIYS--GSRAIWASNT------------- 76 (112)
T ss_dssp CEEEETTEEEEECTTSCEEEEET-TEEEEECCCTT-SCSSEEEEECTTSCEEEEE--TTEEEEECCC-------------
T ss_pred CEEeCCCEEEEEcCCCcEEEEEC-CEEEEeCCCcC-CCCCEEEEEeCCCCEEEEc--CCEEEEECCc-------------
Confidence 34444567899999999999988 89999999863 2235689999999999998 4679999994
Q ss_pred ccccCCceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEc-CCeeeeecCCCCC
Q 006347 160 IDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWN-VSRPYWRSGPWNG 213 (649)
Q Consensus 160 ~~~~~g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~-~~~~yw~sg~~~~ 213 (649)
+|++|.|++.++++|+ ++++. .+.+||+|++|+|
T Consensus 77 ------------------~~~~g~~~l~l~~dGn--lvl~~~~~~~~W~S~~~~g 111 (112)
T 1xd5_A 77 ------------------NRQNGNYYLILQRDRN--VVIYDNSNNAIWATHTNVG 111 (112)
T ss_dssp ------------------CCSCCCCEEEECTTSC--EEEECTTSCEEEECCCCCC
T ss_pred ------------------cCCCCCEEEEEeCCCc--EEEECCCCceEEECCCccC
Confidence 4457889999999998 55555 5689999999986
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.67 E-value=3.7e-16 Score=136.99 Aligned_cols=106 Identities=15% Similarity=0.298 Sum_probs=86.7
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
.++|.+||.|..|+.|.+ |.|.|-|...++ |.+ |.. ...++||.+|+..+. .++.|+|+.||||||+|.
T Consensus 6 ~~tL~~gq~L~~g~~L~~--g~~~L~~q~dGN-----LvL-~~~-~~~~~vWssnt~~~~--~~~~l~l~~dGNLVl~d~ 74 (113)
T 3mez_B 6 RNVLFSSQVMYDNAQLAT--RDYSLVMRDDCN-----LVL-TKG-SKTNIVWESGTSGRG--QHCFMRLGHSGELDITDD 74 (113)
T ss_dssp SSEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEE-EET-TTTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCEeCCCCEECCCCEeEc--CCEEEEEcCCCE-----EEE-EEC-CCCEEEEECCcccCC--cCEEEEEeCCCcEEEECC
Confidence 689999999999999985 889999987765 333 433 136899999998763 357899999999999999
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeee
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqS 144 (649)
++.++|++++.. .....+|+|+|+|||||++ .+||+|
T Consensus 75 ~~~~iW~S~t~~-~~~~~~~~L~~dGnlvly~----~~~W~s 111 (113)
T 3mez_B 75 RLNTVFVSNTVG-QEGDYVLILQINGQAVVYG----PAVWST 111 (113)
T ss_dssp TSCEEEECSCCC-SSSCCEEEECTTSCEEEEC----SEEEES
T ss_pred CCCEEEECCCcC-CCCCEEEEEcCCceEEEec----CCEecC
Confidence 999999999863 2234689999999999996 479997
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* | Back alignment and structure |
|---|
Probab=99.66 E-value=1.7e-16 Score=138.46 Aligned_cols=89 Identities=21% Similarity=0.450 Sum_probs=73.6
Q ss_pred CcceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccC
Q 006347 85 SSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRT 164 (649)
Q Consensus 85 ~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~ 164 (649)
...+|.|+.||||+|++ .+++||++++... .....|+|+|+|||||++. ++.++||||.
T Consensus 20 ~~~~l~~~~dGnlvl~~-~~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~~~-~~~~~W~S~t------------------ 78 (110)
T 3a0c_A 20 PSYRLIMQGDCNFVLYD-SGKPVWASNTGGL-GSGCRLTLHNNGNLVIYDQ-SNRVIWQTKT------------------ 78 (110)
T ss_dssp TTEEEEECTTSCEEEEE-TTEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECCC------------------
T ss_pred CCEEEEEcCCCcEEEEE-CCEEEEECCCCCC-CCcEEEEEeCCCCEEEECC-CCcEEEecCC------------------
Confidence 45789999999999999 4899999998632 3356899999999999985 5679999992
Q ss_pred CceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCC
Q 006347 165 GKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPW 211 (649)
Q Consensus 165 g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~ 211 (649)
++++|.|+++++++|+ ++++++ +||+|+++
T Consensus 79 -------------~~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~ 108 (110)
T 3a0c_A 79 -------------NGKEDHYVLVLQQDRN--VVIYGP--VVWATGSG 108 (110)
T ss_dssp -------------CCSSSCCEEEECTTSC--EEEECS--EEEECSCC
T ss_pred -------------CCCCCCEEEEEeCCcc--EEEECC--CEecCCCc
Confidence 4567899999999998 556665 89999875
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.65 E-value=4.6e-16 Score=135.38 Aligned_cols=107 Identities=22% Similarity=0.428 Sum_probs=86.9
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
.|+|.+||.|..|+.| .+|.|.|.|...++ -+.|.. +|.+|+..+ +.++.|+|+.||||+|+|.
T Consensus 3 ~dtL~~gq~L~~g~~L--~~g~~~L~~q~dGN------Lvl~~~------~Wssnt~~~--~~~~~l~l~~dGnLvl~d~ 66 (109)
T 3r0e_A 3 TNYLLSGQTLDTEGHL--KNGDFDLVMQDDCN------LVLYNG------NWQSNTANN--GRDCKLTLTDYGELVIKNG 66 (109)
T ss_dssp CSEEETTCEECTTCEE--EETTEEEEECTTSC------EEEETT------TEECCCTTS--CSSCEEEECTTSCEEEECT
T ss_pred cCCcCCCCCcCCCCEe--ECCCEEEEEecCCe------EEEEeC------eEEcCCCCC--CCcEEEEEcCCCeEEEEeC
Confidence 6899999999999999 46999999987765 244542 699998865 2357899999999999999
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCC
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPG 155 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg 155 (649)
++.++|++++.. .....+|+|+|+|||||++ .++|+| .|.+||
T Consensus 67 ~~~~vWss~t~~-~~~~~~~~L~~dGNlvly~----~~~W~s-----~t~~~~ 109 (109)
T 3r0e_A 67 DGSTVWKSGAQS-VKGNYAAVVHPDGRLVVFG----PSVFKI-----DPWVRG 109 (109)
T ss_dssp TSCEEEECCCCC-SSSCCEEEEETTTEEEEEC----SEEEEE-----CTTSCC
T ss_pred CCCEEEcCCCcC-CCcCEEEEEcCCCeEEEEe----cCEECC-----CCccCC
Confidence 999999998863 2335689999999999996 479998 555554
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.64 E-value=8.5e-17 Score=170.32 Aligned_cols=138 Identities=14% Similarity=0.173 Sum_probs=100.1
Q ss_pred CcccceeeccCCcEEEEEEEecCCcEEEEEEeccccc--------------ccHHH--------HHHHHHHHhcCCCCCc
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG--------------QGLEE--------FMNEVMVISKLQHRNL 539 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~--------------~~~~~--------f~~E~~~l~~l~H~ni 539 (649)
-|++.+.||+|+||.||+|...+|+.||||.++.... ..... ..+|...|.++++.++
T Consensus 96 iY~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv 175 (397)
T 4gyi_A 96 VYSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGF 175 (397)
T ss_dssp CSEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred EEEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCC
Confidence 3888999999999999999999999999998753210 00111 2345666666654443
Q ss_pred cceEEEEEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC
Q 006347 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE 619 (649)
Q Consensus 540 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~ 619 (649)
.-...+.. ...+|||||+++++|..+... .....++.|++.+|.|||+.+ ||||||||.|||++++
T Consensus 176 ~vp~p~~~--~~~~LVME~i~G~~L~~l~~~---------~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~d 241 (397)
T 4gyi_A 176 PVPEPIAQ--SRHTIVMSLVDALPMRQVSSV---------PDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREE 241 (397)
T ss_dssp SCCCEEEE--ETTEEEEECCSCEEGGGCCCC---------SCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEE
T ss_pred CCCeeeec--cCceEEEEecCCccHhhhccc---------HHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCC
Confidence 22222222 233799999999888665411 123457899999999999987 9999999999999887
Q ss_pred C----------ceEEEecCCceee
Q 006347 620 L----------NPKISDFGMAKIF 633 (649)
Q Consensus 620 ~----------~~Ki~DFGla~~~ 633 (649)
+ .+.|+||+=+...
T Consensus 242 gd~~d~~~~~~~~~iID~~Q~V~~ 265 (397)
T 4gyi_A 242 KDAEDPSSITLTPIIIXFPQMVSM 265 (397)
T ss_dssp ECSSCTTSEEEEEEECCCTTCEET
T ss_pred CCcccccccccceEEEEeCCcccC
Confidence 6 3899999987754
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 | Back alignment and structure |
|---|
Probab=99.61 E-value=2.6e-15 Score=132.70 Aligned_cols=87 Identities=24% Similarity=0.429 Sum_probs=72.0
Q ss_pred cceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCC
Q 006347 86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG 165 (649)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g 165 (649)
..+|.|+.||+|+|++. +++||++++... .....|+|+|+|||||+|. ++.++||||
T Consensus 31 ~~~L~~~~dgnlvly~~-~~~vW~sn~~~~-~~~~~l~l~~dGNLVl~d~-~~~~lW~S~-------------------- 87 (119)
T 1b2p_A 31 VYRFIMQTDCNLVLYDN-NNPIWATNTGGL-GNGCRAVLQPDGVLVVITN-ENVTVWQSP-------------------- 87 (119)
T ss_dssp EEEEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECS--------------------
T ss_pred CEEEEEecCCCEEEEEC-CEEEEeCCCccC-CCceEEEEccCCEEEEEeC-CCcEEEcCC--------------------
Confidence 35799999999999998 899999998632 3357899999999999985 567999999
Q ss_pred ceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 166 ~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
.+|++|.|+++++++|+ +++++ .+||+||+
T Consensus 88 -----------~~~~~g~~~l~l~~~Gn--lvl~~--~~~W~Sg~ 117 (119)
T 1b2p_A 88 -----------VAGKAGHYVLVLQPDRN--VVIYG--DALWATQT 117 (119)
T ss_dssp -----------CCCCSSCEEEEECTTSC--EEEEE--SEEEECCC
T ss_pred -----------CCCCCCCEEEEEECCCc--EEEEC--ccEeCCCC
Confidence 34578899999999998 55555 38999986
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* | Back alignment and structure |
|---|
Probab=99.60 E-value=3.6e-15 Score=131.24 Aligned_cols=91 Identities=26% Similarity=0.425 Sum_probs=74.9
Q ss_pred cceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCC
Q 006347 86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG 165 (649)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g 165 (649)
..+|.|+.||||+|++ .++++|++++... .....++|+++|||||+|. ++.++|||||+
T Consensus 21 ~~~L~~~~dgnlvly~-~~~~vW~sn~~~~-~~~~~l~l~~~GnLvl~d~-~~~~vW~S~~~------------------ 79 (115)
T 2dpf_A 21 AYTLTIQNKCNLVKYQ-NGRQIWASNTDRR-GSGCRLTLLSDGNLVIYDH-NNNDVWGSACW------------------ 79 (115)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECSCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECCCC------------------
T ss_pred CEEEEEcCCCcEEEEe-CCEEEEeCCCCCC-CCceEEEECCCCcEEEECC-CceEEEEcCCC------------------
Confidence 4679999999999998 5889999998632 2356899999999999985 46799999997
Q ss_pred ceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCCCCc
Q 006347 166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNGQ 214 (649)
Q Consensus 166 ~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~~~~ 214 (649)
+++|.|++.++++|+ +++++. +||+|++|...
T Consensus 80 -------------~~~g~~~l~l~~dGn--lvl~~~--~~W~S~~~~~~ 111 (115)
T 2dpf_A 80 -------------GDNGKYALVLQKDGR--FVIYGP--VLWSLGPNGCR 111 (115)
T ss_dssp -------------CSSSCCEEEECTTSC--EEEECS--EEECSSTTCBC
T ss_pred -------------CCCCCEEEEEeCCCe--EEEECC--CEEECCCCCCc
Confidence 346789999999997 556654 89999999643
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.54 E-value=1.8e-14 Score=125.69 Aligned_cols=104 Identities=11% Similarity=0.210 Sum_probs=82.7
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
.++|.+||.|..|+.|. +|.|.|.|...++ -+.|.. .. ||.+|+..+. ..+.|+|..||||||+|.
T Consensus 2 ~~~l~~gq~L~~g~~L~--~g~~~L~~q~dGn------Lvl~~~---~~-vW~snt~~~~--~~~~l~l~~dGNLVl~~~ 67 (111)
T 3mez_A 2 NNVLLTGDVIHTDNQLS--YESAAFVMQGDCN------LVLYNE---AG-GFQSNTHGRG--VDCTLRLNNRGQLEIHSA 67 (111)
T ss_dssp TTEEETTCEECTTCEEE--ETTEEEEECTTSC------EEEECS---SC-CEECCCTTSC--SSCEEEECTTSCEEEECS
T ss_pred cCEeCCCCEeCCCCEEe--cCCEEEEEccCCe------EEEECC---CC-EEECCcccCC--cCEEEEEcCCCcEEEEeC
Confidence 37899999999999994 6899999987765 234543 23 9999998763 357899999999999999
Q ss_pred Cce-EEEEecCcc-cccccccceeecccCeEEeeCCCCceEeee
Q 006347 103 QKE-VLWSSNVSN-LVNNSTSAQLLDSGNLVLRDNINRAIVWES 144 (649)
Q Consensus 103 ~~~-~~Wss~~~~-~~~~~~~a~LldsGNlVl~~~~~~~~~WqS 144 (649)
++. ++|+|++.. ......+|.|+|+|||||++ .++|+|
T Consensus 68 ~~~~~vW~S~t~~~~~~~~~~l~Lq~dGNlvly~----~~~W~s 107 (111)
T 3mez_A 68 NSNTPVWVYPRSVNTVRGNYAATLGPDQHVTIYG----PAIWST 107 (111)
T ss_dssp SCSSCSEEESSSCCCCSSCCEEEECTTSCEEEEC----SEEEEC
T ss_pred CCCEEEEEeccccCCCCcCEEEEECCCCeEEEec----cCEEcc
Confidence 876 599998642 22335689999999999996 479997
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.38 E-value=1.9e-12 Score=113.25 Aligned_cols=96 Identities=21% Similarity=0.346 Sum_probs=72.9
Q ss_pred CCCCCCCCcceEEEeeCCcEEEEcC-CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCC
Q 006347 78 RDNPLKDSSGIITISEDGNLVLVNG-QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGM 156 (649)
Q Consensus 78 r~~pv~~~~~~l~~~~~G~L~l~~~-~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~ 156 (649)
.+.|+.+...+|.++.||||+|++. .+.++|++++... .....|+|+|+|||||++. ++.++|||=.+
T Consensus 17 ~g~~L~~g~~~L~~q~dGNLvL~~~~~~~~vWssnt~~~-~~~~~l~l~~dGNLVl~d~-~~~~iW~S~t~--------- 85 (113)
T 3mez_B 17 DNAQLATRDYSLVMRDDCNLVLTKGSKTNIVWESGTSGR-GQHCFMRLGHSGELDITDD-RLNTVFVSNTV--------- 85 (113)
T ss_dssp TTCEEEETTEEEEECTTSCEEEEETTTTEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TSCEEEECSCC---------
T ss_pred CCCEeEcCCEEEEEcCCCEEEEEECCCCEEEEECCcccC-CcCEEEEEeCCCcEEEECC-CCCEEEECCCc---------
Confidence 4556665668899999999999998 5899999998632 2356899999999999985 46789998221
Q ss_pred cccccccCCceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 157 HHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 157 ~l~~~~~~g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
...|.|.+.++.+|+..+ +. .+.|.||+
T Consensus 86 ----------------------~~~~~~~~~L~~dGnlvl--y~--~~~W~s~~ 113 (113)
T 3mez_B 86 ----------------------GQEGDYVLILQINGQAVV--YG--PAVWSTAA 113 (113)
T ss_dssp ----------------------CSSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred ----------------------CCCCCEEEEEcCCceEEE--ec--CCEecCCC
Confidence 013458889999998544 44 58899875
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.37 E-value=3.8e-12 Score=128.47 Aligned_cols=147 Identities=14% Similarity=0.045 Sum_probs=116.9
Q ss_pred HHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEE
Q 006347 477 ATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 477 ~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV 555 (649)
......|+....++.|+.+.||+.... ++.+++|+...........+.+|+.+++.+. |..+.++++++.+.+..++|
T Consensus 10 ~~~l~~~~~~~~~~g~s~~~v~~~~~~-~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv 88 (263)
T 3tm0_A 10 KKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp HHHHTTSEEEECCSCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred HHHhccceeEeeccCCCCCeEEEEECC-CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEE
Confidence 344467877788888888999999865 6899999986432233456889999999884 77889999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC------------------------------------
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD------------------------------------ 599 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------ 599 (649)
|||++|.+|.+.+.. ......++.+++++|+.||+.
T Consensus 89 ~e~i~G~~l~~~~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (263)
T 3tm0_A 89 MSEADGVLCSEEYED--------EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEE 160 (263)
T ss_dssp EECCSSEEHHHHCCT--------TTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGST
T ss_pred EEecCCeehhhccCC--------cccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccc
Confidence 999999999876421 112346888999999999981
Q ss_pred --------------------CCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 600 --------------------SRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 600 --------------------~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
....++|+|++|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 161 DTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp TCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 114599999999999998876678999999875
|
| >3mez_A Mannose-specific lectin 3 chain 1; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} SCOP: b.78.1.0 | Back alignment and structure |
|---|
Probab=99.34 E-value=3.5e-12 Score=111.16 Aligned_cols=96 Identities=23% Similarity=0.324 Sum_probs=71.3
Q ss_pred CCCCCCCcceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcc
Q 006347 79 DNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHH 158 (649)
Q Consensus 79 ~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l 158 (649)
+.++.+...+|.++.||||||++.++ +|++++... .....|+|+|+|||||++.+...++|||..+
T Consensus 14 g~~L~~g~~~L~~q~dGnLvl~~~~~--vW~snt~~~-~~~~~l~l~~dGNLVl~~~~~~~~vW~S~t~----------- 79 (111)
T 3mez_A 14 DNQLSYESAAFVMQGDCNLVLYNEAG--GFQSNTHGR-GVDCTLRLNNRGQLEIHSANSNTPVWVYPRS----------- 79 (111)
T ss_dssp TCEEEETTEEEEECTTSCEEEECSSC--CEECCCTTS-CSSCEEEECTTSCEEEECSSCSSCSEEESSS-----------
T ss_pred CCEEecCCEEEEEccCCeEEEECCCC--EEECCcccC-CcCEEEEEcCCCcEEEEeCCCCEEEEEeccc-----------
Confidence 33444445789999999999999876 999998632 2346899999999999985333469999621
Q ss_pred cccccCCceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 159 GIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 159 ~~~~~~g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
.....|.|.+.++.+|+..+ +. .++|.+++
T Consensus 80 ------------------~~~~~~~~~l~Lq~dGNlvl--y~--~~~W~s~t 109 (111)
T 3mez_A 80 ------------------VNTVRGNYAATLGPDQHVTI--YG--PAIWSTPA 109 (111)
T ss_dssp ------------------CCCCSSCCEEEECTTSCEEE--EC--SEEEECCC
T ss_pred ------------------cCCCCcCEEEEECCCCeEEE--ec--cCEEccCC
Confidence 11135688999999998554 44 68999875
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* | Back alignment and structure |
|---|
Probab=99.25 E-value=1.2e-11 Score=125.46 Aligned_cols=111 Identities=19% Similarity=0.317 Sum_probs=85.2
Q ss_pred cccccCCCC----cCCCCeEEeCCCeeeEeeeCCC--CCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCc
Q 006347 23 DSSITSSQL----IRDPDAILSNGSNFKLGFFNPA--DSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGN 96 (649)
Q Consensus 23 ~~~l~~g~~----l~~~~~l~S~~g~F~lGF~~~~--~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~ 96 (649)
.|++.||+. |..|+.|.|+ ..++.|+|... .....+ + |.+ ..+++|.+++..+- . ..+.++.+|+
T Consensus 136 tdtlLpg~~~~~~l~~g~~L~S~-~dps~G~fsl~l~~dGnlv--L-y~~--~~~~yW~Sgt~~~~--~-~~l~l~~dGn 206 (276)
T 3m7h_A 136 AIPLVPGAIDSLLLAPGSELVQG-VVYGAGASKLVFQGDGNLV--A-YGP--NGAATWNAGTQGKG--A-VRAVFQGDGN 206 (276)
T ss_dssp TSCCCCSCTTCEEECSSEEECTT-CEEEETTEEEEECTTSCEE--E-ECT--TSSEEEECCCTTTT--C-CEEEECTTSC
T ss_pred ccccccccccccccccCcccccC-CCCCCceEEEeecCCceEE--E-EeC--CCeEEEECCCCCCc--c-EEEEEcCCCe
Confidence 799999999 8888888654 56666665531 122333 3 432 25899999998763 2 6899999999
Q ss_pred EEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCC
Q 006347 97 LVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE 147 (649)
Q Consensus 97 L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~ 147 (649)
|+++|.++.++|++++.. ....+|+|+++|||||++. .++||||||
T Consensus 207 Lvl~d~~~~~vWsS~t~~--~~~~rl~Ld~dGnLvly~~---~~~Wqsf~~ 252 (276)
T 3m7h_A 207 LVVYGAGNAVLWHSHTGG--HASAVLRLQANGSIAILDE---KPVWARFGF 252 (276)
T ss_dssp EEEECTTSCEEEECSCTT--CTTCEEEECTTSCEEEEEE---EEEEESSSC
T ss_pred EEEEeCCCcEEEEecCCC--CCCEEEEEcCCccEEEEcC---CCeEEccCc
Confidence 999999889999998763 2357899999999999973 579999997
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.19 E-value=2.5e-11 Score=121.67 Aligned_cols=138 Identities=17% Similarity=0.159 Sum_probs=104.2
Q ss_pred cCcccceeec-cCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCC--ccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLG-QGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG-~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~g~~~~~~~~~lV~E 557 (649)
.++.+ +.++ .|..+.||+....+|..+++|..... ....+..|+.+++.+.+.+ +.+++++..+++..++|||
T Consensus 20 ~~~~~-~~~~~gg~~~~v~~~~~~~g~~~vlK~~~~~---~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e 95 (264)
T 1nd4_A 20 FGYDW-AQQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLG 95 (264)
T ss_dssp TTCEE-EECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEE
T ss_pred CCCce-EecccCCCCceEEEEecCCCCeEEEEeCCcc---cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEE
Confidence 34444 3454 55569999998877888999987543 3356788999999885434 5678998888888999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS------------------------------------- 600 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 600 (649)
|+++.+|. ... .+ ...++.++++.|..||+..
T Consensus 96 ~i~G~~l~--~~~------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 164 (264)
T 1nd4_A 96 EVPGQDLL--SSH------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG 164 (264)
T ss_dssp CCSSEETT--TSC------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT
T ss_pred ecCCcccC--cCc------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccC
Confidence 99998884 211 12 2357788888888888643
Q ss_pred ------------------CCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 601 ------------------RLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 601 ------------------~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+..++|+|++|.|||++++..++|+||+.|..-
T Consensus 165 ~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g 215 (264)
T 1nd4_A 165 LAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA 215 (264)
T ss_dssp CCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred ccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence 123999999999999998877789999998864
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} SCOP: b.78.1.1 PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* | Back alignment and structure |
|---|
Probab=99.18 E-value=8.1e-11 Score=102.19 Aligned_cols=87 Identities=23% Similarity=0.449 Sum_probs=66.5
Q ss_pred cceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCC
Q 006347 86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG 165 (649)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g 165 (649)
..+|.|+.||||+|++. +.++|++++... .....++|+|+|||||++. ++.++|||....
T Consensus 20 ~~~L~~q~dGnLvly~~-~~~vW~snt~~~-~~~~~l~l~~dGNLvl~~~-~~~~~W~S~t~~----------------- 79 (109)
T 3dzw_A 20 RYVFIMQEDCNLVLYDV-DKPIWATNTGGL-DRRCHLSMQSDGNLVVYSP-RNNPIWASNTGG----------------- 79 (109)
T ss_dssp TEEEEECTTSCEEEEET-TEEEEECCCTTS-SSSCEEEECTTSCEEEECT-TSCEEEECCCCC-----------------
T ss_pred CEEEEEcCCCcEEEEeC-CEEEEECCcccC-CCCEEEEEeCCCCEEEECC-CCCEEEECCCCC-----------------
Confidence 46899999999999988 789999998632 2346899999999999985 457899984311
Q ss_pred ceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 166 ~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
..+.|.+.++.+|+..+ +.. +.|.|++
T Consensus 80 --------------~~~~~~~~L~ddGNlvl--y~~--~~W~s~t 106 (109)
T 3dzw_A 80 --------------ENGNYVCVLQKDRNVVI--YGT--ARWATGT 106 (109)
T ss_dssp --------------SSSCEEEEECTTSCEEE--EES--CCCCCCC
T ss_pred --------------CCCCEEEEEeCCCEEEE--ECC--CEEeCCC
Confidence 12457888999998554 443 7788775
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.15 E-value=9.5e-11 Score=101.83 Aligned_cols=86 Identities=21% Similarity=0.394 Sum_probs=65.1
Q ss_pred cceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCC
Q 006347 86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG 165 (649)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g 165 (649)
...|.++.||||+|++. .++|++++... .....++|+|+|||||++. ++.++|||-.+-
T Consensus 25 ~~~L~~q~dGnLvl~~~--~~vW~snt~~~-~~~~~l~l~~dGNLvl~d~-~~~~iW~S~t~~----------------- 83 (110)
T 3r0e_B 25 NHQLVMQGDCNLVLYGG--KYGWQSNTHGN-GEHCFLRLNHKGELIIKDD-DFKTIWSSRSSS----------------- 83 (110)
T ss_dssp SCEEEECTTSCEEEECS--SSCEECCCTTS-SSSCEEEECTTSCEEEECT-TCCEEEECCCCC-----------------
T ss_pred CEEEEEcCCCeEEEECC--eEEEECCCcCC-CcCEEEEEeCCCcEEEEeC-CCCEEEEcCCcC-----------------
Confidence 46899999999999987 58999998632 2346899999999999985 467899984210
Q ss_pred ceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 166 ~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
..|.|.+.++.+|+..+ +. .+.|.+|+
T Consensus 84 --------------~~~~~~~~L~~dGNlvl--y~--~~~W~t~~ 110 (110)
T 3r0e_B 84 --------------KQGEYVLILQDDGFGVI--YG--PAIFETSS 110 (110)
T ss_dssp --------------SSSCCEEEECTTSCEEE--EC--SEEEESCC
T ss_pred --------------CCCCEEEEEcCCccEEE--ec--CCEecCCC
Confidence 13458888999998544 44 37898864
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} | Back alignment and structure |
|---|
Probab=99.13 E-value=1.5e-10 Score=100.31 Aligned_cols=93 Identities=27% Similarity=0.511 Sum_probs=69.3
Q ss_pred CCCCCCCCcceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCc
Q 006347 78 RDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMH 157 (649)
Q Consensus 78 r~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~ 157 (649)
.+.|+.+....|.++.||||||+++ +|++++... .....++|+++|||||+|. ++.++|+|-.+
T Consensus 14 ~g~~L~~g~~~L~~q~dGNLvl~~~----~Wssnt~~~-~~~~~l~l~~dGnLvl~d~-~~~~vWss~t~---------- 77 (109)
T 3r0e_A 14 TEGHLKNGDFDLVMQDDCNLVLYNG----NWQSNTANN-GRDCKLTLTDYGELVIKNG-DGSTVWKSGAQ---------- 77 (109)
T ss_dssp TTCEEEETTEEEEECTTSCEEEETT----TEECCCTTS-CSSCEEEECTTSCEEEECT-TSCEEEECCCC----------
T ss_pred CCCEeECCCEEEEEecCCeEEEEeC----eEEcCCCCC-CCcEEEEEcCCCeEEEEeC-CCCEEEcCCCc----------
Confidence 3445554567899999999999985 799998732 2356899999999999985 45789976210
Q ss_pred ccccccCCceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCC
Q 006347 158 HGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPW 211 (649)
Q Consensus 158 l~~~~~~g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~ 211 (649)
...+.|.+.++.+|+..+ +. .+.|.+++|
T Consensus 78 ---------------------~~~~~~~~~L~~dGNlvl--y~--~~~W~s~t~ 106 (109)
T 3r0e_A 78 ---------------------SVKGNYAAVVHPDGRLVV--FG--PSVFKIDPW 106 (109)
T ss_dssp ---------------------CSSSCCEEEEETTTEEEE--EC--SEEEEECTT
T ss_pred ---------------------CCCcCEEEEEcCCCeEEE--Ee--cCEECCCCc
Confidence 023567899999997544 44 589999987
|
| >4h3o_A Lectin; cadmium, plant protein; 2.17A {Allium sativum} PDB: 1kj1_A* 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* | Back alignment and structure |
|---|
Probab=99.04 E-value=9.8e-10 Score=94.49 Aligned_cols=78 Identities=26% Similarity=0.356 Sum_probs=60.7
Q ss_pred ceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCc
Q 006347 87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK 166 (649)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~ 166 (649)
-+|.++.||||+|++. +++||++++......+..++|.++|||||+|. +++++|+|-.
T Consensus 21 y~l~~q~DgNLvly~~-~~~vW~ant~~~~~~~~~L~l~~dGnLvL~d~-~~~~vWss~t-------------------- 78 (105)
T 4h3o_A 21 YHFIMQDDCNLVLYDH-STSTWASNTEIGGKSGCSAVLQSDGNFVVYDS-SGRSLWASHS-------------------- 78 (105)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCSCEEEECTTSCEEEECT-TCCEEEECCC--------------------
T ss_pred EEEEECCCCeEEEEEC-CEEEEEecCCCCCCccEEEEEeCCccEEEECC-CcEEEEEecC--------------------
Confidence 5799999999999986 68999999874444456899999999999985 5678998721
Q ss_pred eeEEEEcccCCCCCCceeEEeeeCCCccEEE
Q 006347 167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIF 197 (649)
Q Consensus 167 ~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~ 197 (649)
....+.|.+.++.+|+..++
T Consensus 79 -----------~~~~~~~~l~L~ddGNlVly 98 (105)
T 4h3o_A 79 -----------TRGSGNYILILQDDGNVIIY 98 (105)
T ss_dssp -----------CCCSSCEEEEECTTSCEEEE
T ss_pred -----------CCCCCCEEEEEeCCCeEEEE
Confidence 11345688899999985543
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.04 E-value=9.3e-10 Score=116.33 Aligned_cols=141 Identities=15% Similarity=0.229 Sum_probs=108.2
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEec--ccc-cccHHHHHHHHHHHhcCC--CCCccceEEEEEeC---CeEEEEEe
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLS--KAS-GQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEG---EEKMLIYE 557 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~--~~~-~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~---~~~~lV~E 557 (649)
.+.|+.|.++.||+....+ ..+++|+.. ... ......+.+|+.++..+. +..++++++++.+. +..++|||
T Consensus 43 ~~~l~~G~sn~~y~v~~~~-~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme 121 (359)
T 3dxp_A 43 VEQFKGGQSNPTFKLVTPG-QTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME 121 (359)
T ss_dssp EEECCC-CCSCEEEEECSS-CEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred EEEcCCcccceEEEEEECC-ceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence 4689999999999998764 678888765 221 123457888999999986 56688999998776 34799999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS------------------------------------- 600 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------- 600 (649)
|+++..+.+.. ...++..++..++.++++.|+.||...
T Consensus 122 ~v~G~~l~~~~-----~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (359)
T 3dxp_A 122 FVSGRVLWDQS-----LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPA 196 (359)
T ss_dssp CCCCBCCCCTT-----CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHH
T ss_pred ecCCeecCCCc-----cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChH
Confidence 99998874322 124678888999999999999999731
Q ss_pred ------------------CCceEecCCCCCcEEEcCCCc--eEEEecCCcee
Q 006347 601 ------------------RLRIIHRDLKASNILLDEELN--PKISDFGMAKI 632 (649)
Q Consensus 601 ------------------~~~iiHrDlkp~NILl~~~~~--~Ki~DFGla~~ 632 (649)
...++|+|++|.|||++++.. ++|+||++|..
T Consensus 197 ~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 197 MDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred HHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 356999999999999997753 69999999986
|
| >1dlp_A Lectin scafet precursor; two-domain lectin, beta prism II fold, native, sugar binding protein; 3.30A {Hyacinthoides hispanica} SCOP: b.78.1.1 b.78.1.1 | Back alignment and structure |
|---|
Probab=98.90 E-value=4.8e-09 Score=104.18 Aligned_cols=89 Identities=29% Similarity=0.409 Sum_probs=69.3
Q ss_pred cceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCC
Q 006347 86 SGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTG 165 (649)
Q Consensus 86 ~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g 165 (649)
.-+|.|..||+|+|++. +++||.+|+.+ . ....++|+++|||||+|. ++++||+|+++
T Consensus 27 ~f~l~f~~~gnl~ly~~-~~~vW~an~~~-~-~~~~l~l~~dGnLvl~d~-~~~~vW~s~~~------------------ 84 (236)
T 1dlp_A 27 SFRFTMQSDCNLVLFDS-DVRVWASNTAG-A-TGCRAVLQSDGLLVILTA-QNTIRWSSGTK------------------ 84 (236)
T ss_dssp TEEEEECTTSCEEEEES-SSEEECCCCCS-C-SCCBCCBCSSSCBCCBCT-TTCCSCCCCCC------------------
T ss_pred CEEEEECCCCcEEEEEC-CEEEEECCCCC-C-CCeEEEEcCCCcEEEEcC-CCcEEEeCCcc------------------
Confidence 35688889999999987 78999999863 2 567899999999999985 56789999864
Q ss_pred ceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCCCC
Q 006347 166 KKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPWNG 213 (649)
Q Consensus 166 ~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~~~ 213 (649)
.++|.|.+.++.+|+..+ +.. .||.|..+..
T Consensus 85 -------------~~~~~~~~~l~d~Gnlvl--~~~--~~W~S~~~p~ 115 (236)
T 1dlp_A 85 -------------GSIGNYVLVLQPDRTVTI--YGP--GLWDSGTSNK 115 (236)
T ss_dssp -------------CCSSCCEEEECSSSCEEE--ECS--EEEECSCCCS
T ss_pred -------------ccCCcEEEEEeCCCCEEE--ecC--CEEECCCCCC
Confidence 124567888999988554 332 8999987653
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.56 E-value=1.3e-07 Score=97.32 Aligned_cols=136 Identities=21% Similarity=0.249 Sum_probs=101.1
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCC--ccceEEEEEeCC---eEEEEEecCC
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRN--LVRLLGCCVEGE---EKMLIYEYMP 560 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~n--iv~l~g~~~~~~---~~~lV~Ey~~ 560 (649)
+.++.|....||+.. ..+++|..... .....+.+|.+++..+ .+.. +.++++.....+ ..++|||+++
T Consensus 26 ~~~~~G~~n~v~~v~----~~~vlR~~~~~--~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~ 99 (304)
T 3sg8_A 26 EISGEGNDCIAYEIN----RDFIFKFPKHS--RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK 99 (304)
T ss_dssp CEEEECSSEEEEEST----TSEEEEEESSH--HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred EecCCCCcceEEEEC----CEEEEEecCCc--chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence 568999999999864 45888876432 3456789999999888 3333 455555543333 3479999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----------------------------------------
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD----------------------------------------- 599 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~----------------------------------------- 599 (649)
+.+|.+... ..++..++..++.++++.|+.||..
T Consensus 100 G~~l~~~~~-----~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 174 (304)
T 3sg8_A 100 GVPLTPLLL-----NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVD 174 (304)
T ss_dssp CEECCHHHH-----HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHH
T ss_pred CeECCcccc-----ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHH
Confidence 988865432 2367778888899999999998861
Q ss_pred --------------CCCceEecCCCCCcEEEcC--CCceEEEecCCceee
Q 006347 600 --------------SRLRIIHRDLKASNILLDE--ELNPKISDFGMAKIF 633 (649)
Q Consensus 600 --------------~~~~iiHrDlkp~NILl~~--~~~~Ki~DFGla~~~ 633 (649)
..+.++|+|++|.||++++ +..+.|+||+.+..-
T Consensus 175 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~ 224 (304)
T 3sg8_A 175 DFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAIS 224 (304)
T ss_dssp HHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEE
T ss_pred HHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccC
Confidence 1245899999999999998 566899999999874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.6e-06 Score=89.27 Aligned_cols=136 Identities=18% Similarity=0.143 Sum_probs=97.8
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCC---CccceEEEEE-eCCeEEEEEecCCCC
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHR---NLVRLLGCCV-EGEEKMLIYEYMPNR 562 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~---niv~l~g~~~-~~~~~~lV~Ey~~~g 562 (649)
+.++.|....||+. +..+++|.... ......+..|..++..+.+. .+.+.+.++. ..+..++||||++|.
T Consensus 25 ~~l~~G~~n~v~~v----g~~~VlR~~~~--~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~ 98 (306)
T 3tdw_A 25 ESLGEGFRNYAILV----NGDWVFRFPKS--QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ 98 (306)
T ss_dssp EEEEECSSEEEEEE----TTTEEEEEESS--HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred eecCCCcceeEEEE----CCEEEEEecCC--chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence 56888888899987 56688887532 23456789999999999642 4667777775 344578999999998
Q ss_pred ChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-------------------------------------------
Q 006347 563 SLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD------------------------------------------- 599 (649)
Q Consensus 563 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------------------------------------------- 599 (649)
.|.+.... .++..++..++.++++.|+.||+.
T Consensus 99 ~l~~~~~~-----~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~ 173 (306)
T 3tdw_A 99 ILGEDGMA-----VLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLT 173 (306)
T ss_dssp ECHHHHHT-----TSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHH
T ss_pred ECchhhhh-----hCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHH
Confidence 88764211 234555556666666666666642
Q ss_pred --------------CCCceEecCCCCCcEEEcC---CCc-eEEEecCCceee
Q 006347 600 --------------SRLRIIHRDLKASNILLDE---ELN-PKISDFGMAKIF 633 (649)
Q Consensus 600 --------------~~~~iiHrDlkp~NILl~~---~~~-~Ki~DFGla~~~ 633 (649)
....++|+|++|.|||++. ++. ..|+||+.+..-
T Consensus 174 ~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 174 LRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp HHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred HHHHHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 2335799999999999997 345 589999998864
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.45 E-value=1.1e-06 Score=88.38 Aligned_cols=137 Identities=18% Similarity=0.175 Sum_probs=100.1
Q ss_pred eeeccCCcE-EEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEecCCCCC
Q 006347 487 SKLGQGGFG-PVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRS 563 (649)
Q Consensus 487 ~~LG~G~fG-~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (649)
+.+..|..| .||+.... ++..+.+|+-.. ....++..|...|+.+. +-.+.++++++.+.+..++|||++++.+
T Consensus 30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~---~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~ 106 (272)
T 4gkh_A 30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKG---SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKT 106 (272)
T ss_dssp EEEECSSSSCEEEEEECCTTCCCEEEEEEET---HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEE
T ss_pred EEccCCCcCCeEEEEEecCCCeEEEEEECCC---CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCcc
Confidence 345556555 68988765 466788887643 24567888999988884 5568899999999999999999999988
Q ss_pred hhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC-------------------------------------------
Q 006347 564 LDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS------------------------------------------- 600 (649)
Q Consensus 564 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------- 600 (649)
+.+.... .......++.++++.|+-||...
T Consensus 107 ~~~~~~~-------~~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (272)
T 4gkh_A 107 AFQVLEE-------YPDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQV 179 (272)
T ss_dssp HHHHHHH-------CGGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHH
T ss_pred ccccccC-------CHHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHH
Confidence 8765421 11223345666666666666421
Q ss_pred ------------CCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 601 ------------RLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 601 ------------~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
.+.++|+|+.+.|||++++..+-|+||+.+..-
T Consensus 180 ~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g 224 (272)
T 4gkh_A 180 WKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA 224 (272)
T ss_dssp HHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred HHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence 123799999999999998887889999999863
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=98.34 E-value=1.4e-06 Score=91.56 Aligned_cols=147 Identities=10% Similarity=0.066 Sum_probs=92.1
Q ss_pred ceee-ccCCcEEEEEEEec-------CCcEEEEEEecccc---cccHHHHHHHHHHHhcCC-C--CCccceEEEEEeC--
Q 006347 486 SSKL-GQGGFGPVYWGRLK-------DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQ-H--RNLVRLLGCCVEG-- 549 (649)
Q Consensus 486 ~~~L-G~G~fG~Vykg~~~-------~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~-- 549 (649)
.+.| +.|....+|+.... +++.+++|...... ......+..|+.++..+. + ..+.++++++.+.
T Consensus 25 ~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~ 104 (357)
T 3ats_A 25 ESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDV 104 (357)
T ss_dssp EEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTT
T ss_pred EEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCc
Confidence 3577 88889999998765 26678888764322 111246788888888884 3 4578888887665
Q ss_pred -CeEEEEEecCCCCChhhhhc---CCCCCCCCCHHHHHHHHHHHHH----------------------------------
Q 006347 550 -EEKMLIYEYMPNRSLDALLF---DPLKKERLDWRKRFNIIEGISR---------------------------------- 591 (649)
Q Consensus 550 -~~~~lV~Ey~~~gsL~~~l~---~~~~~~~l~~~~~~~i~~~ia~---------------------------------- 591 (649)
...++||||+++..+.+.+. .......++..++..++.++++
T Consensus 105 ~g~~~~v~e~l~G~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~La~LH~~~~~~~~l~~~~~~~~~~~~~~~~~~~ 184 (357)
T 3ats_A 105 LGTPFFLMDYVEGVVPPDVMPYTFGDNWFADAPAERQRQLQDATVAALATLHSIPNAQNTFSFLTQGRTSDTTLHRHFNW 184 (357)
T ss_dssp TSSCEEEEECCCCBCCCBTTBGGGSCSTTTTSCHHHHHHHHHHHHHHHHHHTTCSSHHHHTGGGC-----CCHHHHHHHH
T ss_pred cCCceEEEEecCCCChhhcCcccccccccCCCCHHHHHHHHHHHHHHHHHHhCCCCccCChhhccCCCCCCchHHHHHHH
Confidence 34689999999877653210 0000001122222222222222
Q ss_pred --------------------HHHHHHhC-------CCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 592 --------------------GLLYLHRD-------SRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 592 --------------------gL~yLH~~-------~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
.+.+|.+. ....++|+|+.|.|||++++..+.|+||+.|..
T Consensus 185 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 185 VRSWYDFAVEGIGRSPLLERTFEWLQSHWPDDAAAREPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp HHHHHHHHHHHHCCCHHHHHHHHHHHHTCCHHHHHSCCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred HHHHHHhhccCCCCChHHHHHHHHHHHhCCCcccCCCceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 23334322 145699999999999999655679999999875
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.00 E-value=3.2e-05 Score=82.49 Aligned_cols=75 Identities=11% Similarity=0.147 Sum_probs=50.9
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEeccccc-------ccHHHHHHHHHHHhcCCC--C-CccceEEEEEeCCeEEE
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-------QGLEEFMNEVMVISKLQH--R-NLVRLLGCCVEGEEKML 554 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~-------~~~~~f~~E~~~l~~l~H--~-niv~l~g~~~~~~~~~l 554 (649)
.+.||.|.++.||++... +++.++||....... .....+..|.+++..+.+ + .+.+++.+ +.+..++
T Consensus 35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l 112 (397)
T 2olc_A 35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 112 (397)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence 468999999999999765 468899997643211 123456789888887732 3 34466654 4556789
Q ss_pred EEecCCCC
Q 006347 555 IYEYMPNR 562 (649)
Q Consensus 555 V~Ey~~~g 562 (649)
||||+++.
T Consensus 113 vmE~l~g~ 120 (397)
T 2olc_A 113 VMEDLSHL 120 (397)
T ss_dssp EECCCTTS
T ss_pred EEEeCCCc
Confidence 99999764
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.99 E-value=2.6e-05 Score=80.88 Aligned_cols=141 Identities=16% Similarity=0.236 Sum_probs=82.7
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCCccceEE------EEEeCCeEEEEEec
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--HRNLVRLLG------CCVEGEEKMLIYEY 558 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g------~~~~~~~~~lV~Ey 558 (649)
+.|+.|....||+....+| .+++|+.... ..++..|..++..+. .-.+.+++. +....+..++||||
T Consensus 38 ~~l~gG~~n~~~~v~~~~~-~~vlk~~~~~----~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~ 112 (346)
T 2q83_A 38 DVIQGNQMALVWKVHTDSG-AVCLKRIHRP----EKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDW 112 (346)
T ss_dssp EECC----CEEEEEEETTE-EEEEEEECSC----HHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEEC
T ss_pred eeccccccCcEEEEEeCCC-CEEEEecCCC----HHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEe
Confidence 4566667889999987654 5889988642 233444555555442 123344443 22356778999999
Q ss_pred CCCCChh-----h---------hhc----CC--CC-----CCCCCHHHHH------------------------------
Q 006347 559 MPNRSLD-----A---------LLF----DP--LK-----KERLDWRKRF------------------------------ 583 (649)
Q Consensus 559 ~~~gsL~-----~---------~l~----~~--~~-----~~~l~~~~~~------------------------------ 583 (649)
+++..+. . -++ .. .. .....|...+
T Consensus 113 i~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 192 (346)
T 2q83_A 113 IEGRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEI 192 (346)
T ss_dssp CCCBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHH
T ss_pred ecCccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHH
Confidence 9986553 0 011 00 00 0112343211
Q ss_pred -HHHHHHHHHHHHHHh----------CCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 584 -NIIEGISRGLLYLHR----------DSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 584 -~i~~~ia~gL~yLH~----------~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
.+...+.+++.+|++ .....++|+|+++.|||++.+..+.|+||+.+..
T Consensus 193 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 193 DGFIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp HHHHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred HHHHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 111224446677763 1245699999999999998888999999999875
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.86 E-value=0.00011 Score=75.56 Aligned_cols=138 Identities=17% Similarity=0.126 Sum_probs=94.0
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC---CCCccceEEEEEeCCeEEEEEecCCCC
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ---HRNLVRLLGCCVEGEEKMLIYEYMPNR 562 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~---H~niv~l~g~~~~~~~~~lV~Ey~~~g 562 (649)
.+.|+.|....+|+.... +..+++|+... .....|..|...|+.|. ...++++++++...+..++||||+++.
T Consensus 41 ~~~l~gG~~n~~y~v~~~-~~~~vlK~~~~---~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~ 116 (312)
T 3jr1_A 41 KEKLYSGEMNEIWLINDE-VQTVFVKINER---SYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKS 116 (312)
T ss_dssp EEEECCSSSSEEEEEESS-SCEEEEEEEEG---GGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCC
T ss_pred eEEeCCccceeeeEEEEC-CCeEEEEeCCc---ccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCC
Confidence 468999999999998864 67888887643 23567889999888884 367889999988888999999999987
Q ss_pred Chhh--------h---hcCCCC-C------------------CCCCHHHHH---HHHH----------------HHHH-H
Q 006347 563 SLDA--------L---LFDPLK-K------------------ERLDWRKRF---NIIE----------------GISR-G 592 (649)
Q Consensus 563 sL~~--------~---l~~~~~-~------------------~~l~~~~~~---~i~~----------------~ia~-g 592 (649)
.+.. . |+.... . -.-+|.+.+ ++.. .+.. .
T Consensus 117 ~~~~~~~~~lG~~LA~LH~~~~~~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l 196 (312)
T 3jr1_A 117 KNKQSSFTIFAEKIAQLHQIQGPDKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIV 196 (312)
T ss_dssp CCCTTHHHHHHHHHHHHHHCCCCSSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHH
T ss_pred CCCchhHHHHHHHHHHHHcCCCCCCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHH
Confidence 6521 1 111100 0 012565432 1111 1111 1
Q ss_pred HHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEecC
Q 006347 593 LLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFG 628 (649)
Q Consensus 593 L~yLH~-~~~~~iiHrDlkp~NILl~~~~~~Ki~DFG 628 (649)
...|.. ..++.++|+|+.+.|++++.++ +.|.||.
T Consensus 197 ~~~L~~~~~~~~l~HgD~~~~N~l~~~~~-~~~iD~~ 232 (312)
T 3jr1_A 197 ADTLSKHNPKPSILHGNLWIENCIQVDDK-IFVCNPA 232 (312)
T ss_dssp HHHHTTCCCCCEEECSSCSGGGEEEETTE-EEECSCC
T ss_pred HHHhccCCCCceeEeCCCCcCcEeecCCC-eEEEcCc
Confidence 223321 2356799999999999999887 8999984
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.76 E-value=9.6e-05 Score=75.03 Aligned_cols=78 Identities=19% Similarity=0.234 Sum_probs=58.5
Q ss_pred cccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-C--CCccceEEEEEeCCeEEEEEecC
Q 006347 483 FQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H--RNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 483 f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H--~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
....+.+|.|..+.||+.++.+|+.+.||+-..........|..|...|+.|. . .-+++++++ + ..++||||+
T Consensus 17 v~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~--~~~lv~e~l 92 (288)
T 3f7w_A 17 VAAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D--DRTLAMEWV 92 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E--TTEEEEECC
T ss_pred eEEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c--CceEEEEee
Confidence 44457899999999999999999999999875544444557889999888884 2 235566654 2 347899999
Q ss_pred CCCCh
Q 006347 560 PNRSL 564 (649)
Q Consensus 560 ~~gsL 564 (649)
+.+..
T Consensus 93 ~~~~~ 97 (288)
T 3f7w_A 93 DERPP 97 (288)
T ss_dssp CCCCC
T ss_pred cccCC
Confidence 87654
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.60 E-value=0.00034 Score=75.15 Aligned_cols=73 Identities=11% Similarity=0.145 Sum_probs=45.8
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEeccc----cc-----ccHHHHHHHHHHHh-cCCCCCccceEEEEEeCCeEEEE
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA----SG-----QGLEEFMNEVMVIS-KLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~----~~-----~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 555 (649)
.+.||.|....||+... +++.++||..... .. .....+..|+..+. ...+..+.+++.+. .+..++|
T Consensus 39 i~~l~~G~~n~vyrv~~-~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~lv 115 (420)
T 2pyw_A 39 IKEVGDGNLNFVFIVVG-SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALIG 115 (420)
T ss_dssp EEECCCSSSCEEEEEEC-SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEEE
T ss_pred EEEccCCCcEEEEEEEc-CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEEE
Confidence 46889999999999965 4678999943211 01 12233434433222 22235677777765 5677999
Q ss_pred EecC-CC
Q 006347 556 YEYM-PN 561 (649)
Q Consensus 556 ~Ey~-~~ 561 (649)
|||+ ++
T Consensus 116 ~e~l~~g 122 (420)
T 2pyw_A 116 MRYLEPP 122 (420)
T ss_dssp ECCCCTT
T ss_pred EeecCCc
Confidence 9999 76
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.50 E-value=0.00078 Score=69.20 Aligned_cols=159 Identities=13% Similarity=0.106 Sum_probs=89.7
Q ss_pred CCHHHHHHHhcCccc-----ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-C-CCccceE
Q 006347 471 FQFEELATATNNFQL-----SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-H-RNLVRLL 543 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~-----~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H-~niv~l~ 543 (649)
.+.+++......|.+ .+.|+.|....+|+....+| .+++|..... ....++..|+.++..+. | -.+.+++
T Consensus 7 ~~~~~l~~~l~~~~~~~~~~~~~i~~G~~n~~~~v~~~~g-~~vlk~~~~~--~~~~~l~~e~~~l~~L~~~g~~vP~~~ 83 (322)
T 2ppq_A 7 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKD-PLILTLYEKR--VEKNDLPFFLGLMQHLAAKGLSCPLPL 83 (322)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSC-CEEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCcceEeeccCCCcccceEEEEeCCc-cEEEEEeCCC--CCHHHHHHHHHHHHHHHHCCCCCCccc
Confidence 444555555555543 24567788889999987755 6778887542 12335566777777663 2 1233444
Q ss_pred EE------EEeCCeEEEEEecCCCCChhh----h----------hc----CCCCC--CC---CCHHHHHHH---------
Q 006347 544 GC------CVEGEEKMLIYEYMPNRSLDA----L----------LF----DPLKK--ER---LDWRKRFNI--------- 585 (649)
Q Consensus 544 g~------~~~~~~~~lV~Ey~~~gsL~~----~----------l~----~~~~~--~~---l~~~~~~~i--------- 585 (649)
.. ....+..++++||+++..+.. . ++ +.... .. ..|...+.-
T Consensus 84 ~~~~g~~~~~~~g~~~~l~~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~ 163 (322)
T 2ppq_A 84 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 163 (322)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred CCCCCCEEEEECCEEEEEEEeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhh
Confidence 21 123456789999999865421 0 11 10000 00 124331110
Q ss_pred ---HHHHHHHHHHHHhC----CCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 586 ---IEGISRGLLYLHRD----SRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 586 ---~~~ia~gL~yLH~~----~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
...+.+.+.++++. .+..++|+|+.+.|||++++..+.|+||+.+..
T Consensus 164 ~~l~~~l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 164 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhhHHHHHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 11244556666532 234699999999999999876678999998875
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.21 E-value=0.0018 Score=66.88 Aligned_cols=142 Identities=15% Similarity=0.105 Sum_probs=74.0
Q ss_pred eeeccCCcEE-EEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCCccceEEEEEeCCeEEEEEecCCCCC
Q 006347 487 SKLGQGGFGP-VYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRS 563 (649)
Q Consensus 487 ~~LG~G~fG~-Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gs 563 (649)
+.|..|.... +|+....++..+++|...... ..++..|+.++..+. .-.+.+++.+..+. -+++||++.+..
T Consensus 24 ~~l~gg~s~~~~~r~~~~~~~~~vlk~~~~~~---~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~--g~ll~e~l~~~~ 98 (333)
T 3csv_A 24 TPLAGDASSRRYQRLRSPTGAKAVLMDWSPEE---GGDTQPFVDLAQYLRNLDISAPEIYAEEHAR--GLLLIEDLGDAL 98 (333)
T ss_dssp CC--------CCEEEECTTCCEEEEEECCTTT---TCCSHHHHHHHHHHHHTTCBCCCEEEEETTT--TEEEECCCCSCB
T ss_pred eECCCCCCCceEEEEEcCCCCeEEEEECCCCC---CccccHHHHHHHHHHhCCCCCCceeeecCCC--CEEEEeeCCCcc
Confidence 4565554444 667765446677777543321 133455666666663 23466777764333 378999997766
Q ss_pred hhhhhcC---------------------CCC--CCCCCHHHHH-------H-------------HHHHHHHHHHHHH---
Q 006347 564 LDALLFD---------------------PLK--KERLDWRKRF-------N-------------IIEGISRGLLYLH--- 597 (649)
Q Consensus 564 L~~~l~~---------------------~~~--~~~l~~~~~~-------~-------------i~~~ia~gL~yLH--- 597 (649)
+.+.+.. ... ...++..... . ....+.+.+..|.
T Consensus 99 l~~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~ 178 (333)
T 3csv_A 99 FTEVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQ 178 (333)
T ss_dssp HHHHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhc
Confidence 6433311 000 0111111100 0 0011122223331
Q ss_pred hCCCCceEecCCCCCcEEEcCC----CceEEEecCCceee
Q 006347 598 RDSRLRIIHRDLKASNILLDEE----LNPKISDFGMAKIF 633 (649)
Q Consensus 598 ~~~~~~iiHrDlkp~NILl~~~----~~~Ki~DFGla~~~ 633 (649)
......++|+|+.+.||+++.+ ..+.|+||+.+..-
T Consensus 179 ~~~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 179 LEGDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CCSCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred ccCCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 1234569999999999999875 67999999998863
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.14 E-value=0.0016 Score=66.23 Aligned_cols=139 Identities=14% Similarity=0.130 Sum_probs=76.2
Q ss_pred ceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEecC-CCCC
Q 006347 486 SSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYM-PNRS 563 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~-~~gs 563 (649)
.+.|+.|....+|+. ..+++|+....... ......|..++..+...++ .+++++ +.+..++|+||+ ++.+
T Consensus 23 i~~l~gG~tN~~~~~-----~~~vlR~~~~~~~~-~~~r~~E~~~l~~l~~~g~~P~~~~~--~~~~~~~v~e~i~~g~~ 94 (301)
T 3dxq_A 23 PLERLGGLTNLVFRA-----GDLCLRIPGKGTEE-YINRANEAVAAREAAKAGVSPEVLHV--DPATGVMVTRYIAGAQT 94 (301)
T ss_dssp CEEEESCSSEEEEEE-----TTEEEEEECC-----CCCHHHHHHHHHHHHHTTSSCCEEEE--CTTTCCEEEECCTTCEE
T ss_pred eeEcCCcccccccee-----eeEEEECCCCCccc-eeCHHHHHHHHHHHHHcCCCCceEEE--ECCCCEEEEeecCCCcc
Confidence 478989999999998 45788876542211 1123467777777642222 466654 444567899999 6655
Q ss_pred hhhh------------------hcCCCC--CCCCCH-HHHHHHHH--------------HHHHHHH----HHH-hCCCCc
Q 006347 564 LDAL------------------LFDPLK--KERLDW-RKRFNIIE--------------GISRGLL----YLH-RDSRLR 603 (649)
Q Consensus 564 L~~~------------------l~~~~~--~~~l~~-~~~~~i~~--------------~ia~gL~----yLH-~~~~~~ 603 (649)
|... |+.... ....+. .....+.. .+.+.+. .|. ......
T Consensus 95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~ 174 (301)
T 3dxq_A 95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA 174 (301)
T ss_dssp CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence 5310 111000 000111 11111100 0111111 111 123345
Q ss_pred eEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 604 IIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 604 iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
++|+|+.|.||+ .+++.+.|+||..|..-
T Consensus 175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~g 203 (301)
T 3dxq_A 175 ACHCDPLCENFL-DTGERMWIVDWEYSGMN 203 (301)
T ss_dssp EECSCCCGGGEE-ECSSCEEECCCTTCEEE
T ss_pred eeccCCCcCCEE-ECCCCEEEEecccccCC
Confidence 899999999999 66677899999988753
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=97.12 E-value=0.0016 Score=70.19 Aligned_cols=72 Identities=19% Similarity=0.334 Sum_probs=49.9
Q ss_pred eeeccCCcEEEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCC-ccceEEEEEeCCeEEEEEe
Q 006347 487 SKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~E 557 (649)
+.|+.|-...+|+....+ +..+.+|+.... .....+..|..++..+...+ ..++++.+. + .+|+|
T Consensus 79 ~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~--~~~~~li~E~~~l~~L~~~g~~P~l~~~~~--~--g~v~e 152 (429)
T 1nw1_A 79 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP--ETESHLVAESVIFTLLSERHLGPKLYGIFS--G--GRLEE 152 (429)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC--CCHHHHHHHHHHHHHHHHTTSSSCEEEEET--T--EEEEC
T ss_pred EEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCC--CcHHHHHHHHHHHHHHHhCCCCCcEEEEeC--C--CEEEE
Confidence 578888889999998763 478888877331 12256668999888884333 367777653 2 38999
Q ss_pred cCCCCCh
Q 006347 558 YMPNRSL 564 (649)
Q Consensus 558 y~~~gsL 564 (649)
|+++.+|
T Consensus 153 ~l~G~~l 159 (429)
T 1nw1_A 153 YIPSRPL 159 (429)
T ss_dssp CCCEEEC
T ss_pred EeCCccc
Confidence 9987554
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.10 E-value=0.0044 Score=63.68 Aligned_cols=143 Identities=15% Similarity=0.164 Sum_probs=84.3
Q ss_pred eeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCC--CCccceEEE-----EEeCCeEEEEEecC
Q 006347 487 SKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH--RNLVRLLGC-----CVEGEEKMLIYEYM 559 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H--~niv~l~g~-----~~~~~~~~lV~Ey~ 559 (649)
..|+ |....||+....+|+.+++|..... .....++..|..++..+.. -.+++++.. ....+..++|||++
T Consensus 32 ~~l~-g~~n~~y~v~~~~g~~~vlK~~~~~-~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i 109 (328)
T 1zyl_A 32 TPLN-SYENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV 109 (328)
T ss_dssp EEEC-CSSSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred Eeec-CcccceEEEEcCCCCEEEEEEcCCC-CCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence 4566 7778999988777778999988532 1245567778888777742 224455443 22345668899999
Q ss_pred CCCChhh-----h---------hc----CCC--CCCCCCHHHH----HHH---------------HHHHHHHHHHHHh--
Q 006347 560 PNRSLDA-----L---------LF----DPL--KKERLDWRKR----FNI---------------IEGISRGLLYLHR-- 598 (649)
Q Consensus 560 ~~gsL~~-----~---------l~----~~~--~~~~l~~~~~----~~i---------------~~~ia~gL~yLH~-- 598 (649)
++..+.. . ++ ... .....++... ..+ ...+.+.+..+.+
T Consensus 110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 189 (328)
T 1zyl_A 110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW 189 (328)
T ss_dssp CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence 8755421 0 11 000 1112232211 001 1111122333322
Q ss_pred --CCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 599 --DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 599 --~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
.....++|+|+++.|||++ + .+.|+||+.+..-
T Consensus 190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~g 224 (328)
T 1zyl_A 190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARNG 224 (328)
T ss_dssp CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCEE
T ss_pred hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCcC
Confidence 1344589999999999999 4 8999999988753
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=97.08 E-value=0.0062 Score=65.98 Aligned_cols=73 Identities=11% Similarity=0.064 Sum_probs=47.6
Q ss_pred eeeccCCcEEEEEEEecC-CcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEecCCCCCh
Q 006347 487 SKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
+.|+.|-...+|+....+ +..+.+|+....... .-.-..|..++..+...++ .++++.+ .+ .+||||+++.+|
T Consensus 114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~-~idR~~E~~vl~~L~~~gl~P~ll~~~--~~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDE-IINREREKKISCILYNKNIAKKIYVFF--TN--GRIEEFMDGYAL 188 (458)
T ss_dssp EEECC--CEEEEEEEETTTTEEEEEEEECC-CCS-CSCHHHHHHHHHHHTTSSSBCCEEEEE--TT--EEEEECCCSEEC
T ss_pred EEcCCCeEeEEEEEEECCCCceEEEEECCCChhh-hcCHHHHHHHHHHHHhcCCCCCEEEEe--CC--eEEEEeeCCccC
Confidence 678888889999998875 477888876432211 1112578888888864444 5777776 23 259999997655
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.03 E-value=0.0021 Score=67.94 Aligned_cols=141 Identities=18% Similarity=0.238 Sum_probs=83.9
Q ss_pred eeeccCCcEEEEEEEec--------CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEe
Q 006347 487 SKLGQGGFGPVYWGRLK--------DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~--------~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (649)
+.|..|-...+|+.... +++.+.+|+... .......+.+|..+++.+. +.-..++++++.+ .+|||
T Consensus 56 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~-~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e 130 (379)
T 3feg_A 56 YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGA-ILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ 130 (379)
T ss_dssp EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC----CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCC-ccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence 46766777889998875 246888887532 2234566678999888874 3334677766543 29999
Q ss_pred cCCCCChhhh-----------------hcCC-C-CCCCCC--HHHHHHHHHHHH-------------------HHHHHHH
Q 006347 558 YMPNRSLDAL-----------------LFDP-L-KKERLD--WRKRFNIIEGIS-------------------RGLLYLH 597 (649)
Q Consensus 558 y~~~gsL~~~-----------------l~~~-~-~~~~l~--~~~~~~i~~~ia-------------------~gL~yLH 597 (649)
|+++..|..- |+.. . -..... |.+..++..++. +.+..|.
T Consensus 131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~ 210 (379)
T 3feg_A 131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR 210 (379)
T ss_dssp CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence 9998665321 1111 0 011122 344444443332 1233332
Q ss_pred ----h-CCCCceEecCCCCCcEEEcCC----CceEEEecCCcee
Q 006347 598 ----R-DSRLRIIHRDLKASNILLDEE----LNPKISDFGMAKI 632 (649)
Q Consensus 598 ----~-~~~~~iiHrDlkp~NILl~~~----~~~Ki~DFGla~~ 632 (649)
. .....++|+|+.+.|||++++ ..+.|+||..|..
T Consensus 211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 2 233469999999999999876 7899999999875
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.69 E-value=0.0036 Score=65.71 Aligned_cols=73 Identities=16% Similarity=0.159 Sum_probs=44.0
Q ss_pred eeeccCCcEEEEEEEecC---------CcEEEEEEecccccccHHHHHHHHHHHhcCCCCC-ccceEEEEEeCCeEEEEE
Q 006347 487 SKLGQGGFGPVYWGRLKD---------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN-LVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~---------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n-iv~l~g~~~~~~~~~lV~ 556 (649)
+.|+.|..-.+|+....+ +..+++|....... .......|..++..+...+ ..++++.. . -++||
T Consensus 39 ~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~-~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~--~~~v~ 113 (369)
T 3c5i_A 39 KQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVD-ELYNTISEFEVYKTMSKYKIAPQLLNTF--N--GGRIE 113 (369)
T ss_dssp EEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGG-GTSCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEE
T ss_pred EEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCcc-ceecHHHHHHHHHHHHhcCCCCceEEec--C--CcEEE
Confidence 567778788999998763 26788887643221 1123457888888774333 45777553 2 36899
Q ss_pred ecCCCCCh
Q 006347 557 EYMPNRSL 564 (649)
Q Consensus 557 Ey~~~gsL 564 (649)
||+++..+
T Consensus 114 e~i~G~~l 121 (369)
T 3c5i_A 114 EWLYGDPL 121 (369)
T ss_dssp ECCCSEEC
T ss_pred EEecCCcC
Confidence 99987654
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=96.65 E-value=0.013 Score=60.81 Aligned_cols=33 Identities=24% Similarity=0.383 Sum_probs=29.1
Q ss_pred CCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 601 ~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+..++|+|+.+.||++++++.+.|+||+.+..-
T Consensus 205 ~~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 205 KYVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA 237 (339)
T ss_dssp GCEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred CceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence 356999999999999998888999999988764
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=94.01 E-value=0.24 Score=52.80 Aligned_cols=140 Identities=17% Similarity=0.181 Sum_probs=83.4
Q ss_pred eeeccCCcEEEEEEEecC--------CcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEe
Q 006347 487 SKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (649)
+.|..|-...+|+....+ +..+.+|+...... ..-.-.+|..+++.+. +.-..++++.+ . .++|||
T Consensus 76 ~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~-~~idR~~E~~~l~~L~~~gi~P~l~~~~--~--~~~I~e 150 (424)
T 3mes_A 76 KQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVG-KFYDSKVELDVFRYLSNINIAPNIIADF--P--EGRIEE 150 (424)
T ss_dssp EEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC--CCCCHHHHHHHHHHHHHTTSSCCEEEEE--T--TEEEEE
T ss_pred EEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcc-hhcCHHHHHHHHHHHHhcCCCCCEEEEc--C--CCEEEE
Confidence 567777788999998763 57888887643221 1122356777777774 33345666533 2 378999
Q ss_pred cCCCCChhhh-h----------------cC--C-----C---CCCCCCHHHHHHHHHHH-------------------HH
Q 006347 558 YMPNRSLDAL-L----------------FD--P-----L---KKERLDWRKRFNIIEGI-------------------SR 591 (649)
Q Consensus 558 y~~~gsL~~~-l----------------~~--~-----~---~~~~l~~~~~~~i~~~i-------------------a~ 591 (649)
|+++..|..- + +. . . ...+.-|....++..++ .+
T Consensus 151 fI~G~~l~~~~l~~~~~~~~ia~~La~LH~~~~~~~~L~~~~~~~p~~~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~ 230 (424)
T 3mes_A 151 FIDGEPLTTKQLQLTHICVEVAKNMGSLHIINSKRADFPSRFDKEPILFKRIYLWREEAKIQVSKNNFQIDKELYSKILE 230 (424)
T ss_dssp CCCSEECCTGGGGSHHHHHHHHHHHHHHHTHHHHCTTSCTTSCCSCCHHHHHHHHHHHHHHHHHTCC--CCHHHHHHHHH
T ss_pred EeCCccCChhhcCCHHHHHHHHHHHHHHhcCchhhccCccccCCCCcHHHHHHHHHHHHHHhhcccchhhccccHHHHHH
Confidence 9998765210 0 10 0 0 11111244333333221 22
Q ss_pred HHHHHHh---------------------CCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 592 GLLYLHR---------------------DSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 592 gL~yLH~---------------------~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
.+.+|.+ .....++|+|+.+.||+ +++..+.|+||..|..
T Consensus 231 e~~~L~~~l~~~~~~~~~r~~~~~~~~~~~~~~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 231 EIDQLEELIMGGEKFSMERALELKLYSPAFSLVFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp HHHHHHHHHHTSSCCCHHHHHHHHTTCGGGCEEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred HHHHHHHHHhhhcccccccccccccccCCCCceEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 3333321 12345899999999999 8888999999999875
|
| >2ll3_A Micronemal protein 4; cell adhesion; NMR {Toxoplasma gondii} PDB: 2ll4_M* | Back alignment and structure |
|---|
Probab=92.18 E-value=0.13 Score=40.97 Aligned_cols=33 Identities=24% Similarity=0.527 Sum_probs=28.4
Q ss_pred CCChhHHHHHhhccCCeEEEEecCC-ceEEEeec
Q 006347 357 PATEDECREQCLKNCSCIAYAFDGG-IGCMVWRS 389 (649)
Q Consensus 357 ~~~~~~C~~~Cl~nCsC~a~~~~~g-~gC~~w~~ 389 (649)
..++++|+++|+.+=.|.||.|+.- ..|+++.+
T Consensus 29 ~~sl~~Cq~aC~a~~~C~aFTyN~~s~~CflKs~ 62 (82)
T 2ll3_A 29 ASSLSECRARCQAEKECSHYTYNVKSGLCYPKRG 62 (82)
T ss_dssp CSSHHHHHHHHHHCTTEEEEEEETTTTEEEEEES
T ss_pred CCCHHHHHHHhhccCCCCeEEeccCCCceEcccC
Confidence 4689999999999999999999843 44999876
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=89.22 E-value=1.3 Score=46.70 Aligned_cols=30 Identities=30% Similarity=0.424 Sum_probs=25.7
Q ss_pred ceEecCCCCCcEEE------cCCCceEEEecCCcee
Q 006347 603 RIIHRDLKASNILL------DEELNPKISDFGMAKI 632 (649)
Q Consensus 603 ~iiHrDlkp~NILl------~~~~~~Ki~DFGla~~ 632 (649)
.++|+|+.+.|||+ +++..++++||-.|..
T Consensus 245 vfcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 245 VFCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EEECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eeEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 35799999999999 4567799999999875
|
| >3cxl_A N-chimerin; SH2, RHO-GAP, structural genomics consortium, SGC, gtpas activation, metal-binding, phorbol-ester binding, SH2 domai finger; 2.60A {Homo sapiens} PDB: 1xa6_A | Back alignment and structure |
|---|
Probab=81.61 E-value=0.17 Score=54.77 Aligned_cols=60 Identities=8% Similarity=0.080 Sum_probs=18.6
Q ss_pred ceeeccCCcEEEEEEEecC-CcEEEE------EEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe
Q 006347 486 SSKLGQGGFGPVYWGRLKD-GQEIAV------KRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE 548 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~-g~~vAV------K~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~ 548 (649)
.++|| ||.||+|.+.. ..+||| |+.... .....+.|.+|..++..++|+|+++.+++...
T Consensus 147 ~~~lG---fG~v~~g~~~~~~~~Vav~~~~~~K~~~~~~~~~e~~~~~~rea~l~~~~~H~niv~~h~f~~~ 215 (463)
T 3cxl_A 147 YEHVG---YTTLNREPAYKKHMPVLKETHDERDSTGQDGVSEKRLTSLVRRATLKENEQIPKYEKIHNFKVH 215 (463)
T ss_dssp TTTSS---BCCC---------CCBGGGC-----------------------------------CBCCCEEEE
T ss_pred cccCC---chhhhcccccccCCchhhhhccCccccccccccccccccccccccccccccccccCCCcceEEe
Confidence 35676 99999999874 468888 766432 23344678899999999999999999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 649 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-49 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 3e-46 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 3e-46 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-46 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 4e-45 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-44 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-44 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 8e-44 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 9e-44 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 3e-43 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 4e-43 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 4e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-42 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 7e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-41 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-41 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-40 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-40 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 5e-40 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-38 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 1e-38 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 1e-38 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 8e-38 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 1e-37 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 3e-37 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-37 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 1e-36 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-36 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 4e-36 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 5e-35 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 6e-35 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-33 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-33 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 3e-33 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 7e-33 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-33 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-32 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-32 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-31 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-30 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 7e-30 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 1e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 3e-29 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 5e-29 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-28 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-28 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 6e-28 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-28 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-27 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 4e-27 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-27 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 6e-27 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-25 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-25 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 3e-24 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-23 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-22 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 3e-18 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 6e-18 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-16 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 4e-04 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 7e-15 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 2e-10 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 1e-09 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 8e-05 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 2e-09 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-49
Identities = 47/169 (27%), Positives = 83/169 (49%), Gaps = 6/169 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ ++G G FG VY G+ + + ++ + Q L+ F NEV V+ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+G + ++ ++ SL L + + + K +I ++G+ YLH S
Sbjct: 68 LFMGYS-TAPQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
IIHRDLK++NI L E+L KI DFG+A + ++ G++
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSI 170
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 3e-46
Identities = 42/167 (25%), Positives = 75/167 (44%), Gaps = 7/167 (4%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGL-EEFMNEVMVISKLQH 536
++F+ S+LG G G V+ K G +A K + + + + E+ V+ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+V G E + E+M SLD +L K R+ + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
+ +I+HRD+K SNIL++ K+ DFG++ + + G
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVG 165
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 3e-46
Identities = 55/169 (32%), Positives = 88/169 (52%), Gaps = 7/169 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L +LG G FG V+ G ++AVK L + S + F+ E ++ +LQH+ LV
Sbjct: 13 ETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPDAFLAEANLMKQLQHQRLV 71
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
RL + E +I EYM N SL L P +L K ++ I+ G+ ++ +
Sbjct: 72 RLYAVVTQ-EPIYIITEYMENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN 129
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
IHRDL+A+NIL+ + L+ KI+DFG+A++ N+ A G +
Sbjct: 130 ---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREG-AKFPI 174
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 9e-46
Identities = 44/164 (26%), Positives = 82/164 (50%), Gaps = 6/164 (3%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ +++ +LG G FG VY + K+ A K + S + LE++M E+ +++ H N
Sbjct: 11 EDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPN 70
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V+LL ++ E+ ++DA++ + + L + + + L YLH
Sbjct: 71 IVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLH- 127
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+IIHRDLKA NIL + + K++DFG++ + D+
Sbjct: 128 --DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS 169
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 160 bits (405), Expect = 4e-45
Identities = 52/180 (28%), Positives = 87/180 (48%), Gaps = 6/180 (3%)
Query: 467 DLPLFQFEELATATNNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFM 525
D +++ + + KLG G +G VY G K +AVK L + + + +EEF+
Sbjct: 3 DPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFL 61
Query: 526 NEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNI 585
E V+ +++H NLV+LLG C +I E+M +L L + ++ + +
Sbjct: 62 KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLREC-NRQEVSAVVLLYM 120
Query: 586 IEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
IS + YL + IHRDL A N L+ E K++DFG++++ G+ A G
Sbjct: 121 ATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAK 177
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (398), Expect = 2e-44
Identities = 44/169 (26%), Positives = 82/169 (48%), Gaps = 7/169 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +LG G FG V +G+ + ++A+K + + S +EF+ E V+ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L G C + +I EYM N L L + + R ++ + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+ +HRDL A N L++++ K+SDFG+++ ++ + G +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG-SKFPV 165
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (400), Expect = 4e-44
Identities = 54/171 (31%), Positives = 84/171 (49%), Gaps = 16/171 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQHRN 538
F ++G G FG VY+ R +++ + +A+K++S + Q ++ + EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
++ GC + L+ EY + D L + K+ L + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLLE---VHKKPLQEVEIAAVTHGALQGLAYLH- 132
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+IHRD+KA NILL E K+ DFG A I A VGT
Sbjct: 133 --SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTP 175
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (395), Expect = 8e-44
Identities = 51/182 (28%), Positives = 83/182 (45%), Gaps = 12/182 (6%)
Query: 474 EELATATNNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKASGQG-LEEFMNEV 528
++L +N ++ +LG G FG V G + ++A+K L + + + EE M E
Sbjct: 1 KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60
Query: 529 MVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEG 588
++ +L + +VRL+G C + E ML+ E L L K+E + ++
Sbjct: 61 QIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQ 117
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVG 647
+S G+ YL +HRDL A N+LL KISDFG++K G +
Sbjct: 118 VSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174
Query: 648 TL 649
L
Sbjct: 175 PL 176
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 9e-44
Identities = 51/191 (26%), Positives = 87/191 (45%), Gaps = 19/191 (9%)
Query: 471 FQFEELATATNNF---------QLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKA- 516
F FE+ A F ++ +G G FG V G LK +A+K L
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 517 SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKER 576
+ + +F++E ++ + H N++ L G + M+I E+M N SLD+ L +
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 577 LDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
+ ++ GI+ G+ YL + +HRDL A NIL++ L K+SDFG+++ +
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 637 QDQADTGRVVG 647
+G
Sbjct: 182 TSDPTYTSALG 192
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 3e-43
Identities = 45/169 (26%), Positives = 76/169 (44%), Gaps = 7/169 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ ++G G FG V+ G + ++A+K + + E+F+ E V+ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIRE-GAMSEEDFIEEAEVMMKLSHPKLV 63
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L G C+E L++E+M + L L ++ + + G+ YL
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLE--- 118
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+IHRDL A N L+ E K+SDFGM + +Q + +
Sbjct: 119 EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPV 166
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 4e-43
Identities = 49/171 (28%), Positives = 75/171 (43%), Gaps = 8/171 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRN 538
++ L LG+G +G V + + +AVK + E E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V+ G EG + L EY L + + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHG 121
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
+ I HRD+K N+LLDE N KISDFG+A +F N + ++ GTL
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 169
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (389), Expect = 4e-43
Identities = 44/169 (26%), Positives = 81/169 (47%), Gaps = 8/169 (4%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRN 538
++++ +G G +G R K DG+ + K L S + ++EV ++ +L+H N
Sbjct: 5 DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPN 64
Query: 539 LVRLLGCCVEGEEKML--IYEYMPNRSLDALLFDPLK-KERLDWRKRFNIIEGISRGLLY 595
+VR ++ L + EY L +++ K ++ LD ++ ++ L
Sbjct: 65 IVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKE 124
Query: 596 LHR--DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
HR D ++HRDLK +N+ LD + N K+ DFG+A+I + A
Sbjct: 125 CHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA 173
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 153 bits (387), Expect = 2e-42
Identities = 48/206 (23%), Positives = 81/206 (39%), Gaps = 31/206 (15%)
Query: 472 QFEELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSK-ASGQGLEEF 524
+ L NN + +G+G FG V+ R +AVK L + AS +F
Sbjct: 4 KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63
Query: 525 MNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFD-------------- 570
E ++++ + N+V+LLG C G+ L++EYM L+ L
Sbjct: 64 QREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDL 123
Query: 571 -------PLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPK 623
L ++ I ++ G+ YL + +HRDL N L+ E + K
Sbjct: 124 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVK 180
Query: 624 ISDFGMAKIFGGNQDQADTGRVVGTL 649
I+DFG+++ G +
Sbjct: 181 IADFGLSRNIYSADYYKADGNDAIPI 206
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 7e-42
Identities = 49/163 (30%), Positives = 78/163 (47%), Gaps = 8/163 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+L +G+G FG V G + G ++AVK + + + F+ E V+++L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 541 RLLGCCVEGEEKM-LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+LLG VE + + ++ EYM SL L + L + + YL +
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGN 122
Query: 600 SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+HRDL A N+L+ E+ K+SDFG+ K QD
Sbjct: 123 ---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL 162
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 53/166 (31%), Positives = 83/166 (50%), Gaps = 6/166 (3%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ +L KLGQG FG V+ G +A+K L + E F+ E V+ KL+H LV
Sbjct: 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLV 75
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
+L E ++ EYM SL L + L + ++ I+ G+ Y+ R
Sbjct: 76 QLYAVV-SEEPIYIVTEYMSKGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVER-- 131
Query: 601 RLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
+ +HRDL+A+NIL+ E L K++DFG+A++ N+ A G
Sbjct: 132 -MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF 176
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 150 bits (380), Expect = 1e-41
Identities = 46/180 (25%), Positives = 75/180 (41%), Gaps = 17/180 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
L +G+G FG V+ G+ + G+E+AVK S + E+ L+H N++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSREERS-WFREAEIYQTVMLRHENIL 60
Query: 541 RLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
+ + L+ +Y + S LFD L + + + + GL +L
Sbjct: 61 GFIAADNKDNGTWTQLWLVSDYHEHGS----LFDYLNRYTVTVEGMIKLALSTASGLAHL 116
Query: 597 HRD-----SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD--TGRVVGTL 649
H + + I HRDLK+ NIL+ + I+D G+A D D VGT
Sbjct: 117 HMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTK 176
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 7e-41
Identities = 51/191 (26%), Positives = 70/191 (36%), Gaps = 26/191 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQG-LEEFMNEVMVISK 533
N LG G FG V +AVK L ++ E M+E+ V+S
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKE---------------RL 577
L H N+V LLG C G ++I EY L L L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
D + +++G+ +L IHRDL A NILL KI DFG+A+ +
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 638 DQADTGRVVGT 648
+ G
Sbjct: 200 NYVVKGNARLP 210
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 1e-40
Identities = 46/197 (23%), Positives = 74/197 (37%), Gaps = 31/197 (15%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKASGQG-LEEFMNEVMVISK 533
N + LG G FG V ++AVK L + + E M+E+ ++++
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 534 L-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKK------------------ 574
L H N+V LLG C LI+EY L L +K
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 575 --ERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632
L + +++G+ +L +HRDL A N+L+ KI DFG+A+
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 633 FGGNQDQADTGRVVGTL 649
+ + G +
Sbjct: 214 IMSDSNYVVRGNARLPV 230
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 5e-40
Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 10/171 (5%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN 538
+ K+GQG G VY + GQE+A+++++ E +NE++V+ + ++ N
Sbjct: 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPN 78
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V L + G+E ++ EY+ S L D + + +D + + + L +LH
Sbjct: 79 IVNYLDSYLVGDELWVVMEYLAGGS----LTDVVTETCMDEGQIAAVCRECLQALEFLH- 133
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
++IHRD+K+ NILL + + K++DFG Q + T +VGT
Sbjct: 134 --SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTP 180
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 5e-40
Identities = 53/173 (30%), Positives = 80/173 (46%), Gaps = 14/173 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
+F++ LG+G FG VY R K +A+K L KA + EV + S L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
N++RL G + LI EY P ++ L K + D ++ I ++ L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQ---KLSKFDEQRTATYITELANALSYC 122
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
H R+IHRD+K N+LL KI+DFG + ++ + GTL
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTL 168
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 5e-39
Identities = 44/175 (25%), Positives = 73/175 (41%), Gaps = 16/175 (9%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRNL 539
+ ++G+G F VY G + E+A L + + F E ++ LQH N+
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNI 70
Query: 540 VRLLGCCVEGEEK----MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
VR + +L+ E M + +L L + + + + + I +GL +
Sbjct: 71 VRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQF 127
Query: 596 LHRDSRLRIIHRDLKASNILLDEELN-PKISDFGMAKIFGGNQDQADTGRVVGTL 649
LH + IIHRDLK NI + KI D G+A + + V+GT
Sbjct: 128 LHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTP 177
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 51/175 (29%), Positives = 71/175 (40%), Gaps = 13/175 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSK---ASGQGLEEFMNEVMVISK 533
+ +L KLG G FG V G +AVK L + + +++F+ EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
L HRNL+RL G + KM + E P SL L + ++ G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
YL R IHRDL A N+LL KI DFG+ + N D
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 176
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 144 bits (363), Expect = 1e-38
Identities = 38/160 (23%), Positives = 68/160 (42%), Gaps = 8/160 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
+++ + +LG G FG V+ G A K + E E+ +S L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
V L + E ++IYE+M L + D + ++ + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 600 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQ 637
+H DLK NI+ + + K+ DFG+ Q
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 1e-38
Identities = 45/168 (26%), Positives = 76/168 (45%), Gaps = 13/168 (7%)
Query: 488 KLGQGGFGPVYWGRLKD---GQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHRNLVRL 542
+LG G FG V G + + +AVK L + +E + E V+ +L + +VR+
Sbjct: 14 ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRM 73
Query: 543 LGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRL 602
+G C E E ML+ E L+ L + + + ++ +S G+ YL
Sbjct: 74 IGIC-EAESWMLVMEMAELGPLNKYLQ---QNRHVKDKNIIELVHQVSMGMKYLEES--- 126
Query: 603 RIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG-RVVGTL 649
+HRDL A N+LL + KISDFG++K +++ +
Sbjct: 127 NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPV 174
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (360), Expect = 2e-38
Identities = 40/165 (24%), Positives = 76/165 (46%), Gaps = 5/165 (3%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHR 537
+ S +G+G +G V + +A+K++S Q + + E+ ++ + +H
Sbjct: 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHE 66
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N++ + + + Y+ + A L+ LK + L + I RGL Y+H
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 126
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
++HRDLK SN+LL+ + KI DFG+A++ + D
Sbjct: 127 ---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 8e-38
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 24/187 (12%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDG---QEIAVKRLSK-ASGQGLEEFMNEVMVISKL-Q 535
N+ + +G+G FG V R+K + A+KR+ + AS +F E+ V+ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALL-------------FDPLKKERLDWRKR 582
H N++ LLG C L EY P+ +L L L ++
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 583 FNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
+ ++RG+ YL + + IHRDL A NIL+ E KI+DFG+++ G +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYVKK 183
Query: 643 GRVVGTL 649
+
Sbjct: 184 TMGRLPV 190
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 1e-37
Identities = 53/170 (31%), Positives = 72/170 (42%), Gaps = 10/170 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHR 537
+F+ LG+G F V R L +E A+K L K + E V+S+L H
Sbjct: 9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
V+L + E+ Y N L + K D I L YLH
Sbjct: 69 FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYLH 125
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVG 647
IIHRDLK NILL+E+++ +I+DFG AK+ QA VG
Sbjct: 126 G---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG 172
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 140 bits (353), Expect = 3e-37
Identities = 35/160 (21%), Positives = 69/160 (43%), Gaps = 8/160 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
+ + + +LG G FG V+ G+ K ++ NE+ ++++L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+ L + E +LI E++ L + + ++ + N + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 600 SRLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQ 637
I+H D+K NI+ + + KI DFG+A ++
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (349), Expect = 4e-37
Identities = 51/173 (29%), Positives = 85/173 (49%), Gaps = 12/173 (6%)
Query: 483 FQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKA-SGQGLEEFMNEVMVISKLQH 536
F+ LG G FG VY G E +A+K L +A S + +E ++E V++ + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
++ RLLG C+ LI + MP L L + K+ + + N I++G+ YL
Sbjct: 71 PHVCRLLGICLTSTV-QLITQLMPFGCL--LDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
R++HRDL A N+L+ + KI+DFG+AK+ G + + +
Sbjct: 128 ED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (345), Expect = 1e-36
Identities = 50/182 (27%), Positives = 82/182 (45%), Gaps = 17/182 (9%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSK-ASGQGLEEFMNEVMVISK 533
+S +LGQG FG VY G K +A+K +++ AS + EF+NE V+ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------DPLKKERLDWRKRFNII 586
++VRLLG +G+ ++I E M L + L + K +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVV 646
I+ G+ YL+ + + +HRDL A N ++ E+ KI DFGM + G+ +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 647 GT 648
Sbjct: 197 LP 198
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 137 bits (347), Expect = 2e-36
Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 13/170 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQ- 535
N+F + +G+GGFG VY R D G+ A+K L K QG +NE +++S +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 536 --HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
+V + ++ I + M L L + I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTG 643
++H +++RDLK +NILLDE + +ISD G+A F + A G
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVG 167
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (342), Expect = 4e-36
Identities = 41/174 (23%), Positives = 78/174 (44%), Gaps = 13/174 (7%)
Query: 484 QLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQG-LEEFMNEVMVISKLQHRN 538
+ +G+G FG VY G L D AVK L++ + G + +F+ E +++ H N
Sbjct: 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPN 89
Query: 539 LVRLLGCCVEGEEK-MLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
++ LLG C+ E +++ YM + L + + + F + +
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAK-----GMK 144
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVGTL 649
+ + +HRDL A N +LDE+ K++DFG+A+ + + + +
Sbjct: 145 FLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 198
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 1e-35
Identities = 39/173 (22%), Positives = 70/173 (40%), Gaps = 12/173 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKASGQGL-EEFMNEVMVISKLQ 535
+L +G+G FG V+ G +A+K + + E+F+ E + + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H ++V+L+G E +I E L + L +K LD +S L Y
Sbjct: 67 HPHIVKLIGVITENP-VWIIMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAY 123
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
L R +HRD+ A N+L+ K+ DFG+++ + +
Sbjct: 124 LES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYK-ASKGKLP 172
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (336), Expect = 2e-35
Identities = 51/191 (26%), Positives = 79/191 (41%), Gaps = 25/191 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASGQG-LEEFMNEVMVISK 533
+ +L LG+G FG V + +AVK L + + M+E+ ++
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 534 -LQHRNLVRLLGCCVE-GEEKMLIYEYMPNRSLDALLF-------------DPLKKERLD 578
H N+V LLG C + G M+I E+ +L L + L K+ L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 579 WRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638
+++G+ +L + IHRDL A NILL E+ KI DFG+A+ + D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 639 QADTGRVVGTL 649
G L
Sbjct: 190 YVRKGDARLPL 200
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 5e-35
Identities = 49/168 (29%), Positives = 82/168 (48%), Gaps = 11/168 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQE-----IAVKRLSKASGQG-LEEFMNEVMVISKL 534
+ +G G FG VY G LK +A+K L + +F+ E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
H N++RL G + + M+I EYM N +LD L + K + ++ GI+ G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
YL + +HRDL A NIL++ L K+SDFG++++ + + T
Sbjct: 125 YLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 169
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 132 bits (333), Expect = 6e-35
Identities = 45/161 (27%), Positives = 76/161 (47%), Gaps = 10/161 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
+FQ+ LG G FG V+ R + +G+ A+K L K + +E +E +++S + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
++R+ G + ++ +I +Y+ L +LL + + + L L
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV------CLAL 117
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
II+RDLK NILLD+ + KI+DFG AK
Sbjct: 118 EYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 127 bits (320), Expect = 1e-33
Identities = 46/178 (25%), Positives = 76/178 (42%), Gaps = 20/178 (11%)
Query: 482 NFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGL---------EEFMNEVMVI 531
N++ LG+G V +E AVK + G E + EV ++
Sbjct: 4 NYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDIL 63
Query: 532 SKLQ-HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGIS 590
K+ H N+++L L+++ M L L +K L ++ I+ +
Sbjct: 64 RKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLT---EKVTLSEKETRKIMRALL 120
Query: 591 RGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ LH+ L I+HRDLK NILLD+++N K++DFG + + V GT
Sbjct: 121 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGT 172
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 127 bits (320), Expect = 2e-33
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 8/164 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQGLEEFMNEVMVISKLQHRN 538
+ K+G+G +G VY + G+ A+K RL K + E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V+L + +L++E++ L + L+ + + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCH- 117
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
R++HRDLK N+L++ E KI+DFG+A+ FG +
Sbjct: 118 --DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 33/160 (20%), Positives = 67/160 (41%), Gaps = 9/160 (5%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
+ ++ LG+G FG V+ + K + K G E+ +++ +HRN++
Sbjct: 6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFV-KVKGTDQVLVKKEISILNIARHRNIL 64
Query: 541 RLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS 600
L EE ++I+E++ + + L+ R+ + + + L +LH
Sbjct: 65 HLHESFESMEELVMIFEFISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLH--- 119
Query: 601 RLRIIHRDLKASNILLDEELNP--KISDFGMAKIFGGNQD 638
I H D++ NI+ + KI +FG A+ +
Sbjct: 120 SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN 159
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (320), Expect = 7e-33
Identities = 45/169 (26%), Positives = 72/169 (42%), Gaps = 15/169 (8%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLV 540
++ + +G G FG VY +L D G+ +A+K++ + E+ ++ KL H N+V
Sbjct: 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNIV 76
Query: 541 RLLGCCVEGEEKM------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
RL EK L+ +Y+P K+ L + + R L
Sbjct: 77 RLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 136
Query: 595 YLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADT 642
Y+H I HRD+K N+LLD + K+ DFG AK +
Sbjct: 137 YIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSY 182
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (316), Expect = 7e-33
Identities = 47/192 (24%), Positives = 82/192 (42%), Gaps = 26/192 (13%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK--------DGQEIAVKRLSK-ASGQGLEEFMNEVMVI 531
+ L LG+G FG V ++AVK L A+ + L + ++E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 532 SKL-QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLF-------------DPLKKERL 577
+ +H+N++ LLG C + +I EY +L L +E+L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 578 DWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
+ + ++RG+ YL + IHRDL A N+L+ E+ KI+DFG+A+
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 638 DQADTGRVVGTL 649
T +
Sbjct: 190 YYKKTTNGRLPV 201
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 125 bits (314), Expect = 2e-32
Identities = 46/175 (26%), Positives = 75/175 (42%), Gaps = 14/175 (8%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE-FMNEVMVISKLQHR 537
+ + LG G F V + + +A+K ++K + +G E NE+ V+ K++H
Sbjct: 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHP 67
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+V L G LI + + L + ++K R +I + + YLH
Sbjct: 68 NIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKYLH 124
Query: 598 RDSRLRIIHRDLKASNILL---DEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
I+HRDLK N+L DE+ ISDFG++K+ GT
Sbjct: 125 DL---GIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS---VLSTACGTP 173
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 123 bits (309), Expect = 4e-32
Identities = 41/178 (23%), Positives = 78/178 (43%), Gaps = 15/178 (8%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG---LEEFMNEVMVISKLQ 535
++ ++L LG GG V+ R L+ +++AVK L + F E + L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 536 HRNLVRLLGCCVE----GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
H +V + G ++ EY+ +L ++ + + ++ +I +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVH---TEGPMTPKRAIEVIADACQ 122
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQAD-TGRVVGT 648
L + H+ IIHRD+K +NI++ K+ DFG+A+ + + T V+GT
Sbjct: 123 ALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGT 177
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (309), Expect = 1e-31
Identities = 51/173 (29%), Positives = 73/173 (42%), Gaps = 13/173 (7%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK---ASGQGLEEFMNEVMVISK-LQ 535
+F L LG+G FG V+ K Q A+K L K +E M E V+S +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 536 HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
H L + E + EY+ L + + D + I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQ---SCHKFDLSRATFYAAEIILGLQF 118
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
LH I++RDLK NILLD++ + KI+DFGM K + +T GT
Sbjct: 119 LHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGT 166
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 118 bits (296), Expect = 6e-30
Identities = 43/182 (23%), Positives = 88/182 (48%), Gaps = 19/182 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQG--LEEFMNEVMVISKLQHR 537
+ ++ +K+GQG FG V+ R K GQ++A+K++ + + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 538 NLVRLLGCCVEGEEKM--------LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGI 589
N+V L+ C L++++ + L +K + ++ ++
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQML--- 126
Query: 590 SRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGR--VVG 647
L L+ R +I+HRD+KA+N+L+ + K++DFG+A+ F ++ V
Sbjct: 127 ---LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 648 TL 649
TL
Sbjct: 184 TL 185
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (294), Expect = 7e-30
Identities = 43/164 (26%), Positives = 79/164 (48%), Gaps = 8/164 (4%)
Query: 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHRN 538
NFQ K+G+G +G VY R K G+ +A+K++ + + E+ ++ +L H N
Sbjct: 3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 62
Query: 539 LVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+V+LL + L++E++ D + + + + +GL + H
Sbjct: 63 IVKLLDVIHTENKLYLVFEFLHQDLKK--FMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 599 DSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADT 642
R++HRDLK N+L++ E K++DFG+A+ FG
Sbjct: 121 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 161
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 117 bits (293), Expect = 1e-29
Identities = 44/158 (27%), Positives = 71/158 (44%), Gaps = 12/158 (7%)
Query: 488 KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEE-----FMNEVMVISKLQHRNLVR 541
LG+G F VY R K Q +A+K++ ++ + E+ ++ +L H N++
Sbjct: 5 FLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIG 64
Query: 542 LLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSR 601
LL L++++M L + +GL YLH+
Sbjct: 65 LLDAFGHKSNISLVFDFMETDLEV---IIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH-- 119
Query: 602 LRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
I+HRDLK +N+LLDE K++DFG+AK FG
Sbjct: 120 -WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA 156
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 3e-29
Identities = 47/181 (25%), Positives = 83/181 (45%), Gaps = 16/181 (8%)
Query: 479 ATNNFQLSSKLGQGGFGPVYWGRLK--DGQEIAVKRLSKASGQG--LEEFMNEVMVISKL 534
A ++ +++G+G +G V+ R G+ +A+KR+ +G+ + EV V+ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 535 ---QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLD---ALLFDPLKKERLDWRKRFNIIEG 588
+H N+VRL C + +D D + + + +++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 589 ISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ RGL +LH R++HRDLK NIL+ K++DFG+A+I+ VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL---TSVVVT 178
Query: 649 L 649
L
Sbjct: 179 L 179
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 116 bits (290), Expect = 5e-29
Identities = 46/173 (26%), Positives = 71/173 (41%), Gaps = 12/173 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQH 536
N+F LG+G FG V R K G+ A+K L K + + + E V+ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
L L + + EY L L ++ + I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHLS---RERVFTEERARFYGAEIVSALEYL 121
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649
H +++RD+K N++LD++ + KI+DFG+ K G D A GT
Sbjct: 122 HS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTP 169
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 114 bits (287), Expect = 2e-28
Identities = 39/160 (24%), Positives = 74/160 (46%), Gaps = 7/160 (4%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK--ASGQGLEEFMNEVMVISKLQHR 537
++ +G G +G V + G ++A+K+L + S + E+ ++ ++H
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE 77
Query: 538 NLVRLLGCCVEGEEKMLIYE-YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
N++ LL E + Y+ + L +K E+L + ++ + +GL Y+
Sbjct: 78 NVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYI 137
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636
H IIHRDLK N+ ++E+ KI DFG+A+
Sbjct: 138 H---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 174
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 114 bits (286), Expect = 2e-28
Identities = 41/161 (25%), Positives = 68/161 (42%), Gaps = 10/161 (6%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSK---ASGQGLEEFMNEVMVISKLQH 536
+ F LG G FG V + + G A+K L K + +E +NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 537 RNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
LV+L + ++ EY+ + + L + R I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLR---RIGRFSEPHARFYAAQIVLTFEYL 157
Query: 597 HRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
H L +I+RDLK N+L+D++ +++DFG AK G
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRT 195
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 111 bits (278), Expect = 6e-28
Identities = 40/178 (22%), Positives = 67/178 (37%), Gaps = 19/178 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEE------FMNEVMVISK 533
+ +Q+ LG GGFG VY G + D +A+K + K E EV+++ K
Sbjct: 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKK 63
Query: 534 LQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
+ ++RLL + +LI E ++ L + +
Sbjct: 64 VSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFIT--ERGALQEELARSFFWQVLE 121
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQADTGRVVGT 648
+ + H ++HRD+K NIL+D K+ DFG + GT
Sbjct: 122 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGT 172
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 111 bits (278), Expect = 9e-28
Identities = 29/180 (16%), Positives = 69/180 (38%), Gaps = 18/180 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
++++ ++G+G FG ++ G L + Q++A+K + S + +E L
Sbjct: 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKLLAGCTG 62
Query: 540 VRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD 599
+ + + ++ + SL+ LL + + + + + +H
Sbjct: 63 IPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIH-- 118
Query: 600 SRLRIIHRDLKASNILLDEELNP-----KISDFGMAKIF-----GGNQDQADTGRVVGTL 649
+++RD+K N L+ + + DFGM K + + + + GT
Sbjct: 119 -EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTA 177
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (274), Expect = 2e-27
Identities = 35/162 (21%), Positives = 76/162 (46%), Gaps = 9/162 (5%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR 537
++ K+G+G +G V+ + + + +A+KR+ + E+ ++ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 538 NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLH 597
N+VRL ++ L++E+ + LD + + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKK---YFDSCNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 598 RDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
++HRDLK N+L++ K+++FG+A+ FG
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 109 bits (273), Expect = 4e-27
Identities = 49/179 (27%), Positives = 75/179 (41%), Gaps = 20/179 (11%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISK 533
+ + +LG G F V R K G + A K + K G E+ EV ++ +
Sbjct: 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKE 69
Query: 534 LQHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
+QH N++ L + +LI E + L +KE L + ++ I G+
Sbjct: 70 IQHPNVITLHEVYENKTDVILILELVAG---GELFDFLAEKESLTEEEATEFLKQILNGV 126
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNP----KISDFGMAKIFGGNQDQADTGRVVGT 648
YLH L+I H DLK NI+L + P KI DFG+A + + GT
Sbjct: 127 YYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGT 179
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (276), Expect = 4e-27
Identities = 36/169 (21%), Positives = 73/169 (43%), Gaps = 19/169 (11%)
Query: 481 NNFQLSSK-LGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHR 537
++++++S+ LG G G V + ++ A+K L + EV + + Q
Sbjct: 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC-----PKARREVELHWRASQCP 65
Query: 538 NLVRLLGCC----VEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGL 593
++VR++ + +++ E + L + + D + R+ I++ I +
Sbjct: 66 HIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD-RGDQAFTEREASEIMKSIGEAI 124
Query: 594 LYLHRDSRLRIIHRDLKASNILLDEELNP---KISDFGMAKIFGGNQDQ 639
YLH + I HRD+K N+L + K++DFG AK +
Sbjct: 125 QYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSL 170
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 109 bits (272), Expect = 6e-27
Identities = 37/179 (20%), Positives = 69/179 (38%), Gaps = 18/179 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL 539
N ++L K+G G FG +Y G + G+E+A+K + + E + +Q
Sbjct: 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKIYKMMQGGVG 64
Query: 540 VRLLG-CCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR 598
+ + C EG+ +++ E + D + + + + + + Y+H
Sbjct: 65 IPTIRWCGAEGDYNVMVMELLGPSLED---LFNFCSRKFSLKTVLLLADQMISRIEYIH- 120
Query: 599 DSRLRIIHRDLKASNIL---LDEELNPKISDFGMAKIFGGNQDQAD-----TGRVVGTL 649
IHRD+K N L + I DFG+AK + + + GT
Sbjct: 121 --SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTA 177
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 106 bits (264), Expect = 1e-25
Identities = 35/164 (21%), Positives = 76/164 (46%), Gaps = 17/164 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRN 538
+++QL KLG+G + V+ + + +++ VK L ++ E+ ++ L+ N
Sbjct: 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKILENLRGGPN 91
Query: 539 LVRLLGCCVEGEEKM--LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYL 596
++ L + + L++E++ N L + L + I + L Y
Sbjct: 92 IITLADIVKDPVSRTPALVFEHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYC 145
Query: 597 HRDSRLRIIHRDLKASNILLDEE-LNPKISDFGMAKIFGGNQDQ 639
H + I+HRD+K N+++D E ++ D+G+A+ + Q+
Sbjct: 146 H---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (264), Expect = 1e-25
Identities = 48/168 (28%), Positives = 77/168 (45%), Gaps = 15/168 (8%)
Query: 481 NNFQLSSKLGQGGFGPVYWGRL----KDGQEIAVKRLSKAS----GQGLEEFMNEVMVIS 532
NF+L LG G +G V+ R G+ A+K L KA+ + E E V+
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 533 KLQHR-NLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
++ LV L + LI +Y+ L L ++ER + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLS---QRERFTEHEVQIYVGEIVL 140
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
L +LH+ L II+RD+K NILLD + ++DFG++K F ++ +
Sbjct: 141 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE 185
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (254), Expect = 3e-24
Identities = 48/170 (28%), Positives = 76/170 (44%), Gaps = 7/170 (4%)
Query: 480 TNNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQH 536
+Q S +G G +G V K G +AVK+LS+ S + E+ ++ ++H
Sbjct: 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKH 76
Query: 537 RNLVRLLGCCVEGEEKMLI-YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLY 595
N++ LL Y+ + A L + +K ++L +I I RGL Y
Sbjct: 77 ENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKY 136
Query: 596 LHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRV 645
+H IIHRDLK SN+ ++E+ KI DFG+A+ R
Sbjct: 137 IH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRW 183
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 100 bits (249), Expect = 2e-23
Identities = 40/166 (24%), Positives = 74/166 (44%), Gaps = 18/166 (10%)
Query: 481 NNFQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHR 537
+Q +G G G V + +A+K+LS+ + + E++++ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 538 NLVRLLGCCV------EGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISR 591
N++ LL E ++ L+ E M + + LD + ++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVI------QMELDHERMSYLLYQMLC 130
Query: 592 GLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637
G+ +LH IIHRDLK SNI++ + KI DFG+A+ G +
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 173
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 93.7 bits (232), Expect = 1e-22
Identities = 31/165 (18%), Positives = 57/165 (34%), Gaps = 20/165 (12%)
Query: 485 LSSKLGQGGFGPVYWGRLKDGQEIAVK--RLSKASGQ--------GLEEFMNEVMVISKL 534
+ +G+G V+ + E VK ++ S + G F + ++
Sbjct: 4 IGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARN 63
Query: 535 QHRNLVRLLGCCVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLL 594
+ R L +L G V +Y + N L L+ +++ I +
Sbjct: 64 EFRALQKLQGLAV-----PKVYAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVA 117
Query: 595 YLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639
+ I+H DL N+L+ EE I DF + G +
Sbjct: 118 KFYHR---GIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGWR 158
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 84.3 bits (207), Expect = 3e-18
Identities = 38/184 (20%), Positives = 73/184 (39%), Gaps = 27/184 (14%)
Query: 483 FQLSSKLGQGGFGPVYWGR-LKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVR 541
+ L KLG G F V+ + + + +A+K + E +E+ ++ ++ + +
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTK 73
Query: 542 LLGCCVEGEEKMLIY---------------EYMPNRSLDALLFDPLKKERLDWRKRFNII 586
K+L + E + L + + L + K+ I
Sbjct: 74 EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQ--IS 131
Query: 587 EGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP------KISDFGMAKIFGGNQDQA 640
+ + GL Y+HR R IIH D+K N+L++ +P KI+D G A + + +
Sbjct: 132 KQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS 189
Query: 641 DTGR 644
R
Sbjct: 190 IQTR 193
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 77.7 bits (191), Expect = 6e-18
Identities = 18/107 (16%), Positives = 40/107 (37%), Gaps = 10/107 (9%)
Query: 39 LSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLV 98
L G + + ++ + ++ +W +N K + DGN V
Sbjct: 10 LYAGQSLDVEPYHFIMQEDCNLVLYDH----STSVWASNTGILGKKGCKA-VLQSDGNFV 64
Query: 99 LVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
+ + + LW+S+ N + L + GN+V+ + +W +
Sbjct: 65 VYDAEGRSLWASHSVR-GNGNYVLVLQEDGNVVIYGS----DIWSTG 106
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 71.5 bits (175), Expect = 9e-16
Identities = 18/84 (21%), Positives = 29/84 (34%), Gaps = 3/84 (3%)
Query: 62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
I Y + L+ S +++ D NLVL + V ++
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTNTAGK--GTGCR 69
Query: 122 AQLLDSGNLVLRDNINRAIVWESF 145
A L +G + + N N VW S
Sbjct: 70 AVLQPNGRMDVLTNQNI-AVWTSG 92
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 38.4 bits (89), Expect = 4e-04
Identities = 20/108 (18%), Positives = 38/108 (35%), Gaps = 10/108 (9%)
Query: 87 GIITISEDGNLVLVNGQKE--VLWSSNVSN-LVNNSTSAQLLDSGNLVLRDNINRAIVWE 143
G + ++ +GN +L + Q + + + L + + NLVL D +R
Sbjct: 1 GSVVVANNGNSILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDRDDRVWSTN 60
Query: 144 SFQEPTDSFLPGMHHG---IDQRTGKKVQLTSWKSLSDPSTGSFSAGL 188
+ + T +G + V W S + S G + L
Sbjct: 61 TAGKGTGCRAVLQPNGRMDVLTNQNIAV----WTSGNSRSAGRYVFVL 104
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 69.2 bits (169), Expect = 7e-15
Identities = 24/84 (28%), Positives = 34/84 (40%), Gaps = 4/84 (4%)
Query: 62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTS 121
I + + E + + L+ SS T+ D NLVL + V W+SN +
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRV-WASNTAG--ATGCR 59
Query: 122 AQLLDSGNLVLRDNINRAIVWESF 145
A L G LV+ N I W S
Sbjct: 60 AVLQSDGLLVILTAQNT-IRWSSG 82
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 56.6 bits (136), Expect = 2e-10
Identities = 20/111 (18%), Positives = 35/111 (31%), Gaps = 17/111 (15%)
Query: 35 PDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISED 94
L+ G +F + + W N S +++ D
Sbjct: 12 TGEFLNYG-SFVFIMQEDCNLVLYDVDKPI---------WATNTGGL--SRSCFLSMQTD 59
Query: 95 GNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESF 145
GNLV+ N + +W+SN N + L N+V+ W +
Sbjct: 60 GNLVVYNPSNKPIWASNTGG-QNGNYVCILQKDRNVVIYGT----DRWATG 105
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 53.9 bits (129), Expect = 1e-09
Identities = 13/73 (17%), Positives = 23/73 (31%), Gaps = 7/73 (9%)
Query: 72 VIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLV 131
IW N + DG LV++ + +W S L N+V
Sbjct: 50 PIWATNTGGLGNGC--RAVLQPDGVLVVITNENVTVWQSP-VAGKAGHYVLVLQPDRNVV 106
Query: 132 LRDNINRAIVWES 144
+ + +W +
Sbjct: 107 IYGD----ALWAT 115
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 40.4 bits (94), Expect = 8e-05
Identities = 18/52 (34%), Positives = 24/52 (46%), Gaps = 3/52 (5%)
Query: 93 EDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144
D NLVL + +W++N L N A L G LV+ N VW+S
Sbjct: 38 TDCNLVLYDNNN-PIWATNTGGLGNGCR-AVLQPDGVLVVITN-ENVTVWQS 86
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 53.6 bits (128), Expect = 2e-09
Identities = 23/116 (19%), Positives = 44/116 (37%), Gaps = 15/116 (12%)
Query: 35 PDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISED 94
L+ G + N + + YD +W + + ++ + D
Sbjct: 12 TGGSLAEG-GYLFIIQNDCNL------VLYDN---NRAVWASGTNGKASGC--VLKMQND 59
Query: 95 GNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD 150
GNLV+ +G + + + +N N + L N+V+ DN N AI W + +
Sbjct: 60 GNLVIYSGSRAIWA--SNTNRQNGNYYLILQRDRNVVIYDNSNNAI-WATHTNVGN 112
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 649 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 99.98 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 99.98 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 99.98 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 99.97 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.97 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 99.97 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 99.97 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 99.97 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 99.97 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 99.97 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 99.97 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 99.97 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 99.97 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 99.97 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 99.97 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 99.97 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 99.97 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 99.97 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 99.97 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 99.97 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 99.97 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 99.96 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 99.96 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 99.96 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 99.96 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 99.96 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 99.96 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 99.96 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 99.96 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 99.96 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 99.96 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 99.96 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 99.96 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 99.96 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 99.96 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 99.96 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 99.96 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 99.96 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 99.96 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 99.96 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 99.95 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 99.95 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 99.95 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 99.95 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 99.95 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 99.95 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 99.95 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 99.94 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.94 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 99.94 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 99.94 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 99.94 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 99.93 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 99.93 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 99.93 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 99.93 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 99.92 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 99.92 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.91 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.85 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.84 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.83 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.83 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.82 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.7 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.64 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.59 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.32 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.1 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.09 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.07 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.0 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.79 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.59 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.08 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.49 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.74 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.19 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.67 | |
| d1emoa2 | 39 | Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | 91.25 | |
| d2vj3a1 | 42 | Neurogenic locus notch homolog protein 1, Notch1 { | 84.32 | |
| d2qj2a1 | 91 | Hepatocyte growth factor {Human (Homo sapiens) [Ta | 84.04 | |
| d1xkba1 | 39 | Factor X, N-terminal module {Human (Homo sapiens) | 81.46 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-33 Score=282.86 Aligned_cols=163 Identities=30% Similarity=0.451 Sum_probs=141.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||||++++++.+++..+|||||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy 84 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEY 84 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEec
Confidence 57899999999999999999976 68999999986543 33456799999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
+++|+|.++|.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+.....
T Consensus 85 ~~gg~L~~~l~~---~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~ 158 (271)
T d1nvra_ 85 CSGGELFDRIEP---DIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR 158 (271)
T ss_dssp CTTEEGGGGSBT---TTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTE
T ss_pred cCCCcHHHHHhc---CCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCc
Confidence 999999999953 456999999999999999999999988 99999999999999999999999999998865544
Q ss_pred ccccCceeecC
Q 006347 639 QADTGRVVGTL 649 (649)
Q Consensus 639 ~~~~~~~~GT~ 649 (649)
.......+||+
T Consensus 159 ~~~~~~~~GT~ 169 (271)
T d1nvra_ 159 ERLLNKMCGTL 169 (271)
T ss_dssp ECCBCCCCSCG
T ss_pred cccccceeeCc
Confidence 44445577874
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.98 E-value=1.9e-33 Score=287.64 Aligned_cols=165 Identities=30% Similarity=0.488 Sum_probs=143.9
Q ss_pred HHhcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 478 TATNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 478 ~~~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
...++|++.++||+|+||+||+|++. +++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..+|||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCc-cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEe
Confidence 34567888999999999999999986 5889999999754 445788999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++... ....+++..++.|+.|||+||+|||+++ |+||||||+||||++++++||+|||+|+....+
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ecccCcchHHHhhhc-cccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEccccceeecCCC
Confidence 999999999998653 3457899999999999999999999987 999999999999999999999999999987655
Q ss_pred CCccccCceeec
Q 006347 637 QDQADTGRVVGT 648 (649)
Q Consensus 637 ~~~~~~~~~~GT 648 (649)
..... ....||
T Consensus 169 ~~~~~-~~~~g~ 179 (287)
T d1opja_ 169 TYTAH-AGAKFP 179 (287)
T ss_dssp SSEEE-TTEEEC
T ss_pred Cceee-cccccc
Confidence 43332 234555
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.4e-32 Score=278.72 Aligned_cols=160 Identities=28% Similarity=0.471 Sum_probs=142.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.++||+|+||+||+|... +|+.||||+++.......+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~ 99 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYL 99 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEec
Confidence 46899999999999999999975 79999999997666566788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCCc
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQDQ 639 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~ 639 (649)
++|+|.+++.+ ..+++.++..++.||+.||+|||+.+ ||||||||+|||++.++++||+|||+|+.+..+...
T Consensus 100 ~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~ 172 (293)
T d1yhwa1 100 AGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK 172 (293)
T ss_dssp TTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred CCCcHHHHhhc----cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeecccccc
Confidence 99999998743 46899999999999999999999988 999999999999999999999999999988544332
Q ss_pred cccCceeecC
Q 006347 640 ADTGRVVGTL 649 (649)
Q Consensus 640 ~~~~~~~GT~ 649 (649)
.....||+
T Consensus 173 --~~~~~gt~ 180 (293)
T d1yhwa1 173 --RSTMVGTP 180 (293)
T ss_dssp --BCCCCSCG
T ss_pred --ccccccCC
Confidence 22356663
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=1.1e-32 Score=278.52 Aligned_cols=151 Identities=30% Similarity=0.538 Sum_probs=131.8
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.++||+|+||+||+|.+.+++.||||+++.. ....++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~ 83 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFME 83 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCT
T ss_pred HHcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCC-cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecC
Confidence 468888999999999999999988899999999753 4556889999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
+|+|.+++.. ....++|..++.|+.|||+||+|||+.+ |+||||||+|||+++++++||+|||+|+.+....
T Consensus 84 ~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~ 155 (263)
T d1sm2a_ 84 HGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ 155 (263)
T ss_dssp TCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC---------
T ss_pred CCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCC
Confidence 9999999865 3456899999999999999999999987 9999999999999999999999999999875443
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.9e-32 Score=278.12 Aligned_cols=152 Identities=34% Similarity=0.609 Sum_probs=135.4
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
.++|++.++||+|+||+||+|.+++++.||||+++.. ....++|.+|+.++++++|||||+++|++.+ +..+|||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccC-cCCHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeC
Confidence 3578888999999999999999998899999999754 3456789999999999999999999998754 5679999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
++|+|.+++... ....++|.++++|+.|||+||.|||+++ |+||||||+||||++++.+||+|||+|+.+....
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~ 163 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE 163 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred CCCcHHHHHhhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeeccccceEEccCCc
Confidence 999999988542 2345899999999999999999999987 9999999999999999999999999999986543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.7e-32 Score=278.83 Aligned_cols=162 Identities=31% Similarity=0.534 Sum_probs=133.2
Q ss_pred hcCcccceeeccCCcEEEEEEEecCCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||+|+||+||+|+.+ ..||||+++.. .....++|.+|+.++.+++|||||+++|++.+ ++.+||||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred cccEEEEEEEeeCCCcEEEEEEEC--CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEe
Confidence 367888899999999999999876 36999998643 34567899999999999999999999998754 56899999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
|+++|+|.+++.. .+..+++..++.|+.|||+||+|||+++ ||||||||+||||++++++||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred cCCCCCHHHHHhh--ccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeeccccC
Confidence 9999999999964 3456999999999999999999999987 9999999999999999999999999999876544
Q ss_pred CccccCceeecC
Q 006347 638 DQADTGRVVGTL 649 (649)
Q Consensus 638 ~~~~~~~~~GT~ 649 (649)
......+..||+
T Consensus 159 ~~~~~~~~~gt~ 170 (276)
T d1uwha_ 159 GSHQFEQLSGSI 170 (276)
T ss_dssp -------CCCCG
T ss_pred CcccccccccCc
Confidence 444444566763
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.3e-32 Score=279.46 Aligned_cols=149 Identities=29% Similarity=0.467 Sum_probs=137.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
+.|++.+.||+|+||+||+|+.. +++.||||+++.......++|.+|++++++++|||||++++++.+.+..+|||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecC
Confidence 45888999999999999999976 68999999998766677789999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++|+|.+++.+ ....+++.++..++.||++||.|||+++ |+||||||+|||++.++++||+|||+|+.+.
T Consensus 92 ~~g~L~~~~~~--~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~ 161 (288)
T d2jfla1 92 AGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161 (288)
T ss_dssp TTEEHHHHHHH--HTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECH
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccC
Confidence 99999999753 2356999999999999999999999998 9999999999999999999999999998764
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.97 E-value=3.5e-32 Score=279.87 Aligned_cols=151 Identities=30% Similarity=0.565 Sum_probs=125.4
Q ss_pred CcccceeeccCCcEEEEEEEec-CC---cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DG---QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g---~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
+|++.+.||+|+||+||+|.+. ++ ..||||++... .....++|.+|+.++++++|||||+++|+|.+++..++||
T Consensus 27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~ 106 (299)
T d1jpaa_ 27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIIT 106 (299)
T ss_dssp GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEE
T ss_pred hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEE
Confidence 4566789999999999999975 23 36899998653 3445678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ....++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++++||+|||+|+.+...
T Consensus 107 Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~ 181 (299)
T d1jpaa_ 107 EFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181 (299)
T ss_dssp ECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred EecCCCcceeeecc--ccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence 99999999999864 3456899999999999999999999987 999999999999999999999999999988654
Q ss_pred C
Q 006347 637 Q 637 (649)
Q Consensus 637 ~ 637 (649)
.
T Consensus 182 ~ 182 (299)
T d1jpaa_ 182 T 182 (299)
T ss_dssp -
T ss_pred C
Confidence 3
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.8e-31 Score=268.50 Aligned_cols=151 Identities=28% Similarity=0.551 Sum_probs=138.3
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.++||+|+||+||+|+.+++++||||++++. ....++|.+|+.++++++|||||+++|+|.+++..++||||++
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~ 82 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMA 82 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCT
T ss_pred HHCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcC-cCCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccC
Confidence 578889999999999999999988889999999764 4456899999999999999999999999999999999999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
+|+|.+++.. ....+++..+.+|+.|||+||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 ~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~ 154 (258)
T d1k2pa_ 83 NGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE 154 (258)
T ss_dssp TEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSS
T ss_pred CCcHHHhhhc--cccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCC
Confidence 9999999864 3456899999999999999999999987 9999999999999999999999999999875443
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.3e-32 Score=274.89 Aligned_cols=163 Identities=32% Similarity=0.426 Sum_probs=139.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||+|+.. +++.||||++++. .....+.+.+|++++++++|||||++++++.+.+..+|||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEE
Confidence 46899999999999999999975 7899999998643 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred EccCCCCHHHhhhc---cCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccC
Confidence 99999999998853 456999999999999999999999988 999999999999999999999999999998655
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
..........||+
T Consensus 162 ~~~~~~~~~~GT~ 174 (288)
T d1uu3a_ 162 SKQARANSFVGTA 174 (288)
T ss_dssp --------CCCCG
T ss_pred CcccccccccCCc
Confidence 5444444567774
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2e-31 Score=268.87 Aligned_cols=150 Identities=32% Similarity=0.476 Sum_probs=135.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||+||+|+.. +++.||||++.+. .....+++.+|+.++++++|||||++++++.+++..+|||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEE
Confidence 46888999999999999999986 6899999998643 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+|+.....
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred eecCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC
Confidence 99999999999953 356899999999999999999999988 999999999999999999999999999876543
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=4.4e-31 Score=269.54 Aligned_cols=151 Identities=32% Similarity=0.587 Sum_probs=131.7
Q ss_pred cCcccce-eeccCCcEEEEEEEec---CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSS-KLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~-~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|.+.+ +||+|+||+||+|.+. ++..||||+++... ....++|.+|++++.+++|||||+++|++.+ +..+||
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEE
Confidence 4566666 5999999999999865 35589999997543 3456789999999999999999999999864 568999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|.+++.. .+..+++.++..|+.|||+||+|||+++ |+||||||+|||+++++.+||+|||+|+.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEeCCCCcHHHHhhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhcccc
Confidence 999999999999854 3456999999999999999999999987 99999999999999999999999999999865
Q ss_pred CC
Q 006347 636 NQ 637 (649)
Q Consensus 636 ~~ 637 (649)
..
T Consensus 162 ~~ 163 (285)
T d1u59a_ 162 DD 163 (285)
T ss_dssp CS
T ss_pred cc
Confidence 44
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=7.4e-32 Score=280.46 Aligned_cols=160 Identities=27% Similarity=0.353 Sum_probs=138.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||||++++++.+.++.+||||
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmE 84 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 84 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred ccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence 467999999999999999999975 78999999997543 3445789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-SRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+++|+|.+++.+ ...+++..+..++.|+++||.|||+. + |+||||||+|||+++++++||+|||+|+.+...
T Consensus 85 y~~gg~L~~~l~~---~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~ 158 (322)
T d1s9ja_ 85 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158 (322)
T ss_dssp CCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred cCCCCcHHHHHhh---cCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence 9999999999953 35689999999999999999999974 6 999999999999999999999999999976432
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
. ..+.+||+
T Consensus 159 ~----~~~~~GT~ 167 (322)
T d1s9ja_ 159 M----ANSFVGTR 167 (322)
T ss_dssp T----C---CCSS
T ss_pred c----cccccCCc
Confidence 2 23456764
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.9e-32 Score=272.13 Aligned_cols=167 Identities=26% Similarity=0.444 Sum_probs=128.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEe--CCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE--GEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~--~~~~~lV 555 (649)
++|++.+.||+|+||+||+|+.. +|+.||||.++... +...+.+.+|++++++++|||||++++++.+ .+..+||
T Consensus 4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~iv 83 (269)
T d2java1 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIV 83 (269)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEE
T ss_pred hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEE
Confidence 56899999999999999999875 78999999986542 3445779999999999999999999999975 3457999
Q ss_pred EecCCCCChhhhhcCCC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 556 YEYMPNRSLDALLFDPL-KKERLDWRKRFNIIEGISRGLLYLHRDS--RLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
|||+++|+|.+++.+.. ....+++..++.++.||+.||+|||+.+ ..+||||||||+|||+++++.+||+|||+|+.
T Consensus 84 mEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~ 163 (269)
T d2java1 84 MEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163 (269)
T ss_dssp EECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHH
T ss_pred EecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceee
Confidence 99999999999985422 2457999999999999999999999854 23599999999999999999999999999998
Q ss_pred eCCCCCccccCceeecC
Q 006347 633 FGGNQDQADTGRVVGTL 649 (649)
Q Consensus 633 ~~~~~~~~~~~~~~GT~ 649 (649)
+..+... .....||+
T Consensus 164 ~~~~~~~--~~~~~gt~ 178 (269)
T d2java1 164 LNHDTSF--AKAFVGTP 178 (269)
T ss_dssp C-------------CCC
T ss_pred cccCCCc--cccCCCCc
Confidence 7544322 23456764
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=2.1e-31 Score=271.76 Aligned_cols=151 Identities=34% Similarity=0.569 Sum_probs=131.9
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMP 560 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~ 560 (649)
++|++.+.||+|+||+||+|+++++++||||+++.. ....++|.+|+.++++++|+|||+++|+|. .++.++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEECCCT
T ss_pred HHEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcc-cCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cCCeEEEEEecC
Confidence 578899999999999999999998889999999653 455688999999999999999999999985 456899999999
Q ss_pred CCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 561 NRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 561 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
+|+|..++... ....++|.+++.|+.|||+||+|||+.+ |+||||||+||||++++++||+|||+|+.+....
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred CCchhhhhhhc-ccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccchhhhccCCC
Confidence 99999998542 2346999999999999999999999987 9999999999999999999999999999875443
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=5.1e-31 Score=274.44 Aligned_cols=167 Identities=28% Similarity=0.427 Sum_probs=139.3
Q ss_pred hcCcccceeeccCCcEEEEEEEecC------CcEEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD------GQEIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~------g~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
.++|++.++||+|+||+||+|+... ...||||++... .....+.|.+|+.++.++ +|||||++++++.+.+.
T Consensus 36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~ 115 (325)
T d1rjba_ 36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP 115 (325)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence 3578889999999999999998752 236999998653 344567899999999998 89999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCC
Q 006347 552 KMLIYEYMPNRSLDALLFDPLK--------------------KERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKA 611 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp 611 (649)
.+|||||+++|+|.++|+.... ...+++.+++.|+.||++||+|||+++ ||||||||
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp 192 (325)
T d1rjba_ 116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAA 192 (325)
T ss_dssp CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSG
T ss_pred EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCch
Confidence 9999999999999999975321 235899999999999999999999987 99999999
Q ss_pred CcEEEcCCCceEEEecCCceeeCCCCCccccCceeecC
Q 006347 612 SNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 612 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
+|||++.++++||+|||+|+...............||+
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 230 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPV 230 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECG
T ss_pred hccccccCCeEEEeeccccccccCCCceeeeccccCCC
Confidence 99999999999999999999876655544444566763
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=99.97 E-value=1.3e-30 Score=273.55 Aligned_cols=152 Identities=25% Similarity=0.443 Sum_probs=138.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.+.||+|+||.||+|+.. +|+.||||++........+.+.+|+.++++++|||||++++++.+.+..+|||||+
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 105 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFM 105 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 57999999999999999999975 78999999998766666788999999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC--CCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE--ELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~--~~~~Ki~DFGla~~~~~~~ 637 (649)
++|+|.+++.+ ....+++.++..|+.||+.||.|||+.+ ||||||||+|||++. ++.+||+|||+|+.+....
T Consensus 106 ~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~ 180 (350)
T d1koaa2 106 SGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180 (350)
T ss_dssp CSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS
T ss_pred CCCCHHHHHHh--hcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheeccccc
Confidence 99999999854 3456999999999999999999999998 999999999999964 6789999999999886544
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.8e-31 Score=265.14 Aligned_cols=158 Identities=28% Similarity=0.392 Sum_probs=133.2
Q ss_pred ccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEe----CCeEEEEE
Q 006347 484 QLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVE----GEEKMLIY 556 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~----~~~~~lV~ 556 (649)
+..++||+|+||+||+|+.. +++.||||++... .....+.|.+|++++++++|||||++++++.+ +...+|||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEE
Confidence 55678999999999999976 6889999998653 23456789999999999999999999999875 34579999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc-CCCceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD-EELNPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~-~~~~~Ki~DFGla~~~~~ 635 (649)
||+++|+|.+++.+ ...+++.++..++.||++||+|||+++ .+|+||||||+|||++ +++.+||+|||+|+....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred eCCCCCcHHHHHhc---cccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC
Confidence 99999999999953 356899999999999999999999874 5699999999999996 578999999999987543
Q ss_pred CCCccccCceeecC
Q 006347 636 NQDQADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~~~~~~~~GT~ 649 (649)
... ....||+
T Consensus 168 ~~~----~~~~GT~ 177 (270)
T d1t4ha_ 168 SFA----KAVIGTP 177 (270)
T ss_dssp TSB----EESCSSC
T ss_pred Ccc----CCcccCc
Confidence 322 2356774
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=8.5e-31 Score=266.43 Aligned_cols=145 Identities=30% Similarity=0.514 Sum_probs=126.2
Q ss_pred eeeccCCcEEEEEEEec---CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecCCC
Q 006347 487 SKLGQGGFGPVYWGRLK---DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYMPN 561 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~---~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~~~ 561 (649)
++||+|+||+||+|.+. .++.||||+++... ....++|.+|+.++++++|||||+++|+|. .+..+|||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~-~~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-AESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEE-SSSEEEEEECCTT
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEec-cCCEEEEEEcCCC
Confidence 47999999999999865 34689999996432 334578999999999999999999999985 4567899999999
Q ss_pred CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCCC
Q 006347 562 RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQD 638 (649)
Q Consensus 562 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~ 638 (649)
|+|.+++.. ...+++..++.|+.|||+||+|||+.+ ||||||||+|||++.++.+||+|||+|+.+.....
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~ 162 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN 162 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred CcHHHHHhh---ccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhcccccc
Confidence 999999853 456999999999999999999999987 99999999999999999999999999998865443
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=1.2e-30 Score=272.34 Aligned_cols=161 Identities=27% Similarity=0.319 Sum_probs=142.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccce
Confidence 57999999999999999999975 7999999999753 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++.....++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+...
T Consensus 85 ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~ 158 (337)
T d1o6la_ 85 EYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158 (337)
T ss_dssp ECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT
T ss_pred eccCCCchhhhhhc---ccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC
Confidence 99999999999853 456899999999999999999999998 999999999999999999999999999987543
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
... .....||+
T Consensus 159 ~~~--~~~~~GT~ 169 (337)
T d1o6la_ 159 GAT--MKTFCGTP 169 (337)
T ss_dssp TCC--BCCCEECG
T ss_pred Ccc--cccceeCH
Confidence 332 33467874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=99.97 E-value=2.4e-30 Score=271.79 Aligned_cols=152 Identities=24% Similarity=0.389 Sum_probs=137.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|++.+.||+|+||.||+|... +|+.||||+++.......+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~ 108 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFL 108 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcC
Confidence 46999999999999999999975 79999999997765556678899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc--CCCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD--EELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~--~~~~~Ki~DFGla~~~~~~~ 637 (649)
++|+|.+++.. ....+++.++..|+.||+.||+|||+.+ ||||||||+||||+ +++.+||+|||+|+.+....
T Consensus 109 ~gg~L~~~~~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~ 183 (352)
T d1koba_ 109 SGGELFDRIAA--EDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE 183 (352)
T ss_dssp CCCBHHHHTTC--TTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred CCChHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCCC
Confidence 99999888743 3446899999999999999999999988 99999999999998 67899999999999986543
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.97 E-value=8.4e-31 Score=270.43 Aligned_cols=148 Identities=33% Similarity=0.549 Sum_probs=133.2
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---ccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---QGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.|+..++||+|+||+||+|+.. +++.||||+++.... ...+++.+|+.++++++|||||++++++.+++..+||||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E 95 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence 4888999999999999999875 788999999975432 344679999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|+++|+|..++. ....+++.++..++.||++||.|||+++ ||||||||+|||+++++++||+|||+|+....
T Consensus 96 ~~~~g~l~~~~~---~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~ 167 (309)
T d1u5ra_ 96 YCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (309)
T ss_dssp CCSEEHHHHHHH---HTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS
T ss_pred ecCCCchHHHHH---hCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC
Confidence 999999987764 3457999999999999999999999988 99999999999999999999999999997643
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.97 E-value=9.4e-31 Score=267.08 Aligned_cols=152 Identities=32% Similarity=0.555 Sum_probs=128.6
Q ss_pred cCcccceeeccCCcEEEEEEEecCC-----cEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDG-----QEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g-----~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
..|+..+.||+|+||.||+|.++.. ..||||+++... .....+|.+|+.++.+++|||||+++|++.+.+..++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEE
Confidence 4577889999999999999987632 479999996543 3345679999999999999999999999999999999
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++++|.+++.. ....++|.+++.++.||++||+|||+.+ |+||||||+||||++++.+||+|||+|+.+.
T Consensus 87 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHH--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEecccCcchhhhhc--ccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccchhhccc
Confidence 9999999999988754 3456899999999999999999999987 9999999999999999999999999999875
Q ss_pred CCC
Q 006347 635 GNQ 637 (649)
Q Consensus 635 ~~~ 637 (649)
...
T Consensus 162 ~~~ 164 (283)
T d1mqba_ 162 DDP 164 (283)
T ss_dssp ---
T ss_pred CCC
Confidence 443
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=5.4e-31 Score=271.34 Aligned_cols=171 Identities=27% Similarity=0.467 Sum_probs=141.8
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEeccccc-ccHHHHHHHHHHHhcCCCCCccceEEEEE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKASG-QGLEEFMNEVMVISKLQHRNLVRLLGCCV 547 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l~H~niv~l~g~~~ 547 (649)
+++...++|++.++||+|+||+||+|+.. +++.||||+++.... ...++|.+|+.++++++||||++++++|.
T Consensus 7 ~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~ 86 (301)
T d1lufa_ 7 SLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 86 (301)
T ss_dssp HTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred hccCCHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeec
Confidence 34445678999999999999999999864 357899999975433 34578999999999999999999999999
Q ss_pred eCCeEEEEEecCCCCChhhhhcCCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEe
Q 006347 548 EGEEKMLIYEYMPNRSLDALLFDPL---------------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIH 606 (649)
Q Consensus 548 ~~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiH 606 (649)
+.+..++||||+++|+|.++++... ....+++..++.|+.|+++||+|||+.+ |||
T Consensus 87 ~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivH 163 (301)
T d1lufa_ 87 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH 163 (301)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEe
Confidence 9999999999999999999986321 1235899999999999999999999987 999
Q ss_pred cCCCCCcEEEcCCCceEEEecCCceeeCCCCCccccCceeec
Q 006347 607 RDLKASNILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 607 rDlkp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
|||||+|||||.++++||+|||+|+.+.........+...||
T Consensus 164 rDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~ 205 (301)
T d1lufa_ 164 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIP 205 (301)
T ss_dssp SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBC
T ss_pred eEEcccceEECCCCcEEEccchhheeccCCccccccCCCCcC
Confidence 999999999999999999999999987554433333334444
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.96 E-value=4.2e-30 Score=266.07 Aligned_cols=158 Identities=32% Similarity=0.447 Sum_probs=139.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.++||+|+||+||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+.+..++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEe
Confidence 46889999999999999999975 6899999999643 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|..++.. ...+++.....++.||+.||+|||+++ ||||||||+|||+++++.+||+|||+|+.+...
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred eecCCccccccccc---cccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc
Confidence 99999999998853 456788899999999999999999987 999999999999999999999999999987533
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
. ..+.||+
T Consensus 158 ~-----~~~~Gt~ 165 (316)
T d1fota_ 158 T-----YTLCGTP 165 (316)
T ss_dssp B-----CCCCSCT
T ss_pred c-----ccccCcc
Confidence 2 2356764
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.96 E-value=2.5e-30 Score=266.79 Aligned_cols=161 Identities=27% Similarity=0.370 Sum_probs=124.2
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
.+.|++.+.||+|+||+||+|+.. +++.||||++.+.. ....+.+.+|+.++++++|||||++++++.+++..+||||
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE 87 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ 87 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred ccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence 356899999999999999999976 68999999997543 2344678899999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEecCCceeeC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFG 634 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~Ki~DFGla~~~~ 634 (649)
|+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+. +++.+||+|||+|+...
T Consensus 88 ~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~ 161 (307)
T d1a06a_ 88 LVSGGELFDRIVE---KGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161 (307)
T ss_dssp CCCSCBHHHHHHT---CSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC-------
T ss_pred ccCCCcHHHhhhc---ccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEcc
Confidence 9999999999954 457999999999999999999999988 99999999999994 57899999999999875
Q ss_pred CCCCccccCceeecC
Q 006347 635 GNQDQADTGRVVGTL 649 (649)
Q Consensus 635 ~~~~~~~~~~~~GT~ 649 (649)
.... .....||+
T Consensus 162 ~~~~---~~~~~GT~ 173 (307)
T d1a06a_ 162 PGSV---LSTACGTP 173 (307)
T ss_dssp --------------C
T ss_pred CCCe---eeeeeeCc
Confidence 4332 22356774
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=99.96 E-value=6.2e-30 Score=259.85 Aligned_cols=150 Identities=29% Similarity=0.406 Sum_probs=135.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc---------ccHHHHHHHHHHHhcCC-CCCccceEEEEEeC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG---------QGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG 549 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~---------~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~ 549 (649)
++|++.+.||+|+||+||+|+.. +++.||||++++... ...+.+.+|+.++++++ |||||++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence 57899999999999999999975 789999999865321 12346889999999996 99999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
+..+|||||+++|+|.++|.. ...+++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~ 156 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGF 156 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTT
T ss_pred cceEEEEEcCCCchHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchh
Confidence 999999999999999999953 456999999999999999999999988 99999999999999999999999999
Q ss_pred ceeeCCC
Q 006347 630 AKIFGGN 636 (649)
Q Consensus 630 a~~~~~~ 636 (649)
|+.+...
T Consensus 157 a~~~~~~ 163 (277)
T d1phka_ 157 SCQLDPG 163 (277)
T ss_dssp CEECCTT
T ss_pred eeEccCC
Confidence 9988654
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.3e-29 Score=259.78 Aligned_cols=150 Identities=31% Similarity=0.425 Sum_probs=134.9
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc------cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS------GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~------~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
+.|++.+.||+|+||+||+|... +|+.||||++++.. ....+.|.+|+.++++++|||||++++++.+.+..+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ 89 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI 89 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence 57999999999999999999975 78999999986432 124678999999999999999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC----ceEEEecCC
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL----NPKISDFGM 629 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~----~~Ki~DFGl 629 (649)
|||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+
T Consensus 90 iv~E~~~gg~L~~~i~~---~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 90 LILELVAGGELFDFLAE---KESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEcCCCccccchhcc---ccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhh
Confidence 99999999999999953 356999999999999999999999988 99999999999998776 499999999
Q ss_pred ceeeCCC
Q 006347 630 AKIFGGN 636 (649)
Q Consensus 630 a~~~~~~ 636 (649)
|+.+...
T Consensus 164 a~~~~~~ 170 (293)
T d1jksa_ 164 AHKIDFG 170 (293)
T ss_dssp CEECTTS
T ss_pred hhhcCCC
Confidence 9987543
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=5.8e-30 Score=265.50 Aligned_cols=163 Identities=30% Similarity=0.529 Sum_probs=132.8
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc----EEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ----EIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~----~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.+|++.++||+|+||+||+|.+. +|+ +||||+++.. ..+..++|.+|+.++++++|||||+++|+|.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeE
Confidence 35899999999999999999875 343 6899998653 345678999999999999999999999999865 5678
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++||+++|+|.+++.. ....+++..+++|+.|||+||+|||+++ ||||||||+|||++.++++||+|||+|+.+.
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEeccCCcccccccc--cccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence 8999999999988864 3456899999999999999999999987 9999999999999999999999999999986
Q ss_pred CCCCccccCceeecC
Q 006347 635 GNQDQADTGRVVGTL 649 (649)
Q Consensus 635 ~~~~~~~~~~~~GT~ 649 (649)
.......+....||+
T Consensus 163 ~~~~~~~~~~~~gt~ 177 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPI 177 (317)
T ss_dssp TTCC--------CCT
T ss_pred cccccccccccccCc
Confidence 655544444456663
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-30 Score=265.92 Aligned_cols=172 Identities=28% Similarity=0.407 Sum_probs=133.6
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCC 546 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~ 546 (649)
+.+...++|++.++||+|+||.||+|+.. +++.||||+++... ....+++.+|...+.++ +|+|||++++++
T Consensus 7 ~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~ 86 (299)
T d1ywna1 7 KWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86 (299)
T ss_dssp HHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeee
Confidence 33334467999999999999999999864 34689999997533 34567788898888887 789999999998
Q ss_pred EeCC-eEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCC
Q 006347 547 VEGE-EKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKAS 612 (649)
Q Consensus 547 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~ 612 (649)
.+.+ ..++||||+++|+|.++|+... ....+++.+++.++.||++||+|||+++ ||||||||+
T Consensus 87 ~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDlKp~ 163 (299)
T d1ywna1 87 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAAR 163 (299)
T ss_dssp CSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGG
T ss_pred ccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcCCcCCcc
Confidence 7654 6899999999999999996422 1345899999999999999999999987 999999999
Q ss_pred cEEEcCCCceEEEecCCceeeCCCCCccccCceeecC
Q 006347 613 NILLDEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 613 NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
||||++++++||+|||+|+...............||+
T Consensus 164 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~ 200 (299)
T d1ywna1 164 NILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 200 (299)
T ss_dssp GEEECGGGCEEECC------CCSCTTSCCTTSCCCGG
T ss_pred ceeECCCCcEEEccCcchhhccccccccccCceeeCc
Confidence 9999999999999999999876655555555567773
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-29 Score=259.81 Aligned_cols=150 Identities=21% Similarity=0.327 Sum_probs=134.2
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++|.+.+.||+|+||+||+|... +++.||||.++... .....+.+|++++++++|||||++++++.+++..+|||||+
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~ 83 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFI 83 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCC
T ss_pred cceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc-ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecC
Confidence 57899999999999999999976 68899999997643 34567889999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCC--CceEEEecCCceeeCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEE--LNPKISDFGMAKIFGGN 636 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~--~~~Ki~DFGla~~~~~~ 636 (649)
++|+|.+++.. ....+++.++..|+.||++||+|||+.+ |+||||||+|||++.+ ..+||+|||+++.....
T Consensus 84 ~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 84 SGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC
Confidence 99999999954 2346899999999999999999999988 9999999999999854 58999999999987543
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.8e-30 Score=262.98 Aligned_cols=166 Identities=30% Similarity=0.469 Sum_probs=140.8
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEK 552 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~ 552 (649)
.++|.+.++||+|+||.||+|.+. +++.||||+++... .+....|.+|+.++++++|||||+++|+|...++.
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCce
Confidence 467888899999999999999864 35789999997543 34456799999999999999999999999999999
Q ss_pred EEEEecCCCCChhhhhcCC-------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 553 MLIYEYMPNRSLDALLFDP-------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 553 ~lV~Ey~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
++||||+++|+|.+++... .....+++..+.+++.|+|+||.|||+++ |+||||||+|||+++++++||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred eEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCceeecCCceEEEe
Confidence 9999999999999998531 12245799999999999999999999987 9999999999999999999999
Q ss_pred ecCCceeeCCCCCccccCceeec
Q 006347 626 DFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 626 DFGla~~~~~~~~~~~~~~~~GT 648 (649)
|||+|+.+..........+..||
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t 198 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLP 198 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEEC
T ss_pred ecccceeccCCcceeeccceecc
Confidence 99999987554443334444555
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=99.96 E-value=2.4e-29 Score=263.99 Aligned_cols=158 Identities=27% Similarity=0.364 Sum_probs=140.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~ 556 (649)
++|++.+.||+|+||.||+|+.. +|+.||||++++. .....+.+.+|+.++++++|||||++++++.+....++||
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred cCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeeccccccccccccccc
Confidence 47999999999999999999976 7999999998643 2345678999999999999999999999999999999999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
||+++|+|.+++.. ...+++..+..++.||++||.|||+.+ ||||||||+|||++.++++||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRR---IGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHH---HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred ccccccchhhhHhh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc
Confidence 99999999999853 356899999999999999999999988 999999999999999999999999999987543
Q ss_pred CCccccCceeecC
Q 006347 637 QDQADTGRVVGTL 649 (649)
Q Consensus 637 ~~~~~~~~~~GT~ 649 (649)
. ....||+
T Consensus 195 ~-----~~~~Gt~ 202 (350)
T d1rdqe_ 195 T-----WTLCGTP 202 (350)
T ss_dssp B-----CCCEECG
T ss_pred c-----ccccCcc
Confidence 2 2356763
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=99.96 E-value=2.6e-29 Score=265.13 Aligned_cols=159 Identities=30% Similarity=0.347 Sum_probs=135.1
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHH---HHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMN---EVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~---E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|++.+.||+|+||.||+|+.. +|+.||||++.+.. ......+.+ |+.+++.++|||||++++++.+.+..+
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEE
Confidence 67999999999999999999976 68999999986421 223334444 467778888999999999999999999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
|||||+++|+|.++|.. ...+++.++..++.||+.||+|||+.+ ||||||||+|||+++++.+||+|||+|+.+
T Consensus 84 ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~ 157 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDF 157 (364)
T ss_dssp EEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEEC
T ss_pred EEEEecCCCcHHHHHHh---cccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeec
Confidence 99999999999999953 356889999999999999999999988 999999999999999999999999999987
Q ss_pred CCCCCccccCceeecC
Q 006347 634 GGNQDQADTGRVVGTL 649 (649)
Q Consensus 634 ~~~~~~~~~~~~~GT~ 649 (649)
..... ....||+
T Consensus 158 ~~~~~----~~~~GT~ 169 (364)
T d1omwa3 158 SKKKP----HASVGTH 169 (364)
T ss_dssp SSSCC----CSCCSCG
T ss_pred CCCcc----ccccccc
Confidence 55432 2345663
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.7e-29 Score=258.59 Aligned_cols=160 Identities=27% Similarity=0.418 Sum_probs=129.3
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHH--HHHHhcCCCCCccceEEEEEeCC----eEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNE--VMVISKLQHRNLVRLLGCCVEGE----EKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E--~~~l~~l~H~niv~l~g~~~~~~----~~~l 554 (649)
++|.+.++||+|+||+||+|++. |+.||||+++.. ..+++..| +..+.+++|||||+++|+|.+.+ ..++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~~-g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKWR-GEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEET-TEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred cEEEEEEEEeeCCCeEEEEEEEC-CEEEEEEEECcc---chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence 35677899999999999999975 889999999643 23444444 45556789999999999998754 5799
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhC-----CCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRD-----SRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
||||+++|+|.++|++ ..++|..+++++.|+|+||+|||+. ...+||||||||+||||++++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEecccCCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCc
Confidence 9999999999999953 3589999999999999999999974 234699999999999999999999999999
Q ss_pred ceeeCCCCCcc--ccCceeec
Q 006347 630 AKIFGGNQDQA--DTGRVVGT 648 (649)
Q Consensus 630 a~~~~~~~~~~--~~~~~~GT 648 (649)
++.+....... ......||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt 175 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGT 175 (303)
T ss_dssp CEEEETTTTEECC----CCSC
T ss_pred cccccCCCcceeccccceecc
Confidence 99985543322 22345566
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=1.6e-29 Score=256.46 Aligned_cols=153 Identities=32% Similarity=0.498 Sum_probs=125.6
Q ss_pred cCcccceeeccCCcEEEEEEEec--CC--cEEEEEEeccc---ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK--DG--QEIAVKRLSKA---SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~--~g--~~vAVK~l~~~---~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~ 553 (649)
++|++.+.||+|+||.||+|++. ++ .+||||++++. .....++|.+|+.++++++|||||+++|++.+ +..+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence 56888999999999999999864 22 47999998653 23445789999999999999999999999965 4678
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceee
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIF 633 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~ 633 (649)
+||||+++|+|.+++.. +...+++..+++++.|||+||.|||+++ |+||||||+||||+.++.+||+|||+|+.+
T Consensus 87 lv~e~~~~~~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHH--HGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred eeeeeecCcchhhhhhc--ccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhc
Confidence 99999999999988754 3456999999999999999999999987 999999999999999999999999999998
Q ss_pred CCCCCc
Q 006347 634 GGNQDQ 639 (649)
Q Consensus 634 ~~~~~~ 639 (649)
......
T Consensus 162 ~~~~~~ 167 (273)
T d1u46a_ 162 PQNDDH 167 (273)
T ss_dssp CC-CCE
T ss_pred ccCCCc
Confidence 655443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=3.5e-29 Score=257.28 Aligned_cols=151 Identities=27% Similarity=0.468 Sum_probs=130.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.++||+|+||+||+|+.. +|+.||||+++... ....+++.+|+.++++++|||||++++++.++++.++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence 57999999999999999999975 78999999996432 2346789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
|+.++.+...... ....+++..+..++.||+.||+|||+.+ ||||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~~~~~~~~--~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~ 155 (298)
T d1gz8a_ 82 FLHQDLKKFMDAS--ALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155 (298)
T ss_dssp CCSEEHHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC
T ss_pred ecCCchhhhhhhh--cccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC
Confidence 9976544433322 3456999999999999999999999988 999999999999999999999999999987543
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4e-29 Score=258.19 Aligned_cols=151 Identities=34% Similarity=0.585 Sum_probs=131.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCc--EEEEEEeccc-ccccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQ--EIAVKRLSKA-SGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~--~vAVK~l~~~-~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~~~lV 555 (649)
++|++.++||+|+||.||+|++. ++. .||||+++.. .....++|.+|++++.++ +|||||+++|+|.+.+..++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence 56788899999999999999986 343 5888988543 334567899999999999 799999999999999999999
Q ss_pred EecCCCCChhhhhcCC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCce
Q 006347 556 YEYMPNRSLDALLFDP-------------LKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNP 622 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~ 622 (649)
|||+++|+|.++|+.. .....+++..+.+++.|||+||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCce
Confidence 9999999999999753 23467999999999999999999999987 9999999999999999999
Q ss_pred EEEecCCceeeC
Q 006347 623 KISDFGMAKIFG 634 (649)
Q Consensus 623 Ki~DFGla~~~~ 634 (649)
||+|||+|+...
T Consensus 167 kl~DfG~a~~~~ 178 (309)
T d1fvra_ 167 KIADFGLSRGQE 178 (309)
T ss_dssp EECCTTCEESSC
T ss_pred EEcccccccccc
Confidence 999999998754
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.3e-29 Score=255.32 Aligned_cols=151 Identities=25% Similarity=0.424 Sum_probs=124.4
Q ss_pred hcCcccceeeccCCcEEEEEEEecC----CcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEE
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD----GQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~----g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~l 554 (649)
.++|++.+.||+|+||+||+|++.. +..||||+++... ....+.|.+|+.++++++|||||+++|++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEE
Confidence 3578889999999999999998752 4579999986543 334578999999999999999999999985 567899
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
||||+++|+|.+++.. ....+++..++.++.||++||.|||+.+ ||||||||+||++++++.+||+|||+|+.+.
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEeccCCcHHhhhhc--cCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccchhheecc
Confidence 9999999999998754 3456899999999999999999999988 9999999999999999999999999999875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 160 ~~ 161 (273)
T d1mp8a_ 160 DS 161 (273)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=4.3e-29 Score=258.92 Aligned_cols=161 Identities=32% Similarity=0.428 Sum_probs=138.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc---ccccHHHHHHHHHHHh-cCCCCCccceEEEEEeCCeEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA---SGQGLEEFMNEVMVIS-KLQHRNLVRLLGCCVEGEEKMLI 555 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~---~~~~~~~f~~E~~~l~-~l~H~niv~l~g~~~~~~~~~lV 555 (649)
++|.+.+.||+|+||+||+|+.. +++.||||++++. .....+.+..|+.++. .++|||||++++++.+++..+||
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence 57889999999999999999986 6899999999653 2345567778877765 68999999999999999999999
Q ss_pred EecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 556 YEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 556 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
|||+++|+|.+++.. ...+++.++..++.||+.||+|||+++ |+||||||+|||+++++++||+|||+|+....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EeecCCCcHHHHhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhccc
Confidence 999999999999953 356889999999999999999999998 99999999999999999999999999997754
Q ss_pred CCCccccCceeecC
Q 006347 636 NQDQADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~~~~~~~~GT~ 649 (649)
.... .....||+
T Consensus 156 ~~~~--~~~~~gt~ 167 (320)
T d1xjda_ 156 GDAK--TNTFCGTP 167 (320)
T ss_dssp TTCC--BCCCCSCG
T ss_pred cccc--ccccCCCC
Confidence 4332 22356663
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=2.6e-29 Score=259.82 Aligned_cols=167 Identities=31% Similarity=0.437 Sum_probs=142.9
Q ss_pred hcCcccceeeccCCcEEEEEEEec------CCcEEEEEEecccc-cccHHHHHHHHHHHhcC-CCCCccceEEEEEeCCe
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK------DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKL-QHRNLVRLLGCCVEGEE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~------~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~~~ 551 (649)
.++|++.+.||+|+||.||+|++. +++.||||+++... .....+|.+|+.++.++ +|||||+++|+|.+++.
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence 367888899999999999999863 45789999997543 34556899999999999 79999999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 552 KMLIYEYMPNRSLDALLFDPL---------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
.+|||||+++|+|.++++... ....+++..+.+++.||++||+|||+++ ||||||||+|||+
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccccccccc
Confidence 999999999999999986432 2236899999999999999999999998 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCCCCccccCceeecC
Q 006347 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~ 649 (649)
+.++.+||+|||+++...............||+
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~ 211 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPV 211 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECG
T ss_pred cccCcccccccchheeccCCCcceEeeecccCh
Confidence 999999999999999886655444455566663
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.96 E-value=8.6e-29 Score=255.67 Aligned_cols=147 Identities=27% Similarity=0.539 Sum_probs=129.0
Q ss_pred ceeeccCCcEEEEEEEecCC----cEEEEEEeccc-ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC-CeEEEEEecC
Q 006347 486 SSKLGQGGFGPVYWGRLKDG----QEIAVKRLSKA-SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-EEKMLIYEYM 559 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~g----~~vAVK~l~~~-~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 559 (649)
.++||+|+||+||+|++.++ ..||||++++. .....++|.+|++++++++|||||+++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEe
Confidence 47899999999999997532 36899999753 445668899999999999999999999999875 5789999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
++|+|.+++.. ....+++..+++++.|+|+||.|||+.+ |+||||||+||||++++.+||+|||+++.+....
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~ 184 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE 184 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred ecCchhhhhcc--ccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence 99999999865 3455789999999999999999999987 9999999999999999999999999999875443
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=99.95 E-value=7e-29 Score=253.47 Aligned_cols=150 Identities=25% Similarity=0.439 Sum_probs=135.0
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.++||+|+||+||+|+.++|+.||||+++... ....+.+.+|+.++++++|||||++++++.+.+..++++||
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence 5789999999999999999999999999999996542 33467899999999999999999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
+.++.+..+.. ....+++..+..|+.||++||+|||+.+ ||||||||+|||++.++.+||+|||+|......
T Consensus 82 ~~~~~~~~~~~---~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~ 153 (286)
T d1ob3a_ 82 LDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP 153 (286)
T ss_dssp CSEEHHHHHHT---STTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-
T ss_pred ehhhhHHHHHh---hcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccC
Confidence 98877776663 3467999999999999999999999987 999999999999999999999999999987543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=2.7e-29 Score=252.98 Aligned_cols=148 Identities=32% Similarity=0.529 Sum_probs=126.4
Q ss_pred cCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeC-CeEEEEEecC
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-EEKMLIYEYM 559 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-~~~~lV~Ey~ 559 (649)
++|++.+.||+|+||.||+|.++ |++||||+++.. ...++|.+|++++++++|||||+++|+|.+. +..++||||+
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~~-~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~ 83 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDYR-GNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 83 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEET-TEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCC
T ss_pred HHeEEeEEEecCCCeEEEEEEEC-CeEEEEEEECcH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEecc
Confidence 46788899999999999999986 789999999653 4557899999999999999999999999765 5679999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGG 635 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~ 635 (649)
++|+|.++|+.. ....++|..+++|+.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++....
T Consensus 84 ~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~ 155 (262)
T d1byga_ 84 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASS 155 (262)
T ss_dssp TTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC------
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccceecCC
Confidence 999999999642 2335899999999999999999999987 99999999999999999999999999998644
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=5.6e-29 Score=255.89 Aligned_cols=146 Identities=30% Similarity=0.419 Sum_probs=125.9
Q ss_pred ceeeccCCcEEEEEEEec-CCcEEEEEEecccccc-----cHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEecC
Q 006347 486 SSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQ-----GLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYEYM 559 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~-----~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~Ey~ 559 (649)
++.||+|+||+||+|+.. +|+.||||+++..... ..+.+.+|+.++++++|||||++++++.+++..+|||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence 478999999999999976 6899999998653221 2356899999999999999999999999999999999999
Q ss_pred CCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCCC
Q 006347 560 PNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGNQ 637 (649)
Q Consensus 560 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~~ 637 (649)
+++++..++. ....+++.++..++.||++||+|||+++ |+||||||+|||+++++.+||+|||+|+.+....
T Consensus 83 ~~~~~~~~~~---~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~ 154 (299)
T d1ua2a_ 83 ETDLEVIIKD---NSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154 (299)
T ss_dssp SEEHHHHHTT---CCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred cchHHhhhhh---cccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc
Confidence 9887776653 3456888999999999999999999988 9999999999999999999999999999875443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=99.95 E-value=1.6e-28 Score=249.62 Aligned_cols=164 Identities=24% Similarity=0.395 Sum_probs=132.7
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc---cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC----e
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS---GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----E 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~---~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~ 551 (649)
.++|++.+.||+|+||+||+|+.. +|+.||||.+++.. ....+.|.+|+.++++++|||||++++++.+.+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred cceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCce
Confidence 367999999999999999999975 78999999997543 233567999999999999999999999998754 3
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.+|||||+++++|.+++.. ...+++.++..|+.||++||+|||+.+ |+||||||+|||++.++..||+|||+++
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEehhhhcc---cCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhh
Confidence 7899999999999998853 356899999999999999999999988 9999999999999999999999999998
Q ss_pred eeCCCCCc-cccCceeecC
Q 006347 632 IFGGNQDQ-ADTGRVVGTL 649 (649)
Q Consensus 632 ~~~~~~~~-~~~~~~~GT~ 649 (649)
........ .......||+
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~ 178 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTA 178 (277)
T ss_dssp ECC----------------
T ss_pred hhccccccccccccccCcc
Confidence 76443222 2333456664
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=8e-29 Score=254.68 Aligned_cols=166 Identities=28% Similarity=0.437 Sum_probs=136.0
Q ss_pred hcCcccceeeccCCcEEEEEEEecC--------CcEEEEEEeccccc-ccHHHHHHHHHHHhcC-CCCCccceEEEEEeC
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLKD--------GQEIAVKRLSKASG-QGLEEFMNEVMVISKL-QHRNLVRLLGCCVEG 549 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~~--------g~~vAVK~l~~~~~-~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~~ 549 (649)
.++|.+.+.||+|+||.||+|+... +..||||++++... ....++.+|+..+.++ +|||||+++++|.++
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC
Confidence 3578888999999999999998642 34799999976443 4567899999999988 899999999999999
Q ss_pred CeEEEEEecCCCCChhhhhcCCC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEE
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPL-------------KKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILL 616 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl 616 (649)
+..++||||+++|+|.++|.... ....+++.++++++.||++||+|||+.+ ||||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---EEeeeecccceee
Confidence 99999999999999999997532 1246899999999999999999999998 9999999999999
Q ss_pred cCCCceEEEecCCceeeCCCCCccccCceeec
Q 006347 617 DEELNPKISDFGMAKIFGGNQDQADTGRVVGT 648 (649)
Q Consensus 617 ~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT 648 (649)
+.++.+||+|||+++..........+....||
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~ 200 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCG
T ss_pred cCCCCeEeccchhhccccccccccccccCCCC
Confidence 99999999999999988655444444444554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=6e-28 Score=251.82 Aligned_cols=148 Identities=25% Similarity=0.339 Sum_probs=127.3
Q ss_pred cCcccce-eeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcC-CCCCccceEEEEEe----CCeEE
Q 006347 481 NNFQLSS-KLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKL-QHRNLVRLLGCCVE----GEEKM 553 (649)
Q Consensus 481 ~~f~~~~-~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l-~H~niv~l~g~~~~----~~~~~ 553 (649)
++|.+.+ .||+|+||+||+|+.. +++.||||+++. .+.+.+|+.++.++ +|||||++++++.+ ....+
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ 85 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL 85 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred cCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-----cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence 5788765 5999999999999974 789999999854 25677899987655 89999999999876 35689
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC---CCceEEEecCCc
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE---ELNPKISDFGMA 630 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~---~~~~Ki~DFGla 630 (649)
||||||++|+|.++|.+. ....+++.++..|+.||+.||+|||+.+ |+||||||+|||+++ ++.+||+|||+|
T Consensus 86 ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a 161 (335)
T d2ozaa1 86 IVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGFA 161 (335)
T ss_dssp EEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTTC
T ss_pred EEEECCCCCcHHHHHHhc-CCCCcCHHHHHHHHHHHHHHHHHHHHcC---Ccccccccccccccccccccccccccccee
Confidence 999999999999999653 2356999999999999999999999988 999999999999985 567999999999
Q ss_pred eeeCCCC
Q 006347 631 KIFGGNQ 637 (649)
Q Consensus 631 ~~~~~~~ 637 (649)
+......
T Consensus 162 ~~~~~~~ 168 (335)
T d2ozaa1 162 KETTSHN 168 (335)
T ss_dssp EECCCCC
T ss_pred eeccCCC
Confidence 9875543
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.95 E-value=4e-28 Score=246.11 Aligned_cols=149 Identities=26% Similarity=0.375 Sum_probs=129.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccccc------ccHHHHHHHHHHHhcCC--CCCccceEEEEEeCCe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASG------QGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGEE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~------~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~ 551 (649)
++|++.+.||+|+||+||+|+.. +|+.||||++++... ...+++.+|+.++++++ |||||++++++.+++.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 57999999999999999999975 789999999865321 12345778999999996 8999999999999999
Q ss_pred EEEEEecCCC-CChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-CCceEEEecCC
Q 006347 552 KMLIYEYMPN-RSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-ELNPKISDFGM 629 (649)
Q Consensus 552 ~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-~~~~Ki~DFGl 629 (649)
.++||||+.+ +++.+++.. ...+++.++..++.||++||+|||+.+ |+||||||+|||++. ++.+||+|||+
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~ 157 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGS 157 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTT
T ss_pred EEEEEEeccCcchHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECcccc
Confidence 9999999976 577777743 456899999999999999999999988 999999999999985 47999999999
Q ss_pred ceeeCC
Q 006347 630 AKIFGG 635 (649)
Q Consensus 630 a~~~~~ 635 (649)
|+....
T Consensus 158 a~~~~~ 163 (273)
T d1xwsa_ 158 GALLKD 163 (273)
T ss_dssp CEECCS
T ss_pred ceeccc
Confidence 998643
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-27 Score=250.68 Aligned_cols=149 Identities=24% Similarity=0.406 Sum_probs=127.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc-cccHHHHHHHHHHHhcCCCCCccceEEEEEeCC----eEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS-GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE----EKML 554 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~-~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~----~~~l 554 (649)
.+|++.++||+|+||+||+|+.. +|+.||||++++.. ....+++++|+.+|++++||||+++++++.... ..++
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~ 87 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVY 87 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEE
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEE
Confidence 46999999999999999999865 79999999997543 334578999999999999999999999997654 2355
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeC
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFG 634 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~ 634 (649)
++||+.+|+|.+++.. ..+++..+..++.||++||+|||+++ ||||||||+|||+++++.+||+|||+|+...
T Consensus 88 l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~ 160 (345)
T d1pmea_ 88 LVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVAD 160 (345)
T ss_dssp EEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred EEEeecCCchhhhhhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeecc
Confidence 5667779999999943 46899999999999999999999988 9999999999999999999999999999875
Q ss_pred CC
Q 006347 635 GN 636 (649)
Q Consensus 635 ~~ 636 (649)
..
T Consensus 161 ~~ 162 (345)
T d1pmea_ 161 PD 162 (345)
T ss_dssp GG
T ss_pred CC
Confidence 44
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=4.5e-27 Score=240.32 Aligned_cols=150 Identities=23% Similarity=0.422 Sum_probs=135.5
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeCCeEEEEEe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~~~~lV~E 557 (649)
++|++.++||+|+||+||+|+.. +++.||||+++... ....+++.+|+.++++++||||+++++++.+....++|+|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence 57999999999999999999975 78999999986432 3456789999999999999999999999999999999999
Q ss_pred cCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCceeeCCC
Q 006347 558 YMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAKIFGGN 636 (649)
Q Consensus 558 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~~~~~ 636 (649)
++.+++|..++.. ...+++..+..++.|+++||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 82 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~ 154 (292)
T d1unla_ 82 FCDQDLKKYFDSC---NGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP 154 (292)
T ss_dssp CCSEEHHHHHHHT---TTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSC
T ss_pred ecccccccccccc---ccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCC
Confidence 9999999888743 456889999999999999999999987 999999999999999999999999999987543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=2.5e-27 Score=248.89 Aligned_cols=149 Identities=28% Similarity=0.393 Sum_probs=123.8
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------eEEE
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------EKML 554 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------~~~l 554 (649)
+|+..++||+|+||+||+|+.. +|+.||||++..... .+.+|+.++++++|+|||++++++.... ..+|
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch----HHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEE
Confidence 5788899999999999999986 689999999965432 2347999999999999999999996533 4689
Q ss_pred EEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceee
Q 006347 555 IYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIF 633 (649)
Q Consensus 555 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~ 633 (649)
||||++++.+..+.........+++.++..++.||++||+|||+++ |+||||||+|||++.++ .+||+|||+|+.+
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecccchhhc
Confidence 9999987654444322223557999999999999999999999987 99999999999999765 8999999999987
Q ss_pred CCCC
Q 006347 634 GGNQ 637 (649)
Q Consensus 634 ~~~~ 637 (649)
...+
T Consensus 174 ~~~~ 177 (350)
T d1q5ka_ 174 VRGE 177 (350)
T ss_dssp CTTS
T ss_pred cCCc
Confidence 5443
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=99.94 E-value=7.1e-27 Score=243.21 Aligned_cols=145 Identities=24% Similarity=0.421 Sum_probs=127.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeC--CeEEEEE
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEG--EEKMLIY 556 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~--~~~~lV~ 556 (649)
++|++.++||+|+||+||+|+.. +++.||||+++.. ..+++.+|+.++.+++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred cCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEE
Confidence 57999999999999999999975 7899999999643 4578899999999995 99999999999854 4589999
Q ss_pred ecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCC-ceEEEecCCceeeCC
Q 006347 557 EYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEEL-NPKISDFGMAKIFGG 635 (649)
Q Consensus 557 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~-~~Ki~DFGla~~~~~ 635 (649)
||+++++|..+. +.+++.++..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||+|+.+..
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred eecCCCcHHHHh------cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccC
Confidence 999999997764 35899999999999999999999998 99999999999998655 699999999998754
Q ss_pred CC
Q 006347 636 NQ 637 (649)
Q Consensus 636 ~~ 637 (649)
.+
T Consensus 183 ~~ 184 (328)
T d3bqca1 183 GQ 184 (328)
T ss_dssp TC
T ss_pred CC
Confidence 43
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.3e-26 Score=240.03 Aligned_cols=150 Identities=27% Similarity=0.497 Sum_probs=128.3
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeC--------
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-------- 549 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-------- 549 (649)
++|++.++||+|+||+||+|+.. +|+.||||++... .....+++.+|+.++++++|+|++++++.+...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~ 89 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCK 89 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC---------
T ss_pred CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccC
Confidence 67999999999999999999975 7999999998543 334567899999999999999999999998653
Q ss_pred CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCC
Q 006347 550 EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGM 629 (649)
Q Consensus 550 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGl 629 (649)
+..++||||++++.+..+.. ....++......++.||+.||.|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 90 ~~~~iv~e~~~~~~~~~~~~---~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 90 GSIYLVFDFCEHDLAGLLSN---VLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp -CEEEEEECCCEEHHHHHTC---TTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTT
T ss_pred ceEEEEEeccCCCccchhhh---cccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecce
Confidence 45789999998887765552 3456888999999999999999999988 99999999999999999999999999
Q ss_pred ceeeCCC
Q 006347 630 AKIFGGN 636 (649)
Q Consensus 630 a~~~~~~ 636 (649)
|+.+...
T Consensus 164 ~~~~~~~ 170 (318)
T d3blha1 164 ARAFSLA 170 (318)
T ss_dssp CEECCC-
T ss_pred eeecccc
Confidence 9987543
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.2e-26 Score=243.44 Aligned_cols=149 Identities=27% Similarity=0.454 Sum_probs=125.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEeccc--ccccHHHHHHHHHHHhcCCCCCccceEEEEEeCC------
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKA--SGQGLEEFMNEVMVISKLQHRNLVRLLGCCVEGE------ 550 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~--~~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~~------ 550 (649)
.++|++.++||+|+||+||+|... +|+.||||++++. .....+.+.+|+.+|++++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~ 96 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT 96 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence 367999999999999999999975 6999999999753 2334568899999999999999999999998765
Q ss_pred eEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCc
Q 006347 551 EKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMA 630 (649)
Q Consensus 551 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla 630 (649)
+.+|||||+ +.+|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+|
T Consensus 97 ~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 97 DFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred eEEEEEecc-cccHHHHHH----hccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccce
Confidence 469999999 567777763 356999999999999999999999998 999999999999999999999999999
Q ss_pred eeeCCC
Q 006347 631 KIFGGN 636 (649)
Q Consensus 631 ~~~~~~ 636 (649)
+.....
T Consensus 169 ~~~~~~ 174 (346)
T d1cm8a_ 169 RQADSE 174 (346)
T ss_dssp EECCSS
T ss_pred eccCCc
Confidence 987543
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=6.2e-27 Score=242.79 Aligned_cols=151 Identities=31% Similarity=0.402 Sum_probs=132.9
Q ss_pred cCcccceeeccCCcEEEEEEEec----CCcEEEEEEecccc----cccHHHHHHHHHHHhcCCC-CCccceEEEEEeCCe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK----DGQEIAVKRLSKAS----GQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~----~g~~vAVK~l~~~~----~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~ 551 (649)
++|++.++||+|+||+||+|+.. +|+.||||.+++.. ....+.+.+|++++.+++| |||+++++++.+...
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence 56999999999999999999852 58899999986432 2345678999999999965 899999999999999
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+.+|+|.+++.. ...+.......++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+|+
T Consensus 104 ~~~v~e~~~~~~L~~~i~~---~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~ 177 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQ---RERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSK 177 (322)
T ss_dssp EEEEECCCCSCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEE
T ss_pred eeeeeecccccHHHHHHHh---cccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchh
Confidence 9999999999999999853 345678888999999999999999988 9999999999999999999999999999
Q ss_pred eeCCCC
Q 006347 632 IFGGNQ 637 (649)
Q Consensus 632 ~~~~~~ 637 (649)
.+....
T Consensus 178 ~~~~~~ 183 (322)
T d1vzoa_ 178 EFVADE 183 (322)
T ss_dssp ECCGGG
T ss_pred hhcccc
Confidence 875433
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.93 E-value=4.4e-26 Score=233.32 Aligned_cols=161 Identities=20% Similarity=0.329 Sum_probs=135.4
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCC-CCccceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQH-RNLVRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H-~niv~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.++||+|+||+||+|+.. +|+.||||.++... ..+.+.+|++++..++| +|++.+++++.++...++||||
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~ 82 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL 82 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEcccc--CcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence 67999999999999999999976 68999999885432 33567889999999964 8999999999999999999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcC-----CCceEEEecCCceee
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDE-----ELNPKISDFGMAKIF 633 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~-----~~~~Ki~DFGla~~~ 633 (649)
+ +++|.+++.. ....+++.++..++.|++.||+|||+.+ ||||||||+|||++. ++.+||+|||+|+.+
T Consensus 83 ~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~ 156 (293)
T d1csna_ 83 L-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFY 156 (293)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEES
T ss_pred c-CCCHHHHHHh--hccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeEEc
Confidence 9 7899998854 3346899999999999999999999988 999999999999974 567999999999997
Q ss_pred CCCCCc-----cccCceeecC
Q 006347 634 GGNQDQ-----ADTGRVVGTL 649 (649)
Q Consensus 634 ~~~~~~-----~~~~~~~GT~ 649 (649)
...... .....++||+
T Consensus 157 ~~~~~~~~~~~~~~~~~~GT~ 177 (293)
T d1csna_ 157 RDPVTKQHIPYREKKNLSGTA 177 (293)
T ss_dssp BCTTTCCBCCCCCCCCCCSCT
T ss_pred ccCccccceeecccCceEEch
Confidence 543222 1233467875
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=2.9e-26 Score=236.03 Aligned_cols=162 Identities=28% Similarity=0.435 Sum_probs=130.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-C-CcEEEEEEecccc--cccHHHHHHHHHHHhcC---CCCCccceEEEEEe----
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-D-GQEIAVKRLSKAS--GQGLEEFMNEVMVISKL---QHRNLVRLLGCCVE---- 548 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~-g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l---~H~niv~l~g~~~~---- 548 (649)
.++|++.++||+|+||+||+|+.. + ++.||||+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred cCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 468999999999999999999974 4 6679999986432 22344567788777665 79999999999864
Q ss_pred -CCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEec
Q 006347 549 -GEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDF 627 (649)
Q Consensus 549 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DF 627 (649)
....+++|||++++.+...... ....+++.....++.|++.||+|||+++ ||||||||+|||+++++.+||+||
T Consensus 86 ~~~~~~~~~e~~~~~~~~~~~~~--~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 86 RETKLTLVFEHVDQDLTTYLDKV--PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SEEEEEEEEECCSCBHHHHHHHS--CTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred cCceEEEEEEeccCCchhhhhhc--cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence 2367899999998877655432 3456899999999999999999999988 999999999999999999999999
Q ss_pred CCceeeCCCCCccccCceeecC
Q 006347 628 GMAKIFGGNQDQADTGRVVGTL 649 (649)
Q Consensus 628 Gla~~~~~~~~~~~~~~~~GT~ 649 (649)
|+++...... ......||+
T Consensus 161 g~~~~~~~~~---~~~~~~gT~ 179 (305)
T d1blxa_ 161 GLARIYSFQM---ALTSVVVTL 179 (305)
T ss_dssp CSCCCCCGGG---GGCCCCCCC
T ss_pred hhhhhhcccc---cCCCcccCh
Confidence 9999764332 223456664
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.92 E-value=2.1e-25 Score=228.88 Aligned_cols=161 Identities=24% Similarity=0.421 Sum_probs=128.7
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc-cceEEEEEeCCeEEEEEec
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL-VRLLGCCVEGEEKMLIYEY 558 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni-v~l~g~~~~~~~~~lV~Ey 558 (649)
++|++.+.||+|+||.||+|+.. +|+.||||.+.... ..+++..|++++++++|+|+ +.+.++..+++..++||||
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~ 84 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKT--KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL 84 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCT--TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhc--cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence 46999999999999999999875 68999999886533 33568899999999977665 4555666778889999999
Q ss_pred CCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEc---CCCceEEEecCCceeeCC
Q 006347 559 MPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLD---EELNPKISDFGMAKIFGG 635 (649)
Q Consensus 559 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~---~~~~~Ki~DFGla~~~~~ 635 (649)
+ +++|.+.+.. ....+++..+..++.|+++||+|||+++ ||||||||+|||++ .+..+||+|||+|+.+..
T Consensus 85 ~-~~~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~ 158 (299)
T d1ckia_ 85 L-GPSLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD 158 (299)
T ss_dssp C-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred c-CCchhhhhhh--ccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence 9 5566666533 3456899999999999999999999988 99999999999986 356799999999999854
Q ss_pred CCCc-----cccCceeecC
Q 006347 636 NQDQ-----ADTGRVVGTL 649 (649)
Q Consensus 636 ~~~~-----~~~~~~~GT~ 649 (649)
.... .....+.||+
T Consensus 159 ~~~~~~~~~~~~~~~~gt~ 177 (299)
T d1ckia_ 159 ARTHQHIPYRENKNLTGTA 177 (299)
T ss_dssp TTTCCBCCCCBCCSCCCCS
T ss_pred cccccceeccccCCcCCCc
Confidence 4322 1233456774
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=6.8e-26 Score=237.60 Aligned_cols=148 Identities=28% Similarity=0.417 Sum_probs=126.1
Q ss_pred hcCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEeC-----Ce
Q 006347 480 TNNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVEG-----EE 551 (649)
Q Consensus 480 ~~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~~-----~~ 551 (649)
.++|++.++||+|+||+||+|+.. +|+.||||++++.. ....+++.+|+.++++++|+|+|++++++... ..
T Consensus 17 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 17 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp ETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence 467999999999999999999965 79999999997543 23456789999999999999999999998743 34
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++++||+.+|+|.+++.. ..+++.++..++.||+.||+|||+++ |+||||||+|||++.++.+|++|||+|.
T Consensus 97 ~~~i~~~~~gg~L~~~~~~----~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~ 169 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKC----QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR 169 (348)
T ss_dssp CCEEEEECCSEEHHHHHTT----CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----
T ss_pred eEEEEEeecCCchhhhccc----ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhc
Confidence 4677788889999999843 46999999999999999999999998 9999999999999999999999999998
Q ss_pred eeC
Q 006347 632 IFG 634 (649)
Q Consensus 632 ~~~ 634 (649)
...
T Consensus 170 ~~~ 172 (348)
T d2gfsa1 170 HTD 172 (348)
T ss_dssp CCT
T ss_pred ccC
Confidence 764
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.91 E-value=4.2e-25 Score=232.27 Aligned_cols=146 Identities=27% Similarity=0.399 Sum_probs=121.0
Q ss_pred cCcccceeeccCCcEEEEEEEec-CCcEEEEEEecccc--cccHHHHHHHHHHHhcCCCCCccceEEEEEe------CCe
Q 006347 481 NNFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKAS--GQGLEEFMNEVMVISKLQHRNLVRLLGCCVE------GEE 551 (649)
Q Consensus 481 ~~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~--~~~~~~f~~E~~~l~~l~H~niv~l~g~~~~------~~~ 551 (649)
++|++.++||+|+||+||+|... +|+.||||++.... ....+++.+|+.++++++|||||++++++.. ...
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~ 96 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD 96 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred CCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence 57999999999999999999976 69999999997532 3345678999999999999999999999964 367
Q ss_pred EEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEEecCCce
Q 006347 552 KMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKISDFGMAK 631 (649)
Q Consensus 552 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~ 631 (649)
.++||||+.++.+. .+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+|++|||+++
T Consensus 97 ~~iv~Ey~~~~l~~-~~~-----~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 97 VYLVMELMDANLCQ-VIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEECCSEEHHH-HHT-----SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred eEEEEeccchHHHH-hhh-----cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhh
Confidence 89999999765554 442 34789999999999999999999998 9999999999999999999999999999
Q ss_pred eeCC
Q 006347 632 IFGG 635 (649)
Q Consensus 632 ~~~~ 635 (649)
....
T Consensus 168 ~~~~ 171 (355)
T d2b1pa1 168 TAGT 171 (355)
T ss_dssp ----
T ss_pred cccc
Confidence 7654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.85 E-value=8.9e-22 Score=187.95 Aligned_cols=135 Identities=19% Similarity=0.216 Sum_probs=106.7
Q ss_pred ccceeeccCCcEEEEEEEecCCcEEEEEEeccccc------------------ccHHHHHHHHHHHhcCCCCCccceEEE
Q 006347 484 QLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASG------------------QGLEEFMNEVMVISKLQHRNLVRLLGC 545 (649)
Q Consensus 484 ~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~------------------~~~~~f~~E~~~l~~l~H~niv~l~g~ 545 (649)
.+.++||+|+||+||+|+..+|++||||.++.... .....+..|...+.+++|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence 45689999999999999998899999998653110 012334568889999999999998865
Q ss_pred EEeCCeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCceEecCCCCCcEEEcCCCceEEE
Q 006347 546 CVEGEEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDSRLRIIHRDLKASNILLDEELNPKIS 625 (649)
Q Consensus 546 ~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iiHrDlkp~NILl~~~~~~Ki~ 625 (649)
. ..+++|||+++..+.++ +......++.|++++|.|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~l----------~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYRV----------RVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGGC----------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred c----CCEEEEEeeccccccch----------hhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCC-CEEEE
Confidence 2 23799999988665332 23334578999999999999988 9999999999999965 58999
Q ss_pred ecCCceeeCCC
Q 006347 626 DFGMAKIFGGN 636 (649)
Q Consensus 626 DFGla~~~~~~ 636 (649)
|||+|+....+
T Consensus 145 DFG~a~~~~~~ 155 (191)
T d1zara2 145 DFPQSVEVGEE 155 (191)
T ss_dssp CCTTCEETTST
T ss_pred ECCCcccCCCC
Confidence 99999987543
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.84 E-value=6.2e-21 Score=165.26 Aligned_cols=112 Identities=17% Similarity=0.422 Sum_probs=93.1
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
+|+|.+||.|..|++|+| |.|+|.|+.+++ |.++. ..++||.||++.|.. ++.|+|+.||+|+|+|.
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~~dGnLvl~~~ 67 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQNDGNLVIYSG 67 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEECTTSCEEEEET
T ss_pred CCEecCCCEecCCCEEEE--CCEEEEEcCCCC-----EEEEc----CCcEEEEccCccCCC--CcEEEEeccccEEEEec
Confidence 489999999999999985 999999998876 33443 368999999998754 46899999999999997
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcc
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTD 150 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTD 150 (649)
+.++|++++.. .....+|+|+|+|||||++. ++.++|||+.+|++
T Consensus 68 -~~~~w~s~t~~-~~~~~~l~L~ddGNlvly~~-~~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 68 -SRAIWASNTNR-QNGNYYLILQRDRNVVIYDN-SNNAIWATHTNVGN 112 (112)
T ss_dssp -TEEEEECCCCC-SCCCCEEEECTTSCEEEECT-TSCEEEECCCCCCC
T ss_pred -CCeEEEEeecc-CCCceEEEEcCCCCEEEECC-CCcEEecCCCccCC
Confidence 56788877652 33456899999999999985 56789999999975
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.83 E-value=7.3e-21 Score=199.80 Aligned_cols=150 Identities=21% Similarity=0.295 Sum_probs=119.7
Q ss_pred CcccceeeccCCcEEEEEEEec-CCcEEEEEEecccccccHHHHHHHHHHHhcCC-----------CCCccceEEEEEeC
Q 006347 482 NFQLSSKLGQGGFGPVYWGRLK-DGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-----------HRNLVRLLGCCVEG 549 (649)
Q Consensus 482 ~f~~~~~LG~G~fG~Vykg~~~-~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-----------H~niv~l~g~~~~~ 549 (649)
+|++.++||+|+||+||+|+.. +|+.||||++++.. ...+.+.+|+.++++++ |+||+++++++...
T Consensus 14 rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~ 92 (362)
T d1q8ya_ 14 RYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK 92 (362)
T ss_dssp TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred cEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccc-cchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence 5899999999999999999975 79999999997542 34567788999888875 57899999988653
Q ss_pred --CeEEEEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCc-----
Q 006347 550 --EEKMLIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELN----- 621 (649)
Q Consensus 550 --~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~----- 621 (649)
...+++|+++..+..............+++..+..++.||++||+|||+ .+ |+||||||+|||++.++.
T Consensus 93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~~ 169 (362)
T d1q8ya_ 93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENLI 169 (362)
T ss_dssp ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTEE
T ss_pred cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcccccc
Confidence 4566777776655443333222345678899999999999999999998 55 999999999999986653
Q ss_pred -eEEEecCCceeeCC
Q 006347 622 -PKISDFGMAKIFGG 635 (649)
Q Consensus 622 -~Ki~DFGla~~~~~ 635 (649)
+|++|||.|+....
T Consensus 170 ~~kl~dfg~s~~~~~ 184 (362)
T d1q8ya_ 170 QIKIADLGNACWYDE 184 (362)
T ss_dssp EEEECCCTTCEETTB
T ss_pred eeeEeeccccccccc
Confidence 89999999997643
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.83 E-value=2.1e-20 Score=160.58 Aligned_cols=107 Identities=18% Similarity=0.337 Sum_probs=90.1
Q ss_pred ccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCC
Q 006347 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ 103 (649)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~ 103 (649)
|+|.+||.|.+|++|.+ |.|.|+|..+++ | +.|. ..++||+||++.|+. ..+.|.|+.||+|+|+|++
T Consensus 2 ~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----L-vl~~---~~~~vW~ant~~~~~-~~~~l~l~~dGnLvl~~~~ 69 (109)
T d1kj1a_ 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----L-VLYD---HSTSVWASNTGILGK-KGCKAVLQSDGNFVVYDAE 69 (109)
T ss_dssp CEEETTCEEETTCEEEE--TTEEEEECTTSC-----E-EEEE---TTEEEEECCCCCTTC-CCCEEEECTTSCEEEECSS
T ss_pred CCccCCCEEeCCCEEEe--CCEEEEecCCCe-----E-EEEe---CCEEEEEeCCCCCCc-eeEEEEEcCCceEEEEeCC
Confidence 78999999999999975 889999988775 2 3343 358999999999986 4578999999999999999
Q ss_pred ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCC
Q 006347 104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE 147 (649)
Q Consensus 104 ~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~ 147 (649)
|.++|+|+++ .+....+|+|+|+|||||+++ .+|||+-|
T Consensus 70 g~~vW~s~t~-~~~~~~~l~L~ddGNlvly~~----~~W~S~t~ 108 (109)
T d1kj1a_ 70 GRSLWASHSV-RGNGNYVLVLQEDGNVVIYGS----DIWSTGTY 108 (109)
T ss_dssp SCEEEECCCC-CCSSCCEEEECTTSCEEEECC----EEEECCCC
T ss_pred CcEEEEEeeE-CCCCCEEEEEeCCCcEEEECC----CEecCCCc
Confidence 9999999986 334456799999999999963 59999865
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.82 E-value=1.8e-20 Score=160.87 Aligned_cols=107 Identities=20% Similarity=0.315 Sum_probs=90.1
Q ss_pred cccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcC
Q 006347 23 DSSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNG 102 (649)
Q Consensus 23 ~~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~ 102 (649)
.|+|.+||.|.+|+.|. +|.|.|.|+.+|+ |.|+. ..++||.||++.|. +.+.|.++.+|+|+|+++
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~~~Gnlvl~~~ 67 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQTDGNLVVYNP 67 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEECTTSCEEEECT
T ss_pred CCCccCCCEecCCCEEE--cCCEEEEECCCCe-----EEEEe----CCceeeEeCCCCCC--CccEEEEeccceEEEECC
Confidence 37899999999999996 5999999998886 34554 25889999999874 356899999999999999
Q ss_pred CceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCC
Q 006347 103 QKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQE 147 (649)
Q Consensus 103 ~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~ 147 (649)
+|.++|++++. ......+|+|+|+|||||++. ++||||+|
T Consensus 68 ~g~~vWsS~t~-~~~~~~~l~L~ddGNlVly~~----~~W~S~t~ 107 (108)
T d1jpca_ 68 SNKPIWASNTG-GQNGNYVCILQKDRNVVIYGT----DRWATGTH 107 (108)
T ss_dssp TCCEEEECCCC-CSCSCEEEEECTTSCEEEEEC----CCCCCCCC
T ss_pred CccceEEcccc-CCCCcEEEEEcCCCCEEEeCC----CcccCCCC
Confidence 99999999876 333455789999999999963 49999987
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.70 E-value=7.9e-18 Score=146.67 Aligned_cols=109 Identities=22% Similarity=0.336 Sum_probs=88.2
Q ss_pred EEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCce
Q 006347 61 GIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAI 140 (649)
Q Consensus 61 gIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~ 140 (649)
.|||.++++++.+|++|++.|+.....+|.|+.||||+|++. +.++|++++.. ......|+|+|+|||||++. ++++
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q~DGNLvL~~~-~~~vW~s~t~~-~~~~~~~~l~~~GnLvl~d~-~~~~ 87 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSMETDCNLVLFDR-DDRVWSTNTAG-KGTGCRAVLQPNGRMDVLTN-QNIA 87 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEETTTEEEEEBT-TBCCSCCCCCS-SCSSCEEEEETTTEEEEEET-TTEE
T ss_pred eEEEcCCCCCCcccEEcCCCeeEcCCEEEEEcCCCcEEEecC-CcEEEEEcccc-CCCcEEEEEeCCeeEEEEcC-CCCE
Confidence 599999999999999999999987667899999999999987 67899998863 23456899999999999986 5789
Q ss_pred EeeecCCCcccccCCCcccccccCCceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeee
Q 006347 141 VWESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWR 207 (649)
Q Consensus 141 ~WqSFD~PTDTlLpg~~l~~~~~~g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~ 207 (649)
+|||+. +.++|.|.+.++++|+..+ |. .++|.
T Consensus 88 lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvl--Y~--~~~W~ 119 (120)
T d1dlpa2 88 VWTSGN-------------------------------SRSAGRYVFVLQPDRNLAI--YG--GALWT 119 (120)
T ss_dssp EEECCC-------------------------------CCSSSCCEEEECSSSCEEE--EC--CCCCB
T ss_pred EEEeCC-------------------------------CCCCCcEEEEECCCCcEEE--eC--CCccc
Confidence 999973 2356788999999998554 42 35665
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.64 E-value=7.7e-17 Score=138.87 Aligned_cols=111 Identities=25% Similarity=0.352 Sum_probs=92.0
Q ss_pred EEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceE
Q 006347 62 IWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIV 141 (649)
Q Consensus 62 Iw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~ 141 (649)
|||.-.++.+..|+.+.+.++.+...+|.|+.||||+|+++ +.++|++++.+ ..++.|.|+|+|||||++. ++++|
T Consensus 3 ~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q~DGNLvL~~~-~~~vW~s~t~~--~~~~~l~l~~dGNLvl~d~-~~~~v 78 (115)
T d1dlpa1 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDS-DVRVWASNTAG--ATGCRAVLQSDGLLVILTA-QNTIR 78 (115)
T ss_dssp CCBCSSSSSCSCSCCCTTCEECSTTEEEEECTTSCEEEEES-SSEEECCCCCS--CSCCBCCBCSSSCBCCBCT-TTCCS
T ss_pred EEEecCCCCCCcceecCCCcEEcCCEEEEECCCCeEEEEcC-CeeEEEcccCC--CCceEEEEeccCCEEEEcc-CCCEE
Confidence 77877777788899999999987778999999999999985 67899998863 3468899999999999985 56789
Q ss_pred eeecCCCcccccCCCcccccccCCceeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCC
Q 006347 142 WESFQEPTDSFLPGMHHGIDQRTGKKVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPW 211 (649)
Q Consensus 142 WqSFD~PTDTlLpg~~l~~~~~~g~~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~ 211 (649)
|||+. +.+.|.|.|.|+++|+.. +| +.++|.+|+-
T Consensus 79 WsS~t-------------------------------~~~~g~y~l~Lq~DGNlv--lY--~~~~Wssgt~ 113 (115)
T d1dlpa1 79 WSSGT-------------------------------KGSIGNYVLVLQPDRTVT--IY--GPGLWDSGTS 113 (115)
T ss_dssp CCCCC-------------------------------CCCSSCCEEEECSSSCEE--EE--CSEEEECSCC
T ss_pred EEcCC-------------------------------CCCCCCEEEEECCCCcEE--Ee--CCCeecCCCC
Confidence 99863 346889999999999854 44 3579999863
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.59 E-value=4e-15 Score=128.88 Aligned_cols=103 Identities=17% Similarity=0.324 Sum_probs=80.7
Q ss_pred ccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCC
Q 006347 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ 103 (649)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~ 103 (649)
.+|.++|+| ...+..|.|.|.|..+|+ -+.|.. .++||.||+..|.. .+.|.|+.||+|+|.|++
T Consensus 15 ~~l~~~q~l----~~~~~~~~y~l~mQ~DGN------LVLy~~---~~~vWssnt~~~~~--~~~l~l~~dGnLvL~d~~ 79 (119)
T d1b2pa_ 15 QILHATESL----EILFGTHVYRFIMQTDCN------LVLYDN---NNPIWATNTGGLGN--GCRAVLQPDGVLVVITNE 79 (119)
T ss_dssp CEEETTCEE----EEEETTEEEEEEECTTSC------EEEEET---TEEEEECCCTTSCS--SCEEEECTTSCEEEECTT
T ss_pred CEEeCCCeE----EEecCCceEEEEECCCCc------EEEEEC---CeEEEEecCCCCCc--ceEEEEEeCCCEEEECCC
Confidence 445555554 246679999999999886 234543 67899999987653 478999999999999999
Q ss_pred ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecC
Q 006347 104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQ 146 (649)
Q Consensus 104 ~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD 146 (649)
|.+||++++.. .....+|+|+|+|||||++ .++|||-.
T Consensus 80 g~~vWsS~t~~-~~~~~~l~Lq~DGNlvlYg----~~~W~S~T 117 (119)
T d1b2pa_ 80 NVTVWQSPVAG-KAGHYVLVLQPDRNVVIYG----DALWATQT 117 (119)
T ss_dssp CCEEEECSCCC-CSSCEEEEECTTSCEEEEE----SEEEECCC
T ss_pred CcEEEECCCcC-CCCceEEEEcCCCCEEEEC----CCEeccCC
Confidence 99999998863 3345579999999999995 36999964
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.32 E-value=8.2e-13 Score=113.26 Aligned_cols=100 Identities=17% Similarity=0.357 Sum_probs=76.5
Q ss_pred CCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCCceEE
Q 006347 28 SSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQKEVL 107 (649)
Q Consensus 28 ~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~~~~~ 107 (649)
..|.|.+++.| .+|.|.|.|..+|+ |.++ . ...+||.+|...+ ..+.+.|..||||+|+|.++.+|
T Consensus 13 ~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~-~---~~~~vW~s~t~~~---~~~~l~l~~dGNLvl~d~~~~~v 78 (115)
T d1dlpa1 13 HPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLF-D---SDVRVWASNTAGA---TGCRAVLQSDGLLVILTAQNTIR 78 (115)
T ss_dssp SCSCCCTTCEE--CSTTEEEEECTTSC-----EEEE-E---SSSEEECCCCCSC---SCCBCCBCSSSCBCCBCTTTCCS
T ss_pred CcceecCCCcE--EcCCEEEEECCCCe-----EEEE-c---CCeeEEEcccCCC---CceEEEEeccCCEEEEccCCCEE
Confidence 34556666666 35889999998876 3343 3 2578999997542 34789999999999999999999
Q ss_pred EEecCcccccccccceeecccCeEEeeCCCCceEeeecC
Q 006347 108 WSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQ 146 (649)
Q Consensus 108 Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD 146 (649)
|++.+.. ..+..+++|+++|||||++ .++|+|-.
T Consensus 79 WsS~t~~-~~g~y~l~Lq~DGNlvlY~----~~~Wssgt 112 (115)
T d1dlpa1 79 WSSGTKG-SIGNYVLVLQPDRTVTIYG----PGLWDSGT 112 (115)
T ss_dssp CCCCCCC-CSSCCEEEECSSSCEEEEC----SEEEECSC
T ss_pred EEcCCCC-CCCCEEEEECCCCcEEEeC----CCeecCCC
Confidence 9998863 3345679999999999995 36999853
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.10 E-value=1.7e-10 Score=99.29 Aligned_cols=85 Identities=25% Similarity=0.425 Sum_probs=66.2
Q ss_pred eEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCce
Q 006347 88 IITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGKK 167 (649)
Q Consensus 88 ~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~~ 167 (649)
+|.+..||||||+++ +.++|++++.+ ......+.|.++|||||++. .+.+||+|.-
T Consensus 33 ~l~mQ~DGNLVLy~~-~~~vWssnt~~-~~~~~~l~l~~dGnLvL~d~-~g~~vWsS~t--------------------- 88 (119)
T d1b2pa_ 33 RFIMQTDCNLVLYDN-NNPIWATNTGG-LGNGCRAVLQPDGVLVVITN-ENVTVWQSPV--------------------- 88 (119)
T ss_dssp EEEECTTSCEEEEET-TEEEEECCCTT-SCSSCEEEECTTSCEEEECT-TCCEEEECSC---------------------
T ss_pred EEEECCCCcEEEEEC-CeEEEEecCCC-CCcceEEEEEeCCCEEEECC-CCcEEEECCC---------------------
Confidence 688999999999986 67899999873 23457899999999999985 5678998631
Q ss_pred eEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 168 VQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 168 ~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
.-+.|.|.+.|+.+|+..+ +. .+.|.|++
T Consensus 89 ----------~~~~~~~~l~Lq~DGNlvl--Yg--~~~W~S~T 117 (119)
T d1b2pa_ 89 ----------AGKAGHYVLVLQPDRNVVI--YG--DALWATQT 117 (119)
T ss_dssp ----------CCCSSCEEEEECTTSCEEE--EE--SEEEECCC
T ss_pred ----------cCCCCceEEEEcCCCCEEE--EC--CCEeccCC
Confidence 1135678899999998555 42 47899876
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.09 E-value=1.1e-10 Score=100.77 Aligned_cols=97 Identities=16% Similarity=0.378 Sum_probs=70.6
Q ss_pred ccccCCCCcCCCCeEEeCCCeeeEeeeCCCCCCceEEEEEEecCCCCcEEEEecCCCCCCCCcceEEEeeCCcEEEEcCC
Q 006347 24 SSITSSQLIRDPDAILSNGSNFKLGFFNPADSPYRYMGIWYDMPSEKAVIWVANRDNPLKDSSGIITISEDGNLVLVNGQ 103 (649)
Q Consensus 24 ~~l~~g~~l~~~~~l~S~~g~F~lGF~~~~~~~~~~lgIw~~~~~~~~~vW~Anr~~pv~~~~~~l~~~~~G~L~l~~~~ 103 (649)
++|.++++|.. |.|.|.|...|+ |.| |. ...+||.++... .+..+.+.|..+|||+|+|.+
T Consensus 24 ~~l~~~q~l~~--------g~y~L~~q~DGN-----LvL-~~---~~~~vW~s~t~~--~~~~~~~~l~~~GnLvl~d~~ 84 (120)
T d1dlpa2 24 QTLHATQSLQL--------SPYRLSMETDCN-----LVL-FD---RDDRVWSTNTAG--KGTGCRAVLQPNGRMDVLTNQ 84 (120)
T ss_dssp CEECSSCCCBC--------SSCEEEEETTTE-----EEE-EB---TTBCCSCCCCCS--SCSSCEEEEETTTEEEEEETT
T ss_pred cEEcCCCeeEc--------CCEEEEEcCCCc-----EEE-ec---CCcEEEEEcccc--CCCcEEEEEeCCeeEEEEcCC
Confidence 35555555543 668888876664 233 32 246789988543 334578999999999999999
Q ss_pred ceEEEEecCcccccccccceeecccCeEEeeCCCCceEeee
Q 006347 104 KEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWES 144 (649)
Q Consensus 104 ~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqS 144 (649)
+.++|+|++.. ......+.|+++|||||++ .++|.|
T Consensus 85 ~~~lW~S~t~~-~~~~~~l~Lq~DGnlvlY~----~~~W~t 120 (120)
T d1dlpa2 85 NIAVWTSGNSR-SAGRYVFVLQPDRNLAIYG----GALWTT 120 (120)
T ss_dssp TEEEEECCCCC-SSSCCEEEECSSSCEEEEC----CCCCBC
T ss_pred CCEEEEeCCCC-CCCcEEEEECCCCcEEEeC----CCcccC
Confidence 99999999863 2345578999999999995 258976
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.07 E-value=3.5e-10 Score=95.84 Aligned_cols=88 Identities=27% Similarity=0.445 Sum_probs=67.6
Q ss_pred ceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCc
Q 006347 87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK 166 (649)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~ 166 (649)
-.|.|..||||+|+.. +.+||++++......+..+.|.++|||||++. +++++|+|=
T Consensus 21 ~~l~~q~dgnLvl~~~-~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~-~g~~vW~s~--------------------- 77 (109)
T d1kj1a_ 21 YHFIMQEDCNLVLYDH-STSVWASNTGILGKKGCKAVLQSDGNFVVYDA-EGRSLWASH--------------------- 77 (109)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCCCTTCCCCEEEECTTSCEEEECS-SSCEEEECC---------------------
T ss_pred EEEEecCCCeEEEEeC-CEEEEEeCCCCCCceeEEEEEcCCceEEEEeC-CCcEEEEEe---------------------
Confidence 5689999999999875 68999999874444467799999999999985 578899871
Q ss_pred eeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCCC
Q 006347 167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGPW 211 (649)
Q Consensus 167 ~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~~ 211 (649)
+....|.|.+.|+++|+..+ +. .+.|.|+++
T Consensus 78 ----------t~~~~~~~~l~L~ddGNlvl--y~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 ----------SVRGNGNYVLVLQEDGNVVI--YG--SDIWSTGTY 108 (109)
T ss_dssp ----------CCCCSSCCEEEECTTSCEEE--EC--CEEEECCCC
T ss_pred ----------eECCCCCEEEEEeCCCcEEE--EC--CCEecCCCc
Confidence 11135678899999998544 43 468988764
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.00 E-value=5.8e-10 Score=94.36 Aligned_cols=86 Identities=24% Similarity=0.451 Sum_probs=65.1
Q ss_pred ceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCc
Q 006347 87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK 166 (649)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~ 166 (649)
-+|.++.||||+|++. +.+||++++.+. .....++|+++|||||++. ++.+||+|=
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~~-~~~~~l~l~~~Gnlvl~~~-~g~~vWsS~--------------------- 76 (108)
T d1jpca_ 21 FVFIMQEDCNLVLYDV-DKPIWATNTGGL-SRSCFLSMQTDGNLVVYNP-SNKPIWASN--------------------- 76 (108)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTTS-CSSCEEEECTTSCEEEECT-TCCEEEECC---------------------
T ss_pred EEEEECCCCeEEEEeC-CceeeEeCCCCC-CCccEEEEeccceEEEECC-CccceEEcc---------------------
Confidence 5799999999999985 689999998732 3356799999999999985 578899861
Q ss_pred eeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcCCeeeeecCC
Q 006347 167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNVSRPYWRSGP 210 (649)
Q Consensus 167 ~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~~~~yw~sg~ 210 (649)
+....+.|.+.|+.+|+..+ +. .+.|.|+.
T Consensus 77 ----------t~~~~~~~~l~L~ddGNlVl--y~--~~~W~S~t 106 (108)
T d1jpca_ 77 ----------TGGQNGNYVCILQKDRNVVI--YG--TDRWATGT 106 (108)
T ss_dssp ----------CCCSCSCEEEEECTTSCEEE--EE--CCCCCCCC
T ss_pred ----------ccCCCCcEEEEEcCCCCEEE--eC--CCcccCCC
Confidence 11235678888999998554 43 35787764
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.79 E-value=1.5e-08 Score=86.17 Aligned_cols=87 Identities=20% Similarity=0.424 Sum_probs=65.1
Q ss_pred ceEEEeeCCcEEEEcCCceEEEEecCcccccccccceeecccCeEEeeCCCCceEeeecCCCcccccCCCcccccccCCc
Q 006347 87 GIITISEDGNLVLVNGQKEVLWSSNVSNLVNNSTSAQLLDSGNLVLRDNINRAIVWESFQEPTDSFLPGMHHGIDQRTGK 166 (649)
Q Consensus 87 ~~l~~~~~G~L~l~~~~~~~~Wss~~~~~~~~~~~a~LldsGNlVl~~~~~~~~~WqSFD~PTDTlLpg~~l~~~~~~g~ 166 (649)
-.|.|+.||||+|++. +.+||++++.. ...++.+.|..+|||||++. +.++|.|
T Consensus 21 ~~l~~q~DGNLvly~~-~~~vW~s~~~~-~~~~~~l~l~~dGnLvl~~~--~~~~w~s---------------------- 74 (112)
T d1xd5a_ 21 YLFIIQNDCNLVLYDN-NRAVWASGTNG-KASGCVLKMQNDGNLVIYSG--SRAIWAS---------------------- 74 (112)
T ss_dssp EEEEECTTSCEEEEET-TEEEEECCCTT-SCSSEEEEECTTSCEEEEET--TEEEEEC----------------------
T ss_pred EEEEEcCCCCEEEEcC-CcEEEEccCcc-CCCCcEEEEeccccEEEEec--CCeEEEE----------------------
Confidence 5799999999999975 68999998763 23457899999999999984 4567765
Q ss_pred eeEEEEcccCCCCCCceeEEeeeCCCccEEEEEcC-CeeeeecCC
Q 006347 167 KVQLTSWKSLSDPSTGSFSAGLIHQNIPEIFVWNV-SRPYWRSGP 210 (649)
Q Consensus 167 ~~~L~S~~s~~dps~G~f~l~~~~~~~~~~~~~~~-~~~yw~sg~ 210 (649)
...-..|.|.+.++.+|+.. +++. +.+.|.|++
T Consensus 75 ---------~t~~~~~~~~l~L~ddGNlv--ly~~~~~~~W~S~t 108 (112)
T d1xd5a_ 75 ---------NTNRQNGNYYLILQRDRNVV--IYDNSNNAIWATHT 108 (112)
T ss_dssp ---------CCCCSCCCCEEEECTTSCEE--EECTTSCEEEECCC
T ss_pred ---------eeccCCCceEEEEcCCCCEE--EECCCCcEEecCCC
Confidence 11123466889999999854 4443 567899875
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.59 E-value=2.2e-07 Score=90.78 Aligned_cols=149 Identities=15% Similarity=0.064 Sum_probs=105.3
Q ss_pred HHHHHhcCcccceeeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEE
Q 006347 475 ELATATNNFQLSSKLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKM 553 (649)
Q Consensus 475 ~l~~~~~~f~~~~~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~ 553 (649)
++...-..|+..+..+-++...||+.... ++.+.||+...........+.+|...+..+. +--+.+++.+..+++..+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~~-~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVGE-NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEECS-SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHhhhceEEEEcCCCCCCCcEEEEEeC-CCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceE
Confidence 45555566765544443445689988754 5667888876554445556788888887774 555788999988899999
Q ss_pred EEEecCCCCChhhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 006347 554 LIYEYMPNRSLDALLFDPLKKERLDWRKRFNIIEGISRGLLYLHRDS--------------------------------- 600 (649)
Q Consensus 554 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 600 (649)
+|||++++..+.+..... .. ...++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEeccccccccccccc-----cc---HHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcc
Confidence 999999998886654211 11 2235566666677777421
Q ss_pred -----------------------CCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 601 -----------------------RLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 601 -----------------------~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
...++|+|+.|.|||++++..+-|+||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred cccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence 11279999999999999887778999999876
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.08 E-value=7.9e-06 Score=78.81 Aligned_cols=131 Identities=18% Similarity=0.173 Sum_probs=89.3
Q ss_pred eeccCCc-EEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCC--CCCccceEEEEEeCCeEEEEEecCCCCCh
Q 006347 488 KLGQGGF-GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQ--HRNLVRLLGCCVEGEEKMLIYEYMPNRSL 564 (649)
Q Consensus 488 ~LG~G~f-G~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~--H~niv~l~g~~~~~~~~~lV~Ey~~~gsL 564 (649)
.+..|.. ..||+....++..+.+|.-... ....+..|...++.+. ...+.+++++..+++..++|||++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~---~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSG---ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSC---TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EcCCcccCCeEEEEEeCCCCEEEEEeCCcc---CHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 4555553 6799999888888888976433 2345677887777663 34577889988888899999999998766
Q ss_pred hhhhcCCCCCCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------------
Q 006347 565 DALLFDPLKKERLDWRKRFNIIEGISRGLLYLHR---------------------------------------------- 598 (649)
Q Consensus 565 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~---------------------------------------------- 598 (649)
.+.. ... ..++.++++.|+-||+
T Consensus 94 ~~~~--------~~~---~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAP---AEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCH---HHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred cccc--------ccH---HHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHH
Confidence 3321 110 1122233333333332
Q ss_pred -----C----CCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 599 -----D----SRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 599 -----~----~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
. ..+.++|+|+.|.|||++++..+-|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 1 112379999999999999887788999999876
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.49 E-value=0.00022 Score=73.36 Aligned_cols=76 Identities=12% Similarity=0.177 Sum_probs=49.8
Q ss_pred ceeeccCCcEEEEEEEecC-CcEEEEEEeccc-------ccccHHHHHHHHHHHhcC-CC--CCccceEEEEEeCCeEEE
Q 006347 486 SSKLGQGGFGPVYWGRLKD-GQEIAVKRLSKA-------SGQGLEEFMNEVMVISKL-QH--RNLVRLLGCCVEGEEKML 554 (649)
Q Consensus 486 ~~~LG~G~fG~Vykg~~~~-g~~vAVK~l~~~-------~~~~~~~f~~E~~~l~~l-~H--~niv~l~g~~~~~~~~~l 554 (649)
.+.||.|..-.||+....+ ++.++||.-... -+....+...|.+.+..+ .+ ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 3579999999999998764 678999964321 011233456688777766 23 346666654 5666789
Q ss_pred EEecCCCCC
Q 006347 555 IYEYMPNRS 563 (649)
Q Consensus 555 V~Ey~~~gs 563 (649)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEeccCCcc
Confidence 999997654
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.74 E-value=0.0036 Score=62.05 Aligned_cols=135 Identities=15% Similarity=0.189 Sum_probs=79.0
Q ss_pred EEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCCc--cceE-----EEEEeCCeEEEEEecCCCCChhh-
Q 006347 495 GPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRNL--VRLL-----GCCVEGEEKMLIYEYMPNRSLDA- 566 (649)
Q Consensus 495 G~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~ni--v~l~-----g~~~~~~~~~lV~Ey~~~gsL~~- 566 (649)
-.||+.+..+|+.+++|..+.. ....+++..|...+..|...++ +..+ .........+.++++++|..+..
T Consensus 36 N~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~ 114 (325)
T d1zyla1 36 NRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEAD 114 (325)
T ss_dssp SEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSS
T ss_pred ceeEEEEcCCCCEEEEEEeCCC-CCCHHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCC
Confidence 4799999999999999987542 3456778889888877742222 1111 12234566789999998644311
Q ss_pred ----h------h---c----C--CCCCCCCCHHH-------------------HHHHHHHHHHHHHHHHh----CCCCce
Q 006347 567 ----L------L---F----D--PLKKERLDWRK-------------------RFNIIEGISRGLLYLHR----DSRLRI 604 (649)
Q Consensus 567 ----~------l---~----~--~~~~~~l~~~~-------------------~~~i~~~ia~gL~yLH~----~~~~~i 604 (649)
+ + + . ......+++.. +-.+...+.+.++.+.. ..+..+
T Consensus 115 ~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~l 194 (325)
T d1zyla1 115 NIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLR 194 (325)
T ss_dssp CHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEE
T ss_pred CHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCcee
Confidence 1 0 0 0 01111222111 11122222233333322 234468
Q ss_pred EecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 605 IHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 605 iHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
||+|+.+.|||++++ ..++||+-+..
T Consensus 195 iHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 195 LHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred ecCCCCcccEEEeCC--ceEEechhccc
Confidence 999999999999754 45899998875
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.19 E-value=0.006 Score=62.18 Aligned_cols=72 Identities=18% Similarity=0.275 Sum_probs=48.3
Q ss_pred eeeccCCcEEEEEEEecCC--------cEEEEEEecccccccHHHHHHHHHHHhcCC-CCCccceEEEEEeCCeEEEEEe
Q 006347 487 SKLGQGGFGPVYWGRLKDG--------QEIAVKRLSKASGQGLEEFMNEVMVISKLQ-HRNLVRLLGCCVEGEEKMLIYE 557 (649)
Q Consensus 487 ~~LG~G~fG~Vykg~~~~g--------~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~-H~niv~l~g~~~~~~~~~lV~E 557 (649)
+.|+.|-.=.+|+....++ ..|.++..- . ........+|..+++.+. |.-..++++++.+ .+|+|
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~-~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e 121 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-N-PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE 121 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-S-CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred EEcCCccccceEEEEeCCCCccccCCCCcEEEEecC-C-cchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence 5788788889999987543 446555543 2 223345567888888884 4334578887642 68999
Q ss_pred cCCCCCh
Q 006347 558 YMPNRSL 564 (649)
Q Consensus 558 y~~~gsL 564 (649)
|+++..|
T Consensus 122 fi~g~~l 128 (395)
T d1nw1a_ 122 YIPSRPL 128 (395)
T ss_dssp CCCEEEC
T ss_pred EeccccC
Confidence 9987555
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.67 E-value=0.46 Score=45.59 Aligned_cols=159 Identities=12% Similarity=0.028 Sum_probs=82.2
Q ss_pred CCHHHHHHHhcCcccce-----eeccCCcEEEEEEEecCCcEEEEEEecccccccHHHHHHHHHHHhcCCCCC--ccceE
Q 006347 471 FQFEELATATNNFQLSS-----KLGQGGFGPVYWGRLKDGQEIAVKRLSKASGQGLEEFMNEVMVISKLQHRN--LVRLL 543 (649)
Q Consensus 471 ~~~~~l~~~~~~f~~~~-----~LG~G~fG~Vykg~~~~g~~vAVK~l~~~~~~~~~~f~~E~~~l~~l~H~n--iv~l~ 543 (649)
.+.++++....+|.+.+ .|..|---+.|+.+..+|+ +++|+.+... ..++...|+.++..+.+.+ +...+
T Consensus 3 ls~~el~~~l~~Y~lg~~~~~~~i~~G~~N~ny~v~t~~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi 79 (316)
T d2ppqa1 3 ITEDELRNFLTQYDVGSLTSYKGIAEGVENSNFLLHTTKDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPL 79 (316)
T ss_dssp CCHHHHHHHHTTBCCCCEEEEEEECC---EEEEEEEESSCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBC
T ss_pred CCHHHHHHHHHhCCCCCceEeecCCCCcccCeEEEEECCCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccc
Confidence 34566777777776643 3445666788998877654 7888875431 2344555666666663222 11111
Q ss_pred E------EEEeCCeEEEEEecCCCCChhhhh--------------c------CCCC-CCCCCH-----------------
Q 006347 544 G------CCVEGEEKMLIYEYMPNRSLDALL--------------F------DPLK-KERLDW----------------- 579 (649)
Q Consensus 544 g------~~~~~~~~~lV~Ey~~~gsL~~~l--------------~------~~~~-~~~l~~----------------- 579 (649)
. +.........++.++++......- + .... .....+
T Consensus 80 ~~~~g~~~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (316)
T d2ppqa1 80 PRKDGELLGELSGRPAALISFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVE 159 (316)
T ss_dssp CBTTCCSCEEETTEEEEEEECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTS
T ss_pred eecCCCcceeeecccceeeeecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcc
Confidence 1 122344566777777654332110 0 0000 000000
Q ss_pred HHHHHHHHHHHHHHHHHHh-CCCCceEecCCCCCcEEEcCCCceEEEecCCcee
Q 006347 580 RKRFNIIEGISRGLLYLHR-DSRLRIIHRDLKASNILLDEELNPKISDFGMAKI 632 (649)
Q Consensus 580 ~~~~~i~~~ia~gL~yLH~-~~~~~iiHrDlkp~NILl~~~~~~Ki~DFGla~~ 632 (649)
......+..+...+.-.+. .-+.++||+|+.+.||+++.+...-|.||+.+..
T Consensus 160 ~~~~~~l~~~~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 160 KGLREEIRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp TTHHHHHHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred hhHHHHHHHHHHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 0111111122222222221 1233599999999999999988889999998864
|
| >d1emoa2 g.3.11.1 (A:2167-2205) Fibrillin-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Fibrillin-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=91.25 E-value=0.034 Score=34.42 Aligned_cols=31 Identities=45% Similarity=0.977 Sum_probs=25.0
Q ss_pred cCCccccccCCcccccCC-CCCcccCCCCCccC
Q 006347 272 TECDVYGKCGAFGICNSQ-EKPICSCLEGFEPK 303 (649)
Q Consensus 272 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~ 303 (649)
|.|.+-..||. |.|+.- ..-.|.|-.||+|.
T Consensus 2 dECsignpCGn-GTCtNviGgFec~C~~GFepg 33 (39)
T d1emoa2 2 DECSVGNPCGN-GTCKNVIGGFECTCEEGFEPG 33 (39)
T ss_dssp CGGGTTCSSSS-SCEEECSSSEEECCSSSSCCC
T ss_pred CccccCCccCC-ceeeecccceEEeecCCcCCC
Confidence 68999999985 889753 34469999999976
|
| >d2vj3a1 g.3.11.1 (A:411-452) Neurogenic locus notch homolog protein 1, Notch1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Neurogenic locus notch homolog protein 1, Notch1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.32 E-value=0.13 Score=33.81 Aligned_cols=30 Identities=30% Similarity=0.755 Sum_probs=23.8
Q ss_pred cCCcc-ccccCCcccccCCC-CCcccCCCCCc
Q 006347 272 TECDV-YGKCGAFGICNSQE-KPICSCLEGFE 301 (649)
Q Consensus 272 ~~C~~-~~~CG~~g~C~~~~-~~~C~C~~gf~ 301 (649)
|+|.. ...|..+|.|.... .-.|.|++||+
T Consensus 4 deC~~~~~pC~n~g~C~n~~g~y~C~C~~G~~ 35 (42)
T d2vj3a1 4 DECSLGANPCEHAGKCINTLGSFECQCLQGYT 35 (42)
T ss_dssp CTTTSSSCSSSTTCEEEECSSSEEEECCTTEE
T ss_pred ccccCCCCCCCCCcEeECCCCCEEeECCCCCc
Confidence 66875 57899999997543 45799999997
|
| >d2qj2a1 g.10.1.1 (A:36-126) Hepatocyte growth factor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Hairpin loop containing domain-like superfamily: Hairpin loop containing domain-like family: Hairpin loop containing domain domain: Hepatocyte growth factor species: Human (Homo sapiens) [TaxId: 9606]
Probab=84.04 E-value=0.26 Score=38.28 Aligned_cols=51 Identities=25% Similarity=0.548 Sum_probs=33.7
Q ss_pred CCeeeeccccCCCCcc-----ccCCCChhHHHHHhhcc----CCeEEEEecCCc-eEEEee
Q 006347 338 DGFSKLNKMKVPDFTE-----WTSPATEDECREQCLKN----CSCIAYAFDGGI-GCMVWR 388 (649)
Q Consensus 338 ~~f~~~~~~~~p~~~~-----~~~~~~~~~C~~~Cl~n----CsC~a~~~~~g~-gC~~w~ 388 (649)
+.|.+..++.+..... .....+.++|.++|+++ =.|.+|.|.... .|.+-.
T Consensus 5 ~dy~kt~~~~L~~~~~~~~~~~~~~~s~eeCA~rC~~~~~~~f~CrSF~y~~~~~~C~Ls~ 65 (91)
T d2qj2a1 5 HEFKKSAKTTLIKIDPALKIKTKKVNTADQCANRCTRNKGLPFTCKAFVFDKARKQCLWFP 65 (91)
T ss_dssp GGEEEETTEEEEECSTTCCCEEEECSCHHHHHHHHHTTTTCSSCCCEEEEETTTTEEEEES
T ss_pred HhhhhcCCceEeccCccccccccccCCHHHHHHHHHccCCCCceEEeEEEECCCCeEEEcc
Confidence 5666666665533221 22345899999999984 469999997444 487743
|
| >d1xkba1 g.3.11.1 (A:48-86) Factor X, N-terminal module {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Small proteins fold: Knottins (small inhibitors, toxins, lectins) superfamily: EGF/Laminin family: EGF-type module domain: Factor X, N-terminal module species: Human (Homo sapiens) [TaxId: 9606]
Probab=81.46 E-value=0.31 Score=31.34 Aligned_cols=31 Identities=39% Similarity=0.917 Sum_probs=22.8
Q ss_pred cCCccccccCCcccccCC-CCCcccCCCCCccC
Q 006347 272 TECDVYGKCGAFGICNSQ-EKPICSCLEGFEPK 303 (649)
Q Consensus 272 ~~C~~~~~CG~~g~C~~~-~~~~C~C~~gf~~~ 303 (649)
|+|. ...|...|.|... ..-.|.|++||+-.
T Consensus 1 D~C~-~~PC~ngg~C~~~~~~y~C~C~~G~~G~ 32 (39)
T d1xkba1 1 DQCE-TSPCQNQGKCKDGLGEYTCTCLEGFEGK 32 (39)
T ss_dssp CTTT-TCCCCSSCEECCCSSSCCEECCTTEETT
T ss_pred CcCC-CCCCCCCcEEECCCCCEEEECCCCCCcC
Confidence 4565 4778889999754 35679999999743
|